data_2maf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2maf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.348 0.118 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.413 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . . . . . . 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.252 1.025 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.498 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 124' ' ' ASP . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' HH21 ' A' ' 66' ' ' ARG . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.621 ' CG ' ' HZ2' ' A' ' 130' ' ' LYS 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.621 ' HZ2' ' CG ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.664 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.664 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' CG ' ' HZ2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.423 ' HZ2' ' CG ' ' A' ' 129' ' ' ASP . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.434 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.421 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.421 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.575 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.575 ' CG ' ' HZ3' ' A' ' 130' ' ' LYS . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 . . . . . 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.444 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.591 0.234 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HG ' ' CG ' ' A' ' 70' ' ' ASP . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' CG ' ' HG ' ' A' ' 57' ' ' SER . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--O 1.239 0.503 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.529 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.529 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.553 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 . . . . . 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.418 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.553 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.404 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.436 HG13 HD22 ' A' ' 216' ' ' ASN . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.539 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.436 HD22 HG13 ' A' ' 194' ' ' VAL . 31.2 m-80 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.384 0.612 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.539 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.637 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.637 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.881 0.848 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.238 0.458 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 235' ' ' ARG . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.4 ' HE ' ' CG ' ' A' ' 209' ' ' ASP . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.265 0.555 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 124' ' ' ASP . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.403 ' CG ' HH12 ' A' ' 66' ' ' ARG . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.481 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.55 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 122.454 1.121 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.55 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp . . . . . 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.432 -1.35 0 CA-C-O 122.359 1.076 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.445 0.64 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.4 ' HG1' ' HB3' ' A' ' 206' ' ' LEU . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.528 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.4 ' HB3' ' HG1' ' A' ' 203' ' ' THR . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.532 -0.271 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.528 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.409 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.318 1.056 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.579 ' CG ' ' HG1' ' A' ' 207' ' ' THR . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.579 ' HG1' ' CG ' ' A' ' 201' ' ' ASP . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.506 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.506 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.524 0.202 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 . . . . . 0 CA--C 1.514 -0.442 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.307 26.0 mt . . . . . 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 121.803 0.811 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 235' ' ' ARG . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 . . . . . 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.477 ' HE ' ' CG ' ' A' ' 209' ' ' ASP . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.481 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.481 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.409 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 237' ' ' ARG . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.584 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.584 ' HZ3' ' CG ' ' A' ' 129' ' ' ASP . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.409 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 . . . . . 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.415 HH12 ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--O 1.238 0.472 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.78 0.8 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.578 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.578 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 119.306 -0.378 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 121.613 0.72 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.215 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp . . . . . 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.534 ' HZ1' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 132' ' ' LYS . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.596 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.596 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 . . . . . 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.744 0.307 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.703 0.763 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 . . . . . 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.235 0.541 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.671 0 CA-C-O 118.694 -1.059 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -159.03 156.54 29.48 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp -120.61 149.6 42.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.23 39.73 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 119.582 -1.949 . . . . 0.0 109.285 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.38 123.05 28.22 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.224 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.26 109.73 21.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.704 -1.248 . . . . 0.0 111.278 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -84.95 140.13 31.31 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.173 169.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.85 -28.71 65.89 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 65.72 41.91 3.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.464 -1.398 . . . . 0.0 114.555 168.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.2 pt -110.46 7.11 8.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 O-C-N 120.444 -1.41 . . . . 0.0 112.944 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -116.13 23.22 12.34 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.699 -1.251 . . . . 0.0 111.823 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.17 157.1 39.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.736 -1.228 . . . . 0.0 109.131 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.545 ' CG ' ' HZ2' ' A' ' 34' ' ' LYS . 1.1 m-20 -58.15 136.88 57.32 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.706 0.803 . . . . 0.0 112.964 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.85 137.12 12.73 Favored Pre-proline 0 C--N 1.351 0.638 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.84 -16.69 18.27 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.522 2.815 . . . . 0.0 112.347 -165.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.4 139.42 91.98 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.07 19.24 0.6 Allowed 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 123.604 2.869 . . . . 0.0 114.394 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 p -60.21 -40.22 89.33 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.642 1.577 . . . . 0.0 113.382 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.77 157.4 54.99 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.957 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.87 140.09 23.98 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 124.932 3.755 . . . . 0.0 116.775 169.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.75 -45.85 87.98 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HZ2' ' CG ' ' A' ' 25' ' ' ASP . 55.9 mttp -156.47 166.21 34.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.643 -1.285 . . . . 0.0 109.019 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 68.08 47.72 1.02 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 169.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.51 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 57.9 mtpt -74.97 71.64 2.08 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -146.94 134.87 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.9 m 67.71 42.0 2.11 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-O 123.108 1.432 . . . . 0.0 112.946 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -149.47 172.72 14.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.708 2.403 . . . . 0.0 105.332 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.38 135.38 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.261 81.1 p -65.05 143.05 58.19 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 119.867 -1.771 . . . . 0.0 114.548 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 33.1 m-20 -52.02 158.22 1.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.233 2.213 . . . . 0.0 116.224 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -87.95 158.08 18.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.039 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -118.19 136.72 53.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -171.28 -8.69 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -90.45 96.94 10.9 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 119.876 -1.765 . . . . 0.0 109.957 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.2 pt -112.41 17.06 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.189 1.396 . . . . 0.0 108.096 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 74.57 10.46 4.11 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.62 1.968 . . . . 0.0 114.631 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 p -77.43 -18.08 57.54 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -120.14 9.65 11.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 m -123.53 -6.68 8.1 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 122.775 0.43 . . . . 0.0 111.559 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.47 -5.68 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 121.082 -1.012 . . . . 0.0 112.631 -167.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -100.19 115.04 65.87 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.154 0.982 . . . . 0.0 110.458 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.4 145.4 0.95 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 125.103 3.869 . . . . 0.0 118.814 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -82.16 144.56 30.65 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.536 -0.728 . . . . 0.0 110.751 168.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.413 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . 76.9 146.48 0.09 Allowed 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.89 85.18 0.12 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.617 1.967 . . . . 0.0 110.979 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -130.28 161.46 31.18 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.071 1.749 . . . . 0.0 111.454 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 61.4 179.9 0.11 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -95.82 -54.12 3.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 108.366 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -118.54 164.18 15.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.717 2.007 . . . . 0.0 110.151 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -111.6 -39.28 4.66 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.269 1.427 . . . . 0.0 111.637 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -64.05 145.0 56.66 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -114.49 11.23 17.08 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.992 0.901 . . . . 0.0 109.651 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -139.9 126.49 20.4 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -113.55 5.73 16.73 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 120.833 -1.167 . . . . 0.0 110.112 -167.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 p -58.92 -35.71 73.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 -159.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.04 8.65 9.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.77 -1.206 . . . . 0.0 111.734 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 78.66 25.93 0.52 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.308 1.443 . . . . 0.0 112.305 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.37 -40.39 87.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.83 -29.15 14.87 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 123.188 1.471 . . . . 0.0 111.294 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -144.49 133.75 23.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.18 155.16 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -70.94 143.69 50.82 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 119.66 -1.9 . . . . 0.0 113.083 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.1 tt -76.96 -25.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.361 -1.462 . . . . 0.0 112.63 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -158.64 151.71 22.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.089 -1.632 . . . . 0.0 106.743 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -66.72 143.81 56.72 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.705 -1.247 . . . . 0.0 110.967 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.13 150.45 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.134 2.173 . . . . 0.0 115.345 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -137.38 129.03 28.57 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 -166.44 54.36 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 118.625 0.648 . . . . 0.0 113.029 -172.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.37 144.75 17.08 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-O 122.99 1.376 . . . . 0.0 110.362 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -72.95 129.28 37.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -102.79 -22.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.887 -1.133 . . . . 0.0 110.661 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -116.01 157.25 24.91 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 49.34 52.57 14.22 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -77.85 -14.21 59.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -96.32 117.24 30.43 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 50.41 -110.64 0.46 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -134.63 138.18 44.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.804 2.441 . . . . 0.0 107.255 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -75.99 161.76 28.65 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.323 -0.861 . . . . 0.0 111.895 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.28 81.8 mt-10 70.34 56.07 0.28 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -171.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -76.28 121.34 22.81 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.393 -1.442 . . . . 0.0 113.453 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.9 -175.44 27.34 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 123.11 1.395 . . . . 0.0 116.019 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -117.92 106.28 12.8 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.553 -1.557 . . . . 0.0 108.119 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.7 132.88 48.04 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.073 -1.642 . . . . 0.0 108.697 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 83.83 6.53 0.68 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.541 1.936 . . . . 0.0 114.927 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.02 20.46 8.95 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.977 -1.702 . . . . 0.0 112.026 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.56 -32.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.038 1.335 . . . . 0.0 112.871 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.79 129.1 37.23 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.804 -1.81 . . . . 0.0 111.063 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 t -163.02 -6.79 0.03 OUTLIER 'General case' 0 C--N 1.348 0.514 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.841 -153.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt -138.25 159.52 41.84 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.343 -1.473 . . . . 0.0 108.527 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.41 176.12 19.28 Favored Glycine 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -141.12 133.87 28.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.41 -29.69 32.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 124.33 1.052 . . . . 0.0 112.554 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.293 38.9 mmt180 71.19 17.64 5.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.308 1.443 . . . . 0.0 114.043 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -155.19 97.49 1.92 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.734 2.413 . . . . 0.0 105.365 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.286 15.1 m 72.62 46.38 0.29 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.522 3.529 . . . . 0.0 113.179 -0.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -132.87 149.19 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.041 1.336 . . . . 0.0 108.823 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -38.43 83.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.595 2.358 . . . . 0.0 111.738 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 m -60.44 130.54 47.09 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.556 1.646 . . . . 0.0 114.543 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.46 149.01 39.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.005 1.322 . . . . 0.0 113.047 168.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -52.81 139.19 27.54 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -60.94 137.23 58.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.483 -0.761 . . . . 0.0 112.307 167.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.9 p -68.22 -42.76 79.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.2 pt -84.18 127.39 39.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 120.19 -1.569 . . . . 0.0 112.244 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' CD ' ' HG ' ' A' ' 184' ' ' SER . 12.2 pt-20 -153.7 10.87 0.42 Allowed 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.245 -1.535 . . . . 0.0 114.165 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.69 121.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 123.752 0.821 . . . . 0.0 108.807 167.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 53.5 m -142.15 125.57 16.64 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.551 -167.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.3 p -122.14 143.59 49.45 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.76 155.41 79.43 Favored Pre-proline 0 C--O 1.235 0.324 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -55.6 144.38 75.06 Favored 'Trans proline' 0 CA--C 1.51 -0.68 0 C-N-CA 123.041 2.494 . . . . 0.0 113.828 167.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -146.76 143.78 28.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -95.33 2.7 54.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.84 92.73 Favored Pre-proline 0 C--N 1.347 0.462 0 O-C-N 121.322 -0.861 . . . . 0.0 113.021 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -44.51 138.78 7.48 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 125.121 3.881 . . . . 0.0 116.448 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.59 54.33 2.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -58.84 -33.83 75.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 120.699 -1.25 . . . . 0.0 115.574 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 9.76 40.4 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.544 -0.974 . . . . 0.0 112.188 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.3 2.9 t 59.73 46.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 123.578 1.656 . . . . 0.0 113.968 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.1 p -93.31 1.91 56.79 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 119.036 -2.29 . . . . 0.0 112.767 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.329 5.7 m 48.96 62.92 2.34 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.635 2.374 . . . . 0.0 115.411 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 62.26 36.41 14.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 126.372 1.869 . . . . 0.0 115.071 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -142.88 163.85 31.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.8 p -81.27 147.41 29.94 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.486 -2.009 . . . . 0.0 113.545 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.64 146.12 86.39 Favored Pre-proline 0 C--N 1.36 1.059 0 O-C-N 120.873 -1.142 . . . . 0.0 112.056 168.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -52.23 -24.29 20.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.153 3.236 . . . . 0.0 116.931 167.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -120.68 -40.07 2.69 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 120.126 1.33 . . . . 0.0 110.013 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.0 m -82.09 76.25 8.98 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 119.572 -1.955 . . . . 0.0 110.164 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -148.14 43.69 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.432 1.111 . . . . 0.0 111.014 -170.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -52.32 -38.28 58.1 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -74.3 -16.08 60.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.314 1.046 . . . . 0.0 112.879 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.69 -18.2 10.34 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.894 -1.129 . . . . 0.0 113.631 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -59.83 139.62 57.19 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.41 ' HG ' ' CD ' ' A' ' 156' ' ' GLU . 8.6 t -65.34 -41.25 94.1 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.186 -1.571 . . . . 0.0 114.658 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -120.57 142.1 49.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . 0.257 66.6 m 61.3 37.31 17.21 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 tt -63.6 147.31 12.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.266 1.826 . . . . 0.0 110.901 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -85.24 122.19 29.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.173 -1.579 . . . . 0.0 111.127 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -130.82 -25.66 2.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.344 -0.848 . . . . 0.0 111.378 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p -81.38 127.83 39.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 124.386 1.074 . . . . 0.0 111.654 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.498 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -155.22 162.85 40.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.52 -85.96 1.07 Allowed Glycine 0 C--N 1.346 1.103 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.7 128.82 55.27 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.6 -0.941 . . . . 0.0 110.296 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.91 137.95 52.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.39 145.08 45.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.29 0.95 . . . . 0.0 110.169 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -175.24 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.961 1.304 . . . . 0.0 112.181 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.318 4.3 m 70.37 49.58 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.004 2.121 . . . . 0.0 112.988 -167.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.295 93.0 mtt180 64.55 41.42 5.49 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.201 2.2 . . . . 0.0 116.834 167.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -83.47 109.99 17.82 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.24 -1.538 . . . . 0.0 112.31 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -108.08 11.23 27.82 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 123.133 1.444 . . . . 0.0 109.131 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.2 p -62.61 136.7 58.02 Favored 'General case' 0 C--N 1.347 0.468 0 O-C-N 119.618 -1.926 . . . . 0.0 112.975 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 99.69 0.06 0.02 OUTLIER 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.972 2.109 . . . . 0.0 111.513 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -60.23 -44.9 94.82 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 123.122 1.439 . . . . 0.0 111.314 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -142.12 160.48 40.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 158.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.115 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -161.03 157.77 26.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 164.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.5 133.38 55.81 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.87 -94.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 120.952 -1.092 . . . . 0.0 110.661 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -64.05 125.3 24.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 -14.52 35.42 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-O 122.462 1.125 . . . . 0.0 111.464 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -161.1 155.23 22.74 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 166.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -116.18 63.27 0.71 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 123.369 1.557 . . . . 0.0 111.002 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -154.02 166.12 34.01 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.71 -12.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.815 0.846 . . . . 0.0 112.662 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 t -157.46 -179.85 8.57 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.558 -1.338 . . . . 0.0 108.65 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -93.94 132.05 38.78 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.455 1.902 . . . . 0.0 113.629 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.07 137.91 34.46 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.6 1.16 . . . . 0.0 112.668 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -60.16 145.05 86.3 Favored Pre-proline 0 C--N 1.347 0.496 0 C-N-CA 126.246 1.818 . . . . 0.0 114.231 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -26.01 22.27 Favored 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.794 2.33 . . . . 0.0 112.925 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.34 157.01 79.2 Favored Pre-proline 0 N--CA 1.443 -0.794 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -39.34 135.11 1.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 124.48 3.453 . . . . 0.0 118.117 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -89.87 -1.89 58.08 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.758 -1.214 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.98 130.84 8.39 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -53.99 128.25 28.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.312 2.675 . . . . 0.0 113.837 166.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -137.14 164.16 29.11 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -157.96 16.75 0.24 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.313 1.054 . . . . 0.0 110.134 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.03 155.83 50.09 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -107.42 110.08 21.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.54 16.97 3.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 122.27 1.033 . . . . 0.0 109.467 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 t -150.88 149.46 29.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.874 -1.141 . . . . 0.0 108.397 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -64.46 -45.72 86.23 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.845 1.658 . . . . 0.0 115.165 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 m -47.48 176.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 131.512 3.925 . . . . 0.0 117.905 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -59.73 143.65 50.29 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 119.062 -2.274 . . . . 0.0 116.516 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 59.09 171.11 0.07 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.681 1.992 . . . . 0.0 114.759 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -64.03 -43.42 95.63 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.926 1.69 . . . . 0.0 112.306 171.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -134.86 123.42 23.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -60.08 143.9 50.91 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 120.409 -1.432 . . . . 0.0 114.815 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -153.11 152.83 31.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.857 -1.152 . . . . 0.0 108.623 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 mt 69.69 106.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 128.524 2.73 . . . . 0.0 112.24 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -30.3 131.32 0.08 Allowed 'General case' 0 C--N 1.359 1.013 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -59.72 145.95 43.18 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.122 1.369 . . . . 0.0 113.067 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -160.48 162.21 33.05 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 119.924 -1.735 . . . . 0.0 109.918 -163.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t 94.42 37.83 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.477 1.911 . . . . 0.0 110.932 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.05 138.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.612 1.565 . . . . 0.0 112.416 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' CE1' ' HA ' ' A' ' 74' ' ' TYR . 37.5 m170 -100.0 125.21 40.85 Favored Pre-proline 0 C--N 1.348 0.518 0 O-C-N 119.97 -1.706 . . . . 0.0 108.021 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -50.43 132.56 35.25 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.344 2.696 . . . . 0.0 115.457 164.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.98 124.63 24.27 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' CG ' HH11 ' A' ' 66' ' ' ARG . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 124' ' ' ASP . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.44 27.97 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.3 mmt-85 -127.08 23.7 6.48 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 125.115 1.366 . . . . 0.0 109.934 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 60.6 t80 -63.87 135.8 56.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.424 1.49 . . . . 0.0 111.814 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -96.03 -25.29 15.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 118.483 -2.635 . . . . 0.0 111.041 -5.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -145.18 48.29 1.29 Allowed 'General case' 0 C--N 1.353 0.733 0 CA-C-O 122.558 1.171 . . . . 0.0 108.033 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 74.01 40.85 0.43 Allowed 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.303 1.525 . . . . 0.0 110.24 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -78.65 149.92 32.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.52 -1.362 . . . . 0.0 112.729 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.4 m120 63.83 42.07 6.35 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -128.72 131.68 47.92 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 120.181 -1.574 . . . . 0.0 107.789 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.32 139.49 58.53 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 110.419 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -128.95 160.96 31.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -87.31 119.11 27.23 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.049 -1.657 . . . . 0.0 109.374 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.8 1.11 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.636 1.208 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -104.46 16.66 25.67 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.758 -1.214 . . . . 0.0 111.344 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.29 -12.06 8.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 165.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 90' ' ' ARG 0.304 52.8 mt-10 38.57 46.47 0.99 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 128.563 2.745 . . . . 0.0 117.063 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.39 -29.66 64.27 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.313 1.845 . . . . 0.0 113.451 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.08 -14.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 126.888 2.075 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 87' ' ' GLU . 77.8 mtt-85 -82.87 -13.06 56.84 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 120.606 -1.309 . . . . 0.0 113.248 168.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.3 mm -104.24 -36.58 4.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.579 -1.326 . . . . 0.0 110.457 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.18 131.59 16.63 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 120.672 -1.268 . . . . 0.0 107.79 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -101.27 -77.37 0.54 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.316 0.579 . . . . 0.0 111.517 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 94' ' ' GLU . 14.1 mp0 -61.56 -46.06 91.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 127.991 2.516 . . . . 0.0 110.16 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.87 32.04 4.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.631 2.772 . . . . 0.0 108.926 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.96 3.08 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 113.61 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 pt -89.78 10.26 2.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 O-C-N 119.98 -1.894 . . . . 0.0 112.484 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 15.53 75.31 0.01 OUTLIER 'General case' 0 C--N 1.353 0.736 0 C-N-CA 131.087 3.755 . . . . 0.0 118.254 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.6 pt -89.42 -2.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 O-C-N 119.915 -1.741 . . . . 0.0 112.623 -160.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.265 33.7 t0 60.3 -142.96 0.53 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.452 1.501 . . . . 0.0 112.618 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 80.02 15.19 0.84 Allowed 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 119.526 -1.984 . . . . 0.0 113.061 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.2 pttm -56.59 -41.9 77.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.415 1.486 . . . . 0.0 113.741 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 92.7 m 113.6 115.85 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 129.182 2.993 . . . . 0.0 105.621 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.66 64.08 6.21 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.806 1.289 . . . . 0.0 111.038 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.96 -46.83 78.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.04 2.136 . . . . 0.0 114.999 -166.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -77.54 -16.66 58.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 119.834 -1.791 . . . . 0.0 115.237 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.81 -46.92 88.63 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -111.23 20.79 17.01 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.079 -1.013 . . . . 0.0 109.862 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.53 23.34 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 117.528 1.771 . . . . 0.0 117.528 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -134.16 160.58 37.37 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 120.815 -1.403 . . . . 0.0 111.074 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.88 20.34 9.23 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.017 -1.677 . . . . 0.0 109.341 169.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -136.98 128.64 28.75 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 127.458 2.303 . . . . 0.0 109.233 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.58 145.84 38.03 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.006 -1.684 . . . . 0.0 115.213 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -72.44 -24.19 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 119.551 -1.968 . . . . 0.0 113.422 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 t -65.76 145.27 56.2 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.0 t -150.05 144.66 25.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.94 133.39 54.39 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' HH21 ' A' ' 66' ' ' ARG . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.621 ' CG ' ' HZ2' ' A' ' 130' ' ' LYS 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.621 ' HZ2' ' CG ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.82 -169.09 39.76 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.97 129.06 51.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 120.647 -1.502 . . . . 0.0 110.6 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.25 160.32 32.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.029 1.332 . . . . 0.0 110.539 -166.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -102.88 111.23 23.46 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.105 -0.997 . . . . 0.0 113.096 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -65.46 155.22 36.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.467 1.107 . . . . 0.0 112.495 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -88.58 -16.62 32.08 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 120.575 -1.328 . . . . 0.0 113.875 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.3 -15.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.199 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -105.39 163.06 12.91 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 122.154 2.252 . . . . 0.0 106.898 159.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -120.68 135.26 55.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.453 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.46 -37.56 75.71 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.729 2.012 . . . . 0.0 114.639 -167.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 51.47 50.39 18.96 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HZ1' ' CG ' ' A' ' 175' ' ' ASP . 8.2 ptpp? -96.29 -3.94 43.09 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.448 -1.407 . . . . 0.0 111.726 -166.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.401 HG21 ' H ' ' A' ' 157' ' ' VAL . 9.4 t -159.98 159.04 31.69 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 6.3 pt -100.66 -6.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.064 0.945 . . . . 0.0 110.195 171.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -63.68 -43.77 95.69 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 125.757 1.623 . . . . 0.0 113.713 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.401 ' H ' HG21 ' A' ' 154' ' ' THR . 61.6 t -130.2 112.37 23.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 O-C-N 119.884 -1.76 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -95.3 104.46 16.35 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 120.676 -1.265 . . . . 0.0 108.516 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.2 m -59.28 117.75 5.15 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.88 157.2 69.41 Favored Pre-proline 0 C--O 1.248 1.025 0 O-C-N 120.948 -1.095 . . . . 0.0 112.472 171.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.84 132.96 2.67 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 124.233 3.289 . . . . 0.0 116.326 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.5 t -61.52 -39.28 90.46 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.979 1.312 . . . . 0.0 114.332 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.11 14.94 18.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.487 -1.383 . . . . 0.0 114.13 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -94.45 138.56 22.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 O-C-N 121.064 -1.023 . . . . 0.0 111.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.96 135.88 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 124.019 3.146 . . . . 0.0 115.633 157.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -131.48 142.5 49.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.52 -10.59 47.05 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 123.969 0.795 . . . . 0.0 112.773 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.15 25.15 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.406 -1.055 . . . . 0.0 111.369 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.17 -43.74 96.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 C-N-CA 125.5 1.52 . . . . 0.0 112.051 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 99.6 m -106.29 124.4 49.54 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -155.99 170.01 23.12 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.87 140.52 48.9 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -91.71 101.92 14.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 119.281 -2.137 . . . . 0.0 107.927 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.1 t -79.81 -18.46 50.86 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 118.929 -2.357 . . . . 0.0 110.97 172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.483 ' CG ' ' HZ1' ' A' ' 153' ' ' LYS . 33.4 m-20 -126.58 156.18 73.6 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -36.7 142.57 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.349 1 C-N-CA 125.363 4.042 . . . . 0.0 117.889 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.42 -42.8 99.72 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.15 149.05 45.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.149 2.179 . . . . 0.0 115.944 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -127.69 139.13 52.89 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.011 -1.681 . . . . 0.0 107.737 165.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . 0.254 68.4 m-20 81.28 26.1 0.22 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.437 1.095 . . . . 0.0 112.126 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.459 ' CG ' HE21 ' A' ' 183' ' ' GLN . 19.3 t0 -117.57 136.49 53.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.76 2.024 . . . . 0.0 108.333 -175.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -112.86 7.64 18.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.749 0.82 . . . . 0.0 111.692 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.459 HE21 ' CG ' ' A' ' 181' ' ' ASP 0.293 6.1 mp0 55.03 54.08 9.41 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -177.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.9 m -51.34 126.61 17.46 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.685 -1.259 . . . . 0.0 114.187 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.266 51.3 m-80 79.04 16.39 0.98 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.362 1.465 . . . . 0.0 113.345 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.5 t -130.18 160.21 34.5 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.221 -1.55 . . . . 0.0 109.208 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.1 pt -94.87 1.66 9.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 123.091 1.424 . . . . 0.0 111.591 -163.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -64.59 -45.66 86.01 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -63.0 -35.0 78.75 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p 178.51 129.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 107.298 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.664 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -24.94 115.29 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 73.64 8.92 77.81 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 116.132 1.213 . . . . 0.0 116.132 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.38 113.75 22.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 43.2 tp -162.71 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 -159.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 221' ' ' GLU . 0.5 OUTLIER -64.94 147.64 53.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.598 1.959 . . . . 0.0 114.062 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 69.94 42.17 1.06 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.986 1.315 . . . . 0.0 112.557 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m 59.13 55.25 4.46 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 123.406 1.574 . . . . 0.0 112.124 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -80.75 99.23 8.13 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 119.479 -2.013 . . . . 0.0 114.383 -163.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.7 145.11 53.37 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 113.961 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . 0.256 26.4 mmtp 69.79 40.24 1.36 Allowed 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.232 1.813 . . . . 0.0 113.161 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.5 p -102.91 -4.25 25.04 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.414 1.485 . . . . 0.0 109.984 168.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -157.9 165.07 36.15 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 120.468 -1.395 . . . . 0.0 108.727 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.2 132.86 15.84 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.772 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.6 132.28 55.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.664 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.526 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -164.68 166.21 20.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 160.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -142.38 161.76 37.22 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.65 135.59 39.93 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.608 0.763 . . . . 0.0 109.187 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -145.04 132.2 20.45 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -172.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.09 156.87 46.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.519 3.528 . . . . 0.0 104.996 -7.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -141.13 119.76 12.46 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 121.917 0.865 . . . . 0.0 111.676 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -117.58 136.61 53.16 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.94 134.39 51.9 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.35 -38.45 69.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 p -96.65 8.4 44.31 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 119.898 -1.751 . . . . 0.0 111.756 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 t60 62.11 28.95 17.45 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.921 1.689 . . . . 0.0 113.428 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -72.8 142.32 48.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.537 1.535 . . . . 0.0 111.561 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.5 106.41 57.85 Favored Pre-proline 0 C--N 1.355 0.828 0 O-C-N 120.822 -1.174 . . . . 0.0 111.427 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.85 -30.24 7.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.268 1.979 . . . . 0.0 113.497 -170.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -139.83 126.07 12.1 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.39 1.476 . . . . 0.0 107.265 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.91 135.93 43.06 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.093 2.529 . . . . 0.0 115.751 -166.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 p -61.64 -44.29 97.25 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 127.748 2.419 . . . . 0.0 116.292 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.0 87.27 Favored Pre-proline 0 C--N 1.343 0.324 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.61 -44.27 26.26 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 124.406 3.404 . . . . 0.0 117.19 160.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -61.36 -46.14 91.45 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -59.8 -35.07 73.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -92.48 16.51 11.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.872 1.269 . . . . 0.0 111.664 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.266 40.6 ttpt 85.03 96.77 0.03 OUTLIER 'General case' 0 C--O 1.244 0.773 0 C-N-CA 128.19 2.596 . . . . 0.0 112.288 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.82 -35.13 45.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 127.191 2.196 . . . . 0.0 114.936 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.3 p -57.43 -31.64 66.1 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 120.678 -1.264 . . . . 0.0 114.37 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m -58.37 -41.33 84.51 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 126.26 1.824 . . . . 0.0 114.325 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.58 -8.73 9.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.497 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.2 m -125.33 48.02 2.1 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.005 -1.059 . . . . 0.0 108.143 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -63.2 -38.85 92.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.457 1.903 . . . . 0.0 112.778 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -56.83 136.83 55.55 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.297 1.439 . . . . 0.0 113.645 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -119.65 116.96 27.06 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.32 -9.81 1.27 Allowed 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.822 -0.548 . . . . 0.0 111.197 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -159.05 156.23 28.87 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.59 133.09 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.696 0.76 . . . . 0.0 112.093 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -151.46 158.98 44.37 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -165.08 -1.96 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.806 1.639 . . . . 0.0 115.189 -168.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.322 19.8 tpt180 54.71 61.72 2.86 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.962 2.905 . . . . 0.0 114.112 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -159.01 163.13 36.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.134 -1.603 . . . . 0.0 107.497 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.11 5.56 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 O-C-N 120.525 -1.359 . . . . 0.0 108.875 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 56.87 66.12 3.4 Favored Pre-proline 0 C--N 1.349 0.587 0 C-N-CA 126.333 1.853 . . . . 0.0 114.868 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -40.33 140.48 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.206 1.937 . . . . 0.0 115.328 147.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -126.97 155.57 42.93 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.06 43.7 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -117.34 -0.91 11.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -144.5 160.14 41.6 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 176.46 1.0 0.0 OUTLIER 'General case' 0 C--N 1.358 0.968 0 CA-C-N 119.763 1.165 . . . . 0.0 112.933 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -158.35 152.47 24.03 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 118.822 -2.424 . . . . 0.0 111.21 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -71.96 -10.32 59.61 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -125.73 118.35 25.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -97.47 -10.33 25.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -168.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.22 144.04 25.86 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.644 -1.285 . . . . 0.0 110.485 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -107.97 114.77 28.93 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.403 -1.436 . . . . 0.0 109.343 -168.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.47 165.86 26.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.24 1.416 . . . . 0.0 107.478 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -96.48 4.01 52.38 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.53 0.732 . . . . 0.0 112.726 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.91 150.27 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.989 0.916 . . . . 0.0 108.561 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.09 137.95 55.12 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.897 -1.127 . . . . 0.0 113.765 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -59.28 150.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 114.261 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.59 -45.08 81.57 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -73.95 -13.83 60.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.859 -1.151 . . . . 0.0 113.81 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.66 2.06 8.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 121.092 -1.005 . . . . 0.0 110.126 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -104.2 -3.64 24.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.373 -1.454 . . . . 0.0 111.368 -172.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.0 pt -110.33 153.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.615 -1.303 . . . . 0.0 110.037 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -77.53 104.52 8.11 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 119.696 -1.878 . . . . 0.0 110.973 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -128.99 157.22 42.31 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.037 0.935 . . . . 0.0 111.968 -168.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.85 149.36 49.03 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.726 1.21 . . . . 0.0 112.073 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -114.34 -8.01 12.89 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.346 -1.471 . . . . 0.0 112.426 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.44 -9.63 81.8 Favored Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.605 1.574 . . . . 0.0 115.069 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.9 pt -92.75 11.76 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.134 1.374 . . . . 0.0 113.26 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -65.45 154.26 39.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 pt -124.35 166.76 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.52 158.65 44.26 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.038 -1.664 . . . . 0.0 108.4 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 107' ' ' GLU . 99.2 mtt180 -83.47 152.86 24.75 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.265 1.426 . . . . 0.0 112.578 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -99.13 -10.64 22.26 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.335 -0.853 . . . . 0.0 111.166 167.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -162.32 154.97 19.62 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.07 61.57 6.96 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.505 -1.372 . . . . 0.0 113.755 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.44 135.85 1.42 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 73.2 -72.45 0.12 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.765 1.269 . . . . 0.0 111.696 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' CD ' HH12 ' A' ' 101' ' ' ARG . 67.9 mt-10 -60.92 -41.19 95.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.497 3.119 . . . . 0.0 116.269 -166.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -121.08 25.16 9.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.5 -17.46 13.53 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 124.256 0.931 . . . . 0.0 113.239 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -153.28 172.79 16.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.277 1.039 . . . . 0.0 108.483 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 47.23 -149.63 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.982 2.513 . . . . 0.0 114.481 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -90.59 22.1 3.65 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 120.165 -1.584 . . . . 0.0 111.298 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 41.64 -133.97 0.34 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 127.403 2.281 . . . . 0.0 115.402 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.51 11.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 124.957 1.303 . . . . 0.0 113.879 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.9 m -58.15 119.62 7.17 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m -62.29 -52.27 64.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.461 1.104 . . . . 0.0 113.602 -167.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -161.3 159.5 28.61 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' CG ' ' HZ2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.423 ' HZ2' ' CG ' ' A' ' 129' ' ' ASP . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.434 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -63.6 179.05 6.51 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -78.41 -28.9 46.91 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.659 -1.495 . . . . 0.0 113.055 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.47 160.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -87.35 -95.55 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.797 0.808 . . . . 0.0 111.553 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.63 170.01 23.11 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m 80.25 92.81 0.05 OUTLIER 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.141 1.776 . . . . 0.0 112.223 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.87 102.55 4.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.77 -5.72 24.54 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 122.801 1.286 . . . . 0.0 111.578 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 56.8 p -77.2 -14.95 59.69 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 120.452 -1.405 . . . . 0.0 114.171 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -153.5 161.03 42.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.656 -1.278 . . . . 0.0 108.956 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -125.51 17.42 8.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.982 1.313 . . . . 0.0 109.679 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -119.01 126.73 52.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 m 64.88 47.3 2.68 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.517 1.151 . . . . 0.0 112.147 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 tp -144.67 145.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.727 -1.233 . . . . 0.0 108.161 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -65.52 142.35 58.16 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.29 1.036 . . . . 0.0 113.215 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.8 -13.77 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 123.586 0.754 . . . . 0.0 111.905 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 23.6 m -91.32 113.26 25.48 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 120.564 -1.335 . . . . 0.0 112.573 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.4 m -92.15 125.33 36.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 163.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.64 142.85 87.35 Favored Pre-proline 0 C--N 1.348 0.522 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.31 154.62 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.197 3.264 . . . . 0.0 117.836 165.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -117.15 120.85 39.58 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 63.15 48.52 3.7 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.0 156.27 58.56 Favored Pre-proline 0 C--N 1.349 0.566 0 O-C-N 120.384 -1.447 . . . . 0.0 111.895 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.19 154.14 14.78 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 123.742 2.962 . . . . 0.0 117.225 165.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.21 -33.2 10.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.248 0.547 . . . . 0.0 109.835 170.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 -80.72 1.55 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 167.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.55 -5.35 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.72 111.66 36.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 O-C-N 119.604 -1.935 . . . . 0.0 112.612 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -57.9 128.72 38.49 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.9 m -100.34 106.47 18.09 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 121.065 -1.022 . . . . 0.0 110.001 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 64.88 98.0 0.04 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -74.58 -26.41 59.91 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.394 -1.441 . . . . 0.0 112.748 165.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 p -132.64 128.74 37.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.075 0.95 . . . . 0.0 109.443 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.14 132.54 92.44 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 128.813 2.845 . . . . 0.0 116.125 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -67.18 -20.5 49.62 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.011 2.474 . . . . 0.0 113.261 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -127.95 109.72 11.85 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 166.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.9 t -58.91 139.67 56.33 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 120.765 -1.209 . . . . 0.0 112.242 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 74.8 10.62 3.9 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 126.114 1.766 . . . . 0.0 113.881 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -129.59 127.08 39.94 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 161.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.2 p30 -104.69 -42.83 5.29 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 120.063 -1.648 . . . . 0.0 112.219 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 58.66 31.19 20.86 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 125.696 1.598 . . . . 0.0 112.022 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.14 -37.32 84.75 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -158.67 165.57 34.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -144.19 156.53 44.35 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.416 -0.803 . . . . 0.0 109.439 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.2 t -115.03 111.82 21.7 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 120.982 -1.073 . . . . 0.0 109.592 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.21 141.31 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 0.0 114.536 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -139.19 -10.34 1.27 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 59.76 38.31 21.65 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 171.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.0 118.99 45.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.421 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.43 -44.18 92.95 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.48 -176.57 22.8 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 58.5 -164.54 0.19 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -150.42 142.41 23.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -143.16 140.81 30.96 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -165.85 169.18 15.2 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 26.9 m -94.17 101.26 13.25 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.292 -1.505 . . . . 0.0 112.155 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 58.01 52.3 7.92 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 126.795 2.038 . . . . 0.0 115.501 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 67.31 41.16 2.55 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 113.108 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -64.79 128.56 36.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 119.854 -1.779 . . . . 0.0 113.473 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.77 138.54 47.64 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.492 1.517 . . . . 0.0 112.764 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -60.32 151.56 27.4 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.585 1.554 . . . . 0.0 114.377 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.94 161.44 19.77 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.96 142.98 42.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.421 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.081 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.04 147.02 40.71 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 118.93 1.365 . . . . 0.0 114.379 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt -102.84 -15.15 16.31 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.28 104.3 13.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.959 -1.713 . . . . 0.0 112.467 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.13 -24.06 13.98 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.255 -1.528 . . . . 0.0 111.134 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.75 106.18 18.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.932 0.872 . . . . 0.0 110.735 -173.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -125.07 14.48 8.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.011 1.324 . . . . 0.0 113.926 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.71 16.51 25.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.858 1.314 . . . . 0.0 110.713 -168.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -92.27 3.11 56.06 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.382 -2.073 . . . . 0.0 112.117 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -122.98 137.16 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -64.12 126.8 28.89 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.674 1.226 . . . . 0.0 110.959 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -63.17 148.92 46.64 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 120.416 -1.427 . . . . 0.0 112.182 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 -15.82 62.26 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-O 122.105 0.955 . . . . 0.0 112.611 -163.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -117.78 132.41 23.66 Favored Pre-proline 0 C--N 1.347 0.479 0 O-C-N 120.571 -1.331 . . . . 0.0 107.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.2 134.83 30.92 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.099 3.199 . . . . 0.0 114.933 170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' CD ' HH12 ' A' ' 75' ' ' ARG . 31.5 mt-10 -96.36 116.37 66.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -44.02 139.34 5.93 Favored 'Trans proline' 0 C--N 1.335 -0.158 0 C-N-CA 124.762 3.642 . . . . 0.0 118.111 165.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -156.56 162.31 39.92 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.87 147.66 19.39 Favored Pre-proline 0 N--CA 1.445 -0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 108.166 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -61.81 -178.01 0.28 Allowed 'Trans proline' 0 C--N 1.334 -0.228 0 C-N-CA 123.875 3.05 . . . . 0.0 113.652 153.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 61.82 32.91 17.98 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 165.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -84.72 13.95 5.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.242 -1.537 . . . . 0.0 114.478 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -112.35 7.78 19.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.642 1.577 . . . . 0.0 110.233 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.3 -41.44 2.41 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 120.887 -1.133 . . . . 0.0 110.388 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 pt -147.89 155.2 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -121.29 150.11 41.89 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.441 -1.412 . . . . 0.0 108.051 165.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -106.15 11.65 31.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.219 1.408 . . . . 0.0 110.286 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.1 152.72 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 m -61.38 -35.84 78.6 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 113.73 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.41 136.88 57.56 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 117.95 2.574 . . . . 0.0 117.95 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.87 155.6 47.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 61.54 46.56 7.27 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -115.7 16.66 16.39 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.453 -0.779 . . . . 0.0 110.321 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.6 m120 51.02 49.52 21.0 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.47 132.88 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 127.049 2.14 . . . . 0.0 114.77 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 82.13 10.29 0.74 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 127.217 2.207 . . . . 0.0 112.938 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.3 p -125.03 135.39 52.71 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 120.264 -1.522 . . . . 0.0 108.424 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.74 2.23 0.08 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.104 -1.623 . . . . 0.0 111.062 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -104.73 -2.98 24.2 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.199 -0.938 . . . . 0.0 112.107 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.06 -34.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 O-C-N 120.384 -1.447 . . . . 0.0 112.743 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -76.34 117.59 65.42 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.48 -1.387 . . . . 0.0 110.199 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.41 -2.02 11.97 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.854 2.369 . . . . 0.0 113.099 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? 66.59 -177.59 0.2 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.71 165.03 35.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 175.54 99.45 0.01 OUTLIER 'General case' 0 C--N 1.351 0.672 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -86.61 -24.64 25.29 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 119.673 -1.892 . . . . 0.0 110.528 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.575 HH12 ' CD ' ' A' ' 28' ' ' GLU . 23.7 mmt180 -150.88 159.53 44.49 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.073 1.349 . . . . 0.0 109.286 -173.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -123.24 142.15 51.23 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.648 -1.908 . . . . 0.0 108.938 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -144.97 144.11 30.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -155.29 170.61 21.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.802 2.041 . . . . 0.0 108.158 -170.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 81.99 11.89 0.66 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.511 1.924 . . . . 0.0 114.161 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -54.49 -34.86 62.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 127.399 2.28 . . . . 0.0 116.066 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HZ1' ' CG ' ' A' ' 149' ' ' ASP . 78.5 tttt -68.13 -21.71 64.92 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 120.378 -1.451 . . . . 0.0 114.518 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.26 -7.6 22.9 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.378 -1.452 . . . . 0.0 111.486 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -69.79 -39.29 76.68 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.985 -1.072 . . . . 0.0 113.688 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -95.66 121.46 46.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 123.696 1.712 . . . . 0.0 112.128 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.35 83.67 7.39 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 118.845 -2.409 . . . . 0.0 110.827 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.6 mm -61.01 -41.62 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 126.545 1.938 . . . . 0.0 111.038 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.71 53.65 1.97 Allowed 'General case' 0 C--N 1.357 0.921 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.99 11.05 12.37 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.528 -1.358 . . . . 0.0 111.647 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.63 153.92 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -127.1 122.25 33.76 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.372 -1.455 . . . . 0.0 110.711 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 129.54 42.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -127.76 137.92 52.59 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.171 -167.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -124.95 138.55 54.23 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 164.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -57.43 -47.27 82.22 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 -167.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -104.37 26.55 8.79 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.438 -1.414 . . . . 0.0 110.725 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.16 152.36 49.2 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 120.761 -1.212 . . . . 0.0 115.625 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.26 166.62 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.62 159.78 36.18 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.95 19.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 123.504 1.621 . . . . 0.0 108.097 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.84 146.66 54.58 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.002 -1.686 . . . . 0.0 112.6 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt-85 -84.96 -11.88 54.55 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 120.022 -1.674 . . . . 0.0 113.513 -165.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.299 78.7 tttt 26.31 64.15 0.07 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 130.089 3.356 . . . . 0.0 117.028 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 t -81.1 156.71 25.65 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 123.037 1.399 . . . . 0.0 112.178 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -101.33 -1.48 33.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.317 1.447 . . . . 0.0 109.579 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m120 56.57 45.35 22.43 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.137 1.375 . . . . 0.0 112.632 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -101.15 -11.18 19.77 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 109.328 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.84 -25.12 63.59 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -164.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -91.35 -3.84 56.37 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.49 17.68 70.48 Favored Glycine 0 C--N 1.36 1.866 0 O-C-N 120.565 -1.334 . . . . 0.0 114.0 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -126.76 137.11 53.18 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.311 -1.111 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.0 9.2 15.99 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.298 -1.501 . . . . 0.0 109.938 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.8 m170 73.67 15.54 4.02 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.716 1.607 . . . . 0.0 112.108 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.33 24.06 6.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.714 1.606 . . . . 0.0 113.565 -163.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 m -92.36 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 O-C-N 120.017 -1.677 . . . . 0.0 109.37 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -20.64 118.34 0.03 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 129.575 3.15 . . . . 0.0 118.156 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -164.16 160.54 21.49 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 -160.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -46.97 130.2 12.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.796 1.638 . . . . 0.0 115.407 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.575 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.6 -13.82 46.17 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -164.26 159.36 19.9 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.049 -1.265 . . . . 0.0 109.143 167.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.67 131.16 22.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.982 2.113 . . . . 0.0 112.608 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.79 -12.54 12.73 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.836 -1.165 . . . . 0.0 112.957 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -165.08 157.37 15.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 t -133.25 120.42 21.08 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 169.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.1 pt -70.9 144.21 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.094 1.757 . . . . 0.0 115.16 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.567 ' CG ' ' HZ1' ' A' ' 81' ' ' LYS . 28.5 m-20 -97.2 -7.17 33.04 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.748 1.219 . . . . 0.0 110.341 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -159.53 166.52 30.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 t -62.65 135.34 57.33 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.403 -1.436 . . . . 0.0 114.281 -171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -85.69 28.81 0.74 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 119.677 -1.889 . . . . 0.0 113.207 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.26 -38.04 84.46 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.377 -1.452 . . . . 0.0 113.906 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.0 m -121.2 131.32 54.17 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.39 128.63 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.12 165.07 28.46 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.545 -1.347 . . . . 0.0 109.917 -167.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.88 120.54 55.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 O-C-N 120.954 -1.091 . . . . 0.0 108.474 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -80.0 107.75 13.03 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 122.168 0.985 . . . . 0.0 112.401 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -66.88 107.91 2.37 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.975 -1.078 . . . . 0.0 112.453 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.43 146.01 43.96 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 121.046 -1.033 . . . . 0.0 110.13 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -53.68 163.1 3.03 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.753 2.969 . . . . 0.0 115.065 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -141.93 173.75 11.23 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.18 -6.98 23.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 164.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.98 120.32 34.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.215 1.006 . . . . 0.0 111.88 -170.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -61.48 119.9 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.637 2.225 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.3 m120 55.18 41.85 31.13 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 127.426 2.29 . . . . 0.0 113.273 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -173.4 -159.91 20.87 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 123.038 1.354 . . . . 0.0 111.273 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -141.39 -60.82 0.48 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.362 1.065 . . . . 0.0 111.584 -171.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.45 -44.14 95.63 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 115.282 -167.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 t -152.59 161.07 43.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.3 p -91.07 -17.81 25.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.858 -1.151 . . . . 0.0 112.11 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -60.93 163.49 5.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.705 2.002 . . . . 0.0 115.293 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -114.24 -1.3 13.64 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.145 -1.597 . . . . 0.0 111.089 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -35.62 75.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.655 1.182 . . . . 0.0 113.292 166.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -113.92 144.44 31.52 Favored Pre-proline 0 C--N 1.351 0.649 0 C-N-CA 123.488 0.715 . . . . 0.0 112.387 -155.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -60.68 98.31 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.059 2.506 . . . . 0.0 113.757 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -99.12 11.65 38.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.0 m -143.87 142.7 30.95 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 119.839 -1.788 . . . . 0.0 109.147 -166.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -132.76 159.74 38.85 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.586 1.154 . . . . 0.0 109.381 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.66 138.12 58.37 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.12 161.39 30.06 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.163 2.985 . . . . 0.0 117.759 -169.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.47 110.52 17.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.529 1.132 . . . . 0.0 109.141 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.86 131.04 49.65 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.309 1.044 . . . . 0.0 112.307 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -65.83 142.46 57.93 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 60.38 18.88 8.52 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.919 1.688 . . . . 0.0 114.972 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.7 t -94.5 127.43 40.42 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 119.797 -1.814 . . . . 0.0 108.634 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.5 mt -88.73 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 O-C-N 119.814 -1.804 . . . . 0.0 108.93 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -86.59 147.94 25.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.515 -0.741 . . . . 0.0 112.951 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . 0.324 76.2 mtt180 76.83 13.31 2.24 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 114.327 170.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.4 148.65 11.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 123.689 0.796 . . . . 0.0 109.326 155.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.575 ' CG ' ' HZ3' ' A' ' 130' ' ' LYS . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 43.18 -138.87 0.24 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -115.7 142.29 17.47 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 120.345 -1.472 . . . . 0.0 111.465 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.274 98.0 mtt180 79.39 -6.02 1.88 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.527 1.931 . . . . 0.0 115.845 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.37 119.09 33.27 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.615 -1.928 . . . . 0.0 113.061 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 49.63 52.28 14.85 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 126.995 2.118 . . . . 0.0 115.894 166.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -57.23 -38.45 73.81 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m -59.35 -36.53 75.88 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 113.543 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -82.02 153.11 26.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.748 1.737 . . . . 0.0 112.555 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.81 165.98 16.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.855 1.312 . . . . 0.0 111.156 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.14 157.42 34.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.297 -1.502 . . . . 0.0 108.563 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 16.4 m -62.63 135.09 57.21 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.686 1.194 . . . . 0.0 111.519 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -122.05 114.49 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -107.67 105.39 15.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.92 72.39 10.42 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.444 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.201 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -160.52 161.56 32.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.14 119.85 33.56 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.71 156.66 35.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.5 148.77 50.11 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 120.796 -1.19 . . . . 0.0 111.409 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.69 134.61 55.69 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 120.216 -1.553 . . . . 0.0 111.966 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -60.51 136.29 58.01 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -171.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.51 141.36 58.8 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 120.275 -1.515 . . . . 0.0 111.225 164.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -134.65 99.95 4.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.093 -1.629 . . . . 0.0 110.682 -172.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.9 tp -133.99 108.73 11.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-O 122.56 1.171 . . . . 0.0 110.008 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 p -99.78 -17.83 17.5 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.457 -1.402 . . . . 0.0 113.797 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 54.39 44.22 29.24 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.954 1.301 . . . . 0.0 113.853 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.92 169.82 23.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -162.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -60.42 133.52 91.05 Favored Pre-proline 0 C--N 1.343 0.29 0 O-C-N 121.273 -0.892 . . . . 0.0 111.727 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.27 132.31 43.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 123.085 2.138 . . . . 0.0 110.784 156.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.06 132.16 95.2 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.27 1.428 . . . . 0.0 110.351 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.38 134.4 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 CA-C-N 123.77 2.382 . . . . 0.0 112.906 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -112.77 11.0 19.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.743 -1.223 . . . . 0.0 111.583 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.12 159.51 21.46 Favored Pre-proline 0 N--CA 1.434 -1.267 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.15 152.75 9.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.189 1.926 . . . . 0.0 110.924 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -100.62 134.58 43.38 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -69.71 -14.8 62.98 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.48 1.512 . . . . 0.0 112.978 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -113.92 126.45 55.17 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 120.429 -1.419 . . . . 0.0 107.95 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -73.63 97.38 2.64 Favored 'General case' 0 C--N 1.346 0.443 0 O-C-N 120.63 -1.294 . . . . 0.0 112.971 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.7 pt -95.17 11.43 4.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-O 121.977 0.894 . . . . 0.0 112.069 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.254 69.2 m 65.64 36.48 6.4 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -95.09 163.8 13.15 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 166.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.4 m -58.73 156.35 2.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -90.83 -13.98 32.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.1 124.4 24.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.669 -1.894 . . . . 0.0 111.018 171.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.61 138.08 51.1 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.831 0.824 . . . . 0.0 108.943 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.05 166.21 18.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.18 0.991 . . . . 0.0 111.373 -169.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -141.45 132.87 26.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 118.956 -2.34 . . . . 0.0 108.77 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 63.26 41.62 7.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 pt -89.69 9.69 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.954 1.835 . . . . 0.0 111.563 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -60.19 127.84 33.79 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.342 1.857 . . . . 0.0 112.961 173.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -127.18 163.3 24.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.606 -1.309 . . . . 0.0 107.943 -175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -112.51 23.75 13.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.006 0.908 . . . . 0.0 109.537 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 t 63.31 -157.96 0.32 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 168.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.7 t -119.45 114.25 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 166.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.428 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 51.6 t60 -157.23 156.19 28.95 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -168.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 53' ' ' HIS . 76.7 Cg_exo -39.64 131.02 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.606 3.538 . . . . 0.0 116.136 164.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -164.25 -59.48 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.434 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HG ' ' CG ' ' A' ' 70' ' ' ASP . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' CG ' ' HG ' ' A' ' 57' ' ' SER . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.74 2.27 0.07 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.414 HH22 ' CD ' ' A' ' 107' ' ' GLU . 71.3 mtm180 -145.98 155.67 42.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.705 -1.872 . . . . 0.0 109.575 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -122.29 -62.66 1.36 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.0 0.905 . . . . 0.0 108.757 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -91.84 3.47 55.08 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.238 -1.539 . . . . 0.0 113.82 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.402 78.0 mttt 74.01 -70.05 0.17 Allowed 'General case' 0 C--N 1.344 0.344 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.363 26.9 m0 93.8 33.74 0.01 OUTLIER 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.365 2.666 . . . . 0.0 113.163 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -102.47 124.22 47.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.67 114.74 25.61 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.762 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -118.64 155.92 30.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 125.006 1.322 . . . . 0.0 112.483 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -117.31 109.29 16.65 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.745 -1.222 . . . . 0.0 111.85 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -74.07 -16.27 61.04 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.9 p -61.65 -36.31 80.44 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.947 1.299 . . . . 0.0 113.96 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.02 127.31 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.504 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 74.25 44.15 0.25 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.434 1.493 . . . . 0.0 111.947 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.54 138.26 20.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' CD ' HH12 ' A' ' 145' ' ' ARG . 2.9 mp0 -61.48 -43.45 98.85 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 128.491 2.717 . . . . 0.0 114.949 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -131.89 149.42 52.45 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.77 136.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.122 0.969 . . . . 0.0 108.587 -171.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -109.57 17.46 21.33 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.432 -1.417 . . . . 0.0 111.868 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.37 28.7 mm 32.66 73.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 128.991 2.916 . . . . 0.0 116.613 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -140.89 168.51 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -106.77 112.48 25.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.19 160.62 33.02 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -168.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -102.69 1.64 34.78 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-O 122.632 1.206 . . . . 0.0 110.085 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.23 -33.28 62.0 Favored Glycine 0 C--N 1.353 1.528 0 O-C-N 120.841 -1.162 . . . . 0.0 113.082 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.9 pt -137.56 136.56 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -122.89 136.84 55.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 121.138 -0.976 . . . . 0.0 111.738 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 pt -97.0 9.44 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -59.69 142.83 52.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.077 1.751 . . . . 0.0 114.444 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -132.0 4.67 4.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.341 -0.849 . . . . 0.0 112.513 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -104.82 -2.79 24.31 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 119.585 -1.947 . . . . 0.0 112.306 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 p -131.72 158.11 42.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 67.74 40.76 2.37 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-O 122.64 1.21 . . . . 0.0 113.004 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.02 -76.87 0.37 Allowed 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.067 -1.645 . . . . 0.0 111.691 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -151.82 164.02 37.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' CD ' HH22 ' A' ' 73' ' ' ARG . 31.8 tt0 -59.01 -40.56 85.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.85 123.9 13.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.972 -1.08 . . . . 0.0 109.784 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.01 -166.76 9.96 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 122.739 1.189 . . . . 0.0 115.758 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.5 t -135.49 168.52 19.07 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -171.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 56.26 37.38 28.78 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 122.763 1.268 . . . . 0.0 114.11 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 64.72 39.81 6.11 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.874 1.27 . . . . 0.0 112.25 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.899 1.68 . . . . 0.0 113.628 169.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -63.24 141.96 17.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 112.753 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 177.3 7.27 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.335 -1.478 . . . . 0.0 110.593 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 p -114.39 132.61 56.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 119.827 -1.795 . . . . 0.0 113.549 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.18 144.49 57.09 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 126.522 1.929 . . . . 0.0 110.845 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.95 -171.59 40.6 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -65.81 130.78 44.46 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 119.614 -2.109 . . . . 0.0 113.953 170.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 m -62.31 -40.0 86.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.219 -1.55 . . . . 0.0 113.991 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.422 HH12 ' CD ' ' A' ' 87' ' ' GLU . 25.5 tpt180 -56.95 131.87 51.03 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 125.663 1.585 . . . . 0.0 114.561 -177.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 m80 54.44 41.98 31.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.829 1.652 . . . . 0.0 114.745 -171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 p -81.55 -46.45 14.45 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.099 -1.625 . . . . 0.0 110.611 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.8 pt -122.79 -21.93 3.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 125.456 1.502 . . . . 0.0 110.009 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.93 136.55 51.68 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.091 -1.631 . . . . 0.0 112.667 157.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.5 m 52.22 53.61 12.14 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.6 p -110.31 -18.33 13.29 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 119.527 -1.983 . . . . 0.0 113.71 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.467 ' HZ3' ' CG ' ' A' ' 181' ' ' ASP . 40.3 mtmt -125.16 -2.5 7.61 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.524 -172.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -162.12 158.58 24.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.9 m 64.88 44.69 3.48 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 123.493 1.616 . . . . 0.0 110.965 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.5 pt -116.49 148.7 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 126.492 1.917 . . . . 0.0 107.88 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 62.28 31.9 17.28 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 123.744 1.735 . . . . 0.0 115.225 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -94.34 -3.16 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 O-C-N 120.514 -1.366 . . . . 0.0 109.773 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 72.5 m -71.16 104.54 3.1 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.437 1.495 . . . . 0.0 110.81 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.6 p -60.36 139.53 57.62 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.24 130.91 52.43 Favored Pre-proline 0 C--N 1.352 0.685 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.308 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -41.43 140.69 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.906 3.737 . . . . 0.0 117.275 161.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -97.04 115.89 28.26 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.287 -1.508 . . . . 0.0 112.35 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 77.21 14.62 1.89 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 126.594 1.957 . . . . 0.0 112.751 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.69 136.23 92.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 O-C-N 120.662 -1.274 . . . . 0.0 113.72 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.0 146.4 17.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.906 3.071 . . . . 0.0 116.529 169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.78 -17.78 65.04 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.233 -0.917 . . . . 0.0 113.123 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.9 -4.56 72.15 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.063 0.84 . . . . 0.0 113.188 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.18 -25.63 12.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 119.002 1.401 . . . . 0.0 111.577 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.51 101.01 11.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 O-C-N 120.676 -1.265 . . . . 0.0 109.33 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 m -63.56 118.99 8.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 120.918 -1.114 . . . . 0.0 111.022 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -62.45 122.34 15.5 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -141.98 89.05 2.15 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.68 167.3 18.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 m -63.78 134.15 54.76 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.973 1.709 . . . . 0.0 110.679 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.6 127.24 92.86 Favored Pre-proline 0 C--N 1.365 1.243 0 O-C-N 119.616 -1.928 . . . . 0.0 111.096 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 3.81 7.0 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.637 2.892 . . . . 0.0 113.929 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -134.82 -32.21 0.99 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 120.177 1.353 . . . . 0.0 112.975 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.6 m -86.58 102.8 14.48 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.443 -1.41 . . . . 0.0 107.721 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -54.1 150.51 8.09 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -39.29 68.14 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.73 2.012 . . . . 0.0 115.647 -166.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' CG ' ' HZ3' ' A' ' 152' ' ' LYS . 1.4 m-20 -57.34 -46.49 83.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.759 -1.213 . . . . 0.0 113.642 172.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -61.64 -41.77 97.98 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.575 -1.953 . . . . 0.0 112.82 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -59.26 -47.28 85.94 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.655 -0.653 . . . . 0.0 112.714 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.3 t -59.89 -45.21 93.25 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.238 1.415 . . . . 0.0 113.343 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.53 -34.33 72.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.979 1.312 . . . . 0.0 113.808 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 58.2 m -62.25 138.97 58.51 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.8 mm -75.04 107.74 5.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.864 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mtm105 -123.6 8.94 8.93 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.067 -1.02 . . . . 0.0 113.486 -166.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.32 12.33 7.02 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.499 -1.376 . . . . 0.0 111.239 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.91 119.55 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.529 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -148.13 132.87 17.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.78 6.78 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 117.745 -3.097 . . . . 0.0 111.809 -11.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.266 22.0 tpt180 80.64 -52.13 0.33 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 164.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.62 9.56 27.21 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.331 1.062 . . . . 0.0 110.266 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.46 146.43 48.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.467 1.507 . . . . 0.0 113.018 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.62 51.13 0.06 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.2 m 55.1 57.14 5.8 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 127.717 2.407 . . . . 0.0 112.84 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -163.15 7.13 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.58 -1.325 . . . . 0.0 114.108 -169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -41.17 158.1 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.154 2.181 . . . . 0.0 115.699 160.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -133.27 158.97 41.58 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.344 -1.472 . . . . 0.0 113.667 -163.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 35.1 p 51.02 63.22 2.33 Favored 'General case' 0 C--N 1.366 1.31 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 158.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.1 -53.06 3.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.163 2.185 . . . . 0.0 110.126 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 57.51 14.24 2.2 Favored 'General case' 0 C--N 1.352 0.703 1 C-N-CA 131.885 4.074 . . . . 0.0 115.898 172.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.67 9.07 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.427 1.891 . . . . 0.0 115.607 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.529 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.47 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -169.28 169.37 9.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 107.374 166.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.04 179.53 8.97 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . 0.269 . . 90.33 170.93 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 125.944 1.698 . . . . 0.0 113.226 164.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -54.27 122.73 10.95 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.56 56.85 1.43 Allowed 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.753 -1.217 . . . . 0.0 113.467 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -146.62 141.97 27.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 129.807 3.243 . . . . 0.0 103.126 -2.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -157.31 166.92 31.79 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.341 -1.474 . . . . 0.0 108.019 -164.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.6 161.67 14.17 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.08 0.552 . . . . 0.0 111.215 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.9 158.63 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 O-C-N 120.315 -1.491 . . . . 0.0 109.178 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -75.73 153.57 36.97 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 120.814 -1.179 . . . . 0.0 109.45 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -124.76 151.83 44.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -102.95 19.81 18.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 112.277 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -64.84 146.39 98.67 Favored Pre-proline 0 C--N 1.358 0.944 0 O-C-N 119.823 -1.798 . . . . 0.0 112.087 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.07 -38.44 32.11 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.588 2.859 . . . . 0.0 115.542 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -96.38 126.73 42.69 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 123.733 0.813 . . . . 0.0 111.842 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.12 133.86 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.365 2.71 . . . . 0.0 114.746 159.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -96.15 12.38 30.99 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 121.25 -0.907 . . . . 0.0 111.714 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.77 124.15 69.61 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.929 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.83 -20.95 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.299 1.999 . . . . 0.0 112.385 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -100.53 31.66 3.38 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.258 1.023 . . . . 0.0 111.355 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 57.3 tptt -104.11 114.97 29.59 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.227 -1.546 . . . . 0.0 112.37 -169.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -82.47 0.73 40.96 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.412 -1.43 . . . . 0.0 113.841 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.62 111.31 14.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.455 -1.403 . . . . 0.0 109.151 171.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -107.83 -43.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -112.3 142.47 44.77 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.397 -0.814 . . . . 0.0 108.835 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.289 45.8 m 63.16 65.44 0.78 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 123.211 1.481 . . . . 0.0 111.779 -171.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.4 t -94.73 117.53 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.944 1.697 . . . . 0.0 108.092 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 m -85.82 -15.09 43.04 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 121.849 -0.532 . . . . 0.0 112.084 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.599 ' CG ' ' HZ1' ' A' ' 34' ' ' LYS . 3.2 m-20 -61.52 144.85 53.61 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -107.96 120.57 42.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.149 -1.594 . . . . 0.0 111.172 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.48 29.27 0.52 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.19 0.996 . . . . 0.0 113.146 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -61.37 143.54 55.59 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.028 1.331 . . . . 0.0 111.093 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.28 170.84 21.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.327 -2.108 . . . . 0.0 108.946 -163.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -99.37 1.23 10.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 CA-C-O 122.131 0.967 . . . . 0.0 110.913 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 20' ' ' GLU . 98.2 mtt180 -74.23 -19.52 60.49 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.846 -1.784 . . . . 0.0 111.284 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -59.3 -40.88 87.59 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 126.446 1.898 . . . . 0.0 112.386 167.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -89.76 50.96 1.98 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 123.076 1.417 . . . . 0.0 110.97 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 t -58.59 141.46 52.15 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 118.264 -2.772 . . . . 0.0 112.231 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.29 -13.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-O 123.139 1.447 . . . . 0.0 109.457 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 229' ' ' GLU . 93.6 m-70 -63.3 142.02 97.81 Favored Pre-proline 0 N--CA 1.439 -0.98 0 O-C-N 120.525 -1.359 . . . . 0.0 114.349 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.02 -25.24 0.84 Allowed 'Cis proline' 0 CA--C 1.51 -0.719 0 CA-C-O 116.499 -1.542 . . . . 0.0 110.673 17.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 80.04 126.63 0.04 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.45 1.9 . . . . 0.0 114.528 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.06 167.42 30.46 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -71.42 144.63 49.7 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.868 -1.77 . . . . 0.0 114.275 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -128.59 -137.61 0.23 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -132.92 162.27 32.06 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -119.26 15.24 13.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.291 28.9 m-20 87.17 -19.87 0.24 Allowed 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.304 1.841 . . . . 0.0 114.527 168.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -115.87 135.66 53.78 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.616 -1.303 . . . . 0.0 110.459 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.96 11.07 13.31 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.502 -1.373 . . . . 0.0 109.354 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -143.04 128.59 19.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.624 1.57 . . . . 0.0 107.258 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -142.08 131.87 24.24 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 t -134.06 160.88 36.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.61 144.12 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -147.44 23.06 1.16 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 109.708 -163.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -64.31 -42.17 94.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.311 35.8 mt-10 51.59 21.23 1.24 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.47 138.69 27.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.7 1.6 . . . . 0.0 107.213 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.48 99.44 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 O-C-N 120.87 -1.144 . . . . 0.0 108.759 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -106.33 3.78 27.91 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 120.095 -1.628 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.0 mm -111.17 107.67 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 123.651 1.691 . . . . 0.0 106.863 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -83.41 28.9 0.52 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 119.942 -1.724 . . . . 0.0 113.802 -162.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -159.01 18.96 0.19 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.598 1.959 . . . . 0.0 110.422 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.0 -39.17 74.19 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.29 1.836 . . . . 0.0 114.267 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -62.35 -9.19 7.43 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.231 1.412 . . . . 0.0 114.658 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.96 13.43 52.78 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 124.521 1.058 . . . . 0.0 112.532 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.31 -68.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 CA-C-N 118.565 1.183 . . . . 0.0 108.894 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.286 23.3 mmt180 52.17 38.98 25.87 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 118.988 2.959 . . . . 0.0 118.988 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.303 1.5 tp 104.07 -7.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 129.609 3.163 . . . . 0.0 112.99 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.259 47.5 t0 16.73 79.19 0.01 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.332 3.053 . . . . 0.0 115.738 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 64.89 12.67 7.98 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.508 ' HZ3' ' CD ' ' A' ' 104' ' ' GLU 0.325 61.3 tttm 54.15 67.8 0.95 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.72 2.408 . . . . 0.0 117.131 175.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.4 p -72.48 -12.98 61.32 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 119.424 -2.047 . . . . 0.0 113.208 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' CD ' ' HZ3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER 68.8 35.45 2.98 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.579 1.551 . . . . 0.0 111.253 -170.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 m120 84.39 28.2 0.07 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.32 1.448 . . . . 0.0 114.126 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.34 158.11 44.07 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.62 140.57 46.12 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 161.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 63.3 23.3 13.73 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -103.74 175.27 23.23 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 124.975 1.274 . . . . 0.0 114.252 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 136.49 28.48 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.274 -1.721 . . . . 0.0 110.343 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.0 t80 169.57 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.313 2.645 . . . . 0.0 105.333 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -158.37 161.34 37.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.426 -1.421 . . . . 0.0 108.121 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.62 73.79 1.48 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.0 t -114.52 -32.51 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 124.391 1.077 . . . . 0.0 113.001 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -83.74 150.09 26.04 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 119.705 -1.872 . . . . 0.0 111.988 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.7 p -118.4 22.81 11.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.504 1.122 . . . . 0.0 112.966 -172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -61.5 146.36 48.86 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.172 -0.955 . . . . 0.0 112.326 163.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.21 17.63 Favored Glycine 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -144.0 136.7 27.1 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.054 -1.851 . . . . 0.0 109.206 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.77 163.7 6.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.37 112.67 10.76 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.508 -1.37 . . . . 0.0 112.067 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -165.22 4.44 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.376 0.608 . . . . 0.0 111.246 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.2 m -61.83 149.36 40.37 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.699 -1.251 . . . . 0.0 114.074 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -53.26 120.24 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.962 1.305 . . . . 0.0 112.644 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.22 -52.07 6.17 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.374 1.87 . . . . 0.0 112.282 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.2 t -158.08 156.2 30.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -89.68 -48.94 6.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -69.83 -37.7 76.28 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 172.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . 0.361 66.3 mttm 75.92 153.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.312 12.1 p 77.68 149.63 0.11 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.401 1.88 . . . . 0.0 112.612 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.297 23.0 mt 72.49 -88.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.95 0.9 . . . . 0.0 111.928 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.26 127.73 35.79 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.355 -1.466 . . . . 0.0 112.107 -168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.254 26.3 t 74.53 103.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 127.632 2.373 . . . . 0.0 112.187 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 32.6 p -85.52 137.15 33.08 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 119.519 -1.988 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.6 t -142.61 167.65 21.58 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 119.987 -1.696 . . . . 0.0 109.903 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.19 141.9 98.19 Favored Pre-proline 0 C--N 1.349 0.573 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.18 156.72 63.44 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.662 2.241 . . . . 0.0 112.135 151.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.7 m -60.75 -37.52 82.07 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.14 0.976 . . . . 0.0 112.277 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 76.46 22.01 1.29 Allowed 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.029 0.932 . . . . 0.0 112.303 165.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.5 154.3 89.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -35.82 136.3 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 125.534 4.156 . . . . 0.0 118.767 169.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -85.27 133.93 34.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.87 0.868 . . . . 0.0 112.79 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.3 -174.62 54.53 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 121.549 -0.719 . . . . 0.0 113.363 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.17 96.81 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.259 48.1 t 67.88 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 125.863 1.665 . . . . 0.0 112.519 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.6 p -77.19 126.32 30.75 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 118.109 -2.87 . . . . 0.0 112.713 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.3 p -93.43 -7.07 45.59 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.649 0.78 . . . . 0.0 112.608 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -118.53 117.49 29.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.92 164.91 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 t -102.82 -24.75 13.68 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.779 1.276 . . . . 0.0 109.508 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.609 ' CG ' ' HZ1' ' A' ' 177' ' ' LYS . 6.2 p-10 -103.5 128.96 26.33 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 126.717 2.007 . . . . 0.0 107.543 171.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -56.73 121.04 9.34 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 123.791 2.994 . . . . 0.0 116.947 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.609 ' HZ1' ' CG ' ' A' ' 175' ' ' ASP . 11.9 ptpt -161.13 165.6 29.28 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 120.923 -1.11 . . . . 0.0 113.404 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.6 p 59.92 -163.05 0.24 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.921 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . 0.277 39.2 mt-30 66.02 108.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.651 0 N-CA-C 118.291 2.701 . . . . 0.0 118.291 170.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 69.59 46.56 0.71 Allowed 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.876 -1.765 . . . . 0.0 112.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.8 -45.02 82.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.784 2.034 . . . . 0.0 115.943 -161.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -112.95 17.13 19.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.619 1.167 . . . . 0.0 110.153 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.317 82.9 mt-30 67.27 17.53 10.25 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t -158.86 152.43 22.99 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.194 -1.566 . . . . 0.0 107.852 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -104.65 -14.25 15.67 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.274 -1.516 . . . . 0.0 110.903 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.3 m -71.22 125.88 28.11 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.018 -1.676 . . . . 0.0 110.072 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -85.57 -7.45 10.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 147.41 30.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -114.5 56.93 0.71 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 124.821 1.248 . . . . 0.0 111.6 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.97 163.79 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.553 ' HZ2' ' C ' ' A' ' 238' ' ' PHE . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -155.47 155.52 33.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.32 118.44 7.29 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.039 0.828 . . . . 0.0 114.101 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.5 ptt85 169.1 15.07 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.043 1.337 . . . . 0.0 111.338 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.17 164.87 13.85 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -32.57 147.64 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 119.739 3.236 . . . . 0.0 119.739 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -60.94 -7.12 2.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 33.8 p -88.46 -9.13 53.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.312 -2.118 . . . . 0.0 113.974 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -75.04 -13.38 60.49 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 119.559 -1.963 . . . . 0.0 115.192 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -64.64 -14.13 56.77 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -117.3 9.28 13.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.933 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.1 t -90.61 148.98 22.3 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.216 -1.553 . . . . 0.0 110.272 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -137.46 143.17 41.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 53' ' ' HIS . 2.6 mt-10 -109.1 -72.72 0.71 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.05 147.18 30.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.971 1.26 . . . . 0.0 113.34 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.418 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.553 ' C ' ' HZ2' ' A' ' 205' ' ' LYS . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.42 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -139.11 133.27 31.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 174.37 10.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . 0.29 . . 87.05 -168.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 123.468 1.604 . . . . 0.0 115.3 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -142.3 152.17 42.71 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.872 1.669 . . . . 0.0 107.238 -161.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.98 86.79 2.0 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 120.894 -1.129 . . . . 0.0 108.13 168.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.35 157.75 45.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.35 3.06 . . . . 0.0 107.078 9.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.19 170.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -120.26 164.37 16.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.988 1.715 . . . . 0.0 109.675 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.33 173.19 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.484 1.135 . . . . 0.0 113.005 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 157.2 6.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.323 1.849 . . . . 0.0 113.786 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -63.5 140.68 58.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.6 -43.49 89.57 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 120.449 -1.407 . . . . 0.0 114.713 164.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -119.0 117.61 33.47 Favored Pre-proline 0 C--N 1.351 0.65 0 O-C-N 120.743 -1.223 . . . . 0.0 109.81 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.15 136.46 61.78 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.118 3.212 . . . . 0.0 117.573 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -120.39 141.5 32.08 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 126.363 1.865 . . . . 0.0 111.07 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.88 157.89 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.533 2.822 . . . . 0.0 114.08 167.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -61.34 -40.18 93.33 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 113.468 166.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.03 145.01 17.67 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 161.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.72 146.78 1.33 Allowed 'Trans proline' 0 C--N 1.335 -0.179 0 C-N-CA 124.764 3.643 . . . . 0.0 117.377 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -159.54 3.28 0.09 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.742 0.782 . . . . 0.0 111.117 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -157.63 158.05 34.78 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -55.26 -36.85 66.52 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 113.91 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.52 117.75 20.76 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.33 -1.481 . . . . 0.0 111.109 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.09 -18.59 7.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.2 t -107.88 117.87 35.26 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.303 -2.123 . . . . 0.0 108.706 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.291 23.4 m 67.69 51.58 0.8 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-O 123.813 1.768 . . . . 0.0 111.068 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -65.19 148.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 125.401 1.48 . . . . 0.0 112.569 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -66.93 -36.13 81.55 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 122.173 0.987 . . . . 0.0 112.851 166.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -63.35 138.07 58.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.773 2.029 . . . . 0.0 115.247 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -118.62 126.0 50.99 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.214 -2.179 . . . . 0.0 112.79 -170.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -120.91 159.81 24.77 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 123.523 1.63 . . . . 0.0 114.008 -165.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -92.85 106.28 18.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -140.72 175.08 9.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.361 -1.462 . . . . 0.0 107.375 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -60.78 -44.86 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.455 -1.403 . . . . 0.0 113.709 -172.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.16 -43.29 98.7 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -77.39 -14.26 59.75 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.766 -1.209 . . . . 0.0 113.757 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -107.09 21.55 17.38 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.133 0.973 . . . . 0.0 112.709 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 t -63.13 140.42 58.87 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.538 -1.351 . . . . 0.0 114.465 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.67 -1.5 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 110.837 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -62.87 143.62 97.09 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.923 1.689 . . . . 0.0 114.098 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.0 -21.2 5.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.397 20.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 72.46 120.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.45 166.66 31.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.99 124.1 23.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -121.55 127.71 51.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -171.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.32 130.01 41.77 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.59 -0.694 . . . . 0.0 111.944 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -146.41 141.19 26.92 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -63.43 -35.34 80.1 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 126.649 1.979 . . . . 0.0 115.744 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m120 60.57 31.55 20.26 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.99 165.46 23.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.888 1.275 . . . . 0.0 107.81 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -145.47 36.67 1.09 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -162.52 152.81 16.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 121.004 -1.06 . . . . 0.0 109.128 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -106.23 153.04 22.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 123.327 1.537 . . . . 0.0 110.312 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.5 m -74.93 156.52 36.27 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.216 -1.553 . . . . 0.0 111.177 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.31 140.28 19.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 O-C-N 119.901 -1.75 . . . . 0.0 114.776 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.9 89.34 0.4 Allowed 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.081 -1.637 . . . . 0.0 110.984 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tt -90.09 9.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 O-C-N 120.619 -1.301 . . . . 0.0 110.872 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' CD ' HH22 ' A' ' 92' ' ' ARG 0.357 24.8 mm-40 66.86 -2.44 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 169.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -57.67 -42.46 83.61 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.548 -1.97 . . . . 0.0 111.881 164.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.35 99.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 120.563 -1.336 . . . . 0.0 108.801 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -76.69 -20.27 56.79 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.9 tp -66.07 121.66 15.57 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.452 HH22 ' CD ' ' A' ' 87' ' ' GLU . 28.7 mmt180 -106.86 -9.87 16.2 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.296 -1.502 . . . . 0.0 111.739 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.544 ' HZ2' ' CG ' ' A' ' 175' ' ' ASP . 48.9 mttm -105.67 32.29 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.675 -1.265 . . . . 0.0 110.261 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.05 -46.68 82.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.047 2.139 . . . . 0.0 115.207 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.1 -25.23 59.68 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.402 -1.437 . . . . 0.0 112.018 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.2 -39.68 92.38 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 124.983 1.278 . . . . 0.0 113.218 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.2 pt -88.38 -8.38 10.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 122.083 -0.657 . . . . 0.0 110.415 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 54.69 3.5 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.736 1.615 . . . . 0.0 112.066 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 tt -37.94 132.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 127.144 2.178 . . . . 0.0 116.746 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.03 31.45 13.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 127.64 2.376 . . . . 0.0 114.818 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.279 94.6 mtt-85 73.76 39.62 0.53 Allowed 'General case' 0 C--N 1.352 0.695 0 C-N-CA 128.176 2.59 . . . . 0.0 112.663 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.589 ' HZ3' ' CD ' ' A' ' 104' ' ' GLU . 45.4 tttm 75.14 58.61 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.608 1.963 . . . . 0.0 111.452 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 p -60.14 -46.35 89.95 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.589 ' CD ' ' HZ3' ' A' ' 102' ' ' LYS . 83.7 mt-10 29.5 77.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.81 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 m120 76.27 47.42 0.08 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.613 1.165 . . . . 0.0 113.193 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -149.71 146.14 27.07 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 120.905 -1.122 . . . . 0.0 108.744 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -104.99 143.35 33.3 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.139 0.495 . . . . 0.0 111.407 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 66.01 48.78 1.7 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.17 169.69 45.09 Favored Glycine 0 C--N 1.362 1.984 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.9 t -45.45 153.4 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 118.602 2.815 . . . . 0.0 118.602 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -100.26 139.04 36.51 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.45 -1.406 . . . . 0.0 109.957 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -128.82 129.3 45.43 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 125.919 1.687 . . . . 0.0 109.89 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.61 40.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.48 -31.28 15.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 O-C-N 119.027 -2.296 . . . . 0.0 110.749 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -96.56 145.35 25.8 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -155.91 162.15 40.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.36 156.57 36.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 168.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -133.74 144.44 16.39 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -146.23 150.31 35.57 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.45 144.34 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 167.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -118.05 114.27 22.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.663 -1.273 . . . . 0.0 108.412 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.14 152.55 20.13 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.435 1.894 . . . . 0.0 114.536 171.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.735 1.214 . . . . 0.0 111.223 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.23 95.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 120.271 -1.518 . . . . 0.0 107.799 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -74.49 -33.73 62.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.165 1.459 . . . . 0.0 114.178 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -137.1 130.01 30.61 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 119.631 -1.918 . . . . 0.0 109.008 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -82.86 -42.85 17.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 110.187 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.26 -40.42 62.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.5 mttp 49.71 -130.87 1.94 Allowed 'General case' 0 C--N 1.356 0.855 0 O-C-N 120.966 -1.084 . . . . 0.0 113.871 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 16.7 p 48.3 -126.61 1.9 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 128.261 2.625 . . . . 0.0 116.895 170.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 tt -115.79 -6.91 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.763 2.025 . . . . 0.0 107.228 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.616 -1.303 . . . . 0.0 114.208 170.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.16 107.05 14.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 O-C-N 120.949 -1.094 . . . . 0.0 110.301 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.1 m -70.32 122.72 20.09 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 120.881 -1.137 . . . . 0.0 109.629 165.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -148.71 161.7 41.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.54 140.34 94.67 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.829 0.852 . . . . 0.0 112.333 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -64.61 134.97 43.3 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.98 2.453 . . . . 0.0 113.035 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -83.56 -11.77 56.97 Favored 'General case' 0 CA--C 1.513 -0.469 0 O-C-N 120.787 -1.196 . . . . 0.0 111.663 169.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 87.11 29.92 0.03 OUTLIER 'General case' 0 C--N 1.362 1.144 0 C-N-CA 127.821 2.448 . . . . 0.0 110.623 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.32 146.48 98.94 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -37.99 143.97 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 125.182 3.922 . . . . 0.0 119.234 164.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -57.32 -39.18 75.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.787 2.435 . . . . 0.0 113.292 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.91 -7.06 78.57 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 120.807 -1.183 . . . . 0.0 113.899 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.47 -43.16 16.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.86 -1.377 . . . . 0.0 110.335 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.79 -46.96 81.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.222 -1.549 . . . . 0.0 113.401 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -106.52 103.67 13.18 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.8 p -96.24 6.2 49.33 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.409 1.084 . . . . 0.0 112.608 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -110.57 106.4 15.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -123.67 141.71 51.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 120.566 -1.334 . . . . 0.0 109.547 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.8 p -95.74 12.34 30.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 124.949 1.299 . . . . 0.0 110.015 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.544 ' CG ' ' HZ2' ' A' ' 93' ' ' LYS . 59.8 m-20 -86.85 120.35 71.63 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.043 1.737 . . . . 0.0 113.712 -173.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -49.73 128.18 20.68 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.892 3.061 . . . . 0.0 119.627 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -82.27 70.56 9.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.99 1.316 . . . . 0.0 112.742 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.4 p -66.62 -35.25 79.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.39 -161.98 0.21 Allowed 'General case' 0 C--N 1.351 0.654 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.2 m120 70.6 2.48 4.12 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.908 1.683 . . . . 0.0 113.243 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -49.8 -52.22 33.76 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.841 2.856 . . . . 0.0 115.204 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -104.52 15.89 27.19 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.529 -0.732 . . . . 0.0 111.774 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.335 68.7 mt-30 58.38 45.84 16.22 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -96.04 160.89 14.22 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.364 1.466 . . . . 0.0 110.004 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -114.02 19.06 16.8 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.394 1.078 . . . . 0.0 109.494 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.8 t -136.1 151.09 49.44 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.196 1.398 . . . . 0.0 107.718 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.5 pt -105.41 8.71 9.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 123.211 1.481 . . . . 0.0 109.894 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -144.56 147.46 33.21 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 124.989 1.316 . . . . 0.0 108.663 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -95.7 28.62 2.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 124.008 0.923 . . . . 0.0 112.464 -166.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.82 123.91 45.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.436 HG13 HD22 ' A' ' 216' ' ' ASN . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.539 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.436 HD22 HG13 ' A' ' 194' ' ' VAL . 31.2 m-80 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -149.55 134.15 17.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.4 125.83 12.29 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 120.762 -1.211 . . . . 0.0 113.94 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -150.88 -23.55 0.22 Allowed 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.429 -1.042 . . . . 0.0 112.42 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.9 mt -74.09 165.75 24.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.234 -1.541 . . . . 0.0 111.729 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -22.21 133.03 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 131.929 4.092 . . . . 0.0 117.387 171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -69.31 -3.69 15.03 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 119.853 -1.779 . . . . 0.0 115.022 -171.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.2 p -73.23 -18.06 61.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.554 1.942 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -74.59 -15.37 60.84 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -59.08 -38.45 79.49 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -110.72 6.67 21.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.029 -1.044 . . . . 0.0 113.238 -168.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.7 t -105.11 159.07 16.14 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -101.72 152.85 20.37 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.376 1.084 . . . . 0.0 112.148 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.31 -57.73 2.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.385 1.074 . . . . 0.0 112.144 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.99 168.99 18.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 123.791 0.836 . . . . 0.0 110.195 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.539 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.629 0 N-CA-C 119.314 2.485 . . . . 0.0 119.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -153.6 156.24 37.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 0.8 OUTLIER -153.83 179.57 8.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.68 -169.94 0.2 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -129.42 156.9 43.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.91 1.684 . . . . 0.0 108.322 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.63 58.44 1.73 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.959 -1.088 . . . . 0.0 112.223 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.37 147.88 29.72 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 130.688 3.595 . . . . 0.0 108.066 -6.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -154.21 165.12 37.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.159 0.983 . . . . 0.0 109.155 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -56.1 153.13 9.5 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.715 2.006 . . . . 0.0 115.056 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 pt -58.1 154.48 2.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 125.588 1.555 . . . . 0.0 114.909 -170.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -62.03 147.46 47.13 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.907 -1.121 . . . . 0.0 110.821 171.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -89.76 139.68 30.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.861 -1.149 . . . . 0.0 112.744 -173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -59.81 -45.03 93.62 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.621 -1.299 . . . . 0.0 113.29 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -139.35 155.34 72.21 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.5 152.74 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.374 3.383 . . . . 0.0 117.827 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -107.93 104.67 54.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -166.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -61.08 129.49 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.409 2.74 . . . . 0.0 114.976 165.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 p -109.65 1.14 19.37 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 124.7 1.2 . . . . 0.0 111.536 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.76 136.33 31.09 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 121.017 -1.052 . . . . 0.0 112.383 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -65.96 -34.15 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.482 2.121 . . . . 0.0 115.447 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -95.89 10.82 35.93 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -165.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.22 119.92 34.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.123 -1.611 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -69.74 -39.83 76.53 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -90.65 108.6 19.92 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 119.592 -1.943 . . . . 0.0 109.011 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.1 pt -112.22 -23.48 4.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -101.82 120.26 40.09 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 120.468 -1.395 . . . . 0.0 109.98 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m 59.68 61.44 1.95 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.204 1.402 . . . . 0.0 112.013 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.7 m -63.95 149.02 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 120.852 -1.155 . . . . 0.0 112.936 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 p -101.56 7.81 42.12 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.982 1.313 . . . . 0.0 110.607 168.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.65 158.96 15.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.11 2.564 . . . . 0.0 110.515 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -104.51 137.59 42.13 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.051 -1.03 . . . . 0.0 108.32 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.46 127.89 49.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.45 144.19 54.58 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.692 1.197 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -157.13 162.64 39.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.64 12.22 8.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 CA-C-O 123.307 1.527 . . . . 0.0 110.432 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -84.12 -1.72 55.47 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 119.004 -2.31 . . . . 0.0 110.491 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -93.18 -3.59 53.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.077 2.151 . . . . 0.0 111.544 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -107.99 4.19 24.91 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 123.504 0.722 . . . . 0.0 110.606 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -59.78 141.83 54.5 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 125.504 1.522 . . . . 0.0 114.19 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.19 -15.78 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.125 1.37 . . . . 0.0 112.478 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.436 ' CE1' ' HA ' ' A' ' 15' ' ' LEU . 33.0 m-70 -87.44 142.73 33.35 Favored Pre-proline 0 C--N 1.357 0.904 0 O-C-N 121.58 -0.7 . . . . 0.0 112.277 -173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.01 149.65 32.47 Favored 'Cis proline' 0 CA--C 1.515 -0.431 0 CA-C-N 121.379 1.528 . . . . 0.0 111.371 5.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.42 160.85 40.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.71 138.39 44.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -95.76 110.93 23.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -66.79 129.43 39.85 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -83.62 127.32 33.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.194 0.997 . . . . 0.0 108.742 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -133.51 160.24 38.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.493 -1.379 . . . . 0.0 109.995 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -70.04 -41.66 73.93 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 61.72 36.64 16.29 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.543 1.937 . . . . 0.0 116.095 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.15 138.07 46.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.71 18.72 18.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 122.718 1.247 . . . . 0.0 108.609 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -147.6 145.81 29.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.044 -1.66 . . . . 0.0 108.443 -169.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.92 165.86 17.33 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 124.058 0.943 . . . . 0.0 108.888 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -61.44 -43.71 98.39 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 126.969 2.108 . . . . 0.0 112.934 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.04 156.79 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.714 1.606 . . . . 0.0 109.867 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -69.47 129.31 39.37 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.158 -1.588 . . . . 0.0 109.449 161.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 pt -98.23 163.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 123.351 0.66 . . . . 0.0 109.357 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' CD ' HH12 ' A' ' 92' ' ' ARG . 66.4 mm-40 61.32 36.02 17.79 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.22 -40.04 92.51 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.516 -1.99 . . . . 0.0 112.502 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.78 112.87 41.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 CA-C-O 123.318 1.532 . . . . 0.0 107.871 163.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -64.95 -48.85 72.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.86 109.42 20.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 O-C-N 120.366 -1.458 . . . . 0.0 109.086 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.437 HH12 ' CD ' ' A' ' 87' ' ' GLU . 31.5 ptt-85 -161.16 165.89 28.75 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -99.19 20.99 12.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.258 -0.902 . . . . 0.0 109.867 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.8 -40.99 85.67 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 119.418 -2.052 . . . . 0.0 114.229 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -78.54 -7.48 57.57 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.967 1.307 . . . . 0.0 111.978 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -94.18 -34.99 6.18 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 121.139 -0.976 . . . . 0.0 112.99 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.9 tp -82.31 -27.35 8.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 CA-C-N 118.613 1.206 . . . . 0.0 111.617 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.314 63.3 mtt180 72.85 50.61 0.16 Allowed 'General case' 0 C--N 1.356 0.887 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 161.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mt -52.64 111.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 126.349 1.86 . . . . 0.0 112.553 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 50.88 35.18 11.75 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 114.431 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 60.07 40.47 18.49 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.429 1.492 . . . . 0.0 112.553 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.0 tttp 68.02 43.12 1.7 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.874 1.67 . . . . 0.0 112.924 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -60.13 -33.41 72.1 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.662 1.185 . . . . 0.0 111.298 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.98 64.46 0.87 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 127.038 2.135 . . . . 0.0 113.878 163.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 62.92 50.65 3.15 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -120.61 143.15 48.8 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 122.903 1.335 . . . . 0.0 112.541 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.04 126.04 27.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.5 1.52 . . . . 0.0 114.737 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 81.78 17.26 0.43 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 126.592 1.957 . . . . 0.0 112.477 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.83 23.5 70.91 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 123.958 0.789 . . . . 0.0 113.565 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -161.31 159.28 28.31 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.11 178.28 4.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.841 1.256 . . . . 0.0 111.077 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.74 118.51 15.76 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.807 -1.183 . . . . 0.0 111.19 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.04 -1.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.38 -15.25 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 122.16 0.981 . . . . 0.0 112.763 -168.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 t -85.71 169.56 13.32 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.236 -1.54 . . . . 0.0 109.038 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.1 p -168.58 164.44 12.4 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.36 165.96 26.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.637 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.46 160.83 31.81 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -100.97 -11.19 19.9 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 113.903 -1.149 . . . . 0.0 111.108 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.47 134.7 62.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.997 1.319 . . . . 0.0 109.126 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -123.76 125.11 44.14 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 101.404 -3.554 . . . . 0.0 101.404 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -17.77 3.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.538 1.063 . . . . 0.0 109.988 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.6 m -91.38 90.81 7.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 125.99 1.716 . . . . 0.0 107.784 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.4 tt -135.53 145.55 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.41 146.02 41.54 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 127.202 2.201 . . . . 0.0 115.968 -171.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.9 t -179.89 119.97 0.06 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.944 1.698 . . . . 0.0 106.802 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -57.79 -40.79 80.71 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.356 2.263 . . . . 0.0 113.046 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -106.06 2.57 27.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.843 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.7 mttm 62.44 38.6 12.68 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.114 1.366 . . . . 0.0 113.79 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 t -144.9 158.51 43.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.5 tt -98.17 5.86 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 109.392 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.57 -15.15 57.37 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.438 1.495 . . . . 0.0 113.625 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.86 158.48 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -48.45 111.16 0.42 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.6 m -121.57 132.78 54.88 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 64.6 t -98.14 116.3 65.62 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 120.663 -1.273 . . . . 0.0 108.105 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.98 149.2 53.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.481 2.788 . . . . 0.0 115.524 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.1 t -153.21 52.01 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.63 53.94 9.94 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.74 151.15 54.06 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -46.43 148.48 3.35 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.164 3.243 . . . . 0.0 116.466 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -56.08 -43.31 77.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.655 1.582 . . . . 0.0 115.157 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.67 -6.09 85.92 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 120.201 -1.562 . . . . 0.0 114.225 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.39 92.16 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.599 1.2 . . . . 0.0 114.05 -174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.46 -41.49 84.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 126.592 1.957 . . . . 0.0 113.357 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 45.3 m -84.29 124.82 31.65 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.307 0.643 . . . . 0.0 111.52 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.7 t -140.82 134.87 30.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.168 -0.958 . . . . 0.0 108.945 161.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.93 154.89 47.35 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -155.18 162.21 41.01 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.4 p -67.09 -42.33 84.81 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.476 -0.765 . . . . 0.0 112.192 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 141.67 87.11 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.549 1.94 . . . . 0.0 113.209 174.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 148.84 10.45 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-N 123.279 2.207 . . . . 0.0 112.7 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.2 mttm 62.2 30.69 17.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.229 1.412 . . . . 0.0 114.484 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.5 p -71.55 143.06 50.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.602 0.761 . . . . 0.0 111.14 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -139.61 160.12 40.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.29 1.043 . . . . 0.0 109.697 -170.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 62.24 59.4 1.61 Allowed 'General case' 0 C--N 1.349 0.559 0 C-N-CA 125.476 1.511 . . . . 0.0 113.705 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -68.97 -19.94 64.17 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.463 1.125 . . . . 0.0 113.285 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -72.9 -20.26 61.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.546 1.138 . . . . 0.0 112.952 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 55.9 33.35 21.47 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 127.096 2.158 . . . . 0.0 112.293 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m -83.43 153.17 24.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.33 -0.856 . . . . 0.0 112.33 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -52.3 -41.34 62.85 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.899 1.68 . . . . 0.0 110.796 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 t -149.99 144.31 25.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 157.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.4 pt -93.28 0.89 9.73 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.129 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -78.67 106.25 10.52 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.813 -1.18 . . . . 0.0 108.349 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -89.88 0.83 56.83 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -165.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.43 120.1 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.637 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -160.04 160.85 33.7 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.14 88.01 1.43 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 121.019 -1.051 . . . . 0.0 110.723 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -157.98 -1.95 0.1 Allowed 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.26 -1.141 . . . . 0.0 112.897 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.2 mt -96.72 153.71 17.71 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.775 -1.203 . . . . 0.0 109.662 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.87 146.08 54.65 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.089 1.355 . . . . 0.0 113.869 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -74.17 -17.6 60.89 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.33 -1.481 . . . . 0.0 114.217 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 58.1 p -96.92 4.05 51.79 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 119.832 -1.792 . . . . 0.0 111.822 -167.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -77.03 -9.92 59.03 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.397 1.079 . . . . 0.0 110.849 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -87.84 24.57 1.73 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.413 1.485 . . . . 0.0 112.324 171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -110.44 14.05 22.64 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 125.296 1.438 . . . . 0.0 111.008 167.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -157.24 149.96 23.31 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 162.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -79.95 117.05 20.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 119.592 -1.943 . . . . 0.0 112.451 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -71.08 -19.7 62.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.5 167.97 16.99 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.483 1.113 . . . . 0.0 108.81 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.75 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -143.89 116.61 8.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -99.68 121.21 40.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 13.44 0.08 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.759 -1.213 . . . . 0.0 110.728 -162.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.44 167.33 22.41 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.188 0.994 . . . . 0.0 110.885 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.14 164.94 25.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.754 1.622 . . . . 0.0 112.557 167.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -59.52 -39.79 85.01 Favored 'General case' 0 C--N 1.362 1.123 0 O-C-N 120.608 -1.307 . . . . 0.0 113.586 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -123.16 122.57 38.75 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -123.58 25.88 8.01 Favored 'General case' 0 CA--C 1.502 -0.87 0 O-C-N 120.754 -1.216 . . . . 0.0 110.397 -171.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -41.36 156.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 C-N-CA 126.867 2.067 . . . . 0.0 116.328 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -30.78 61.56 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 119.374 -2.078 . . . . 0.0 111.426 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -164.3 158.86 19.25 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.149 2.18 . . . . 0.0 105.848 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.84 144.14 49.4 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -68.23 148.57 98.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.361 1.464 . . . . 0.0 114.609 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -39.25 123.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 124.722 3.614 . . . . 0.0 117.574 164.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.58 -49.58 92.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.94 133.94 41.0 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 125.062 2.844 . . . . 0.0 112.765 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 p -56.5 158.14 4.62 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 126.314 1.846 . . . . 0.0 112.958 170.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 139.37 92.53 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 118.483 -2.636 . . . . 0.0 113.494 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.05 121.62 2.42 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.641 3.56 . . . . 0.0 117.269 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.03 44.84 15.63 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -50.7 -38.0 44.54 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -163.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -77.29 -16.08 59.14 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.292 -1.505 . . . . 0.0 114.294 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -87.57 -28.51 21.9 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.429 -1.419 . . . . 0.0 110.971 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.8 pt -93.33 146.81 5.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 122.571 1.177 . . . . 0.0 111.759 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 m -59.62 142.5 52.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -53.85 -35.59 61.68 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 120.252 -1.53 . . . . 0.0 114.317 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.98 -9.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -74.44 109.83 8.24 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.877 -1.765 . . . . 0.0 111.911 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -104.22 140.12 38.28 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 123.181 1.467 . . . . 0.0 111.481 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -114.63 6.38 15.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.224 1.81 . . . . 0.0 108.461 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . 0.256 83.2 m-85 69.37 44.59 0.92 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.322 2.249 . . . . 0.0 112.86 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 mtp85 -87.01 -17.12 33.74 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 120.914 -1.116 . . . . 0.0 112.909 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -114.03 -7.89 13.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.141 -0.974 . . . . 0.0 112.282 -164.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.0 pt -67.67 150.11 11.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 124.406 1.082 . . . . 0.0 111.306 165.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.256 86.6 mtm-85 79.15 21.45 0.65 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.138 -1.601 . . . . 0.0 113.049 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 t -120.5 148.67 43.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -73.78 136.23 43.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.774 -1.203 . . . . 0.0 111.179 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.0 p -72.56 168.24 19.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 119.353 -2.092 . . . . 0.0 112.884 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.31 -47.14 91.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 O-C-N 119.857 -1.777 . . . . 0.0 111.369 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 41.25 67.08 3.23 Favored Pre-proline 0 C--N 1.349 0.55 0 C-N-CA 125.782 1.633 . . . . 0.0 114.911 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -40.37 154.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 124.731 3.621 . . . . 0.0 116.248 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -72.06 117.51 13.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 121.054 -1.029 . . . . 0.0 111.565 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 48.38 58.39 5.24 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -161.55 154.41 20.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 119.888 -1.758 . . . . 0.0 111.561 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -125.87 24.05 7.12 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.184 0.994 . . . . 0.0 109.928 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -73.67 150.12 41.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -105.99 -70.38 0.79 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.329 1.061 . . . . 0.0 109.438 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.99 167.89 28.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 120.499 -1.375 . . . . 0.0 107.362 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -66.39 127.85 33.88 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 163.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -161.19 162.27 31.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.37 157.18 16.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 110.334 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -95.22 142.08 28.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.56 31.92 0.88 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.518 1.151 . . . . 0.0 108.849 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 m -70.08 -17.24 63.22 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.82 -56.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-O 121.705 0.764 . . . . 0.0 109.584 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -123.82 131.83 53.66 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.042 -1.662 . . . . 0.0 107.906 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 pt -84.99 -1.1 6.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 120.353 -1.467 . . . . 0.0 112.565 -167.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.38 5.41 45.25 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.216 1.006 . . . . 0.0 112.316 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -90.36 2.62 55.38 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.836 1.303 . . . . 0.0 109.649 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.1 135.87 62.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 155.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -124.8 144.54 50.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.254 9.0 mm 51.38 60.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.166 0 CA-C-O 123.261 1.505 . . . . 0.0 112.686 -164.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.641 HH21 ' CD ' ' A' ' 94' ' ' GLU . 47.4 ttp180 -62.0 -41.5 98.12 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU 0.292 93.0 mttt 86.05 32.94 0.03 OUTLIER 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.049 1.739 . . . . 0.0 111.796 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.641 ' CD ' HH21 ' A' ' 92' ' ' ARG . 31.6 tp10 -53.48 -46.75 70.11 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 -168.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.87 10.3 36.46 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.237 -1.539 . . . . 0.0 109.983 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.89 35.06 46.83 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 125.328 1.442 . . . . 0.0 116.501 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.6 mm -60.32 129.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 O-C-N 121.178 -1.189 . . . . 0.0 111.493 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -61.66 133.8 56.04 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 122.676 1.227 . . . . 0.0 112.115 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.3 pt -104.02 -0.37 10.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 122.683 1.23 . . . . 0.0 110.124 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 66.9 102.28 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.545 2.738 . . . . 0.0 114.984 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 57.76 63.8 1.72 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -140.06 159.98 40.96 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.984 1.313 . . . . 0.0 107.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.4 m -77.34 119.14 20.56 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.494 -1.379 . . . . 0.0 111.236 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.72 166.0 25.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 110.051 -170.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -98.38 1.51 47.0 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.204 -0.935 . . . . 0.0 111.761 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 70.16 44.17 0.79 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 110.893 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 93' ' ' LYS . 1.9 mp0 -69.97 -15.88 63.11 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -100.12 -1.37 36.91 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 122.369 1.081 . . . . 0.0 111.476 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.46 -62.75 0.43 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 170.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -98.39 108.41 21.1 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 124.242 1.972 . . . . 0.0 110.969 -168.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -153.77 153.18 31.71 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 120.02 15.38 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 121.26 -0.9 . . . . 0.0 108.647 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -111.36 -24.38 10.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.672 0.789 . . . . 0.0 111.433 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.51 119.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.2 m -73.07 122.39 21.71 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -63.93 144.94 56.68 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp -145.53 157.43 43.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.16 165.17 10.39 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -145.78 161.24 40.4 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.323 -1.692 . . . . 0.0 109.762 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.66 161.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 124.811 1.244 . . . . 0.0 110.236 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -145.02 16.77 1.57 Allowed 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.424 -1.422 . . . . 0.0 111.347 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -120.98 159.43 25.61 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.1 m 69.16 43.93 1.04 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.856 2.062 . . . . 0.0 111.489 -166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.6 mm -99.44 114.93 39.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.573 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.584 ' CG ' ' HZ1' ' A' ' 177' ' ' LYS . 65.1 m-20 -88.52 -18.07 28.95 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.118 1.367 . . . . 0.0 113.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.61 -18.56 44.3 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.892 -2.38 . . . . 0.0 115.77 -167.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 p -83.64 156.52 22.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 124.419 2.057 . . . . 0.0 114.653 -171.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -74.93 124.15 26.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 114.075 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -76.06 -14.5 60.2 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.116 0.966 . . . . 0.0 112.809 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -60.43 -36.87 79.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.899 2.08 . . . . 0.0 114.452 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.6 pt -112.22 15.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-O 122.408 1.099 . . . . 0.0 110.198 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.52 29.67 19.19 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 160.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 m -90.4 -4.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.499 -1.375 . . . . 0.0 111.695 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.1 t -119.35 155.56 31.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -56.88 142.78 39.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 127.42 2.288 . . . . 0.0 113.46 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -60.94 138.32 93.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 0.0 111.945 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -59.03 160.8 17.47 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.83 2.353 . . . . 0.0 113.218 162.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.8 t -163.52 166.98 22.01 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.03 13.57 12.17 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.428 0.632 . . . . 0.0 109.931 165.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 120.81 56.8 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 120.561 -1.337 . . . . 0.0 109.441 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -61.63 123.58 12.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.493 2.129 . . . . 0.0 113.096 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -163.22 166.61 23.05 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.865 -1.147 . . . . 0.0 109.237 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.53 68.68 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 120.786 -1.196 . . . . 0.0 114.513 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.06 62.67 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 120.96 -1.318 . . . . 0.0 113.715 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.06 2.47 9.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 121.114 -0.991 . . . . 0.0 110.262 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . 0.336 30.1 p 53.04 36.12 21.31 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 128.912 2.885 . . . . 0.0 115.107 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.7 t -150.42 148.94 29.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.926 1.346 . . . . 0.0 111.263 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -112.92 8.28 18.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.793 1.637 . . . . 0.0 108.658 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -102.61 137.99 40.1 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.345 -1.472 . . . . 0.0 110.444 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 m -61.82 -44.08 97.57 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.376 1.07 . . . . 0.0 113.27 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -65.69 145.21 99.05 Favored Pre-proline 0 C--N 1.343 0.297 0 C-N-CA 125.45 1.5 . . . . 0.0 114.364 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -57.6 154.69 35.14 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.1 2.534 . . . . 0.0 113.569 165.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.584 ' HZ1' ' CG ' ' A' ' 149' ' ' ASP . 26.5 ttpp -62.42 133.14 54.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.2 t -56.29 147.27 21.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.68 -0.57 39.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.201 1.8 . . . . 0.0 110.075 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -99.27 147.81 24.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.32 0.648 . . . . 0.0 109.314 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.287 72.0 m-20 65.99 149.91 0.05 OUTLIER 'General case' 0 C--N 1.351 0.635 0 CA-C-O 124.64 2.162 . . . . 0.0 115.343 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -76.67 131.04 38.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 119.067 -2.27 . . . . 0.0 110.018 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -108.57 1.76 21.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.298 -0.876 . . . . 0.0 112.975 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m 55.69 47.08 21.32 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.31 -26.71 7.5 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.499 -1.375 . . . . 0.0 112.098 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -65.59 -39.88 92.07 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.407 -1.433 . . . . 0.0 114.625 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.2 149.86 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -137.58 136.79 37.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 120.815 -1.178 . . . . 0.0 108.792 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -85.09 172.76 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.912 -1.118 . . . . 0.0 111.131 165.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m -56.99 139.24 16.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 O-C-N 120.682 -1.262 . . . . 0.0 112.73 165.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 235' ' ' ARG . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -84.56 -23.93 29.47 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.38 -140.4 6.4 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -71.8 149.25 45.47 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 119.983 -1.892 . . . . 0.0 112.543 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.81 144.55 38.15 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -89.55 158.39 17.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.731 1.612 . . . . 0.0 115.016 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.7 m120 55.25 -91.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.86 2.064 . . . . 0.0 114.535 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 62.6 p -99.53 -10.01 22.61 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.368 -1.457 . . . . 0.0 112.418 -168.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 60.09 44.3 13.24 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 166.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.41 156.76 34.85 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 120.536 -1.352 . . . . 0.0 110.952 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -139.02 126.75 22.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 163.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.6 p -113.55 2.24 15.27 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.353 0.661 . . . . 0.0 110.908 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.0 140.93 21.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -164.68 -6.95 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.72 -1.238 . . . . 0.0 112.679 -161.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -140.01 149.56 43.37 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.754 -1.841 . . . . 0.0 108.296 -172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.4 ' HE ' ' CG ' ' A' ' 209' ' ' ASP . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.667 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.17 155.22 40.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.166 1.483 . . . . 0.0 110.274 149.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.91 137.75 56.42 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.95 134.25 52.1 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -158.01 -14.89 0.08 Allowed 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.8 -1.187 . . . . 0.0 112.381 -162.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.04 -4.73 29.31 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 119.731 -1.856 . . . . 0.0 113.928 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 60.37 38.38 19.56 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.15 14.09 17.1 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.706 -1.246 . . . . 0.0 111.404 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -96.93 6.4 48.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.114 1.366 . . . . 0.0 110.884 168.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 pt -138.69 163.77 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.321 1.048 . . . . 0.0 108.687 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.8 m -112.48 117.7 33.11 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.497 1.119 . . . . 0.0 109.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -81.26 -21.4 39.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.01 147.7 29.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 119.993 -1.692 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.63 127.36 26.92 Favored Pre-proline 0 C--N 1.356 0.884 0 O-C-N 120.628 -1.295 . . . . 0.0 108.509 -174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.39 -37.58 3.15 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.96 1.774 . . . . 0.0 113.096 -155.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.58 -46.66 97.28 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.25 -31.31 9.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 CA-C-N 123.66 2.343 . . . . 0.0 112.569 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.2 m -59.71 -41.15 90.18 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 119.649 1.113 . . . . 0.0 112.395 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.01 58.0 18.12 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -42.83 131.84 5.67 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 124.051 3.168 . . . . 0.0 116.528 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 79.96 15.12 0.85 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.4 -33.2 63.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 119.731 -1.855 . . . . 0.0 115.826 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -112.71 22.68 14.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 120.692 -1.255 . . . . 0.0 112.05 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -163.21 158.18 21.33 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 120.353 -1.467 . . . . 0.0 110.448 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.29 -40.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 O-C-N 120.353 -1.467 . . . . 0.0 114.279 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 t -163.85 171.45 15.41 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 119.513 -1.992 . . . . 0.0 109.699 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -143.89 123.93 13.62 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 159.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.47 109.06 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 O-C-N 120.431 -1.418 . . . . 0.0 107.832 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 t -149.23 130.49 14.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.87 -13.78 62.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.11 -18.4 62.53 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 120.265 -1.522 . . . . 0.0 113.939 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -120.82 9.45 10.69 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.195 -0.94 . . . . 0.0 113.233 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.1 172.35 12.96 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 56.57 -148.32 0.49 Allowed 'General case' 0 C--N 1.356 0.873 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.32 138.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 124.749 1.22 . . . . 0.0 110.286 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -102.28 -4.26 25.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 119.738 -1.851 . . . . 0.0 113.792 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 m -61.96 110.21 1.49 Allowed 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.454 1.102 . . . . 0.0 112.258 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -137.62 120.32 16.24 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -92.86 172.21 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.567 1.147 . . . . 0.0 110.842 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -53.59 136.56 53.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -69.58 -8.76 24.45 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.78 2.32 . . . . 0.0 115.017 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -134.32 119.0 18.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.884 0.874 . . . . 0.0 112.358 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 124' ' ' ASP . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.92 175.31 14.11 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.41 113.34 2.36 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -87.73 5.21 41.04 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.328 -1.483 . . . . 0.0 110.846 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -125.75 123.86 39.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.764 -1.21 . . . . 0.0 110.119 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -161.16 159.72 29.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.413 1.885 . . . . 0.0 106.404 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -142.88 166.98 23.15 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -96.77 -3.83 41.63 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 120.763 -1.21 . . . . 0.0 112.521 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -118.03 114.33 22.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.95 164.94 27.77 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.914 0.864 . . . . 0.0 111.161 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -105.83 112.92 26.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -100.6 -11.29 20.17 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' A' ' 100' ' ' ASP . 37.9 t -147.91 -174.13 4.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 120.222 -1.549 . . . . 0.0 107.132 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.54 -45.29 94.08 Favored 'Isoleucine or valine' 0 C--N 1.348 0.523 0 O-C-N 120.711 -1.243 . . . . 0.0 113.43 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.1 m120 47.39 53.3 11.14 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 127.221 2.208 . . . . 0.0 114.766 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tp -112.68 -12.78 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.35 125.76 40.19 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 119.447 -2.033 . . . . 0.0 110.412 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.04 -9.48 18.78 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 111.75 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.96 -45.11 95.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 125.209 1.404 . . . . 0.0 114.728 -169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -94.62 24.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.608 -1.307 . . . . 0.0 113.856 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.5 mt -109.69 127.7 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.298 1.439 . . . . 0.0 107.673 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -131.87 10.31 4.64 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.944 -1.723 . . . . 0.0 113.413 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -165.28 149.92 8.91 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.8 12.54 18.99 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.481 1.512 . . . . 0.0 111.733 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -139.98 128.82 23.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 119.53 -1.981 . . . . 0.0 108.966 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.3 -174.7 21.44 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 tt -161.07 166.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -120.93 130.18 53.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 167.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.96 112.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 118.204 0.456 . . . . 0.0 111.364 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' A' ' 83' ' ' SER . 14.2 t70 -59.25 -43.51 92.41 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.534 1.934 . . . . 0.0 115.797 -154.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.1 mmt85 -103.39 3.06 34.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.994 -1.691 . . . . 0.0 109.426 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.344 79.7 tttt 76.24 -40.13 0.38 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.581 1.953 . . . . 0.0 115.132 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 p -97.83 -13.08 21.51 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.488 1.115 . . . . 0.0 111.018 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -156.2 151.87 27.13 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -165.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.5 14.91 10.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 120.662 -1.274 . . . . 0.0 110.24 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -155.26 161.1 41.21 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.329 1.061 . . . . 0.0 111.4 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.9 126.77 28.53 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 155.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -58.68 138.24 57.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.756 -1.215 . . . . 0.0 111.845 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.43 8.17 58.76 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 121.614 -0.679 . . . . 0.0 114.147 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -90.75 108.54 19.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.368 -1.078 . . . . 0.0 110.294 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -119.87 108.29 14.18 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.817 -1.177 . . . . 0.0 111.797 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.03 -11.43 12.74 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.065 -1.022 . . . . 0.0 111.795 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.78 -59.86 1.62 Allowed 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.66 -1.275 . . . . 0.0 110.187 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.5 t -58.73 126.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.4 m -147.47 150.9 35.47 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 113.61 21.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.93 140.96 49.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.403 ' CG ' HH12 ' A' ' 66' ' ' ARG . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.48 159.2 19.11 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 t60 69.03 35.11 2.89 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.66 135.85 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.278 75.1 mtp85 59.72 46.3 11.81 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -118.16 164.15 15.59 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.659 1.184 . . . . 0.0 110.277 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t -90.62 -175.77 4.52 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.933 1.293 . . . . 0.0 110.815 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.2 pt -58.27 143.68 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.607 1.963 . . . . 0.0 116.255 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -62.09 149.03 42.38 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.7 p -75.91 152.99 37.0 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.646 -1.284 . . . . 0.0 111.527 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.8 p -83.3 26.22 0.66 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.917 -1.739 . . . . 0.0 112.638 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -126.56 1.96 6.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 120.547 -1.346 . . . . 0.0 110.689 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 156' ' ' GLU . 63.8 tttp -113.42 115.22 27.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.177 0.991 . . . . 0.0 108.883 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.8 p -97.36 1.97 50.01 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.299 3.0 mt 47.42 59.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 125.801 1.64 . . . . 0.0 115.185 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 153' ' ' LYS . 15.9 tp10 -163.41 58.73 0.18 Allowed 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 117.85 -3.031 . . . . 0.0 108.351 20.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.28 4.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 O-C-N 120.693 -1.255 . . . . 0.0 111.367 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 p -118.02 124.04 47.17 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -63.22 128.9 37.97 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.908 -1.12 . . . . 0.0 112.17 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.3 122.42 26.01 Favored Pre-proline 0 C--N 1.347 0.467 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -42.33 139.31 2.88 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.502 3.468 . . . . 0.0 116.815 167.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -145.22 139.88 27.48 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -168.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -108.61 30.73 6.2 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 108.894 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.19 -16.89 0.08 OUTLIER Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.78 146.49 66.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 CA-C-N 127.007 3.538 . . . . 0.0 114.859 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 66.91 39.62 3.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.696 1.199 . . . . 0.0 113.618 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.22 -36.97 0.2 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 120.666 -1.271 . . . . 0.0 114.8 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.37 -21.96 18.63 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 120.393 2.096 . . . . 0.0 110.65 171.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.58 160.11 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 161.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 t -151.13 179.78 7.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.288 95.0 m 78.45 104.81 0.07 Allowed 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.837 2.055 . . . . 0.0 113.332 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 29.75 61.71 0.17 Allowed 'General case' 0 C--N 1.361 1.069 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.87 34.02 0.28 Allowed 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.526 -1.359 . . . . 0.0 114.512 -169.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -42.08 86.16 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.33 2.652 . . . . 0.0 113.168 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.15 114.72 40.27 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.311 1.444 . . . . 0.0 111.776 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.42 141.07 11.1 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 111.978 -167.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -109.59 3.27 20.96 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.327 -1.483 . . . . 0.0 113.859 -169.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m 54.47 57.28 5.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.203 1.801 . . . . 0.0 114.35 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -148.73 147.21 28.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -99.23 -12.12 20.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.17 0.896 . . . . 0.0 110.435 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.4 105.75 15.99 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.019 -1.676 . . . . 0.0 108.36 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -99.76 6.42 45.47 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.312 -1.493 . . . . 0.0 113.56 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.05 1.99 56.1 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.827 1.299 . . . . 0.0 111.408 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 t -135.21 160.47 38.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -100.65 7.67 43.81 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 120.8 -1.187 . . . . 0.0 112.829 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.6 t -162.54 154.37 18.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 pt -83.63 -12.4 11.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 C-N-CA 123.503 0.721 . . . . 0.0 110.856 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -67.67 135.36 52.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.325 -1.484 . . . . 0.0 111.821 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.22 -40.03 5.07 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.859 -1.151 . . . . 0.0 111.411 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t -122.27 125.13 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.481 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.55 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.01 18.35 2.29 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.06 -175.89 49.92 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 120.066 -1.646 . . . . 0.0 114.08 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -97.37 -6.92 33.05 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.1 mt -145.29 -64.03 0.33 Allowed 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 59.04 49.76 9.06 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.156 1.782 . . . . 0.0 112.127 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.9 m120 70.98 42.48 0.74 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.549 1.54 . . . . 0.0 111.786 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.0 m 47.35 57.16 6.08 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.705 2.402 . . . . 0.0 114.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 138.57 32.94 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.82 132.65 54.7 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.612 -1.305 . . . . 0.0 109.617 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 67.27 -179.19 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.435 15.6 p 82.34 19.29 0.31 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 130.026 3.33 . . . . 0.0 113.829 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -117.31 -39.29 3.21 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.69 -1.256 . . . . 0.0 110.774 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -52.57 177.66 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 131.574 3.95 . . . . 0.0 118.394 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -49.47 118.77 2.94 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.55 1.54 . . . . 0.0 113.77 167.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.55 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.991 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -163.28 154.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.045 1.423 . . . . 0.0 111.226 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -146.67 139.32 25.15 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 60.33 52.55 4.77 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 167.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -129.9 160.29 34.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.07 161.2 40.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 120.812 -1.18 . . . . 0.0 107.938 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.12 135.38 54.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.88 144.18 27.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -158.18 84.62 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.262 -1.524 . . . . 0.0 110.083 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.18 108.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 123.324 1.535 . . . . 0.0 114.724 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.7 p -88.2 -1.21 57.88 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 118.303 -2.748 . . . . 0.0 111.508 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -93.26 1.94 56.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.47 1.508 . . . . 0.0 112.314 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -66.92 149.39 50.67 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.673 -0.642 . . . . 0.0 111.805 170.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.3 t80 16.43 78.77 0.11 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 130.245 3.418 . . . . 0.0 118.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.25 -4.24 5.89 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.287 1.991 . . . . 0.0 111.737 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.24 -38.74 71.6 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -103.83 31.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 CA-C-N 125.333 2.94 . . . . 0.0 109.367 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -151.06 -178.06 6.39 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.858 -1.151 . . . . 0.0 108.535 -175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.29 103.84 23.0 Favored Pre-proline 0 N--CA 1.444 -0.751 0 O-C-N 120.567 -1.333 . . . . 0.0 108.822 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.01 146.37 80.76 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 C-N-CA 122.871 2.381 . . . . 0.0 113.377 164.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.77 5.27 14.13 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 121.203 -0.936 . . . . 0.0 112.632 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.3 120.97 10.48 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.278 -1.514 . . . . 0.0 108.172 165.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.26 147.03 45.85 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.9 tttt 81.8 -49.3 0.23 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.357 2.263 . . . . 0.0 113.036 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.96 -25.34 6.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 O-C-N 121.845 -0.534 . . . . 0.0 111.847 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.255 72.3 m 64.1 31.37 13.45 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -62.14 127.46 31.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.895 -1.128 . . . . 0.0 113.593 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.07 109.1 26.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-O 122.898 1.332 . . . . 0.0 109.664 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.8 m -76.65 -23.55 53.29 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 120.251 -1.53 . . . . 0.0 112.085 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.75 -45.31 94.45 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 120.144 -1.597 . . . . 0.0 112.842 171.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -60.07 -41.81 93.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.785 1.634 . . . . 0.0 113.894 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -75.37 -10.62 59.62 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -101.72 -10.07 20.3 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.202 -0.936 . . . . 0.0 112.836 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 pt -95.31 179.05 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 119.844 -1.785 . . . . 0.0 111.914 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 63.06 169.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.383 3.7 p 46.37 -147.88 0.14 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.296 2.638 . . . . 0.0 117.461 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 53.06 62.19 2.8 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m 62.72 60.43 1.3 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.09 -43.62 93.22 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 124.96 1.304 . . . . 0.0 114.319 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -142.66 82.11 12.8 Favored Pre-proline 0 C--N 1.347 0.491 0 O-C-N 120.842 -1.161 . . . . 0.0 112.295 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -88.48 75.82 1.71 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.612 1.542 . . . . 0.0 108.679 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.2 160.94 34.65 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 124.491 1.116 . . . . 0.0 109.856 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.55 118.4 20.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -86.18 -17.86 33.77 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 119.779 -1.825 . . . . 0.0 113.227 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.48 105.3 4.78 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.185 -171.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.28 -28.26 67.03 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 46.44 42.17 10.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 127.473 2.309 . . . . 0.0 114.062 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -66.99 143.11 56.99 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.29 -37.89 70.49 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.82 13.74 34.01 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.998 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 62.74 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -155.73 8.72 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.634 -1.291 . . . . 0.0 113.068 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . 0.268 86.6 m-85 60.03 50.7 6.39 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -63.82 134.7 55.72 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.7 165.51 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.922 1.289 . . . . 0.0 109.298 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.1 m120 55.63 35.37 25.1 Favored 'General case' 0 C--N 1.365 1.266 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.58 -46.22 95.53 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' CD ' HH22 ' A' ' 90' ' ' ARG . 0.4 OUTLIER -145.12 -3.97 0.74 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.68 -1.262 . . . . 0.0 111.884 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -162.12 166.13 26.14 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.16 -42.85 94.9 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 120.113 -1.617 . . . . 0.0 112.622 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.451 HH22 ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -61.96 134.35 56.54 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.29 151.18 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 O-C-N 120.727 -1.233 . . . . 0.0 112.478 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.19 164.64 28.67 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -79.31 -27.03 42.14 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -85.18 92.85 8.51 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.44 -1.413 . . . . 0.0 110.49 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -104.4 0.94 29.58 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.967 -1.083 . . . . 0.0 111.773 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.13 173.44 50.28 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 124.424 1.012 . . . . 0.0 111.673 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.3 mt -118.82 133.42 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.942 1.297 . . . . 0.0 108.794 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -87.61 116.65 25.88 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 120.829 -1.17 . . . . 0.0 110.325 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.4 pt -92.48 175.2 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 122.499 1.142 . . . . 0.0 112.43 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -95.44 3.03 54.68 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.144 2.978 . . . . 0.0 112.649 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -116.03 148.69 39.91 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 120.756 -1.215 . . . . 0.0 113.963 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -82.32 165.27 20.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.945 1.298 . . . . 0.0 113.339 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -129.29 166.25 19.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.344 3.3 mm-40 70.51 48.43 0.46 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 124.615 2.15 . . . . 0.0 112.781 -169.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -94.38 7.76 44.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.662 -173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 65.98 37.93 5.14 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-O 123.83 1.776 . . . . 0.0 112.273 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 166.77 139.21 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -145.48 132.11 19.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -170.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.24 163.45 0.52 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 119.348 2.499 . . . . 0.0 119.348 -169.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -54.88 136.1 47.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.254 1.821 . . . . 0.0 115.737 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.69 0.72 10.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.413 1.101 . . . . 0.0 108.396 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -74.51 -10.56 59.67 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 119.661 -1.899 . . . . 0.0 112.752 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.36 45.75 2.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.725 1.21 . . . . 0.0 109.293 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.93 120.93 61.97 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.804 -1.185 . . . . 0.0 108.598 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . 0.331 92.5 p 10.96 96.76 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 129.195 2.998 . . . . 0.0 118.359 -169.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.4 p -160.46 164.63 32.07 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.028 -1.045 . . . . 0.0 110.393 -171.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt -140.43 140.36 35.42 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.56 154.65 30.32 Favored Glycine 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 65.64 32.51 9.1 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.2 m -63.16 -41.14 91.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -163.9 158.47 19.87 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -94.02 -11.61 30.37 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.981 0.896 . . . . 0.0 112.142 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.7 t -167.0 172.85 9.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.8 tt -111.32 -8.35 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.877 0.871 . . . . 0.0 110.557 163.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -63.72 144.59 56.91 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.57 -1.332 . . . . 0.0 113.117 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.4 t -138.44 19.0 2.73 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 78.6 m -60.38 138.87 57.91 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.034 -1.666 . . . . 0.0 114.106 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -138.58 24.79 2.65 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.941 -1.724 . . . . 0.0 110.682 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -128.16 116.56 20.11 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.992 -1.067 . . . . 0.0 109.24 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 m -63.66 -40.24 96.36 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.405 1.082 . . . . 0.0 113.065 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 25.8 pt -143.06 157.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.78 137.91 37.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.123 0.969 . . . . 0.0 110.655 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.96 -5.28 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 123.849 0.86 . . . . 0.0 110.587 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.9 m -85.12 122.4 29.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.344 -0.848 . . . . 0.0 109.163 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 p -59.15 147.75 34.04 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.066 1.412 . . . . 0.0 114.134 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 119.59 71.95 Favored Pre-proline 0 C--O 1.243 0.754 0 O-C-N 120.262 -1.524 . . . . 0.0 111.567 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.39 132.82 12.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.391 3.394 . . . . 0.0 116.718 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t 77.54 7.7 2.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.969 2.107 . . . . 0.0 113.618 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -103.56 109.29 20.9 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 120.55 -1.344 . . . . 0.0 109.527 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.85 93.35 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.17 115.75 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 CA-C-N 124.985 2.816 . . . . 0.0 111.93 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -60.32 -42.12 94.96 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.881 -1.137 . . . . 0.0 113.127 165.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 136.12 -174.63 21.34 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 178.33 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.262 1.425 . . . . 0.0 110.374 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.79 -30.03 23.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-O 123.803 1.763 . . . . 0.0 109.919 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -152.51 166.34 32.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 86.7 m -94.7 128.46 41.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.492 1.117 . . . . 0.0 108.852 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -93.43 139.03 31.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.115 -0.991 . . . . 0.0 113.385 -171.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 69.16 48.47 0.67 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.52 1.528 . . . . 0.0 112.642 168.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 p -95.86 8.69 42.88 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.277 1.831 . . . . 0.0 110.178 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.59 112.72 7.1 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.672 2.389 . . . . 0.0 111.264 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -62.02 128.79 25.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.955 1.77 . . . . 0.0 113.885 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -65.98 106.56 1.62 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.682 -0.636 . . . . 0.0 111.547 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.4 p -64.25 148.53 49.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.7 2.0 . . . . 0.0 114.888 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.69 137.21 53.47 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.681 -1.262 . . . . 0.0 109.182 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.59 149.55 41.16 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.63 116.6 20.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.892 0.853 . . . . 0.0 112.372 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.64 6.32 14.51 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.382 1.073 . . . . 0.0 109.571 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -104.98 -34.05 8.13 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 120.164 -1.585 . . . . 0.0 111.69 -164.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.4 p -69.47 -29.34 66.98 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.05 -1.031 . . . . 0.0 112.636 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.28 29.09 18.58 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.673 1.189 . . . . 0.0 112.234 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 t 69.76 101.86 0.06 Allowed 'General case' 0 C--N 1.346 0.44 0 C-N-CA 127.841 2.456 . . . . 0.0 113.137 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.6 pt -74.81 -19.78 16.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 122.924 1.345 . . . . 0.0 114.558 -173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -120.09 144.15 47.76 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 119.261 -2.15 . . . . 0.0 106.871 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.403 HH12 ' CD ' ' A' ' 221' ' ' GLU . 99.3 mtt180 -137.37 161.09 37.24 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.65 -170.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.73 134.9 29.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 124.936 1.294 . . . . 0.0 111.301 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.4 ' HG1' ' HB3' ' A' ' 206' ' ' LEU . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.528 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.4 ' HB3' ' HG1' ' A' ' 203' ' ' THR . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -56.16 146.09 24.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.77 -163.13 13.98 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 112.224 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -65.51 151.38 46.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.635 1.974 . . . . 0.0 115.507 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.23 9.21 34.74 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -165.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' CD ' HH12 ' A' ' 189' ' ' ARG . 5.0 mt-10 -53.73 -37.35 63.24 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -163.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -122.63 22.0 9.96 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 89.9 m -113.71 106.25 14.27 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 120.886 -1.134 . . . . 0.0 110.324 -165.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -65.83 -40.2 91.55 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 120.389 -1.445 . . . . 0.0 114.194 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -143.9 134.32 24.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.965 -1.085 . . . . 0.0 108.659 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -103.59 -5.61 22.51 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.931 1.348 . . . . 0.0 109.606 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 p -91.0 1.64 56.92 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.091 1.756 . . . . 0.0 111.141 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.508 ' CD2' ' HG3' ' A' ' 229' ' ' GLU . 8.9 t-160 59.42 -106.52 0.29 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 165.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 228' ' ' HIS . 48.7 mt-10 -149.27 142.46 25.04 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.433 1.493 . . . . 0.0 107.807 -171.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -151.67 163.13 39.78 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.318 -1.489 . . . . 0.0 111.162 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.528 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.053 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.05 136.95 30.7 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -98.04 -62.55 1.23 Allowed 'General case' 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.57 156.51 32.75 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.196 -0.94 . . . . 0.0 112.106 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -124.32 137.03 54.53 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 120.965 -1.085 . . . . 0.0 108.321 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.47 20.57 1.35 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.364 1.554 . . . . 0.0 111.81 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . 0.262 26.5 p90 -135.71 162.89 31.47 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.273 -1.517 . . . . 0.0 111.613 173.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.35 136.97 58.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.682 2.393 . . . . 0.0 113.976 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -104.43 -6.19 20.95 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.375 -1.453 . . . . 0.0 114.305 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.257 10.4 mm 35.97 60.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 128.517 2.727 . . . . 0.0 116.109 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -59.13 -40.74 86.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -166.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.59 14.53 26.3 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 120.294 -1.504 . . . . 0.0 114.04 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.457 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 69.2 m-20 70.26 17.12 7.17 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 120.42 -1.425 . . . . 0.0 114.579 172.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -67.73 142.81 96.18 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 120.582 -1.324 . . . . 0.0 112.349 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -103.94 -10.12 0.13 Allowed 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 122.027 1.76 . . . . 0.0 108.299 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.93 153.4 54.85 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 129.256 3.022 . . . . 0.0 113.744 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -38.49 134.52 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.6 2.867 . . . . 0.0 117.059 156.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -72.5 -25.2 61.32 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 126.15 1.78 . . . . 0.0 113.783 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.18 144.4 58.41 Favored Pre-proline 0 N--CA 1.446 -0.641 0 O-C-N 121.488 -0.757 . . . . 0.0 111.627 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -57.05 159.55 14.68 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.248 1.965 . . . . 0.0 113.198 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 76.54 47.19 0.08 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.476 1.11 . . . . 0.0 111.856 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.8 -35.96 75.74 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.493 1.917 . . . . 0.0 115.434 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 55.63 49.16 17.04 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.257 62.9 tttm 92.5 -10.7 0.19 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.742 2.417 . . . . 0.0 112.076 172.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.1 mt -81.66 118.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 O-C-N 120.184 -1.572 . . . . 0.0 109.743 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 t -151.79 -89.87 0.06 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.47 0.708 . . . . 0.0 109.727 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 -3.94 57.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.725 -1.859 . . . . 0.0 112.19 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -115.32 120.0 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -154.17 154.49 33.63 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.76 147.85 36.42 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.18 -39.02 69.07 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -71.71 -16.07 62.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.577 1.551 . . . . 0.0 112.422 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -85.65 -1.9 57.63 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 119.423 -2.048 . . . . 0.0 111.554 174.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 48.64 58.27 5.44 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.44 121.95 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.267 92.6 mtt-85 72.22 3.53 4.71 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -152.74 19.96 0.61 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.125 -2.235 . . . . 0.0 110.82 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -58.88 -42.93 90.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.7 t -67.08 151.93 46.7 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.26 -68.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.69 1.596 . . . . 0.0 110.385 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -53.31 105.73 0.57 Allowed Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -166.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -60.03 173.3 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.677 3.585 . . . . 0.0 115.531 165.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -114.0 -24.09 9.22 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -156.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.409 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.11 168.97 25.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -133.9 41.32 3.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -61.68 -39.43 91.42 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.223 1.409 . . . . 0.0 113.535 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -86.4 161.2 18.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.005 0.922 . . . . 0.0 111.297 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HZ1' ' CG ' ' A' ' 25' ' ' ASP . 44.1 mmtm -60.02 147.63 38.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 123.007 1.384 . . . . 0.0 114.231 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -148.71 147.24 28.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -166.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 56.11 53.97 8.43 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.734 1.614 . . . . 0.0 114.384 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -102.95 111.41 23.73 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.411 -1.431 . . . . 0.0 111.361 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -116.17 143.42 45.52 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 111.097 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -114.92 115.62 27.21 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.63 -1.294 . . . . 0.0 110.389 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -101.71 -6.02 24.23 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 122.95 0.5 . . . . 0.0 111.26 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 p -85.3 122.03 28.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.559 -1.338 . . . . 0.0 110.343 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -98.49 -20.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.859 -1.15 . . . . 0.0 111.675 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -97.06 168.56 10.38 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.755 -1.216 . . . . 0.0 112.208 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 mm -63.14 117.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 124.198 0.999 . . . . 0.0 110.544 165.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -85.3 135.33 33.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.873 -1.142 . . . . 0.0 110.154 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -124.55 133.06 53.42 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 119.398 -2.063 . . . . 0.0 109.588 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.35 166.99 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.774 0.83 . . . . 0.0 109.861 -164.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -113.74 11.86 18.18 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.368 -0.833 . . . . 0.0 112.071 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 pt -91.28 138.51 19.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.811 0.815 . . . . 0.0 110.549 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -91.08 134.9 34.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 119.982 -1.699 . . . . 0.0 112.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -116.91 120.24 37.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.6 -44.97 93.22 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -109.75 142.75 40.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 120.409 -1.432 . . . . 0.0 109.967 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.17 178.6 0.05 OUTLIER Glycine 0 C--N 1.356 1.684 0 N-CA-C 120.042 2.777 . . . . 0.0 120.042 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.306 9.8 mt 71.44 122.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.339 1.856 . . . . 0.0 114.255 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -78.54 144.13 35.91 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 110.581 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 tp -158.52 10.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.658 0 O-C-N 120.165 -1.584 . . . . 0.0 111.488 -168.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 20.14 -107.44 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 130.142 3.377 . . . . 0.0 118.761 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -96.51 18.47 14.01 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 120.874 -1.141 . . . . 0.0 111.884 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 62.94 51.89 2.77 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.109 2.163 . . . . 0.0 116.805 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.4 p -103.64 -1.04 28.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.238 -0.914 . . . . 0.0 112.142 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.18 140.67 57.87 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.641 1.21 . . . . 0.0 112.888 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -122.01 111.22 16.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -167.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . 0.32 36.4 mt-30 110.61 14.42 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 C-N-CA 130.014 3.325 . . . . 0.0 110.912 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.33 165.41 22.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 123.642 1.687 . . . . 0.0 108.892 172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.64 -38.81 82.39 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.404 -1.435 . . . . 0.0 112.813 173.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.95 21.66 29.15 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 124.746 1.165 . . . . 0.0 115.613 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -57.51 119.71 7.0 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.779 1.289 . . . . 0.0 110.376 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -67.99 -28.11 67.16 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.643 -1.911 . . . . 0.0 115.564 -168.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -94.58 15.97 16.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.056 -1.028 . . . . 0.0 113.121 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.0 -19.64 57.04 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.833 -1.792 . . . . 0.0 111.666 168.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -118.37 147.62 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 t -84.01 -179.89 7.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 123.173 1.463 . . . . 0.0 110.361 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.6 m -102.64 9.34 39.35 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 119.777 -1.827 . . . . 0.0 109.396 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt -128.53 151.07 49.86 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.072 1.349 . . . . 0.0 113.763 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.56 154.61 22.62 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -89.53 135.94 33.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.327 1.06 . . . . 0.0 112.778 -167.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.76 159.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -162.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.336 99.2 mtt180 89.21 20.71 0.04 OUTLIER 'General case' 0 C--N 1.362 1.145 0 C-N-CA 126.608 1.963 . . . . 0.0 113.603 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -81.99 128.51 34.15 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.298 1.039 . . . . 0.0 112.475 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.07 125.59 30.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.764 0.825 . . . . 0.0 109.636 166.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.8 tp -67.53 -33.64 63.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 123.098 1.428 . . . . 0.0 111.291 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -44.04 97.02 Favored 'General case' 0 N--CA 1.439 -1.005 1 C-N-CA 133.013 4.525 . . . . 0.0 112.663 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.1 t -85.24 175.56 8.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 124.222 1.963 . . . . 0.0 114.138 -166.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.1 p -65.46 119.37 10.91 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 119.955 -1.716 . . . . 0.0 112.645 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.99 -4.26 49.95 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 120.871 -1.143 . . . . 0.0 112.924 -169.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 78.28 18.42 1.09 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.66 1.584 . . . . 0.0 112.523 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 154.63 38.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.67 2.788 . . . . 0.0 116.445 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.55 22.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 120.805 -1.184 . . . . 0.0 110.615 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.52 129.51 40.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.9 m -117.98 11.05 7.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 124.417 1.087 . . . . 0.0 112.705 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.7 m -97.24 104.68 16.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 119.314 -2.116 . . . . 0.0 110.272 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 113.15 2.73 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.889 1.276 . . . . 0.0 114.26 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.94 147.08 96.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.904 1.282 . . . . 0.0 113.934 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.44 -8.56 18.45 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.391 2.06 . . . . 0.0 112.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.3 t -161.69 155.63 21.93 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -103.1 5.77 38.15 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.641 0.776 . . . . 0.0 111.29 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.05 73.13 Favored Pre-proline 0 N--CA 1.444 -0.768 0 O-C-N 121.448 -0.783 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.2 166.36 3.34 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.614 2.876 . . . . 0.0 116.143 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.259 34.7 m120 80.73 26.6 0.26 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 163.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.51 165.56 6.19 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-O 122.415 1.008 . . . . 0.0 115.54 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.65 135.13 57.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.02 -1.871 . . . . 0.0 115.37 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.276 2.9 t 61.25 42.62 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 123.956 1.836 . . . . 0.0 113.026 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -98.97 3.52 47.03 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 120.044 -1.66 . . . . 0.0 111.914 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -119.11 138.83 52.63 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.589 -1.319 . . . . 0.0 110.784 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -69.0 -29.02 67.12 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 77.46 37.55 0.24 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.233 1.413 . . . . 0.0 113.359 168.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.7 m -171.31 107.45 0.26 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -75.07 145.13 80.32 Favored Pre-proline 0 C--N 1.354 0.768 0 O-C-N 120.939 -1.1 . . . . 0.0 113.167 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.16 152.26 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.194 3.263 . . . . 0.0 116.964 157.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.14 149.91 21.23 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 121.934 0.873 . . . . 0.0 112.852 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.8 p -85.47 115.48 23.21 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 121.101 -1.0 . . . . 0.0 111.331 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -156.72 150.72 24.95 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 86.76 27.65 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.841 1.656 . . . . 0.0 112.81 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.56 -41.25 76.55 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.983 3.313 . . . . 0.0 113.575 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -60.02 -33.78 72.48 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.157 1.383 . . . . 0.0 114.663 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -99.6 -1.48 38.03 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.141 1.164 . . . . 0.0 114.141 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 98.8 p -153.39 147.45 25.57 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.349 -1.469 . . . . 0.0 113.324 -166.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -136.13 124.55 23.43 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 118.305 -2.747 . . . . 0.0 109.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.7 t -59.2 144.67 45.29 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . 0.488 42.2 pt 50.96 13.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.803 0 N-CA-C 119.159 3.022 . . . . 0.0 119.159 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -60.6 -35.96 77.39 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 126.049 1.739 . . . . 0.0 111.791 170.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 79.18 -52.91 0.44 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 127.65 2.38 . . . . 0.0 113.529 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.62 148.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.644 1.578 . . . . 0.0 114.326 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.579 ' CG ' ' HG1' ' A' ' 207' ' ' THR . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.579 ' HG1' ' CG ' ' A' ' 201' ' ' ASP . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 220' ' ' LEU . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -62.33 127.52 31.71 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.28 -1.22 57.33 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.691 0.662 . . . . 0.0 113.459 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -128.96 -36.86 1.75 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 126.746 2.018 . . . . 0.0 108.702 166.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.402 ' HA ' ' CD2' ' A' ' 215' ' ' HIS . 67.1 tp -65.13 128.52 36.13 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.313 1.445 . . . . 0.0 113.773 167.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -157.52 -86.65 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 75.09 12.55 3.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.553 1.541 . . . . 0.0 113.574 165.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 4.4 m 64.94 36.0 7.91 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.539 1.637 . . . . 0.0 111.695 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -94.44 96.98 9.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 119.461 -2.025 . . . . 0.0 114.843 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -75.95 -17.91 59.54 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 119.632 -1.917 . . . . 0.0 113.974 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -152.14 157.31 41.37 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.492 1.517 . . . . 0.0 107.086 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.9 m -156.01 146.77 22.02 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -147.43 149.36 32.56 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.32 -159.12 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.176 1.79 . . . . 0.0 113.789 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.85 -13.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.457 -1.402 . . . . 0.0 114.104 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.951 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 -109.93 151.48 27.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 155.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.34 144.98 49.42 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.65 12.33 0.61 Allowed 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.561 -1.337 . . . . 0.0 114.334 -167.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -90.19 2.99 54.78 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 118.863 -2.398 . . . . 0.0 112.786 -167.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.68 50.03 8.59 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 118.073 2.619 . . . . 0.0 118.073 170.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -100.6 92.22 5.01 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.165 -1.584 . . . . 0.0 110.768 -164.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.601 ' CD ' ' HZ3' ' A' ' 226' ' ' LYS . 24.9 pt-20 -107.19 -16.08 14.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -100.08 -2.09 35.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.554 -1.341 . . . . 0.0 112.943 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.263 5.0 mm 41.02 56.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 127.967 2.507 . . . . 0.0 115.52 172.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 p -89.46 5.98 42.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 119.665 -1.897 . . . . 0.0 113.014 -167.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 50.35 37.2 14.72 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 128.837 2.855 . . . . 0.0 116.409 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -108.54 -10.57 15.23 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 121.092 -1.005 . . . . 0.0 112.194 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.21 -44.52 77.05 Favored Pre-proline 0 C--N 1.349 0.587 0 CA-C-O 116.851 -1.547 . . . . 0.0 114.301 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -44.72 140.19 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.82 3.013 . . . . 0.0 117.3 159.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' CD ' HH12 ' A' ' 45' ' ' ARG . 65.0 mm-40 -64.55 139.87 97.85 Favored Pre-proline 0 C--N 1.354 0.789 0 O-C-N 121.3 -0.875 . . . . 0.0 113.05 164.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -90.05 136.68 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.598 1.606 . . . . 0.0 112.325 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 p -89.99 -16.55 29.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.79 151.04 22.51 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 120.647 -1.283 . . . . 0.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.06 136.7 76.29 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.607 2.204 . . . . 0.0 112.21 155.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.49 159.38 41.31 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 120.169 1.349 . . . . 0.0 110.815 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 62.54 42.67 8.39 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.646 1.578 . . . . 0.0 112.765 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 65.06 42.78 3.99 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.813 1.245 . . . . 0.0 113.191 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.1 159.88 37.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -138.64 143.2 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 O-C-N 121.167 -0.958 . . . . 0.0 109.35 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.5 m -89.01 12.52 15.28 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 121.111 -0.993 . . . . 0.0 112.193 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.73 3.67 47.65 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 111.424 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.89 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.0 p -63.74 133.63 53.87 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.106 -0.996 . . . . 0.0 113.535 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' CG ' ' HE ' ' A' ' 48' ' ' ARG . 62.2 m-20 65.83 19.63 11.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -96.81 3.81 52.06 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.135 -2.228 . . . . 0.0 111.422 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -156.08 154.06 30.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 119.894 -1.754 . . . . 0.0 109.74 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.439 HH12 ' CD ' ' A' ' 28' ' ' GLU 0.328 60.1 ttt180 76.77 -58.57 0.51 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 127.066 2.147 . . . . 0.0 114.992 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 m120 63.77 44.34 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 160.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.38 -3.68 9.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 O-C-N 120.528 -1.357 . . . . 0.0 113.543 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HE ' ' CG ' ' A' ' 42' ' ' ASP . 31.1 ptt85 -74.6 -15.95 60.81 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.229 -2.169 . . . . 0.0 114.568 -168.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -97.37 -0.71 45.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.629 1.972 . . . . 0.0 111.181 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -75.93 117.41 17.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.048 -1.032 . . . . 0.0 111.693 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -76.59 128.63 35.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.104 -1.622 . . . . 0.0 110.695 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.12 123.79 48.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-O 122.498 1.142 . . . . 0.0 109.032 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -88.36 124.67 65.77 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 126.603 1.961 . . . . 0.0 110.603 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -58.99 147.3 90.72 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 123.701 2.358 . . . . 0.0 111.534 162.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -120.7 116.02 24.47 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.506 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.09 -87.15 0.58 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.49 ' NH2' ' HH ' ' A' ' 82' ' ' TYR . 11.4 ptt180 -144.69 134.12 23.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.199 -1.563 . . . . 0.0 108.131 172.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.78 145.29 35.38 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.494 HH21 ' CE1' ' A' ' 143' ' ' HIS . 29.6 mmt180 -73.73 78.21 1.55 Allowed 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.641 -1.287 . . . . 0.0 112.803 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.08 20.13 16.58 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 120.81 -1.181 . . . . 0.0 110.473 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.26 47.8 m95 64.04 0.91 1.05 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -69.44 -30.72 68.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.041 -1.662 . . . . 0.0 114.517 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.49 160.55 25.35 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.044 -1.035 . . . . 0.0 113.222 -165.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.268 14.0 m-80 88.64 43.22 0.01 OUTLIER 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.48 2.312 . . . . 0.0 113.78 176.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -111.59 21.81 15.72 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.043 -1.036 . . . . 0.0 112.457 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' HH ' ' NH2' ' A' ' 73' ' ' ARG . 26.7 m-85 -59.83 -40.65 89.17 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 126.89 2.076 . . . . 0.0 113.609 -171.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -124.73 109.6 13.32 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 120.846 -1.159 . . . . 0.0 110.168 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.22 127.46 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 120.54 -1.35 . . . . 0.0 108.161 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -120.53 35.83 4.75 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.1 mt -118.54 116.07 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 165.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -118.71 133.04 56.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.84 2.33 3.4 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.353 -0.842 . . . . 0.0 112.349 -166.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -39.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.878 0.847 . . . . 0.0 109.921 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -97.6 159.99 14.59 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.29 1.519 . . . . 0.0 113.637 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.86 126.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 O-C-N 120.28 -1.512 . . . . 0.0 111.747 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -112.93 131.4 55.76 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.171 -1.581 . . . . 0.0 109.972 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -147.73 151.01 35.36 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.72 163.62 39.63 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -99.93 99.73 10.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.61 -145.37 5.11 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 126.227 1.87 . . . . 0.0 116.492 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.4 pt -43.87 164.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -110.62 20.83 17.26 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 120.232 -1.543 . . . . 0.0 114.845 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.9 mm -112.26 120.24 62.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 O-C-N 120.872 -1.142 . . . . 0.0 109.843 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.64 38.95 6.81 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.882 2.073 . . . . 0.0 115.976 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -114.56 14.76 17.77 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU . 32.1 mmtp -136.34 127.69 28.36 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 121.017 -1.052 . . . . 0.0 109.006 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -62.53 103.64 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.92 -1.113 . . . . 0.0 112.946 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.88 37.59 12.0 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -154.78 144.6 21.62 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 119.588 -1.945 . . . . 0.0 107.543 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -116.36 132.64 56.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.123 -0.985 . . . . 0.0 112.667 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 102' ' ' LYS . 11.6 pt-20 -122.26 7.98 9.69 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.958 -1.089 . . . . 0.0 112.954 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.4 145.03 56.71 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 119.037 -2.289 . . . . 0.0 113.108 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.24 -7.98 3.81 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 110.634 167.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 88.39 6.09 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 121.388 -1.066 . . . . 0.0 108.618 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -116.89 128.75 55.54 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.767 1.27 . . . . 0.0 111.553 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -59.73 151.11 25.99 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.784 1.634 . . . . 0.0 113.179 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 54.48 4.52 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 121.053 3.723 . . . . 0.0 121.053 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -33.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 126.539 1.936 . . . . 0.0 116.224 -168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.9 m -127.05 21.56 6.79 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.573 -1.329 . . . . 0.0 112.294 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.0 m -61.92 150.5 37.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp -113.93 129.89 56.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.506 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.21 173.18 53.08 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.494 ' CE1' HH21 ' A' ' 75' ' ' ARG . 46.5 p-80 -93.79 6.02 49.76 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.549 -1.559 . . . . 0.0 111.778 -172.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 141.48 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.293 1.044 . . . . 0.0 108.231 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -138.07 137.56 37.9 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.255 1.422 . . . . 0.0 107.354 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -110.64 155.78 21.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.405 1.097 . . . . 0.0 111.201 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.1 p -72.93 154.82 40.39 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.73 1.212 . . . . 0.0 110.597 158.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.3 tt -89.51 143.31 11.45 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 O-C-N 121.068 -1.02 . . . . 0.0 111.579 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -87.46 141.7 28.43 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-O 121.94 0.876 . . . . 0.0 111.857 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 m -99.76 24.38 8.44 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.85 -1.156 . . . . 0.0 113.917 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.22 168.93 24.89 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 119.506 -1.997 . . . . 0.0 109.708 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -82.28 -23.77 35.06 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.476 -1.39 . . . . 0.0 112.717 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.504 ' HZ3' ' CD ' ' A' ' 156' ' ' GLU . 28.7 ttmt -134.39 103.85 5.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.7 m -74.46 -37.18 63.31 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 121.267 -0.896 . . . . 0.0 112.858 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.95 160.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' CD ' ' HZ3' ' A' ' 153' ' ' LYS . 41.2 tp10 -59.4 -39.81 84.6 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -172.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.7 m -75.66 -17.44 15.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 24.5 m -87.15 117.73 26.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 122.021 0.915 . . . . 0.0 109.058 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 m -59.8 133.84 56.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.4 130.33 94.6 Favored Pre-proline 0 C--N 1.356 0.883 0 O-C-N 119.86 -1.775 . . . . 0.0 113.21 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 137.03 3.46 Favored 'Trans proline' 0 C--O 1.235 0.356 0 CA-C-N 122.701 2.0 . . . . 0.0 112.528 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 m -94.88 -9.33 34.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.85 1.26 . . . . 0.0 112.307 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -105.93 25.41 10.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.986 0.898 . . . . 0.0 111.061 -167.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.62 141.71 82.9 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.31 153.0 18.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.596 3.53 . . . . 0.0 116.822 166.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -58.86 107.42 0.52 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.04 -2.83 33.46 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.165 0.888 . . . . 0.0 111.923 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.52 131.44 55.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.346 -1.09 . . . . 0.0 109.587 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.96 9.63 8.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 O-C-N 120.182 -1.573 . . . . 0.0 111.861 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 t -158.6 162.11 37.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -157.47 156.21 31.71 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.93 -1.106 . . . . 0.0 109.291 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -122.35 106.39 11.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -107.37 115.17 29.68 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.983 -1.073 . . . . 0.0 111.427 -163.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 91.7 m -65.33 -45.44 84.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.55 122.65 88.0 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 125.614 1.566 . . . . 0.0 112.849 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.72 -9.53 19.79 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.427 2.26 . . . . 0.0 113.127 -168.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -64.99 -34.77 79.24 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 112.539 168.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 m -95.89 -8.82 32.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.097 1.359 . . . . 0.0 109.326 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.17 133.05 48.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.38 -1.45 . . . . 0.0 112.22 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.84 8.43 44.18 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.72 -1.237 . . . . 0.0 110.983 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.11 -176.26 4.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -77.59 -22.93 50.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.347 -1.471 . . . . 0.0 114.327 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -156.93 163.7 38.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.008 0.909 . . . . 0.0 108.716 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.5 t -138.95 130.07 26.7 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 120.551 -1.343 . . . . 0.0 107.99 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -38.79 155.18 0.02 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 130.891 3.676 . . . . 0.0 118.85 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.9 t -83.24 65.1 8.09 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 110.656 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.4 mm -95.4 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 58.73 36.92 25.11 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -94.95 -0.15 54.16 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.769 -1.207 . . . . 0.0 114.11 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.11 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 O-C-N 119.726 -1.859 . . . . 0.0 112.858 168.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -37.7 153.64 0.02 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -177.3 -3.74 0.02 OUTLIER Glycine 0 C--N 1.356 1.642 0 O-C-N 119.804 -1.81 . . . . 0.0 116.738 -169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -145.43 135.24 23.53 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.21 -1.759 . . . . 0.0 109.914 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.0 tp 104.11 126.78 0.01 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 127.851 2.46 . . . . 0.0 106.345 -165.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . 0.315 22.5 mt-10 40.89 40.33 0.98 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 118.124 2.638 . . . . 0.0 118.124 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.01 24.19 12.4 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 168.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.2 p -58.88 130.74 48.41 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 228' ' ' HIS . 30.8 ptt180 -151.22 143.39 24.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.139 -1.601 . . . . 0.0 110.69 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -130.73 -166.93 1.76 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 122.772 1.272 . . . . 0.0 110.03 -167.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.601 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 92.3 mttt -89.96 -0.86 57.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.29 -1.506 . . . . 0.0 110.796 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.1 p -96.71 12.74 30.83 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.984 1.714 . . . . 0.0 110.848 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.576 ' CE1' ' HA ' ' A' ' 224' ' ' ARG . 8.1 m80 -92.18 83.96 5.17 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 165.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.33 122.44 35.73 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.35 122.92 21.98 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 120.567 -1.333 . . . . 0.0 110.729 154.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.996 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -157.43 168.48 27.2 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 171.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.307 26.0 mt 67.13 37.93 3.58 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.08 110.6 15.98 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -124.62 16.18 8.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 109.763 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.02 113.24 26.06 Favored 'General case' 0 N--CA 1.435 -1.18 0 O-C-N 121.209 -0.932 . . . . 0.0 110.514 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 71.67 44.42 0.51 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-O 122.408 1.099 . . . . 0.0 113.539 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CD ' ' HZ3' ' A' ' 226' ' ' LYS . 5.3 tp10 -114.66 141.5 47.72 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.78 -1.2 . . . . 0.0 108.675 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.519 ' CE1' ' H ' ' A' ' 50' ' ' ARG . 30.4 t60 54.55 26.78 7.63 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 128.072 2.549 . . . . 0.0 114.871 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 pt -63.84 140.22 20.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 119.156 -2.215 . . . . 0.0 112.713 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m 63.78 73.07 0.45 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.629 1.204 . . . . 0.0 114.043 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.461 ' CG ' ' H ' ' A' ' 25' ' ' ASP . 28.4 t60 -76.67 170.67 16.0 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.629 -1.295 . . . . 0.0 111.894 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' H ' ' CG ' ' A' ' 24' ' ' HIS . 2.6 t70 -66.14 148.28 52.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.342 1.457 . . . . 0.0 112.815 166.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -96.48 145.21 29.18 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 120.738 -1.226 . . . . 0.0 110.991 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -61.68 150.75 84.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.349 2.699 . . . . 0.0 114.444 169.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 142.11 96.87 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.37 141.92 18.11 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 115.909 158.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -61.33 -40.26 93.57 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.29 136.73 96.88 Favored Pre-proline 0 C--N 1.352 0.686 0 O-C-N 120.366 -1.458 . . . . 0.0 112.269 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.95 117.42 3.54 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 123.005 2.47 . . . . 0.0 114.457 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.39 155.31 36.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.275 88.2 mttt 76.6 11.38 2.66 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.619 1.168 . . . . 0.0 113.613 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -49.34 -34.49 15.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 129.195 2.998 . . . . 0.0 114.933 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.04 -42.11 97.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.348 -1.47 . . . . 0.0 114.96 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.83 -49.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 O-C-N 120.981 -1.074 . . . . 0.0 112.358 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.2 t -158.08 150.17 21.95 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.4 p -102.58 -10.68 19.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 120.989 -1.069 . . . . 0.0 111.368 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -121.39 -2.34 8.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.26 62.5 m 84.77 22.41 0.1 Allowed 'General case' 0 C--N 1.347 0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 114.809 166.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.49 -39.1 89.74 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -169.45 105.01 0.36 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.12 0.968 . . . . 0.0 109.032 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -94.02 -21.31 19.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 119.986 -1.696 . . . . 0.0 113.074 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -170.79 171.68 6.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.552 -1.342 . . . . 0.0 110.84 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.66 129.79 40.53 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.58 125.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 125.422 1.489 . . . . 0.0 113.706 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -101.11 3.66 41.43 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 119.387 -2.071 . . . . 0.0 114.421 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 m -65.63 111.42 3.16 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.943 -1.723 . . . . 0.0 113.484 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.519 ' H ' ' CE1' ' A' ' 21' ' ' HIS . 36.9 mtm180 -126.59 165.46 19.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -157.32 155.65 31.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 119.685 -1.885 . . . . 0.0 107.945 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.51 148.57 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 128.121 2.569 . . . . 0.0 114.533 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.57 ' HE1' ' CG ' ' A' ' 112' ' ' HIS . 92.8 m-70 -124.48 96.08 41.94 Favored Pre-proline 0 CA--C 1.501 -0.935 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.295 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.28 122.03 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.267 1.978 . . . . 0.0 110.982 154.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -133.56 158.14 43.92 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.886 0.874 . . . . 0.0 108.834 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 173.67 15.17 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 172.32 71.88 0.0 OUTLIER 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.907 1.283 . . . . 0.0 113.636 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -103.07 19.81 18.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.111 -0.993 . . . . 0.0 113.262 -168.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -114.93 141.55 47.8 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 119.854 -1.779 . . . . 0.0 107.706 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.56 140.35 58.86 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.107 -1.621 . . . . 0.0 112.211 168.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -108.55 -0.01 20.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.908 -1.12 . . . . 0.0 111.577 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.9 69.16 0.76 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.039 1.736 . . . . 0.0 113.858 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 81.0 147.65 0.09 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 127.353 2.261 . . . . 0.0 113.734 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -67.6 101.11 0.96 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.375 1.07 . . . . 0.0 111.166 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -162.86 163.43 26.46 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.058 -1.026 . . . . 0.0 108.591 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.61 96.37 6.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.105 -0.997 . . . . 0.0 109.014 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.7 m -73.97 -23.86 59.54 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.982 -1.699 . . . . 0.0 112.774 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.23 124.02 53.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -148.85 141.79 24.76 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.815 0.816 . . . . 0.0 110.909 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.8 mt -61.48 -46.47 96.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 126.35 1.86 . . . . 0.0 112.363 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.78 173.72 9.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.64 111.3 19.95 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.202 -1.561 . . . . 0.0 112.449 -165.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.65 17.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.907 -1.12 . . . . 0.0 111.873 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -136.56 151.8 49.78 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.806 -1.809 . . . . 0.0 110.72 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -59.81 -41.36 85.36 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-O 123.158 1.456 . . . . 0.0 112.252 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -162.75 177.29 9.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.37 160.71 28.71 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -57.7 -36.39 71.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.364 3.065 . . . . 0.0 112.854 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -15.32 60.93 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.863 1.265 . . . . 0.0 113.088 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.65 68.79 Favored Glycine 0 C--N 1.352 1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 113.786 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 pt -116.7 17.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 125.482 1.513 . . . . 0.0 110.537 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -149.51 159.83 43.98 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.37 1.89 8.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.98 8.11 43.92 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.157 -1.589 . . . . 0.0 110.58 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -156.25 145.47 20.59 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.308 -1.495 . . . . 0.0 107.99 -168.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -140.26 -21.57 0.85 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.145 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.6 m -71.21 116.15 11.18 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 120.837 -1.165 . . . . 0.0 113.373 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -58.63 126.53 28.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 55.28 41.72 31.01 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 125.171 1.388 . . . . 0.0 113.413 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -59.64 -42.25 92.34 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -83.2 10.69 7.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.633 1.573 . . . . 0.0 110.776 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -112.36 0.45 15.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.437 1.495 . . . . 0.0 111.346 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.9 177.08 13.63 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 125.512 1.529 . . . . 0.0 116.25 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -66.64 132.83 49.0 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 120.205 -1.762 . . . . 0.0 115.066 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 57.48 175.32 0.05 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 126.775 2.03 . . . . 0.0 116.015 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.57 ' CG ' ' HE1' ' A' ' 53' ' ' HIS 0.286 67.7 m-70 80.19 49.98 0.03 OUTLIER 'General case' 0 C--N 1.349 0.575 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 164.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.18 122.59 38.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.799 -1.188 . . . . 0.0 109.755 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . 0.348 39.4 t 78.09 -56.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 126.858 2.063 . . . . 0.0 113.937 174.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.8 t -151.01 139.24 20.24 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.177 0.899 . . . . 0.0 109.961 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.9 p -173.1 -178.99 1.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.49 1.516 . . . . 0.0 108.594 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt 66.36 -156.64 0.25 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.561 1.944 . . . . 0.0 114.118 -173.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.39 -31.89 11.09 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -159.78 156.59 27.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.702 2.001 . . . . 0.0 107.431 171.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.42 140.59 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.576 1.15 . . . . 0.0 113.632 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.06 -45.61 91.37 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . 0.298 87.0 m-70 62.47 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.847 1.259 . . . . 0.0 113.862 -169.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -148.0 -8.36 0.41 Allowed 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.462 -1.399 . . . . 0.0 112.209 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.91 117.96 35.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.44 -1.412 . . . . 0.0 107.802 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.07 -47.8 81.4 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 120.486 -1.383 . . . . 0.0 112.309 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -61.33 145.51 51.23 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 128.534 2.733 . . . . 0.0 113.474 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 p -91.25 -1.08 57.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.674 0.79 . . . . 0.0 111.243 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 62.27 43.08 8.68 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.921 1.288 . . . . 0.0 112.99 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -85.23 121.68 28.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.65 0.78 . . . . 0.0 112.615 -170.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 51.5 m -61.1 106.06 0.56 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.086 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.9 pt -49.29 159.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -68.97 133.98 48.89 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.644 1.578 . . . . 0.0 111.483 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.14 -41.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 124.466 1.106 . . . . 0.0 113.34 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.1 m -106.53 105.72 15.88 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.604 1.192 . . . . 0.0 108.596 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.9 m -78.32 122.88 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 120.442 -1.411 . . . . 0.0 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.7 t -88.45 115.04 62.18 Favored Pre-proline 0 N--CA 1.447 -0.615 0 O-C-N 121.165 -0.959 . . . . 0.0 108.994 168.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.69 -16.81 18.53 Favored 'Trans proline' 0 CA--C 1.513 -0.573 0 C-N-CA 123.399 2.733 . . . . 0.0 111.499 -170.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.8 m -73.19 -19.4 61.11 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.71 1.604 . . . . 0.0 111.326 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -115.27 -42.77 3.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 124.171 0.988 . . . . 0.0 111.004 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.14 145.43 96.81 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -35.15 114.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 124.799 3.666 . . . . 0.0 119.066 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 47.93 42.5 16.42 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 88.57 16.01 59.18 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 120.434 -1.416 . . . . 0.0 113.15 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 67.39 39.94 2.82 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.119 1.368 . . . . 0.0 113.966 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.64 -2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 CA-C-O 122.762 1.268 . . . . 0.0 111.559 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.1 t -154.27 156.36 36.87 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 169.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 99.7 m -143.16 132.09 22.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.55 148.43 41.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -82.6 50.97 1.76 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.336 -0.852 . . . . 0.0 109.466 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 67.4 m -146.08 139.92 26.37 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -57.47 138.78 81.28 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.874 1.27 . . . . 0.0 114.026 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -58.97 149.53 78.59 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 115.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 181' ' ' ASP . 31.1 mtmm -89.72 -36.1 15.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.362 1.077 . . . . 0.0 111.714 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.7 p -133.85 158.27 43.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -54.55 -42.91 71.49 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.557 1.143 . . . . 0.0 113.312 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -102.58 106.64 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 177' ' ' LYS . 21.3 t0 -93.58 156.72 16.56 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 123.243 1.497 . . . . 0.0 113.402 -165.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.15 147.46 46.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 123.176 1.465 . . . . 0.0 111.497 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.32 -37.59 83.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 119.569 -1.957 . . . . 0.0 113.221 162.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.7 m -55.41 129.85 40.29 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 114.527 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.25 47.7 m-20 80.55 132.63 0.06 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.794 2.038 . . . . 0.0 114.525 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -97.66 154.97 17.21 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.043 -1.661 . . . . 0.0 111.279 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.3 tt -126.62 113.58 33.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 124.539 1.135 . . . . 0.0 109.191 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . 0.45 31.2 ttm180 62.88 64.01 0.91 Allowed 'General case' 0 C--N 1.352 0.704 1 O-C-N 116.067 -4.146 . . . . 0.0 114.884 4.477 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -73.16 68.75 1.01 Allowed 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.393 -1.442 . . . . 0.0 113.69 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t -128.53 128.54 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 235' ' ' ARG . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -154.14 159.38 41.42 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.28 25.33 55.11 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.445 -0.785 . . . . 0.0 112.6 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.63 138.81 53.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.477 1.511 . . . . 0.0 108.253 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.5 -41.72 97.72 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -127.6 137.01 52.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 122.648 1.213 . . . . 0.0 110.094 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -83.38 91.85 7.43 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.3 -1.5 . . . . 0.0 113.3 -168.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.2 m 70.61 45.27 0.6 Allowed 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.543 1.639 . . . . 0.0 110.08 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -153.15 161.15 42.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -28.84 130.47 0.06 Allowed 'General case' 0 C--N 1.353 0.753 0 N-CA-C 121.222 3.786 . . . . 0.0 121.222 -166.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.542 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 54.8 pttt -62.29 150.5 39.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 117.399 -3.313 . . . . 0.0 115.394 -7.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.2 p -140.49 148.99 41.94 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 71.73 38.1 1.0 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 124.2 20.37 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.548 1.139 . . . . 0.0 111.696 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -133.62 153.83 51.36 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 119.891 -1.756 . . . . 0.0 114.897 -163.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.477 ' HE ' ' CG ' ' A' ' 209' ' ' ASP . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.481 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.481 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -75.2 153.64 38.02 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.002 1.901 . . . . 0.0 112.697 -162.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.409 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.1 125.57 27.14 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.05 126.88 50.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -134.59 -17.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 121.693 -0.629 . . . . 0.0 111.981 -174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.72 -173.92 0.07 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.754 1.622 . . . . 0.0 115.005 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -125.34 9.28 7.88 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.692 -1.255 . . . . 0.0 108.281 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -65.17 145.48 56.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.942 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -138.59 166.85 23.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.046 -1.034 . . . . 0.0 108.329 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.9 pt -98.62 -7.0 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -163.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 p -83.69 147.13 27.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 119.446 -2.033 . . . . 0.0 114.571 -170.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -72.8 -31.42 64.83 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.978 -1.701 . . . . 0.0 113.457 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.276 56.4 m-20 60.8 42.05 13.87 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 127.637 2.375 . . . . 0.0 114.312 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -147.93 154.17 43.11 Favored Pre-proline 0 C--N 1.354 0.769 0 C-N-CA 126.111 1.764 . . . . 0.0 106.551 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.49 147.22 0.25 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 124.078 3.185 . . . . 0.0 117.708 161.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -63.28 139.99 97.64 Favored Pre-proline 0 N--CA 1.436 -1.138 0 C-N-CA 123.942 0.897 . . . . 0.0 113.192 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 137.37 4.01 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 121.97 1.78 . . . . 0.0 109.855 -168.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 p -76.49 -20.0 57.43 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 121.402 -0.811 . . . . 0.0 112.92 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.72 149.5 95.25 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.814 1.245 . . . . 0.0 113.935 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.63 82.03 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.852 3.035 . . . . 0.0 119.138 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -104.08 -2.06 26.46 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 119.888 -1.757 . . . . 0.0 113.465 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.12 -40.58 85.87 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -165.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -103.27 17.54 23.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.949 -1.094 . . . . 0.0 110.553 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -110.44 3.72 19.91 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 120.49 -1.381 . . . . 0.0 113.528 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -59.84 143.76 13.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.0 m -89.34 -2.5 58.46 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.022 -1.049 . . . . 0.0 112.379 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.5 p -103.65 15.15 29.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -59.06 135.65 23.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.635 1.174 . . . . 0.0 112.38 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 t -76.31 145.67 39.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.89 -0.95 57.64 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 110.657 170.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 72.22 11.49 5.91 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.982 2.113 . . . . 0.0 114.768 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -99.22 -15.0 19.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 119.893 -1.754 . . . . 0.0 111.974 -169.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -170.87 174.6 4.77 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.906 -1.747 . . . . 0.0 109.135 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -61.36 120.2 9.98 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 120.693 -1.255 . . . . 0.0 111.754 163.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.71 156.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 128.381 2.672 . . . . 0.0 114.484 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -165.75 171.78 12.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.697 -1.252 . . . . 0.0 107.911 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 p -60.75 149.8 34.47 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -89.22 45.98 1.34 Allowed 'General case' 0 C--N 1.355 0.821 0 O-C-N 119.762 -1.836 . . . . 0.0 109.102 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.5 t -92.82 -177.16 4.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.676 1.99 . . . . 0.0 111.69 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.41 153.36 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 125.516 1.526 . . . . 0.0 112.395 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -130.93 144.25 52.76 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 121.112 -0.992 . . . . 0.0 109.675 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.78 160.92 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.682 3.588 . . . . 0.0 117.884 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -134.04 162.62 31.59 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.93 167.66 10.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -120.85 108.77 14.33 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.384 -1.447 . . . . 0.0 113.767 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 121.9 22.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.714 -0.616 . . . . 0.0 110.481 154.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -78.28 -18.95 54.59 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.46 -1.4 . . . . 0.0 112.076 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -143.96 126.63 16.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -131.7 157.16 44.49 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -58.75 145.51 40.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.91 126.72 36.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -61.14 125.62 24.41 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.772 1.629 . . . . 0.0 114.548 -163.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -114.69 13.17 17.3 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 121.416 -0.803 . . . . 0.0 111.126 168.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.47 43.31 13.27 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 164.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 p -155.69 168.94 25.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.87 15.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-O 122.833 1.301 . . . . 0.0 108.724 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.85 17.58 14.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.447 1.899 . . . . 0.0 108.715 -168.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.79 0.83 10.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 126.014 1.726 . . . . 0.0 111.72 -172.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.8 165.74 34.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -117.15 123.18 46.08 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.936 -1.728 . . . . 0.0 108.474 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.62 -5.58 10.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 O-C-N 120.761 -1.212 . . . . 0.0 110.899 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 56.45 30.9 17.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 119.295 3.072 . . . . 0.0 119.295 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.91 12.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 CA-C-O 124.139 1.923 . . . . 0.0 111.46 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -164.72 175.47 9.68 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -86.09 139.79 30.81 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.526 1.057 . . . . 0.0 109.933 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.7 175.19 6.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.728 1.211 . . . . 0.0 112.053 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -80.8 -5.64 57.47 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 125.518 1.527 . . . . 0.0 111.496 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.67 -179.14 46.35 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 123.589 1.66 . . . . 0.0 113.538 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.5 pt -86.51 169.56 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.681 0 O-C-N 119.856 -1.967 . . . . 0.0 111.646 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -147.11 176.65 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -55.91 141.77 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.9 0.88 . . . . 0.0 112.625 167.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.13 -14.99 21.15 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.79 -1.194 . . . . 0.0 111.189 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.82 145.9 43.78 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 122.746 1.26 . . . . 0.0 113.494 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -64.66 138.67 58.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.198 -1.564 . . . . 0.0 110.862 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.2 t -151.13 144.68 24.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -99.23 5.14 46.8 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.827 0.823 . . . . 0.0 109.661 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -130.55 136.12 48.6 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.776 1.23 . . . . 0.0 108.598 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -104.48 120.97 42.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 67.78 14.03 9.36 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.889 1.276 . . . . 0.0 112.516 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 m120 64.13 45.05 4.23 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.603 1.961 . . . . 0.0 113.684 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.04 28.68 2.58 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -64.24 141.82 58.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.653 1.692 . . . . 0.0 113.895 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.78 -42.37 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . 0.284 97.9 m-70 81.74 101.27 0.06 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.419 2.288 . . . . 0.0 110.268 -165.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.16 87.05 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -163.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.3 t 35.77 62.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 128.338 2.655 . . . . 0.0 114.191 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.3 m -159.14 1.85 0.09 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 119.839 -1.788 . . . . 0.0 113.871 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -61.73 -45.6 93.23 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 120.027 -1.671 . . . . 0.0 113.553 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt -145.74 149.26 34.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.254 1.422 . . . . 0.0 108.417 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' CG ' HH12 ' A' ' 237' ' ' ARG . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.584 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.584 ' HZ3' ' CG ' ' A' ' 129' ' ' ASP . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.409 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.36 -33.44 6.84 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -80.12 116.96 20.52 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 118.6 1.2 . . . . 0.0 109.24 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.1 t -64.55 -47.18 90.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-O 121.922 0.868 . . . . 0.0 113.291 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -160.74 157.67 27.33 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 170.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -121.19 6.03 10.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.824 0.821 . . . . 0.0 110.882 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t -154.32 167.53 29.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 119.706 -1.871 . . . . 0.0 106.094 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.55 146.65 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.423 1.106 . . . . 0.0 112.792 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.47 156.15 20.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.766 1.27 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -130.85 166.58 20.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 m -39.43 -29.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.022 2.929 . . . . 0.0 118.354 -166.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.72 11.83 5.74 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.9 pttp 167.0 156.66 0.03 OUTLIER 'General case' 0 C--N 1.359 0.999 0 CA-C-N 121.081 1.764 . . . . 0.0 112.259 -169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.2 t -52.88 145.76 12.02 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.406 1.882 . . . . 0.0 113.11 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.8 pt -125.83 138.93 52.93 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 120.343 -1.473 . . . . 0.0 110.482 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.4 126.13 31.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 119.969 -1.707 . . . . 0.0 112.203 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.02 -43.51 13.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 110.635 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.5 p -138.91 118.96 13.39 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.6 m -63.74 131.43 47.85 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.44 1.496 . . . . 0.0 112.987 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.9 t -95.49 111.97 57.26 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 120.919 -1.113 . . . . 0.0 108.631 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.25 -28.56 10.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 CA-C-N 122.266 1.845 . . . . 0.0 113.234 -163.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 t -160.56 158.4 29.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 119.492 1.042 . . . . 0.0 110.821 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -120.36 17.03 12.23 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.041 1.736 . . . . 0.0 111.226 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 127.5 83.24 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-O 118.188 -0.91 . . . . 0.0 112.629 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -59.74 93.98 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 166.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.97 149.34 27.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -64.0 -21.49 65.77 Favored Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.71 8.59 43.03 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 118.36 1.08 . . . . 0.0 113.285 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.02 131.0 43.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 120.33 -1.481 . . . . 0.0 110.22 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -60.26 -32.98 71.67 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.844 2.058 . . . . 0.0 115.976 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.8 p -77.14 -15.03 59.69 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 120.382 -1.449 . . . . 0.0 112.85 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -74.06 -22.91 59.34 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 120.975 -1.078 . . . . 0.0 111.991 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.9 -37.37 84.34 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.097 -1.627 . . . . 0.0 114.221 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -84.44 -20.13 32.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.403 1.081 . . . . 0.0 111.219 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.73 150.38 95.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.445 1.098 . . . . 0.0 112.566 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 -2.58 12.52 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.582 2.188 . . . . 0.0 113.226 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 68.9 39.76 1.8 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-N 120.402 1.456 . . . . 0.0 114.173 166.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.1 p -119.72 138.54 53.24 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.683 0.793 . . . . 0.0 109.509 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 76.91 45.5 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.337 1.455 . . . . 0.0 111.413 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.88 -16.14 58.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.808 -1.183 . . . . 0.0 113.536 -162.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -33.83 74.53 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 128.616 2.767 . . . . 0.0 112.533 174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.93 139.27 58.75 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -57.61 -34.53 69.36 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 t -149.88 142.98 25.0 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.158 -1.589 . . . . 0.0 107.384 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -114.18 19.06 16.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.915 1.286 . . . . 0.0 109.635 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.9 m -60.02 135.82 57.83 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.991 -1.068 . . . . 0.0 112.433 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 29.2 pt -62.66 148.56 10.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 64.77 44.45 3.72 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -59.08 148.19 32.07 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.573 1.149 . . . . 0.0 112.123 173.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.85 133.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 120.787 -1.196 . . . . 0.0 112.147 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 56.07 32.38 19.91 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.26 2.15 46.6 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 -173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.186 -2.361 . . . . 0.0 114.733 -166.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.1 mt -102.93 10.74 38.1 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.524 -1.36 . . . . 0.0 110.004 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.75 114.27 6.21 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -69.36 -42.51 75.12 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.058 -1.651 . . . . 0.0 113.417 164.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.3 t -166.09 159.84 15.78 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.447 77.7 mtt180 74.7 51.28 0.09 Allowed 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 169.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . 0.314 48.7 t80 25.43 84.05 0.01 OUTLIER 'General case' 0 C--N 1.35 0.606 0 C-N-CA 130.795 3.638 . . . . 0.0 119.105 166.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.55 2.19 33.17 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.1 m -61.27 -46.41 90.48 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -89.86 38.12 0.91 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.485 -1.384 . . . . 0.0 113.34 -166.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -59.75 128.2 35.77 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.706 1.241 . . . . 0.0 114.134 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.83 28.89 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.415 HH12 ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.505 0 CA-C-O 118.732 -1.038 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.49 143.62 26.26 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 119.264 1.532 . . . . 0.0 107.202 164.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -116.57 148.37 40.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.56 166.43 28.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 122.833 1.302 . . . . 0.0 111.986 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.82 144.77 51.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.601 1.56 . . . . 0.0 112.303 171.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.61 146.72 30.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.472 -1.392 . . . . 0.0 108.882 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -151.44 144.52 24.61 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.48 159.2 42.24 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.792 0.806 . . . . 0.0 111.358 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 113.658 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.341 2.2 mt 51.26 63.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 126.895 2.078 . . . . 0.0 115.807 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.8 p -79.55 156.61 27.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.218 -1.551 . . . . 0.0 109.138 164.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -164.15 -1.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.293 41.3 m-20 61.33 37.59 16.92 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 42.21 60.24 9.56 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.39 135.22 46.69 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.507 2.805 . . . . 0.0 115.921 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.01 -42.02 92.94 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.44 -20.57 18.13 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 126.193 3.248 . . . . 0.0 113.409 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 p -101.96 17.64 22.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.974 0.91 . . . . 0.0 110.577 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.21 142.59 66.81 Favored Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 126.372 1.869 . . . . 0.0 115.144 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -39.98 135.58 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.539 1 C-N-CA 125.336 4.024 . . . . 0.0 117.471 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -158.24 8.4 0.14 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.045 0.839 . . . . 0.0 112.376 -173.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -147.48 133.4 19.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.336 -1.478 . . . . 0.0 113.712 -169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.12 148.91 45.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.154 1.382 . . . . 0.0 111.493 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -112.02 120.14 40.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.581 -1.324 . . . . 0.0 108.343 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.62 123.92 66.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.2 m -135.32 -19.86 1.66 Allowed 'General case' 0 C--N 1.348 0.525 0 O-C-N 122.103 -0.373 . . . . 0.0 111.174 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 m 69.22 34.77 2.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.711 1.719 . . . . 0.0 113.193 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.62 162.21 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 126.801 2.041 . . . . 0.0 107.314 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -66.63 132.0 47.21 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.115 1.366 . . . . 0.0 114.49 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 50.89 54.49 11.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 163.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -104.88 -1.31 26.12 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 119.052 -2.28 . . . . 0.0 114.399 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -148.56 115.04 5.92 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.057 -1.652 . . . . 0.0 106.889 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 70.21 59.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 116.827 -3.67 . . . . 0.0 116.172 -11.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -64.97 -34.84 79.4 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.83 -1.794 . . . . 0.0 110.869 161.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -57.18 129.16 18.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 129.034 2.934 . . . . 0.0 114.199 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -61.27 121.7 13.24 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 124.044 0.938 . . . . 0.0 111.939 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.8 p -108.43 -1.84 19.53 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.848 -1.782 . . . . 0.0 113.44 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -133.59 109.65 9.37 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 120.43 -1.419 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HG ' ' CE1' ' A' ' 53' ' ' HIS . 4.2 t -140.79 130.91 24.78 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.038 -2.914 . . . . 0.0 106.631 -20.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.17 1.08 5.48 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 124.248 1.019 . . . . 0.0 111.597 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.475 ' CE1' ' HG ' ' A' ' 51' ' ' SER . 79.6 m80 40.26 63.37 5.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 120.15 3.389 . . . . 0.0 120.15 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.52 126.54 22.62 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.33 2.687 . . . . 0.0 114.481 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -149.42 146.06 27.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.56 175.7 11.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -139.51 125.81 20.17 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.431 -1.418 . . . . 0.0 109.961 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -124.96 19.41 8.43 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 120.499 -1.376 . . . . 0.0 113.697 -168.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 67.03 -179.93 0.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -64.03 136.51 57.36 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 126.316 1.846 . . . . 0.0 113.274 166.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -76.43 -24.53 53.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.515 1.126 . . . . 0.0 112.565 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -85.07 113.38 21.43 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 163.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.21 -11.33 0.05 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.059 -0.401 . . . . 0.0 111.565 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.51 161.36 14.68 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -157.23 -11.82 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 121.094 -1.004 . . . . 0.0 113.356 171.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 57.85 -153.34 0.38 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 m -91.61 16.7 10.0 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 120.828 -1.17 . . . . 0.0 111.547 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.79 112.27 8.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 125.132 1.373 . . . . 0.0 112.411 174.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 76.15 141.19 0.07 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.01 1.724 . . . . 0.0 114.394 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 pt -58.85 152.8 3.81 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 O-C-N 120.458 -1.401 . . . . 0.0 112.171 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' CD ' HH21 ' A' ' 92' ' ' ARG . 45.8 mt-10 -90.56 2.99 55.28 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 119.937 -1.727 . . . . 0.0 113.197 -168.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m120 60.51 41.99 14.92 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.977 2.111 . . . . 0.0 115.721 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.18 157.22 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 C-N-CA 124.365 1.066 . . . . 0.0 108.311 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -77.99 -32.66 51.34 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.8 tp -154.7 150.94 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.459 HH21 ' CD ' ' A' ' 87' ' ' GLU . 25.4 mmt180 -119.41 127.07 52.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 165.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -69.35 -31.6 70.14 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -137.26 153.41 50.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -114.18 5.51 15.93 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 120.784 -1.198 . . . . 0.0 111.386 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.23 -2.44 19.99 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 118.118 2.007 . . . . 0.0 118.118 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.259 9.9 mm 70.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.262 1.825 . . . . 0.0 113.549 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.82 132.08 36.71 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 118.727 -2.483 . . . . 0.0 109.953 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 pt -151.11 14.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.647 0 C-N-CA 125.37 1.468 . . . . 0.0 111.885 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.28 42.5 m-20 53.2 53.81 11.28 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -175.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -126.97 109.2 11.66 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.708 -1.87 . . . . 0.0 113.091 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.8 mttp 72.97 44.32 0.36 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.837 1.655 . . . . 0.0 110.547 -168.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.7 p -108.62 -1.41 19.59 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.473 1.109 . . . . 0.0 110.891 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.39 144.8 50.06 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 128.408 2.683 . . . . 0.0 111.944 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -119.09 0.34 11.24 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.968 -1.083 . . . . 0.0 111.902 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.18 115.91 7.39 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.347 -1.471 . . . . 0.0 113.008 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -89.56 125.2 35.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.017 -1.677 . . . . 0.0 110.872 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -129.93 140.55 50.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 119.429 -2.045 . . . . 0.0 109.804 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.55 32.59 41.45 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 120.509 -1.369 . . . . 0.0 112.845 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -119.86 162.11 19.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 127.4 2.28 . . . . 0.0 107.003 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.294 32.2 m-85 73.51 37.33 0.71 Allowed 'General case' 0 C--N 1.354 0.79 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -109.04 108.73 19.55 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.793 -1.192 . . . . 0.0 111.046 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 61.02 51.09 4.65 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.913 1.685 . . . . 0.0 114.957 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.35 141.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.76 1.743 . . . . 0.0 112.686 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 t -158.75 165.52 34.12 Favored 'General case' 0 C--N 1.356 0.853 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -149.76 172.77 14.58 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 120.143 1.338 . . . . 0.0 112.237 -160.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.37 143.04 54.05 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 128.971 2.908 . . . . 0.0 114.649 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.37 68.57 0.49 Allowed Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -60.42 -42.75 96.65 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.755 -0.85 . . . . 0.0 113.236 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.525 35.6 m 41.65 -125.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 128.501 2.72 . . . . 0.0 118.322 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -141.95 30.28 1.64 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 120.024 1.284 . . . . 0.0 111.131 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -81.63 132.24 35.29 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 119.178 -2.201 . . . . 0.0 108.432 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -158.11 171.61 19.92 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 120.645 -1.284 . . . . 0.0 107.921 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -45.19 156.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 131.152 3.781 . . . . 0.0 117.701 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' CG ' ' HZ1' ' A' ' 152' ' ' LYS . 38.3 t0 -71.59 129.72 39.42 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.161 -0.962 . . . . 0.0 111.082 164.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 91.2 p -69.05 145.59 53.36 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.7 m -63.45 111.3 2.26 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.484 1.113 . . . . 0.0 109.73 156.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HZ1' ' CG ' ' A' ' 149' ' ' ASP . 39.6 mttp -97.95 139.35 33.92 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 120.711 -1.243 . . . . 0.0 111.151 -169.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -102.42 -8.41 21.15 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.807 -1.183 . . . . 0.0 112.556 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 t -160.73 169.5 22.65 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.6 tt -116.33 126.96 74.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 108.577 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.93 -10.11 20.93 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.902 -1.123 . . . . 0.0 113.755 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.26 132.05 33.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 O-C-N 120.707 -1.246 . . . . 0.0 111.354 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.4 p -71.78 149.83 44.97 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.3 t -82.41 158.32 23.35 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.354 -1.467 . . . . 0.0 110.144 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.56 137.75 94.9 Favored Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 130.8 41.85 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.819 3.013 . . . . 0.0 112.78 154.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.7 t -85.4 -21.91 28.6 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.03 1.286 . . . . 0.0 112.441 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -145.59 26.89 1.25 Allowed 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.94 -1.725 . . . . 0.0 112.81 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.57 125.82 86.9 Favored Pre-proline 0 C--N 1.353 0.734 0 O-C-N 119.115 -2.24 . . . . 0.0 112.413 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.78 126.11 20.83 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.231 2.621 . . . . 0.0 115.604 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -60.8 -42.94 98.59 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.74 -166.29 46.75 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.92 -1.112 . . . . 0.0 114.544 -167.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.8 143.54 56.14 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.27 109.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -77.45 -30.54 53.33 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.035 -1.666 . . . . 0.0 112.545 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.0 m -142.73 127.85 18.58 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 111.102 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -83.33 98.86 9.68 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.147 170.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -63.26 -44.94 93.73 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.2 m -108.64 -9.42 15.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 118.776 -2.453 . . . . 0.0 109.845 -16.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.541 ' CG ' ' HZ3' ' A' ' 177' ' ' LYS . 8.9 p-10 -70.62 150.7 95.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.613 175.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -55.57 131.85 48.6 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 123.295 2.663 . . . . 0.0 114.188 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.541 ' HZ3' ' CG ' ' A' ' 175' ' ' ASP . 72.6 mmtt -112.64 2.57 16.21 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.8 m 11.75 77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 130.292 3.437 . . . . 0.0 117.196 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.67 115.53 23.41 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.747 -1.22 . . . . 0.0 108.558 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -115.52 5.06 14.35 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.519 -0.738 . . . . 0.0 112.885 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -64.75 -50.05 68.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.205 1.002 . . . . 0.0 113.56 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -69.43 -33.83 73.54 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.25 -20.51 34.38 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.585 -1.947 . . . . 0.0 114.175 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -102.91 107.87 18.85 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 118.97 -2.331 . . . . 0.0 111.475 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.64 146.79 29.44 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -115.99 124.46 50.57 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 120.775 -1.203 . . . . 0.0 111.215 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.08 -42.32 95.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.0 156.53 29.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.028 -2.295 . . . . 0.0 105.497 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -144.59 175.75 9.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.116 -0.99 . . . . 0.0 111.426 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -127.55 152.82 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -139.73 24.42 2.42 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.25 -6.08 73.81 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.472 -2.018 . . . . 0.0 114.53 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -151.73 174.77 13.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.265 1.826 . . . . 0.0 107.961 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.5 mt -108.04 25.77 11.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 122.748 1.261 . . . . 0.0 111.211 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -55.95 -41.47 74.74 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.85 2.06 . . . . 0.0 115.682 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -128.47 16.26 6.53 Favored 'General case' 0 C--N 1.344 0.336 0 O-C-N 119.109 -2.244 . . . . 0.0 111.921 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.9 t -165.42 153.78 11.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -172.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -113.1 8.14 18.23 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.238 -0.914 . . . . 0.0 111.978 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -138.77 149.08 44.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -140.08 -19.69 0.89 Allowed 'General case' 0 C--N 1.35 0.629 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.8 m -79.54 112.43 16.79 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.651 -1.281 . . . . 0.0 113.061 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.46 18.32 12.11 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.665 1.221 . . . . 0.0 110.554 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.41 102.99 13.19 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.241 1.816 . . . . 0.0 111.117 -160.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -174.79 47.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.13 0 CA-C-O 118.091 -1.394 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -147.35 167.75 23.54 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp -123.13 117.78 26.16 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.72 147.01 23.53 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 119.913 -1.742 . . . . 0.0 113.942 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -62.57 -42.82 99.79 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.99 56.76 3.42 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 159.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -61.03 138.45 58.19 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' CD ' HH22 ' A' ' 48' ' ' ARG . 39.9 mt-10 -94.87 -174.24 3.21 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.711 1.205 . . . . 0.0 112.169 176.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -70.02 -22.08 63.13 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 118.862 -2.399 . . . . 0.0 114.874 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.4 tp -156.73 157.34 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 169.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.1 m -116.81 127.97 54.83 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 168.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -152.31 147.53 26.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.73 128.78 37.88 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 26.24 66.26 0.5 Allowed Pre-proline 0 C--N 1.362 1.13 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.8 134.73 17.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.015 3.143 . . . . 0.0 117.962 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.92 -18.37 0.45 Allowed Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 120.44 3.496 . . . . 0.0 120.44 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -66.84 -26.97 44.28 Favored 'Trans proline' 0 C--N 1.351 0.705 1 CA-C-N 128.569 4.096 . . . . 0.0 114.994 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 p -106.2 8.57 32.08 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 111.234 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.74 149.74 84.05 Favored Pre-proline 0 N--CA 1.446 -0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 114.222 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -64.03 -28.77 66.05 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 121.911 1.718 . . . . 0.0 115.183 -165.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -103.01 29.53 5.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.371 1.468 . . . . 0.0 109.683 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -133.92 -65.08 0.68 Allowed 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.494 1.118 . . . . 0.0 110.536 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.07 53.38 6.77 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.344 25.1 mtpp 55.54 -122.3 1.82 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.5 pt -112.46 2.48 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 121.153 -0.967 . . . . 0.0 111.166 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 p -171.48 -4.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -167.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.267 13.7 m 62.95 64.37 0.88 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.33 1.423 . . . . 0.0 113.734 -172.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -62.92 140.4 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.506 -1.371 . . . . 0.0 113.847 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -83.87 154.59 23.36 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.7 -1.25 . . . . 0.0 109.732 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 73.67 7.59 5.01 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.691 1.71 . . . . 0.0 113.034 162.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -107.67 -39.39 5.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.445 1.098 . . . . 0.0 111.288 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -96.32 136.68 36.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.081 1.353 . . . . 0.0 112.029 -172.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.273 6.4 mmp_? 59.94 54.33 4.29 Favored 'General case' 0 C--O 1.219 -0.521 1 O-C-N 116.092 -4.13 . . . . 0.0 118.468 -13.835 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.78 -39.37 84.67 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.326 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -58.81 140.64 16.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 125.493 1.517 . . . . 0.0 112.761 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.413 HH22 ' CD ' ' A' ' 20' ' ' GLU . 61.0 ttt-85 -82.04 113.58 20.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.115 -1.616 . . . . 0.0 112.495 -167.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.3 p -99.07 14.25 29.95 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 126.105 1.762 . . . . 0.0 111.897 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -107.16 155.38 19.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.105 -0.997 . . . . 0.0 108.799 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.99 16.51 11.69 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 119.53 -1.981 . . . . 0.0 113.189 5.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.84 132.43 62.87 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 O-C-N 121.05 -1.031 . . . . 0.0 110.313 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -81.41 141.73 49.53 Favored Pre-proline 0 C--N 1.36 1.029 0 O-C-N 119.73 -1.857 . . . . 0.0 112.375 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -48.52 132.75 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.595 2.863 . . . . 0.0 115.551 164.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.57 135.08 53.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.12 30.16 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -89.17 70.32 8.33 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.311 -1.493 . . . . 0.0 114.483 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -76.94 -20.8 55.71 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 119.337 -2.102 . . . . 0.0 115.158 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . 0.28 77.1 mtp180 101.56 -78.12 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 128.711 2.805 . . . . 0.0 114.516 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.47 138.5 24.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 102.98 -2.97 . . . . 0.0 102.98 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -62.97 -47.05 84.85 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 122.016 0.912 . . . . 0.0 113.095 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -79.94 124.13 28.4 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 120.206 -1.559 . . . . 0.0 110.816 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.15 135.23 28.81 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -113.0 125.0 53.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU . 85.4 mttt -110.69 1.07 17.69 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.668 -1.27 . . . . 0.0 112.798 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 45.71 37.59 3.48 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.198 2.199 . . . . 0.0 115.11 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.7 m -93.35 58.91 2.91 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.378 -2.076 . . . . 0.0 109.118 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -68.16 140.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 73.49 5.04 4.92 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 170.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.7 pt -62.66 138.51 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -97.72 -16.59 19.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.55 1.14 . . . . 0.0 113.278 -169.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 66.35 39.69 3.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.903 2.481 . . . . 0.0 114.463 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.3 125.15 57.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 O-C-N 120.133 -1.605 . . . . 0.0 110.951 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -118.53 33.58 5.58 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 119.901 -1.749 . . . . 0.0 114.223 -162.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.74 -0.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -169.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -61.52 149.14 39.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 119.772 -1.83 . . . . 0.0 113.918 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -57.22 -41.68 79.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 123.614 1.673 . . . . 0.0 113.489 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -85.19 4.84 32.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.987 2.915 . . . . 0.0 110.249 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -114.09 4.82 15.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 119.757 -1.839 . . . . 0.0 109.988 168.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.33 64.54 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 125.056 1.312 . . . . 0.0 115.046 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.33 6.7 mt 44.18 55.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 CA-C-O 125.167 2.413 . . . . 0.0 113.435 -177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -94.59 102.87 14.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 119.928 -1.733 . . . . 0.0 111.672 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.6 pt -78.15 -16.89 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 O-C-N 120.841 -1.162 . . . . 0.0 112.384 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 138.58 58.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 123.556 1.645 . . . . 0.0 113.987 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -162.66 171.66 16.54 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.897 2.079 . . . . 0.0 107.941 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -109.03 166.74 10.61 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.915 0.886 . . . . 0.0 110.755 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -62.73 -42.86 99.87 Favored 'General case' 0 C--N 1.344 0.359 0 O-C-N 120.766 -1.209 . . . . 0.0 113.227 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -65.21 144.14 57.37 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.85 1.26 . . . . 0.0 113.787 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -79.9 -10.94 59.83 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 120.831 -1.168 . . . . 0.0 112.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.67 142.89 55.23 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.508 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 12.9 pt-20 -58.36 150.07 23.09 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -171.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.77 152.96 44.63 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.855 2.062 . . . . 0.0 114.198 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.14 22.2 61.38 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -87.94 132.24 34.3 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.55 -1.559 . . . . 0.0 112.218 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 78.25 35.97 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 125.829 1.652 . . . . 0.0 114.677 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -75.95 129.2 36.55 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.168 -1.582 . . . . 0.0 114.849 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.8 41.64 14.42 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.96 103.58 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -167.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.8 t -88.32 -51.85 5.53 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.9 -1.75 . . . . 0.0 111.479 165.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t 58.57 -171.24 0.11 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp -53.4 131.45 37.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.298 2.639 . . . . 0.0 112.099 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.95 -6.02 4.17 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 27.4 t60 70.48 -73.79 0.09 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.73 1.612 . . . . 0.0 113.306 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.415 28.0 m 48.26 -138.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 128.6 2.76 . . . . 0.0 115.605 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -154.51 152.94 30.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -128.69 128.3 43.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.6 m -89.12 164.02 15.21 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 108.974 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.5 tt -146.56 129.87 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 120.126 -1.609 . . . . 0.0 109.203 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.44 -23.43 29.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.235 -1.541 . . . . 0.0 112.338 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.7 m -60.52 -22.19 63.31 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.865 1.666 . . . . 0.0 115.285 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -112.56 7.29 18.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.986 -1.071 . . . . 0.0 111.553 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.31 119.47 16.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 120.519 -1.363 . . . . 0.0 114.524 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.65 -35.84 79.09 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.198 -0.939 . . . . 0.0 113.297 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.1 m -123.92 120.73 33.37 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 23.2 pt -80.52 148.2 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.66 -10.27 25.34 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 112.304 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.4 t -126.11 112.41 30.04 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-O 122.098 0.951 . . . . 0.0 110.271 -175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.1 m -116.09 129.51 56.37 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.7 m -77.81 112.66 14.9 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.35 -1.469 . . . . 0.0 110.23 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.16 128.08 26.25 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 119.82 -1.8 . . . . 0.0 109.572 -174.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.45 125.29 18.03 Favored 'Trans proline' 0 C--O 1.22 -0.383 0 C-N-CA 123.998 3.132 . . . . 0.0 115.509 170.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 m -82.58 -28.24 31.03 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -119.74 23.09 11.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.964 -1.085 . . . . 0.0 112.051 -165.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.31 149.83 46.07 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.007 -1.058 . . . . 0.0 108.715 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.17 139.58 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.759 2.973 . . . . 0.0 114.453 162.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.49 171.64 18.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.518 0.675 . . . . 0.0 110.7 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.8 177.44 7.17 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 125.024 1.297 . . . . 0.0 114.75 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.87 -17.5 63.36 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.296 -1.709 . . . . 0.0 113.509 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.06 -20.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 C-N-CA 124.613 1.165 . . . . 0.0 111.709 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 m 58.6 56.7 4.12 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.099 1.76 . . . . 0.0 112.721 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.6 t -152.6 169.95 21.41 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.682 -1.886 . . . . 0.0 110.462 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.6 158.88 34.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.133 1.373 . . . . 0.0 112.518 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.19 -42.64 91.34 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.66 90.27 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 129.318 3.047 . . . . 0.0 114.755 -16.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.63 135.52 88.2 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.372 2.269 . . . . 0.0 113.593 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.77 133.07 2.6 Favored 'Trans proline' 0 N--CA 1.476 0.451 1 C-N-CA 125.572 4.181 . . . . 0.0 118.888 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -118.78 4.05 11.58 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 p -69.29 139.25 54.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 119.812 -1.805 . . . . 0.0 114.492 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.29 43.02 1.91 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.267 -1.521 . . . . 0.0 112.026 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -77.61 -10.14 59.34 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.953 -1.717 . . . . 0.0 113.082 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 8.64 40.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.52 1.128 . . . . 0.0 111.869 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.69 24.53 9.1 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.92 1.288 . . . . 0.0 108.927 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -122.31 138.24 54.58 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.847 0.859 . . . . 0.0 109.118 -167.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -122.32 125.65 46.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.254 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.8 6.81 15.63 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 119.78 -1.825 . . . . 0.0 113.609 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.2 t -136.52 132.45 35.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.534 1.159 . . . . 0.0 109.563 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.4 tt -91.62 2.02 8.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.974 -1.079 . . . . 0.0 111.471 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.99 163.98 39.54 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 119.834 -1.791 . . . . 0.0 109.454 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -156.51 170.16 22.98 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m -107.8 136.08 44.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 167.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.578 ' HZ1' ' C ' ' A' ' 238' ' ' PHE . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -142.25 37.28 1.54 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -69.97 -39.32 74.63 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 120.593 -1.317 . . . . 0.0 114.199 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -134.82 166.11 23.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 102.109 -3.293 . . . . 0.0 102.109 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.9 mp -86.9 45.6 1.28 Allowed 'General case' 0 C--O 1.224 -0.274 0 O-C-N 120.401 -1.437 . . . . 0.0 111.774 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.24 -43.1 82.62 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.481 1.512 . . . . 0.0 114.912 -165.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -115.34 27.88 9.06 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.586 -1.322 . . . . 0.0 111.541 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.0 t -148.87 162.89 38.93 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.313 -2.117 . . . . 0.0 112.528 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -114.34 1.18 14.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.985 -1.697 . . . . 0.0 111.176 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -143.63 137.29 28.19 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -106.68 -38.89 5.99 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.644 -1.285 . . . . 0.0 113.665 -163.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.2 m -61.96 106.27 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -163.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.79 -3.36 0.04 OUTLIER 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.544 -1.348 . . . . 0.0 111.873 175.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -58.57 -43.43 89.39 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.339 2.656 . . . . 0.0 113.743 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -67.24 138.38 56.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.578 ' C ' ' HZ1' ' A' ' 205' ' ' LYS . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.444 0 CA-C-O 118.39 -1.228 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -91.43 170.46 9.95 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 119.436 1.618 . . . . 0.0 109.984 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.97 127.73 48.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 146.73 52.62 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 121.045 -1.034 . . . . 0.0 112.844 170.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -96.23 -0.84 49.29 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.336 -1.478 . . . . 0.0 112.2 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.54 164.36 29.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 171.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.51 -15.27 17.92 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.985 0.898 . . . . 0.0 111.817 -170.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 6.8 pt-20 -168.61 174.34 6.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -162.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.403 ' CE1' ' HG1' ' A' ' 49' ' ' THR . 27.1 p-80 -103.17 -2.52 27.19 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.765 -1.209 . . . . 0.0 114.241 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -76.41 144.21 12.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.148 -1.595 . . . . 0.0 113.806 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -125.34 8.99 7.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.881 1.324 . . . . 0.0 110.464 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 169.41 20.27 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.416 2.286 . . . . 0.0 106.856 -165.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 44.09 49.97 7.45 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.827 2.051 . . . . 0.0 116.334 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -55.41 -38.18 65.05 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -164.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.5 141.6 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 124.483 3.455 . . . . 0.0 117.131 169.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.76 134.94 94.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -56.12 125.8 20.26 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.805 3.003 . . . . 0.0 118.988 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -68.08 111.19 4.32 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.0 69.34 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -86.85 102.36 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 125.391 2.961 . . . . 0.0 113.709 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.46 -41.22 98.59 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.597 1.159 . . . . 0.0 113.783 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -120.13 141.03 50.2 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.203 -0.936 . . . . 0.0 108.502 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -81.81 -15.15 55.12 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.406 0.622 . . . . 0.0 112.013 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.78 133.84 34.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.592 -1.318 . . . . 0.0 108.615 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.1 mt -69.35 141.96 16.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 C-N-CA 124.9 1.28 . . . . 0.0 113.601 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -90.07 158.43 17.32 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.212 -1.555 . . . . 0.0 112.442 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -58.82 -37.39 76.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.026 1.731 . . . . 0.0 114.487 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -78.09 -19.0 13.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 114.104 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.317 10.1 t 79.98 70.17 0.03 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.648 1.579 . . . . 0.0 112.487 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 43' ' ' TYR 0.267 14.7 t70 57.85 -160.54 0.25 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.298 2.639 . . . . 0.0 116.251 178.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 81.4 m-85 -149.3 146.82 27.74 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 119.968 -1.707 . . . . 0.0 111.049 -161.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.73 154.94 33.62 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.43 -1.419 . . . . 0.0 107.936 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -147.9 147.8 30.13 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.116 -2.24 . . . . 0.0 111.276 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -100.42 11.06 40.29 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.755 -1.215 . . . . 0.0 112.77 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -62.85 -36.49 75.76 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -80.39 101.49 9.03 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.725 -1.234 . . . . 0.0 112.907 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.403 ' HG1' ' CE1' ' A' ' 21' ' ' HIS . 15.0 p -90.32 -8.78 49.98 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.066 -1.021 . . . . 0.0 112.915 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 83.0 mtt180 -55.28 106.44 0.23 Allowed 'General case' 0 C--N 1.351 0.649 0 N-CA-C 115.545 1.684 . . . . 0.0 115.545 171.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.7 t -159.11 175.64 13.23 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 -165.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 1.8 t 53.15 61.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 126.79 2.036 . . . . 0.0 114.333 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -59.55 149.26 71.31 Favored Pre-proline 0 C--N 1.352 0.675 0 O-C-N 119.221 -2.174 . . . . 0.0 112.275 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -35.23 133.75 0.2 Allowed 'Trans proline' 0 C--O 1.246 0.925 1 C-N-CA 125.384 4.056 . . . . 0.0 116.708 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.43 170.24 22.38 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.179 -164.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.87 95.42 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 55.4 52.7 10.9 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.809 1.644 . . . . 0.0 115.063 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -66.38 128.73 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.855 -1.778 . . . . 0.0 110.238 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -79.17 104.44 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 119.148 -2.22 . . . . 0.0 112.195 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -119.91 129.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -164.93 156.86 15.52 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.216 1.008 . . . . 0.0 110.395 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -142.57 147.14 35.4 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -60.2 -44.66 94.94 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 122.347 1.07 . . . . 0.0 112.293 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -62.58 151.19 38.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 113.878 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.65 128.88 46.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.645 -1.284 . . . . 0.0 107.98 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.72 -49.91 1.62 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.455 0.702 . . . . 0.0 110.619 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -57.9 -41.62 83.01 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -132.11 127.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 164.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -87.12 136.4 32.94 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.231 0.612 . . . . 0.0 110.716 -173.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -92.23 125.49 44.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 O-C-N 120.954 -1.091 . . . . 0.0 112.742 -175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 -42.25 99.18 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 128.13 2.572 . . . . 0.0 115.917 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -58.21 140.2 53.53 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.48 -11.02 9.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 O-C-N 119.816 -1.803 . . . . 0.0 112.592 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -137.12 160.27 39.46 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 119.342 -2.099 . . . . 0.0 105.445 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.82 25.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 123.477 1.608 . . . . 0.0 111.446 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -66.2 -38.12 87.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 119.477 -2.015 . . . . 0.0 113.915 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 66.25 42.21 3.16 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.285 1.434 . . . . 0.0 113.498 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -97.19 161.11 13.96 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.822 1.649 . . . . 0.0 114.827 -171.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 57.81 -161.47 0.23 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 127.574 2.35 . . . . 0.0 115.713 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -97.82 -164.84 31.54 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 120.77 -1.206 . . . . 0.0 110.452 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.56 7.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 O-C-N 120.707 -1.466 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -158.88 154.39 25.95 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.784 -1.822 . . . . 0.0 107.159 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.332 53.8 mt 86.33 112.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 126.137 1.775 . . . . 0.0 112.476 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -34.99 148.93 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 129.441 3.096 . . . . 0.0 117.823 168.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 46.0 ttm-85 -64.69 114.35 4.37 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.81 134.12 56.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 120.61 -1.306 . . . . 0.0 113.237 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -63.55 117.56 6.94 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.278 -1.514 . . . . 0.0 111.899 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -157.76 163.98 37.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -167.96 -5.16 0.02 OUTLIER 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -111.27 5.22 19.72 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 119.901 -1.749 . . . . 0.0 111.653 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 108' ' ' ASN . 9.6 tp10 -84.3 173.12 11.22 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.951 1.301 . . . . 0.0 112.572 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.487 ' H ' ' CD ' ' A' ' 107' ' ' GLU 0.282 89.1 m-20 62.01 -125.38 0.76 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 119.214 -2.179 . . . . 0.0 111.781 -168.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.58 -3.92 52.74 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -167.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.8 m -33.06 135.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 128.339 2.655 . . . . 0.0 117.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 62.58 -112.06 0.41 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.318 -1.489 . . . . 0.0 113.113 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -108.77 2.85 22.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.963 1.305 . . . . 0.0 111.88 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.5 53.37 2.59 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -158.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.42 -16.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t 56.55 64.21 1.74 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -159.67 158.03 30.7 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 116.522 -3.861 . . . . 0.0 104.978 7.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp -118.28 136.01 53.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.23 30.66 5.59 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -144.08 179.66 7.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 107.885 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.8 145.93 9.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 O-C-N 120.372 -1.455 . . . . 0.0 113.991 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -115.97 15.97 16.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.027 1.331 . . . . 0.0 112.293 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -158.88 163.89 36.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.2 m -60.14 104.05 0.28 Allowed 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 128.868 2.867 . . . . 0.0 113.384 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tp -151.47 153.61 9.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 121.335 -0.853 . . . . 0.0 108.919 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -159.72 178.84 9.4 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 90.5 p -77.0 -21.96 53.84 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.991 1.723 . . . . 0.0 113.433 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 t -60.72 142.12 56.16 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.743 1.258 . . . . 0.0 112.085 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -87.18 -7.03 58.38 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 119.798 -1.814 . . . . 0.0 111.617 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -71.51 131.98 44.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 120.915 -1.116 . . . . 0.0 112.623 168.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -61.78 134.67 57.02 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 120.979 -1.076 . . . . 0.0 113.033 170.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.7 pt -124.88 149.98 29.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 110.875 -173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 67.04 46.57 1.52 Allowed 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.63 1.972 . . . . 0.0 110.453 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.57 135.94 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.675 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.8 m -84.76 110.18 18.61 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.673 -1.267 . . . . 0.0 110.961 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.2 m -67.71 117.92 10.27 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.317 -1.489 . . . . 0.0 111.266 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.22 111.74 61.64 Favored Pre-proline 0 C--N 1.348 0.536 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -62.19 138.44 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 CA-C-N 122.287 1.852 . . . . 0.0 112.855 168.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -96.12 164.67 12.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -75.72 -18.24 59.65 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 122.019 0.914 . . . . 0.0 110.63 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -75.47 146.15 80.39 Favored Pre-proline 0 N--CA 1.443 -0.816 0 O-C-N 121.169 -0.957 . . . . 0.0 112.251 167.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.17 162.93 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.461 1.44 . . . . 0.0 110.284 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 73.14 41.25 0.5 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 169.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.37 149.24 32.27 Favored Glycine 0 C--N 1.359 1.843 0 O-C-N 121.152 -0.967 . . . . 0.0 115.002 167.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.45 -19.45 58.04 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.5 t -127.11 122.76 60.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.8 p -110.49 9.29 23.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.707 0.803 . . . . 0.0 110.693 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -110.43 144.18 39.61 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.629 -1.294 . . . . 0.0 110.102 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -113.7 4.94 16.23 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.711 175.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -96.25 21.89 8.41 Favored 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.55 -1.344 . . . . 0.0 110.894 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -107.97 1.15 22.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.496 2.318 . . . . 0.0 112.764 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -117.65 127.05 26.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 0.0 108.154 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.19 135.57 5.43 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 122.819 2.043 . . . . 0.0 112.405 -167.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -66.65 -29.45 69.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.074 -1.641 . . . . 0.0 113.767 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.8 t -69.35 140.72 54.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.789 1.236 . . . . 0.0 111.385 165.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -117.23 18.78 14.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.5 5.55 11.1 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 121.011 -1.055 . . . . 0.0 110.296 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -164.48 176.33 9.09 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.38 167.97 11.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.898 2.479 . . . . 0.0 115.134 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -71.92 -38.79 69.83 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.411 -1.431 . . . . 0.0 112.834 166.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.9 t -151.21 140.29 21.13 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.731 -1.231 . . . . 0.0 109.459 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -117.36 18.22 14.45 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 124.334 1.054 . . . . 0.0 109.77 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 78.0 p -59.23 -46.57 88.12 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.1 tt -99.5 134.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.975 1.369 . . . . 0.0 109.486 165.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.62 145.6 48.88 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.72 -1.863 . . . . 0.0 111.565 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -119.69 171.4 8.41 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.96 147.95 6.08 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 O-C-N 121.281 -0.887 . . . . 0.0 111.945 165.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -172.37 60.04 0.03 OUTLIER 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 66.15 175.62 6.32 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 125.656 1.598 . . . . 0.0 116.069 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -166.04 -7.72 0.02 OUTLIER 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -48.19 80.52 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 120.483 1.492 . . . . 0.0 113.31 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.91 -46.07 1.41 Allowed 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.329 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -129.77 135.98 49.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.4 m -102.97 107.68 18.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 129.005 2.922 . . . . 0.0 110.791 -0.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -61.02 -40.03 92.03 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.995 -1.69 . . . . 0.0 115.053 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -56.41 144.38 31.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.77 9.85 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.525 1.13 . . . . 0.0 108.333 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.3 p -105.17 -8.29 18.48 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.171 -0.956 . . . . 0.0 111.61 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -70.84 129.72 39.79 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.058 -1.026 . . . . 0.0 112.033 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mt-10 67.12 40.53 2.84 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.03 122.96 47.5 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 168.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.18 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -93.74 160.89 14.56 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 141.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.42 158.31 35.6 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.62 106.29 12.46 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.701 -1.874 . . . . 0.0 109.809 172.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 65.43 -23.55 0.09 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.24 2.216 . . . . 0.0 115.945 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.31 157.86 34.96 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.14 -38.44 88.97 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.916 1.287 . . . . 0.0 113.758 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' CD ' HH22 ' A' ' 73' ' ' ARG . 75.3 tt0 -122.4 131.34 53.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 153.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -29.59 125.49 0.14 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 120.063 3.357 . . . . 0.0 120.063 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.03 -27.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 120.938 -1.101 . . . . 0.0 112.117 165.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 p -99.45 29.98 3.77 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.359 -1.463 . . . . 0.0 110.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.09 130.19 45.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.67 152.78 29.95 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.61 123.98 15.53 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 120.106 -1.621 . . . . 0.0 113.569 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.61 -7.9 15.83 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 122.172 1.915 . . . . 0.0 112.73 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.89 151.99 27.44 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.76 -8.21 14.57 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.349 2.033 . . . . 0.0 111.844 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 112.63 78.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 130.164 3.386 . . . . 0.0 106.957 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -175.04 112.29 0.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 120.654 -1.279 . . . . 0.0 110.894 -167.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.97 120.04 7.67 Favored 'Trans proline' 0 C--O 1.23 0.081 0 C-N-CA 123.369 2.712 . . . . 0.0 117.029 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -77.69 134.66 38.08 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 111.412 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -99.84 -4.61 30.05 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 47.4 42.14 13.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 119.243 3.053 . . . . 0.0 119.243 166.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -56.76 -37.57 71.25 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -165.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.02 22.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 109.351 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -114.93 126.16 54.46 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.447 -1.408 . . . . 0.0 112.267 -163.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -62.26 126.25 26.68 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.844 0.858 . . . . 0.0 110.297 167.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -97.88 140.94 16.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 O-C-N 121.448 -0.783 . . . . 0.0 112.033 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -62.0 -46.84 87.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.619 -1.926 . . . . 0.0 113.482 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.36 134.95 36.56 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -172.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.69 -34.41 78.24 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 122.457 1.122 . . . . 0.0 112.091 166.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.87 143.71 57.76 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -102.02 121.08 41.49 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.453 -1.404 . . . . 0.0 109.672 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -84.25 -51.38 7.06 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.423 -1.423 . . . . 0.0 111.921 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . 0.322 19.8 mt 80.55 -55.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 127.733 2.413 . . . . 0.0 112.3 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.46 161.34 38.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 t -152.07 176.28 11.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 119.982 -1.699 . . . . 0.0 107.402 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -115.02 108.51 16.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 p -108.04 -54.8 2.45 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.53 -0.732 . . . . 0.0 112.919 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -71.25 -52.53 26.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 72.13 143.32 0.1 OUTLIER Pre-proline 0 C--N 1.352 0.699 0 C-N-CA 125.676 1.59 . . . . 0.0 113.634 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -59.91 132.34 44.43 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.247 2.631 . . . . 0.0 113.292 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -71.99 131.03 42.36 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 68.84 1.31 Allowed 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.463 HH22 ' CD ' ' A' ' 20' ' ' GLU 0.385 30.4 mtm180 58.2 166.78 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -165.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -119.29 13.28 12.75 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.142 -1.599 . . . . 0.0 113.229 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.2 24.1 12.49 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -97.28 10.61 39.09 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 119.775 -1.828 . . . . 0.0 111.658 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -66.98 147.97 52.56 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 112.073 163.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m120 72.26 122.18 0.04 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.684 1.594 . . . . 0.0 112.318 -167.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -147.07 10.31 1.01 Allowed 'General case' 0 C--N 1.351 0.639 0 O-C-N 120.737 -1.227 . . . . 0.0 109.706 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.11 166.96 16.76 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -118.14 17.96 13.91 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.339 1.055 . . . . 0.0 111.054 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.65 124.45 44.33 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.656 -1.278 . . . . 0.0 107.695 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m 71.95 25.2 3.12 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.063 0.945 . . . . 0.0 113.147 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.78 13.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 110.377 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -92.21 154.58 18.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.363 1.465 . . . . 0.0 111.976 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.0 mt -117.65 -30.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.63 145.03 50.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.903 1.681 . . . . 0.0 114.346 169.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -100.5 -8.39 23.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.17 -1.581 . . . . 0.0 112.517 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -154.99 151.06 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 64.84 48.07 2.51 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -170.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.26 141.41 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.652 1.581 . . . . 0.0 114.394 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -56.58 148.82 18.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -105.49 -6.66 19.24 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.1 -1.625 . . . . 0.0 112.743 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.52 140.26 58.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.247 1.819 . . . . 0.0 114.377 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -116.16 -9.85 11.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.773 -0.58 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.07 11.88 83.73 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 125.423 1.487 . . . . 0.0 114.821 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.72 -31.18 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.401 1.08 . . . . 0.0 109.688 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.79 41.06 30.64 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 165.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.265 3.1 mp 55.56 56.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 126.106 1.762 . . . . 0.0 110.799 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.33 50.2 m-20 71.66 40.27 0.8 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.547 1.939 . . . . 0.0 114.719 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 71.59 40.33 0.81 Allowed 'General case' 0 C--N 1.349 0.554 0 C-N-CA 127.015 2.126 . . . . 0.0 112.954 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.62 119.18 8.15 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 p -63.87 -41.17 97.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.36 178.83 8.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.767 1.227 . . . . 0.0 110.946 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 59.57 63.79 1.45 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 125.153 1.381 . . . . 0.0 113.937 -172.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -170.17 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -170.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 58.04 38.5 26.69 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 123.295 1.521 . . . . 0.0 114.75 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -156.46 165.97 34.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.38 -16.64 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 121.401 -0.812 . . . . 0.0 112.777 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.6 m -70.05 95.69 0.98 Allowed 'General case' 0 C--N 1.353 0.742 0 CA-C-O 123.383 1.563 . . . . 0.0 111.963 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.255 92.2 m-85 49.09 49.14 20.01 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 127.189 2.196 . . . . 0.0 115.847 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -94.73 -1.07 53.69 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.319 -0.863 . . . . 0.0 112.022 166.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.6 159.56 30.18 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.047 -1.033 . . . . 0.0 110.973 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 50.0 t -57.08 -46.9 84.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -172.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.3 t -120.99 12.06 11.12 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 116.468 -3.895 . . . . 0.0 110.995 -3.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -128.43 111.88 13.78 Favored 'General case' 0 C--N 1.358 0.964 0 O-C-N 119.523 -1.986 . . . . 0.0 108.143 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp -132.21 122.75 25.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 164.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' HZ1' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.01 -9.05 26.81 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m170 68.85 44.0 1.14 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.976 1.311 . . . . 0.0 113.662 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 m -146.69 146.11 19.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 123.783 0.833 . . . . 0.0 109.609 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.259 85.8 mtm180 90.0 38.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.717 3.207 . . . . 0.0 110.297 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -133.66 -20.34 2.04 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 t -114.55 137.6 51.67 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-O 122.387 1.089 . . . . 0.0 110.01 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.4 pt -117.66 8.98 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 120.82 -1.175 . . . . 0.0 109.68 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.92 128.04 40.01 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.491 1.516 . . . . 0.0 113.773 -159.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -159.95 164.54 33.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.298 -1.501 . . . . 0.0 110.592 160.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.5 m -61.49 -25.58 67.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.467 3.107 . . . . 0.0 116.361 -164.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -135.66 10.78 3.42 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 120.08 -1.637 . . . . 0.0 113.137 169.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -150.4 132.2 15.04 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.246 -1.534 . . . . 0.0 112.252 -164.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 m -79.57 115.13 19.01 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.7 mt 68.05 108.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 127.271 2.229 . . . . 0.0 112.864 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -91.58 97.02 10.79 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 119.177 -2.202 . . . . 0.0 108.8 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.68 155.65 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 C-N-CA 126.889 2.076 . . . . 0.0 106.484 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 1.8 p -51.58 148.14 5.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 128.159 2.584 . . . . 0.0 114.54 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -56.61 130.84 46.93 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.615 -1.303 . . . . 0.0 113.316 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.11 131.95 49.49 Favored Pre-proline 0 C--N 1.352 0.713 0 O-C-N 120.963 -1.086 . . . . 0.0 109.592 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.66 123.93 12.45 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.381 2.721 . . . . 0.0 116.972 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 131.0 49.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 m120 74.5 16.05 3.3 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.8 122.12 85.95 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 118.752 0.706 . . . . 0.0 111.982 168.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -92.06 167.11 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.911 1.741 . . . . 0.0 110.47 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.4 164.6 20.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.4 -118.82 2.07 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.83 5.11 52.74 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.977 -1.308 . . . . 0.0 112.738 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -91.7 -12.06 9.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.844 -1.16 . . . . 0.0 113.62 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.2 t -163.15 161.71 25.23 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.6 p -98.0 2.64 49.11 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.321 1.058 . . . . 0.0 110.994 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -83.62 123.78 30.13 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.923 -1.11 . . . . 0.0 111.682 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 15.3 m120 61.52 40.89 13.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 m -58.96 -45.09 91.34 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.632 1.573 . . . . 0.0 112.621 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.37 132.76 28.33 Favored Pre-proline 0 N--CA 1.436 -1.145 0 C-N-CA 124.516 1.126 . . . . 0.0 111.592 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.09 115.05 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.464 2.776 . . . . 0.0 115.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.282 66.7 mttm 89.69 10.95 0.07 Allowed 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.86 2.064 . . . . 0.0 115.144 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.1 t -94.61 164.91 12.77 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 120.775 -1.203 . . . . 0.0 111.618 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -135.6 159.06 42.78 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.837 1.255 . . . . 0.0 108.789 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -137.53 164.75 27.97 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.202 -1.561 . . . . 0.0 108.273 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -79.64 -16.29 56.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.28 37.94 23.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.447 1.499 . . . . 0.0 114.711 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -157.28 169.02 25.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.0 t -106.21 154.56 20.54 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.638 -1.289 . . . . 0.0 107.575 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 69.16 44.18 1.02 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 166.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 t -82.46 138.7 34.3 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.193 -1.567 . . . . 0.0 110.748 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 pt -133.45 161.66 40.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.891 0 O-C-N 119.505 -1.997 . . . . 0.0 111.601 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 57.35 -127.23 1.76 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 79.96 -37.66 0.16 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.508 1.523 . . . . 0.0 111.004 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.87 148.61 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 132' ' ' LYS . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.596 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.596 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -57.82 120.26 8.13 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 118.06 -7.31 14.85 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -57.83 -35.65 71.19 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 16.0 tp 62.23 34.37 16.07 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 124.245 1.974 . . . . 0.0 114.497 163.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' A' ' 224' ' ' ARG . 45.4 mt-10 -80.96 103.5 10.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 119.757 -1.84 . . . . 0.0 112.288 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.88 -44.08 81.89 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.651 -1.28 . . . . 0.0 113.51 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 m -75.62 -15.35 60.35 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 120.808 -1.182 . . . . 0.0 111.793 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.47 HH11 ' CE1' ' A' ' 228' ' ' HIS . 23.1 ttp180 -147.22 70.74 1.19 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.085 -2.26 . . . . 0.0 112.111 -173.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -58.72 -43.15 90.06 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.297 -1.502 . . . . 0.0 113.941 173.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -94.63 136.64 34.71 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.223 -1.548 . . . . 0.0 111.629 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.5 m -61.73 121.56 13.15 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.964 -1.085 . . . . 0.0 111.835 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.47 ' CE1' HH11 ' A' ' 224' ' ' ARG . 5.8 p-80 -102.22 3.26 38.1 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 120.678 -1.263 . . . . 0.0 112.099 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.89 -35.12 79.3 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.62 132.54 22.78 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.789 -1.194 . . . . 0.0 111.445 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.32 0 CA-C-O 120.31 -0.161 . . . . 0.0 113.437 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -93.14 174.65 7.11 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.601 1.56 . . . . 0.0 107.624 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -108.17 127.08 53.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.38 140.01 43.62 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.937 1.351 . . . . 0.0 112.59 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.09 144.65 33.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.965 1.306 . . . . 0.0 112.236 161.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.73 10.23 31.64 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.082 -1.636 . . . . 0.0 114.912 -153.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.853 -1.154 . . . . 0.0 110.926 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.28 46.2 mt-10 57.21 29.38 16.61 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 164.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 70.62 32.61 2.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 119.908 -1.745 . . . . 0.0 112.96 165.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.8 pt -52.78 134.64 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.896 1.278 . . . . 0.0 113.465 171.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.7 p -101.54 -3.37 28.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.182 -0.949 . . . . 0.0 110.348 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -84.94 110.86 19.18 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.645 1.212 . . . . 0.0 112.268 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -59.75 -41.46 91.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.712 2.405 . . . . 0.0 115.175 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -124.14 145.66 49.01 Favored Pre-proline 0 CA--C 1.51 -0.571 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -88.47 166.21 6.45 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.704 1.602 . . . . 0.0 111.236 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -86.65 142.64 34.94 Favored Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 124.326 1.05 . . . . 0.0 108.534 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -53.76 162.03 4.02 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 123.192 2.595 . . . . 0.0 118.561 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -62.33 141.85 58.08 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 113.672 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.18 17.79 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 165.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -44.52 149.84 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.823 3.682 . . . . 0.0 118.568 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -148.5 27.96 0.9 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.28 1.514 . . . . 0.0 108.23 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -145.15 138.21 26.43 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.4 11.92 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.812 0.845 . . . . 0.0 112.452 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -91.84 5.07 51.33 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.869 -1.145 . . . . 0.0 111.877 -166.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.8 mt -82.94 114.88 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -162.01 164.18 28.43 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.4 p -101.98 -2.81 28.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.154 0.982 . . . . 0.0 112.773 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.4 m -65.65 -40.56 88.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -109.14 -11.93 14.87 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.693 -1.254 . . . . 0.0 112.93 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.601 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 17.3 m-20 -129.47 126.03 37.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 109.065 -167.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 58.47 39.54 24.96 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 131.327 3.851 . . . . 0.0 114.201 0.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -64.28 141.3 58.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -170.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -57.65 152.14 15.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -57.38 125.52 23.18 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.2 mt -115.21 108.74 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 166.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -123.43 0.67 8.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.651 -1.281 . . . . 0.0 111.938 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 t -159.88 170.1 22.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -147.16 159.38 43.69 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.8 p -34.83 137.15 0.14 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 159.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t 78.78 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 127.445 2.298 . . . . 0.0 113.291 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 47.33 67.28 4.62 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 127.462 2.305 . . . . 0.0 115.793 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 -29.13 10.04 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.678 2.252 . . . . 0.0 113.037 -158.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -114.98 133.81 55.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 124.901 1.28 . . . . 0.0 109.143 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.55 135.44 55.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -59.44 -42.53 92.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.3 t80 79.19 -57.92 0.41 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 127.577 2.351 . . . . 0.0 111.937 166.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 81.22 51.93 0.02 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.321 2.649 . . . . 0.0 107.883 -171.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -71.24 -45.97 62.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 119.45 3.13 . . . . 0.0 119.45 -161.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CZ2' ' HE1' ' A' ' 146' ' ' HIS . 21.4 m-90 -121.66 113.09 19.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.021 -1.05 . . . . 0.0 110.788 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -127.98 125.91 40.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.467 -0.771 . . . . 0.0 110.505 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.283 98.7 m-20 65.73 60.11 0.72 Allowed 'General case' 0 C--N 1.345 0.377 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 174.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.0 t30 76.9 104.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.236 2.614 . . . . 0.0 114.49 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.96 172.29 13.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 117.007 -3.558 . . . . 0.0 108.232 -4.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.83 5.49 41.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 130.135 3.374 . . . . 0.0 110.813 -7.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -154.94 154.27 32.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.78 130.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 CA-C-O 121.916 0.865 . . . . 0.0 111.256 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.12 10.76 12.19 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 123.781 0.833 . . . . 0.0 112.191 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 tp -138.79 145.96 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 119.493 -2.005 . . . . 0.0 108.142 -174.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.16 149.81 47.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.44 -29.42 70.71 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.37 -31.45 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 O-C-N 120.874 -1.141 . . . . 0.0 113.901 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 mtp85 -84.29 -21.38 31.08 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.406 -1.433 . . . . 0.0 113.109 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.2 pt -114.39 6.1 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 123.607 0.763 . . . . 0.0 111.082 -172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.55 148.21 52.21 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.628 1.68 . . . . 0.0 111.549 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.64 -41.08 97.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -120.1 132.94 55.61 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.001 0.52 . . . . 0.0 110.019 -168.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 59.85 58.45 2.78 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.273 1.029 . . . . 0.0 113.18 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -62.57 -171.82 1.47 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-O 124.046 1.914 . . . . 0.0 113.641 167.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.86 140.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 119.819 -1.989 . . . . 0.0 108.912 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -61.09 132.78 54.86 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 119.86 -1.775 . . . . 0.0 112.725 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -131.99 -6.61 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 121.643 -0.66 . . . . 0.0 112.656 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.26 11.1 m-20 49.22 -160.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.47 137.73 57.63 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 119.413 -2.054 . . . . 0.0 114.299 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.601 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -150.73 157.81 43.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 -171.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -99.73 146.45 26.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 123.412 1.577 . . . . 0.0 110.932 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -131.7 16.75 4.8 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.127 1.371 . . . . 0.0 107.305 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.91 -9.45 19.86 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 120.493 -1.38 . . . . 0.0 111.725 -173.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.38 -2.42 57.32 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.304 -1.497 . . . . 0.0 112.711 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -115.89 15.19 16.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 124.199 0.999 . . . . 0.0 109.685 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 62.07 35.33 15.94 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.652 1.581 . . . . 0.0 114.301 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.56 154.96 37.72 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.761 1.172 . . . . 0.0 114.918 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t -147.83 151.16 35.49 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.38 -1.659 . . . . 0.0 108.132 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.88 -39.78 83.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.629 -1.92 . . . . 0.0 113.67 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -161.84 156.69 22.97 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.252 -0.905 . . . . 0.0 109.007 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.41 170.58 21.46 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.06 110.88 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-O 122.695 1.236 . . . . 0.0 110.61 171.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.4 t -155.48 -166.59 2.28 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.238 -1.539 . . . . 0.0 109.092 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.254 21.2 m 78.1 131.62 0.05 Allowed 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 128.141 2.577 . . . . 0.0 113.056 170.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.48 146.82 33.95 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.62 43.91 11.39 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -58.69 -39.24 80.16 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.777 1.631 . . . . 0.0 114.17 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.18 -26.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 123.339 1.542 . . . . 0.0 107.349 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -87.89 172.32 9.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 120.39 -1.444 . . . . 0.0 114.449 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.487 ' HE1' ' CZ2' ' A' ' 77' ' ' TRP . 16.5 t60 -61.65 153.89 26.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 158.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.7 m -107.38 103.33 12.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 160.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.48 144.74 29.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 128.153 2.581 . . . . 0.0 108.752 -11.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.8 -37.74 16.32 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m 52.36 32.21 10.75 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.256 1.822 . . . . 0.0 115.01 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 83.6 m -70.02 125.22 26.12 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 120.213 -1.554 . . . . 0.0 112.476 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -61.64 -42.67 99.23 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.13 -40.61 90.78 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 113.338 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 m -70.67 120.67 16.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.219 1.485 . . . . 0.0 112.516 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.45 167.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -115.07 150.61 35.67 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 112.087 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.27 5.8 t 66.57 73.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 125.202 1.401 . . . . 0.0 113.317 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.1 p -130.89 154.79 47.72 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 119.864 -1.773 . . . . 0.0 111.031 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.4 m -68.48 144.09 54.76 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.965 1.306 . . . . 0.0 111.853 167.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.3 t -107.03 115.96 59.28 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.69 163.28 22.01 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.172 1.914 . . . . 0.0 114.463 174.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -87.54 169.01 12.56 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 122.21 1.005 . . . . 0.0 111.083 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -102.11 6.88 41.13 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.145 1.378 . . . . 0.0 110.415 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.7 162.0 48.9 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 125.721 1.608 . . . . 0.0 107.035 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.37 163.98 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.163 2.575 . . . . 0.0 115.673 161.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.255 85.5 m-20 69.49 47.49 0.67 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.602 1.192 . . . . 0.0 114.139 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.88 -166.03 34.81 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.495 160.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.51 -23.43 62.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.275 1.83 . . . . 0.0 114.799 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.8 p -56.23 -35.21 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.886 2.074 . . . . 0.0 113.458 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.1 m -83.25 -48.75 10.13 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.091 -1.005 . . . . 0.0 109.893 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -171.21 156.26 4.63 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -122.04 138.17 54.54 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.531 -0.73 . . . . 0.0 109.973 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -115.4 131.17 57.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 121.384 -0.822 . . . . 0.0 108.821 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.5 p -78.58 -21.12 49.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -74.3 119.05 74.53 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.936 1.295 . . . . 0.0 112.262 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -66.17 138.19 50.77 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 123.592 2.862 . . . . 0.0 114.732 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.33 -7.9 15.16 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 122.352 1.072 . . . . 0.0 110.313 165.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.9 t -164.06 158.75 19.77 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -64.85 -40.92 95.92 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.44 -44.09 95.54 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 11.7 t70 58.4 -155.56 0.34 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.095 1.358 . . . . 0.0 114.025 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.523 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 29.9 m-85 -119.41 -32.16 4.43 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 127.191 2.196 . . . . 0.0 108.939 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -160.34 -11.13 0.05 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t -63.05 -48.19 79.77 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.522 -1.361 . . . . 0.0 112.303 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -65.46 -37.34 86.59 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.339 -1.476 . . . . 0.0 112.72 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 57.5 m -54.84 -36.17 64.76 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 114.837 -174.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.4 pt -91.4 3.93 6.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 123.805 0.842 . . . . 0.0 111.634 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.7 17.06 11.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 120.777 -1.202 . . . . 0.0 110.243 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -90.07 -2.06 58.05 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.734 -1.229 . . . . 0.0 113.629 -171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.01 123.62 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.401 ' CZ3' ' HD2' ' A' ' 224' ' ' ARG . 73.4 t-105 -151.07 132.98 15.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.21 160.58 16.29 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 128.484 2.945 . . . . 0.0 114.659 -7.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -149.6 162.03 40.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 117.245 -3.503 . . . . 0.0 107.466 2.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.2 tp -176.64 117.45 0.12 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -82.07 -21.98 36.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -86.31 158.24 19.72 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.635 -1.29 . . . . 0.0 112.372 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.1 m -41.36 115.28 0.6 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.826 2.05 . . . . 0.0 114.863 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.401 ' HD2' ' CZ3' ' A' ' 217' ' ' TRP . 26.5 mtp-105 -86.72 151.25 23.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.62 164.17 13.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.884 167.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -86.08 134.26 33.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 111.074 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 -3.26 15.84 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.371 -176.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . 0.258 92.0 m-70 69.18 40.1 1.6 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 123.515 1.626 . . . . 0.0 111.41 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.51 -40.97 88.84 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.2 2.2 . . . . 0.0 114.734 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.51 128.1 34.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.742 1.217 . . . . 0.0 112.441 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.348 0.118 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.41 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . . . . . . 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.41 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.252 1.025 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.408 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 192' ' ' LEU . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 . . . . . 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.591 0.234 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--O 1.239 0.503 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.47 ' H ' HG21 ' A' ' 190' ' ' VAL . . . . . . . . 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 . . . . . 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.403 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.384 0.612 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.417 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.519 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.881 0.848 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.238 0.458 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.265 0.555 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 122.454 1.121 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp . . . . . 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.432 -1.35 0 CA-C-O 122.359 1.076 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.445 0.64 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.532 -0.271 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.318 1.056 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 190' ' ' VAL . . . . . . . . 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 142' ' ' GLY . 22.9 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' CG ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HE ' ' CG ' ' A' ' 14' ' ' ASP . 22.4 tpt180 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.483 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.524 0.202 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 . . . . . 0 CA--C 1.514 -0.442 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 14' ' ' ASP 0.307 26.0 mt . . . . . 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 121.803 0.811 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 . . . . . 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.454 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 215' ' ' HIS . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 193' ' ' GLY . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 . . . . . 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--O 1.238 0.472 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.78 0.8 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 215' ' ' HIS . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.425 ' HA ' ' CA ' ' A' ' 193' ' ' GLY . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 119.306 -0.378 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 121.613 0.72 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.215 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp . . . . . 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.675 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.675 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 . . . . . 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.744 0.307 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.703 0.763 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 . . . . . 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.235 0.541 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.491 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.671 0 CA-C-O 118.694 -1.059 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -159.03 156.54 29.48 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp -120.61 149.6 42.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.23 39.73 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 119.582 -1.949 . . . . 0.0 109.285 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.38 123.05 28.22 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.224 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.26 109.73 21.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.704 -1.248 . . . . 0.0 111.278 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -84.95 140.13 31.31 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.173 169.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.85 -28.71 65.89 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.7 m80 65.72 41.91 3.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.464 -1.398 . . . . 0.0 114.555 168.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.2 pt -110.46 7.11 8.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 O-C-N 120.444 -1.41 . . . . 0.0 112.944 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -116.13 23.22 12.34 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.699 -1.251 . . . . 0.0 111.823 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.17 157.1 39.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.736 -1.228 . . . . 0.0 109.131 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.15 136.88 57.32 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.706 0.803 . . . . 0.0 112.964 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.85 137.12 12.73 Favored Pre-proline 0 C--N 1.351 0.638 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.84 -16.69 18.27 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.522 2.815 . . . . 0.0 112.347 -165.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.4 139.42 91.98 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.07 19.24 0.6 Allowed 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 123.604 2.869 . . . . 0.0 114.394 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 p -60.21 -40.22 89.33 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.642 1.577 . . . . 0.0 113.382 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.77 157.4 54.99 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.957 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.87 140.09 23.98 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 124.932 3.755 . . . . 0.0 116.775 169.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.75 -45.85 87.98 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -156.47 166.21 34.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.643 -1.285 . . . . 0.0 109.019 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 68.08 47.72 1.02 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 169.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -74.97 71.64 2.08 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -146.94 134.87 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.9 m 67.71 42.0 2.11 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-O 123.108 1.432 . . . . 0.0 112.946 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -149.47 172.72 14.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.708 2.403 . . . . 0.0 105.332 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.38 135.38 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.261 81.1 p -65.05 143.05 58.19 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 119.867 -1.771 . . . . 0.0 114.548 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -52.02 158.22 1.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.233 2.213 . . . . 0.0 116.224 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -87.95 158.08 18.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.039 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -118.19 136.72 53.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -171.28 -8.69 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -90.45 96.94 10.9 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 119.876 -1.765 . . . . 0.0 109.957 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.2 pt -112.41 17.06 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.189 1.396 . . . . 0.0 108.096 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 74.57 10.46 4.11 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.62 1.968 . . . . 0.0 114.631 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 p -77.43 -18.08 57.54 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -120.14 9.65 11.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 m -123.53 -6.68 8.1 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 122.775 0.43 . . . . 0.0 111.559 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.47 -5.68 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 121.082 -1.012 . . . . 0.0 112.631 -167.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -100.19 115.04 65.87 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.154 0.982 . . . . 0.0 110.458 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.4 145.4 0.95 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 125.103 3.869 . . . . 0.0 118.814 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -82.16 144.56 30.65 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.536 -0.728 . . . . 0.0 110.751 168.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.41 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . 76.9 146.48 0.09 Allowed 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.89 85.18 0.12 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.617 1.967 . . . . 0.0 110.979 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -130.28 161.46 31.18 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.071 1.749 . . . . 0.0 111.454 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 61.4 179.9 0.11 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -95.82 -54.12 3.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 108.366 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -118.54 164.18 15.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.717 2.007 . . . . 0.0 110.151 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -111.6 -39.28 4.66 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.269 1.427 . . . . 0.0 111.637 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -64.05 145.0 56.66 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -114.49 11.23 17.08 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.992 0.901 . . . . 0.0 109.651 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -139.9 126.49 20.4 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -113.55 5.73 16.73 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 120.833 -1.167 . . . . 0.0 110.112 -167.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 p -58.92 -35.71 73.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 -159.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.04 8.65 9.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.77 -1.206 . . . . 0.0 111.734 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 78.66 25.93 0.52 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.308 1.443 . . . . 0.0 112.305 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.37 -40.39 87.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.83 -29.15 14.87 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 123.188 1.471 . . . . 0.0 111.294 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -144.49 133.75 23.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.18 155.16 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -70.94 143.69 50.82 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 119.66 -1.9 . . . . 0.0 113.083 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.1 tt -76.96 -25.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.361 -1.462 . . . . 0.0 112.63 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -158.64 151.71 22.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.089 -1.632 . . . . 0.0 106.743 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -66.72 143.81 56.72 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.705 -1.247 . . . . 0.0 110.967 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.13 150.45 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.134 2.173 . . . . 0.0 115.345 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -137.38 129.03 28.57 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 -166.44 54.36 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 118.625 0.648 . . . . 0.0 113.029 -172.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.37 144.75 17.08 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-O 122.99 1.376 . . . . 0.0 110.362 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -72.95 129.28 37.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -102.79 -22.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.887 -1.133 . . . . 0.0 110.661 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -116.01 157.25 24.91 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 49.34 52.57 14.22 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -77.85 -14.21 59.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -96.32 117.24 30.43 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 50.41 -110.64 0.46 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -134.63 138.18 44.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.804 2.441 . . . . 0.0 107.255 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -75.99 161.76 28.65 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.323 -0.861 . . . . 0.0 111.895 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.28 81.8 mt-10 70.34 56.07 0.28 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -171.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -76.28 121.34 22.81 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.393 -1.442 . . . . 0.0 113.453 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.9 -175.44 27.34 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 123.11 1.395 . . . . 0.0 116.019 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -117.92 106.28 12.8 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.553 -1.557 . . . . 0.0 108.119 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.7 132.88 48.04 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.073 -1.642 . . . . 0.0 108.697 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 83.83 6.53 0.68 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.541 1.936 . . . . 0.0 114.927 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.02 20.46 8.95 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.977 -1.702 . . . . 0.0 112.026 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.56 -32.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.038 1.335 . . . . 0.0 112.871 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.79 129.1 37.23 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.804 -1.81 . . . . 0.0 111.063 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 t -163.02 -6.79 0.03 OUTLIER 'General case' 0 C--N 1.348 0.514 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.841 -153.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt -138.25 159.52 41.84 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.343 -1.473 . . . . 0.0 108.527 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.41 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.478 HH22 ' CE1' ' A' ' 228' ' ' HIS . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.41 176.12 19.28 Favored Glycine 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -141.12 133.87 28.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.41 -29.69 32.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 124.33 1.052 . . . . 0.0 112.554 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.293 38.9 mmt180 71.19 17.64 5.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.308 1.443 . . . . 0.0 114.043 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -155.19 97.49 1.92 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.734 2.413 . . . . 0.0 105.365 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.286 15.1 m 72.62 46.38 0.29 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.522 3.529 . . . . 0.0 113.179 -0.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -132.87 149.19 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.041 1.336 . . . . 0.0 108.823 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -38.43 83.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.595 2.358 . . . . 0.0 111.738 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 m -60.44 130.54 47.09 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.556 1.646 . . . . 0.0 114.543 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.46 149.01 39.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.005 1.322 . . . . 0.0 113.047 168.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -52.81 139.19 27.54 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -60.94 137.23 58.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.483 -0.761 . . . . 0.0 112.307 167.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.9 p -68.22 -42.76 79.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.2 pt -84.18 127.39 39.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 120.19 -1.569 . . . . 0.0 112.244 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.7 10.87 0.42 Allowed 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.245 -1.535 . . . . 0.0 114.165 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.69 121.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 123.752 0.821 . . . . 0.0 108.807 167.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 53.5 m -142.15 125.57 16.64 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.551 -167.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.3 p -122.14 143.59 49.45 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.76 155.41 79.43 Favored Pre-proline 0 C--O 1.235 0.324 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -55.6 144.38 75.06 Favored 'Trans proline' 0 CA--C 1.51 -0.68 0 C-N-CA 123.041 2.494 . . . . 0.0 113.828 167.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -146.76 143.78 28.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -95.33 2.7 54.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.84 92.73 Favored Pre-proline 0 C--N 1.347 0.462 0 O-C-N 121.322 -0.861 . . . . 0.0 113.021 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -44.51 138.78 7.48 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 125.121 3.881 . . . . 0.0 116.448 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.59 54.33 2.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -58.84 -33.83 75.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 120.699 -1.25 . . . . 0.0 115.574 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 9.76 40.4 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.544 -0.974 . . . . 0.0 112.188 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.3 2.9 t 59.73 46.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 123.578 1.656 . . . . 0.0 113.968 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.1 p -93.31 1.91 56.79 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 119.036 -2.29 . . . . 0.0 112.767 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.329 5.7 m 48.96 62.92 2.34 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.635 2.374 . . . . 0.0 115.411 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 62.26 36.41 14.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 126.372 1.869 . . . . 0.0 115.071 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -142.88 163.85 31.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.8 p -81.27 147.41 29.94 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.486 -2.009 . . . . 0.0 113.545 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.64 146.12 86.39 Favored Pre-proline 0 C--N 1.36 1.059 0 O-C-N 120.873 -1.142 . . . . 0.0 112.056 168.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -52.23 -24.29 20.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.153 3.236 . . . . 0.0 116.931 167.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -120.68 -40.07 2.69 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 120.126 1.33 . . . . 0.0 110.013 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.0 m -82.09 76.25 8.98 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 119.572 -1.955 . . . . 0.0 110.164 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -148.14 43.69 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.432 1.111 . . . . 0.0 111.014 -170.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -52.32 -38.28 58.1 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -74.3 -16.08 60.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.314 1.046 . . . . 0.0 112.879 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.69 -18.2 10.34 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.894 -1.129 . . . . 0.0 113.631 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -59.83 139.62 57.19 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t -65.34 -41.25 94.1 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.186 -1.571 . . . . 0.0 114.658 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -120.57 142.1 49.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . 0.257 66.6 m 61.3 37.31 17.21 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 tt -63.6 147.31 12.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.266 1.826 . . . . 0.0 110.901 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -85.24 122.19 29.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.173 -1.579 . . . . 0.0 111.127 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -130.82 -25.66 2.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.344 -0.848 . . . . 0.0 111.378 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p -81.38 127.83 39.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 124.386 1.074 . . . . 0.0 111.654 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -155.22 162.85 40.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.52 -85.96 1.07 Allowed Glycine 0 C--N 1.346 1.103 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.7 128.82 55.27 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.6 -0.941 . . . . 0.0 110.296 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.91 137.95 52.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.39 145.08 45.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.29 0.95 . . . . 0.0 110.169 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -175.24 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.961 1.304 . . . . 0.0 112.181 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.318 4.3 m 70.37 49.58 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.004 2.121 . . . . 0.0 112.988 -167.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.295 93.0 mtt180 64.55 41.42 5.49 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.201 2.2 . . . . 0.0 116.834 167.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -83.47 109.99 17.82 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.24 -1.538 . . . . 0.0 112.31 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -108.08 11.23 27.82 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 123.133 1.444 . . . . 0.0 109.131 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.2 p -62.61 136.7 58.02 Favored 'General case' 0 C--N 1.347 0.468 0 O-C-N 119.618 -1.926 . . . . 0.0 112.975 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.478 ' CE1' HH22 ' A' ' 138' ' ' ARG . 2.2 t-160 99.69 0.06 0.02 OUTLIER 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.972 2.109 . . . . 0.0 111.513 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -60.23 -44.9 94.82 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 123.122 1.439 . . . . 0.0 111.314 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -142.12 160.48 40.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 158.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.115 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -161.03 157.77 26.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 164.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.5 133.38 55.81 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.87 -94.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 120.952 -1.092 . . . . 0.0 110.661 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -64.05 125.3 24.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 -14.52 35.42 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-O 122.462 1.125 . . . . 0.0 111.464 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -161.1 155.23 22.74 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 166.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -116.18 63.27 0.71 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 123.369 1.557 . . . . 0.0 111.002 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -154.02 166.12 34.01 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.71 -12.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.815 0.846 . . . . 0.0 112.662 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 t -157.46 -179.85 8.57 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.558 -1.338 . . . . 0.0 108.65 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -93.94 132.05 38.78 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.455 1.902 . . . . 0.0 113.629 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.07 137.91 34.46 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.6 1.16 . . . . 0.0 112.668 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -60.16 145.05 86.3 Favored Pre-proline 0 C--N 1.347 0.496 0 C-N-CA 126.246 1.818 . . . . 0.0 114.231 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -26.01 22.27 Favored 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.794 2.33 . . . . 0.0 112.925 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.34 157.01 79.2 Favored Pre-proline 0 N--CA 1.443 -0.794 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -39.34 135.11 1.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 124.48 3.453 . . . . 0.0 118.117 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -89.87 -1.89 58.08 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.758 -1.214 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.98 130.84 8.39 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -53.99 128.25 28.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.312 2.675 . . . . 0.0 113.837 166.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -137.14 164.16 29.11 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -157.96 16.75 0.24 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.313 1.054 . . . . 0.0 110.134 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.03 155.83 50.09 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -107.42 110.08 21.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.54 16.97 3.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 122.27 1.033 . . . . 0.0 109.467 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 t -150.88 149.46 29.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.874 -1.141 . . . . 0.0 108.397 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -64.46 -45.72 86.23 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.845 1.658 . . . . 0.0 115.165 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 m -47.48 176.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 131.512 3.925 . . . . 0.0 117.905 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -59.73 143.65 50.29 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 119.062 -2.274 . . . . 0.0 116.516 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 59.09 171.11 0.07 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.681 1.992 . . . . 0.0 114.759 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -64.03 -43.42 95.63 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.926 1.69 . . . . 0.0 112.306 171.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -134.86 123.42 23.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -60.08 143.9 50.91 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 120.409 -1.432 . . . . 0.0 114.815 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -153.11 152.83 31.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.857 -1.152 . . . . 0.0 108.623 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 mt 69.69 106.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 128.524 2.73 . . . . 0.0 112.24 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -30.3 131.32 0.08 Allowed 'General case' 0 C--N 1.359 1.013 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -59.72 145.95 43.18 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.122 1.369 . . . . 0.0 113.067 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -160.48 162.21 33.05 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 119.924 -1.735 . . . . 0.0 109.918 -163.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t 94.42 37.83 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.477 1.911 . . . . 0.0 110.932 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.05 138.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.612 1.565 . . . . 0.0 112.416 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -100.0 125.21 40.85 Favored Pre-proline 0 C--N 1.348 0.518 0 O-C-N 119.97 -1.706 . . . . 0.0 108.021 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -50.43 132.56 35.25 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.344 2.696 . . . . 0.0 115.457 164.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.98 124.63 24.27 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.44 27.97 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.3 mmt-85 -127.08 23.7 6.48 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 125.115 1.366 . . . . 0.0 109.934 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 60.6 t80 -63.87 135.8 56.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.424 1.49 . . . . 0.0 111.814 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 55.2 ttp180 -96.03 -25.29 15.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 118.483 -2.635 . . . . 0.0 111.041 -5.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -145.18 48.29 1.29 Allowed 'General case' 0 C--N 1.353 0.733 0 CA-C-O 122.558 1.171 . . . . 0.0 108.033 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 74.01 40.85 0.43 Allowed 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.303 1.525 . . . . 0.0 110.24 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -78.65 149.92 32.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.52 -1.362 . . . . 0.0 112.729 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.4 m120 63.83 42.07 6.35 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -128.72 131.68 47.92 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 120.181 -1.574 . . . . 0.0 107.789 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.32 139.49 58.53 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 110.419 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -128.95 160.96 31.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -87.31 119.11 27.23 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.049 -1.657 . . . . 0.0 109.374 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.8 1.11 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.636 1.208 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -104.46 16.66 25.67 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.758 -1.214 . . . . 0.0 111.344 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.29 -12.06 8.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 165.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.304 52.8 mt-10 38.57 46.47 0.99 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 128.563 2.745 . . . . 0.0 117.063 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.39 -29.66 64.27 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.313 1.845 . . . . 0.0 113.451 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.08 -14.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 126.888 2.075 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -82.87 -13.06 56.84 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 120.606 -1.309 . . . . 0.0 113.248 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.3 mm -104.24 -36.58 4.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.579 -1.326 . . . . 0.0 110.457 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.18 131.59 16.63 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 120.672 -1.268 . . . . 0.0 107.79 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -101.27 -77.37 0.54 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.316 0.579 . . . . 0.0 111.517 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 14.1 mp0 -61.56 -46.06 91.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 127.991 2.516 . . . . 0.0 110.16 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.87 32.04 4.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.631 2.772 . . . . 0.0 108.926 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.96 3.08 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 113.61 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 pt -89.78 10.26 2.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 O-C-N 119.98 -1.894 . . . . 0.0 112.484 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 15.53 75.31 0.01 OUTLIER 'General case' 0 C--N 1.353 0.736 0 C-N-CA 131.087 3.755 . . . . 0.0 118.254 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.6 pt -89.42 -2.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 O-C-N 119.915 -1.741 . . . . 0.0 112.623 -160.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.265 33.7 t0 60.3 -142.96 0.53 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.452 1.501 . . . . 0.0 112.618 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 80.02 15.19 0.84 Allowed 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 119.526 -1.984 . . . . 0.0 113.061 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.2 pttm -56.59 -41.9 77.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.415 1.486 . . . . 0.0 113.741 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 92.7 m 113.6 115.85 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 129.182 2.993 . . . . 0.0 105.621 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.66 64.08 6.21 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.806 1.289 . . . . 0.0 111.038 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.96 -46.83 78.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.04 2.136 . . . . 0.0 114.999 -166.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -77.54 -16.66 58.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 119.834 -1.791 . . . . 0.0 115.237 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.81 -46.92 88.63 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -111.23 20.79 17.01 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.079 -1.013 . . . . 0.0 109.862 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.53 23.34 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 117.528 1.771 . . . . 0.0 117.528 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -134.16 160.58 37.37 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 120.815 -1.403 . . . . 0.0 111.074 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.88 20.34 9.23 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.017 -1.677 . . . . 0.0 109.341 169.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -136.98 128.64 28.75 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 127.458 2.303 . . . . 0.0 109.233 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.58 145.84 38.03 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.006 -1.684 . . . . 0.0 115.213 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -72.44 -24.19 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 119.551 -1.968 . . . . 0.0 113.422 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 t -65.76 145.27 56.2 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.0 t -150.05 144.66 25.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.94 133.39 54.39 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.82 -169.09 39.76 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.97 129.06 51.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 120.647 -1.502 . . . . 0.0 110.6 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.25 160.32 32.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.029 1.332 . . . . 0.0 110.539 -166.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -102.88 111.23 23.46 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.105 -0.997 . . . . 0.0 113.096 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -65.46 155.22 36.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.467 1.107 . . . . 0.0 112.495 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -88.58 -16.62 32.08 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 120.575 -1.328 . . . . 0.0 113.875 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.3 -15.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.199 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -105.39 163.06 12.91 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 122.154 2.252 . . . . 0.0 106.898 159.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -120.68 135.26 55.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.453 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.46 -37.56 75.71 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.729 2.012 . . . . 0.0 114.639 -167.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 51.47 50.39 18.96 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 175' ' ' ASP . 8.2 ptpp? -96.29 -3.94 43.09 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.448 -1.407 . . . . 0.0 111.726 -166.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 157' ' ' VAL . 9.4 t -159.98 159.04 31.69 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 6.3 pt -100.66 -6.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.064 0.945 . . . . 0.0 110.195 171.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -63.68 -43.77 95.69 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 125.757 1.623 . . . . 0.0 113.713 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 154' ' ' THR . 61.6 t -130.2 112.37 23.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 O-C-N 119.884 -1.76 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -95.3 104.46 16.35 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 120.676 -1.265 . . . . 0.0 108.516 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.2 m -59.28 117.75 5.15 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.88 157.2 69.41 Favored Pre-proline 0 C--O 1.248 1.025 0 O-C-N 120.948 -1.095 . . . . 0.0 112.472 171.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.84 132.96 2.67 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 124.233 3.289 . . . . 0.0 116.326 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.5 t -61.52 -39.28 90.46 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.979 1.312 . . . . 0.0 114.332 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.11 14.94 18.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.487 -1.383 . . . . 0.0 114.13 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -94.45 138.56 22.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 O-C-N 121.064 -1.023 . . . . 0.0 111.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.96 135.88 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 124.019 3.146 . . . . 0.0 115.633 157.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -131.48 142.5 49.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.52 -10.59 47.05 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 123.969 0.795 . . . . 0.0 112.773 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.15 25.15 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.406 -1.055 . . . . 0.0 111.369 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.17 -43.74 96.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 C-N-CA 125.5 1.52 . . . . 0.0 112.051 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 99.6 m -106.29 124.4 49.54 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -155.99 170.01 23.12 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.87 140.52 48.9 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -91.71 101.92 14.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 119.281 -2.137 . . . . 0.0 107.927 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.1 t -79.81 -18.46 50.86 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 118.929 -2.357 . . . . 0.0 110.97 172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 153' ' ' LYS . 33.4 m-20 -126.58 156.18 73.6 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -36.7 142.57 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.349 1 C-N-CA 125.363 4.042 . . . . 0.0 117.889 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.42 -42.8 99.72 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.15 149.05 45.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.149 2.179 . . . . 0.0 115.944 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -127.69 139.13 52.89 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.011 -1.681 . . . . 0.0 107.737 165.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . 0.254 68.4 m-20 81.28 26.1 0.22 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.437 1.095 . . . . 0.0 112.126 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.57 136.49 53.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.76 2.024 . . . . 0.0 108.333 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -112.86 7.64 18.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.749 0.82 . . . . 0.0 111.692 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.293 1.7 mp0 55.03 54.08 9.41 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.9 m -51.34 126.61 17.46 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.685 -1.259 . . . . 0.0 114.187 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.266 51.3 m-80 79.04 16.39 0.98 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.362 1.465 . . . . 0.0 113.345 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.5 t -130.18 160.21 34.5 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.221 -1.55 . . . . 0.0 109.208 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.1 pt -94.87 1.66 9.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 123.091 1.424 . . . . 0.0 111.591 -163.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -64.59 -45.66 86.01 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -63.0 -35.0 78.75 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p 178.51 129.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 107.298 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -24.94 115.29 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 73.64 8.92 77.81 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 116.132 1.213 . . . . 0.0 116.132 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.38 113.75 22.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 43.2 tp -162.71 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 -159.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 147.64 53.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.598 1.959 . . . . 0.0 114.062 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 69.94 42.17 1.06 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.986 1.315 . . . . 0.0 112.557 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m 59.13 55.25 4.46 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 123.406 1.574 . . . . 0.0 112.124 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -80.75 99.23 8.13 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 119.479 -2.013 . . . . 0.0 114.383 -163.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.7 145.11 53.37 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 113.961 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . 0.256 26.4 mmtp 69.79 40.24 1.36 Allowed 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.232 1.813 . . . . 0.0 113.161 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.5 p -102.91 -4.25 25.04 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.414 1.485 . . . . 0.0 109.984 168.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -157.9 165.07 36.15 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 120.468 -1.395 . . . . 0.0 108.727 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.2 132.86 15.84 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.772 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.6 132.28 55.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.526 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -164.68 166.21 20.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 160.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -142.38 161.76 37.22 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.65 135.59 39.93 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.608 0.763 . . . . 0.0 109.187 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -145.04 132.2 20.45 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -172.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.09 156.87 46.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.519 3.528 . . . . 0.0 104.996 -7.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -141.13 119.76 12.46 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 121.917 0.865 . . . . 0.0 111.676 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -117.58 136.61 53.16 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.94 134.39 51.9 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.35 -38.45 69.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 p -96.65 8.4 44.31 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 119.898 -1.751 . . . . 0.0 111.756 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 t60 62.11 28.95 17.45 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.921 1.689 . . . . 0.0 113.428 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -72.8 142.32 48.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.537 1.535 . . . . 0.0 111.561 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.5 106.41 57.85 Favored Pre-proline 0 C--N 1.355 0.828 0 O-C-N 120.822 -1.174 . . . . 0.0 111.427 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.85 -30.24 7.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.268 1.979 . . . . 0.0 113.497 -170.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -139.83 126.07 12.1 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.39 1.476 . . . . 0.0 107.265 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.91 135.93 43.06 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.093 2.529 . . . . 0.0 115.751 -166.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 p -61.64 -44.29 97.25 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 127.748 2.419 . . . . 0.0 116.292 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.0 87.27 Favored Pre-proline 0 C--N 1.343 0.324 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.61 -44.27 26.26 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 124.406 3.404 . . . . 0.0 117.19 160.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -61.36 -46.14 91.45 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -59.8 -35.07 73.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -92.48 16.51 11.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.872 1.269 . . . . 0.0 111.664 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.266 40.6 ttpt 85.03 96.77 0.03 OUTLIER 'General case' 0 C--O 1.244 0.773 0 C-N-CA 128.19 2.596 . . . . 0.0 112.288 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.82 -35.13 45.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 127.191 2.196 . . . . 0.0 114.936 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.3 p -57.43 -31.64 66.1 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 120.678 -1.264 . . . . 0.0 114.37 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m -58.37 -41.33 84.51 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 126.26 1.824 . . . . 0.0 114.325 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.58 -8.73 9.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.497 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.2 m -125.33 48.02 2.1 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.005 -1.059 . . . . 0.0 108.143 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -63.2 -38.85 92.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.457 1.903 . . . . 0.0 112.778 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -56.83 136.83 55.55 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.297 1.439 . . . . 0.0 113.645 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -119.65 116.96 27.06 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.32 -9.81 1.27 Allowed 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.822 -0.548 . . . . 0.0 111.197 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -159.05 156.23 28.87 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.59 133.09 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.696 0.76 . . . . 0.0 112.093 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -151.46 158.98 44.37 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -165.08 -1.96 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.806 1.639 . . . . 0.0 115.189 -168.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.322 19.8 tpt180 54.71 61.72 2.86 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.962 2.905 . . . . 0.0 114.112 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -159.01 163.13 36.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.134 -1.603 . . . . 0.0 107.497 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.11 5.56 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 O-C-N 120.525 -1.359 . . . . 0.0 108.875 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 56.87 66.12 3.4 Favored Pre-proline 0 C--N 1.349 0.587 0 C-N-CA 126.333 1.853 . . . . 0.0 114.868 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -40.33 140.48 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.206 1.937 . . . . 0.0 115.328 147.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -126.97 155.57 42.93 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.06 43.7 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -117.34 -0.91 11.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -144.5 160.14 41.6 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 176.46 1.0 0.0 OUTLIER 'General case' 0 C--N 1.358 0.968 0 CA-C-N 119.763 1.165 . . . . 0.0 112.933 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -158.35 152.47 24.03 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 118.822 -2.424 . . . . 0.0 111.21 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -71.96 -10.32 59.61 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -125.73 118.35 25.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -97.47 -10.33 25.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -168.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.22 144.04 25.86 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.644 -1.285 . . . . 0.0 110.485 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -107.97 114.77 28.93 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.403 -1.436 . . . . 0.0 109.343 -168.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.47 165.86 26.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.24 1.416 . . . . 0.0 107.478 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -96.48 4.01 52.38 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.53 0.732 . . . . 0.0 112.726 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.91 150.27 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.989 0.916 . . . . 0.0 108.561 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.09 137.95 55.12 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.897 -1.127 . . . . 0.0 113.765 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -59.28 150.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 114.261 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.59 -45.08 81.57 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -73.95 -13.83 60.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.859 -1.151 . . . . 0.0 113.81 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.66 2.06 8.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 121.092 -1.005 . . . . 0.0 110.126 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -104.2 -3.64 24.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.373 -1.454 . . . . 0.0 111.368 -172.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.0 pt -110.33 153.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.615 -1.303 . . . . 0.0 110.037 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -77.53 104.52 8.11 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 119.696 -1.878 . . . . 0.0 110.973 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -128.99 157.22 42.31 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.037 0.935 . . . . 0.0 111.968 -168.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.85 149.36 49.03 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.726 1.21 . . . . 0.0 112.073 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -114.34 -8.01 12.89 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.346 -1.471 . . . . 0.0 112.426 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.44 -9.63 81.8 Favored Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.605 1.574 . . . . 0.0 115.069 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.9 pt -92.75 11.76 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.134 1.374 . . . . 0.0 113.26 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -65.45 154.26 39.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 pt -124.35 166.76 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.52 158.65 44.26 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.038 -1.664 . . . . 0.0 108.4 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 107' ' ' GLU . 99.2 mtt180 -83.47 152.86 24.75 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.265 1.426 . . . . 0.0 112.578 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -99.13 -10.64 22.26 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.335 -0.853 . . . . 0.0 111.166 167.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -162.32 154.97 19.62 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.07 61.57 6.96 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.505 -1.372 . . . . 0.0 113.755 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.44 135.85 1.42 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 73.2 -72.45 0.12 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.765 1.269 . . . . 0.0 111.696 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 101' ' ' ARG . 67.9 mt-10 -60.92 -41.19 95.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.497 3.119 . . . . 0.0 116.269 -166.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -121.08 25.16 9.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.5 -17.46 13.53 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 124.256 0.931 . . . . 0.0 113.239 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -153.28 172.79 16.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.277 1.039 . . . . 0.0 108.483 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 47.23 -149.63 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.982 2.513 . . . . 0.0 114.481 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -90.59 22.1 3.65 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 120.165 -1.584 . . . . 0.0 111.298 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 41.64 -133.97 0.34 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 127.403 2.281 . . . . 0.0 115.402 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.51 11.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 124.957 1.303 . . . . 0.0 113.879 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.9 m -58.15 119.62 7.17 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m -62.29 -52.27 64.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.461 1.104 . . . . 0.0 113.602 -167.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -161.3 159.5 28.61 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.408 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -63.6 179.05 6.51 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -78.41 -28.9 46.91 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.659 -1.495 . . . . 0.0 113.055 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.47 160.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -87.35 -95.55 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.797 0.808 . . . . 0.0 111.553 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.63 170.01 23.11 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m 80.25 92.81 0.05 OUTLIER 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.141 1.776 . . . . 0.0 112.223 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.87 102.55 4.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.77 -5.72 24.54 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 122.801 1.286 . . . . 0.0 111.578 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 56.8 p -77.2 -14.95 59.69 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 120.452 -1.405 . . . . 0.0 114.171 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -153.5 161.03 42.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.656 -1.278 . . . . 0.0 108.956 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -125.51 17.42 8.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.982 1.313 . . . . 0.0 109.679 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -119.01 126.73 52.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 m 64.88 47.3 2.68 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.517 1.151 . . . . 0.0 112.147 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 tp -144.67 145.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.727 -1.233 . . . . 0.0 108.161 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -65.52 142.35 58.16 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.29 1.036 . . . . 0.0 113.215 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.8 -13.77 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 123.586 0.754 . . . . 0.0 111.905 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 23.6 m -91.32 113.26 25.48 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 120.564 -1.335 . . . . 0.0 112.573 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.4 m -92.15 125.33 36.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 163.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.64 142.85 87.35 Favored Pre-proline 0 C--N 1.348 0.522 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.31 154.62 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.197 3.264 . . . . 0.0 117.836 165.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -117.15 120.85 39.58 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 63.15 48.52 3.7 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.0 156.27 58.56 Favored Pre-proline 0 C--N 1.349 0.566 0 O-C-N 120.384 -1.447 . . . . 0.0 111.895 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.19 154.14 14.78 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 123.742 2.962 . . . . 0.0 117.225 165.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.21 -33.2 10.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.248 0.547 . . . . 0.0 109.835 170.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 -80.72 1.55 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 167.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.55 -5.35 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.72 111.66 36.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 O-C-N 119.604 -1.935 . . . . 0.0 112.612 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -57.9 128.72 38.49 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.9 m -100.34 106.47 18.09 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 121.065 -1.022 . . . . 0.0 110.001 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 64.88 98.0 0.04 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -74.58 -26.41 59.91 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.394 -1.441 . . . . 0.0 112.748 165.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 p -132.64 128.74 37.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.075 0.95 . . . . 0.0 109.443 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.14 132.54 92.44 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 128.813 2.845 . . . . 0.0 116.125 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -67.18 -20.5 49.62 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.011 2.474 . . . . 0.0 113.261 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -127.95 109.72 11.85 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 166.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.9 t -58.91 139.67 56.33 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 120.765 -1.209 . . . . 0.0 112.242 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 74.8 10.62 3.9 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 126.114 1.766 . . . . 0.0 113.881 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -129.59 127.08 39.94 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 161.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.2 p30 -104.69 -42.83 5.29 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 120.063 -1.648 . . . . 0.0 112.219 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 58.66 31.19 20.86 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 125.696 1.598 . . . . 0.0 112.022 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.14 -37.32 84.75 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -158.67 165.57 34.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -144.19 156.53 44.35 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.416 -0.803 . . . . 0.0 109.439 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.2 t -115.03 111.82 21.7 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 120.982 -1.073 . . . . 0.0 109.592 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.21 141.31 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 0.0 114.536 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -139.19 -10.34 1.27 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 59.76 38.31 21.65 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 171.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.0 118.99 45.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.43 -44.18 92.95 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.48 -176.57 22.8 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 58.5 -164.54 0.19 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -150.42 142.41 23.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -143.16 140.81 30.96 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -165.85 169.18 15.2 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 26.9 m -94.17 101.26 13.25 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.292 -1.505 . . . . 0.0 112.155 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 58.01 52.3 7.92 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 126.795 2.038 . . . . 0.0 115.501 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 67.31 41.16 2.55 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 113.108 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -64.79 128.56 36.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 119.854 -1.779 . . . . 0.0 113.473 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.77 138.54 47.64 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.492 1.517 . . . . 0.0 112.764 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -60.32 151.56 27.4 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.585 1.554 . . . . 0.0 114.377 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.94 161.44 19.77 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.96 142.98 42.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.081 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.04 147.02 40.71 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 118.93 1.365 . . . . 0.0 114.379 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt -102.84 -15.15 16.31 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.28 104.3 13.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.959 -1.713 . . . . 0.0 112.467 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.13 -24.06 13.98 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.255 -1.528 . . . . 0.0 111.134 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.75 106.18 18.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.932 0.872 . . . . 0.0 110.735 -173.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -125.07 14.48 8.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.011 1.324 . . . . 0.0 113.926 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.71 16.51 25.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.858 1.314 . . . . 0.0 110.713 -168.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -92.27 3.11 56.06 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.382 -2.073 . . . . 0.0 112.117 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -122.98 137.16 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -64.12 126.8 28.89 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.674 1.226 . . . . 0.0 110.959 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -63.17 148.92 46.64 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 120.416 -1.427 . . . . 0.0 112.182 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 -15.82 62.26 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-O 122.105 0.955 . . . . 0.0 112.611 -163.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -117.78 132.41 23.66 Favored Pre-proline 0 C--N 1.347 0.479 0 O-C-N 120.571 -1.331 . . . . 0.0 107.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.2 134.83 30.92 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.099 3.199 . . . . 0.0 114.933 170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' CD ' HH12 ' A' ' 75' ' ' ARG . 31.5 mt-10 -96.36 116.37 66.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -44.02 139.34 5.93 Favored 'Trans proline' 0 C--N 1.335 -0.158 0 C-N-CA 124.762 3.642 . . . . 0.0 118.111 165.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -156.56 162.31 39.92 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.87 147.66 19.39 Favored Pre-proline 0 N--CA 1.445 -0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 108.166 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -61.81 -178.01 0.28 Allowed 'Trans proline' 0 C--N 1.334 -0.228 0 C-N-CA 123.875 3.05 . . . . 0.0 113.652 153.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 61.82 32.91 17.98 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 165.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -84.72 13.95 5.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.242 -1.537 . . . . 0.0 114.478 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -112.35 7.78 19.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.642 1.577 . . . . 0.0 110.233 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.3 -41.44 2.41 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 120.887 -1.133 . . . . 0.0 110.388 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 pt -147.89 155.2 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -121.29 150.11 41.89 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.441 -1.412 . . . . 0.0 108.051 165.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -106.15 11.65 31.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.219 1.408 . . . . 0.0 110.286 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.1 152.72 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 m -61.38 -35.84 78.6 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 113.73 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.41 136.88 57.56 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 117.95 2.574 . . . . 0.0 117.95 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.87 155.6 47.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 61.54 46.56 7.27 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -115.7 16.66 16.39 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.453 -0.779 . . . . 0.0 110.321 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.6 m120 51.02 49.52 21.0 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.47 132.88 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 127.049 2.14 . . . . 0.0 114.77 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 82.13 10.29 0.74 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 127.217 2.207 . . . . 0.0 112.938 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.3 p -125.03 135.39 52.71 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 120.264 -1.522 . . . . 0.0 108.424 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.74 2.23 0.08 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.104 -1.623 . . . . 0.0 111.062 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -104.73 -2.98 24.2 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.199 -0.938 . . . . 0.0 112.107 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.06 -34.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 O-C-N 120.384 -1.447 . . . . 0.0 112.743 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -76.34 117.59 65.42 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.48 -1.387 . . . . 0.0 110.199 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.41 -2.02 11.97 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.854 2.369 . . . . 0.0 113.099 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? 66.59 -177.59 0.2 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.71 165.03 35.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 175.54 99.45 0.01 OUTLIER 'General case' 0 C--N 1.351 0.672 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -86.61 -24.64 25.29 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 119.673 -1.892 . . . . 0.0 110.528 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.586 HH12 ' CD ' ' A' ' 28' ' ' GLU . 23.7 mmt180 -150.88 159.53 44.49 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.073 1.349 . . . . 0.0 109.286 -173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -123.24 142.15 51.23 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.648 -1.908 . . . . 0.0 108.938 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -144.97 144.11 30.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -155.29 170.61 21.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.802 2.041 . . . . 0.0 108.158 -170.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 81.99 11.89 0.66 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.511 1.924 . . . . 0.0 114.161 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -54.49 -34.86 62.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 127.399 2.28 . . . . 0.0 116.066 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -68.13 -21.71 64.92 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 120.378 -1.451 . . . . 0.0 114.518 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.26 -7.6 22.9 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.378 -1.452 . . . . 0.0 111.486 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -69.79 -39.29 76.68 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.985 -1.072 . . . . 0.0 113.688 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -95.66 121.46 46.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 123.696 1.712 . . . . 0.0 112.128 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.35 83.67 7.39 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 118.845 -2.409 . . . . 0.0 110.827 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.6 mm -61.01 -41.62 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 126.545 1.938 . . . . 0.0 111.038 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.71 53.65 1.97 Allowed 'General case' 0 C--N 1.357 0.921 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.99 11.05 12.37 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.528 -1.358 . . . . 0.0 111.647 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.63 153.92 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -127.1 122.25 33.76 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.372 -1.455 . . . . 0.0 110.711 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 129.54 42.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -127.76 137.92 52.59 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.171 -167.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -124.95 138.55 54.23 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 164.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -57.43 -47.27 82.22 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 -167.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -104.37 26.55 8.79 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.438 -1.414 . . . . 0.0 110.725 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.16 152.36 49.2 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 120.761 -1.212 . . . . 0.0 115.625 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.26 166.62 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.62 159.78 36.18 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.95 19.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 123.504 1.621 . . . . 0.0 108.097 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.84 146.66 54.58 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.002 -1.686 . . . . 0.0 112.6 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt-85 -84.96 -11.88 54.55 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 120.022 -1.674 . . . . 0.0 113.513 -165.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.299 78.7 tttt 26.31 64.15 0.07 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 130.089 3.356 . . . . 0.0 117.028 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 t -81.1 156.71 25.65 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 123.037 1.399 . . . . 0.0 112.178 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -101.33 -1.48 33.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.317 1.447 . . . . 0.0 109.579 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m120 56.57 45.35 22.43 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.137 1.375 . . . . 0.0 112.632 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -101.15 -11.18 19.77 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 109.328 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.84 -25.12 63.59 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -164.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -91.35 -3.84 56.37 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.49 17.68 70.48 Favored Glycine 0 C--N 1.36 1.866 0 O-C-N 120.565 -1.334 . . . . 0.0 114.0 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -126.76 137.11 53.18 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.311 -1.111 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.0 9.2 15.99 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.298 -1.501 . . . . 0.0 109.938 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.8 m170 73.67 15.54 4.02 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.716 1.607 . . . . 0.0 112.108 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.33 24.06 6.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.714 1.606 . . . . 0.0 113.565 -163.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 m -92.36 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 O-C-N 120.017 -1.677 . . . . 0.0 109.37 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -20.64 118.34 0.03 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 129.575 3.15 . . . . 0.0 118.156 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -164.16 160.54 21.49 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 -160.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -46.97 130.2 12.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.796 1.638 . . . . 0.0 115.407 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.6 -13.82 46.17 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -164.26 159.36 19.9 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.049 -1.265 . . . . 0.0 109.143 167.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.67 131.16 22.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.982 2.113 . . . . 0.0 112.608 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.79 -12.54 12.73 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.836 -1.165 . . . . 0.0 112.957 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -165.08 157.37 15.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 t -133.25 120.42 21.08 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 169.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.1 pt -70.9 144.21 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.094 1.757 . . . . 0.0 115.16 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -97.2 -7.17 33.04 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.748 1.219 . . . . 0.0 110.341 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -159.53 166.52 30.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 t -62.65 135.34 57.33 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.403 -1.436 . . . . 0.0 114.281 -171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -85.69 28.81 0.74 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 119.677 -1.889 . . . . 0.0 113.207 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.26 -38.04 84.46 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.377 -1.452 . . . . 0.0 113.906 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.0 m -121.2 131.32 54.17 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.39 128.63 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.12 165.07 28.46 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.545 -1.347 . . . . 0.0 109.917 -167.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.88 120.54 55.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 O-C-N 120.954 -1.091 . . . . 0.0 108.474 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -80.0 107.75 13.03 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 122.168 0.985 . . . . 0.0 112.401 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -66.88 107.91 2.37 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.975 -1.078 . . . . 0.0 112.453 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.43 146.01 43.96 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 121.046 -1.033 . . . . 0.0 110.13 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -53.68 163.1 3.03 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.753 2.969 . . . . 0.0 115.065 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -141.93 173.75 11.23 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.18 -6.98 23.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 164.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.98 120.32 34.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.215 1.006 . . . . 0.0 111.88 -170.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -61.48 119.9 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.637 2.225 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.3 m120 55.18 41.85 31.13 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 127.426 2.29 . . . . 0.0 113.273 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -173.4 -159.91 20.87 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 123.038 1.354 . . . . 0.0 111.273 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -141.39 -60.82 0.48 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.362 1.065 . . . . 0.0 111.584 -171.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.45 -44.14 95.63 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 115.282 -167.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 t -152.59 161.07 43.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.3 p -91.07 -17.81 25.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.858 -1.151 . . . . 0.0 112.11 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -60.93 163.49 5.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.705 2.002 . . . . 0.0 115.293 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -114.24 -1.3 13.64 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.145 -1.597 . . . . 0.0 111.089 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -35.62 75.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.655 1.182 . . . . 0.0 113.292 166.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -113.92 144.44 31.52 Favored Pre-proline 0 C--N 1.351 0.649 0 C-N-CA 123.488 0.715 . . . . 0.0 112.387 -155.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -60.68 98.31 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.059 2.506 . . . . 0.0 113.757 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -99.12 11.65 38.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.0 m -143.87 142.7 30.95 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 119.839 -1.788 . . . . 0.0 109.147 -166.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -132.76 159.74 38.85 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.586 1.154 . . . . 0.0 109.381 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.66 138.12 58.37 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.12 161.39 30.06 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.163 2.985 . . . . 0.0 117.759 -169.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.47 110.52 17.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.529 1.132 . . . . 0.0 109.141 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.86 131.04 49.65 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.309 1.044 . . . . 0.0 112.307 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -65.83 142.46 57.93 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 60.38 18.88 8.52 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.919 1.688 . . . . 0.0 114.972 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.7 t -94.5 127.43 40.42 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 119.797 -1.814 . . . . 0.0 108.634 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.5 mt -88.73 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 O-C-N 119.814 -1.804 . . . . 0.0 108.93 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -86.59 147.94 25.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.515 -0.741 . . . . 0.0 112.951 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . 0.324 76.2 mtt180 76.83 13.31 2.24 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 114.327 170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.4 148.65 11.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 123.689 0.796 . . . . 0.0 109.326 155.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 192' ' ' LEU . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 43.18 -138.87 0.24 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -115.7 142.29 17.47 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 120.345 -1.472 . . . . 0.0 111.465 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.274 98.0 mtt180 79.39 -6.02 1.88 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.527 1.931 . . . . 0.0 115.845 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.37 119.09 33.27 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.615 -1.928 . . . . 0.0 113.061 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 49.63 52.28 14.85 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 126.995 2.118 . . . . 0.0 115.894 166.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -57.23 -38.45 73.81 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m -59.35 -36.53 75.88 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 113.543 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -82.02 153.11 26.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.748 1.737 . . . . 0.0 112.555 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.81 165.98 16.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.855 1.312 . . . . 0.0 111.156 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.14 157.42 34.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.297 -1.502 . . . . 0.0 108.563 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 16.4 m -62.63 135.09 57.21 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.686 1.194 . . . . 0.0 111.519 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -122.05 114.49 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -107.67 105.39 15.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.92 72.39 10.42 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.201 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -160.52 161.56 32.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.14 119.85 33.56 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.71 156.66 35.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.5 148.77 50.11 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 120.796 -1.19 . . . . 0.0 111.409 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.69 134.61 55.69 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 120.216 -1.553 . . . . 0.0 111.966 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -60.51 136.29 58.01 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -171.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.51 141.36 58.8 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 120.275 -1.515 . . . . 0.0 111.225 164.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -134.65 99.95 4.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.093 -1.629 . . . . 0.0 110.682 -172.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.9 tp -133.99 108.73 11.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-O 122.56 1.171 . . . . 0.0 110.008 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 p -99.78 -17.83 17.5 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.457 -1.402 . . . . 0.0 113.797 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 54.39 44.22 29.24 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.954 1.301 . . . . 0.0 113.853 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.92 169.82 23.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -162.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -60.42 133.52 91.05 Favored Pre-proline 0 C--N 1.343 0.29 0 O-C-N 121.273 -0.892 . . . . 0.0 111.727 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.27 132.31 43.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 123.085 2.138 . . . . 0.0 110.784 156.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.06 132.16 95.2 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.27 1.428 . . . . 0.0 110.351 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.38 134.4 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 CA-C-N 123.77 2.382 . . . . 0.0 112.906 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -112.77 11.0 19.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.743 -1.223 . . . . 0.0 111.583 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.12 159.51 21.46 Favored Pre-proline 0 N--CA 1.434 -1.267 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.15 152.75 9.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.189 1.926 . . . . 0.0 110.924 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -100.62 134.58 43.38 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -69.71 -14.8 62.98 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.48 1.512 . . . . 0.0 112.978 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -113.92 126.45 55.17 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 120.429 -1.419 . . . . 0.0 107.95 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -73.63 97.38 2.64 Favored 'General case' 0 C--N 1.346 0.443 0 O-C-N 120.63 -1.294 . . . . 0.0 112.971 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.7 pt -95.17 11.43 4.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-O 121.977 0.894 . . . . 0.0 112.069 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.254 69.2 m 65.64 36.48 6.4 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -95.09 163.8 13.15 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 166.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.4 m -58.73 156.35 2.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -90.83 -13.98 32.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.1 124.4 24.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.669 -1.894 . . . . 0.0 111.018 171.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.61 138.08 51.1 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.831 0.824 . . . . 0.0 108.943 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.05 166.21 18.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.18 0.991 . . . . 0.0 111.373 -169.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -141.45 132.87 26.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 118.956 -2.34 . . . . 0.0 108.77 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 63.26 41.62 7.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 pt -89.69 9.69 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.954 1.835 . . . . 0.0 111.563 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -60.19 127.84 33.79 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.342 1.857 . . . . 0.0 112.961 173.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -127.18 163.3 24.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.606 -1.309 . . . . 0.0 107.943 -175.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -112.51 23.75 13.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.006 0.908 . . . . 0.0 109.537 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 t 63.31 -157.96 0.32 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 168.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.7 t -119.45 114.25 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 166.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 51.6 t60 -157.23 156.19 28.95 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -168.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 53' ' ' HIS . 76.7 Cg_exo -39.64 131.02 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.606 3.538 . . . . 0.0 116.136 164.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -164.25 -59.48 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.434 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.74 2.27 0.07 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 107' ' ' GLU . 71.3 mtm180 -145.98 155.67 42.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.705 -1.872 . . . . 0.0 109.575 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -122.29 -62.66 1.36 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.0 0.905 . . . . 0.0 108.757 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -91.84 3.47 55.08 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.238 -1.539 . . . . 0.0 113.82 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.402 78.0 mttt 74.01 -70.05 0.17 Allowed 'General case' 0 C--N 1.344 0.344 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.363 26.9 m0 93.8 33.74 0.01 OUTLIER 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.365 2.666 . . . . 0.0 113.163 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -102.47 124.22 47.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.67 114.74 25.61 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.762 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -118.64 155.92 30.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 125.006 1.322 . . . . 0.0 112.483 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -117.31 109.29 16.65 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.745 -1.222 . . . . 0.0 111.85 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -74.07 -16.27 61.04 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.9 p -61.65 -36.31 80.44 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.947 1.299 . . . . 0.0 113.96 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.02 127.31 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.504 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 74.25 44.15 0.25 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.434 1.493 . . . . 0.0 111.947 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.54 138.26 20.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.48 -43.45 98.85 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 128.491 2.717 . . . . 0.0 114.949 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -131.89 149.42 52.45 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.77 136.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.122 0.969 . . . . 0.0 108.587 -171.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -109.57 17.46 21.33 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.432 -1.417 . . . . 0.0 111.868 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.37 28.7 mm 32.66 73.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 128.991 2.916 . . . . 0.0 116.613 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -140.89 168.51 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -106.77 112.48 25.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.19 160.62 33.02 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -168.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -102.69 1.64 34.78 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-O 122.632 1.206 . . . . 0.0 110.085 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.23 -33.28 62.0 Favored Glycine 0 C--N 1.353 1.528 0 O-C-N 120.841 -1.162 . . . . 0.0 113.082 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.9 pt -137.56 136.56 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -122.89 136.84 55.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 121.138 -0.976 . . . . 0.0 111.738 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 pt -97.0 9.44 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -59.69 142.83 52.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.077 1.751 . . . . 0.0 114.444 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -132.0 4.67 4.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.341 -0.849 . . . . 0.0 112.513 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -104.82 -2.79 24.31 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 119.585 -1.947 . . . . 0.0 112.306 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 p -131.72 158.11 42.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 67.74 40.76 2.37 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-O 122.64 1.21 . . . . 0.0 113.004 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.02 -76.87 0.37 Allowed 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.067 -1.645 . . . . 0.0 111.691 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -151.82 164.02 37.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' CD ' HH22 ' A' ' 73' ' ' ARG . 31.8 tt0 -59.01 -40.56 85.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -143.85 123.9 13.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.972 -1.08 . . . . 0.0 109.784 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.01 -166.76 9.96 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 122.739 1.189 . . . . 0.0 115.758 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.5 t -135.49 168.52 19.07 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -171.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 56.26 37.38 28.78 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 122.763 1.268 . . . . 0.0 114.11 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 64.72 39.81 6.11 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.874 1.27 . . . . 0.0 112.25 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.899 1.68 . . . . 0.0 113.628 169.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -63.24 141.96 17.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 112.753 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 177.3 7.27 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.335 -1.478 . . . . 0.0 110.593 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 p -114.39 132.61 56.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 119.827 -1.795 . . . . 0.0 113.549 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.18 144.49 57.09 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 126.522 1.929 . . . . 0.0 110.845 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.95 -171.59 40.6 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -65.81 130.78 44.46 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 119.614 -2.109 . . . . 0.0 113.953 170.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 m -62.31 -40.0 86.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.219 -1.55 . . . . 0.0 113.991 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -56.95 131.87 51.03 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 125.663 1.585 . . . . 0.0 114.561 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 m80 54.44 41.98 31.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.829 1.652 . . . . 0.0 114.745 -171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 p -81.55 -46.45 14.45 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.099 -1.625 . . . . 0.0 110.611 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.8 pt -122.79 -21.93 3.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 125.456 1.502 . . . . 0.0 110.009 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.93 136.55 51.68 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.091 -1.631 . . . . 0.0 112.667 157.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.5 m 52.22 53.61 12.14 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.6 p -110.31 -18.33 13.29 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 119.527 -1.983 . . . . 0.0 113.71 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -125.16 -2.5 7.61 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.524 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -162.12 158.58 24.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.9 m 64.88 44.69 3.48 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 123.493 1.616 . . . . 0.0 110.965 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.5 pt -116.49 148.7 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 126.492 1.917 . . . . 0.0 107.88 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 62.28 31.9 17.28 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 123.744 1.735 . . . . 0.0 115.225 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -94.34 -3.16 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 O-C-N 120.514 -1.366 . . . . 0.0 109.773 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 72.5 m -71.16 104.54 3.1 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.437 1.495 . . . . 0.0 110.81 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.6 p -60.36 139.53 57.62 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.24 130.91 52.43 Favored Pre-proline 0 C--N 1.352 0.685 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.308 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -41.43 140.69 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.906 3.737 . . . . 0.0 117.275 161.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -97.04 115.89 28.26 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.287 -1.508 . . . . 0.0 112.35 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 77.21 14.62 1.89 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 126.594 1.957 . . . . 0.0 112.751 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.69 136.23 92.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 O-C-N 120.662 -1.274 . . . . 0.0 113.72 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.0 146.4 17.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.906 3.071 . . . . 0.0 116.529 169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.78 -17.78 65.04 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.233 -0.917 . . . . 0.0 113.123 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.9 -4.56 72.15 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.063 0.84 . . . . 0.0 113.188 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.18 -25.63 12.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 119.002 1.401 . . . . 0.0 111.577 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.51 101.01 11.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 O-C-N 120.676 -1.265 . . . . 0.0 109.33 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 m -63.56 118.99 8.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 120.918 -1.114 . . . . 0.0 111.022 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -62.45 122.34 15.5 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -141.98 89.05 2.15 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.68 167.3 18.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 m -63.78 134.15 54.76 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.973 1.709 . . . . 0.0 110.679 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.6 127.24 92.86 Favored Pre-proline 0 C--N 1.365 1.243 0 O-C-N 119.616 -1.928 . . . . 0.0 111.096 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 3.81 7.0 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.637 2.892 . . . . 0.0 113.929 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -134.82 -32.21 0.99 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 120.177 1.353 . . . . 0.0 112.975 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.6 m -86.58 102.8 14.48 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.443 -1.41 . . . . 0.0 107.721 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -54.1 150.51 8.09 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -39.29 68.14 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.73 2.012 . . . . 0.0 115.647 -166.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.34 -46.49 83.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.759 -1.213 . . . . 0.0 113.642 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -61.64 -41.77 97.98 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.575 -1.953 . . . . 0.0 112.82 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -59.26 -47.28 85.94 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.655 -0.653 . . . . 0.0 112.714 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.3 t -59.89 -45.21 93.25 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.238 1.415 . . . . 0.0 113.343 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.53 -34.33 72.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.979 1.312 . . . . 0.0 113.808 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 58.2 m -62.25 138.97 58.51 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.8 mm -75.04 107.74 5.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.864 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mtm105 -123.6 8.94 8.93 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.067 -1.02 . . . . 0.0 113.486 -166.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.32 12.33 7.02 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.499 -1.376 . . . . 0.0 111.239 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.91 119.55 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -148.13 132.87 17.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.78 6.78 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 117.745 -3.097 . . . . 0.0 111.809 -11.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.266 22.0 tpt180 80.64 -52.13 0.33 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 164.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.62 9.56 27.21 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.331 1.062 . . . . 0.0 110.266 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.46 146.43 48.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.467 1.507 . . . . 0.0 113.018 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.62 51.13 0.06 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.2 m 55.1 57.14 5.8 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 127.717 2.407 . . . . 0.0 112.84 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -163.15 7.13 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.58 -1.325 . . . . 0.0 114.108 -169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -41.17 158.1 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.154 2.181 . . . . 0.0 115.699 160.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -133.27 158.97 41.58 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.344 -1.472 . . . . 0.0 113.667 -163.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 35.1 p 51.02 63.22 2.33 Favored 'General case' 0 C--N 1.366 1.31 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 158.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.1 -53.06 3.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.163 2.185 . . . . 0.0 110.126 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 57.51 14.24 2.2 Favored 'General case' 0 C--N 1.352 0.703 1 C-N-CA 131.885 4.074 . . . . 0.0 115.898 172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.67 9.07 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.427 1.891 . . . . 0.0 115.607 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.47 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -169.28 169.37 9.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 107.374 166.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.04 179.53 8.97 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . 0.269 . . 90.33 170.93 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 125.944 1.698 . . . . 0.0 113.226 164.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -54.27 122.73 10.95 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.56 56.85 1.43 Allowed 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.753 -1.217 . . . . 0.0 113.467 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -146.62 141.97 27.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 129.807 3.243 . . . . 0.0 103.126 -2.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.31 166.92 31.79 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.341 -1.474 . . . . 0.0 108.019 -164.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' CE1' HH22 ' A' ' 48' ' ' ARG . 9.4 p80 -105.6 161.67 14.17 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.08 0.552 . . . . 0.0 111.215 172.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.9 158.63 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 O-C-N 120.315 -1.491 . . . . 0.0 109.178 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -75.73 153.57 36.97 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 120.814 -1.179 . . . . 0.0 109.45 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -124.76 151.83 44.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -102.95 19.81 18.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 112.277 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -64.84 146.39 98.67 Favored Pre-proline 0 C--N 1.358 0.944 0 O-C-N 119.823 -1.798 . . . . 0.0 112.087 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.07 -38.44 32.11 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.588 2.859 . . . . 0.0 115.542 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -96.38 126.73 42.69 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 123.733 0.813 . . . . 0.0 111.842 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.12 133.86 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.365 2.71 . . . . 0.0 114.746 159.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -96.15 12.38 30.99 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 121.25 -0.907 . . . . 0.0 111.714 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.77 124.15 69.61 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.929 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.83 -20.95 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.299 1.999 . . . . 0.0 112.385 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -100.53 31.66 3.38 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.258 1.023 . . . . 0.0 111.355 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -104.11 114.97 29.59 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.227 -1.546 . . . . 0.0 112.37 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -82.47 0.73 40.96 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.412 -1.43 . . . . 0.0 113.841 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.62 111.31 14.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.455 -1.403 . . . . 0.0 109.151 171.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -107.83 -43.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -112.3 142.47 44.77 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.397 -0.814 . . . . 0.0 108.835 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.289 45.8 m 63.16 65.44 0.78 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 123.211 1.481 . . . . 0.0 111.779 -171.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.4 t -94.73 117.53 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.944 1.697 . . . . 0.0 108.092 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 m -85.82 -15.09 43.04 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 121.849 -0.532 . . . . 0.0 112.084 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.52 144.85 53.61 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -107.96 120.57 42.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.149 -1.594 . . . . 0.0 111.172 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.48 29.27 0.52 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.19 0.996 . . . . 0.0 113.146 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -61.37 143.54 55.59 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.028 1.331 . . . . 0.0 111.093 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.28 170.84 21.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.327 -2.108 . . . . 0.0 108.946 -163.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -99.37 1.23 10.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 CA-C-O 122.131 0.967 . . . . 0.0 110.913 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.542 HH22 ' CE1' ' A' ' 21' ' ' HIS . 98.2 mtt180 -74.23 -19.52 60.49 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.846 -1.784 . . . . 0.0 111.284 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -59.3 -40.88 87.59 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 126.446 1.898 . . . . 0.0 112.386 167.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -89.76 50.96 1.98 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 123.076 1.417 . . . . 0.0 110.97 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 t -58.59 141.46 52.15 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 118.264 -2.772 . . . . 0.0 112.231 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.29 -13.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-O 123.139 1.447 . . . . 0.0 109.457 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 229' ' ' GLU . 93.6 m-70 -63.3 142.02 97.81 Favored Pre-proline 0 N--CA 1.439 -0.98 0 O-C-N 120.525 -1.359 . . . . 0.0 114.349 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.02 -25.24 0.84 Allowed 'Cis proline' 0 CA--C 1.51 -0.719 0 CA-C-O 116.499 -1.542 . . . . 0.0 110.673 17.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 80.04 126.63 0.04 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.45 1.9 . . . . 0.0 114.528 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.06 167.42 30.46 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -71.42 144.63 49.7 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.868 -1.77 . . . . 0.0 114.275 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -128.59 -137.61 0.23 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -132.92 162.27 32.06 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -119.26 15.24 13.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.291 28.9 m-20 87.17 -19.87 0.24 Allowed 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.304 1.841 . . . . 0.0 114.527 168.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -115.87 135.66 53.78 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.616 -1.303 . . . . 0.0 110.459 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.96 11.07 13.31 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.502 -1.373 . . . . 0.0 109.354 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -143.04 128.59 19.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.624 1.57 . . . . 0.0 107.258 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -142.08 131.87 24.24 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 t -134.06 160.88 36.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.61 144.12 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -147.44 23.06 1.16 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 109.708 -163.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -64.31 -42.17 94.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.311 35.8 mt-10 51.59 21.23 1.24 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.47 138.69 27.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.7 1.6 . . . . 0.0 107.213 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.48 99.44 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 O-C-N 120.87 -1.144 . . . . 0.0 108.759 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -106.33 3.78 27.91 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 120.095 -1.628 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.0 mm -111.17 107.67 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 123.651 1.691 . . . . 0.0 106.863 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -83.41 28.9 0.52 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 119.942 -1.724 . . . . 0.0 113.802 -162.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -159.01 18.96 0.19 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.598 1.959 . . . . 0.0 110.422 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.0 -39.17 74.19 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.29 1.836 . . . . 0.0 114.267 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -62.35 -9.19 7.43 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.231 1.412 . . . . 0.0 114.658 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.96 13.43 52.78 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 124.521 1.058 . . . . 0.0 112.532 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.31 -68.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 CA-C-N 118.565 1.183 . . . . 0.0 108.894 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.286 23.3 mmt180 52.17 38.98 25.87 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 118.988 2.959 . . . . 0.0 118.988 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.303 1.5 tp 104.07 -7.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 129.609 3.163 . . . . 0.0 112.99 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.259 47.5 t0 16.73 79.19 0.01 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.332 3.053 . . . . 0.0 115.738 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 64.89 12.67 7.98 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.325 61.3 tttm 54.15 67.8 0.95 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.72 2.408 . . . . 0.0 117.131 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.4 p -72.48 -12.98 61.32 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 119.424 -2.047 . . . . 0.0 113.208 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.8 35.45 2.98 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.579 1.551 . . . . 0.0 111.253 -170.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 m120 84.39 28.2 0.07 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.32 1.448 . . . . 0.0 114.126 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.34 158.11 44.07 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.62 140.57 46.12 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 161.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 63.3 23.3 13.73 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -103.74 175.27 23.23 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 124.975 1.274 . . . . 0.0 114.252 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 136.49 28.48 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.274 -1.721 . . . . 0.0 110.343 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.0 t80 169.57 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.313 2.645 . . . . 0.0 105.333 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -158.37 161.34 37.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.426 -1.421 . . . . 0.0 108.121 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.62 73.79 1.48 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.0 t -114.52 -32.51 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 124.391 1.077 . . . . 0.0 113.001 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -83.74 150.09 26.04 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 119.705 -1.872 . . . . 0.0 111.988 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.7 p -118.4 22.81 11.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.504 1.122 . . . . 0.0 112.966 -172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -61.5 146.36 48.86 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.172 -0.955 . . . . 0.0 112.326 163.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.47 ' H ' HG21 ' A' ' 190' ' ' VAL . . . -103.66 -147.21 17.63 Favored Glycine 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -144.0 136.7 27.1 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.054 -1.851 . . . . 0.0 109.206 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.77 163.7 6.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.37 112.67 10.76 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.508 -1.37 . . . . 0.0 112.067 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -165.22 4.44 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.376 0.608 . . . . 0.0 111.246 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.2 m -61.83 149.36 40.37 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.699 -1.251 . . . . 0.0 114.074 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -53.26 120.24 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.962 1.305 . . . . 0.0 112.644 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.22 -52.07 6.17 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.374 1.87 . . . . 0.0 112.282 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.2 t -158.08 156.2 30.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -89.68 -48.94 6.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -69.83 -37.7 76.28 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 172.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . 0.361 66.3 mttm 75.92 153.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.312 12.1 p 77.68 149.63 0.11 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.401 1.88 . . . . 0.0 112.612 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.297 23.0 mt 72.49 -88.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.95 0.9 . . . . 0.0 111.928 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.26 127.73 35.79 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.355 -1.466 . . . . 0.0 112.107 -168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.254 26.3 t 74.53 103.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 127.632 2.373 . . . . 0.0 112.187 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 32.6 p -85.52 137.15 33.08 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 119.519 -1.988 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.6 t -142.61 167.65 21.58 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 119.987 -1.696 . . . . 0.0 109.903 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.19 141.9 98.19 Favored Pre-proline 0 C--N 1.349 0.573 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.18 156.72 63.44 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.662 2.241 . . . . 0.0 112.135 151.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.7 m -60.75 -37.52 82.07 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.14 0.976 . . . . 0.0 112.277 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 76.46 22.01 1.29 Allowed 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.029 0.932 . . . . 0.0 112.303 165.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.5 154.3 89.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -35.82 136.3 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 125.534 4.156 . . . . 0.0 118.767 169.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -85.27 133.93 34.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.87 0.868 . . . . 0.0 112.79 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.3 -174.62 54.53 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 121.549 -0.719 . . . . 0.0 113.363 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.17 96.81 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.259 48.1 t 67.88 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 125.863 1.665 . . . . 0.0 112.519 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.6 p -77.19 126.32 30.75 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 118.109 -2.87 . . . . 0.0 112.713 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.3 p -93.43 -7.07 45.59 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.649 0.78 . . . . 0.0 112.608 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -118.53 117.49 29.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.92 164.91 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 t -102.82 -24.75 13.68 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.779 1.276 . . . . 0.0 109.508 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -103.5 128.96 26.33 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 126.717 2.007 . . . . 0.0 107.543 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -56.73 121.04 9.34 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 123.791 2.994 . . . . 0.0 116.947 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -161.13 165.6 29.28 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 120.923 -1.11 . . . . 0.0 113.404 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.6 p 59.92 -163.05 0.24 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.921 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . 0.277 39.2 mt-30 66.02 108.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.651 0 N-CA-C 118.291 2.701 . . . . 0.0 118.291 170.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 69.59 46.56 0.71 Allowed 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.876 -1.765 . . . . 0.0 112.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.8 -45.02 82.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.784 2.034 . . . . 0.0 115.943 -161.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -112.95 17.13 19.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.619 1.167 . . . . 0.0 110.153 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.317 82.9 mt-30 67.27 17.53 10.25 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t -158.86 152.43 22.99 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.194 -1.566 . . . . 0.0 107.852 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -104.65 -14.25 15.67 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.274 -1.516 . . . . 0.0 110.903 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.3 m -71.22 125.88 28.11 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.018 -1.676 . . . . 0.0 110.072 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -85.57 -7.45 10.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 147.41 30.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -114.5 56.93 0.71 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 124.821 1.248 . . . . 0.0 111.6 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -151.97 163.79 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -155.47 155.52 33.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.32 118.44 7.29 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.039 0.828 . . . . 0.0 114.101 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.5 ptt85 169.1 15.07 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.043 1.337 . . . . 0.0 111.338 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.17 164.87 13.85 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -32.57 147.64 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 119.739 3.236 . . . . 0.0 119.739 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -60.94 -7.12 2.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 33.8 p -88.46 -9.13 53.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.312 -2.118 . . . . 0.0 113.974 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -75.04 -13.38 60.49 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 119.559 -1.963 . . . . 0.0 115.192 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -64.64 -14.13 56.77 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -117.3 9.28 13.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.933 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.1 t -90.61 148.98 22.3 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.216 -1.553 . . . . 0.0 110.272 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -137.46 143.17 41.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 53' ' ' HIS . 2.6 mt-10 -109.1 -72.72 0.71 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.05 147.18 30.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.971 1.26 . . . . 0.0 113.34 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.403 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.42 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -139.11 133.27 31.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 174.37 10.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 17' ' ' TYR 0.29 . . 87.05 -168.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 123.468 1.604 . . . . 0.0 115.3 171.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' H ' ' HB1' ' A' ' 16' ' ' ALA . 24.6 m-85 -142.3 152.17 42.71 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.872 1.669 . . . . 0.0 107.238 -161.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.98 86.79 2.0 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 120.894 -1.129 . . . . 0.0 108.13 168.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.35 157.75 45.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.35 3.06 . . . . 0.0 107.078 9.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.19 170.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -120.26 164.37 16.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.988 1.715 . . . . 0.0 109.675 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.33 173.19 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.484 1.135 . . . . 0.0 113.005 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 157.2 6.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.323 1.849 . . . . 0.0 113.786 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -63.5 140.68 58.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.6 -43.49 89.57 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 120.449 -1.407 . . . . 0.0 114.713 164.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -119.0 117.61 33.47 Favored Pre-proline 0 C--N 1.351 0.65 0 O-C-N 120.743 -1.223 . . . . 0.0 109.81 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.15 136.46 61.78 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.118 3.212 . . . . 0.0 117.573 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -120.39 141.5 32.08 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 126.363 1.865 . . . . 0.0 111.07 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.88 157.89 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.533 2.822 . . . . 0.0 114.08 167.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -61.34 -40.18 93.33 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 113.468 166.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.03 145.01 17.67 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 161.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.72 146.78 1.33 Allowed 'Trans proline' 0 C--N 1.335 -0.179 0 C-N-CA 124.764 3.643 . . . . 0.0 117.377 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -159.54 3.28 0.09 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.742 0.782 . . . . 0.0 111.117 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -157.63 158.05 34.78 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -55.26 -36.85 66.52 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 113.91 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.52 117.75 20.76 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.33 -1.481 . . . . 0.0 111.109 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.09 -18.59 7.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.2 t -107.88 117.87 35.26 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.303 -2.123 . . . . 0.0 108.706 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.291 23.4 m 67.69 51.58 0.8 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-O 123.813 1.768 . . . . 0.0 111.068 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -65.19 148.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 125.401 1.48 . . . . 0.0 112.569 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -66.93 -36.13 81.55 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 122.173 0.987 . . . . 0.0 112.851 166.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -63.35 138.07 58.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.773 2.029 . . . . 0.0 115.247 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -118.62 126.0 50.99 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.214 -2.179 . . . . 0.0 112.79 -170.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -120.91 159.81 24.77 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 123.523 1.63 . . . . 0.0 114.008 -165.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -92.85 106.28 18.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -140.72 175.08 9.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.361 -1.462 . . . . 0.0 107.375 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -60.78 -44.86 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.455 -1.403 . . . . 0.0 113.709 -172.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.16 -43.29 98.7 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -77.39 -14.26 59.75 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.766 -1.209 . . . . 0.0 113.757 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -107.09 21.55 17.38 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.133 0.973 . . . . 0.0 112.709 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 t -63.13 140.42 58.87 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.538 -1.351 . . . . 0.0 114.465 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.67 -1.5 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 110.837 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -62.87 143.62 97.09 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.923 1.689 . . . . 0.0 114.098 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.0 -21.2 5.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.397 20.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 72.46 120.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.45 166.66 31.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.99 124.1 23.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -121.55 127.71 51.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -171.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.32 130.01 41.77 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.59 -0.694 . . . . 0.0 111.944 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -146.41 141.19 26.92 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -63.43 -35.34 80.1 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 126.649 1.979 . . . . 0.0 115.744 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m120 60.57 31.55 20.26 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.99 165.46 23.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.888 1.275 . . . . 0.0 107.81 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -145.47 36.67 1.09 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -162.52 152.81 16.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 121.004 -1.06 . . . . 0.0 109.128 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -106.23 153.04 22.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 123.327 1.537 . . . . 0.0 110.312 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.5 m -74.93 156.52 36.27 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.216 -1.553 . . . . 0.0 111.177 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.31 140.28 19.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 O-C-N 119.901 -1.75 . . . . 0.0 114.776 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.9 89.34 0.4 Allowed 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.081 -1.637 . . . . 0.0 110.984 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tt -90.09 9.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 O-C-N 120.619 -1.301 . . . . 0.0 110.872 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' CD ' HH22 ' A' ' 92' ' ' ARG 0.357 24.8 mm-40 66.86 -2.44 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 169.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -57.67 -42.46 83.61 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.548 -1.97 . . . . 0.0 111.881 164.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.35 99.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 120.563 -1.336 . . . . 0.0 108.801 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -76.69 -20.27 56.79 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.9 tp -66.07 121.66 15.57 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.444 HH22 ' CD ' ' A' ' 87' ' ' GLU . 28.7 mmt180 -106.86 -9.87 16.2 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.296 -1.502 . . . . 0.0 111.739 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -105.67 32.29 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.675 -1.265 . . . . 0.0 110.261 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.05 -46.68 82.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.047 2.139 . . . . 0.0 115.207 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.1 -25.23 59.68 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.402 -1.437 . . . . 0.0 112.018 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.2 -39.68 92.38 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 124.983 1.278 . . . . 0.0 113.218 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.2 pt -88.38 -8.38 10.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 122.083 -0.657 . . . . 0.0 110.415 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 54.69 3.5 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.736 1.615 . . . . 0.0 112.066 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 tt -37.94 132.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 127.144 2.178 . . . . 0.0 116.746 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.03 31.45 13.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 127.64 2.376 . . . . 0.0 114.818 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.279 94.6 mtt-85 73.76 39.62 0.53 Allowed 'General case' 0 C--N 1.352 0.695 0 C-N-CA 128.176 2.59 . . . . 0.0 112.663 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 75.14 58.61 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.608 1.963 . . . . 0.0 111.452 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 p -60.14 -46.35 89.95 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 29.5 77.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.81 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 m120 76.27 47.42 0.08 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.613 1.165 . . . . 0.0 113.193 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -149.71 146.14 27.07 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 120.905 -1.122 . . . . 0.0 108.744 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -104.99 143.35 33.3 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.139 0.495 . . . . 0.0 111.407 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 66.01 48.78 1.7 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.17 169.69 45.09 Favored Glycine 0 C--N 1.362 1.984 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.9 t -45.45 153.4 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 118.602 2.815 . . . . 0.0 118.602 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -100.26 139.04 36.51 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.45 -1.406 . . . . 0.0 109.957 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -128.82 129.3 45.43 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 125.919 1.687 . . . . 0.0 109.89 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.61 40.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.48 -31.28 15.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 O-C-N 119.027 -2.296 . . . . 0.0 110.749 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -96.56 145.35 25.8 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -155.91 162.15 40.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.36 156.57 36.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 168.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -133.74 144.44 16.39 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -146.23 150.31 35.57 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.45 144.34 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 167.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -118.05 114.27 22.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.663 -1.273 . . . . 0.0 108.412 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.14 152.55 20.13 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.435 1.894 . . . . 0.0 114.536 171.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.735 1.214 . . . . 0.0 111.223 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.23 95.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 120.271 -1.518 . . . . 0.0 107.799 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -74.49 -33.73 62.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.165 1.459 . . . . 0.0 114.178 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -137.1 130.01 30.61 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 119.631 -1.918 . . . . 0.0 109.008 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -82.86 -42.85 17.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 110.187 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.26 -40.42 62.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.5 mttp 49.71 -130.87 1.94 Allowed 'General case' 0 C--N 1.356 0.855 0 O-C-N 120.966 -1.084 . . . . 0.0 113.871 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 16.7 p 48.3 -126.61 1.9 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 128.261 2.625 . . . . 0.0 116.895 170.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 tt -115.79 -6.91 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.763 2.025 . . . . 0.0 107.228 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.616 -1.303 . . . . 0.0 114.208 170.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.16 107.05 14.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 O-C-N 120.949 -1.094 . . . . 0.0 110.301 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.1 m -70.32 122.72 20.09 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 120.881 -1.137 . . . . 0.0 109.629 165.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -148.71 161.7 41.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.54 140.34 94.67 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.829 0.852 . . . . 0.0 112.333 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -64.61 134.97 43.3 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.98 2.453 . . . . 0.0 113.035 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -83.56 -11.77 56.97 Favored 'General case' 0 CA--C 1.513 -0.469 0 O-C-N 120.787 -1.196 . . . . 0.0 111.663 169.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 87.11 29.92 0.03 OUTLIER 'General case' 0 C--N 1.362 1.144 0 C-N-CA 127.821 2.448 . . . . 0.0 110.623 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.32 146.48 98.94 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -37.99 143.97 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 125.182 3.922 . . . . 0.0 119.234 164.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -57.32 -39.18 75.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.787 2.435 . . . . 0.0 113.292 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.91 -7.06 78.57 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 120.807 -1.183 . . . . 0.0 113.899 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.47 -43.16 16.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.86 -1.377 . . . . 0.0 110.335 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.79 -46.96 81.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.222 -1.549 . . . . 0.0 113.401 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -106.52 103.67 13.18 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.8 p -96.24 6.2 49.33 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.409 1.084 . . . . 0.0 112.608 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -110.57 106.4 15.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -123.67 141.71 51.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 120.566 -1.334 . . . . 0.0 109.547 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.8 p -95.74 12.34 30.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 124.949 1.299 . . . . 0.0 110.015 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -86.85 120.35 71.63 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.043 1.737 . . . . 0.0 113.712 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -49.73 128.18 20.68 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.892 3.061 . . . . 0.0 119.627 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -82.27 70.56 9.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.99 1.316 . . . . 0.0 112.742 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.4 p -66.62 -35.25 79.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.39 -161.98 0.21 Allowed 'General case' 0 C--N 1.351 0.654 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.2 m120 70.6 2.48 4.12 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.908 1.683 . . . . 0.0 113.243 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -49.8 -52.22 33.76 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.841 2.856 . . . . 0.0 115.204 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -104.52 15.89 27.19 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.529 -0.732 . . . . 0.0 111.774 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.335 68.7 mt-30 58.38 45.84 16.22 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -96.04 160.89 14.22 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.364 1.466 . . . . 0.0 110.004 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -114.02 19.06 16.8 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.394 1.078 . . . . 0.0 109.494 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.8 t -136.1 151.09 49.44 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.196 1.398 . . . . 0.0 107.718 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.5 pt -105.41 8.71 9.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 123.211 1.481 . . . . 0.0 109.894 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -144.56 147.46 33.21 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 124.989 1.316 . . . . 0.0 108.663 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -95.7 28.62 2.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 124.008 0.923 . . . . 0.0 112.464 -166.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.82 123.91 45.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -149.55 134.15 17.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.4 125.83 12.29 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 120.762 -1.211 . . . . 0.0 113.94 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -150.88 -23.55 0.22 Allowed 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.429 -1.042 . . . . 0.0 112.42 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.9 mt -74.09 165.75 24.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.234 -1.541 . . . . 0.0 111.729 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -22.21 133.03 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 131.929 4.092 . . . . 0.0 117.387 171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -69.31 -3.69 15.03 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 119.853 -1.779 . . . . 0.0 115.022 -171.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.2 p -73.23 -18.06 61.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.554 1.942 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -74.59 -15.37 60.84 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -59.08 -38.45 79.49 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -110.72 6.67 21.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.029 -1.044 . . . . 0.0 113.238 -168.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.7 t -105.11 159.07 16.14 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -101.72 152.85 20.37 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.376 1.084 . . . . 0.0 112.148 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.31 -57.73 2.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.385 1.074 . . . . 0.0 112.144 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.99 168.99 18.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 123.791 0.836 . . . . 0.0 110.195 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.417 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.629 0 N-CA-C 119.314 2.485 . . . . 0.0 119.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -153.6 156.24 37.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 0.8 OUTLIER -153.83 179.57 8.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.68 -169.94 0.2 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -129.42 156.9 43.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.91 1.684 . . . . 0.0 108.322 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.63 58.44 1.73 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.959 -1.088 . . . . 0.0 112.223 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.37 147.88 29.72 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 130.688 3.595 . . . . 0.0 108.066 -6.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -154.21 165.12 37.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.159 0.983 . . . . 0.0 109.155 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -56.1 153.13 9.5 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.715 2.006 . . . . 0.0 115.056 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 pt -58.1 154.48 2.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 125.588 1.555 . . . . 0.0 114.909 -170.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -62.03 147.46 47.13 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.907 -1.121 . . . . 0.0 110.821 171.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -89.76 139.68 30.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.861 -1.149 . . . . 0.0 112.744 -173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -59.81 -45.03 93.62 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.621 -1.299 . . . . 0.0 113.29 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -139.35 155.34 72.21 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.5 152.74 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.374 3.383 . . . . 0.0 117.827 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -107.93 104.67 54.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -166.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -61.08 129.49 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.409 2.74 . . . . 0.0 114.976 165.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 p -109.65 1.14 19.37 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 124.7 1.2 . . . . 0.0 111.536 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.76 136.33 31.09 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 121.017 -1.052 . . . . 0.0 112.383 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -65.96 -34.15 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.482 2.121 . . . . 0.0 115.447 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -95.89 10.82 35.93 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -165.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.22 119.92 34.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.123 -1.611 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -69.74 -39.83 76.53 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -90.65 108.6 19.92 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 119.592 -1.943 . . . . 0.0 109.011 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.1 pt -112.22 -23.48 4.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -101.82 120.26 40.09 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 120.468 -1.395 . . . . 0.0 109.98 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m 59.68 61.44 1.95 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.204 1.402 . . . . 0.0 112.013 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.7 m -63.95 149.02 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 120.852 -1.155 . . . . 0.0 112.936 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 p -101.56 7.81 42.12 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.982 1.313 . . . . 0.0 110.607 168.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.65 158.96 15.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.11 2.564 . . . . 0.0 110.515 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -104.51 137.59 42.13 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.051 -1.03 . . . . 0.0 108.32 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.46 127.89 49.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.45 144.19 54.58 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.692 1.197 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -157.13 162.64 39.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.64 12.22 8.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 CA-C-O 123.307 1.527 . . . . 0.0 110.432 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -84.12 -1.72 55.47 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 119.004 -2.31 . . . . 0.0 110.491 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -93.18 -3.59 53.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.077 2.151 . . . . 0.0 111.544 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -107.99 4.19 24.91 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 123.504 0.722 . . . . 0.0 110.606 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -59.78 141.83 54.5 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 125.504 1.522 . . . . 0.0 114.19 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.19 -15.78 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.125 1.37 . . . . 0.0 112.478 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 15' ' ' LEU . 33.0 m-70 -87.44 142.73 33.35 Favored Pre-proline 0 C--N 1.357 0.904 0 O-C-N 121.58 -0.7 . . . . 0.0 112.277 -173.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.01 149.65 32.47 Favored 'Cis proline' 0 CA--C 1.515 -0.431 0 CA-C-N 121.379 1.528 . . . . 0.0 111.371 5.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.42 160.85 40.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.71 138.39 44.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -95.76 110.93 23.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -66.79 129.43 39.85 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -83.62 127.32 33.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.194 0.997 . . . . 0.0 108.742 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -133.51 160.24 38.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.493 -1.379 . . . . 0.0 109.995 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -70.04 -41.66 73.93 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 61.72 36.64 16.29 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.543 1.937 . . . . 0.0 116.095 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.15 138.07 46.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.71 18.72 18.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 122.718 1.247 . . . . 0.0 108.609 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -147.6 145.81 29.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.044 -1.66 . . . . 0.0 108.443 -169.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.92 165.86 17.33 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 124.058 0.943 . . . . 0.0 108.888 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -61.44 -43.71 98.39 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 126.969 2.108 . . . . 0.0 112.934 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.04 156.79 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.714 1.606 . . . . 0.0 109.867 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -69.47 129.31 39.37 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.158 -1.588 . . . . 0.0 109.449 161.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 pt -98.23 163.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 123.351 0.66 . . . . 0.0 109.357 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 92' ' ' ARG . 66.4 mm-40 61.32 36.02 17.79 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.22 -40.04 92.51 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.516 -1.99 . . . . 0.0 112.502 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.78 112.87 41.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 CA-C-O 123.318 1.532 . . . . 0.0 107.871 163.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -64.95 -48.85 72.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.86 109.42 20.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 O-C-N 120.366 -1.458 . . . . 0.0 109.086 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 87' ' ' GLU . 31.5 ptt-85 -161.16 165.89 28.75 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -99.19 20.99 12.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.258 -0.902 . . . . 0.0 109.867 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.8 -40.99 85.67 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 119.418 -2.052 . . . . 0.0 114.229 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -78.54 -7.48 57.57 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.967 1.307 . . . . 0.0 111.978 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -94.18 -34.99 6.18 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 121.139 -0.976 . . . . 0.0 112.99 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.9 tp -82.31 -27.35 8.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 CA-C-N 118.613 1.206 . . . . 0.0 111.617 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.314 63.3 mtt180 72.85 50.61 0.16 Allowed 'General case' 0 C--N 1.356 0.887 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 161.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mt -52.64 111.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 126.349 1.86 . . . . 0.0 112.553 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 50.88 35.18 11.75 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 114.431 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 60.07 40.47 18.49 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.429 1.492 . . . . 0.0 112.553 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.0 tttp 68.02 43.12 1.7 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.874 1.67 . . . . 0.0 112.924 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -60.13 -33.41 72.1 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.662 1.185 . . . . 0.0 111.298 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.98 64.46 0.87 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 127.038 2.135 . . . . 0.0 113.878 163.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 62.92 50.65 3.15 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -120.61 143.15 48.8 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 122.903 1.335 . . . . 0.0 112.541 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.04 126.04 27.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.5 1.52 . . . . 0.0 114.737 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 81.78 17.26 0.43 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 126.592 1.957 . . . . 0.0 112.477 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.83 23.5 70.91 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 123.958 0.789 . . . . 0.0 113.565 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -161.31 159.28 28.31 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.11 178.28 4.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.841 1.256 . . . . 0.0 111.077 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.74 118.51 15.76 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.807 -1.183 . . . . 0.0 111.19 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.04 -1.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 224' ' ' ARG . 21.8 t -86.38 -15.25 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 122.16 0.981 . . . . 0.0 112.763 -168.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 t -85.71 169.56 13.32 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.236 -1.54 . . . . 0.0 109.038 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.1 p -168.58 164.44 12.4 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.36 165.96 26.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.46 160.83 31.81 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -100.97 -11.19 19.9 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 113.903 -1.149 . . . . 0.0 111.108 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.47 134.7 62.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.997 1.319 . . . . 0.0 109.126 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -123.76 125.11 44.14 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 101.404 -3.554 . . . . 0.0 101.404 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -17.77 3.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.538 1.063 . . . . 0.0 109.988 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.6 m -91.38 90.81 7.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 125.99 1.716 . . . . 0.0 107.784 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.4 tt -135.53 145.55 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.41 146.02 41.54 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 127.202 2.201 . . . . 0.0 115.968 -171.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.9 t -179.89 119.97 0.06 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.944 1.698 . . . . 0.0 106.802 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -57.79 -40.79 80.71 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.356 2.263 . . . . 0.0 113.046 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -106.06 2.57 27.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.843 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.7 mttm 62.44 38.6 12.68 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.114 1.366 . . . . 0.0 113.79 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 t -144.9 158.51 43.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.5 tt -98.17 5.86 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 109.392 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.57 -15.15 57.37 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.438 1.495 . . . . 0.0 113.625 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.86 158.48 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -48.45 111.16 0.42 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.6 m -121.57 132.78 54.88 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 64.6 t -98.14 116.3 65.62 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 120.663 -1.273 . . . . 0.0 108.105 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.98 149.2 53.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.481 2.788 . . . . 0.0 115.524 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.1 t -153.21 52.01 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.63 53.94 9.94 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.74 151.15 54.06 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -46.43 148.48 3.35 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.164 3.243 . . . . 0.0 116.466 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -56.08 -43.31 77.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.655 1.582 . . . . 0.0 115.157 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.67 -6.09 85.92 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 120.201 -1.562 . . . . 0.0 114.225 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.39 92.16 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.599 1.2 . . . . 0.0 114.05 -174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.46 -41.49 84.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 126.592 1.957 . . . . 0.0 113.357 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 45.3 m -84.29 124.82 31.65 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.307 0.643 . . . . 0.0 111.52 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.7 t -140.82 134.87 30.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.168 -0.958 . . . . 0.0 108.945 161.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.93 154.89 47.35 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -155.18 162.21 41.01 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.4 p -67.09 -42.33 84.81 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.476 -0.765 . . . . 0.0 112.192 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 141.67 87.11 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.549 1.94 . . . . 0.0 113.209 174.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 148.84 10.45 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-N 123.279 2.207 . . . . 0.0 112.7 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.2 mttm 62.2 30.69 17.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.229 1.412 . . . . 0.0 114.484 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.5 p -71.55 143.06 50.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.602 0.761 . . . . 0.0 111.14 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -139.61 160.12 40.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.29 1.043 . . . . 0.0 109.697 -170.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 62.24 59.4 1.61 Allowed 'General case' 0 C--N 1.349 0.559 0 C-N-CA 125.476 1.511 . . . . 0.0 113.705 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -68.97 -19.94 64.17 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.463 1.125 . . . . 0.0 113.285 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -72.9 -20.26 61.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.546 1.138 . . . . 0.0 112.952 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 55.9 33.35 21.47 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 127.096 2.158 . . . . 0.0 112.293 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m -83.43 153.17 24.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.33 -0.856 . . . . 0.0 112.33 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -52.3 -41.34 62.85 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.899 1.68 . . . . 0.0 110.796 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 t -149.99 144.31 25.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 157.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.4 pt -93.28 0.89 9.73 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.129 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -78.67 106.25 10.52 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.813 -1.18 . . . . 0.0 108.349 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -89.88 0.83 56.83 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -165.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.43 120.1 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.519 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -160.04 160.85 33.7 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.14 88.01 1.43 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 121.019 -1.051 . . . . 0.0 110.723 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -157.98 -1.95 0.1 Allowed 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.26 -1.141 . . . . 0.0 112.897 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.2 mt -96.72 153.71 17.71 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.775 -1.203 . . . . 0.0 109.662 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.87 146.08 54.65 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.089 1.355 . . . . 0.0 113.869 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -74.17 -17.6 60.89 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.33 -1.481 . . . . 0.0 114.217 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 58.1 p -96.92 4.05 51.79 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 119.832 -1.792 . . . . 0.0 111.822 -167.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 114' ' ' VAL . 45.6 ptt85 -77.03 -9.92 59.03 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.397 1.079 . . . . 0.0 110.849 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -87.84 24.57 1.73 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.413 1.485 . . . . 0.0 112.324 171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -110.44 14.05 22.64 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 125.296 1.438 . . . . 0.0 111.008 167.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -157.24 149.96 23.31 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 162.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -79.95 117.05 20.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 119.592 -1.943 . . . . 0.0 112.451 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -71.08 -19.7 62.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.5 167.97 16.99 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.483 1.113 . . . . 0.0 108.81 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.75 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -143.89 116.61 8.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -99.68 121.21 40.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 13.44 0.08 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.759 -1.213 . . . . 0.0 110.728 -162.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.44 167.33 22.41 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.188 0.994 . . . . 0.0 110.885 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.14 164.94 25.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.754 1.622 . . . . 0.0 112.557 167.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -59.52 -39.79 85.01 Favored 'General case' 0 C--N 1.362 1.123 0 O-C-N 120.608 -1.307 . . . . 0.0 113.586 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -123.16 122.57 38.75 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -123.58 25.88 8.01 Favored 'General case' 0 CA--C 1.502 -0.87 0 O-C-N 120.754 -1.216 . . . . 0.0 110.397 -171.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -41.36 156.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 C-N-CA 126.867 2.067 . . . . 0.0 116.328 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -30.78 61.56 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 119.374 -2.078 . . . . 0.0 111.426 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -164.3 158.86 19.25 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.149 2.18 . . . . 0.0 105.848 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.84 144.14 49.4 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -68.23 148.57 98.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.361 1.464 . . . . 0.0 114.609 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -39.25 123.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 124.722 3.614 . . . . 0.0 117.574 164.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.58 -49.58 92.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.94 133.94 41.0 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 125.062 2.844 . . . . 0.0 112.765 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 p -56.5 158.14 4.62 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 126.314 1.846 . . . . 0.0 112.958 170.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 139.37 92.53 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 118.483 -2.636 . . . . 0.0 113.494 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.05 121.62 2.42 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.641 3.56 . . . . 0.0 117.269 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.03 44.84 15.63 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -50.7 -38.0 44.54 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -163.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -77.29 -16.08 59.14 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.292 -1.505 . . . . 0.0 114.294 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -87.57 -28.51 21.9 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.429 -1.419 . . . . 0.0 110.971 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.8 pt -93.33 146.81 5.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 122.571 1.177 . . . . 0.0 111.759 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 m -59.62 142.5 52.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -53.85 -35.59 61.68 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 120.252 -1.53 . . . . 0.0 114.317 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.98 -9.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -74.44 109.83 8.24 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.877 -1.765 . . . . 0.0 111.911 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -104.22 140.12 38.28 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 123.181 1.467 . . . . 0.0 111.481 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -114.63 6.38 15.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.224 1.81 . . . . 0.0 108.461 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . 0.256 83.2 m-85 69.37 44.59 0.92 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.322 2.249 . . . . 0.0 112.86 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 mtp85 -87.01 -17.12 33.74 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 120.914 -1.116 . . . . 0.0 112.909 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -114.03 -7.89 13.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.141 -0.974 . . . . 0.0 112.282 -164.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.0 pt -67.67 150.11 11.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 124.406 1.082 . . . . 0.0 111.306 165.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.256 86.6 mtm-85 79.15 21.45 0.65 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.138 -1.601 . . . . 0.0 113.049 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 t -120.5 148.67 43.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -73.78 136.23 43.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.774 -1.203 . . . . 0.0 111.179 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.0 p -72.56 168.24 19.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 119.353 -2.092 . . . . 0.0 112.884 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.31 -47.14 91.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 O-C-N 119.857 -1.777 . . . . 0.0 111.369 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 41.25 67.08 3.23 Favored Pre-proline 0 C--N 1.349 0.55 0 C-N-CA 125.782 1.633 . . . . 0.0 114.911 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -40.37 154.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 124.731 3.621 . . . . 0.0 116.248 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -72.06 117.51 13.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 121.054 -1.029 . . . . 0.0 111.565 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 48.38 58.39 5.24 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -161.55 154.41 20.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 119.888 -1.758 . . . . 0.0 111.561 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -125.87 24.05 7.12 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.184 0.994 . . . . 0.0 109.928 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -73.67 150.12 41.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -105.99 -70.38 0.79 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.329 1.061 . . . . 0.0 109.438 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.99 167.89 28.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 120.499 -1.375 . . . . 0.0 107.362 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -66.39 127.85 33.88 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 163.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -161.19 162.27 31.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.37 157.18 16.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 110.334 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -95.22 142.08 28.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.56 31.92 0.88 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.518 1.151 . . . . 0.0 108.849 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 m -70.08 -17.24 63.22 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.82 -56.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-O 121.705 0.764 . . . . 0.0 109.584 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -123.82 131.83 53.66 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.042 -1.662 . . . . 0.0 107.906 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 pt -84.99 -1.1 6.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 120.353 -1.467 . . . . 0.0 112.565 -167.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.38 5.41 45.25 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.216 1.006 . . . . 0.0 112.316 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -90.36 2.62 55.38 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.836 1.303 . . . . 0.0 109.649 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.1 135.87 62.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 155.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -124.8 144.54 50.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.254 9.0 mm 51.38 60.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.166 0 CA-C-O 123.261 1.505 . . . . 0.0 112.686 -164.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.684 HH21 ' CD ' ' A' ' 94' ' ' GLU . 47.4 ttp180 -62.0 -41.5 98.12 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . 0.292 93.0 mttt 86.05 32.94 0.03 OUTLIER 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.049 1.739 . . . . 0.0 111.796 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.684 ' CD ' HH21 ' A' ' 92' ' ' ARG . 31.6 tp10 -53.48 -46.75 70.11 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 -168.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.87 10.3 36.46 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.237 -1.539 . . . . 0.0 109.983 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.89 35.06 46.83 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 125.328 1.442 . . . . 0.0 116.501 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.6 mm -60.32 129.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 O-C-N 121.178 -1.189 . . . . 0.0 111.493 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -61.66 133.8 56.04 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 122.676 1.227 . . . . 0.0 112.115 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.3 pt -104.02 -0.37 10.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 122.683 1.23 . . . . 0.0 110.124 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 66.9 102.28 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.545 2.738 . . . . 0.0 114.984 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 57.76 63.8 1.72 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -140.06 159.98 40.96 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.984 1.313 . . . . 0.0 107.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.4 m -77.34 119.14 20.56 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.494 -1.379 . . . . 0.0 111.236 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.72 166.0 25.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 110.051 -170.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -98.38 1.51 47.0 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.204 -0.935 . . . . 0.0 111.761 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 70.16 44.17 0.79 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 110.893 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.97 -15.88 63.11 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -100.12 -1.37 36.91 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 122.369 1.081 . . . . 0.0 111.476 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.46 -62.75 0.43 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 170.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -98.39 108.41 21.1 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 124.242 1.972 . . . . 0.0 110.969 -168.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -153.77 153.18 31.71 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 120.02 15.38 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 121.26 -0.9 . . . . 0.0 108.647 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -111.36 -24.38 10.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.672 0.789 . . . . 0.0 111.433 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.51 119.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.2 m -73.07 122.39 21.71 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -63.93 144.94 56.68 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp -145.53 157.43 43.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.16 165.17 10.39 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -145.78 161.24 40.4 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.323 -1.692 . . . . 0.0 109.762 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.66 161.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 124.811 1.244 . . . . 0.0 110.236 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -145.02 16.77 1.57 Allowed 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.424 -1.422 . . . . 0.0 111.347 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -120.98 159.43 25.61 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.1 m 69.16 43.93 1.04 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.856 2.062 . . . . 0.0 111.489 -166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.6 mm -99.44 114.93 39.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.573 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -88.52 -18.07 28.95 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.118 1.367 . . . . 0.0 113.123 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.61 -18.56 44.3 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.892 -2.38 . . . . 0.0 115.77 -167.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 p -83.64 156.52 22.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 124.419 2.057 . . . . 0.0 114.653 -171.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -74.93 124.15 26.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 114.075 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -76.06 -14.5 60.2 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.116 0.966 . . . . 0.0 112.809 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -60.43 -36.87 79.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.899 2.08 . . . . 0.0 114.452 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.6 pt -112.22 15.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-O 122.408 1.099 . . . . 0.0 110.198 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.52 29.67 19.19 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 160.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 m -90.4 -4.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.499 -1.375 . . . . 0.0 111.695 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.1 t -119.35 155.56 31.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -56.88 142.78 39.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 127.42 2.288 . . . . 0.0 113.46 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -60.94 138.32 93.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 0.0 111.945 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -59.03 160.8 17.47 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.83 2.353 . . . . 0.0 113.218 162.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.8 t -163.52 166.98 22.01 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.03 13.57 12.17 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.428 0.632 . . . . 0.0 109.931 165.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 120.81 56.8 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 120.561 -1.337 . . . . 0.0 109.441 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -61.63 123.58 12.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.493 2.129 . . . . 0.0 113.096 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -163.22 166.61 23.05 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.865 -1.147 . . . . 0.0 109.237 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.53 68.68 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 120.786 -1.196 . . . . 0.0 114.513 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.06 62.67 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 120.96 -1.318 . . . . 0.0 113.715 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.06 2.47 9.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 121.114 -0.991 . . . . 0.0 110.262 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . 0.336 30.1 p 53.04 36.12 21.31 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 128.912 2.885 . . . . 0.0 115.107 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.7 t -150.42 148.94 29.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.926 1.346 . . . . 0.0 111.263 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -112.92 8.28 18.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.793 1.637 . . . . 0.0 108.658 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -102.61 137.99 40.1 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.345 -1.472 . . . . 0.0 110.444 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 m -61.82 -44.08 97.57 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.376 1.07 . . . . 0.0 113.27 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -65.69 145.21 99.05 Favored Pre-proline 0 C--N 1.343 0.297 0 C-N-CA 125.45 1.5 . . . . 0.0 114.364 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -57.6 154.69 35.14 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.1 2.534 . . . . 0.0 113.569 165.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -62.42 133.14 54.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.2 t -56.29 147.27 21.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.68 -0.57 39.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.201 1.8 . . . . 0.0 110.075 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -99.27 147.81 24.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.32 0.648 . . . . 0.0 109.314 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.287 72.0 m-20 65.99 149.91 0.05 OUTLIER 'General case' 0 C--N 1.351 0.635 0 CA-C-O 124.64 2.162 . . . . 0.0 115.343 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -76.67 131.04 38.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 119.067 -2.27 . . . . 0.0 110.018 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -108.57 1.76 21.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.298 -0.876 . . . . 0.0 112.975 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m 55.69 47.08 21.32 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.31 -26.71 7.5 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.499 -1.375 . . . . 0.0 112.098 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -65.59 -39.88 92.07 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.407 -1.433 . . . . 0.0 114.625 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.2 149.86 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -137.58 136.79 37.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 120.815 -1.178 . . . . 0.0 108.792 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -85.09 172.76 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.912 -1.118 . . . . 0.0 111.131 165.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m -56.99 139.24 16.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 O-C-N 120.682 -1.262 . . . . 0.0 112.73 165.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -84.56 -23.93 29.47 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.38 -140.4 6.4 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -71.8 149.25 45.47 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 119.983 -1.892 . . . . 0.0 112.543 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.81 144.55 38.15 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -89.55 158.39 17.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.731 1.612 . . . . 0.0 115.016 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.7 m120 55.25 -91.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.86 2.064 . . . . 0.0 114.535 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 62.6 p -99.53 -10.01 22.61 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.368 -1.457 . . . . 0.0 112.418 -168.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 60.09 44.3 13.24 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 166.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.41 156.76 34.85 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 120.536 -1.352 . . . . 0.0 110.952 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -139.02 126.75 22.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 163.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.6 p -113.55 2.24 15.27 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.353 0.661 . . . . 0.0 110.908 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.0 140.93 21.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -164.68 -6.95 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.72 -1.238 . . . . 0.0 112.679 -161.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -140.01 149.56 43.37 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.754 -1.841 . . . . 0.0 108.296 -172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.667 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.17 155.22 40.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.166 1.483 . . . . 0.0 110.274 149.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.91 137.75 56.42 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.95 134.25 52.1 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -158.01 -14.89 0.08 Allowed 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.8 -1.187 . . . . 0.0 112.381 -162.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.04 -4.73 29.31 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 119.731 -1.856 . . . . 0.0 113.928 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 60.37 38.38 19.56 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.15 14.09 17.1 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.706 -1.246 . . . . 0.0 111.404 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -96.93 6.4 48.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.114 1.366 . . . . 0.0 110.884 168.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 pt -138.69 163.77 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.321 1.048 . . . . 0.0 108.687 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.8 m -112.48 117.7 33.11 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.497 1.119 . . . . 0.0 109.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -81.26 -21.4 39.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.01 147.7 29.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 119.993 -1.692 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.63 127.36 26.92 Favored Pre-proline 0 C--N 1.356 0.884 0 O-C-N 120.628 -1.295 . . . . 0.0 108.509 -174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.39 -37.58 3.15 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.96 1.774 . . . . 0.0 113.096 -155.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.58 -46.66 97.28 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.25 -31.31 9.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 CA-C-N 123.66 2.343 . . . . 0.0 112.569 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.2 m -59.71 -41.15 90.18 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 119.649 1.113 . . . . 0.0 112.395 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.01 58.0 18.12 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -42.83 131.84 5.67 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 124.051 3.168 . . . . 0.0 116.528 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 79.96 15.12 0.85 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.4 -33.2 63.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 119.731 -1.855 . . . . 0.0 115.826 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -112.71 22.68 14.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 120.692 -1.255 . . . . 0.0 112.05 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -163.21 158.18 21.33 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 120.353 -1.467 . . . . 0.0 110.448 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.29 -40.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 O-C-N 120.353 -1.467 . . . . 0.0 114.279 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 t -163.85 171.45 15.41 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 119.513 -1.992 . . . . 0.0 109.699 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -143.89 123.93 13.62 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 159.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.47 109.06 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 O-C-N 120.431 -1.418 . . . . 0.0 107.832 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 t -149.23 130.49 14.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.87 -13.78 62.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.11 -18.4 62.53 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 120.265 -1.522 . . . . 0.0 113.939 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -120.82 9.45 10.69 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.195 -0.94 . . . . 0.0 113.233 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.1 172.35 12.96 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 56.57 -148.32 0.49 Allowed 'General case' 0 C--N 1.356 0.873 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.32 138.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 124.749 1.22 . . . . 0.0 110.286 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -102.28 -4.26 25.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 119.738 -1.851 . . . . 0.0 113.792 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 m -61.96 110.21 1.49 Allowed 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.454 1.102 . . . . 0.0 112.258 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -137.62 120.32 16.24 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -92.86 172.21 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.567 1.147 . . . . 0.0 110.842 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -53.59 136.56 53.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -69.58 -8.76 24.45 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.78 2.32 . . . . 0.0 115.017 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -134.32 119.0 18.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.884 0.874 . . . . 0.0 112.358 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.92 175.31 14.11 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.491 HH12 ' CE1' ' A' ' 112' ' ' HIS . 11.7 ptm180 -60.41 113.34 2.36 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -87.73 5.21 41.04 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.328 -1.483 . . . . 0.0 110.846 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -125.75 123.86 39.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.764 -1.21 . . . . 0.0 110.119 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -161.16 159.72 29.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.413 1.885 . . . . 0.0 106.404 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -142.88 166.98 23.15 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -96.77 -3.83 41.63 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 120.763 -1.21 . . . . 0.0 112.521 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -118.03 114.33 22.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.95 164.94 27.77 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.914 0.864 . . . . 0.0 111.161 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -105.83 112.92 26.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -100.6 -11.29 20.17 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.9 t -147.91 -174.13 4.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 120.222 -1.549 . . . . 0.0 107.132 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.54 -45.29 94.08 Favored 'Isoleucine or valine' 0 C--N 1.348 0.523 0 O-C-N 120.711 -1.243 . . . . 0.0 113.43 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.1 m120 47.39 53.3 11.14 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 127.221 2.208 . . . . 0.0 114.766 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tp -112.68 -12.78 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.35 125.76 40.19 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 119.447 -2.033 . . . . 0.0 110.412 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.04 -9.48 18.78 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 111.75 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.96 -45.11 95.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 125.209 1.404 . . . . 0.0 114.728 -169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -94.62 24.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.608 -1.307 . . . . 0.0 113.856 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.5 mt -109.69 127.7 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.298 1.439 . . . . 0.0 107.673 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -131.87 10.31 4.64 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.944 -1.723 . . . . 0.0 113.413 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -165.28 149.92 8.91 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.8 12.54 18.99 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.481 1.512 . . . . 0.0 111.733 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -139.98 128.82 23.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 119.53 -1.981 . . . . 0.0 108.966 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.3 -174.7 21.44 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 tt -161.07 166.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -120.93 130.18 53.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 167.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.96 112.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 118.204 0.456 . . . . 0.0 111.364 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.25 -43.51 92.41 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.534 1.934 . . . . 0.0 115.797 -154.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.1 mmt85 -103.39 3.06 34.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.994 -1.691 . . . . 0.0 109.426 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.344 79.7 tttt 76.24 -40.13 0.38 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.581 1.953 . . . . 0.0 115.132 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 p -97.83 -13.08 21.51 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.488 1.115 . . . . 0.0 111.018 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -156.2 151.87 27.13 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -165.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.5 14.91 10.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 120.662 -1.274 . . . . 0.0 110.24 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -155.26 161.1 41.21 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.329 1.061 . . . . 0.0 111.4 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.9 126.77 28.53 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 155.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -58.68 138.24 57.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.756 -1.215 . . . . 0.0 111.845 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.43 8.17 58.76 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 121.614 -0.679 . . . . 0.0 114.147 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -90.75 108.54 19.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.368 -1.078 . . . . 0.0 110.294 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -119.87 108.29 14.18 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.817 -1.177 . . . . 0.0 111.797 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.491 ' CE1' HH12 ' A' ' 73' ' ' ARG . 96.9 m-70 -114.03 -11.43 12.74 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.065 -1.022 . . . . 0.0 111.795 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.78 -59.86 1.62 Allowed 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.66 -1.275 . . . . 0.0 110.187 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.5 t -58.73 126.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.4 m -147.47 150.9 35.47 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 113.61 21.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.93 140.96 49.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.48 159.2 19.11 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 t60 69.03 35.11 2.89 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.66 135.85 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.278 75.1 mtp85 59.72 46.3 11.81 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -118.16 164.15 15.59 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.659 1.184 . . . . 0.0 110.277 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t -90.62 -175.77 4.52 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.933 1.293 . . . . 0.0 110.815 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.2 pt -58.27 143.68 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.607 1.963 . . . . 0.0 116.255 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -62.09 149.03 42.38 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.7 p -75.91 152.99 37.0 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.646 -1.284 . . . . 0.0 111.527 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.8 p -83.3 26.22 0.66 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.917 -1.739 . . . . 0.0 112.638 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -126.56 1.96 6.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 120.547 -1.346 . . . . 0.0 110.689 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -113.42 115.22 27.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.177 0.991 . . . . 0.0 108.883 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.8 p -97.36 1.97 50.01 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.299 3.0 mt 47.42 59.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 125.801 1.64 . . . . 0.0 115.185 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -163.41 58.73 0.18 Allowed 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 117.85 -3.031 . . . . 0.0 108.351 20.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.28 4.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 O-C-N 120.693 -1.255 . . . . 0.0 111.367 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 p -118.02 124.04 47.17 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -63.22 128.9 37.97 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.908 -1.12 . . . . 0.0 112.17 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.3 122.42 26.01 Favored Pre-proline 0 C--N 1.347 0.467 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -42.33 139.31 2.88 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.502 3.468 . . . . 0.0 116.815 167.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -145.22 139.88 27.48 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -168.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -108.61 30.73 6.2 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 108.894 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.19 -16.89 0.08 OUTLIER Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.78 146.49 66.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 CA-C-N 127.007 3.538 . . . . 0.0 114.859 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 66.91 39.62 3.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.696 1.199 . . . . 0.0 113.618 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.22 -36.97 0.2 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 120.666 -1.271 . . . . 0.0 114.8 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.37 -21.96 18.63 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 120.393 2.096 . . . . 0.0 110.65 171.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.58 160.11 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 161.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 t -151.13 179.78 7.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.288 95.0 m 78.45 104.81 0.07 Allowed 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.837 2.055 . . . . 0.0 113.332 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 29.75 61.71 0.17 Allowed 'General case' 0 C--N 1.361 1.069 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.87 34.02 0.28 Allowed 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.526 -1.359 . . . . 0.0 114.512 -169.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -42.08 86.16 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.33 2.652 . . . . 0.0 113.168 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.15 114.72 40.27 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.311 1.444 . . . . 0.0 111.776 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.42 141.07 11.1 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 111.978 -167.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -109.59 3.27 20.96 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.327 -1.483 . . . . 0.0 113.859 -169.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m 54.47 57.28 5.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.203 1.801 . . . . 0.0 114.35 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -148.73 147.21 28.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -99.23 -12.12 20.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.17 0.896 . . . . 0.0 110.435 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.4 105.75 15.99 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.019 -1.676 . . . . 0.0 108.36 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -99.76 6.42 45.47 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.312 -1.493 . . . . 0.0 113.56 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.05 1.99 56.1 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.827 1.299 . . . . 0.0 111.408 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 t -135.21 160.47 38.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -100.65 7.67 43.81 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 120.8 -1.187 . . . . 0.0 112.829 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.6 t -162.54 154.37 18.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 pt -83.63 -12.4 11.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 C-N-CA 123.503 0.721 . . . . 0.0 110.856 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -67.67 135.36 52.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.325 -1.484 . . . . 0.0 111.821 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.22 -40.03 5.07 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.859 -1.151 . . . . 0.0 111.411 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t -122.27 125.13 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 229' ' ' GLU . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.01 18.35 2.29 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.06 -175.89 49.92 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 120.066 -1.646 . . . . 0.0 114.08 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -97.37 -6.92 33.05 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.1 mt -145.29 -64.03 0.33 Allowed 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 59.04 49.76 9.06 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.156 1.782 . . . . 0.0 112.127 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.9 m120 70.98 42.48 0.74 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.549 1.54 . . . . 0.0 111.786 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.0 m 47.35 57.16 6.08 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.705 2.402 . . . . 0.0 114.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 138.57 32.94 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.82 132.65 54.7 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.612 -1.305 . . . . 0.0 109.617 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 67.27 -179.19 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.435 15.6 p 82.34 19.29 0.31 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 130.026 3.33 . . . . 0.0 113.829 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -117.31 -39.29 3.21 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.69 -1.256 . . . . 0.0 110.774 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 212' ' ' TYR . 12.2 pm0 -52.57 177.66 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 131.574 3.95 . . . . 0.0 118.394 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -49.47 118.77 2.94 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.55 1.54 . . . . 0.0 113.77 167.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.991 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -163.28 154.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.045 1.423 . . . . 0.0 111.226 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -146.67 139.32 25.15 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 60.33 52.55 4.77 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 167.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -129.9 160.29 34.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.07 161.2 40.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 120.812 -1.18 . . . . 0.0 107.938 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.12 135.38 54.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.88 144.18 27.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -158.18 84.62 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.262 -1.524 . . . . 0.0 110.083 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.18 108.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 123.324 1.535 . . . . 0.0 114.724 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.7 p -88.2 -1.21 57.88 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 118.303 -2.748 . . . . 0.0 111.508 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -93.26 1.94 56.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.47 1.508 . . . . 0.0 112.314 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -66.92 149.39 50.67 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.673 -0.642 . . . . 0.0 111.805 170.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.3 t80 16.43 78.77 0.11 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 130.245 3.418 . . . . 0.0 118.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.25 -4.24 5.89 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.287 1.991 . . . . 0.0 111.737 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.24 -38.74 71.6 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -103.83 31.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 CA-C-N 125.333 2.94 . . . . 0.0 109.367 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -151.06 -178.06 6.39 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.858 -1.151 . . . . 0.0 108.535 -175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.29 103.84 23.0 Favored Pre-proline 0 N--CA 1.444 -0.751 0 O-C-N 120.567 -1.333 . . . . 0.0 108.822 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.01 146.37 80.76 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 C-N-CA 122.871 2.381 . . . . 0.0 113.377 164.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.77 5.27 14.13 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 121.203 -0.936 . . . . 0.0 112.632 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.3 120.97 10.48 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.278 -1.514 . . . . 0.0 108.172 165.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.26 147.03 45.85 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.9 tttt 81.8 -49.3 0.23 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.357 2.263 . . . . 0.0 113.036 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.96 -25.34 6.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 O-C-N 121.845 -0.534 . . . . 0.0 111.847 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.255 72.3 m 64.1 31.37 13.45 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -62.14 127.46 31.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.895 -1.128 . . . . 0.0 113.593 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.07 109.1 26.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-O 122.898 1.332 . . . . 0.0 109.664 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.8 m -76.65 -23.55 53.29 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 120.251 -1.53 . . . . 0.0 112.085 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.75 -45.31 94.45 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 120.144 -1.597 . . . . 0.0 112.842 171.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -60.07 -41.81 93.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.785 1.634 . . . . 0.0 113.894 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -75.37 -10.62 59.62 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -101.72 -10.07 20.3 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.202 -0.936 . . . . 0.0 112.836 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 pt -95.31 179.05 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 119.844 -1.785 . . . . 0.0 111.914 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 63.06 169.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.383 3.7 p 46.37 -147.88 0.14 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.296 2.638 . . . . 0.0 117.461 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 53.06 62.19 2.8 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m 62.72 60.43 1.3 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.09 -43.62 93.22 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 124.96 1.304 . . . . 0.0 114.319 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.66 82.11 12.8 Favored Pre-proline 0 C--N 1.347 0.491 0 O-C-N 120.842 -1.161 . . . . 0.0 112.295 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -88.48 75.82 1.71 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.612 1.542 . . . . 0.0 108.679 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.2 160.94 34.65 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 124.491 1.116 . . . . 0.0 109.856 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.55 118.4 20.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -86.18 -17.86 33.77 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 119.779 -1.825 . . . . 0.0 113.227 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.48 105.3 4.78 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.185 -171.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.28 -28.26 67.03 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 46.44 42.17 10.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 127.473 2.309 . . . . 0.0 114.062 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -66.99 143.11 56.99 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.29 -37.89 70.49 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -100.82 13.74 34.01 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.998 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 62.74 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -155.73 8.72 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.634 -1.291 . . . . 0.0 113.068 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . 0.268 86.6 m-85 60.03 50.7 6.39 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -63.82 134.7 55.72 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.7 165.51 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.922 1.289 . . . . 0.0 109.298 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.1 m120 55.63 35.37 25.1 Favored 'General case' 0 C--N 1.365 1.266 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.58 -46.22 95.53 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' CD ' HH22 ' A' ' 90' ' ' ARG . 0.4 OUTLIER -145.12 -3.97 0.74 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.68 -1.262 . . . . 0.0 111.884 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -162.12 166.13 26.14 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.16 -42.85 94.9 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 120.113 -1.617 . . . . 0.0 112.622 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.475 HH22 ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -61.96 134.35 56.54 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.29 151.18 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 O-C-N 120.727 -1.233 . . . . 0.0 112.478 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.19 164.64 28.67 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -79.31 -27.03 42.14 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -85.18 92.85 8.51 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.44 -1.413 . . . . 0.0 110.49 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -104.4 0.94 29.58 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.967 -1.083 . . . . 0.0 111.773 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.13 173.44 50.28 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 124.424 1.012 . . . . 0.0 111.673 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.3 mt -118.82 133.42 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.942 1.297 . . . . 0.0 108.794 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -87.61 116.65 25.88 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 120.829 -1.17 . . . . 0.0 110.325 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.4 pt -92.48 175.2 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 122.499 1.142 . . . . 0.0 112.43 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -95.44 3.03 54.68 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.144 2.978 . . . . 0.0 112.649 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -116.03 148.69 39.91 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 120.756 -1.215 . . . . 0.0 113.963 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -82.32 165.27 20.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.945 1.298 . . . . 0.0 113.339 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -129.29 166.25 19.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.344 3.3 mm-40 70.51 48.43 0.46 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 124.615 2.15 . . . . 0.0 112.781 -169.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -94.38 7.76 44.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.662 -173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 65.98 37.93 5.14 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-O 123.83 1.776 . . . . 0.0 112.273 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 166.77 139.21 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -145.48 132.11 19.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -170.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.24 163.45 0.52 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 119.348 2.499 . . . . 0.0 119.348 -169.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -54.88 136.1 47.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.254 1.821 . . . . 0.0 115.737 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.69 0.72 10.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.413 1.101 . . . . 0.0 108.396 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -74.51 -10.56 59.67 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 119.661 -1.899 . . . . 0.0 112.752 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.36 45.75 2.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.725 1.21 . . . . 0.0 109.293 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.93 120.93 61.97 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.804 -1.185 . . . . 0.0 108.598 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . 0.331 92.5 p 10.96 96.76 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 129.195 2.998 . . . . 0.0 118.359 -169.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.4 p -160.46 164.63 32.07 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.028 -1.045 . . . . 0.0 110.393 -171.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt -140.43 140.36 35.42 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.56 154.65 30.32 Favored Glycine 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 65.64 32.51 9.1 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.2 m -63.16 -41.14 91.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -163.9 158.47 19.87 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -94.02 -11.61 30.37 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.981 0.896 . . . . 0.0 112.142 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.7 t -167.0 172.85 9.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.8 tt -111.32 -8.35 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.877 0.871 . . . . 0.0 110.557 163.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -63.72 144.59 56.91 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.57 -1.332 . . . . 0.0 113.117 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.4 t -138.44 19.0 2.73 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 78.6 m -60.38 138.87 57.91 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.034 -1.666 . . . . 0.0 114.106 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -138.58 24.79 2.65 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.941 -1.724 . . . . 0.0 110.682 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -128.16 116.56 20.11 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.992 -1.067 . . . . 0.0 109.24 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 m -63.66 -40.24 96.36 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.405 1.082 . . . . 0.0 113.065 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 25.8 pt -143.06 157.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.78 137.91 37.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.123 0.969 . . . . 0.0 110.655 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.96 -5.28 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 123.849 0.86 . . . . 0.0 110.587 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.9 m -85.12 122.4 29.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.344 -0.848 . . . . 0.0 109.163 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 p -59.15 147.75 34.04 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.066 1.412 . . . . 0.0 114.134 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 119.59 71.95 Favored Pre-proline 0 C--O 1.243 0.754 0 O-C-N 120.262 -1.524 . . . . 0.0 111.567 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.39 132.82 12.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.391 3.394 . . . . 0.0 116.718 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t 77.54 7.7 2.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.969 2.107 . . . . 0.0 113.618 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -103.56 109.29 20.9 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 120.55 -1.344 . . . . 0.0 109.527 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.85 93.35 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.17 115.75 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 CA-C-N 124.985 2.816 . . . . 0.0 111.93 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -60.32 -42.12 94.96 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.881 -1.137 . . . . 0.0 113.127 165.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 136.12 -174.63 21.34 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 178.33 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.262 1.425 . . . . 0.0 110.374 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.79 -30.03 23.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-O 123.803 1.763 . . . . 0.0 109.919 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -152.51 166.34 32.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 86.7 m -94.7 128.46 41.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.492 1.117 . . . . 0.0 108.852 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -93.43 139.03 31.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.115 -0.991 . . . . 0.0 113.385 -171.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 69.16 48.47 0.67 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.52 1.528 . . . . 0.0 112.642 168.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 p -95.86 8.69 42.88 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.277 1.831 . . . . 0.0 110.178 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.59 112.72 7.1 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.672 2.389 . . . . 0.0 111.264 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -62.02 128.79 25.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.955 1.77 . . . . 0.0 113.885 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -65.98 106.56 1.62 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.682 -0.636 . . . . 0.0 111.547 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.4 p -64.25 148.53 49.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.7 2.0 . . . . 0.0 114.888 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.69 137.21 53.47 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.681 -1.262 . . . . 0.0 109.182 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.59 149.55 41.16 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.63 116.6 20.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.892 0.853 . . . . 0.0 112.372 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.64 6.32 14.51 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.382 1.073 . . . . 0.0 109.571 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -104.98 -34.05 8.13 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 120.164 -1.585 . . . . 0.0 111.69 -164.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.4 p -69.47 -29.34 66.98 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.05 -1.031 . . . . 0.0 112.636 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.28 29.09 18.58 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.673 1.189 . . . . 0.0 112.234 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 t 69.76 101.86 0.06 Allowed 'General case' 0 C--N 1.346 0.44 0 C-N-CA 127.841 2.456 . . . . 0.0 113.137 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.6 pt -74.81 -19.78 16.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 122.924 1.345 . . . . 0.0 114.558 -173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -120.09 144.15 47.76 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 119.261 -2.15 . . . . 0.0 106.871 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -137.37 161.09 37.24 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.65 -170.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.73 134.9 29.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 124.936 1.294 . . . . 0.0 111.301 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -56.16 146.09 24.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.77 -163.13 13.98 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 112.224 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -65.51 151.38 46.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.635 1.974 . . . . 0.0 115.507 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.23 9.21 34.74 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -165.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -53.73 -37.35 63.24 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -163.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -122.63 22.0 9.96 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 89.9 m -113.71 106.25 14.27 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 120.886 -1.134 . . . . 0.0 110.324 -165.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -65.83 -40.2 91.55 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 120.389 -1.445 . . . . 0.0 114.194 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -143.9 134.32 24.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.965 -1.085 . . . . 0.0 108.659 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -103.59 -5.61 22.51 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.931 1.348 . . . . 0.0 109.606 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 p -91.0 1.64 56.92 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.091 1.756 . . . . 0.0 111.141 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 229' ' ' GLU . 8.9 t-160 59.42 -106.52 0.29 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 165.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HG3' ' CD2' ' A' ' 228' ' ' HIS . 48.7 mt-10 -149.27 142.46 25.04 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.433 1.493 . . . . 0.0 107.807 -171.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -151.67 163.13 39.78 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.318 -1.489 . . . . 0.0 111.162 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.053 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.05 136.95 30.7 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -98.04 -62.55 1.23 Allowed 'General case' 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.57 156.51 32.75 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.196 -0.94 . . . . 0.0 112.106 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -124.32 137.03 54.53 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 120.965 -1.085 . . . . 0.0 108.321 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.47 20.57 1.35 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.364 1.554 . . . . 0.0 111.81 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . 0.262 26.5 p90 -135.71 162.89 31.47 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.273 -1.517 . . . . 0.0 111.613 173.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.35 136.97 58.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.682 2.393 . . . . 0.0 113.976 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -104.43 -6.19 20.95 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.375 -1.453 . . . . 0.0 114.305 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.257 10.4 mm 35.97 60.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 128.517 2.727 . . . . 0.0 116.109 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -59.13 -40.74 86.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -166.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.59 14.53 26.3 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 120.294 -1.504 . . . . 0.0 114.04 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 70.26 17.12 7.17 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 120.42 -1.425 . . . . 0.0 114.579 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -67.73 142.81 96.18 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 120.582 -1.324 . . . . 0.0 112.349 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -103.94 -10.12 0.13 Allowed 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 122.027 1.76 . . . . 0.0 108.299 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.93 153.4 54.85 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 129.256 3.022 . . . . 0.0 113.744 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -38.49 134.52 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.6 2.867 . . . . 0.0 117.059 156.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -72.5 -25.2 61.32 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 126.15 1.78 . . . . 0.0 113.783 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.18 144.4 58.41 Favored Pre-proline 0 N--CA 1.446 -0.641 0 O-C-N 121.488 -0.757 . . . . 0.0 111.627 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -57.05 159.55 14.68 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.248 1.965 . . . . 0.0 113.198 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 76.54 47.19 0.08 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.476 1.11 . . . . 0.0 111.856 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.8 -35.96 75.74 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.493 1.917 . . . . 0.0 115.434 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 55.63 49.16 17.04 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.257 62.9 tttm 92.5 -10.7 0.19 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.742 2.417 . . . . 0.0 112.076 172.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.1 mt -81.66 118.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 O-C-N 120.184 -1.572 . . . . 0.0 109.743 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 t -151.79 -89.87 0.06 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.47 0.708 . . . . 0.0 109.727 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 -3.94 57.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.725 -1.859 . . . . 0.0 112.19 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -115.32 120.0 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -154.17 154.49 33.63 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.76 147.85 36.42 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.18 -39.02 69.07 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -71.71 -16.07 62.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.577 1.551 . . . . 0.0 112.422 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -85.65 -1.9 57.63 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 119.423 -2.048 . . . . 0.0 111.554 174.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 48.64 58.27 5.44 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.44 121.95 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.267 92.6 mtt-85 72.22 3.53 4.71 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -152.74 19.96 0.61 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.125 -2.235 . . . . 0.0 110.82 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -58.88 -42.93 90.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.7 t -67.08 151.93 46.7 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.26 -68.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.69 1.596 . . . . 0.0 110.385 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -53.31 105.73 0.57 Allowed Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -166.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -60.03 173.3 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.677 3.585 . . . . 0.0 115.531 165.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -114.0 -24.09 9.22 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -156.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.11 168.97 25.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -133.9 41.32 3.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -61.68 -39.43 91.42 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.223 1.409 . . . . 0.0 113.535 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -86.4 161.2 18.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.005 0.922 . . . . 0.0 111.297 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -60.02 147.63 38.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 123.007 1.384 . . . . 0.0 114.231 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -148.71 147.24 28.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -166.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 56.11 53.97 8.43 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.734 1.614 . . . . 0.0 114.384 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -102.95 111.41 23.73 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.411 -1.431 . . . . 0.0 111.361 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -116.17 143.42 45.52 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 111.097 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -114.92 115.62 27.21 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.63 -1.294 . . . . 0.0 110.389 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -101.71 -6.02 24.23 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 122.95 0.5 . . . . 0.0 111.26 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 p -85.3 122.03 28.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.559 -1.338 . . . . 0.0 110.343 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -98.49 -20.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.859 -1.15 . . . . 0.0 111.675 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -97.06 168.56 10.38 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.755 -1.216 . . . . 0.0 112.208 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 mm -63.14 117.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 124.198 0.999 . . . . 0.0 110.544 165.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -85.3 135.33 33.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.873 -1.142 . . . . 0.0 110.154 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -124.55 133.06 53.42 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 119.398 -2.063 . . . . 0.0 109.588 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.35 166.99 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.774 0.83 . . . . 0.0 109.861 -164.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -113.74 11.86 18.18 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.368 -0.833 . . . . 0.0 112.071 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 pt -91.28 138.51 19.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.811 0.815 . . . . 0.0 110.549 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -91.08 134.9 34.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 119.982 -1.699 . . . . 0.0 112.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -116.91 120.24 37.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.6 -44.97 93.22 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -109.75 142.75 40.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 120.409 -1.432 . . . . 0.0 109.967 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.17 178.6 0.05 OUTLIER Glycine 0 C--N 1.356 1.684 0 N-CA-C 120.042 2.777 . . . . 0.0 120.042 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.306 9.8 mt 71.44 122.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.339 1.856 . . . . 0.0 114.255 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -78.54 144.13 35.91 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 110.581 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 tp -158.52 10.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.658 0 O-C-N 120.165 -1.584 . . . . 0.0 111.488 -168.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 20.14 -107.44 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 130.142 3.377 . . . . 0.0 118.761 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -96.51 18.47 14.01 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 120.874 -1.141 . . . . 0.0 111.884 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 62.94 51.89 2.77 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.109 2.163 . . . . 0.0 116.805 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.4 p -103.64 -1.04 28.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.238 -0.914 . . . . 0.0 112.142 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.18 140.67 57.87 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.641 1.21 . . . . 0.0 112.888 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -122.01 111.22 16.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -167.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . 0.32 36.4 mt-30 110.61 14.42 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 C-N-CA 130.014 3.325 . . . . 0.0 110.912 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.33 165.41 22.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 123.642 1.687 . . . . 0.0 108.892 172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.64 -38.81 82.39 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.404 -1.435 . . . . 0.0 112.813 173.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.95 21.66 29.15 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 124.746 1.165 . . . . 0.0 115.613 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -57.51 119.71 7.0 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.779 1.289 . . . . 0.0 110.376 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -67.99 -28.11 67.16 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.643 -1.911 . . . . 0.0 115.564 -168.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -94.58 15.97 16.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.056 -1.028 . . . . 0.0 113.121 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.0 -19.64 57.04 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.833 -1.792 . . . . 0.0 111.666 168.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -118.37 147.62 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 t -84.01 -179.89 7.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 123.173 1.463 . . . . 0.0 110.361 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.6 m -102.64 9.34 39.35 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 119.777 -1.827 . . . . 0.0 109.396 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt -128.53 151.07 49.86 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.072 1.349 . . . . 0.0 113.763 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 190' ' ' VAL . . . -137.56 154.61 22.62 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -89.53 135.94 33.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.327 1.06 . . . . 0.0 112.778 -167.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.76 159.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -162.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.336 99.2 mtt180 89.21 20.71 0.04 OUTLIER 'General case' 0 C--N 1.362 1.145 0 C-N-CA 126.608 1.963 . . . . 0.0 113.603 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -81.99 128.51 34.15 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.298 1.039 . . . . 0.0 112.475 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.07 125.59 30.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.764 0.825 . . . . 0.0 109.636 166.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.8 tp -67.53 -33.64 63.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 123.098 1.428 . . . . 0.0 111.291 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -44.04 97.02 Favored 'General case' 0 N--CA 1.439 -1.005 1 C-N-CA 133.013 4.525 . . . . 0.0 112.663 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.1 t -85.24 175.56 8.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 124.222 1.963 . . . . 0.0 114.138 -166.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.1 p -65.46 119.37 10.91 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 119.955 -1.716 . . . . 0.0 112.645 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.99 -4.26 49.95 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 120.871 -1.143 . . . . 0.0 112.924 -169.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 78.28 18.42 1.09 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.66 1.584 . . . . 0.0 112.523 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 154.63 38.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.67 2.788 . . . . 0.0 116.445 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.55 22.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 120.805 -1.184 . . . . 0.0 110.615 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.52 129.51 40.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.9 m -117.98 11.05 7.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 124.417 1.087 . . . . 0.0 112.705 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.7 m -97.24 104.68 16.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 119.314 -2.116 . . . . 0.0 110.272 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 113.15 2.73 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.889 1.276 . . . . 0.0 114.26 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.94 147.08 96.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.904 1.282 . . . . 0.0 113.934 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.44 -8.56 18.45 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.391 2.06 . . . . 0.0 112.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.3 t -161.69 155.63 21.93 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -103.1 5.77 38.15 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.641 0.776 . . . . 0.0 111.29 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.05 73.13 Favored Pre-proline 0 N--CA 1.444 -0.768 0 O-C-N 121.448 -0.783 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.2 166.36 3.34 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.614 2.876 . . . . 0.0 116.143 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.259 34.7 m120 80.73 26.6 0.26 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 163.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.51 165.56 6.19 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-O 122.415 1.008 . . . . 0.0 115.54 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.65 135.13 57.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.02 -1.871 . . . . 0.0 115.37 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.276 2.9 t 61.25 42.62 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 123.956 1.836 . . . . 0.0 113.026 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -98.97 3.52 47.03 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 120.044 -1.66 . . . . 0.0 111.914 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -119.11 138.83 52.63 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.589 -1.319 . . . . 0.0 110.784 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -69.0 -29.02 67.12 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 77.46 37.55 0.24 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.233 1.413 . . . . 0.0 113.359 168.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.7 m -171.31 107.45 0.26 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -75.07 145.13 80.32 Favored Pre-proline 0 C--N 1.354 0.768 0 O-C-N 120.939 -1.1 . . . . 0.0 113.167 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.16 152.26 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.194 3.263 . . . . 0.0 116.964 157.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.14 149.91 21.23 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 121.934 0.873 . . . . 0.0 112.852 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.8 p -85.47 115.48 23.21 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 121.101 -1.0 . . . . 0.0 111.331 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -156.72 150.72 24.95 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 86.76 27.65 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.841 1.656 . . . . 0.0 112.81 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.56 -41.25 76.55 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.983 3.313 . . . . 0.0 113.575 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -60.02 -33.78 72.48 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.157 1.383 . . . . 0.0 114.663 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -99.6 -1.48 38.03 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.141 1.164 . . . . 0.0 114.141 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 98.8 p -153.39 147.45 25.57 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.349 -1.469 . . . . 0.0 113.324 -166.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -136.13 124.55 23.43 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 118.305 -2.747 . . . . 0.0 109.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.7 t -59.2 144.67 45.29 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . 0.488 42.2 pt 50.96 13.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.803 0 N-CA-C 119.159 3.022 . . . . 0.0 119.159 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -60.6 -35.96 77.39 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 126.049 1.739 . . . . 0.0 111.791 170.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 79.18 -52.91 0.44 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 127.65 2.38 . . . . 0.0 113.529 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 142' ' ' GLY . 22.9 m -58.62 148.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.644 1.578 . . . . 0.0 114.326 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 220' ' ' LEU . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -62.33 127.52 31.71 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.28 -1.22 57.33 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.691 0.662 . . . . 0.0 113.459 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -128.96 -36.86 1.75 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 126.746 2.018 . . . . 0.0 108.702 166.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 215' ' ' HIS . 67.1 tp -65.13 128.52 36.13 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.313 1.445 . . . . 0.0 113.773 167.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -157.52 -86.65 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 75.09 12.55 3.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.553 1.541 . . . . 0.0 113.574 165.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 4.4 m 64.94 36.0 7.91 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.539 1.637 . . . . 0.0 111.695 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -94.44 96.98 9.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 119.461 -2.025 . . . . 0.0 114.843 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -75.95 -17.91 59.54 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 119.632 -1.917 . . . . 0.0 113.974 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -152.14 157.31 41.37 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.492 1.517 . . . . 0.0 107.086 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.9 m -156.01 146.77 22.02 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -147.43 149.36 32.56 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.32 -159.12 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.176 1.79 . . . . 0.0 113.789 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.85 -13.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.457 -1.402 . . . . 0.0 114.104 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.951 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 -109.93 151.48 27.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 155.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' CG ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.34 144.98 49.42 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.65 12.33 0.61 Allowed 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.561 -1.337 . . . . 0.0 114.334 -167.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -90.19 2.99 54.78 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 118.863 -2.398 . . . . 0.0 112.786 -167.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.68 50.03 8.59 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 118.073 2.619 . . . . 0.0 118.073 170.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -100.6 92.22 5.01 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.165 -1.584 . . . . 0.0 110.768 -164.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.556 ' CD ' ' HZ3' ' A' ' 226' ' ' LYS . 24.9 pt-20 -107.19 -16.08 14.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -100.08 -2.09 35.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.554 -1.341 . . . . 0.0 112.943 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.263 5.0 mm 41.02 56.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 127.967 2.507 . . . . 0.0 115.52 172.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 p -89.46 5.98 42.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 119.665 -1.897 . . . . 0.0 113.014 -167.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.2 m80 50.35 37.2 14.72 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 128.837 2.855 . . . . 0.0 116.409 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -108.54 -10.57 15.23 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 121.092 -1.005 . . . . 0.0 112.194 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.21 -44.52 77.05 Favored Pre-proline 0 C--N 1.349 0.587 0 CA-C-O 116.851 -1.547 . . . . 0.0 114.301 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -44.72 140.19 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.82 3.013 . . . . 0.0 117.3 159.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -64.55 139.87 97.85 Favored Pre-proline 0 C--N 1.354 0.789 0 O-C-N 121.3 -0.875 . . . . 0.0 113.05 164.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -90.05 136.68 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.598 1.606 . . . . 0.0 112.325 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 p -89.99 -16.55 29.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.79 151.04 22.51 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 120.647 -1.283 . . . . 0.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.06 136.7 76.29 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.607 2.204 . . . . 0.0 112.21 155.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.49 159.38 41.31 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 120.169 1.349 . . . . 0.0 110.815 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 62.54 42.67 8.39 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.646 1.578 . . . . 0.0 112.765 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 65.06 42.78 3.99 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.813 1.245 . . . . 0.0 113.191 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.1 159.88 37.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -138.64 143.2 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 O-C-N 121.167 -0.958 . . . . 0.0 109.35 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.5 m -89.01 12.52 15.28 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 121.111 -0.993 . . . . 0.0 112.193 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.73 3.67 47.65 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 111.424 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.89 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.0 p -63.74 133.63 53.87 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.106 -0.996 . . . . 0.0 113.535 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 65.83 19.63 11.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -96.81 3.81 52.06 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.135 -2.228 . . . . 0.0 111.422 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -156.08 154.06 30.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 119.894 -1.754 . . . . 0.0 109.74 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.328 60.1 ttt180 76.77 -58.57 0.51 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 127.066 2.147 . . . . 0.0 114.992 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 m120 63.77 44.34 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 160.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.38 -3.68 9.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 O-C-N 120.528 -1.357 . . . . 0.0 113.543 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -74.6 -15.95 60.81 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.229 -2.169 . . . . 0.0 114.568 -168.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -97.37 -0.71 45.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.629 1.972 . . . . 0.0 111.181 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -75.93 117.41 17.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.048 -1.032 . . . . 0.0 111.693 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -76.59 128.63 35.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.104 -1.622 . . . . 0.0 110.695 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.12 123.79 48.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-O 122.498 1.142 . . . . 0.0 109.032 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -88.36 124.67 65.77 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 126.603 1.961 . . . . 0.0 110.603 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -58.99 147.3 90.72 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 123.701 2.358 . . . . 0.0 111.534 162.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HE ' ' CG ' ' A' ' 14' ' ' ASP . 22.4 tpt180 -120.7 116.02 24.47 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.483 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.09 -87.15 0.58 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -144.69 134.12 23.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.199 -1.563 . . . . 0.0 108.131 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.78 145.29 35.38 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.73 78.21 1.55 Allowed 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.641 -1.287 . . . . 0.0 112.803 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.08 20.13 16.58 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 120.81 -1.181 . . . . 0.0 110.473 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.26 47.8 m95 64.04 0.91 1.05 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -69.44 -30.72 68.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.041 -1.662 . . . . 0.0 114.517 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.49 160.55 25.35 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.044 -1.035 . . . . 0.0 113.222 -165.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.268 14.0 m-80 88.64 43.22 0.01 OUTLIER 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.48 2.312 . . . . 0.0 113.78 176.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -111.59 21.81 15.72 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.043 -1.036 . . . . 0.0 112.457 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -59.83 -40.65 89.17 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 126.89 2.076 . . . . 0.0 113.609 -171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -124.73 109.6 13.32 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 120.846 -1.159 . . . . 0.0 110.168 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 86' ' ' ILE . 89.9 t -93.22 127.46 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 120.54 -1.35 . . . . 0.0 108.161 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -120.53 35.83 4.75 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 84' ' ' VAL . 41.1 mt -118.54 116.07 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 165.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -118.71 133.04 56.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.84 2.33 3.4 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.353 -0.842 . . . . 0.0 112.349 -166.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -39.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.878 0.847 . . . . 0.0 109.921 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -97.6 159.99 14.59 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.29 1.519 . . . . 0.0 113.637 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.86 126.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 O-C-N 120.28 -1.512 . . . . 0.0 111.747 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -112.93 131.4 55.76 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.171 -1.581 . . . . 0.0 109.972 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -147.73 151.01 35.36 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.72 163.62 39.63 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -99.93 99.73 10.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.61 -145.37 5.11 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 126.227 1.87 . . . . 0.0 116.492 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.4 pt -43.87 164.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -110.62 20.83 17.26 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 120.232 -1.543 . . . . 0.0 114.845 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.9 mm -112.26 120.24 62.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 O-C-N 120.872 -1.142 . . . . 0.0 109.843 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.64 38.95 6.81 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.882 2.073 . . . . 0.0 115.976 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -114.56 14.76 17.77 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -136.34 127.69 28.36 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 121.017 -1.052 . . . . 0.0 109.006 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -62.53 103.64 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.92 -1.113 . . . . 0.0 112.946 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.88 37.59 12.0 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -154.78 144.6 21.62 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 119.588 -1.945 . . . . 0.0 107.543 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -116.36 132.64 56.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.123 -0.985 . . . . 0.0 112.667 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.26 7.98 9.69 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.958 -1.089 . . . . 0.0 112.954 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.4 145.03 56.71 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 119.037 -2.289 . . . . 0.0 113.108 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.24 -7.98 3.81 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 110.634 167.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 88.39 6.09 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 121.388 -1.066 . . . . 0.0 108.618 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -116.89 128.75 55.54 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.767 1.27 . . . . 0.0 111.553 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -59.73 151.11 25.99 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.784 1.634 . . . . 0.0 113.179 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 54.48 4.52 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 121.053 3.723 . . . . 0.0 121.053 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -33.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 126.539 1.936 . . . . 0.0 116.224 -168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.9 m -127.05 21.56 6.79 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.573 -1.329 . . . . 0.0 112.294 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.0 m -61.92 150.5 37.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp -113.93 129.89 56.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.21 173.18 53.08 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -93.79 6.02 49.76 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.549 -1.559 . . . . 0.0 111.778 -172.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 141.48 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.293 1.044 . . . . 0.0 108.231 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -138.07 137.56 37.9 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.255 1.422 . . . . 0.0 107.354 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -110.64 155.78 21.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.405 1.097 . . . . 0.0 111.201 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.1 p -72.93 154.82 40.39 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.73 1.212 . . . . 0.0 110.597 158.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.3 tt -89.51 143.31 11.45 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 O-C-N 121.068 -1.02 . . . . 0.0 111.579 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -87.46 141.7 28.43 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-O 121.94 0.876 . . . . 0.0 111.857 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 m -99.76 24.38 8.44 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.85 -1.156 . . . . 0.0 113.917 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.22 168.93 24.89 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 119.506 -1.997 . . . . 0.0 109.708 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -82.28 -23.77 35.06 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.476 -1.39 . . . . 0.0 112.717 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -134.39 103.85 5.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.7 m -74.46 -37.18 63.31 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 121.267 -0.896 . . . . 0.0 112.858 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.95 160.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.4 -39.81 84.6 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.7 m -75.66 -17.44 15.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 24.5 m -87.15 117.73 26.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 122.021 0.915 . . . . 0.0 109.058 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 m -59.8 133.84 56.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.4 130.33 94.6 Favored Pre-proline 0 C--N 1.356 0.883 0 O-C-N 119.86 -1.775 . . . . 0.0 113.21 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 137.03 3.46 Favored 'Trans proline' 0 C--O 1.235 0.356 0 CA-C-N 122.701 2.0 . . . . 0.0 112.528 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 m -94.88 -9.33 34.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.85 1.26 . . . . 0.0 112.307 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -105.93 25.41 10.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.986 0.898 . . . . 0.0 111.061 -167.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.62 141.71 82.9 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.31 153.0 18.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.596 3.53 . . . . 0.0 116.822 166.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -58.86 107.42 0.52 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.04 -2.83 33.46 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.165 0.888 . . . . 0.0 111.923 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.52 131.44 55.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.346 -1.09 . . . . 0.0 109.587 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.96 9.63 8.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 O-C-N 120.182 -1.573 . . . . 0.0 111.861 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 t -158.6 162.11 37.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -157.47 156.21 31.71 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.93 -1.106 . . . . 0.0 109.291 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -122.35 106.39 11.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -107.37 115.17 29.68 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.983 -1.073 . . . . 0.0 111.427 -163.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 91.7 m -65.33 -45.44 84.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.55 122.65 88.0 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 125.614 1.566 . . . . 0.0 112.849 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.72 -9.53 19.79 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.427 2.26 . . . . 0.0 113.127 -168.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -64.99 -34.77 79.24 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 112.539 168.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 m -95.89 -8.82 32.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.097 1.359 . . . . 0.0 109.326 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.17 133.05 48.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.38 -1.45 . . . . 0.0 112.22 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.84 8.43 44.18 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.72 -1.237 . . . . 0.0 110.983 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.11 -176.26 4.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -77.59 -22.93 50.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.347 -1.471 . . . . 0.0 114.327 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -156.93 163.7 38.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.008 0.909 . . . . 0.0 108.716 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.5 t -138.95 130.07 26.7 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 120.551 -1.343 . . . . 0.0 107.99 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -38.79 155.18 0.02 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 130.891 3.676 . . . . 0.0 118.85 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.9 t -83.24 65.1 8.09 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 110.656 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.4 mm -95.4 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 58.73 36.92 25.11 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -94.95 -0.15 54.16 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.769 -1.207 . . . . 0.0 114.11 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.11 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 O-C-N 119.726 -1.859 . . . . 0.0 112.858 168.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -37.7 153.64 0.02 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -177.3 -3.74 0.02 OUTLIER Glycine 0 C--N 1.356 1.642 0 O-C-N 119.804 -1.81 . . . . 0.0 116.738 -169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -145.43 135.24 23.53 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.21 -1.759 . . . . 0.0 109.914 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.0 tp 104.11 126.78 0.01 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 127.851 2.46 . . . . 0.0 106.345 -165.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . 0.315 22.5 mt-10 40.89 40.33 0.98 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 118.124 2.638 . . . . 0.0 118.124 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.01 24.19 12.4 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 168.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.2 p -58.88 130.74 48.41 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.589 ' HA ' ' CE1' ' A' ' 228' ' ' HIS . 30.8 ptt180 -151.22 143.39 24.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.139 -1.601 . . . . 0.0 110.69 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -130.73 -166.93 1.76 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 122.772 1.272 . . . . 0.0 110.03 -167.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.556 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 92.3 mttt -89.96 -0.86 57.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.29 -1.506 . . . . 0.0 110.796 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.1 p -96.71 12.74 30.83 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.984 1.714 . . . . 0.0 110.848 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 224' ' ' ARG . 8.1 m80 -92.18 83.96 5.17 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 165.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.33 122.44 35.73 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.35 122.92 21.98 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 120.567 -1.333 . . . . 0.0 110.729 154.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.996 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -157.43 168.48 27.2 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 171.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 14' ' ' ASP 0.307 26.0 mt 67.13 37.93 3.58 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.08 110.6 15.98 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -124.62 16.18 8.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 109.763 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.02 113.24 26.06 Favored 'General case' 0 N--CA 1.435 -1.18 0 O-C-N 121.209 -0.932 . . . . 0.0 110.514 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 71.67 44.42 0.51 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-O 122.408 1.099 . . . . 0.0 113.539 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -114.66 141.5 47.72 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.78 -1.2 . . . . 0.0 108.675 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.535 ' CE1' ' H ' ' A' ' 50' ' ' ARG . 30.4 t60 54.55 26.78 7.63 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 128.072 2.549 . . . . 0.0 114.871 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 pt -63.84 140.22 20.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 119.156 -2.215 . . . . 0.0 112.713 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m 63.78 73.07 0.45 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.629 1.204 . . . . 0.0 114.043 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.425 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 28.4 t60 -76.67 170.67 16.0 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.629 -1.295 . . . . 0.0 111.894 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' N ' ' CG ' ' A' ' 24' ' ' HIS . 2.6 t70 -66.14 148.28 52.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.342 1.457 . . . . 0.0 112.815 166.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -96.48 145.21 29.18 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 120.738 -1.226 . . . . 0.0 110.991 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -61.68 150.75 84.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.349 2.699 . . . . 0.0 114.444 169.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 142.11 96.87 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.37 141.92 18.11 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 115.909 158.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -61.33 -40.26 93.57 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.29 136.73 96.88 Favored Pre-proline 0 C--N 1.352 0.686 0 O-C-N 120.366 -1.458 . . . . 0.0 112.269 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.95 117.42 3.54 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 123.005 2.47 . . . . 0.0 114.457 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.39 155.31 36.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.275 88.2 mttt 76.6 11.38 2.66 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.619 1.168 . . . . 0.0 113.613 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -49.34 -34.49 15.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 129.195 2.998 . . . . 0.0 114.933 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.04 -42.11 97.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.348 -1.47 . . . . 0.0 114.96 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.83 -49.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 O-C-N 120.981 -1.074 . . . . 0.0 112.358 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.2 t -158.08 150.17 21.95 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.4 p -102.58 -10.68 19.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 120.989 -1.069 . . . . 0.0 111.368 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -121.39 -2.34 8.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.26 62.5 m 84.77 22.41 0.1 Allowed 'General case' 0 C--N 1.347 0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 114.809 166.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.49 -39.1 89.74 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -169.45 105.01 0.36 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.12 0.968 . . . . 0.0 109.032 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -94.02 -21.31 19.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 119.986 -1.696 . . . . 0.0 113.074 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -170.79 171.68 6.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.552 -1.342 . . . . 0.0 110.84 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.66 129.79 40.53 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 15.8 tt -68.58 125.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 125.422 1.489 . . . . 0.0 113.706 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -101.11 3.66 41.43 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 119.387 -2.071 . . . . 0.0 114.421 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 m -65.63 111.42 3.16 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.943 -1.723 . . . . 0.0 113.484 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' H ' ' CE1' ' A' ' 21' ' ' HIS . 36.9 mtm180 -126.59 165.46 19.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -157.32 155.65 31.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 119.685 -1.885 . . . . 0.0 107.945 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.51 148.57 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 128.121 2.569 . . . . 0.0 114.533 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -124.48 96.08 41.94 Favored Pre-proline 0 CA--C 1.501 -0.935 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.295 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.28 122.03 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.267 1.978 . . . . 0.0 110.982 154.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -133.56 158.14 43.92 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.886 0.874 . . . . 0.0 108.834 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 173.67 15.17 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 172.32 71.88 0.0 OUTLIER 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.907 1.283 . . . . 0.0 113.636 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -103.07 19.81 18.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.111 -0.993 . . . . 0.0 113.262 -168.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -114.93 141.55 47.8 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 119.854 -1.779 . . . . 0.0 107.706 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.56 140.35 58.86 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.107 -1.621 . . . . 0.0 112.211 168.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -108.55 -0.01 20.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.908 -1.12 . . . . 0.0 111.577 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.9 69.16 0.76 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.039 1.736 . . . . 0.0 113.858 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 81.0 147.65 0.09 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 127.353 2.261 . . . . 0.0 113.734 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -67.6 101.11 0.96 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.375 1.07 . . . . 0.0 111.166 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -162.86 163.43 26.46 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.058 -1.026 . . . . 0.0 108.591 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.61 96.37 6.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.105 -0.997 . . . . 0.0 109.014 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.7 m -73.97 -23.86 59.54 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.982 -1.699 . . . . 0.0 112.774 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.23 124.02 53.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -148.85 141.79 24.76 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.815 0.816 . . . . 0.0 110.909 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.8 mt -61.48 -46.47 96.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 126.35 1.86 . . . . 0.0 112.363 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.78 173.72 9.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.64 111.3 19.95 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.202 -1.561 . . . . 0.0 112.449 -165.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.65 17.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.907 -1.12 . . . . 0.0 111.873 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -136.56 151.8 49.78 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.806 -1.809 . . . . 0.0 110.72 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -59.81 -41.36 85.36 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-O 123.158 1.456 . . . . 0.0 112.252 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -162.75 177.29 9.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.37 160.71 28.71 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -57.7 -36.39 71.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.364 3.065 . . . . 0.0 112.854 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -15.32 60.93 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.863 1.265 . . . . 0.0 113.088 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.65 68.79 Favored Glycine 0 C--N 1.352 1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 113.786 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 pt -116.7 17.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 125.482 1.513 . . . . 0.0 110.537 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -149.51 159.83 43.98 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.37 1.89 8.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.98 8.11 43.92 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.157 -1.589 . . . . 0.0 110.58 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -156.25 145.47 20.59 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.308 -1.495 . . . . 0.0 107.99 -168.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -140.26 -21.57 0.85 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.145 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.6 m -71.21 116.15 11.18 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 120.837 -1.165 . . . . 0.0 113.373 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -58.63 126.53 28.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 55.28 41.72 31.01 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 125.171 1.388 . . . . 0.0 113.413 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -59.64 -42.25 92.34 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -83.2 10.69 7.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.633 1.573 . . . . 0.0 110.776 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -112.36 0.45 15.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.437 1.495 . . . . 0.0 111.346 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.9 177.08 13.63 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 125.512 1.529 . . . . 0.0 116.25 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -66.64 132.83 49.0 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 120.205 -1.762 . . . . 0.0 115.066 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 57.48 175.32 0.05 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 126.775 2.03 . . . . 0.0 116.015 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . 0.286 67.7 m-70 80.19 49.98 0.03 OUTLIER 'General case' 0 C--N 1.349 0.575 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 164.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.18 122.59 38.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.799 -1.188 . . . . 0.0 109.755 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . 0.348 39.4 t 78.09 -56.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 126.858 2.063 . . . . 0.0 113.937 174.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.8 t -151.01 139.24 20.24 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.177 0.899 . . . . 0.0 109.961 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.9 p -173.1 -178.99 1.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.49 1.516 . . . . 0.0 108.594 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt 66.36 -156.64 0.25 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.561 1.944 . . . . 0.0 114.118 -173.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.39 -31.89 11.09 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -159.78 156.59 27.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.702 2.001 . . . . 0.0 107.431 171.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.42 140.59 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.576 1.15 . . . . 0.0 113.632 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.06 -45.61 91.37 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . 0.298 87.0 m-70 62.47 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.847 1.259 . . . . 0.0 113.862 -169.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -148.0 -8.36 0.41 Allowed 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.462 -1.399 . . . . 0.0 112.209 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.91 117.96 35.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.44 -1.412 . . . . 0.0 107.802 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.07 -47.8 81.4 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 120.486 -1.383 . . . . 0.0 112.309 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -61.33 145.51 51.23 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 128.534 2.733 . . . . 0.0 113.474 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 p -91.25 -1.08 57.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.674 0.79 . . . . 0.0 111.243 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 62.27 43.08 8.68 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.921 1.288 . . . . 0.0 112.99 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -85.23 121.68 28.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.65 0.78 . . . . 0.0 112.615 -170.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 51.5 m -61.1 106.06 0.56 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.086 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.9 pt -49.29 159.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -68.97 133.98 48.89 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.644 1.578 . . . . 0.0 111.483 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.14 -41.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 124.466 1.106 . . . . 0.0 113.34 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.1 m -106.53 105.72 15.88 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.604 1.192 . . . . 0.0 108.596 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.9 m -78.32 122.88 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 120.442 -1.411 . . . . 0.0 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.7 t -88.45 115.04 62.18 Favored Pre-proline 0 N--CA 1.447 -0.615 0 O-C-N 121.165 -0.959 . . . . 0.0 108.994 168.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.69 -16.81 18.53 Favored 'Trans proline' 0 CA--C 1.513 -0.573 0 C-N-CA 123.399 2.733 . . . . 0.0 111.499 -170.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.8 m -73.19 -19.4 61.11 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.71 1.604 . . . . 0.0 111.326 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -115.27 -42.77 3.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 124.171 0.988 . . . . 0.0 111.004 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.14 145.43 96.81 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -35.15 114.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 124.799 3.666 . . . . 0.0 119.066 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 47.93 42.5 16.42 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 88.57 16.01 59.18 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 120.434 -1.416 . . . . 0.0 113.15 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 67.39 39.94 2.82 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.119 1.368 . . . . 0.0 113.966 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.64 -2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 CA-C-O 122.762 1.268 . . . . 0.0 111.559 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.1 t -154.27 156.36 36.87 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 169.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 99.7 m -143.16 132.09 22.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.55 148.43 41.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -82.6 50.97 1.76 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.336 -0.852 . . . . 0.0 109.466 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 67.4 m -146.08 139.92 26.37 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -57.47 138.78 81.28 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.874 1.27 . . . . 0.0 114.026 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -58.97 149.53 78.59 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 115.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -89.72 -36.1 15.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.362 1.077 . . . . 0.0 111.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.7 p -133.85 158.27 43.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -54.55 -42.91 71.49 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.557 1.143 . . . . 0.0 113.312 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -102.58 106.64 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.58 156.72 16.56 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 123.243 1.497 . . . . 0.0 113.402 -165.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.15 147.46 46.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 123.176 1.465 . . . . 0.0 111.497 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.32 -37.59 83.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 119.569 -1.957 . . . . 0.0 113.221 162.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.7 m -55.41 129.85 40.29 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 114.527 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.25 47.7 m-20 80.55 132.63 0.06 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.794 2.038 . . . . 0.0 114.525 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -97.66 154.97 17.21 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.043 -1.661 . . . . 0.0 111.279 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.3 tt -126.62 113.58 33.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 124.539 1.135 . . . . 0.0 109.191 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . 0.45 31.2 ttm180 62.88 64.01 0.91 Allowed 'General case' 0 C--N 1.352 0.704 1 O-C-N 116.067 -4.146 . . . . 0.0 114.884 4.477 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -73.16 68.75 1.01 Allowed 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.393 -1.442 . . . . 0.0 113.69 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t -128.53 128.54 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -154.14 159.38 41.42 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.28 25.33 55.11 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.445 -0.785 . . . . 0.0 112.6 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.63 138.81 53.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.477 1.511 . . . . 0.0 108.253 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.5 -41.72 97.72 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -127.6 137.01 52.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 122.648 1.213 . . . . 0.0 110.094 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -83.38 91.85 7.43 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.3 -1.5 . . . . 0.0 113.3 -168.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.2 m 70.61 45.27 0.6 Allowed 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.543 1.639 . . . . 0.0 110.08 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -153.15 161.15 42.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -28.84 130.47 0.06 Allowed 'General case' 0 C--N 1.353 0.753 0 N-CA-C 121.222 3.786 . . . . 0.0 121.222 -166.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -62.29 150.5 39.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 117.399 -3.313 . . . . 0.0 115.394 -7.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.2 p -140.49 148.99 41.94 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 71.73 38.1 1.0 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 124.2 20.37 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.548 1.139 . . . . 0.0 111.696 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -133.62 153.83 51.36 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 119.891 -1.756 . . . . 0.0 114.897 -163.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.454 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -75.2 153.64 38.02 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.002 1.901 . . . . 0.0 112.697 -162.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.1 125.57 27.14 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.05 126.88 50.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -134.59 -17.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 121.693 -0.629 . . . . 0.0 111.981 -174.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.72 -173.92 0.07 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.754 1.622 . . . . 0.0 115.005 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -125.34 9.28 7.88 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.692 -1.255 . . . . 0.0 108.281 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -65.17 145.48 56.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.942 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -138.59 166.85 23.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.046 -1.034 . . . . 0.0 108.329 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.9 pt -98.62 -7.0 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -163.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 p -83.69 147.13 27.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 119.446 -2.033 . . . . 0.0 114.571 -170.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -72.8 -31.42 64.83 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.978 -1.701 . . . . 0.0 113.457 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.276 56.4 m-20 60.8 42.05 13.87 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 127.637 2.375 . . . . 0.0 114.312 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -147.93 154.17 43.11 Favored Pre-proline 0 C--N 1.354 0.769 0 C-N-CA 126.111 1.764 . . . . 0.0 106.551 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.49 147.22 0.25 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 124.078 3.185 . . . . 0.0 117.708 161.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -63.28 139.99 97.64 Favored Pre-proline 0 N--CA 1.436 -1.138 0 C-N-CA 123.942 0.897 . . . . 0.0 113.192 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 137.37 4.01 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 121.97 1.78 . . . . 0.0 109.855 -168.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 p -76.49 -20.0 57.43 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 121.402 -0.811 . . . . 0.0 112.92 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.72 149.5 95.25 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.814 1.245 . . . . 0.0 113.935 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.63 82.03 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.852 3.035 . . . . 0.0 119.138 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -104.08 -2.06 26.46 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 119.888 -1.757 . . . . 0.0 113.465 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.12 -40.58 85.87 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -165.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -103.27 17.54 23.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.949 -1.094 . . . . 0.0 110.553 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -110.44 3.72 19.91 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 120.49 -1.381 . . . . 0.0 113.528 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -59.84 143.76 13.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.0 m -89.34 -2.5 58.46 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.022 -1.049 . . . . 0.0 112.379 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.5 p -103.65 15.15 29.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -59.06 135.65 23.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.635 1.174 . . . . 0.0 112.38 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 t -76.31 145.67 39.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.89 -0.95 57.64 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 110.657 170.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 72.22 11.49 5.91 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.982 2.113 . . . . 0.0 114.768 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -99.22 -15.0 19.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 119.893 -1.754 . . . . 0.0 111.974 -169.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -170.87 174.6 4.77 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.906 -1.747 . . . . 0.0 109.135 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -61.36 120.2 9.98 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 120.693 -1.255 . . . . 0.0 111.754 163.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.71 156.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 128.381 2.672 . . . . 0.0 114.484 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -165.75 171.78 12.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.697 -1.252 . . . . 0.0 107.911 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 p -60.75 149.8 34.47 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -89.22 45.98 1.34 Allowed 'General case' 0 C--N 1.355 0.821 0 O-C-N 119.762 -1.836 . . . . 0.0 109.102 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.5 t -92.82 -177.16 4.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.676 1.99 . . . . 0.0 111.69 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.41 153.36 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 125.516 1.526 . . . . 0.0 112.395 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -130.93 144.25 52.76 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 121.112 -0.992 . . . . 0.0 109.675 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.78 160.92 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.682 3.588 . . . . 0.0 117.884 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HE ' ' CB ' ' A' ' 115' ' ' SER . 78.3 mtt180 -134.04 162.62 31.59 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 175.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.93 167.66 10.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -120.85 108.77 14.33 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.384 -1.447 . . . . 0.0 113.767 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 121.9 22.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.714 -0.616 . . . . 0.0 110.481 154.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -78.28 -18.95 54.59 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.46 -1.4 . . . . 0.0 112.076 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -143.96 126.63 16.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -131.7 157.16 44.49 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -58.75 145.51 40.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.91 126.72 36.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -61.14 125.62 24.41 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.772 1.629 . . . . 0.0 114.548 -163.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -114.69 13.17 17.3 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 121.416 -0.803 . . . . 0.0 111.126 168.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.47 43.31 13.27 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 164.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 p -155.69 168.94 25.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.87 15.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-O 122.833 1.301 . . . . 0.0 108.724 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.85 17.58 14.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.447 1.899 . . . . 0.0 108.715 -168.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.79 0.83 10.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 126.014 1.726 . . . . 0.0 111.72 -172.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.8 165.74 34.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -117.15 123.18 46.08 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.936 -1.728 . . . . 0.0 108.474 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.62 -5.58 10.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 O-C-N 120.761 -1.212 . . . . 0.0 110.899 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 56.45 30.9 17.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 119.295 3.072 . . . . 0.0 119.295 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.91 12.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 CA-C-O 124.139 1.923 . . . . 0.0 111.46 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -164.72 175.47 9.68 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -86.09 139.79 30.81 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.526 1.057 . . . . 0.0 109.933 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.7 175.19 6.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.728 1.211 . . . . 0.0 112.053 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -80.8 -5.64 57.47 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 125.518 1.527 . . . . 0.0 111.496 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.67 -179.14 46.35 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 123.589 1.66 . . . . 0.0 113.538 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.5 pt -86.51 169.56 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.681 0 O-C-N 119.856 -1.967 . . . . 0.0 111.646 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -147.11 176.65 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -55.91 141.77 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.9 0.88 . . . . 0.0 112.625 167.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.13 -14.99 21.15 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.79 -1.194 . . . . 0.0 111.189 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.82 145.9 43.78 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 122.746 1.26 . . . . 0.0 113.494 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -64.66 138.67 58.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.198 -1.564 . . . . 0.0 110.862 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.2 t -151.13 144.68 24.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -99.23 5.14 46.8 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.827 0.823 . . . . 0.0 109.661 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -130.55 136.12 48.6 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.776 1.23 . . . . 0.0 108.598 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -104.48 120.97 42.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 25.4 tt0 67.78 14.03 9.36 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.889 1.276 . . . . 0.0 112.516 171.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 m120 64.13 45.05 4.23 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.603 1.961 . . . . 0.0 113.684 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.04 28.68 2.58 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' GLU . 1.8 t -64.24 141.82 58.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.653 1.692 . . . . 0.0 113.895 169.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.78 -42.37 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . 0.284 97.9 m-70 81.74 101.27 0.06 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.419 2.288 . . . . 0.0 110.268 -165.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.16 87.05 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -163.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.3 t 35.77 62.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 128.338 2.655 . . . . 0.0 114.191 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.4 ' CB ' ' HE ' ' A' ' 55' ' ' ARG . 25.3 m -159.14 1.85 0.09 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 119.839 -1.788 . . . . 0.0 113.871 -168.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -61.73 -45.6 93.23 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 120.027 -1.671 . . . . 0.0 113.553 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt -145.74 149.26 34.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.254 1.422 . . . . 0.0 108.417 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.36 -33.44 6.84 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -80.12 116.96 20.52 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 118.6 1.2 . . . . 0.0 109.24 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.1 t -64.55 -47.18 90.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-O 121.922 0.868 . . . . 0.0 113.291 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -160.74 157.67 27.33 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 170.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -121.19 6.03 10.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.824 0.821 . . . . 0.0 110.882 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t -154.32 167.53 29.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 119.706 -1.871 . . . . 0.0 106.094 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.55 146.65 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.423 1.106 . . . . 0.0 112.792 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.47 156.15 20.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.766 1.27 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -130.85 166.58 20.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 m -39.43 -29.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.022 2.929 . . . . 0.0 118.354 -166.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.72 11.83 5.74 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.9 pttp 167.0 156.66 0.03 OUTLIER 'General case' 0 C--N 1.359 0.999 0 CA-C-N 121.081 1.764 . . . . 0.0 112.259 -169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.2 t -52.88 145.76 12.02 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.406 1.882 . . . . 0.0 113.11 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.8 pt -125.83 138.93 52.93 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 120.343 -1.473 . . . . 0.0 110.482 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.4 126.13 31.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 119.969 -1.707 . . . . 0.0 112.203 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.02 -43.51 13.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 110.635 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.5 p -138.91 118.96 13.39 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.6 m -63.74 131.43 47.85 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.44 1.496 . . . . 0.0 112.987 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.9 t -95.49 111.97 57.26 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 120.919 -1.113 . . . . 0.0 108.631 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.25 -28.56 10.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 CA-C-N 122.266 1.845 . . . . 0.0 113.234 -163.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 t -160.56 158.4 29.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 119.492 1.042 . . . . 0.0 110.821 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -120.36 17.03 12.23 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.041 1.736 . . . . 0.0 111.226 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 127.5 83.24 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-O 118.188 -0.91 . . . . 0.0 112.629 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -59.74 93.98 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 166.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.97 149.34 27.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -64.0 -21.49 65.77 Favored Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.71 8.59 43.03 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 118.36 1.08 . . . . 0.0 113.285 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.02 131.0 43.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 120.33 -1.481 . . . . 0.0 110.22 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -60.26 -32.98 71.67 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.844 2.058 . . . . 0.0 115.976 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.8 p -77.14 -15.03 59.69 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 120.382 -1.449 . . . . 0.0 112.85 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -74.06 -22.91 59.34 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 120.975 -1.078 . . . . 0.0 111.991 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.9 -37.37 84.34 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.097 -1.627 . . . . 0.0 114.221 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -84.44 -20.13 32.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.403 1.081 . . . . 0.0 111.219 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.73 150.38 95.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.445 1.098 . . . . 0.0 112.566 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 -2.58 12.52 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.582 2.188 . . . . 0.0 113.226 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 68.9 39.76 1.8 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-N 120.402 1.456 . . . . 0.0 114.173 166.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.1 p -119.72 138.54 53.24 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.683 0.793 . . . . 0.0 109.509 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 76.91 45.5 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.337 1.455 . . . . 0.0 111.413 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.88 -16.14 58.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.808 -1.183 . . . . 0.0 113.536 -162.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -33.83 74.53 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 128.616 2.767 . . . . 0.0 112.533 174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.93 139.27 58.75 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -57.61 -34.53 69.36 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 t -149.88 142.98 25.0 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.158 -1.589 . . . . 0.0 107.384 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -114.18 19.06 16.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.915 1.286 . . . . 0.0 109.635 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.9 m -60.02 135.82 57.83 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.991 -1.068 . . . . 0.0 112.433 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 29.2 pt -62.66 148.56 10.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 64.77 44.45 3.72 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -59.08 148.19 32.07 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.573 1.149 . . . . 0.0 112.123 173.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.85 133.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 120.787 -1.196 . . . . 0.0 112.147 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 215' ' ' HIS . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 193' ' ' GLY . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 56.07 32.38 19.91 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.26 2.15 46.6 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 -173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.186 -2.361 . . . . 0.0 114.733 -166.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.1 mt -102.93 10.74 38.1 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.524 -1.36 . . . . 0.0 110.004 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.75 114.27 6.21 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -69.36 -42.51 75.12 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.058 -1.651 . . . . 0.0 113.417 164.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.3 t -166.09 159.84 15.78 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.447 77.7 mtt180 74.7 51.28 0.09 Allowed 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 169.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . 0.314 48.7 t80 25.43 84.05 0.01 OUTLIER 'General case' 0 C--N 1.35 0.606 0 C-N-CA 130.795 3.638 . . . . 0.0 119.105 166.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.55 2.19 33.17 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.1 m -61.27 -46.41 90.48 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -89.86 38.12 0.91 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.485 -1.384 . . . . 0.0 113.34 -166.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -59.75 128.2 35.77 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.706 1.241 . . . . 0.0 114.134 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.83 28.89 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.505 0 CA-C-O 118.732 -1.038 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.49 143.62 26.26 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 119.264 1.532 . . . . 0.0 107.202 164.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -116.57 148.37 40.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.56 166.43 28.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 122.833 1.302 . . . . 0.0 111.986 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.82 144.77 51.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.601 1.56 . . . . 0.0 112.303 171.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.61 146.72 30.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.472 -1.392 . . . . 0.0 108.882 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -151.44 144.52 24.61 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.48 159.2 42.24 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.792 0.806 . . . . 0.0 111.358 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 113.658 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.341 2.2 mt 51.26 63.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 126.895 2.078 . . . . 0.0 115.807 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.8 p -79.55 156.61 27.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.218 -1.551 . . . . 0.0 109.138 164.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -164.15 -1.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.293 41.3 m-20 61.33 37.59 16.92 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 42.21 60.24 9.56 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.39 135.22 46.69 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.507 2.805 . . . . 0.0 115.921 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.01 -42.02 92.94 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.44 -20.57 18.13 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 126.193 3.248 . . . . 0.0 113.409 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 p -101.96 17.64 22.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.974 0.91 . . . . 0.0 110.577 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.21 142.59 66.81 Favored Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 126.372 1.869 . . . . 0.0 115.144 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -39.98 135.58 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.539 1 C-N-CA 125.336 4.024 . . . . 0.0 117.471 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -158.24 8.4 0.14 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.045 0.839 . . . . 0.0 112.376 -173.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -147.48 133.4 19.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.336 -1.478 . . . . 0.0 113.712 -169.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.12 148.91 45.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.154 1.382 . . . . 0.0 111.493 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -112.02 120.14 40.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.581 -1.324 . . . . 0.0 108.343 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.62 123.92 66.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.2 m -135.32 -19.86 1.66 Allowed 'General case' 0 C--N 1.348 0.525 0 O-C-N 122.103 -0.373 . . . . 0.0 111.174 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 m 69.22 34.77 2.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.711 1.719 . . . . 0.0 113.193 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.62 162.21 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 126.801 2.041 . . . . 0.0 107.314 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -66.63 132.0 47.21 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.115 1.366 . . . . 0.0 114.49 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 50.89 54.49 11.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 163.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -104.88 -1.31 26.12 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 119.052 -2.28 . . . . 0.0 114.399 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -148.56 115.04 5.92 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.057 -1.652 . . . . 0.0 106.889 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 70.21 59.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 116.827 -3.67 . . . . 0.0 116.172 -11.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -64.97 -34.84 79.4 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.83 -1.794 . . . . 0.0 110.869 161.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -57.18 129.16 18.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 129.034 2.934 . . . . 0.0 114.199 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -61.27 121.7 13.24 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 124.044 0.938 . . . . 0.0 111.939 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.8 p -108.43 -1.84 19.53 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.848 -1.782 . . . . 0.0 113.44 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -133.59 109.65 9.37 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 120.43 -1.419 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.2 t -140.79 130.91 24.78 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.038 -2.914 . . . . 0.0 106.631 -20.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.17 1.08 5.48 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 124.248 1.019 . . . . 0.0 111.597 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 40.26 63.37 5.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 120.15 3.389 . . . . 0.0 120.15 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.52 126.54 22.62 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.33 2.687 . . . . 0.0 114.481 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -149.42 146.06 27.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.56 175.7 11.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -139.51 125.81 20.17 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.431 -1.418 . . . . 0.0 109.961 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -124.96 19.41 8.43 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 120.499 -1.376 . . . . 0.0 113.697 -168.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 67.03 -179.93 0.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -64.03 136.51 57.36 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 126.316 1.846 . . . . 0.0 113.274 166.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -76.43 -24.53 53.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.515 1.126 . . . . 0.0 112.565 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -85.07 113.38 21.43 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 163.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.21 -11.33 0.05 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.059 -0.401 . . . . 0.0 111.565 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.51 161.36 14.68 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -157.23 -11.82 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 121.094 -1.004 . . . . 0.0 113.356 171.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 57.85 -153.34 0.38 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 m -91.61 16.7 10.0 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 120.828 -1.17 . . . . 0.0 111.547 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.79 112.27 8.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 125.132 1.373 . . . . 0.0 112.411 174.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 76.15 141.19 0.07 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.01 1.724 . . . . 0.0 114.394 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 pt -58.85 152.8 3.81 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 O-C-N 120.458 -1.401 . . . . 0.0 112.171 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 92' ' ' ARG . 45.8 mt-10 -90.56 2.99 55.28 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 119.937 -1.727 . . . . 0.0 113.197 -168.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m120 60.51 41.99 14.92 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.977 2.111 . . . . 0.0 115.721 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.18 157.22 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 C-N-CA 124.365 1.066 . . . . 0.0 108.311 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -77.99 -32.66 51.34 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.8 tp -154.7 150.94 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 87' ' ' GLU . 25.4 mmt180 -119.41 127.07 52.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 165.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -69.35 -31.6 70.14 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -137.26 153.41 50.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -114.18 5.51 15.93 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 120.784 -1.198 . . . . 0.0 111.386 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.23 -2.44 19.99 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 118.118 2.007 . . . . 0.0 118.118 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.259 9.9 mm 70.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.262 1.825 . . . . 0.0 113.549 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.82 132.08 36.71 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 118.727 -2.483 . . . . 0.0 109.953 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 pt -151.11 14.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.647 0 C-N-CA 125.37 1.468 . . . . 0.0 111.885 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.28 42.5 m-20 53.2 53.81 11.28 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -175.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -126.97 109.2 11.66 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.708 -1.87 . . . . 0.0 113.091 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.8 mttp 72.97 44.32 0.36 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.837 1.655 . . . . 0.0 110.547 -168.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.7 p -108.62 -1.41 19.59 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.473 1.109 . . . . 0.0 110.891 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.39 144.8 50.06 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 128.408 2.683 . . . . 0.0 111.944 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -119.09 0.34 11.24 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.968 -1.083 . . . . 0.0 111.902 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -67.18 115.91 7.39 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.347 -1.471 . . . . 0.0 113.008 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -89.56 125.2 35.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.017 -1.677 . . . . 0.0 110.872 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -129.93 140.55 50.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 119.429 -2.045 . . . . 0.0 109.804 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.55 32.59 41.45 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 120.509 -1.369 . . . . 0.0 112.845 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -119.86 162.11 19.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 127.4 2.28 . . . . 0.0 107.003 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.294 32.2 m-85 73.51 37.33 0.71 Allowed 'General case' 0 C--N 1.354 0.79 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -109.04 108.73 19.55 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.793 -1.192 . . . . 0.0 111.046 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 61.02 51.09 4.65 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.913 1.685 . . . . 0.0 114.957 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.35 141.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.76 1.743 . . . . 0.0 112.686 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 t -158.75 165.52 34.12 Favored 'General case' 0 C--N 1.356 0.853 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -149.76 172.77 14.58 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 120.143 1.338 . . . . 0.0 112.237 -160.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.37 143.04 54.05 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 128.971 2.908 . . . . 0.0 114.649 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.37 68.57 0.49 Allowed Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -60.42 -42.75 96.65 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.755 -0.85 . . . . 0.0 113.236 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.525 35.6 m 41.65 -125.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 128.501 2.72 . . . . 0.0 118.322 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -141.95 30.28 1.64 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 120.024 1.284 . . . . 0.0 111.131 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -81.63 132.24 35.29 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 119.178 -2.201 . . . . 0.0 108.432 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -158.11 171.61 19.92 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 120.645 -1.284 . . . . 0.0 107.921 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -45.19 156.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 131.152 3.781 . . . . 0.0 117.701 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -71.59 129.72 39.42 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.161 -0.962 . . . . 0.0 111.082 164.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 91.2 p -69.05 145.59 53.36 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.7 m -63.45 111.3 2.26 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.484 1.113 . . . . 0.0 109.73 156.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -97.95 139.35 33.92 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 120.711 -1.243 . . . . 0.0 111.151 -169.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -102.42 -8.41 21.15 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.807 -1.183 . . . . 0.0 112.556 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 t -160.73 169.5 22.65 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.6 tt -116.33 126.96 74.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 108.577 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.93 -10.11 20.93 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.902 -1.123 . . . . 0.0 113.755 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.26 132.05 33.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 O-C-N 120.707 -1.246 . . . . 0.0 111.354 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.4 p -71.78 149.83 44.97 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.3 t -82.41 158.32 23.35 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.354 -1.467 . . . . 0.0 110.144 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.56 137.75 94.9 Favored Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 130.8 41.85 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.819 3.013 . . . . 0.0 112.78 154.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.7 t -85.4 -21.91 28.6 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.03 1.286 . . . . 0.0 112.441 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -145.59 26.89 1.25 Allowed 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.94 -1.725 . . . . 0.0 112.81 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.57 125.82 86.9 Favored Pre-proline 0 C--N 1.353 0.734 0 O-C-N 119.115 -2.24 . . . . 0.0 112.413 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.78 126.11 20.83 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.231 2.621 . . . . 0.0 115.604 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -60.8 -42.94 98.59 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.74 -166.29 46.75 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.92 -1.112 . . . . 0.0 114.544 -167.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.8 143.54 56.14 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.27 109.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -77.45 -30.54 53.33 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.035 -1.666 . . . . 0.0 112.545 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.0 m -142.73 127.85 18.58 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 111.102 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -83.33 98.86 9.68 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.147 170.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -63.26 -44.94 93.73 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.2 m -108.64 -9.42 15.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 118.776 -2.453 . . . . 0.0 109.845 -16.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -70.62 150.7 95.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.613 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -55.57 131.85 48.6 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 123.295 2.663 . . . . 0.0 114.188 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -112.64 2.57 16.21 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.8 m 11.75 77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 130.292 3.437 . . . . 0.0 117.196 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.67 115.53 23.41 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.747 -1.22 . . . . 0.0 108.558 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -115.52 5.06 14.35 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.519 -0.738 . . . . 0.0 112.885 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -64.75 -50.05 68.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.205 1.002 . . . . 0.0 113.56 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -69.43 -33.83 73.54 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.25 -20.51 34.38 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.585 -1.947 . . . . 0.0 114.175 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -102.91 107.87 18.85 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 118.97 -2.331 . . . . 0.0 111.475 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.64 146.79 29.44 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -115.99 124.46 50.57 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 120.775 -1.203 . . . . 0.0 111.215 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.08 -42.32 95.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.0 156.53 29.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.028 -2.295 . . . . 0.0 105.497 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -144.59 175.75 9.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.116 -0.99 . . . . 0.0 111.426 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -127.55 152.82 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -139.73 24.42 2.42 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.25 -6.08 73.81 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.472 -2.018 . . . . 0.0 114.53 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -151.73 174.77 13.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.265 1.826 . . . . 0.0 107.961 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.5 mt -108.04 25.77 11.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 122.748 1.261 . . . . 0.0 111.211 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -55.95 -41.47 74.74 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.85 2.06 . . . . 0.0 115.682 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -128.47 16.26 6.53 Favored 'General case' 0 C--N 1.344 0.336 0 O-C-N 119.109 -2.244 . . . . 0.0 111.921 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.9 t -165.42 153.78 11.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -172.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -113.1 8.14 18.23 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.238 -0.914 . . . . 0.0 111.978 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -138.77 149.08 44.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -140.08 -19.69 0.89 Allowed 'General case' 0 C--N 1.35 0.629 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.8 m -79.54 112.43 16.79 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.651 -1.281 . . . . 0.0 113.061 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.46 18.32 12.11 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.665 1.221 . . . . 0.0 110.554 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.41 102.99 13.19 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.241 1.816 . . . . 0.0 111.117 -160.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -174.79 47.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.13 0 CA-C-O 118.091 -1.394 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -147.35 167.75 23.54 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp -123.13 117.78 26.16 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.72 147.01 23.53 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 119.913 -1.742 . . . . 0.0 113.942 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -62.57 -42.82 99.79 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.99 56.76 3.42 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 159.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -61.03 138.45 58.19 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.87 -174.24 3.21 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.711 1.205 . . . . 0.0 112.169 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -70.02 -22.08 63.13 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 118.862 -2.399 . . . . 0.0 114.874 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' ILE . 8.4 tp -156.73 157.34 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 169.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.1 m -116.81 127.97 54.83 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 168.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -152.31 147.53 26.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.73 128.78 37.88 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 26.24 66.26 0.5 Allowed Pre-proline 0 C--N 1.362 1.13 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.8 134.73 17.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.015 3.143 . . . . 0.0 117.962 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.92 -18.37 0.45 Allowed Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 120.44 3.496 . . . . 0.0 120.44 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -66.84 -26.97 44.28 Favored 'Trans proline' 0 C--N 1.351 0.705 1 CA-C-N 128.569 4.096 . . . . 0.0 114.994 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 p -106.2 8.57 32.08 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 111.234 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.74 149.74 84.05 Favored Pre-proline 0 N--CA 1.446 -0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 114.222 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -64.03 -28.77 66.05 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 121.911 1.718 . . . . 0.0 115.183 -165.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -103.01 29.53 5.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.371 1.468 . . . . 0.0 109.683 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -133.92 -65.08 0.68 Allowed 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.494 1.118 . . . . 0.0 110.536 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.07 53.38 6.77 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.344 25.1 mtpp 55.54 -122.3 1.82 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.5 pt -112.46 2.48 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 121.153 -0.967 . . . . 0.0 111.166 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 p -171.48 -4.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -167.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.267 13.7 m 62.95 64.37 0.88 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.33 1.423 . . . . 0.0 113.734 -172.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -62.92 140.4 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.506 -1.371 . . . . 0.0 113.847 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -83.87 154.59 23.36 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.7 -1.25 . . . . 0.0 109.732 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 73.67 7.59 5.01 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.691 1.71 . . . . 0.0 113.034 162.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -107.67 -39.39 5.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.445 1.098 . . . . 0.0 111.288 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -96.32 136.68 36.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.081 1.353 . . . . 0.0 112.029 -172.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.273 6.4 mmp_? 59.94 54.33 4.29 Favored 'General case' 0 C--O 1.219 -0.521 1 O-C-N 116.092 -4.13 . . . . 0.0 118.468 -13.835 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.78 -39.37 84.67 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.326 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -58.81 140.64 16.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 125.493 1.517 . . . . 0.0 112.761 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -82.04 113.58 20.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.115 -1.616 . . . . 0.0 112.495 -167.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.3 p -99.07 14.25 29.95 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 126.105 1.762 . . . . 0.0 111.897 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -107.16 155.38 19.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.105 -0.997 . . . . 0.0 108.799 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.99 16.51 11.69 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 119.53 -1.981 . . . . 0.0 113.189 5.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.84 132.43 62.87 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 O-C-N 121.05 -1.031 . . . . 0.0 110.313 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -81.41 141.73 49.53 Favored Pre-proline 0 C--N 1.36 1.029 0 O-C-N 119.73 -1.857 . . . . 0.0 112.375 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -48.52 132.75 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.595 2.863 . . . . 0.0 115.551 164.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.57 135.08 53.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.12 30.16 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -89.17 70.32 8.33 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.311 -1.493 . . . . 0.0 114.483 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -76.94 -20.8 55.71 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 119.337 -2.102 . . . . 0.0 115.158 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . 0.28 77.1 mtp180 101.56 -78.12 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 128.711 2.805 . . . . 0.0 114.516 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.47 138.5 24.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 102.98 -2.97 . . . . 0.0 102.98 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -62.97 -47.05 84.85 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 122.016 0.912 . . . . 0.0 113.095 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -79.94 124.13 28.4 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 120.206 -1.559 . . . . 0.0 110.816 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.15 135.23 28.81 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -113.0 125.0 53.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -110.69 1.07 17.69 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.668 -1.27 . . . . 0.0 112.798 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 45.71 37.59 3.48 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.198 2.199 . . . . 0.0 115.11 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.7 m -93.35 58.91 2.91 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.378 -2.076 . . . . 0.0 109.118 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -68.16 140.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 73.49 5.04 4.92 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 170.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.7 pt -62.66 138.51 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -97.72 -16.59 19.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.55 1.14 . . . . 0.0 113.278 -169.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 66.35 39.69 3.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.903 2.481 . . . . 0.0 114.463 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.3 125.15 57.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 O-C-N 120.133 -1.605 . . . . 0.0 110.951 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -118.53 33.58 5.58 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 119.901 -1.749 . . . . 0.0 114.223 -162.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.74 -0.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -169.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -61.52 149.14 39.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 119.772 -1.83 . . . . 0.0 113.918 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -57.22 -41.68 79.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 123.614 1.673 . . . . 0.0 113.489 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -85.19 4.84 32.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.987 2.915 . . . . 0.0 110.249 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -114.09 4.82 15.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 119.757 -1.839 . . . . 0.0 109.988 168.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.33 64.54 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 125.056 1.312 . . . . 0.0 115.046 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.33 6.7 mt 44.18 55.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 CA-C-O 125.167 2.413 . . . . 0.0 113.435 -177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -94.59 102.87 14.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 119.928 -1.733 . . . . 0.0 111.672 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.6 pt -78.15 -16.89 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 O-C-N 120.841 -1.162 . . . . 0.0 112.384 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 138.58 58.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 123.556 1.645 . . . . 0.0 113.987 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -162.66 171.66 16.54 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.897 2.079 . . . . 0.0 107.941 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -109.03 166.74 10.61 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.915 0.886 . . . . 0.0 110.755 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -62.73 -42.86 99.87 Favored 'General case' 0 C--N 1.344 0.359 0 O-C-N 120.766 -1.209 . . . . 0.0 113.227 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -65.21 144.14 57.37 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.85 1.26 . . . . 0.0 113.787 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -79.9 -10.94 59.83 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 120.831 -1.168 . . . . 0.0 112.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.67 142.89 55.23 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.36 150.07 23.09 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.77 152.96 44.63 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.855 2.062 . . . . 0.0 114.198 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.14 22.2 61.38 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -87.94 132.24 34.3 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.55 -1.559 . . . . 0.0 112.218 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 78.25 35.97 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 125.829 1.652 . . . . 0.0 114.677 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -75.95 129.2 36.55 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.168 -1.582 . . . . 0.0 114.849 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.8 41.64 14.42 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.96 103.58 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -167.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.8 t -88.32 -51.85 5.53 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.9 -1.75 . . . . 0.0 111.479 165.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t 58.57 -171.24 0.11 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp -53.4 131.45 37.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.298 2.639 . . . . 0.0 112.099 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.95 -6.02 4.17 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 27.4 t60 70.48 -73.79 0.09 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.73 1.612 . . . . 0.0 113.306 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.415 28.0 m 48.26 -138.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 128.6 2.76 . . . . 0.0 115.605 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -154.51 152.94 30.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -128.69 128.3 43.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.6 m -89.12 164.02 15.21 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 108.974 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.5 tt -146.56 129.87 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 120.126 -1.609 . . . . 0.0 109.203 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.44 -23.43 29.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.235 -1.541 . . . . 0.0 112.338 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.7 m -60.52 -22.19 63.31 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.865 1.666 . . . . 0.0 115.285 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -112.56 7.29 18.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.986 -1.071 . . . . 0.0 111.553 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.31 119.47 16.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 120.519 -1.363 . . . . 0.0 114.524 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.65 -35.84 79.09 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.198 -0.939 . . . . 0.0 113.297 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.1 m -123.92 120.73 33.37 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 23.2 pt -80.52 148.2 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.66 -10.27 25.34 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 112.304 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.4 t -126.11 112.41 30.04 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-O 122.098 0.951 . . . . 0.0 110.271 -175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.1 m -116.09 129.51 56.37 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.7 m -77.81 112.66 14.9 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.35 -1.469 . . . . 0.0 110.23 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.16 128.08 26.25 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 119.82 -1.8 . . . . 0.0 109.572 -174.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.45 125.29 18.03 Favored 'Trans proline' 0 C--O 1.22 -0.383 0 C-N-CA 123.998 3.132 . . . . 0.0 115.509 170.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 m -82.58 -28.24 31.03 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -119.74 23.09 11.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.964 -1.085 . . . . 0.0 112.051 -165.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.31 149.83 46.07 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.007 -1.058 . . . . 0.0 108.715 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.17 139.58 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.759 2.973 . . . . 0.0 114.453 162.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.49 171.64 18.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.518 0.675 . . . . 0.0 110.7 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.8 177.44 7.17 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 125.024 1.297 . . . . 0.0 114.75 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.87 -17.5 63.36 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.296 -1.709 . . . . 0.0 113.509 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.06 -20.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 C-N-CA 124.613 1.165 . . . . 0.0 111.709 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 m 58.6 56.7 4.12 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.099 1.76 . . . . 0.0 112.721 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.6 t -152.6 169.95 21.41 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.682 -1.886 . . . . 0.0 110.462 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.6 158.88 34.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.133 1.373 . . . . 0.0 112.518 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.19 -42.64 91.34 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.66 90.27 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 129.318 3.047 . . . . 0.0 114.755 -16.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.63 135.52 88.2 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.372 2.269 . . . . 0.0 113.593 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.77 133.07 2.6 Favored 'Trans proline' 0 N--CA 1.476 0.451 1 C-N-CA 125.572 4.181 . . . . 0.0 118.888 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -118.78 4.05 11.58 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 p -69.29 139.25 54.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 119.812 -1.805 . . . . 0.0 114.492 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.29 43.02 1.91 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.267 -1.521 . . . . 0.0 112.026 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -77.61 -10.14 59.34 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.953 -1.717 . . . . 0.0 113.082 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 8.64 40.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.52 1.128 . . . . 0.0 111.869 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.69 24.53 9.1 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.92 1.288 . . . . 0.0 108.927 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -122.31 138.24 54.58 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.847 0.859 . . . . 0.0 109.118 -167.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -122.32 125.65 46.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.254 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.8 6.81 15.63 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 119.78 -1.825 . . . . 0.0 113.609 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.2 t -136.52 132.45 35.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.534 1.159 . . . . 0.0 109.563 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.4 tt -91.62 2.02 8.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.974 -1.079 . . . . 0.0 111.471 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.99 163.98 39.54 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 119.834 -1.791 . . . . 0.0 109.454 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -156.51 170.16 22.98 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m -107.8 136.08 44.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 167.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 215' ' ' HIS . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.425 ' HA ' ' CA ' ' A' ' 193' ' ' GLY . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -142.25 37.28 1.54 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -69.97 -39.32 74.63 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 120.593 -1.317 . . . . 0.0 114.199 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -134.82 166.11 23.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 102.109 -3.293 . . . . 0.0 102.109 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.9 mp -86.9 45.6 1.28 Allowed 'General case' 0 C--O 1.224 -0.274 0 O-C-N 120.401 -1.437 . . . . 0.0 111.774 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.24 -43.1 82.62 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.481 1.512 . . . . 0.0 114.912 -165.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -115.34 27.88 9.06 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.586 -1.322 . . . . 0.0 111.541 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.0 t -148.87 162.89 38.93 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.313 -2.117 . . . . 0.0 112.528 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -114.34 1.18 14.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.985 -1.697 . . . . 0.0 111.176 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -143.63 137.29 28.19 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -106.68 -38.89 5.99 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.644 -1.285 . . . . 0.0 113.665 -163.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.2 m -61.96 106.27 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -163.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 229' ' ' GLU . 0.3 OUTLIER -162.79 -3.36 0.04 OUTLIER 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.544 -1.348 . . . . 0.0 111.873 175.09 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 228' ' ' HIS . 27.1 mp0 -58.57 -43.43 89.39 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.339 2.656 . . . . 0.0 113.743 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -67.24 138.38 56.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.444 0 CA-C-O 118.39 -1.228 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -91.43 170.46 9.95 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 119.436 1.618 . . . . 0.0 109.984 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.97 127.73 48.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 146.73 52.62 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 121.045 -1.034 . . . . 0.0 112.844 170.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -96.23 -0.84 49.29 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.336 -1.478 . . . . 0.0 112.2 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.54 164.36 29.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 171.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.51 -15.27 17.92 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.985 0.898 . . . . 0.0 111.817 -170.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 6.8 pt-20 -168.61 174.34 6.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -162.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -103.17 -2.52 27.19 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.765 -1.209 . . . . 0.0 114.241 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -76.41 144.21 12.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.148 -1.595 . . . . 0.0 113.806 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -125.34 8.99 7.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.881 1.324 . . . . 0.0 110.464 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 169.41 20.27 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.416 2.286 . . . . 0.0 106.856 -165.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 44.09 49.97 7.45 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.827 2.051 . . . . 0.0 116.334 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -55.41 -38.18 65.05 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -164.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.5 141.6 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 124.483 3.455 . . . . 0.0 117.131 169.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.76 134.94 94.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -56.12 125.8 20.26 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.805 3.003 . . . . 0.0 118.988 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -68.08 111.19 4.32 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.0 69.34 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -86.85 102.36 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 125.391 2.961 . . . . 0.0 113.709 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.46 -41.22 98.59 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.597 1.159 . . . . 0.0 113.783 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -120.13 141.03 50.2 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.203 -0.936 . . . . 0.0 108.502 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -81.81 -15.15 55.12 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.406 0.622 . . . . 0.0 112.013 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.78 133.84 34.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.592 -1.318 . . . . 0.0 108.615 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.1 mt -69.35 141.96 16.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 C-N-CA 124.9 1.28 . . . . 0.0 113.601 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -90.07 158.43 17.32 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.212 -1.555 . . . . 0.0 112.442 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -58.82 -37.39 76.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.026 1.731 . . . . 0.0 114.487 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -78.09 -19.0 13.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 114.104 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.317 10.1 t 79.98 70.17 0.03 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.648 1.579 . . . . 0.0 112.487 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.267 14.7 t70 57.85 -160.54 0.25 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.298 2.639 . . . . 0.0 116.251 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -149.3 146.82 27.74 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 119.968 -1.707 . . . . 0.0 111.049 -161.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.73 154.94 33.62 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.43 -1.419 . . . . 0.0 107.936 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -147.9 147.8 30.13 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.116 -2.24 . . . . 0.0 111.276 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -100.42 11.06 40.29 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.755 -1.215 . . . . 0.0 112.77 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -62.85 -36.49 75.76 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -80.39 101.49 9.03 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.725 -1.234 . . . . 0.0 112.907 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.0 p -90.32 -8.78 49.98 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.066 -1.021 . . . . 0.0 112.915 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 83.0 mtt180 -55.28 106.44 0.23 Allowed 'General case' 0 C--N 1.351 0.649 0 N-CA-C 115.545 1.684 . . . . 0.0 115.545 171.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.7 t -159.11 175.64 13.23 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 -165.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 1.8 t 53.15 61.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 126.79 2.036 . . . . 0.0 114.333 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -59.55 149.26 71.31 Favored Pre-proline 0 C--N 1.352 0.675 0 O-C-N 119.221 -2.174 . . . . 0.0 112.275 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -35.23 133.75 0.2 Allowed 'Trans proline' 0 C--O 1.246 0.925 1 C-N-CA 125.384 4.056 . . . . 0.0 116.708 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.43 170.24 22.38 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.179 -164.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.87 95.42 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 55.4 52.7 10.9 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.809 1.644 . . . . 0.0 115.063 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -66.38 128.73 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.855 -1.778 . . . . 0.0 110.238 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -79.17 104.44 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 119.148 -2.22 . . . . 0.0 112.195 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -119.91 129.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -164.93 156.86 15.52 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.216 1.008 . . . . 0.0 110.395 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -142.57 147.14 35.4 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -60.2 -44.66 94.94 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 122.347 1.07 . . . . 0.0 112.293 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -62.58 151.19 38.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 113.878 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.65 128.88 46.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.645 -1.284 . . . . 0.0 107.98 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.72 -49.91 1.62 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.455 0.702 . . . . 0.0 110.619 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -57.9 -41.62 83.01 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -132.11 127.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 164.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -87.12 136.4 32.94 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.231 0.612 . . . . 0.0 110.716 -173.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -92.23 125.49 44.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 O-C-N 120.954 -1.091 . . . . 0.0 112.742 -175.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 -42.25 99.18 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 128.13 2.572 . . . . 0.0 115.917 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -58.21 140.2 53.53 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.48 -11.02 9.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 O-C-N 119.816 -1.803 . . . . 0.0 112.592 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -137.12 160.27 39.46 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 119.342 -2.099 . . . . 0.0 105.445 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.82 25.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 123.477 1.608 . . . . 0.0 111.446 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -66.2 -38.12 87.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 119.477 -2.015 . . . . 0.0 113.915 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 66.25 42.21 3.16 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.285 1.434 . . . . 0.0 113.498 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' CD ' HH12 ' A' ' 101' ' ' ARG . 57.5 mt-10 -97.19 161.11 13.96 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.822 1.649 . . . . 0.0 114.827 -171.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 57.81 -161.47 0.23 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 127.574 2.35 . . . . 0.0 115.713 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -97.82 -164.84 31.54 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 120.77 -1.206 . . . . 0.0 110.452 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.56 7.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 O-C-N 120.707 -1.466 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -158.88 154.39 25.95 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.784 -1.822 . . . . 0.0 107.159 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.332 53.8 mt 86.33 112.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 126.137 1.775 . . . . 0.0 112.476 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -34.99 148.93 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 129.441 3.096 . . . . 0.0 117.823 168.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 94' ' ' GLU . 46.0 ttm-85 -64.69 114.35 4.37 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.81 134.12 56.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 120.61 -1.306 . . . . 0.0 113.237 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -63.55 117.56 6.94 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.278 -1.514 . . . . 0.0 111.899 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -157.76 163.98 37.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -167.96 -5.16 0.02 OUTLIER 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -111.27 5.22 19.72 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 119.901 -1.749 . . . . 0.0 111.653 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 108' ' ' ASN . 9.6 tp10 -84.3 173.12 11.22 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.951 1.301 . . . . 0.0 112.572 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.485 ' H ' ' CD ' ' A' ' 107' ' ' GLU 0.282 89.1 m-20 62.01 -125.38 0.76 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 119.214 -2.179 . . . . 0.0 111.781 -168.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.58 -3.92 52.74 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -167.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.8 m -33.06 135.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 128.339 2.655 . . . . 0.0 117.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 62.58 -112.06 0.41 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.318 -1.489 . . . . 0.0 113.113 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -108.77 2.85 22.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.963 1.305 . . . . 0.0 111.88 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.5 53.37 2.59 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -158.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.42 -16.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t 56.55 64.21 1.74 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -159.67 158.03 30.7 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 116.522 -3.861 . . . . 0.0 104.978 7.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp -118.28 136.01 53.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.23 30.66 5.59 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -144.08 179.66 7.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 107.885 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.8 145.93 9.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 O-C-N 120.372 -1.455 . . . . 0.0 113.991 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -115.97 15.97 16.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.027 1.331 . . . . 0.0 112.293 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -158.88 163.89 36.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.2 m -60.14 104.05 0.28 Allowed 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 128.868 2.867 . . . . 0.0 113.384 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tp -151.47 153.61 9.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 121.335 -0.853 . . . . 0.0 108.919 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -159.72 178.84 9.4 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 90.5 p -77.0 -21.96 53.84 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.991 1.723 . . . . 0.0 113.433 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 t -60.72 142.12 56.16 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.743 1.258 . . . . 0.0 112.085 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -87.18 -7.03 58.38 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 119.798 -1.814 . . . . 0.0 111.617 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -71.51 131.98 44.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 120.915 -1.116 . . . . 0.0 112.623 168.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -61.78 134.67 57.02 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 120.979 -1.076 . . . . 0.0 113.033 170.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.7 pt -124.88 149.98 29.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 110.875 -173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 67.04 46.57 1.52 Allowed 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.63 1.972 . . . . 0.0 110.453 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.57 135.94 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.675 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.8 m -84.76 110.18 18.61 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.673 -1.267 . . . . 0.0 110.961 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.2 m -67.71 117.92 10.27 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.317 -1.489 . . . . 0.0 111.266 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.22 111.74 61.64 Favored Pre-proline 0 C--N 1.348 0.536 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -62.19 138.44 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 CA-C-N 122.287 1.852 . . . . 0.0 112.855 168.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -96.12 164.67 12.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -75.72 -18.24 59.65 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 122.019 0.914 . . . . 0.0 110.63 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -75.47 146.15 80.39 Favored Pre-proline 0 N--CA 1.443 -0.816 0 O-C-N 121.169 -0.957 . . . . 0.0 112.251 167.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.17 162.93 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.461 1.44 . . . . 0.0 110.284 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 73.14 41.25 0.5 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 169.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.37 149.24 32.27 Favored Glycine 0 C--N 1.359 1.843 0 O-C-N 121.152 -0.967 . . . . 0.0 115.002 167.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.45 -19.45 58.04 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.5 t -127.11 122.76 60.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.8 p -110.49 9.29 23.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.707 0.803 . . . . 0.0 110.693 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -110.43 144.18 39.61 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.629 -1.294 . . . . 0.0 110.102 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -113.7 4.94 16.23 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.711 175.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -96.25 21.89 8.41 Favored 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.55 -1.344 . . . . 0.0 110.894 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -107.97 1.15 22.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.496 2.318 . . . . 0.0 112.764 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -117.65 127.05 26.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 0.0 108.154 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.19 135.57 5.43 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 122.819 2.043 . . . . 0.0 112.405 -167.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -66.65 -29.45 69.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.074 -1.641 . . . . 0.0 113.767 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.8 t -69.35 140.72 54.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.789 1.236 . . . . 0.0 111.385 165.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -117.23 18.78 14.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.5 5.55 11.1 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 121.011 -1.055 . . . . 0.0 110.296 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -164.48 176.33 9.09 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.38 167.97 11.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.898 2.479 . . . . 0.0 115.134 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -71.92 -38.79 69.83 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.411 -1.431 . . . . 0.0 112.834 166.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.9 t -151.21 140.29 21.13 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.731 -1.231 . . . . 0.0 109.459 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -117.36 18.22 14.45 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 124.334 1.054 . . . . 0.0 109.77 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 78.0 p -59.23 -46.57 88.12 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.1 tt -99.5 134.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.975 1.369 . . . . 0.0 109.486 165.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.62 145.6 48.88 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.72 -1.863 . . . . 0.0 111.565 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -119.69 171.4 8.41 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.96 147.95 6.08 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 O-C-N 121.281 -0.887 . . . . 0.0 111.945 165.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -172.37 60.04 0.03 OUTLIER 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 66.15 175.62 6.32 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 125.656 1.598 . . . . 0.0 116.069 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -166.04 -7.72 0.02 OUTLIER 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -48.19 80.52 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 120.483 1.492 . . . . 0.0 113.31 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.91 -46.07 1.41 Allowed 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.329 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -129.77 135.98 49.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.4 m -102.97 107.68 18.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 129.005 2.922 . . . . 0.0 110.791 -0.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -61.02 -40.03 92.03 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.995 -1.69 . . . . 0.0 115.053 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -56.41 144.38 31.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.77 9.85 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.525 1.13 . . . . 0.0 108.333 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.3 p -105.17 -8.29 18.48 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.171 -0.956 . . . . 0.0 111.61 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -70.84 129.72 39.79 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.058 -1.026 . . . . 0.0 112.033 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mt-10 67.12 40.53 2.84 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.03 122.96 47.5 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 168.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.18 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -93.74 160.89 14.56 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 141.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.42 158.31 35.6 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.62 106.29 12.46 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.701 -1.874 . . . . 0.0 109.809 172.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 65.43 -23.55 0.09 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.24 2.216 . . . . 0.0 115.945 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.31 157.86 34.96 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.14 -38.44 88.97 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.916 1.287 . . . . 0.0 113.758 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.4 131.34 53.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 153.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -29.59 125.49 0.14 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 120.063 3.357 . . . . 0.0 120.063 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.03 -27.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 120.938 -1.101 . . . . 0.0 112.117 165.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 p -99.45 29.98 3.77 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.359 -1.463 . . . . 0.0 110.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.09 130.19 45.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.67 152.78 29.95 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.61 123.98 15.53 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 120.106 -1.621 . . . . 0.0 113.569 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.61 -7.9 15.83 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 122.172 1.915 . . . . 0.0 112.73 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.89 151.99 27.44 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.76 -8.21 14.57 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.349 2.033 . . . . 0.0 111.844 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 112.63 78.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 130.164 3.386 . . . . 0.0 106.957 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -175.04 112.29 0.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 120.654 -1.279 . . . . 0.0 110.894 -167.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.97 120.04 7.67 Favored 'Trans proline' 0 C--O 1.23 0.081 0 C-N-CA 123.369 2.712 . . . . 0.0 117.029 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -77.69 134.66 38.08 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 111.412 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -99.84 -4.61 30.05 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 47.4 42.14 13.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 119.243 3.053 . . . . 0.0 119.243 166.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -56.76 -37.57 71.25 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -165.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.02 22.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 109.351 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -114.93 126.16 54.46 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.447 -1.408 . . . . 0.0 112.267 -163.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -62.26 126.25 26.68 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.844 0.858 . . . . 0.0 110.297 167.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -97.88 140.94 16.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 O-C-N 121.448 -0.783 . . . . 0.0 112.033 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -62.0 -46.84 87.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.619 -1.926 . . . . 0.0 113.482 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.36 134.95 36.56 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -172.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.69 -34.41 78.24 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 122.457 1.122 . . . . 0.0 112.091 166.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.87 143.71 57.76 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -102.02 121.08 41.49 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.453 -1.404 . . . . 0.0 109.672 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -84.25 -51.38 7.06 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.423 -1.423 . . . . 0.0 111.921 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . 0.322 19.8 mt 80.55 -55.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 127.733 2.413 . . . . 0.0 112.3 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.46 161.34 38.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 t -152.07 176.28 11.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 119.982 -1.699 . . . . 0.0 107.402 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -115.02 108.51 16.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 p -108.04 -54.8 2.45 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.53 -0.732 . . . . 0.0 112.919 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -71.25 -52.53 26.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 72.13 143.32 0.1 OUTLIER Pre-proline 0 C--N 1.352 0.699 0 C-N-CA 125.676 1.59 . . . . 0.0 113.634 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -59.91 132.34 44.43 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.247 2.631 . . . . 0.0 113.292 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -71.99 131.03 42.36 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 68.84 1.31 Allowed 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.385 30.4 mtm180 58.2 166.78 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -165.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -119.29 13.28 12.75 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.142 -1.599 . . . . 0.0 113.229 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.2 24.1 12.49 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -97.28 10.61 39.09 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 119.775 -1.828 . . . . 0.0 111.658 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -66.98 147.97 52.56 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 112.073 163.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m120 72.26 122.18 0.04 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.684 1.594 . . . . 0.0 112.318 -167.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -147.07 10.31 1.01 Allowed 'General case' 0 C--N 1.351 0.639 0 O-C-N 120.737 -1.227 . . . . 0.0 109.706 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.11 166.96 16.76 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -118.14 17.96 13.91 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.339 1.055 . . . . 0.0 111.054 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.65 124.45 44.33 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.656 -1.278 . . . . 0.0 107.695 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m 71.95 25.2 3.12 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.063 0.945 . . . . 0.0 113.147 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.78 13.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 110.377 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -92.21 154.58 18.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.363 1.465 . . . . 0.0 111.976 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.0 mt -117.65 -30.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.63 145.03 50.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.903 1.681 . . . . 0.0 114.346 169.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -100.5 -8.39 23.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.17 -1.581 . . . . 0.0 112.517 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -154.99 151.06 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 64.84 48.07 2.51 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -170.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.26 141.41 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.652 1.581 . . . . 0.0 114.394 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -56.58 148.82 18.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -105.49 -6.66 19.24 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.1 -1.625 . . . . 0.0 112.743 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.52 140.26 58.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.247 1.819 . . . . 0.0 114.377 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -116.16 -9.85 11.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.773 -0.58 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.07 11.88 83.73 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 125.423 1.487 . . . . 0.0 114.821 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.72 -31.18 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.401 1.08 . . . . 0.0 109.688 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.79 41.06 30.64 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 165.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.265 3.1 mp 55.56 56.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 126.106 1.762 . . . . 0.0 110.799 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.33 50.2 m-20 71.66 40.27 0.8 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.547 1.939 . . . . 0.0 114.719 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 71.59 40.33 0.81 Allowed 'General case' 0 C--N 1.349 0.554 0 C-N-CA 127.015 2.126 . . . . 0.0 112.954 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.62 119.18 8.15 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 p -63.87 -41.17 97.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.36 178.83 8.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.767 1.227 . . . . 0.0 110.946 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 59.57 63.79 1.45 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 125.153 1.381 . . . . 0.0 113.937 -172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -170.17 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -170.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 58.04 38.5 26.69 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 123.295 1.521 . . . . 0.0 114.75 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -156.46 165.97 34.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.38 -16.64 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 121.401 -0.812 . . . . 0.0 112.777 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.6 m -70.05 95.69 0.98 Allowed 'General case' 0 C--N 1.353 0.742 0 CA-C-O 123.383 1.563 . . . . 0.0 111.963 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.255 92.2 m-85 49.09 49.14 20.01 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 127.189 2.196 . . . . 0.0 115.847 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -94.73 -1.07 53.69 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.319 -0.863 . . . . 0.0 112.022 166.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.6 159.56 30.18 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.047 -1.033 . . . . 0.0 110.973 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 50.0 t -57.08 -46.9 84.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -172.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.3 t -120.99 12.06 11.12 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 116.468 -3.895 . . . . 0.0 110.995 -3.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -128.43 111.88 13.78 Favored 'General case' 0 C--N 1.358 0.964 0 O-C-N 119.523 -1.986 . . . . 0.0 108.143 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp -132.21 122.75 25.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 164.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.01 -9.05 26.81 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m170 68.85 44.0 1.14 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.976 1.311 . . . . 0.0 113.662 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 m -146.69 146.11 19.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 123.783 0.833 . . . . 0.0 109.609 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.259 85.8 mtm180 90.0 38.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.717 3.207 . . . . 0.0 110.297 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -133.66 -20.34 2.04 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 t -114.55 137.6 51.67 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-O 122.387 1.089 . . . . 0.0 110.01 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.4 pt -117.66 8.98 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 120.82 -1.175 . . . . 0.0 109.68 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.92 128.04 40.01 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.491 1.516 . . . . 0.0 113.773 -159.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -159.95 164.54 33.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.298 -1.501 . . . . 0.0 110.592 160.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.5 m -61.49 -25.58 67.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.467 3.107 . . . . 0.0 116.361 -164.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -135.66 10.78 3.42 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 120.08 -1.637 . . . . 0.0 113.137 169.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -150.4 132.2 15.04 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.246 -1.534 . . . . 0.0 112.252 -164.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 m -79.57 115.13 19.01 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.7 mt 68.05 108.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 127.271 2.229 . . . . 0.0 112.864 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -91.58 97.02 10.79 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 119.177 -2.202 . . . . 0.0 108.8 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.68 155.65 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 C-N-CA 126.889 2.076 . . . . 0.0 106.484 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 1.8 p -51.58 148.14 5.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 128.159 2.584 . . . . 0.0 114.54 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -56.61 130.84 46.93 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.615 -1.303 . . . . 0.0 113.316 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.11 131.95 49.49 Favored Pre-proline 0 C--N 1.352 0.713 0 O-C-N 120.963 -1.086 . . . . 0.0 109.592 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.66 123.93 12.45 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.381 2.721 . . . . 0.0 116.972 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 131.0 49.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 m120 74.5 16.05 3.3 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.8 122.12 85.95 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 118.752 0.706 . . . . 0.0 111.982 168.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -92.06 167.11 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.911 1.741 . . . . 0.0 110.47 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.4 164.6 20.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.4 -118.82 2.07 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.83 5.11 52.74 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.977 -1.308 . . . . 0.0 112.738 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -91.7 -12.06 9.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.844 -1.16 . . . . 0.0 113.62 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.2 t -163.15 161.71 25.23 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.6 p -98.0 2.64 49.11 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.321 1.058 . . . . 0.0 110.994 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -83.62 123.78 30.13 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.923 -1.11 . . . . 0.0 111.682 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 15.3 m120 61.52 40.89 13.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 m -58.96 -45.09 91.34 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.632 1.573 . . . . 0.0 112.621 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.37 132.76 28.33 Favored Pre-proline 0 N--CA 1.436 -1.145 0 C-N-CA 124.516 1.126 . . . . 0.0 111.592 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.09 115.05 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.464 2.776 . . . . 0.0 115.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.282 66.7 mttm 89.69 10.95 0.07 Allowed 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.86 2.064 . . . . 0.0 115.144 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.1 t -94.61 164.91 12.77 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 120.775 -1.203 . . . . 0.0 111.618 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -135.6 159.06 42.78 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.837 1.255 . . . . 0.0 108.789 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -137.53 164.75 27.97 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.202 -1.561 . . . . 0.0 108.273 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -79.64 -16.29 56.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.28 37.94 23.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.447 1.499 . . . . 0.0 114.711 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -157.28 169.02 25.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.0 t -106.21 154.56 20.54 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.638 -1.289 . . . . 0.0 107.575 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 69.16 44.18 1.02 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 166.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 t -82.46 138.7 34.3 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.193 -1.567 . . . . 0.0 110.748 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 pt -133.45 161.66 40.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.891 0 O-C-N 119.505 -1.997 . . . . 0.0 111.601 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 57.35 -127.23 1.76 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 79.96 -37.66 0.16 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.508 1.523 . . . . 0.0 111.004 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.87 148.61 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.675 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.675 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -57.82 120.26 8.13 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 118.06 -7.31 14.85 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -57.83 -35.65 71.19 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 16.0 tp 62.23 34.37 16.07 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 124.245 1.974 . . . . 0.0 114.497 163.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.96 103.5 10.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 119.757 -1.84 . . . . 0.0 112.288 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.88 -44.08 81.89 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.651 -1.28 . . . . 0.0 113.51 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 m -75.62 -15.35 60.35 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 120.808 -1.182 . . . . 0.0 111.793 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.546 HH11 ' CE1' ' A' ' 228' ' ' HIS . 23.1 ttp180 -147.22 70.74 1.19 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.085 -2.26 . . . . 0.0 112.111 -173.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -58.72 -43.15 90.06 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.297 -1.502 . . . . 0.0 113.941 173.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -94.63 136.64 34.71 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.223 -1.548 . . . . 0.0 111.629 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.5 m -61.73 121.56 13.15 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.964 -1.085 . . . . 0.0 111.835 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.546 ' CE1' HH11 ' A' ' 224' ' ' ARG . 5.8 p-80 -102.22 3.26 38.1 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 120.678 -1.263 . . . . 0.0 112.099 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.89 -35.12 79.3 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.62 132.54 22.78 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.789 -1.194 . . . . 0.0 111.445 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.32 0 CA-C-O 120.31 -0.161 . . . . 0.0 113.437 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -93.14 174.65 7.11 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.601 1.56 . . . . 0.0 107.624 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -108.17 127.08 53.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.38 140.01 43.62 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.937 1.351 . . . . 0.0 112.59 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.09 144.65 33.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.965 1.306 . . . . 0.0 112.236 161.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.73 10.23 31.64 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.082 -1.636 . . . . 0.0 114.912 -153.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.853 -1.154 . . . . 0.0 110.926 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.28 46.2 mt-10 57.21 29.38 16.61 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 164.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 228' ' ' HIS . 6.5 m80 70.62 32.61 2.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 119.908 -1.745 . . . . 0.0 112.96 165.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.8 pt -52.78 134.64 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.896 1.278 . . . . 0.0 113.465 171.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.7 p -101.54 -3.37 28.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.182 -0.949 . . . . 0.0 110.348 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -84.94 110.86 19.18 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.645 1.212 . . . . 0.0 112.268 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -59.75 -41.46 91.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.712 2.405 . . . . 0.0 115.175 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -124.14 145.66 49.01 Favored Pre-proline 0 CA--C 1.51 -0.571 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -88.47 166.21 6.45 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.704 1.602 . . . . 0.0 111.236 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -86.65 142.64 34.94 Favored Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 124.326 1.05 . . . . 0.0 108.534 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -53.76 162.03 4.02 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 123.192 2.595 . . . . 0.0 118.561 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -62.33 141.85 58.08 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 113.672 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.18 17.79 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 165.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -44.52 149.84 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.823 3.682 . . . . 0.0 118.568 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -148.5 27.96 0.9 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.28 1.514 . . . . 0.0 108.23 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -145.15 138.21 26.43 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.4 11.92 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.812 0.845 . . . . 0.0 112.452 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -91.84 5.07 51.33 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.869 -1.145 . . . . 0.0 111.877 -166.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.8 mt -82.94 114.88 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -162.01 164.18 28.43 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.4 p -101.98 -2.81 28.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.154 0.982 . . . . 0.0 112.773 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.4 m -65.65 -40.56 88.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -109.14 -11.93 14.87 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.693 -1.254 . . . . 0.0 112.93 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 17.3 m-20 -129.47 126.03 37.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 109.065 -167.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 58.47 39.54 24.96 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 131.327 3.851 . . . . 0.0 114.201 0.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -64.28 141.3 58.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -170.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -57.65 152.14 15.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -57.38 125.52 23.18 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.2 mt -115.21 108.74 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 166.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -123.43 0.67 8.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.651 -1.281 . . . . 0.0 111.938 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 t -159.88 170.1 22.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -147.16 159.38 43.69 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.8 p -34.83 137.15 0.14 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 159.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t 78.78 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 127.445 2.298 . . . . 0.0 113.291 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 47.33 67.28 4.62 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 127.462 2.305 . . . . 0.0 115.793 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 -29.13 10.04 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.678 2.252 . . . . 0.0 113.037 -158.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -114.98 133.81 55.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 124.901 1.28 . . . . 0.0 109.143 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.55 135.44 55.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -59.44 -42.53 92.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.3 t80 79.19 -57.92 0.41 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 127.577 2.351 . . . . 0.0 111.937 166.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 81.22 51.93 0.02 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.321 2.649 . . . . 0.0 107.883 -171.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -71.24 -45.97 62.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 119.45 3.13 . . . . 0.0 119.45 -161.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -121.66 113.09 19.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.021 -1.05 . . . . 0.0 110.788 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -127.98 125.91 40.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.467 -0.771 . . . . 0.0 110.505 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.283 98.7 m-20 65.73 60.11 0.72 Allowed 'General case' 0 C--N 1.345 0.377 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 174.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.0 t30 76.9 104.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.236 2.614 . . . . 0.0 114.49 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.96 172.29 13.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 117.007 -3.558 . . . . 0.0 108.232 -4.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.83 5.49 41.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 130.135 3.374 . . . . 0.0 110.813 -7.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -154.94 154.27 32.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.78 130.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 CA-C-O 121.916 0.865 . . . . 0.0 111.256 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.12 10.76 12.19 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 123.781 0.833 . . . . 0.0 112.191 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 tp -138.79 145.96 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 119.493 -2.005 . . . . 0.0 108.142 -174.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.16 149.81 47.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.44 -29.42 70.71 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.37 -31.45 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 O-C-N 120.874 -1.141 . . . . 0.0 113.901 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 mtp85 -84.29 -21.38 31.08 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.406 -1.433 . . . . 0.0 113.109 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.2 pt -114.39 6.1 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 123.607 0.763 . . . . 0.0 111.082 -172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.55 148.21 52.21 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.628 1.68 . . . . 0.0 111.549 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.64 -41.08 97.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -120.1 132.94 55.61 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.001 0.52 . . . . 0.0 110.019 -168.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 59.85 58.45 2.78 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.273 1.029 . . . . 0.0 113.18 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -62.57 -171.82 1.47 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-O 124.046 1.914 . . . . 0.0 113.641 167.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.86 140.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 119.819 -1.989 . . . . 0.0 108.912 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -61.09 132.78 54.86 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 119.86 -1.775 . . . . 0.0 112.725 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -131.99 -6.61 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 121.643 -0.66 . . . . 0.0 112.656 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.26 11.1 m-20 49.22 -160.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.47 137.73 57.63 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 119.413 -2.054 . . . . 0.0 114.299 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -150.73 157.81 43.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 -171.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -99.73 146.45 26.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 123.412 1.577 . . . . 0.0 110.932 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -131.7 16.75 4.8 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.127 1.371 . . . . 0.0 107.305 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.91 -9.45 19.86 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 120.493 -1.38 . . . . 0.0 111.725 -173.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.38 -2.42 57.32 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.304 -1.497 . . . . 0.0 112.711 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -115.89 15.19 16.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 124.199 0.999 . . . . 0.0 109.685 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 62.07 35.33 15.94 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.652 1.581 . . . . 0.0 114.301 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.56 154.96 37.72 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.761 1.172 . . . . 0.0 114.918 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t -147.83 151.16 35.49 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.38 -1.659 . . . . 0.0 108.132 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.88 -39.78 83.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.629 -1.92 . . . . 0.0 113.67 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -161.84 156.69 22.97 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.252 -0.905 . . . . 0.0 109.007 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.41 170.58 21.46 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.06 110.88 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-O 122.695 1.236 . . . . 0.0 110.61 171.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.4 t -155.48 -166.59 2.28 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.238 -1.539 . . . . 0.0 109.092 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.254 21.2 m 78.1 131.62 0.05 Allowed 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 128.141 2.577 . . . . 0.0 113.056 170.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.48 146.82 33.95 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.62 43.91 11.39 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -58.69 -39.24 80.16 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.777 1.631 . . . . 0.0 114.17 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.18 -26.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 123.339 1.542 . . . . 0.0 107.349 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -87.89 172.32 9.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 120.39 -1.444 . . . . 0.0 114.449 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -61.65 153.89 26.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' ILE . 46.7 m -107.38 103.33 12.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 160.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.6 pt -121.48 144.74 29.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 128.153 2.581 . . . . 0.0 108.752 -11.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.8 -37.74 16.32 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m 52.36 32.21 10.75 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.256 1.822 . . . . 0.0 115.01 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 83.6 m -70.02 125.22 26.12 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 120.213 -1.554 . . . . 0.0 112.476 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -61.64 -42.67 99.23 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.13 -40.61 90.78 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 113.338 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 m -70.67 120.67 16.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.219 1.485 . . . . 0.0 112.516 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.45 167.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -115.07 150.61 35.67 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 112.087 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.27 5.8 t 66.57 73.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 125.202 1.401 . . . . 0.0 113.317 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.1 p -130.89 154.79 47.72 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 119.864 -1.773 . . . . 0.0 111.031 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.4 m -68.48 144.09 54.76 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.965 1.306 . . . . 0.0 111.853 167.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.3 t -107.03 115.96 59.28 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.69 163.28 22.01 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.172 1.914 . . . . 0.0 114.463 174.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -87.54 169.01 12.56 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 122.21 1.005 . . . . 0.0 111.083 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -102.11 6.88 41.13 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.145 1.378 . . . . 0.0 110.415 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.7 162.0 48.9 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 125.721 1.608 . . . . 0.0 107.035 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.37 163.98 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.163 2.575 . . . . 0.0 115.673 161.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.255 85.5 m-20 69.49 47.49 0.67 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.602 1.192 . . . . 0.0 114.139 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.88 -166.03 34.81 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.495 160.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.51 -23.43 62.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.275 1.83 . . . . 0.0 114.799 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.8 p -56.23 -35.21 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.886 2.074 . . . . 0.0 113.458 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.1 m -83.25 -48.75 10.13 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.091 -1.005 . . . . 0.0 109.893 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -171.21 156.26 4.63 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -122.04 138.17 54.54 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.531 -0.73 . . . . 0.0 109.973 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -115.4 131.17 57.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 121.384 -0.822 . . . . 0.0 108.821 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.5 p -78.58 -21.12 49.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -74.3 119.05 74.53 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.936 1.295 . . . . 0.0 112.262 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -66.17 138.19 50.77 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 123.592 2.862 . . . . 0.0 114.732 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.33 -7.9 15.16 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 122.352 1.072 . . . . 0.0 110.313 165.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 181' ' ' ASP . 4.9 t -164.06 158.75 19.77 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -64.85 -40.92 95.92 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.44 -44.09 95.54 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 11.7 t70 58.4 -155.56 0.34 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.095 1.358 . . . . 0.0 114.025 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.487 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 29.9 m-85 -119.41 -32.16 4.43 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 127.191 2.196 . . . . 0.0 108.939 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -160.34 -11.13 0.05 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t -63.05 -48.19 79.77 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.522 -1.361 . . . . 0.0 112.303 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -65.46 -37.34 86.59 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.339 -1.476 . . . . 0.0 112.72 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 57.5 m -54.84 -36.17 64.76 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 114.837 -174.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.4 pt -91.4 3.93 6.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 123.805 0.842 . . . . 0.0 111.634 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.7 17.06 11.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 120.777 -1.202 . . . . 0.0 110.243 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -90.07 -2.06 58.05 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.734 -1.229 . . . . 0.0 113.629 -171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.01 123.62 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.41 ' CZ3' ' HD2' ' A' ' 224' ' ' ARG . 73.4 t-105 -151.07 132.98 15.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.21 160.58 16.29 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 128.484 2.945 . . . . 0.0 114.659 -7.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -149.6 162.03 40.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 117.245 -3.503 . . . . 0.0 107.466 2.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.2 tp -176.64 117.45 0.12 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -82.07 -21.98 36.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -86.31 158.24 19.72 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.635 -1.29 . . . . 0.0 112.372 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.1 m -41.36 115.28 0.6 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.826 2.05 . . . . 0.0 114.863 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.41 ' HD2' ' CZ3' ' A' ' 217' ' ' TRP . 26.5 mtp-105 -86.72 151.25 23.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.62 164.17 13.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.884 167.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -86.08 134.26 33.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 111.074 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 -3.26 15.84 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.371 -176.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 21' ' ' HIS 0.258 92.0 m-70 69.18 40.1 1.6 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 123.515 1.626 . . . . 0.0 111.41 -178.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.51 -40.97 88.84 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.2 2.2 . . . . 0.0 114.734 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.51 128.1 34.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.742 1.217 . . . . 0.0 112.441 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.491 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.348 0.118 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.41 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . . . . . . 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.41 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.252 1.025 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.408 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 192' ' ' LEU . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 . . . . . 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.591 0.234 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--O 1.239 0.503 0 CA-C-O 119.605 -0.236 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.47 ' H ' HG21 ' A' ' 190' ' ' VAL . . . . . . . . 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 . . . . . 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.403 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.459 HG13 HD21 ' A' ' 216' ' ' ASN . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.459 HD21 HG13 ' A' ' 194' ' ' VAL . 31.2 m-80 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.384 0.612 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.417 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.519 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.881 0.848 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.238 0.458 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.024 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.265 0.555 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 122.454 1.121 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp . . . . . 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.432 -1.35 0 CA-C-O 122.359 1.076 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.445 0.64 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.532 -0.271 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.318 1.056 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 190' ' ' VAL . . . . . . . . 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 142' ' ' GLY . 22.9 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' CG ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HE ' ' CG ' ' A' ' 14' ' ' ASP . 22.4 tpt180 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.483 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 . . . . . 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.524 0.202 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 . . . . . 0 CA--C 1.514 -0.442 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 14' ' ' ASP 0.307 26.0 mt . . . . . 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 121.803 0.811 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 . . . . . 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.454 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 215' ' ' HIS . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 193' ' ' GLY . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 . . . . . 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--O 1.238 0.472 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.44 -0.962 0 CA-C-O 121.78 0.8 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 215' ' ' HIS . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.425 ' HA ' ' CA ' ' A' ' 193' ' ' GLY . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 119.306 -0.378 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 121.613 0.72 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.945 0.402 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.215 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp . . . . . 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.675 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.675 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 . . . . . 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.744 0.307 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.703 0.763 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 . . . . . 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.235 0.541 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.491 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.671 0 CA-C-O 118.694 -1.059 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -159.03 156.54 29.48 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.07 175.94 38.17 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.19 146.41 1.86 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 125.089 3.86 . . . . 0.0 116.857 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -131.23 139.64 49.71 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.319 0.58 . . . . 0.0 110.726 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.77 134.87 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 169.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -123.0 136.12 54.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.447 1.499 . . . . 0.0 109.241 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.18 115.87 17.63 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.743 0.782 . . . . 0.0 109.017 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -109.77 128.72 55.48 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 110.735 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 tp -120.61 149.6 42.21 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.876 1.322 . . . . 0.0 109.51 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.23 39.73 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 119.582 -1.949 . . . . 0.0 109.285 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -81.38 123.05 28.22 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.224 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.26 109.73 21.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 120.704 -1.248 . . . . 0.0 111.278 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -84.95 140.13 31.31 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.173 169.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.85 -28.71 65.89 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 65.72 41.91 3.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.464 -1.398 . . . . 0.0 114.555 168.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.2 pt -110.46 7.11 8.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 O-C-N 120.444 -1.41 . . . . 0.0 112.944 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -116.13 23.22 12.34 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.699 -1.251 . . . . 0.0 111.823 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -153.17 157.1 39.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.736 -1.228 . . . . 0.0 109.131 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.15 136.88 57.32 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.706 0.803 . . . . 0.0 112.964 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.85 137.12 12.73 Favored Pre-proline 0 C--N 1.351 0.638 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.84 -16.69 18.27 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.522 2.815 . . . . 0.0 112.347 -165.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.4 139.42 91.98 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.07 19.24 0.6 Allowed 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 123.604 2.869 . . . . 0.0 114.394 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 p -60.21 -40.22 89.33 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.642 1.577 . . . . 0.0 113.382 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.77 157.4 54.99 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.957 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.87 140.09 23.98 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 124.932 3.755 . . . . 0.0 116.775 169.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.75 -45.85 87.98 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -156.47 166.21 34.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.643 -1.285 . . . . 0.0 109.019 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 68.08 47.72 1.02 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 169.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -74.97 71.64 2.08 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -146.94 134.87 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.9 m 67.71 42.0 2.11 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-O 123.108 1.432 . . . . 0.0 112.946 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -149.47 172.72 14.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.708 2.403 . . . . 0.0 105.332 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.38 135.38 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.261 81.1 p -65.05 143.05 58.19 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 119.867 -1.771 . . . . 0.0 114.548 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -52.02 158.22 1.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.233 2.213 . . . . 0.0 116.224 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -87.95 158.08 18.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.039 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -118.19 136.72 53.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -171.28 -8.69 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -90.45 96.94 10.9 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 119.876 -1.765 . . . . 0.0 109.957 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.2 pt -112.41 17.06 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.189 1.396 . . . . 0.0 108.096 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 74.57 10.46 4.11 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.62 1.968 . . . . 0.0 114.631 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 p -77.43 -18.08 57.54 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -120.14 9.65 11.18 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 m -123.53 -6.68 8.1 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 122.775 0.43 . . . . 0.0 111.559 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.47 -5.68 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 121.082 -1.012 . . . . 0.0 112.631 -167.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -100.19 115.04 65.87 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.154 0.982 . . . . 0.0 110.458 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.4 145.4 0.95 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 125.103 3.869 . . . . 0.0 118.814 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -82.16 144.56 30.65 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.536 -0.728 . . . . 0.0 110.751 168.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.7 t -121.25 137.13 55.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 O-C-N 121.413 -0.805 . . . . 0.0 110.431 -167.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -120.28 122.83 41.73 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.46 134.55 66.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 O-C-N 119.631 -1.918 . . . . 0.0 111.744 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -162.19 -152.11 6.6 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.955 -1.716 . . . . 0.0 113.859 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -141.3 141.22 33.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -125.23 130.53 52.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 123.224 1.488 . . . . 0.0 110.595 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 95.73 5.47 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 125.036 1.334 . . . . 0.0 107.909 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.68 19.61 76.71 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 120.328 -1.482 . . . . 0.0 115.347 171.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 10.66 59.32 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 121.328 -1.101 . . . . 0.0 112.843 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -118.06 126.48 52.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.41 HH22 ' CG ' ' A' ' 124' ' ' ASP . 23.4 ptt-85 -156.39 156.25 33.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 120.329 -1.482 . . . . 0.0 114.165 -163.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 tt -123.89 136.64 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.23 161.32 37.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.885 1.274 . . . . 0.0 109.771 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.43 134.25 55.22 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.337 1.455 . . . . 0.0 110.328 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -95.25 124.64 39.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.733 1.254 . . . . 0.0 112.167 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.04 165.81 24.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.495 1.616 . . . . 0.0 112.19 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . 0.256 . . 76.9 146.48 0.09 Allowed 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.44 1.896 . . . . 0.0 114.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.89 85.18 0.12 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.617 1.967 . . . . 0.0 110.979 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -130.28 161.46 31.18 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.071 1.749 . . . . 0.0 111.454 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 61.4 179.9 0.11 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -95.82 -54.12 3.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.505 1.122 . . . . 0.0 108.366 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -118.54 164.18 15.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.717 2.007 . . . . 0.0 110.151 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -111.6 -39.28 4.66 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.269 1.427 . . . . 0.0 111.637 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -64.05 145.0 56.66 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -114.49 11.23 17.08 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.992 0.901 . . . . 0.0 109.651 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -139.9 126.49 20.4 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -113.55 5.73 16.73 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 120.833 -1.167 . . . . 0.0 110.112 -167.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 p -58.92 -35.71 73.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 -159.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.04 8.65 9.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.77 -1.206 . . . . 0.0 111.734 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 78.66 25.93 0.52 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.308 1.443 . . . . 0.0 112.305 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.37 -40.39 87.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.83 -29.15 14.87 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 123.188 1.471 . . . . 0.0 111.294 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -144.49 133.75 23.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.18 155.16 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -70.94 143.69 50.82 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 119.66 -1.9 . . . . 0.0 113.083 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.1 tt -76.96 -25.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 O-C-N 120.361 -1.462 . . . . 0.0 112.63 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -158.64 151.71 22.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.089 -1.632 . . . . 0.0 106.743 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -66.72 143.81 56.72 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.705 -1.247 . . . . 0.0 110.967 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.13 150.45 29.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.134 2.173 . . . . 0.0 115.345 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -137.38 129.03 28.57 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 -166.44 54.36 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 118.625 0.648 . . . . 0.0 113.029 -172.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.37 144.75 17.08 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-O 122.99 1.376 . . . . 0.0 110.362 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -72.95 129.28 37.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -102.79 -22.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.887 -1.133 . . . . 0.0 110.661 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -116.01 157.25 24.91 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 49.34 52.57 14.22 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -77.85 -14.21 59.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -96.32 117.24 30.43 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 50.41 -110.64 0.46 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -134.63 138.18 44.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.804 2.441 . . . . 0.0 107.255 -171.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -75.99 161.76 28.65 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 121.323 -0.861 . . . . 0.0 111.895 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.28 81.8 mt-10 70.34 56.07 0.28 Allowed 'General case' 0 C--N 1.353 0.752 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -171.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -76.28 121.34 22.81 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 120.393 -1.442 . . . . 0.0 113.453 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.9 -175.44 27.34 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 123.11 1.395 . . . . 0.0 116.019 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -117.92 106.28 12.8 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.553 -1.557 . . . . 0.0 108.119 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.7 132.88 48.04 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.073 -1.642 . . . . 0.0 108.697 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 83.83 6.53 0.68 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.541 1.936 . . . . 0.0 114.927 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.02 20.46 8.95 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.977 -1.702 . . . . 0.0 112.026 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.56 -32.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.038 1.335 . . . . 0.0 112.871 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.79 129.1 37.23 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.804 -1.81 . . . . 0.0 111.063 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 t -163.02 -6.79 0.03 OUTLIER 'General case' 0 C--N 1.348 0.514 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.841 -153.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.0 mt -138.25 159.52 41.84 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.343 -1.473 . . . . 0.0 108.527 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.2 172.42 37.45 Favored Glycine 0 CA--C 1.497 -1.031 0 O-C-N 121.219 -0.926 . . . . 0.0 112.548 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.75 143.56 50.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.3 m -128.85 131.43 47.69 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.27 -0.893 . . . . 0.0 109.988 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.26 55.91 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.36 141.27 41.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 O-C-N 120.69 -1.256 . . . . 0.0 110.759 -168.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.09 117.42 27.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.426 1.49 . . . . 0.0 111.371 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.41 ' CG ' HH22 ' A' ' 66' ' ' ARG . 79.8 m-20 -81.68 126.8 32.21 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.588 1.555 . . . . 0.0 113.022 172.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -80.02 68.94 6.3 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.186 -1.571 . . . . 0.0 112.606 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -75.23 67.1 1.81 Allowed 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.302 -1.499 . . . . 0.0 114.109 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -100.2 -22.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 124.786 1.234 . . . . 0.0 110.427 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -110.94 152.1 27.16 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.855 -1.778 . . . . 0.0 108.258 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.63 -31.98 62.15 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 121.015 -1.053 . . . . 0.0 112.194 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -106.51 -7.92 17.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -154.91 149.83 26.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.919 1.342 . . . . 0.0 111.953 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -124.34 111.32 28.3 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.246 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.48 153.88 57.62 Favored 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 122.393 2.062 . . . . 0.0 111.814 153.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -150.74 158.65 44.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.702 1.592 . . . . 0.0 113.191 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.5 pt -142.46 152.04 17.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -178.34 165.81 35.36 Favored Glycine 0 CA--C 1.494 -1.232 0 O-C-N 121.189 -0.945 . . . . 0.0 111.107 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.35 142.39 48.19 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.675 1.59 . . . . 0.0 110.148 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.478 HH22 ' CE1' ' A' ' 228' ' ' HIS . 58.5 mtp180 -118.36 141.45 48.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.294 -0.878 . . . . 0.0 108.662 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.3 p -125.47 134.46 66.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 O-C-N 120.513 -1.367 . . . . 0.0 109.378 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.1 140.61 52.73 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 119.974 -1.704 . . . . 0.0 111.08 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -153.7 175.45 13.25 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-O 122.974 1.369 . . . . 0.0 109.903 -173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.41 176.12 19.28 Favored Glycine 0 CA--C 1.487 -1.668 0 O-C-N 119.918 -1.739 . . . . 0.0 113.422 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -141.12 133.87 28.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.41 -29.69 32.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 124.33 1.052 . . . . 0.0 112.554 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.293 38.9 mmt180 71.19 17.64 5.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.308 1.443 . . . . 0.0 114.043 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -155.19 97.49 1.92 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.734 2.413 . . . . 0.0 105.365 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.286 15.1 m 72.62 46.38 0.29 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.522 3.529 . . . . 0.0 113.179 -0.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -132.87 149.19 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.041 1.336 . . . . 0.0 108.823 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -38.43 83.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.595 2.358 . . . . 0.0 111.738 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 m -60.44 130.54 47.09 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.556 1.646 . . . . 0.0 114.543 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.46 149.01 39.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.005 1.322 . . . . 0.0 113.047 168.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -52.81 139.19 27.54 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -60.94 137.23 58.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.483 -0.761 . . . . 0.0 112.307 167.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.9 p -68.22 -42.76 79.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.2 pt -84.18 127.39 39.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 120.19 -1.569 . . . . 0.0 112.244 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.7 10.87 0.42 Allowed 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.245 -1.535 . . . . 0.0 114.165 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.69 121.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 123.752 0.821 . . . . 0.0 108.807 167.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 53.5 m -142.15 125.57 16.64 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.551 -167.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.3 p -122.14 143.59 49.45 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.76 155.41 79.43 Favored Pre-proline 0 C--O 1.235 0.324 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -55.6 144.38 75.06 Favored 'Trans proline' 0 CA--C 1.51 -0.68 0 C-N-CA 123.041 2.494 . . . . 0.0 113.828 167.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -146.76 143.78 28.92 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -95.33 2.7 54.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.621 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.84 92.73 Favored Pre-proline 0 C--N 1.347 0.462 0 O-C-N 121.322 -0.861 . . . . 0.0 113.021 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -44.51 138.78 7.48 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 125.121 3.881 . . . . 0.0 116.448 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.59 54.33 2.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -58.84 -33.83 75.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 120.699 -1.25 . . . . 0.0 115.574 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 9.76 40.4 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.544 -0.974 . . . . 0.0 112.188 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.3 2.9 t 59.73 46.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 123.578 1.656 . . . . 0.0 113.968 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.1 p -93.31 1.91 56.79 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 119.036 -2.29 . . . . 0.0 112.767 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.329 5.7 m 48.96 62.92 2.34 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.635 2.374 . . . . 0.0 115.411 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 62.26 36.41 14.75 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 126.372 1.869 . . . . 0.0 115.071 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -142.88 163.85 31.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.8 p -81.27 147.41 29.94 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.486 -2.009 . . . . 0.0 113.545 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.64 146.12 86.39 Favored Pre-proline 0 C--N 1.36 1.059 0 O-C-N 120.873 -1.142 . . . . 0.0 112.056 168.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -52.23 -24.29 20.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.153 3.236 . . . . 0.0 116.931 167.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -120.68 -40.07 2.69 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 120.126 1.33 . . . . 0.0 110.013 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.0 m -82.09 76.25 8.98 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 119.572 -1.955 . . . . 0.0 110.164 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -148.14 43.69 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.432 1.111 . . . . 0.0 111.014 -170.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -52.32 -38.28 58.1 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -74.3 -16.08 60.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.314 1.046 . . . . 0.0 112.879 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.69 -18.2 10.34 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.894 -1.129 . . . . 0.0 113.631 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -59.83 139.62 57.19 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t -65.34 -41.25 94.1 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.186 -1.571 . . . . 0.0 114.658 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -120.57 142.1 49.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . 0.257 66.6 m 61.3 37.31 17.21 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 tt -63.6 147.31 12.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 126.266 1.826 . . . . 0.0 110.901 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -85.24 122.19 29.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.173 -1.579 . . . . 0.0 111.127 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -130.82 -25.66 2.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.344 -0.848 . . . . 0.0 111.378 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 p -81.38 127.83 39.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 124.386 1.074 . . . . 0.0 111.654 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.88 155.74 15.94 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 tp -139.77 129.58 24.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -140.11 -172.87 13.01 Favored Glycine 0 CA--C 1.498 -0.973 0 O-C-N 120.931 -1.105 . . . . 0.0 115.133 -172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.86 134.71 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.8 1.286 . . . . 0.0 110.153 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.45 112.91 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 108.399 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.4 139.89 21.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.788 -1.195 . . . . 0.0 108.448 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 171.02 -147.69 10.62 Favored Glycine 0 CA--C 1.493 -1.341 0 CA-C-O 121.845 0.692 . . . . 0.0 111.413 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.51 140.14 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.908 0.861 . . . . 0.0 109.446 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.47 146.89 18.9 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.95 128.69 53.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.637 1.175 . . . . 0.0 110.433 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 132' ' ' LYS . 1.6 m-20 -71.71 128.53 36.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.978 1.371 . . . . 0.0 113.922 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mm -105.82 -36.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 123.466 1.603 . . . . 0.0 108.603 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 163.54 36.98 Favored Pre-proline 0 C--N 1.346 0.418 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.74 7.24 2.43 Favored 'Trans proline' 0 C--O 1.235 0.354 0 CA-C-N 124.104 2.501 . . . . 0.0 112.362 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -121.01 -2.26 9.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.72 1.145 . . . . 0.0 113.453 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 9.2 tt -132.28 128.06 37.0 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 120.328 1.422 . . . . 0.0 110.703 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -123.95 133.75 53.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.172 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 35.7 tp -93.47 132.6 37.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -139.61 134.25 31.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 121.576 -0.702 . . . . 0.0 110.711 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -148.51 145.15 27.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.1 -164.78 30.58 Favored Glycine 0 CA--C 1.485 -1.817 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.389 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.2 147.64 46.35 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.237 1.018 . . . . 0.0 111.832 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.84 27.74 2.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 162.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -30.75 135.92 0.05 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 129.343 3.057 . . . . 0.0 116.659 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.03 159.74 41.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.021 -1.049 . . . . 0.0 109.028 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -118.96 144.27 46.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -155.22 162.85 40.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.52 -85.96 1.07 Allowed Glycine 0 C--N 1.346 1.103 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.7 128.82 55.27 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.6 -0.941 . . . . 0.0 110.296 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.91 137.95 52.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.39 145.08 45.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.29 0.95 . . . . 0.0 110.169 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -175.24 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.961 1.304 . . . . 0.0 112.181 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.318 4.3 m 70.37 49.58 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.004 2.121 . . . . 0.0 112.988 -167.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.295 93.0 mtt180 64.55 41.42 5.49 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.201 2.2 . . . . 0.0 116.834 167.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -83.47 109.99 17.82 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.24 -1.538 . . . . 0.0 112.31 171.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -108.08 11.23 27.82 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 123.133 1.444 . . . . 0.0 109.131 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.2 p -62.61 136.7 58.02 Favored 'General case' 0 C--N 1.347 0.468 0 O-C-N 119.618 -1.926 . . . . 0.0 112.975 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.478 ' CE1' HH22 ' A' ' 138' ' ' ARG . 2.2 t-160 99.69 0.06 0.02 OUTLIER 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.972 2.109 . . . . 0.0 111.513 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -60.23 -44.9 94.82 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 123.122 1.439 . . . . 0.0 111.314 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -142.12 160.48 40.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 158.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 m -155.76 163.91 39.24 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 121.241 -0.912 . . . . 0.0 110.559 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.28 129.02 55.64 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.18 174.0 25.4 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-O 123.218 1.454 . . . . 0.0 113.542 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.99 136.12 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.31 2.9 ppt_? -134.03 136.78 44.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.072 -1.017 . . . . 0.0 111.094 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -126.25 138.41 53.61 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.8 119.32 22.09 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.299 1.047 . . . . 0.0 108.232 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.438 -1.059 0 C-N-CA 125.006 1.322 . . . . 0.0 110.504 -168.21 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.115 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -161.03 157.77 26.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 164.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.03 169.16 24.98 Favored Glycine 0 CA--C 1.497 -1.057 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 93.0 Cg_endo -87.55 163.03 8.03 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 CA-C-N 123.006 3.403 . . . . 0.0 109.007 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.89 155.1 35.08 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.931 -1.106 . . . . 0.0 110.535 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.09 155.45 31.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 120.629 -1.294 . . . . 0.0 110.144 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -146.22 146.35 30.76 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.43 1.092 . . . . 0.0 112.163 -169.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.08 137.76 26.2 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.813 -0.554 . . . . 0.0 110.731 169.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.81 147.32 48.79 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 122.232 1.015 . . . . 0.0 111.202 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.5 133.38 55.81 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.87 -94.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 120.952 -1.092 . . . . 0.0 110.661 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -64.05 125.3 24.02 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.36 -14.52 35.42 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-O 122.462 1.125 . . . . 0.0 111.464 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -161.1 155.23 22.74 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 166.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -116.18 63.27 0.71 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 123.369 1.557 . . . . 0.0 111.002 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -154.02 166.12 34.01 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.71 -12.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.815 0.846 . . . . 0.0 112.662 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 t -157.46 -179.85 8.57 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.558 -1.338 . . . . 0.0 108.65 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -93.94 132.05 38.78 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.455 1.902 . . . . 0.0 113.629 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.07 137.91 34.46 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.6 1.16 . . . . 0.0 112.668 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -60.16 145.05 86.3 Favored Pre-proline 0 C--N 1.347 0.496 0 C-N-CA 126.246 1.818 . . . . 0.0 114.231 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -26.01 22.27 Favored 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.794 2.33 . . . . 0.0 112.925 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.34 157.01 79.2 Favored Pre-proline 0 N--CA 1.443 -0.794 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -39.34 135.11 1.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 124.48 3.453 . . . . 0.0 118.117 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -89.87 -1.89 58.08 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 120.758 -1.214 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.98 130.84 8.39 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -53.99 128.25 28.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.312 2.675 . . . . 0.0 113.837 166.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -137.14 164.16 29.11 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -157.96 16.75 0.24 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.313 1.054 . . . . 0.0 110.134 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.03 155.83 50.09 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -107.42 110.08 21.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.54 16.97 3.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 122.27 1.033 . . . . 0.0 109.467 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.8 t -150.88 149.46 29.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 120.874 -1.141 . . . . 0.0 108.397 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -64.46 -45.72 86.23 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.845 1.658 . . . . 0.0 115.165 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 m -47.48 176.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.78 0 C-N-CA 131.512 3.925 . . . . 0.0 117.905 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -59.73 143.65 50.29 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 119.062 -2.274 . . . . 0.0 116.516 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t0 59.09 171.11 0.07 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.681 1.992 . . . . 0.0 114.759 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -64.03 -43.42 95.63 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.926 1.69 . . . . 0.0 112.306 171.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -134.86 123.42 23.46 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -60.08 143.9 50.91 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 120.409 -1.432 . . . . 0.0 114.815 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -153.11 152.83 31.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 120.857 -1.152 . . . . 0.0 108.623 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 mt 69.69 106.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 128.524 2.73 . . . . 0.0 112.24 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -30.3 131.32 0.08 Allowed 'General case' 0 C--N 1.359 1.013 0 N-CA-C 117.643 2.46 . . . . 0.0 117.643 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -59.72 145.95 43.18 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.122 1.369 . . . . 0.0 113.067 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -160.48 162.21 33.05 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 119.924 -1.735 . . . . 0.0 109.918 -163.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t 94.42 37.83 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.477 1.911 . . . . 0.0 110.932 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.05 138.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 125.612 1.565 . . . . 0.0 112.416 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 74' ' ' TYR . 37.5 m170 -100.0 125.21 40.85 Favored Pre-proline 0 C--N 1.348 0.518 0 O-C-N 119.97 -1.706 . . . . 0.0 108.021 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -50.43 132.56 35.25 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.344 2.696 . . . . 0.0 115.457 164.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -68.98 124.63 24.27 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.84 138.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.481 1.112 . . . . 0.0 109.549 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -152.95 146.83 25.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 120.615 -1.303 . . . . 0.0 108.673 -171.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.98 145.02 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.12 -162.39 11.37 Favored Glycine 0 CA--C 1.493 -1.291 0 CA-C-O 122.573 1.096 . . . . 0.0 115.255 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.5 t80 -124.66 140.71 52.68 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 125.456 1.502 . . . . 0.0 108.033 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.18 126.1 53.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.744 1.218 . . . . 0.0 110.102 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.65 161.95 19.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.44 95.98 0.71 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 119.544 -1.973 . . . . 0.0 112.867 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.68 -7.85 34.07 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 124.584 1.087 . . . . 0.0 112.518 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -139.96 122.75 16.47 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.53 1.132 . . . . 0.0 109.797 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -126.89 127.7 45.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 pt -124.25 134.84 65.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.18 157.04 31.92 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.431 -1.418 . . . . 0.0 112.753 -171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.0 139.48 54.03 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.762 1.225 . . . . 0.0 110.985 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.3 133.22 43.01 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 122.7 1.238 . . . . 0.0 110.822 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -124.58 140.99 52.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.693 1.597 . . . . 0.0 108.678 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.44 27.97 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.604 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.3 mmt-85 -127.08 23.7 6.48 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 125.115 1.366 . . . . 0.0 109.934 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 60.6 t80 -63.87 135.8 56.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.424 1.49 . . . . 0.0 111.814 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 55.2 ttp180 -96.03 -25.29 15.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 118.483 -2.635 . . . . 0.0 111.041 -5.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -145.18 48.29 1.29 Allowed 'General case' 0 C--N 1.353 0.733 0 CA-C-O 122.558 1.171 . . . . 0.0 108.033 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 74.01 40.85 0.43 Allowed 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.303 1.525 . . . . 0.0 110.24 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -78.65 149.92 32.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.52 -1.362 . . . . 0.0 112.729 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.4 m120 63.83 42.07 6.35 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -128.72 131.68 47.92 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 120.181 -1.574 . . . . 0.0 107.789 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.32 139.49 58.53 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 110.419 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -128.95 160.96 31.03 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -87.31 119.11 27.23 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.049 -1.657 . . . . 0.0 109.374 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.8 1.11 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.636 1.208 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -104.46 16.66 25.67 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.758 -1.214 . . . . 0.0 111.344 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.29 -12.06 8.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 165.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.304 52.8 mt-10 38.57 46.47 0.99 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 128.563 2.745 . . . . 0.0 117.063 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.39 -29.66 64.27 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.313 1.845 . . . . 0.0 113.451 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.08 -14.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 126.888 2.075 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -82.87 -13.06 56.84 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 120.606 -1.309 . . . . 0.0 113.248 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.3 mm -104.24 -36.58 4.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.579 -1.326 . . . . 0.0 110.457 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.18 131.59 16.63 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 120.672 -1.268 . . . . 0.0 107.79 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -101.27 -77.37 0.54 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.316 0.579 . . . . 0.0 111.517 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 94' ' ' GLU . 14.1 mp0 -61.56 -46.06 91.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 127.991 2.516 . . . . 0.0 110.16 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.87 32.04 4.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.631 2.772 . . . . 0.0 108.926 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.96 3.08 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 113.61 166.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 pt -89.78 10.26 2.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 O-C-N 119.98 -1.894 . . . . 0.0 112.484 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 15.53 75.31 0.01 OUTLIER 'General case' 0 C--N 1.353 0.736 0 C-N-CA 131.087 3.755 . . . . 0.0 118.254 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.6 pt -89.42 -2.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 O-C-N 119.915 -1.741 . . . . 0.0 112.623 -160.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.265 33.7 t0 60.3 -142.96 0.53 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.452 1.501 . . . . 0.0 112.618 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 80.02 15.19 0.84 Allowed 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 119.526 -1.984 . . . . 0.0 113.061 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.2 pttm -56.59 -41.9 77.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.415 1.486 . . . . 0.0 113.741 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 92.7 m 113.6 115.85 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 129.182 2.993 . . . . 0.0 105.621 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.66 64.08 6.21 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.806 1.289 . . . . 0.0 111.038 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.96 -46.83 78.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.04 2.136 . . . . 0.0 114.999 -166.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -77.54 -16.66 58.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 119.834 -1.791 . . . . 0.0 115.237 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.81 -46.92 88.63 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -111.23 20.79 17.01 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.079 -1.013 . . . . 0.0 109.862 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.53 23.34 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 117.528 1.771 . . . . 0.0 117.528 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -134.16 160.58 37.37 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 120.815 -1.403 . . . . 0.0 111.074 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -123.88 20.34 9.23 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 120.017 -1.677 . . . . 0.0 109.341 169.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -136.98 128.64 28.75 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 127.458 2.303 . . . . 0.0 109.233 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.58 145.84 38.03 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.006 -1.684 . . . . 0.0 115.213 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -72.44 -24.19 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 119.551 -1.968 . . . . 0.0 113.422 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 t -65.76 145.27 56.2 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.0 t -150.05 144.66 25.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -122.94 133.39 54.39 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -126.69 157.02 20.3 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 120.748 -1.22 . . . . 0.0 114.548 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.22 132.21 56.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.3 m -117.25 135.58 53.71 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 121.162 -0.961 . . . . 0.0 109.953 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.5 117.13 25.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 163.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -128.65 150.09 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.87 138.94 54.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -118.64 125.87 50.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 123.021 1.391 . . . . 0.0 110.583 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -84.43 139.97 31.85 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 122.398 1.094 . . . . 0.0 111.906 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -93.02 11.85 26.08 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 121.098 -1.001 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.9 pt -71.11 -17.84 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 O-C-N 120.687 -1.258 . . . . 0.0 113.123 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -117.33 25.56 10.37 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.468 -0.77 . . . . 0.0 109.56 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.373 10.1 t0 70.92 -90.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.325 1.45 . . . . 0.0 113.371 167.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -99.67 -6.98 26.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.734 -1.229 . . . . 0.0 111.432 173.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -94.47 137.39 33.66 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -127.63 109.27 20.71 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 121.27 -0.894 . . . . 0.0 112.607 -160.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.41 130.47 32.06 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.79 2.327 . . . . 0.0 112.666 148.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.98 130.9 56.47 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 119.198 0.908 . . . . 0.0 110.822 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.1 tp -138.82 141.33 37.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -169.26 -170.57 33.98 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 120.036 -1.665 . . . . 0.0 112.823 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.06 153.51 41.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.635 0.731 . . . . 0.0 111.647 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -131.06 124.99 32.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.723 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.63 137.54 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.44 148.14 34.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 120.754 -1.216 . . . . 0.0 110.45 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.22 138.25 51.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.82 -169.09 39.76 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 120.633 -1.292 . . . . 0.0 110.88 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.97 129.06 51.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 120.647 -1.502 . . . . 0.0 110.6 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.25 160.32 32.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.029 1.332 . . . . 0.0 110.539 -166.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -102.88 111.23 23.46 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.105 -0.997 . . . . 0.0 113.096 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -65.46 155.22 36.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.467 1.107 . . . . 0.0 112.495 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -88.58 -16.62 32.08 Favored 'General case' 0 C--O 1.221 -0.416 0 O-C-N 120.575 -1.328 . . . . 0.0 113.875 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.3 -15.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.199 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -105.39 163.06 12.91 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 122.154 2.252 . . . . 0.0 106.898 159.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -120.68 135.26 55.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.453 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.46 -37.56 75.71 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.729 2.012 . . . . 0.0 114.639 -167.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 51.47 50.39 18.96 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 175' ' ' ASP . 8.2 ptpp? -96.29 -3.94 43.09 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.448 -1.407 . . . . 0.0 111.726 -166.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 157' ' ' VAL . 9.4 t -159.98 159.04 31.69 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 6.3 pt -100.66 -6.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.064 0.945 . . . . 0.0 110.195 171.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -63.68 -43.77 95.69 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 125.757 1.623 . . . . 0.0 113.713 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 154' ' ' THR . 61.6 t -130.2 112.37 23.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 O-C-N 119.884 -1.76 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -95.3 104.46 16.35 Favored 'General case' 0 C--N 1.347 0.476 0 O-C-N 120.676 -1.265 . . . . 0.0 108.516 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.2 m -59.28 117.75 5.15 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.88 157.2 69.41 Favored Pre-proline 0 C--O 1.248 1.025 0 O-C-N 120.948 -1.095 . . . . 0.0 112.472 171.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -40.84 132.96 2.67 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 124.233 3.289 . . . . 0.0 116.326 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.5 t -61.52 -39.28 90.46 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.979 1.312 . . . . 0.0 114.332 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.11 14.94 18.4 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.487 -1.383 . . . . 0.0 114.13 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -94.45 138.56 22.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 O-C-N 121.064 -1.023 . . . . 0.0 111.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.96 135.88 1.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 124.019 3.146 . . . . 0.0 115.633 157.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -131.48 142.5 49.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.52 -10.59 47.05 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 123.969 0.795 . . . . 0.0 112.773 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.15 25.15 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 121.406 -1.055 . . . . 0.0 111.369 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.17 -43.74 96.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 C-N-CA 125.5 1.52 . . . . 0.0 112.051 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 99.6 m -106.29 124.4 49.54 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -155.99 170.01 23.12 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -114.87 140.52 48.9 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -91.71 101.92 14.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 119.281 -2.137 . . . . 0.0 107.927 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.1 t -79.81 -18.46 50.86 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 118.929 -2.357 . . . . 0.0 110.97 172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 153' ' ' LYS . 33.4 m-20 -126.58 156.18 73.6 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -36.7 142.57 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.349 1 C-N-CA 125.363 4.042 . . . . 0.0 117.889 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.42 -42.8 99.72 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.15 149.05 45.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.149 2.179 . . . . 0.0 115.944 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -127.69 139.13 52.89 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.011 -1.681 . . . . 0.0 107.737 165.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . 0.254 68.4 m-20 81.28 26.1 0.22 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.437 1.095 . . . . 0.0 112.126 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.488 ' CG ' HE21 ' A' ' 183' ' ' GLN . 19.3 t0 -117.57 136.49 53.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.76 2.024 . . . . 0.0 108.333 -175.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -112.86 7.64 18.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.749 0.82 . . . . 0.0 111.692 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.488 HE21 ' CG ' ' A' ' 181' ' ' ASP 0.293 6.1 mp0 55.03 54.08 9.41 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -177.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.9 m -51.34 126.61 17.46 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.685 -1.259 . . . . 0.0 114.187 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.266 51.3 m-80 79.04 16.39 0.98 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.362 1.465 . . . . 0.0 113.345 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.5 t -130.18 160.21 34.5 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.221 -1.55 . . . . 0.0 109.208 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.1 pt -94.87 1.66 9.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.678 0 CA-C-O 123.091 1.424 . . . . 0.0 111.591 -163.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -64.59 -45.66 86.01 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -63.0 -35.0 78.75 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.7 p 178.51 129.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 107.298 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -117.15 139.33 14.96 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 120.568 -1.332 . . . . 0.0 110.052 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.01 133.1 56.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 120.902 -1.352 . . . . 0.0 111.937 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.86 169.2 23.99 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-O 123.333 1.518 . . . . 0.0 114.022 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.48 132.49 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 pt -122.82 136.49 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 O-C-N 120.286 -1.508 . . . . 0.0 109.732 -168.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -135.33 161.18 36.14 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.01 177.62 44.64 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -146.97 144.02 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.97 -159.64 15.11 Favored Glycine 0 CA--C 1.49 -1.47 0 O-C-N 120.754 -1.216 . . . . 0.0 113.557 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -155.83 148.31 23.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.61 -0.935 . . . . 0.0 112.225 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.28 104.13 15.52 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.108 -1.62 . . . . 0.0 108.584 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 mt -61.1 -42.19 92.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 126.57 1.948 . . . . 0.0 111.303 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.3 p -138.77 164.84 36.86 Favored Pre-proline 0 CA--C 1.511 -0.534 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.4 -25.3 4.81 Favored 'Trans proline' 0 C--N 1.33 -0.429 0 C-N-CA 123.424 2.75 . . . . 0.0 117.233 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -111.21 -12.68 14.09 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 69.8 tp -116.72 127.98 54.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 120.839 1.654 . . . . 0.0 109.715 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -145.7 147.09 31.58 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.39 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.14 124.13 24.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.655 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -135.5 160.48 38.35 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 122.984 1.373 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.69 135.37 53.83 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.8 145.89 17.88 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.813 0.72 . . . . 0.0 111.907 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.59 121.62 18.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -133.93 140.65 46.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.99 -1.069 . . . . 0.0 109.249 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -120.89 125.99 48.88 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.22 1.008 . . . . 0.0 108.339 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -138.57 157.2 46.6 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 120.397 -1.439 . . . . 0.0 109.604 -167.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 66.04 42.64 3.2 Favored 'General case' 0 C--N 1.348 0.521 0 C-N-CA 125.834 1.653 . . . . 0.0 114.753 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -24.94 115.29 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 119.034 2.976 . . . . 0.0 119.034 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 73.64 8.92 77.81 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 116.132 1.213 . . . . 0.0 116.132 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.38 113.75 22.54 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 43.2 tp -162.71 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 -159.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 147.64 53.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.598 1.959 . . . . 0.0 114.062 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 69.94 42.17 1.06 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.986 1.315 . . . . 0.0 112.557 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m 59.13 55.25 4.46 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 123.406 1.574 . . . . 0.0 112.124 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -80.75 99.23 8.13 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 119.479 -2.013 . . . . 0.0 114.383 -163.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.7 145.11 53.37 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 113.961 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . 0.256 26.4 mmtp 69.79 40.24 1.36 Allowed 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.232 1.813 . . . . 0.0 113.161 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.5 p -102.91 -4.25 25.04 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.414 1.485 . . . . 0.0 109.984 168.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -157.9 165.07 36.15 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 120.468 -1.395 . . . . 0.0 108.727 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.2 132.86 15.84 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.772 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.6 132.28 55.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 p -151.52 154.96 37.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.465 -0.772 . . . . 0.0 112.497 -163.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 66.2 tp -119.51 126.0 50.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -139.53 149.59 20.85 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 120.682 -1.262 . . . . 0.0 114.901 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.8 147.92 19.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.72 146.12 32.03 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.79 138.77 32.49 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.179 -0.951 . . . . 0.0 109.545 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -100.93 144.03 30.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.709 1.204 . . . . 0.0 109.47 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 C--O 1.258 1.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.704 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.526 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -164.68 166.21 20.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 160.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.26 159.06 8.98 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.18 160.88 5.74 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.77 2.314 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -150.79 158.15 43.79 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 123.055 1.407 . . . . 0.0 111.334 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.27 149.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 162.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -144.65 142.63 30.26 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.137 0.975 . . . . 0.0 110.391 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.66 128.52 56.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' CG ' HH22 ' A' ' 138' ' ' ARG . 56.9 m-20 -117.79 131.93 56.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 123.172 0.589 . . . . 0.0 110.636 -169.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -142.38 161.76 37.22 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 120.947 -1.096 . . . . 0.0 109.981 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.65 135.59 39.93 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.608 0.763 . . . . 0.0 109.187 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -145.04 132.2 20.45 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -172.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.09 156.87 46.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.519 3.528 . . . . 0.0 104.996 -7.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -141.13 119.76 12.46 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 121.917 0.865 . . . . 0.0 111.676 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -117.58 136.61 53.16 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.94 134.39 51.9 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.35 -38.45 69.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 p -96.65 8.4 44.31 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 119.898 -1.751 . . . . 0.0 111.756 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 t60 62.11 28.95 17.45 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.921 1.689 . . . . 0.0 113.428 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -72.8 142.32 48.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.537 1.535 . . . . 0.0 111.561 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -110.5 106.41 57.85 Favored Pre-proline 0 C--N 1.355 0.828 0 O-C-N 120.822 -1.174 . . . . 0.0 111.427 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.85 -30.24 7.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.268 1.979 . . . . 0.0 113.497 -170.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -139.83 126.07 12.1 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.39 1.476 . . . . 0.0 107.265 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.91 135.93 43.06 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.093 2.529 . . . . 0.0 115.751 -166.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 p -61.64 -44.29 97.25 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 127.748 2.419 . . . . 0.0 116.292 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.0 87.27 Favored Pre-proline 0 C--N 1.343 0.324 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.61 -44.27 26.26 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 124.406 3.404 . . . . 0.0 117.19 160.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -61.36 -46.14 91.45 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -59.8 -35.07 73.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -92.48 16.51 11.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.872 1.269 . . . . 0.0 111.664 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.266 40.6 ttpt 85.03 96.77 0.03 OUTLIER 'General case' 0 C--O 1.244 0.773 0 C-N-CA 128.19 2.596 . . . . 0.0 112.288 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.82 -35.13 45.37 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 127.191 2.196 . . . . 0.0 114.936 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.3 p -57.43 -31.64 66.1 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 120.678 -1.264 . . . . 0.0 114.37 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m -58.37 -41.33 84.51 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 126.26 1.824 . . . . 0.0 114.325 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.58 -8.73 9.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.497 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.2 m -125.33 48.02 2.1 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.005 -1.059 . . . . 0.0 108.143 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -63.2 -38.85 92.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.457 1.903 . . . . 0.0 112.778 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -56.83 136.83 55.55 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.297 1.439 . . . . 0.0 113.645 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -119.65 116.96 27.06 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.32 -9.81 1.27 Allowed 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.822 -0.548 . . . . 0.0 111.197 167.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -159.05 156.23 28.87 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.59 133.09 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.696 0.76 . . . . 0.0 112.093 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -151.46 158.98 44.37 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -165.08 -1.96 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.806 1.639 . . . . 0.0 115.189 -168.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.322 19.8 tpt180 54.71 61.72 2.86 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.962 2.905 . . . . 0.0 114.112 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -159.01 163.13 36.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.134 -1.603 . . . . 0.0 107.497 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.11 5.56 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 O-C-N 120.525 -1.359 . . . . 0.0 108.875 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 56.87 66.12 3.4 Favored Pre-proline 0 C--N 1.349 0.587 0 C-N-CA 126.333 1.853 . . . . 0.0 114.868 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -40.33 140.48 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.206 1.937 . . . . 0.0 115.328 147.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -126.97 155.57 42.93 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -116.47 134.99 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.5 m -115.99 124.96 51.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.028 0.931 . . . . 0.0 109.357 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.0 t -117.57 127.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 O-C-N 120.735 -1.228 . . . . 0.0 107.894 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.82 -164.43 15.71 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 117.024 1.569 . . . . 0.0 117.024 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -147.14 139.37 24.58 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.079 1.352 . . . . 0.0 111.311 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -93.41 143.68 26.05 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.884 1.273 . . . . 0.0 112.339 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.42 -147.3 0.41 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.6 1.667 . . . . 0.0 109.496 166.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.82 81.42 0.65 Allowed Glycine 0 C--N 1.35 1.314 0 O-C-N 119.035 -2.291 . . . . 0.0 111.683 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.31 10.57 56.98 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 117.838 0.819 . . . . 0.0 112.729 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -155.64 154.51 31.71 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -152.77 147.66 26.32 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.467 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 tt -139.85 143.35 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-O 122.311 1.053 . . . . 0.0 108.92 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.59 154.02 35.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.867 0.842 . . . . 0.0 110.291 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.96 138.5 32.01 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 120.913 -1.117 . . . . 0.0 109.482 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -104.16 135.73 45.09 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 126.514 1.925 . . . . 0.0 108.801 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.08 147.1 26.67 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 120.106 -1.621 . . . . 0.0 114.108 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.06 43.7 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 114.205 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -117.34 -0.91 11.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -144.5 160.14 41.6 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 176.46 1.0 0.0 OUTLIER 'General case' 0 C--N 1.358 0.968 0 CA-C-N 119.763 1.165 . . . . 0.0 112.933 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -158.35 152.47 24.03 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 118.822 -2.424 . . . . 0.0 111.21 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -71.96 -10.32 59.61 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -125.73 118.35 25.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -97.47 -10.33 25.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -168.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.22 144.04 25.86 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.644 -1.285 . . . . 0.0 110.485 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -107.97 114.77 28.93 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 120.403 -1.436 . . . . 0.0 109.343 -168.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.47 165.86 26.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.24 1.416 . . . . 0.0 107.478 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -96.48 4.01 52.38 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 123.53 0.732 . . . . 0.0 112.726 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.91 150.27 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.989 0.916 . . . . 0.0 108.561 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.09 137.95 55.12 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.897 -1.127 . . . . 0.0 113.765 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -59.28 150.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.029 1.332 . . . . 0.0 114.261 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.59 -45.08 81.57 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -73.95 -13.83 60.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 120.859 -1.151 . . . . 0.0 113.81 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.66 2.06 8.82 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 121.092 -1.005 . . . . 0.0 110.126 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -104.2 -3.64 24.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.373 -1.454 . . . . 0.0 111.368 -172.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.0 pt -110.33 153.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.615 -1.303 . . . . 0.0 110.037 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -77.53 104.52 8.11 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 119.696 -1.878 . . . . 0.0 110.973 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -128.99 157.22 42.31 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.037 0.935 . . . . 0.0 111.968 -168.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.85 149.36 49.03 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.726 1.21 . . . . 0.0 112.073 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -114.34 -8.01 12.89 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.346 -1.471 . . . . 0.0 112.426 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.44 -9.63 81.8 Favored Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.605 1.574 . . . . 0.0 115.069 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.9 pt -92.75 11.76 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.134 1.374 . . . . 0.0 113.26 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -65.45 154.26 39.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 pt -124.35 166.76 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -148.52 158.65 44.26 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.038 -1.664 . . . . 0.0 108.4 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 107' ' ' GLU . 99.2 mtt180 -83.47 152.86 24.75 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.265 1.426 . . . . 0.0 112.578 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -99.13 -10.64 22.26 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.335 -0.853 . . . . 0.0 111.166 167.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -162.32 154.97 19.62 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.07 61.57 6.96 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.505 -1.372 . . . . 0.0 113.755 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.44 135.85 1.42 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 73.2 -72.45 0.12 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.765 1.269 . . . . 0.0 111.696 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 101' ' ' ARG . 67.9 mt-10 -60.92 -41.19 95.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.497 3.119 . . . . 0.0 116.269 -166.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -121.08 25.16 9.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.5 -17.46 13.53 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 124.256 0.931 . . . . 0.0 113.239 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -153.28 172.79 16.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.277 1.039 . . . . 0.0 108.483 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 47.23 -149.63 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.982 2.513 . . . . 0.0 114.481 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -90.59 22.1 3.65 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 120.165 -1.584 . . . . 0.0 111.298 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 41.64 -133.97 0.34 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 127.403 2.281 . . . . 0.0 115.402 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.51 11.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 124.957 1.303 . . . . 0.0 113.879 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.9 m -58.15 119.62 7.17 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m -62.29 -52.27 64.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.461 1.104 . . . . 0.0 113.602 -167.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -161.3 159.5 28.61 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.27 -167.16 24.35 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-O 122.658 1.143 . . . . 0.0 114.161 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 tp -121.27 135.52 55.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.44 1.896 . . . . 0.0 109.294 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.1 t -126.94 126.79 43.83 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.734 1.213 . . . . 0.0 109.17 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.14 130.07 32.73 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.645 -1.284 . . . . 0.0 108.945 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.52 135.75 51.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 123.103 0.561 . . . . 0.0 110.138 -170.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.91 120.57 42.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.396 1.478 . . . . 0.0 108.545 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -96.57 131.82 42.81 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.3 -0.875 . . . . 0.0 111.474 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -102.09 104.32 14.94 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.81 -1.181 . . . . 0.0 110.462 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -80.26 98.67 7.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 119.908 -1.745 . . . . 0.0 111.769 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.95 0.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 122.917 1.342 . . . . 0.0 109.212 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -160.43 165.0 31.85 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -45.74 88.09 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 125.463 1.505 . . . . 0.0 112.068 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -111.46 -30.51 7.36 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -90.43 124.88 35.32 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 130.15 23.46 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.614 1.165 . . . . 0.0 113.765 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.38 145.62 98.29 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 123.814 3.009 . . . . 0.0 111.854 138.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -144.08 159.48 42.55 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.4 tp -138.43 130.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 122.259 1.028 . . . . 0.0 108.566 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.93 23.66 Favored Glycine 0 CA--C 1.49 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.673 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.26 153.73 39.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 121.591 -0.947 . . . . 0.0 109.648 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.408 HH22 ' CG ' ' A' ' 14' ' ' ASP . 19.1 ttm180 -139.06 123.9 18.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.76 119.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.99 149.28 34.88 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -121.81 132.81 54.79 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-O 122.793 1.283 . . . . 0.0 113.39 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -63.6 179.05 6.51 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 120.036 -1.665 . . . . 0.0 114.625 163.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -78.41 -28.9 46.91 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.659 -1.495 . . . . 0.0 113.055 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.47 160.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -87.35 -95.55 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.797 0.808 . . . . 0.0 111.553 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.63 170.01 23.11 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m 80.25 92.81 0.05 OUTLIER 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.141 1.776 . . . . 0.0 112.223 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.87 102.55 4.54 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.77 -5.72 24.54 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 122.801 1.286 . . . . 0.0 111.578 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 56.8 p -77.2 -14.95 59.69 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 120.452 -1.405 . . . . 0.0 114.171 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -153.5 161.03 42.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.656 -1.278 . . . . 0.0 108.956 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -125.51 17.42 8.19 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.982 1.313 . . . . 0.0 109.679 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -119.01 126.73 52.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 m 64.88 47.3 2.68 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.517 1.151 . . . . 0.0 112.147 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 tp -144.67 145.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 120.727 -1.233 . . . . 0.0 108.161 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -65.52 142.35 58.16 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.29 1.036 . . . . 0.0 113.215 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.8 -13.77 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 123.586 0.754 . . . . 0.0 111.905 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 23.6 m -91.32 113.26 25.48 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 120.564 -1.335 . . . . 0.0 112.573 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.4 m -92.15 125.33 36.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 163.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -59.64 142.85 87.35 Favored Pre-proline 0 C--N 1.348 0.522 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.31 154.62 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.197 3.264 . . . . 0.0 117.836 165.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -117.15 120.85 39.58 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 63.15 48.52 3.7 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.0 156.27 58.56 Favored Pre-proline 0 C--N 1.349 0.566 0 O-C-N 120.384 -1.447 . . . . 0.0 111.895 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.19 154.14 14.78 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 123.742 2.962 . . . . 0.0 117.225 165.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.21 -33.2 10.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.248 0.547 . . . . 0.0 109.835 170.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 -80.72 1.55 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 167.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.55 -5.35 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.72 111.66 36.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 O-C-N 119.604 -1.935 . . . . 0.0 112.612 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -57.9 128.72 38.49 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.9 m -100.34 106.47 18.09 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 121.065 -1.022 . . . . 0.0 110.001 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 64.88 98.0 0.04 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -74.58 -26.41 59.91 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.394 -1.441 . . . . 0.0 112.748 165.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 p -132.64 128.74 37.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.075 0.95 . . . . 0.0 109.443 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.14 132.54 92.44 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 128.813 2.845 . . . . 0.0 116.125 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -67.18 -20.5 49.62 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.011 2.474 . . . . 0.0 113.261 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -127.95 109.72 11.85 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 166.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.9 t -58.91 139.67 56.33 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 120.765 -1.209 . . . . 0.0 112.242 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 74.8 10.62 3.9 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 126.114 1.766 . . . . 0.0 113.881 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -129.59 127.08 39.94 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 161.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.2 p30 -104.69 -42.83 5.29 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 120.063 -1.648 . . . . 0.0 112.219 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 58.66 31.19 20.86 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 125.696 1.598 . . . . 0.0 112.022 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.14 -37.32 84.75 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.1 t -158.67 165.57 34.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -144.19 156.53 44.35 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.416 -0.803 . . . . 0.0 109.439 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.2 t -115.03 111.82 21.7 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 120.982 -1.073 . . . . 0.0 109.592 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.21 141.31 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 0.0 114.536 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -139.19 -10.34 1.27 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 59.76 38.31 21.65 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 171.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.0 118.99 45.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.66 100.05 2.14 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 112.122 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.9 mt -116.11 130.19 56.69 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -166.51 163.27 36.83 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 122.878 1.265 . . . . 0.0 113.619 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.9 t -108.31 143.53 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -116.39 109.81 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 119.637 -1.914 . . . . 0.0 107.109 168.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -121.74 128.81 52.18 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.52 -151.2 9.3 Favored Glycine 0 CA--C 1.488 -1.628 0 C-N-CA 119.295 -1.431 . . . . 0.0 112.327 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.38 158.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 108.512 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.75 45.45 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 120.303 -1.498 . . . . 0.0 113.198 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -126.89 115.18 18.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.661 -1.27 . . . . 0.0 110.775 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.27 68.59 9.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 122.861 1.315 . . . . 0.0 108.832 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.12 -48.85 83.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 C-N-CA 126.065 1.746 . . . . 0.0 114.937 -169.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 t -161.4 155.97 19.65 Favored Pre-proline 0 CA--C 1.508 -0.662 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.09 -31.41 45.68 Favored 'Trans proline' 0 C--N 1.328 -0.528 0 CA-C-N 126.468 3.346 . . . . 0.0 112.784 -165.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -89.63 7.27 37.35 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 124.757 1.223 . . . . 0.0 113.629 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.2 tp -159.51 94.26 1.15 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 123.36 1.552 . . . . 0.0 107.691 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.7 p -121.24 144.03 48.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.755 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.0 130.89 34.27 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 235' ' ' ARG . 69.2 m-20 -118.72 128.28 54.35 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.912 1.285 . . . . 0.0 107.937 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -121.33 137.17 54.82 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.04 176.28 39.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 119.965 -1.709 . . . . 0.0 116.719 -171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.82 168.84 18.86 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.975 1.71 . . . . 0.0 110.839 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 87.85 18.1 0.07 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 128.549 2.74 . . . . 0.0 111.493 169.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -89.79 9.54 26.95 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 120.725 -1.234 . . . . 0.0 112.981 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -120.06 105.49 11.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 69.46 149.65 0.08 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 128.072 2.549 . . . . 0.0 113.843 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.43 -44.18 92.95 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.461 -1.399 . . . . 0.0 114.351 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.48 -176.57 22.8 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 58.5 -164.54 0.19 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -150.42 142.41 23.93 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -143.16 140.81 30.96 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -165.85 169.18 15.2 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 26.9 m -94.17 101.26 13.25 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.292 -1.505 . . . . 0.0 112.155 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 58.01 52.3 7.92 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 126.795 2.038 . . . . 0.0 115.501 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 67.31 41.16 2.55 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.47 1.108 . . . . 0.0 113.108 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -64.79 128.56 36.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 119.854 -1.779 . . . . 0.0 113.473 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.77 138.54 47.64 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.492 1.517 . . . . 0.0 112.764 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -60.32 151.56 27.4 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.585 1.554 . . . . 0.0 114.377 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.94 161.44 19.77 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.96 142.98 42.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.1 p -99.39 136.92 38.63 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.343 1.068 . . . . 0.0 108.745 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.5 mt -118.64 120.55 37.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -108.73 112.54 3.53 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.04 124.3 64.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 209' ' ' ASP . 25.2 ttp-105 -130.07 137.68 50.34 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -160.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -117.01 113.8 22.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.428 1.491 . . . . 0.0 108.573 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -92.27 145.12 24.73 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 120.949 -1.094 . . . . 0.0 108.723 162.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 C--O 1.254 1.294 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.278 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.081 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.04 147.02 40.71 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 118.93 1.365 . . . . 0.0 114.379 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.78 178.19 40.16 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.04 128.68 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.752 2.968 . . . . 0.0 109.82 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -138.78 150.28 45.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.937 0.875 . . . . 0.0 111.81 -168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.53 149.88 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.462 -163.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -145.68 149.99 35.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.206 1.402 . . . . 0.0 111.087 -171.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.42 145.54 46.15 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -71.03 175.09 5.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 123.364 1.554 . . . . 0.0 111.561 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.9 mt -102.84 -15.15 16.31 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 119.633 -1.917 . . . . 0.0 110.661 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.28 104.3 13.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.959 -1.713 . . . . 0.0 112.467 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.13 -24.06 13.98 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.255 -1.528 . . . . 0.0 111.134 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.75 106.18 18.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.932 0.872 . . . . 0.0 110.735 -173.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -125.07 14.48 8.44 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.011 1.324 . . . . 0.0 113.926 -170.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.71 16.51 25.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.858 1.314 . . . . 0.0 110.713 -168.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -92.27 3.11 56.06 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.382 -2.073 . . . . 0.0 112.117 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -122.98 137.16 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 m -64.12 126.8 28.89 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.674 1.226 . . . . 0.0 110.959 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -63.17 148.92 46.64 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 120.416 -1.427 . . . . 0.0 112.182 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 -15.82 62.26 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-O 122.105 0.955 . . . . 0.0 112.611 -163.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -117.78 132.41 23.66 Favored Pre-proline 0 C--N 1.347 0.479 0 O-C-N 120.571 -1.331 . . . . 0.0 107.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.2 134.83 30.92 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.099 3.199 . . . . 0.0 114.933 170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' CD ' HH12 ' A' ' 75' ' ' ARG . 31.5 mt-10 -96.36 116.37 66.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -44.02 139.34 5.93 Favored 'Trans proline' 0 C--N 1.335 -0.158 0 C-N-CA 124.762 3.642 . . . . 0.0 118.111 165.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -156.56 162.31 39.92 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.87 147.66 19.39 Favored Pre-proline 0 N--CA 1.445 -0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 108.166 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -61.81 -178.01 0.28 Allowed 'Trans proline' 0 C--N 1.334 -0.228 0 C-N-CA 123.875 3.05 . . . . 0.0 113.652 153.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 61.82 32.91 17.98 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 165.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -84.72 13.95 5.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.242 -1.537 . . . . 0.0 114.478 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -112.35 7.78 19.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.642 1.577 . . . . 0.0 110.233 168.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.3 -41.44 2.41 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 120.887 -1.133 . . . . 0.0 110.388 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 pt -147.89 155.2 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -121.29 150.11 41.89 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.441 -1.412 . . . . 0.0 108.051 165.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -106.15 11.65 31.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.219 1.408 . . . . 0.0 110.286 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.1 152.72 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 m -61.38 -35.84 78.6 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 113.73 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.41 136.88 57.56 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 117.95 2.574 . . . . 0.0 117.95 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.87 155.6 47.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 61.54 46.56 7.27 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -115.7 16.66 16.39 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.453 -0.779 . . . . 0.0 110.321 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.6 m120 51.02 49.52 21.0 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.47 132.88 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 127.049 2.14 . . . . 0.0 114.77 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 82.13 10.29 0.74 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 127.217 2.207 . . . . 0.0 112.938 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.3 p -125.03 135.39 52.71 Favored 'General case' 0 CA--C 1.506 -0.723 0 O-C-N 120.264 -1.522 . . . . 0.0 108.424 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.74 2.23 0.08 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.104 -1.623 . . . . 0.0 111.062 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -104.73 -2.98 24.2 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.199 -0.938 . . . . 0.0 112.107 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.06 -34.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 O-C-N 120.384 -1.447 . . . . 0.0 112.743 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -76.34 117.59 65.42 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.48 -1.387 . . . . 0.0 110.199 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.41 -2.02 11.97 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.854 2.369 . . . . 0.0 113.099 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.296 8.6 mpt_? 66.59 -177.59 0.2 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.4 134.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 119.991 -1.693 . . . . 0.0 107.383 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.8 t -116.0 125.2 52.16 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.69 167.22 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 119.891 -1.756 . . . . 0.0 106.993 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.46 33.48 Favored Glycine 0 CA--C 1.481 -2.057 0 O-C-N 119.027 -2.296 . . . . 0.0 109.788 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -140.45 131.33 25.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 138.41 46.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.122 0.963 . . . . 0.0 110.279 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.59 -160.35 0.77 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 123.27 1.509 . . . . 0.0 109.136 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.75 1.36 Allowed Glycine 0 C--N 1.359 1.821 0 O-C-N 119.209 -2.182 . . . . 0.0 112.45 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.06 62.0 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 123.662 0.649 . . . . 0.0 114.236 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -159.6 167.58 28.13 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -151.75 150.13 29.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.098 -1.001 . . . . 0.0 111.23 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -117.38 125.7 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.17 152.93 48.21 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 120.61 -1.307 . . . . 0.0 110.792 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.16 125.45 29.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.572 1.149 . . . . 0.0 109.23 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -96.34 122.27 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.149 0.979 . . . . 0.0 108.438 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -101.02 103.54 14.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.005 -1.684 . . . . 0.0 111.21 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.71 165.03 35.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 122.405 1.098 . . . . 0.0 111.641 -168.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 175.54 99.45 0.01 OUTLIER 'General case' 0 C--N 1.351 0.672 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -86.61 -24.64 25.29 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 119.673 -1.892 . . . . 0.0 110.528 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.586 HH12 ' CD ' ' A' ' 28' ' ' GLU . 23.7 mmt180 -150.88 159.53 44.49 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.073 1.349 . . . . 0.0 109.286 -173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -123.24 142.15 51.23 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.648 -1.908 . . . . 0.0 108.938 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -144.97 144.11 30.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -155.29 170.61 21.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.802 2.041 . . . . 0.0 108.158 -170.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 81.99 11.89 0.66 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.511 1.924 . . . . 0.0 114.161 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.404 HD21 ' CE1' ' A' ' 112' ' ' HIS . 33.2 m120 -54.49 -34.86 62.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 127.399 2.28 . . . . 0.0 116.066 -174.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -68.13 -21.71 64.92 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 120.378 -1.451 . . . . 0.0 114.518 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.26 -7.6 22.9 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.378 -1.452 . . . . 0.0 111.486 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -69.79 -39.29 76.68 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 120.985 -1.072 . . . . 0.0 113.688 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -95.66 121.46 46.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 123.696 1.712 . . . . 0.0 112.128 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.35 83.67 7.39 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 118.845 -2.409 . . . . 0.0 110.827 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.6 mm -61.01 -41.62 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 126.545 1.938 . . . . 0.0 111.038 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.71 53.65 1.97 Allowed 'General case' 0 C--N 1.357 0.921 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.99 11.05 12.37 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.528 -1.358 . . . . 0.0 111.647 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.63 153.92 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -127.1 122.25 33.76 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.372 -1.455 . . . . 0.0 110.711 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 129.54 42.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -127.76 137.92 52.59 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.171 -167.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -124.95 138.55 54.23 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 164.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -57.43 -47.27 82.22 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 -167.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -104.37 26.55 8.79 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.438 -1.414 . . . . 0.0 110.725 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.16 152.36 49.2 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 120.761 -1.212 . . . . 0.0 115.625 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.26 166.62 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.62 159.78 36.18 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.95 19.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 123.504 1.621 . . . . 0.0 108.097 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.84 146.66 54.58 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.002 -1.686 . . . . 0.0 112.6 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt-85 -84.96 -11.88 54.55 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 120.022 -1.674 . . . . 0.0 113.513 -165.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.299 78.7 tttt 26.31 64.15 0.07 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 130.089 3.356 . . . . 0.0 117.028 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 t -81.1 156.71 25.65 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 123.037 1.399 . . . . 0.0 112.178 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -101.33 -1.48 33.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.317 1.447 . . . . 0.0 109.579 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m120 56.57 45.35 22.43 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 125.137 1.375 . . . . 0.0 112.632 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -101.15 -11.18 19.77 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 109.328 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.84 -25.12 63.59 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -164.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -91.35 -3.84 56.37 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 121.062 -1.024 . . . . 0.0 111.301 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.49 17.68 70.48 Favored Glycine 0 C--N 1.36 1.866 0 O-C-N 120.565 -1.334 . . . . 0.0 114.0 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -126.76 137.11 53.18 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.311 -1.111 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.0 9.2 15.99 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.298 -1.501 . . . . 0.0 109.938 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.404 ' CE1' HD21 ' A' ' 80' ' ' ASN . 30.8 m170 73.67 15.54 4.02 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.716 1.607 . . . . 0.0 112.108 -177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.33 24.06 6.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.714 1.606 . . . . 0.0 113.565 -163.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 m -92.36 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 O-C-N 120.017 -1.677 . . . . 0.0 109.37 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -20.64 118.34 0.03 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 129.575 3.15 . . . . 0.0 118.156 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -164.16 160.54 21.49 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 -160.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.9 tp -46.97 130.2 12.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.796 1.638 . . . . 0.0 115.407 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -159.21 167.62 35.0 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 120.721 -1.237 . . . . 0.0 115.847 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.6 tp -122.74 127.81 49.69 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.208 1.803 . . . . 0.0 109.639 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -127.43 135.53 50.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.049 1.339 . . . . 0.0 111.682 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.75 130.71 55.95 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.93 -1.731 . . . . 0.0 109.428 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.17 135.13 47.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 123.817 0.847 . . . . 0.0 108.808 -166.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -101.55 139.11 37.65 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.972 1.309 . . . . 0.0 109.35 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -104.85 106.72 17.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -67.53 131.95 46.64 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 119.97 -1.706 . . . . 0.0 112.984 170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.56 62.12 0.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.106 -0.996 . . . . 0.0 109.651 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.0 pt -100.05 -1.75 9.87 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.43 0.634 . . . . 0.0 110.234 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -152.84 141.37 20.79 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -61.58 -49.93 74.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -67.9 -47.61 68.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -112.25 117.49 32.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.456 -0.777 . . . . 0.0 110.996 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -111.85 106.46 56.5 Favored Pre-proline 0 C--O 1.237 0.406 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 142.63 98.97 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.211 3.274 . . . . 0.0 114.018 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -124.61 142.75 51.14 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.33 1.052 . . . . 0.0 111.443 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.91 136.14 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.14 -170.98 32.69 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.183 -1.573 . . . . 0.0 112.831 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.14 149.74 40.18 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 122.007 -0.702 . . . . 0.0 109.761 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -128.86 135.12 48.66 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.399 1.08 . . . . 0.0 111.644 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.48 128.66 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.768 1.27 . . . . 0.0 108.621 165.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.83 137.24 54.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.555 -1.966 . . . . 0.0 110.541 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.32 80.03 0.75 Allowed 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.88 -1.137 . . . . 0.0 109.503 -165.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -96.6 -13.82 46.17 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 120.592 -1.318 . . . . 0.0 114.977 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -164.26 159.36 19.9 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.049 -1.265 . . . . 0.0 109.143 167.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.67 131.16 22.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.982 2.113 . . . . 0.0 112.608 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.79 -12.54 12.73 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.836 -1.165 . . . . 0.0 112.957 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -165.08 157.37 15.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 t -133.25 120.42 21.08 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 169.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.1 pt -70.9 144.21 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 126.094 1.757 . . . . 0.0 115.16 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -97.2 -7.17 33.04 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.748 1.219 . . . . 0.0 110.341 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -159.53 166.52 30.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 t -62.65 135.34 57.33 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.403 -1.436 . . . . 0.0 114.281 -171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -85.69 28.81 0.74 Allowed 'General case' 0 CA--C 1.531 0.243 0 O-C-N 119.677 -1.889 . . . . 0.0 113.207 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.26 -38.04 84.46 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.377 -1.452 . . . . 0.0 113.906 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.0 m -121.2 131.32 54.17 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.39 128.63 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.12 165.07 28.46 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.545 -1.347 . . . . 0.0 109.917 -167.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.88 120.54 55.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 O-C-N 120.954 -1.091 . . . . 0.0 108.474 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -80.0 107.75 13.03 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 122.168 0.985 . . . . 0.0 112.401 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -66.88 107.91 2.37 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.975 -1.078 . . . . 0.0 112.453 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.43 146.01 43.96 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 121.046 -1.033 . . . . 0.0 110.13 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -53.68 163.1 3.03 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.753 2.969 . . . . 0.0 115.065 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -141.93 173.75 11.23 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.18 -6.98 23.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 164.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.98 120.32 34.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.215 1.006 . . . . 0.0 111.88 -170.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -61.48 119.9 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.637 2.225 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.3 m120 55.18 41.85 31.13 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 127.426 2.29 . . . . 0.0 113.273 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -173.4 -159.91 20.87 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 123.038 1.354 . . . . 0.0 111.273 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -141.39 -60.82 0.48 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.362 1.065 . . . . 0.0 111.584 -171.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.45 -44.14 95.63 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 115.282 -167.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 t -152.59 161.07 43.08 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.3 p -91.07 -17.81 25.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 120.858 -1.151 . . . . 0.0 112.11 -171.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -60.93 163.49 5.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.705 2.002 . . . . 0.0 115.293 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -114.24 -1.3 13.64 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.145 -1.597 . . . . 0.0 111.089 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -35.62 75.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.655 1.182 . . . . 0.0 113.292 166.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -113.92 144.44 31.52 Favored Pre-proline 0 C--N 1.351 0.649 0 C-N-CA 123.488 0.715 . . . . 0.0 112.387 -155.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -60.68 98.31 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.059 2.506 . . . . 0.0 113.757 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -99.12 11.65 38.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.0 m -143.87 142.7 30.95 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 119.839 -1.788 . . . . 0.0 109.147 -166.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -132.76 159.74 38.85 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.586 1.154 . . . . 0.0 109.381 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -63.66 138.12 58.37 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.12 161.39 30.06 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.163 2.985 . . . . 0.0 117.759 -169.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.47 110.52 17.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.529 1.132 . . . . 0.0 109.141 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.86 131.04 49.65 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.309 1.044 . . . . 0.0 112.307 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -65.83 142.46 57.93 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 60.38 18.88 8.52 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.919 1.688 . . . . 0.0 114.972 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.7 t -94.5 127.43 40.42 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 119.797 -1.814 . . . . 0.0 108.634 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.5 mt -88.73 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 O-C-N 119.814 -1.804 . . . . 0.0 108.93 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -86.59 147.94 25.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.515 -0.741 . . . . 0.0 112.951 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . 0.324 76.2 mtt180 76.83 13.31 2.24 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 114.327 170.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.4 148.65 11.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 123.689 0.796 . . . . 0.0 109.326 155.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.94 105.23 3.21 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.026 -1.046 . . . . 0.0 113.617 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 192' ' ' LEU . 1.9 pt? -119.7 123.0 42.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.501 1.143 . . . . 0.0 110.711 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -157.53 178.75 33.72 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 119.363 -2.086 . . . . 0.0 114.508 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.91 146.75 19.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 125.994 1.717 . . . . 0.0 108.461 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.11 130.58 70.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -140.48 150.17 43.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -179.82 -176.72 47.5 Favored Glycine 0 CA--C 1.492 -1.345 0 O-C-N 120.205 -1.56 . . . . 0.0 113.846 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.06 132.76 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -130.64 165.26 22.85 Favored Glycine 0 CA--C 1.48 -2.102 0 O-C-N 120.059 -1.651 . . . . 0.0 111.27 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -143.82 149.55 37.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -81.09 127.95 33.19 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.832 1.777 . . . . 0.0 110.776 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.71 8.62 7.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.925 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.3 t 165.71 143.79 0.04 OUTLIER Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 130.537 3.535 . . . . 0.0 102.874 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -56.61 -25.93 61.99 Favored 'Trans proline' 0 CA--C 1.512 -0.61 0 N-CA-C 119.547 2.864 . . . . 0.0 119.547 -156.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -99.57 1.99 44.27 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.9 111.23 18.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.341 -1.474 . . . . 0.0 109.914 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 70.2 p -104.71 129.03 52.96 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-O 122.432 1.11 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 100.98 13.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.32 116.83 27.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.095 -1.003 . . . . 0.0 108.927 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -99.58 138.83 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -170.85 -163.55 25.08 Favored Glycine 0 CA--C 1.485 -1.82 0 O-C-N 119.067 -2.271 . . . . 0.0 112.333 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -146.28 142.69 28.57 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -123.68 121.48 35.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -114.5 127.6 55.9 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.344 -169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.12 142.09 28.18 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 124.074 0.95 . . . . 0.0 113.399 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.258 55.8 m-20 82.69 23.9 0.17 Allowed 'General case' 0 C--N 1.356 0.891 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 167.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . 0.314 65.4 m95 43.18 -138.87 0.24 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -115.7 142.29 17.47 Favored Glycine 0 C--N 1.358 1.784 0 O-C-N 120.345 -1.472 . . . . 0.0 111.465 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.274 98.0 mtt180 79.39 -6.02 1.88 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.527 1.931 . . . . 0.0 115.845 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.37 119.09 33.27 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.615 -1.928 . . . . 0.0 113.061 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 49.63 52.28 14.85 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 126.995 2.118 . . . . 0.0 115.894 166.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -57.23 -38.45 73.81 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m -59.35 -36.53 75.88 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 113.543 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -82.02 153.11 26.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.748 1.737 . . . . 0.0 112.555 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.81 165.98 16.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.855 1.312 . . . . 0.0 111.156 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.14 157.42 34.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.297 -1.502 . . . . 0.0 108.563 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 16.4 m -62.63 135.09 57.21 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.686 1.194 . . . . 0.0 111.519 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -122.05 114.49 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -107.67 105.39 15.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.92 72.39 10.42 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.021 0.915 . . . . 0.0 110.868 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.3 t -159.15 164.79 34.91 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.256 -1.528 . . . . 0.0 110.029 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.2 tt -145.86 -66.08 0.3 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.71 176.11 19.35 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 119.535 1.062 . . . . 0.0 113.708 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.67 122.65 67.27 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.11 -1.818 . . . . 0.0 108.606 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -128.29 130.91 48.56 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.383 -0.823 . . . . 0.0 111.749 -165.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -102.08 116.67 33.18 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.745 0.818 . . . . 0.0 109.733 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 146.45 26.2 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -156.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 23.5 t80 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 127.549 2.34 . . . . 0.0 116.9 154.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.201 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -160.52 161.56 32.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 100.227 -3.99 . . . . 0.0 100.227 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.31 177.35 30.33 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -39.67 136.48 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 125.069 3.846 . . . . 0.0 116.481 163.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -120.44 123.68 43.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.08 132.58 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -122.33 124.17 43.09 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.223 1.009 . . . . 0.0 108.891 170.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 98.95 9.86 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.87 146.2 47.34 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.338 1.542 . . . . 0.0 114.128 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.14 119.85 33.56 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.71 156.66 35.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.5 148.77 50.11 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 120.796 -1.19 . . . . 0.0 111.409 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.69 134.61 55.69 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 120.216 -1.553 . . . . 0.0 111.966 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -60.51 136.29 58.01 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -171.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.51 141.36 58.8 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 120.275 -1.515 . . . . 0.0 111.225 164.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -134.65 99.95 4.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.093 -1.629 . . . . 0.0 110.682 -172.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.9 tp -133.99 108.73 11.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-O 122.56 1.171 . . . . 0.0 110.008 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 p -99.78 -17.83 17.5 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.457 -1.402 . . . . 0.0 113.797 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 54.39 44.22 29.24 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.954 1.301 . . . . 0.0 113.853 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.92 169.82 23.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -162.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -60.42 133.52 91.05 Favored Pre-proline 0 C--N 1.343 0.29 0 O-C-N 121.273 -0.892 . . . . 0.0 111.727 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.27 132.31 43.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 123.085 2.138 . . . . 0.0 110.784 156.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.06 132.16 95.2 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.27 1.428 . . . . 0.0 110.351 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.38 134.4 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 CA-C-N 123.77 2.382 . . . . 0.0 112.906 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -112.77 11.0 19.28 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.743 -1.223 . . . . 0.0 111.583 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.12 159.51 21.46 Favored Pre-proline 0 N--CA 1.434 -1.267 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.15 152.75 9.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.189 1.926 . . . . 0.0 110.924 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -100.62 134.58 43.38 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -69.71 -14.8 62.98 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.48 1.512 . . . . 0.0 112.978 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -113.92 126.45 55.17 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 120.429 -1.419 . . . . 0.0 107.95 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -73.63 97.38 2.64 Favored 'General case' 0 C--N 1.346 0.443 0 O-C-N 120.63 -1.294 . . . . 0.0 112.971 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.7 pt -95.17 11.43 4.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-O 121.977 0.894 . . . . 0.0 112.069 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.254 69.2 m 65.64 36.48 6.4 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -95.09 163.8 13.15 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 166.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.4 m -58.73 156.35 2.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -90.83 -13.98 32.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.1 124.4 24.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.669 -1.894 . . . . 0.0 111.018 171.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.61 138.08 51.1 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.831 0.824 . . . . 0.0 108.943 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.05 166.21 18.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.18 0.991 . . . . 0.0 111.373 -169.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -141.45 132.87 26.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 118.956 -2.34 . . . . 0.0 108.77 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 63.26 41.62 7.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 pt -89.69 9.69 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 123.954 1.835 . . . . 0.0 111.563 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -60.19 127.84 33.79 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.342 1.857 . . . . 0.0 112.961 173.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -127.18 163.3 24.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.606 -1.309 . . . . 0.0 107.943 -175.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -112.51 23.75 13.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.006 0.908 . . . . 0.0 109.537 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.0 t 63.31 -157.96 0.32 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.462 1.505 . . . . 0.0 113.165 168.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.7 t -119.45 114.25 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 166.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 51.6 t60 -157.23 156.19 28.95 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -168.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 53' ' ' HIS . 76.7 Cg_exo -39.64 131.02 1.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 124.606 3.538 . . . . 0.0 116.136 164.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -164.25 -59.48 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.434 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 p -153.54 145.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -134.07 114.91 13.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.46 135.33 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -163.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.86 -126.8 0.99 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 120.341 -1.475 . . . . 0.0 114.229 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.81 157.57 43.09 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 120.965 -1.315 . . . . 0.0 108.249 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.26 149.9 47.45 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 120.702 -1.249 . . . . 0.0 111.49 174.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.04 105.38 8.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 109.448 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.97 31.25 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 119.915 -1.741 . . . . 0.0 116.448 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.15 -12.21 6.79 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 118.52 1.16 . . . . 0.0 112.543 -168.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -90.46 114.97 27.25 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.631 1.173 . . . . 0.0 108.478 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -128.4 127.5 42.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.936 0.874 . . . . 0.0 109.607 -163.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 tt -131.35 134.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 O-C-N 120.293 -1.504 . . . . 0.0 110.089 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.7 25.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.133 -0.979 . . . . 0.0 111.937 -167.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.97 34.13 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.662 1.185 . . . . 0.0 109.823 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.6 147.21 46.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 122.045 0.926 . . . . 0.0 113.271 -153.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.283 20.0 m-85 69.84 39.77 1.41 Allowed 'General case' 0 C--N 1.349 0.579 0 C-N-CA 127.909 2.484 . . . . 0.0 116.706 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.74 2.27 0.07 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 121.08 3.733 . . . . 0.0 121.08 164.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 107' ' ' GLU . 71.3 mtm180 -145.98 155.67 42.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.705 -1.872 . . . . 0.0 109.575 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -122.29 -62.66 1.36 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.0 0.905 . . . . 0.0 108.757 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -91.84 3.47 55.08 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.238 -1.539 . . . . 0.0 113.82 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.402 78.0 mttt 74.01 -70.05 0.17 Allowed 'General case' 0 C--N 1.344 0.344 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.363 26.9 m0 93.8 33.74 0.01 OUTLIER 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.365 2.666 . . . . 0.0 113.163 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -102.47 124.22 47.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.67 114.74 25.61 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.762 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -118.64 155.92 30.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 125.006 1.322 . . . . 0.0 112.483 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -117.31 109.29 16.65 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.745 -1.222 . . . . 0.0 111.85 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -74.07 -16.27 61.04 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.9 p -61.65 -36.31 80.44 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.947 1.299 . . . . 0.0 113.96 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.02 127.31 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.504 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 74.25 44.15 0.25 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.434 1.493 . . . . 0.0 111.947 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.54 138.26 20.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.48 -43.45 98.85 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 128.491 2.717 . . . . 0.0 114.949 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -131.89 149.42 52.45 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.77 136.81 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.122 0.969 . . . . 0.0 108.587 -171.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -109.57 17.46 21.33 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.432 -1.417 . . . . 0.0 111.868 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.37 28.7 mm 32.66 73.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 128.991 2.916 . . . . 0.0 116.613 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -140.89 168.51 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -106.77 112.48 25.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.19 160.62 33.02 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -168.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -102.69 1.64 34.78 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-O 122.632 1.206 . . . . 0.0 110.085 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.23 -33.28 62.0 Favored Glycine 0 C--N 1.353 1.528 0 O-C-N 120.841 -1.162 . . . . 0.0 113.082 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.9 pt -137.56 136.56 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -122.89 136.84 55.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 121.138 -0.976 . . . . 0.0 111.738 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 pt -97.0 9.44 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -59.69 142.83 52.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.077 1.751 . . . . 0.0 114.444 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -132.0 4.67 4.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.341 -0.849 . . . . 0.0 112.513 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -104.82 -2.79 24.31 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 119.585 -1.947 . . . . 0.0 112.306 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 p -131.72 158.11 42.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 67.74 40.76 2.37 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-O 122.64 1.21 . . . . 0.0 113.004 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.02 -76.87 0.37 Allowed 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.067 -1.645 . . . . 0.0 111.691 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -151.82 164.02 37.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' CD ' HH22 ' A' ' 73' ' ' ARG . 31.8 tt0 -59.01 -40.56 85.31 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.85 123.9 13.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.972 -1.08 . . . . 0.0 109.784 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.01 -166.76 9.96 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 122.739 1.189 . . . . 0.0 115.758 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.5 t -135.49 168.52 19.07 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -171.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 56.26 37.38 28.78 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 122.763 1.268 . . . . 0.0 114.11 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 64.72 39.81 6.11 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.874 1.27 . . . . 0.0 112.25 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.899 1.68 . . . . 0.0 113.628 169.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -63.24 141.96 17.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 112.753 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 177.3 7.27 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 120.335 -1.478 . . . . 0.0 110.593 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 p -114.39 132.61 56.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 119.827 -1.795 . . . . 0.0 113.549 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.18 144.49 57.09 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 126.522 1.929 . . . . 0.0 110.845 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.09 32.54 Favored Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 118.99 -1.576 . . . . 0.0 116.022 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.1 tp -122.99 123.5 41.04 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.4 m -110.06 134.19 52.41 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 120.9 -1.125 . . . . 0.0 110.926 -171.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 115.7 23.36 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 122.47 1.129 . . . . 0.0 109.325 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.27 138.05 55.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 C-N-CA 125.47 1.508 . . . . 0.0 108.034 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.65 128.08 54.99 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.592 -1.317 . . . . 0.0 108.915 170.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -95.06 120.83 35.95 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.131 0.967 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.28 115.93 18.35 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.783 -1.823 . . . . 0.0 111.187 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -111.1 24.03 13.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 120.391 -1.443 . . . . 0.0 109.706 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.16 2.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.855 1.262 . . . . 0.0 111.1 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -131.0 33.15 4.21 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.109 -1.619 . . . . 0.0 108.238 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 45.62 -110.69 0.25 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.115 2.166 . . . . 0.0 115.132 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -59.2 -39.17 81.79 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.677 1.991 . . . . 0.0 113.869 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -79.15 117.39 20.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.209 0.528 . . . . 0.0 109.608 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -121.0 98.67 47.3 Favored Pre-proline 0 N--CA 1.438 -1.06 0 O-C-N 120.595 -1.316 . . . . 0.0 109.364 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.54 150.23 44.11 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 123.533 2.822 . . . . 0.0 112.383 158.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -146.79 148.45 31.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.32 138.47 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -153.31 172.27 32.2 Favored Glycine 0 CA--C 1.495 -1.169 0 CA-C-O 123.762 1.757 . . . . 0.0 113.268 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.5 162.15 33.46 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.724 1.609 . . . . 0.0 107.748 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -145.46 150.9 37.33 Favored 'General case' 0 CA--C 1.507 -0.692 0 O-C-N 121.045 -1.034 . . . . 0.0 108.356 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.04 132.25 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -140.98 145.28 35.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 120.677 -1.265 . . . . 0.0 110.209 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -120.71 129.02 53.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.622 1.201 . . . . 0.0 113.06 -164.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.95 -171.59 40.6 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 120.396 -1.44 . . . . 0.0 113.178 171.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -65.81 130.78 44.46 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 119.614 -2.109 . . . . 0.0 113.953 170.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 m -62.31 -40.0 86.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.219 -1.55 . . . . 0.0 113.991 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -56.95 131.87 51.03 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 125.663 1.585 . . . . 0.0 114.561 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 m80 54.44 41.98 31.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.829 1.652 . . . . 0.0 114.745 -171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 p -81.55 -46.45 14.45 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.099 -1.625 . . . . 0.0 110.611 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.8 pt -122.79 -21.93 3.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 125.456 1.502 . . . . 0.0 110.009 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.93 136.55 51.68 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.091 -1.631 . . . . 0.0 112.667 157.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.5 m 52.22 53.61 12.14 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.6 p -110.31 -18.33 13.29 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 119.527 -1.983 . . . . 0.0 113.71 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -125.16 -2.5 7.61 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.524 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -162.12 158.58 24.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 101.827 -3.397 . . . . 0.0 101.827 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.9 m 64.88 44.69 3.48 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 123.493 1.616 . . . . 0.0 110.965 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.5 pt -116.49 148.7 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 126.492 1.917 . . . . 0.0 107.88 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 62.28 31.9 17.28 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 123.744 1.735 . . . . 0.0 115.225 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -94.34 -3.16 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 O-C-N 120.514 -1.366 . . . . 0.0 109.773 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 72.5 m -71.16 104.54 3.1 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.437 1.495 . . . . 0.0 110.81 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.6 p -60.36 139.53 57.62 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.24 130.91 52.43 Favored Pre-proline 0 C--N 1.352 0.685 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.308 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -41.43 140.69 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.906 3.737 . . . . 0.0 117.275 161.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.7 t -97.04 115.89 28.26 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.287 -1.508 . . . . 0.0 112.35 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 77.21 14.62 1.89 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 126.594 1.957 . . . . 0.0 112.751 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.69 136.23 92.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 O-C-N 120.662 -1.274 . . . . 0.0 113.72 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.0 146.4 17.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.906 3.071 . . . . 0.0 116.529 169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.78 -17.78 65.04 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.233 -0.917 . . . . 0.0 113.123 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.9 -4.56 72.15 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.063 0.84 . . . . 0.0 113.188 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.18 -25.63 12.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 119.002 1.401 . . . . 0.0 111.577 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.51 101.01 11.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 O-C-N 120.676 -1.265 . . . . 0.0 109.33 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.5 m -63.56 118.99 8.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 120.918 -1.114 . . . . 0.0 111.022 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -62.45 122.34 15.5 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -141.98 89.05 2.15 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.68 167.3 18.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 m -63.78 134.15 54.76 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.973 1.709 . . . . 0.0 110.679 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.6 127.24 92.86 Favored Pre-proline 0 C--N 1.365 1.243 0 O-C-N 119.616 -1.928 . . . . 0.0 111.096 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 3.81 7.0 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.637 2.892 . . . . 0.0 113.929 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -134.82 -32.21 0.99 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 120.177 1.353 . . . . 0.0 112.975 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.6 m -86.58 102.8 14.48 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.443 -1.41 . . . . 0.0 107.721 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -54.1 150.51 8.09 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -39.29 68.14 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.73 2.012 . . . . 0.0 115.647 -166.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.34 -46.49 83.25 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.759 -1.213 . . . . 0.0 113.642 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -61.64 -41.77 97.98 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.575 -1.953 . . . . 0.0 112.82 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -59.26 -47.28 85.94 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.655 -0.653 . . . . 0.0 112.714 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.3 t -59.89 -45.21 93.25 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.238 1.415 . . . . 0.0 113.343 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.53 -34.33 72.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.979 1.312 . . . . 0.0 113.808 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 58.2 m -62.25 138.97 58.51 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.8 mm -75.04 107.74 5.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.864 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 23.0 mtm105 -123.6 8.94 8.93 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.067 -1.02 . . . . 0.0 113.486 -166.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.32 12.33 7.02 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.499 -1.376 . . . . 0.0 111.239 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.91 119.55 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -122.31 144.57 16.17 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.51 162.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 120.928 -1.337 . . . . 0.0 109.085 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.35 161.96 24.76 Favored Glycine 0 CA--C 1.497 -1.036 0 O-C-N 120.625 -1.297 . . . . 0.0 110.502 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.9 129.88 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.3 mt -126.07 132.36 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.33 144.28 23.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.375 -1.453 . . . . 0.0 111.251 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.15 -164.17 32.77 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-O 121.798 0.666 . . . . 0.0 112.624 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.25 126.39 30.17 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 124.573 1.149 . . . . 0.0 108.477 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -111.87 168.88 12.89 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 125.34 1.448 . . . . 0.0 113.221 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -141.66 133.38 27.14 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 122.424 -0.457 . . . . 0.0 110.693 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.36 132.4 52.98 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.9 mm -106.82 -41.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 p -140.19 166.05 26.23 Favored Pre-proline 0 C--N 1.35 0.599 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.5 9.82 1.14 Allowed 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-N 123.325 2.223 . . . . 0.0 114.072 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.01 -12.88 9.46 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.095 0.958 . . . . 0.0 111.047 170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.5 tp -129.4 123.61 32.1 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.999 -1.063 . . . . 0.0 111.428 -168.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 81.1 p -121.67 150.01 42.38 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.089 0.947 . . . . 0.0 110.61 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.3 tp -113.55 118.63 34.97 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 1.1 m-20 -114.78 133.6 55.79 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-O 122.425 1.107 . . . . 0.0 113.185 -167.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -111.3 148.69 32.39 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 120.964 -1.085 . . . . 0.0 108.38 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.24 -156.36 28.1 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.59 166.7 31.23 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.185 0.993 . . . . 0.0 111.784 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -119.43 132.63 55.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -114.02 130.89 56.52 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 119.788 -1.82 . . . . 0.0 106.526 163.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -143.05 135.13 27.05 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 121.358 -0.839 . . . . 0.0 109.607 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 68.64 42.72 1.43 Allowed 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.892 1.677 . . . . 0.0 110.579 -161.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -148.13 132.87 17.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.08 0.952 . . . . 0.0 109.373 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.78 6.78 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 117.745 -3.097 . . . . 0.0 111.809 -11.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . 0.266 22.0 tpt180 80.64 -52.13 0.33 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 164.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -108.62 9.56 27.21 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.331 1.062 . . . . 0.0 110.266 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.46 146.43 48.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.467 1.507 . . . . 0.0 113.018 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.62 51.13 0.06 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 19.2 m 55.1 57.14 5.8 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 127.717 2.407 . . . . 0.0 112.84 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -163.15 7.13 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.58 -1.325 . . . . 0.0 114.108 -169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -41.17 158.1 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.154 2.181 . . . . 0.0 115.699 160.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -133.27 158.97 41.58 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.344 -1.472 . . . . 0.0 113.667 -163.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 35.1 p 51.02 63.22 2.33 Favored 'General case' 0 C--N 1.366 1.31 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 158.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.1 -53.06 3.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.163 2.185 . . . . 0.0 110.126 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 57.51 14.24 2.2 Favored 'General case' 0 C--N 1.352 0.703 1 C-N-CA 131.885 4.074 . . . . 0.0 115.898 172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 47.27 39.67 9.07 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.427 1.891 . . . . 0.0 115.607 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 52.8 p -156.48 173.16 17.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 120.123 -1.611 . . . . 0.0 112.105 -167.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 24.9 tp -128.71 -95.06 0.42 Allowed 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 154.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.07 -158.04 30.51 Favored Glycine 0 C--N 1.357 1.7 0 O-C-N 119.678 -1.889 . . . . 0.0 113.336 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.62 125.53 54.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.23 142.27 47.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.66 -1.275 . . . . 0.0 110.71 -174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -122.3 152.48 40.05 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 120.717 -1.239 . . . . 0.0 110.307 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -117.12 111.43 19.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.059 2.144 . . . . 0.0 108.103 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.259 1.564 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.47 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -169.28 169.37 9.2 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 107.374 166.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.44 -95.75 0.16 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-O 117.977 -1.457 . . . . 0.0 111.457 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.21 131.55 37.11 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 CA-C-N 122.016 2.908 . . . . 0.0 112.743 172.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -118.7 127.1 53.25 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.16 129.14 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -139.86 140.08 36.44 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.334 -0.854 . . . . 0.0 111.773 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.42 128.06 48.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 120.685 -1.259 . . . . 0.0 109.947 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -120.81 118.03 28.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.04 179.53 8.97 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . 0.269 . . 90.33 170.93 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 125.944 1.698 . . . . 0.0 113.226 164.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -54.27 122.73 10.95 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.56 56.85 1.43 Allowed 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.753 -1.217 . . . . 0.0 113.467 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -146.62 141.97 27.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 129.807 3.243 . . . . 0.0 103.126 -2.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.31 166.92 31.79 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 120.341 -1.474 . . . . 0.0 108.019 -164.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' CE1' HH22 ' A' ' 48' ' ' ARG . 9.4 p80 -105.6 161.67 14.17 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.08 0.552 . . . . 0.0 111.215 172.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.9 158.63 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 O-C-N 120.315 -1.491 . . . . 0.0 109.178 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -75.73 153.57 36.97 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 120.814 -1.179 . . . . 0.0 109.45 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -124.76 151.83 44.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -102.95 19.81 18.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 112.277 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -64.84 146.39 98.67 Favored Pre-proline 0 C--N 1.358 0.944 0 O-C-N 119.823 -1.798 . . . . 0.0 112.087 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.07 -38.44 32.11 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.588 2.859 . . . . 0.0 115.542 163.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -96.38 126.73 42.69 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 123.733 0.813 . . . . 0.0 111.842 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.12 133.86 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.365 2.71 . . . . 0.0 114.746 159.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -96.15 12.38 30.99 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 121.25 -0.907 . . . . 0.0 111.714 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.77 124.15 69.61 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.929 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.83 -20.95 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.299 1.999 . . . . 0.0 112.385 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -100.53 31.66 3.38 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.258 1.023 . . . . 0.0 111.355 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -104.11 114.97 29.59 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.227 -1.546 . . . . 0.0 112.37 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -82.47 0.73 40.96 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.412 -1.43 . . . . 0.0 113.841 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.62 111.31 14.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.455 -1.403 . . . . 0.0 109.151 171.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -107.83 -43.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -112.3 142.47 44.77 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.397 -0.814 . . . . 0.0 108.835 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.289 45.8 m 63.16 65.44 0.78 Allowed 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 123.211 1.481 . . . . 0.0 111.779 -171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.4 t -94.73 117.53 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.944 1.697 . . . . 0.0 108.092 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 m -85.82 -15.09 43.04 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 121.849 -0.532 . . . . 0.0 112.084 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.52 144.85 53.61 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -107.96 120.57 42.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 120.149 -1.594 . . . . 0.0 111.172 173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.48 29.27 0.52 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.19 0.996 . . . . 0.0 113.146 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -61.37 143.54 55.59 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.028 1.331 . . . . 0.0 111.093 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.28 170.84 21.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.327 -2.108 . . . . 0.0 108.946 -163.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -99.37 1.23 10.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 CA-C-O 122.131 0.967 . . . . 0.0 110.913 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.542 HH22 ' CE1' ' A' ' 21' ' ' HIS . 98.2 mtt180 -74.23 -19.52 60.49 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.846 -1.784 . . . . 0.0 111.284 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.0 p -59.3 -40.88 87.59 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 126.446 1.898 . . . . 0.0 112.386 167.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -89.76 50.96 1.98 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 123.076 1.417 . . . . 0.0 110.97 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 t -58.59 141.46 52.15 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 118.264 -2.772 . . . . 0.0 112.231 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.29 -13.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-O 123.139 1.447 . . . . 0.0 109.457 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 229' ' ' GLU . 93.6 m-70 -63.3 142.02 97.81 Favored Pre-proline 0 N--CA 1.439 -0.98 0 O-C-N 120.525 -1.359 . . . . 0.0 114.349 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.02 -25.24 0.84 Allowed 'Cis proline' 0 CA--C 1.51 -0.719 0 CA-C-O 116.499 -1.542 . . . . 0.0 110.673 17.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 80.04 126.63 0.04 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.45 1.9 . . . . 0.0 114.528 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.55 117.06 51.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-O 121.474 0.654 . . . . 0.0 109.268 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -103.32 121.86 43.62 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.607 1.163 . . . . 0.0 108.373 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -127.84 130.25 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.4 -162.24 11.03 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 120.766 -1.209 . . . . 0.0 114.331 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.32 133.56 54.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.842 1.257 . . . . 0.0 110.578 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.93 120.43 35.12 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 125.885 1.674 . . . . 0.0 110.16 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -133.87 130.03 37.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 167.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.78 -116.38 4.83 Favored Glycine 0 N--CA 1.477 1.371 0 O-C-N 119.663 -1.898 . . . . 0.0 116.356 -174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 15.11 21.69 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.084 1.326 . . . . 0.0 110.169 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -113.33 139.95 48.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.77 135.1 41.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 120.646 -1.284 . . . . 0.0 111.034 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -111.11 120.8 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.42 159.27 42.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 120.881 -1.137 . . . . 0.0 111.219 -170.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.11 131.71 55.15 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.812 1.245 . . . . 0.0 108.843 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.29 122.37 43.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 120.855 -1.153 . . . . 0.0 111.553 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -101.48 129.18 47.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 126.671 1.989 . . . . 0.0 110.644 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.06 167.42 30.46 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -71.42 144.63 49.7 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.868 -1.77 . . . . 0.0 114.275 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -128.59 -137.61 0.23 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -132.92 162.27 32.06 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -119.26 15.24 13.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.291 28.9 m-20 87.17 -19.87 0.24 Allowed 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.304 1.841 . . . . 0.0 114.527 168.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -115.87 135.66 53.78 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.616 -1.303 . . . . 0.0 110.459 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.96 11.07 13.31 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.502 -1.373 . . . . 0.0 109.354 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -143.04 128.59 19.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.624 1.57 . . . . 0.0 107.258 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -142.08 131.87 24.24 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 t -134.06 160.88 36.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 p -147.61 144.12 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -147.44 23.06 1.16 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 109.708 -163.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -64.31 -42.17 94.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.311 35.8 mt-10 51.59 21.23 1.24 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.47 138.69 27.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.7 1.6 . . . . 0.0 107.213 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.48 99.44 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 O-C-N 120.87 -1.144 . . . . 0.0 108.759 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.6 ptt85 -106.33 3.78 27.91 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 120.095 -1.628 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.0 mm -111.17 107.67 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 123.651 1.691 . . . . 0.0 106.863 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -83.41 28.9 0.52 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 119.942 -1.724 . . . . 0.0 113.802 -162.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -159.01 18.96 0.19 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.598 1.959 . . . . 0.0 110.422 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.0 -39.17 74.19 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.29 1.836 . . . . 0.0 114.267 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -62.35 -9.19 7.43 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.231 1.412 . . . . 0.0 114.658 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.96 13.43 52.78 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 124.521 1.058 . . . . 0.0 112.532 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.31 -68.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 CA-C-N 118.565 1.183 . . . . 0.0 108.894 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.286 23.3 mmt180 52.17 38.98 25.87 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 118.988 2.959 . . . . 0.0 118.988 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.303 1.5 tp 104.07 -7.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 129.609 3.163 . . . . 0.0 112.99 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.259 47.5 t0 16.73 79.19 0.01 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.332 3.053 . . . . 0.0 115.738 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 64.89 12.67 7.98 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.325 61.3 tttm 54.15 67.8 0.95 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.72 2.408 . . . . 0.0 117.131 175.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.4 p -72.48 -12.98 61.32 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 119.424 -2.047 . . . . 0.0 113.208 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.8 35.45 2.98 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 125.579 1.551 . . . . 0.0 111.253 -170.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 m120 84.39 28.2 0.07 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.32 1.448 . . . . 0.0 114.126 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.34 158.11 44.07 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.62 140.57 46.12 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 161.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 63.3 23.3 13.73 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -103.74 175.27 23.23 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 124.975 1.274 . . . . 0.0 114.252 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 136.49 28.48 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.274 -1.721 . . . . 0.0 110.343 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.0 t80 169.57 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.313 2.645 . . . . 0.0 105.333 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -158.37 161.34 37.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.426 -1.421 . . . . 0.0 108.121 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.62 73.79 1.48 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.0 t -114.52 -32.51 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 124.391 1.077 . . . . 0.0 113.001 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -83.74 150.09 26.04 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 119.705 -1.872 . . . . 0.0 111.988 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.7 p -118.4 22.81 11.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.504 1.122 . . . . 0.0 112.966 -172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -61.5 146.36 48.86 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.172 -0.955 . . . . 0.0 112.326 163.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 143.56 -141.83 10.73 Favored Glycine 0 CA--C 1.491 -1.459 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -115.98 134.72 54.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.672 -0.899 . . . . 0.0 111.831 -171.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 m -120.75 131.64 54.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.896 1.278 . . . . 0.0 110.784 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.01 112.23 21.5 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.458 1.103 . . . . 0.0 108.025 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.96 136.25 60.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 O-C-N 120.867 -1.146 . . . . 0.0 112.838 -164.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.67 128.05 53.43 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.006 1.323 . . . . 0.0 107.903 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -122.4 107.27 11.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -71.56 131.69 43.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -170.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -114.92 10.63 16.4 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.165 -0.96 . . . . 0.0 113.223 -168.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.49 -3.77 10.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 122.794 1.283 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.11 109.58 21.43 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 120.503 -1.373 . . . . 0.0 110.804 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -50.03 -58.09 6.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.265 3.026 . . . . 0.0 116.348 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -94.77 -13.24 25.83 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 -161.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -164.98 160.2 18.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -114.53 108.56 49.39 Favored Pre-proline 0 C--O 1.24 0.566 0 O-C-N 121.031 -1.043 . . . . 0.0 113.045 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -65.41 137.22 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 CA-C-N 122.98 2.1 . . . . 0.0 112.106 159.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -118.71 139.6 51.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 tp -147.11 139.82 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 122.588 1.185 . . . . 0.0 108.573 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.75 170.77 40.7 Favored Glycine 0 CA--C 1.495 -1.212 0 O-C-N 119.785 -1.822 . . . . 0.0 112.017 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.48 141.86 48.79 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.56 1.544 . . . . 0.0 110.022 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -130.18 128.25 41.35 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 120.742 -1.224 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.8 114.76 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.94 134.8 38.8 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.448 1.118 . . . . 0.0 110.916 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -121.17 108.39 13.73 Favored 'General case' 0 N--CA 1.437 -1.113 0 O-C-N 120.421 -1.424 . . . . 0.0 107.725 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.47 ' H ' HG21 ' A' ' 190' ' ' VAL . . . -103.66 -147.21 17.63 Favored Glycine 0 CA--C 1.488 -1.621 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -144.0 136.7 27.1 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.054 -1.851 . . . . 0.0 109.206 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.77 163.7 6.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.37 112.67 10.76 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.508 -1.37 . . . . 0.0 112.067 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -165.22 4.44 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.376 0.608 . . . . 0.0 111.246 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.2 m -61.83 149.36 40.37 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.699 -1.251 . . . . 0.0 114.074 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -53.26 120.24 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.962 1.305 . . . . 0.0 112.644 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.22 -52.07 6.17 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.374 1.87 . . . . 0.0 112.282 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.2 t -158.08 156.2 30.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -89.68 -48.94 6.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -69.83 -37.7 76.28 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 172.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . 0.361 66.3 mttm 75.92 153.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.312 12.1 p 77.68 149.63 0.11 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.401 1.88 . . . . 0.0 112.612 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.297 23.0 mt 72.49 -88.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.95 0.9 . . . . 0.0 111.928 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.26 127.73 35.79 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 120.355 -1.466 . . . . 0.0 112.107 -168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.254 26.3 t 74.53 103.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 127.632 2.373 . . . . 0.0 112.187 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 32.6 p -85.52 137.15 33.08 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 119.519 -1.988 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.6 t -142.61 167.65 21.58 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 119.987 -1.696 . . . . 0.0 109.903 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.19 141.9 98.19 Favored Pre-proline 0 C--N 1.349 0.573 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.18 156.72 63.44 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.662 2.241 . . . . 0.0 112.135 151.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.7 m -60.75 -37.52 82.07 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.14 0.976 . . . . 0.0 112.277 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 76.46 22.01 1.29 Allowed 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.029 0.932 . . . . 0.0 112.303 165.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.5 154.3 89.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -35.82 136.3 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 125.534 4.156 . . . . 0.0 118.767 169.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -85.27 133.93 34.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.87 0.868 . . . . 0.0 112.79 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.3 -174.62 54.53 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 121.549 -0.719 . . . . 0.0 113.363 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.17 96.81 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.259 48.1 t 67.88 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 125.863 1.665 . . . . 0.0 112.519 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.6 p -77.19 126.32 30.75 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 118.109 -2.87 . . . . 0.0 112.713 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.3 p -93.43 -7.07 45.59 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.649 0.78 . . . . 0.0 112.608 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -118.53 117.49 29.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.92 164.91 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 t -102.82 -24.75 13.68 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.779 1.276 . . . . 0.0 109.508 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -103.5 128.96 26.33 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 126.717 2.007 . . . . 0.0 107.543 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -56.73 121.04 9.34 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 123.791 2.994 . . . . 0.0 116.947 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -161.13 165.6 29.28 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 120.923 -1.11 . . . . 0.0 113.404 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.6 p 59.92 -163.05 0.24 Allowed 'General case' 0 C--N 1.356 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.921 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . 0.277 39.2 mt-30 66.02 108.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.651 0 N-CA-C 118.291 2.701 . . . . 0.0 118.291 170.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 69.59 46.56 0.71 Allowed 'General case' 0 C--N 1.354 0.795 0 O-C-N 119.876 -1.765 . . . . 0.0 112.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.8 -45.02 82.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.784 2.034 . . . . 0.0 115.943 -161.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -112.95 17.13 19.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.619 1.167 . . . . 0.0 110.153 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.317 82.9 mt-30 67.27 17.53 10.25 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t -158.86 152.43 22.99 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.194 -1.566 . . . . 0.0 107.852 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -104.65 -14.25 15.67 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.274 -1.516 . . . . 0.0 110.903 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.3 m -71.22 125.88 28.11 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.018 -1.676 . . . . 0.0 110.072 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -85.57 -7.45 10.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 147.41 30.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -114.5 56.93 0.71 Allowed 'General case' 0 C--N 1.351 0.665 0 C-N-CA 124.821 1.248 . . . . 0.0 111.6 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -151.97 163.79 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.91 -171.51 20.98 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 123.719 1.733 . . . . 0.0 116.163 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.6 mt -132.66 121.39 23.07 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -129.24 -172.02 13.08 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 121.921 0.734 . . . . 0.0 112.316 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.61 168.12 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.7 135.32 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.63 155.26 35.72 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 120.533 -1.354 . . . . 0.0 108.968 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.47 175.05 45.25 Favored Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.35 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.76 120.67 23.33 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 C-N-CA 124.582 1.153 . . . . 0.0 110.092 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.26 154.92 16.52 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.689 1.614 . . . . 0.0 115.396 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -135.79 123.46 22.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.652 1.981 . . . . 0.0 108.216 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . 0.328 11.9 p-10 -67.56 144.54 55.56 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.3 mm -104.49 -30.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.3 p -156.5 160.06 30.98 Favored Pre-proline 0 C--N 1.348 0.53 0 N-CA-C 102.569 -3.123 . . . . 0.0 102.569 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.61 -22.14 71.49 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 CA-C-N 126.129 3.225 . . . . 0.0 115.293 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -63.24 -39.01 93.41 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.39 1.876 . . . . 0.0 113.519 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -136.86 122.31 19.51 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.674 1.19 . . . . 0.0 110.255 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 143.59 48.73 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 125.835 1.654 . . . . 0.0 107.248 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pp -114.87 136.91 52.58 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.67 154.6 50.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.459 1.123 . . . . 0.0 109.573 -158.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -82.24 135.0 35.31 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 149.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 232' ' ' LEU . . . -143.85 95.48 0.18 Allowed Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -168.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -118.87 119.47 34.46 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 123.574 1.654 . . . . 0.0 111.134 -166.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -159.06 166.55 31.42 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 120.348 -1.47 . . . . 0.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -164.78 -177.14 4.57 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -92.02 134.41 34.84 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.052 -1.03 . . . . 0.0 109.961 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -58.7 -38.05 77.42 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 118.715 2.858 . . . . 0.0 118.715 -154.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -155.47 155.52 33.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.453 -1.404 . . . . 0.0 111.275 -171.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.32 118.44 7.29 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.039 0.828 . . . . 0.0 114.101 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.5 ptt85 169.1 15.07 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.043 1.337 . . . . 0.0 111.338 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.17 164.87 13.85 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -32.57 147.64 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 119.739 3.236 . . . . 0.0 119.739 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -60.94 -7.12 2.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 33.8 p -88.46 -9.13 53.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.312 -2.118 . . . . 0.0 113.974 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -75.04 -13.38 60.49 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 119.559 -1.963 . . . . 0.0 115.192 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -64.64 -14.13 56.77 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -117.3 9.28 13.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.933 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.1 t -90.61 148.98 22.3 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.216 -1.553 . . . . 0.0 110.272 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -137.46 143.17 41.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 53' ' ' HIS . 2.6 mt-10 -109.1 -72.72 0.71 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.05 147.18 30.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 119.971 1.26 . . . . 0.0 113.34 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.4 p -131.74 -22.51 2.37 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.422 0.689 . . . . 0.0 112.531 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.403 ' HA ' ' H ' ' A' ' 211' ' ' GLY 0.265 2.4 pp -144.17 166.42 25.08 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 120.059 -1.651 . . . . 0.0 110.452 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -167.28 -169.72 31.21 Favored Glycine 0 C--N 1.358 1.792 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.932 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.9 t -139.71 136.69 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -125.57 135.16 51.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.797 1.285 . . . . 0.0 111.257 167.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -141.4 132.74 26.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 120.703 -1.248 . . . . 0.0 107.913 -168.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -142.29 134.76 27.98 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.334 -1.479 . . . . 0.0 111.869 -165.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.9 t80 . . . . . 0 C--O 1.266 1.945 0 C-N-CA 125.343 1.457 . . . . 0.0 112.491 169.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.42 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -139.11 133.27 31.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.01 -106.16 0.19 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-O 117.117 -1.935 . . . . 0.0 109.41 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -57.71 157.88 22.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 CA-C-N 123.637 3.718 . . . . 0.0 114.44 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -145.58 162.48 37.36 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.83 142.27 43.8 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -140.23 162.51 35.09 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 122.308 1.051 . . . . 0.0 110.862 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.85 137.88 22.75 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 124.268 1.027 . . . . 0.0 108.908 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' CG ' HH12 ' A' ' 235' ' ' ARG . 52.3 m-20 -123.78 112.79 17.74 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 174.37 10.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.245 1.018 . . . . 0.0 111.176 -156.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 17' ' ' TYR 0.29 . . 87.05 -168.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 123.468 1.604 . . . . 0.0 115.3 171.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' H ' ' HB1' ' A' ' 16' ' ' ALA . 24.6 m-85 -142.3 152.17 42.71 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.872 1.669 . . . . 0.0 107.238 -161.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.98 86.79 2.0 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 120.894 -1.129 . . . . 0.0 108.13 168.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.35 157.75 45.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.35 3.06 . . . . 0.0 107.078 9.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.19 170.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -120.26 164.37 16.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.988 1.715 . . . . 0.0 109.675 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.33 173.19 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.484 1.135 . . . . 0.0 113.005 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.33 157.2 6.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.323 1.849 . . . . 0.0 113.786 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -63.5 140.68 58.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.6 -43.49 89.57 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 120.449 -1.407 . . . . 0.0 114.713 164.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -119.0 117.61 33.47 Favored Pre-proline 0 C--N 1.351 0.65 0 O-C-N 120.743 -1.223 . . . . 0.0 109.81 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.15 136.46 61.78 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.118 3.212 . . . . 0.0 117.573 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -120.39 141.5 32.08 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 126.363 1.865 . . . . 0.0 111.07 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.88 157.89 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.533 2.822 . . . . 0.0 114.08 167.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -61.34 -40.18 93.33 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 113.468 166.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.03 145.01 17.67 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 161.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.72 146.78 1.33 Allowed 'Trans proline' 0 C--N 1.335 -0.179 0 C-N-CA 124.764 3.643 . . . . 0.0 117.377 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -159.54 3.28 0.09 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.742 0.782 . . . . 0.0 111.117 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -157.63 158.05 34.78 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -55.26 -36.85 66.52 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 113.91 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.52 117.75 20.76 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.33 -1.481 . . . . 0.0 111.109 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.09 -18.59 7.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.2 t -107.88 117.87 35.26 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.303 -2.123 . . . . 0.0 108.706 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.291 23.4 m 67.69 51.58 0.8 Allowed 'General case' 0 C--N 1.353 0.722 0 CA-C-O 123.813 1.768 . . . . 0.0 111.068 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -65.19 148.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 125.401 1.48 . . . . 0.0 112.569 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -66.93 -36.13 81.55 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 122.173 0.987 . . . . 0.0 112.851 166.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -63.35 138.07 58.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.773 2.029 . . . . 0.0 115.247 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -118.62 126.0 50.99 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.214 -2.179 . . . . 0.0 112.79 -170.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -120.91 159.81 24.77 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 123.523 1.63 . . . . 0.0 114.008 -165.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -92.85 106.28 18.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.651 1.181 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -140.72 175.08 9.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.361 -1.462 . . . . 0.0 107.375 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -60.78 -44.86 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.455 -1.403 . . . . 0.0 113.709 -172.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.16 -43.29 98.7 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -77.39 -14.26 59.75 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.766 -1.209 . . . . 0.0 113.757 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -107.09 21.55 17.38 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.133 0.973 . . . . 0.0 112.709 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 t -63.13 140.42 58.87 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.538 -1.351 . . . . 0.0 114.465 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.67 -1.5 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 110.837 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -62.87 143.62 97.09 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.923 1.689 . . . . 0.0 114.098 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.0 -21.2 5.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.397 20.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.317 81.2 mtm180 72.46 120.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.93 146.94 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.938 0.875 . . . . 0.0 109.498 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -145.4 135.66 23.97 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.116 -1.615 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.96 128.96 75.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.502 -1.374 . . . . 0.0 108.654 -171.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.23 -173.38 18.34 Favored Glycine 0 CA--C 1.485 -1.837 0 O-C-N 119.874 -1.767 . . . . 0.0 115.062 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.13 142.84 51.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.44 1.496 . . . . 0.0 110.617 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -122.93 117.13 24.83 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.575 1.15 . . . . 0.0 112.034 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -125.29 104.85 8.71 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 120.809 -1.182 . . . . 0.0 110.274 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.11 -104.6 0.91 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 119.162 -2.211 . . . . 0.0 114.073 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.91 -5.43 38.44 Favored Glycine 0 C--N 1.354 1.556 0 C-N-CA 124.599 1.095 . . . . 0.0 112.459 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -98.84 137.98 36.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.91 1.684 . . . . 0.0 109.562 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.1 149.18 39.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 120.839 -1.163 . . . . 0.0 108.311 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.2 tp -139.44 142.87 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.86 156.9 33.94 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 120.544 -1.347 . . . . 0.0 110.957 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.72 131.22 56.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.398 1.479 . . . . 0.0 109.906 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -96.59 134.52 39.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.516 1.126 . . . . 0.0 112.956 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -128.18 145.64 50.96 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 124.044 1.878 . . . . 0.0 113.413 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.45 166.66 31.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -70.99 124.1 23.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -121.55 127.71 51.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -171.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.32 130.01 41.77 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.59 -0.694 . . . . 0.0 111.944 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -146.41 141.19 26.92 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -63.43 -35.34 80.1 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 126.649 1.979 . . . . 0.0 115.744 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.4 m120 60.57 31.55 20.26 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.99 165.46 23.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.888 1.275 . . . . 0.0 107.81 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -145.47 36.67 1.09 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -162.52 152.81 16.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 121.004 -1.06 . . . . 0.0 109.128 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -106.23 153.04 22.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 123.327 1.537 . . . . 0.0 110.312 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.5 m -74.93 156.52 36.27 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.216 -1.553 . . . . 0.0 111.177 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.31 140.28 19.6 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 O-C-N 119.901 -1.75 . . . . 0.0 114.776 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -68.9 89.34 0.4 Allowed 'General case' 0 C--N 1.356 0.859 0 O-C-N 120.081 -1.637 . . . . 0.0 110.984 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tt -90.09 9.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 O-C-N 120.619 -1.301 . . . . 0.0 110.872 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' CD ' HH22 ' A' ' 92' ' ' ARG 0.357 24.8 mm-40 66.86 -2.44 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 169.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -57.67 -42.46 83.61 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.548 -1.97 . . . . 0.0 111.881 164.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.35 99.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 120.563 -1.336 . . . . 0.0 108.801 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -76.69 -20.27 56.79 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.9 tp -66.07 121.66 15.57 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.444 HH22 ' CD ' ' A' ' 87' ' ' GLU . 28.7 mmt180 -106.86 -9.87 16.2 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.296 -1.502 . . . . 0.0 111.739 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -105.67 32.29 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.675 -1.265 . . . . 0.0 110.261 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.05 -46.68 82.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.047 2.139 . . . . 0.0 115.207 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.1 -25.23 59.68 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.402 -1.437 . . . . 0.0 112.018 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.2 -39.68 92.38 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 124.983 1.278 . . . . 0.0 113.218 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.2 pt -88.38 -8.38 10.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 122.083 -0.657 . . . . 0.0 110.415 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 54.69 3.5 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.736 1.615 . . . . 0.0 112.066 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 tt -37.94 132.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 127.144 2.178 . . . . 0.0 116.746 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.03 31.45 13.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 127.64 2.376 . . . . 0.0 114.818 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.279 94.6 mtt-85 73.76 39.62 0.53 Allowed 'General case' 0 C--N 1.352 0.695 0 C-N-CA 128.176 2.59 . . . . 0.0 112.663 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 75.14 58.61 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.608 1.963 . . . . 0.0 111.452 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 p -60.14 -46.35 89.95 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 29.5 77.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.81 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 m120 76.27 47.42 0.08 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 124.613 1.165 . . . . 0.0 113.193 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -149.71 146.14 27.07 Favored 'General case' 0 N--CA 1.436 -1.13 0 O-C-N 120.905 -1.122 . . . . 0.0 108.744 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -104.99 143.35 33.3 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.139 0.495 . . . . 0.0 111.407 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 66.01 48.78 1.7 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.17 169.69 45.09 Favored Glycine 0 C--N 1.362 1.984 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.9 t -45.45 153.4 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 118.602 2.815 . . . . 0.0 118.602 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -100.26 139.04 36.51 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.45 -1.406 . . . . 0.0 109.957 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -128.82 129.3 45.43 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 125.919 1.687 . . . . 0.0 109.89 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.61 40.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.48 -31.28 15.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 O-C-N 119.027 -2.296 . . . . 0.0 110.749 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -96.56 145.35 25.8 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.8 p -155.91 162.15 40.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.36 156.57 36.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 168.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.94 -153.49 14.89 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 117.21 -2.424 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.2 tp -137.61 139.11 40.15 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -135.5 143.29 45.72 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.885 0.874 . . . . 0.0 109.614 -165.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.73 132.6 37.05 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 120.854 -1.154 . . . . 0.0 108.75 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 tt -145.6 138.97 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-O 122.104 0.954 . . . . 0.0 109.665 -171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -121.85 132.17 54.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.496 1.118 . . . . 0.0 109.374 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . 0.254 2.5 p30 -129.61 138.93 51.53 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.77 130.23 36.06 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 120.639 -1.288 . . . . 0.0 110.23 -164.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.2 14.79 21.01 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 119.995 -1.69 . . . . 0.0 110.947 -168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.2 pt -106.86 5.01 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.55 1.54 . . . . 0.0 108.158 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.26 109.57 20.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 120.455 -1.403 . . . . 0.0 108.052 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.67 -40.59 17.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.428 1.585 . . . . 0.0 111.192 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -74.89 -22.03 58.88 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -169.64 166.57 9.88 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.155 0.979 . . . . 0.0 110.125 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.95 110.89 62.39 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 120.593 -1.317 . . . . 0.0 108.39 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.06 118.02 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 107.914 -1.61 . . . . 0.0 107.914 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -92.23 142.6 27.3 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.93 149.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 159.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.74 -170.05 39.51 Favored Glycine 0 CA--C 1.499 -0.931 0 O-C-N 120.544 -1.347 . . . . 0.0 109.954 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.35 37.77 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -151.39 144.21 24.44 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.706 -1.246 . . . . 0.0 112.187 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.59 130.5 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 125.281 1.432 . . . . 0.0 108.45 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.72 119.6 33.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.991 -1.068 . . . . 0.0 110.032 -173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.8 151.56 31.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 109.83 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -133.74 144.44 16.39 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 166.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -146.23 150.31 35.57 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.45 144.34 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 167.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -118.05 114.27 22.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.663 -1.273 . . . . 0.0 108.412 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.14 152.55 20.13 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.435 1.894 . . . . 0.0 114.536 171.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.735 1.214 . . . . 0.0 111.223 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.23 95.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 120.271 -1.518 . . . . 0.0 107.799 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -74.49 -33.73 62.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.165 1.459 . . . . 0.0 114.178 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.1 t -137.1 130.01 30.61 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 119.631 -1.918 . . . . 0.0 109.008 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -82.86 -42.85 17.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.858 1.263 . . . . 0.0 110.187 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.26 -40.42 62.35 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.5 mttp 49.71 -130.87 1.94 Allowed 'General case' 0 C--N 1.356 0.855 0 O-C-N 120.966 -1.084 . . . . 0.0 113.871 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 16.7 p 48.3 -126.61 1.9 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 128.261 2.625 . . . . 0.0 116.895 170.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 tt -115.79 -6.91 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.763 2.025 . . . . 0.0 107.228 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.355 0.842 0 O-C-N 120.616 -1.303 . . . . 0.0 114.208 170.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.16 107.05 14.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 O-C-N 120.949 -1.094 . . . . 0.0 110.301 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.1 m -70.32 122.72 20.09 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 120.881 -1.137 . . . . 0.0 109.629 165.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.7 t -148.71 161.7 41.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.54 140.34 94.67 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.829 0.852 . . . . 0.0 112.333 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -64.61 134.97 43.3 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.98 2.453 . . . . 0.0 113.035 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -83.56 -11.77 56.97 Favored 'General case' 0 CA--C 1.513 -0.469 0 O-C-N 120.787 -1.196 . . . . 0.0 111.663 169.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 87.11 29.92 0.03 OUTLIER 'General case' 0 C--N 1.362 1.144 0 C-N-CA 127.821 2.448 . . . . 0.0 110.623 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.32 146.48 98.94 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -37.99 143.97 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 125.182 3.922 . . . . 0.0 119.234 164.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -57.32 -39.18 75.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.787 2.435 . . . . 0.0 113.292 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.91 -7.06 78.57 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 120.807 -1.183 . . . . 0.0 113.899 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.47 -43.16 16.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.86 -1.377 . . . . 0.0 110.335 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.79 -46.96 81.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.222 -1.549 . . . . 0.0 113.401 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -106.52 103.67 13.18 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.8 p -96.24 6.2 49.33 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.409 1.084 . . . . 0.0 112.608 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -110.57 106.4 15.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -123.67 141.71 51.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 120.566 -1.334 . . . . 0.0 109.547 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.8 p -95.74 12.34 30.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 124.949 1.299 . . . . 0.0 110.015 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -86.85 120.35 71.63 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.043 1.737 . . . . 0.0 113.712 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -49.73 128.18 20.68 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.892 3.061 . . . . 0.0 119.627 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -82.27 70.56 9.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.99 1.316 . . . . 0.0 112.742 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.4 p -66.62 -35.25 79.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.39 -161.98 0.21 Allowed 'General case' 0 C--N 1.351 0.654 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.2 m120 70.6 2.48 4.12 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.908 1.683 . . . . 0.0 113.243 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -49.8 -52.22 33.76 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.841 2.856 . . . . 0.0 115.204 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -104.52 15.89 27.19 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.529 -0.732 . . . . 0.0 111.774 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . 0.335 68.7 mt-30 58.38 45.84 16.22 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -96.04 160.89 14.22 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.364 1.466 . . . . 0.0 110.004 170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -114.02 19.06 16.8 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.394 1.078 . . . . 0.0 109.494 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.8 t -136.1 151.09 49.44 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.196 1.398 . . . . 0.0 107.718 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.5 pt -105.41 8.71 9.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 123.211 1.481 . . . . 0.0 109.894 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -144.56 147.46 33.21 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 124.989 1.316 . . . . 0.0 108.663 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -95.7 28.62 2.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 124.008 0.923 . . . . 0.0 112.464 -166.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.82 123.91 45.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 0.0 112.043 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -102.07 142.82 15.76 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 120.675 -1.266 . . . . 0.0 110.366 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.1 tp -125.07 109.24 12.68 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 121.034 -1.274 . . . . 0.0 107.878 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.94 158.59 14.54 Favored Glycine 0 CA--C 1.49 -1.511 0 C-N-CA 123.998 0.809 . . . . 0.0 111.406 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.459 HG13 HD21 ' A' ' 216' ' ' ASN . 0.8 OUTLIER -125.87 154.95 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 C-N-CA 125.731 1.612 . . . . 0.0 108.299 178.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.82 136.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.254 1.422 . . . . 0.0 107.819 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.73 165.88 34.6 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 147.08 -166.58 28.45 Favored Glycine 0 CA--C 1.489 -1.541 0 O-C-N 119.464 -2.023 . . . . 0.0 113.921 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.99 130.59 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 209' ' ' ASP . . . -120.57 154.92 16.33 Favored Glycine 0 CA--C 1.484 -1.895 0 C-N-CA 124.389 0.995 . . . . 0.0 113.061 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -131.11 126.54 36.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.3 136.25 56.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 119.721 -1.862 . . . . 0.0 113.086 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 42.8 mm -102.06 -24.77 3.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 CA-C-O 122.902 1.334 . . . . 0.0 107.489 171.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -165.25 156.92 13.01 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.33 -21.42 67.1 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 CA-C-N 126.489 3.353 . . . . 0.0 117.022 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.68 -11.37 23.59 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.2 tp -127.6 120.11 27.43 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.457 1.122 . . . . 0.0 109.971 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.1 t -112.14 143.46 43.15 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 15.8 tp -120.62 114.39 21.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.787 1.279 . . . . 0.0 109.247 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 199' ' ' GLY . 9.9 m-20 -121.32 145.05 48.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.21 1.005 . . . . 0.0 113.008 -155.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -87.72 95.22 9.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.54 110.89 3.56 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -109.48 129.03 55.58 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 120.629 -1.512 . . . . 0.0 108.644 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.66 140.1 28.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 120.8 -1.187 . . . . 0.0 108.272 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -158.05 174.45 15.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -96.55 136.43 37.07 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.285 2.234 . . . . 0.0 112.25 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.459 HD21 HG13 ' A' ' 194' ' ' VAL . 31.2 m-80 -59.62 -41.61 90.79 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -149.55 134.15 17.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -71.4 125.83 12.29 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 120.762 -1.211 . . . . 0.0 113.94 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -150.88 -23.55 0.22 Allowed 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 121.429 -1.042 . . . . 0.0 112.42 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.9 mt -74.09 165.75 24.6 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.234 -1.541 . . . . 0.0 111.729 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -22.21 133.03 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 131.929 4.092 . . . . 0.0 117.387 171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -69.31 -3.69 15.03 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 119.853 -1.779 . . . . 0.0 115.022 -171.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.2 p -73.23 -18.06 61.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.554 1.942 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -74.59 -15.37 60.84 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -59.08 -38.45 79.49 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -110.72 6.67 21.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.029 -1.044 . . . . 0.0 113.238 -168.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.7 t -105.11 159.07 16.14 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -101.72 152.85 20.37 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.376 1.084 . . . . 0.0 112.148 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.31 -57.73 2.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.385 1.074 . . . . 0.0 112.144 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.99 168.99 18.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 123.791 0.836 . . . . 0.0 110.195 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.3 p -152.4 -11.45 0.18 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.735 1.214 . . . . 0.0 110.882 163.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 tp -130.64 137.48 49.63 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -133.86 158.66 23.4 Favored Glycine 0 CA--C 1.491 -1.422 0 O-C-N 120.454 -1.404 . . . . 0.0 110.774 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.95 140.22 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.949 -1.324 . . . . 0.0 108.28 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.417 HH12 ' CG ' ' A' ' 14' ' ' ASP . 6.1 mtm-85 -139.21 124.79 19.41 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.025 0.917 . . . . 0.0 112.106 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -119.51 129.53 54.75 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.952 -1.092 . . . . 0.0 108.643 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.17 119.5 35.78 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.269 2.128 0 C-N-CA 125.021 1.328 . . . . 0.0 113.726 178.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.629 0 N-CA-C 119.314 2.485 . . . . 0.0 119.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -153.6 156.24 37.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 -88.27 0.13 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-O 117.485 -1.73 . . . . 0.0 109.778 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -53.81 143.77 57.84 Favored 'Trans proline' 0 C--N 1.333 -0.275 0 CA-C-N 122.556 3.178 . . . . 0.0 114.028 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -155.06 159.72 40.48 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 122.344 1.068 . . . . 0.0 109.176 173.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 m -123.36 145.54 30.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 C-N-CA 126.342 1.857 . . . . 0.0 108.103 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.45 157.25 44.97 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 156.29 41.68 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.98 139.52 49.17 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 0.8 OUTLIER -153.83 179.57 8.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.823 0.82 . . . . 0.0 111.34 -166.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.68 -169.94 0.2 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -129.42 156.9 43.34 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.91 1.684 . . . . 0.0 108.322 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.63 58.44 1.73 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 120.959 -1.088 . . . . 0.0 112.223 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.37 147.88 29.72 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 130.688 3.595 . . . . 0.0 108.066 -6.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -154.21 165.12 37.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.159 0.983 . . . . 0.0 109.155 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -56.1 153.13 9.5 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.715 2.006 . . . . 0.0 115.056 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 pt -58.1 154.48 2.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 125.588 1.555 . . . . 0.0 114.909 -170.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 t -62.03 147.46 47.13 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.907 -1.121 . . . . 0.0 110.821 171.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -89.76 139.68 30.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.861 -1.149 . . . . 0.0 112.744 -173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -59.81 -45.03 93.62 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.621 -1.299 . . . . 0.0 113.29 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -139.35 155.34 72.21 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.5 152.74 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.374 3.383 . . . . 0.0 117.827 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -107.93 104.67 54.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -166.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -61.08 129.49 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.409 2.74 . . . . 0.0 114.976 165.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 p -109.65 1.14 19.37 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 124.7 1.2 . . . . 0.0 111.536 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.76 136.33 31.09 Favored Pre-proline 0 N--CA 1.441 -0.886 0 O-C-N 121.017 -1.052 . . . . 0.0 112.383 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -65.96 -34.15 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.482 2.121 . . . . 0.0 115.447 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -95.89 10.82 35.93 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -165.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.22 119.92 34.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.123 -1.611 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -69.74 -39.83 76.53 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -90.65 108.6 19.92 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 119.592 -1.943 . . . . 0.0 109.011 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.1 pt -112.22 -23.48 4.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -101.82 120.26 40.09 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 120.468 -1.395 . . . . 0.0 109.98 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m 59.68 61.44 1.95 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.204 1.402 . . . . 0.0 112.013 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.7 m -63.95 149.02 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 120.852 -1.155 . . . . 0.0 112.936 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 p -101.56 7.81 42.12 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.982 1.313 . . . . 0.0 110.607 168.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.65 158.96 15.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.11 2.564 . . . . 0.0 110.515 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -104.51 137.59 42.13 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.051 -1.03 . . . . 0.0 108.32 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.46 127.89 49.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.45 144.19 54.58 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.692 1.197 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -157.13 162.64 39.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.64 12.22 8.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 CA-C-O 123.307 1.527 . . . . 0.0 110.432 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -84.12 -1.72 55.47 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 119.004 -2.31 . . . . 0.0 110.491 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -93.18 -3.59 53.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.077 2.151 . . . . 0.0 111.544 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -107.99 4.19 24.91 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 123.504 0.722 . . . . 0.0 110.606 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 t -59.78 141.83 54.5 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 125.504 1.522 . . . . 0.0 114.19 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.19 -15.78 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.125 1.37 . . . . 0.0 112.478 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 15' ' ' LEU . 33.0 m-70 -87.44 142.73 33.35 Favored Pre-proline 0 C--N 1.357 0.904 0 O-C-N 121.58 -0.7 . . . . 0.0 112.277 -173.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.01 149.65 32.47 Favored 'Cis proline' 0 CA--C 1.515 -0.431 0 CA-C-N 121.379 1.528 . . . . 0.0 111.371 5.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.42 160.85 40.97 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.12 160.76 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 -167.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -138.25 135.1 35.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.75 136.75 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 O-C-N 120.637 -1.289 . . . . 0.0 109.115 -162.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 -149.57 6.76 Favored Glycine 0 CA--C 1.492 -1.388 0 O-C-N 119.746 -1.846 . . . . 0.0 112.16 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -137.69 140.69 40.93 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 122.806 1.289 . . . . 0.0 109.676 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -115.98 110.16 18.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 126.951 2.101 . . . . 0.0 108.14 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -125.44 111.4 15.06 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 120.624 -1.298 . . . . 0.0 108.518 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.48 -117.65 10.54 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 119.244 -2.16 . . . . 0.0 115.039 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.56 -1.91 65.78 Favored Glycine 0 C--N 1.36 1.915 0 C-N-CA 124.476 1.036 . . . . 0.0 113.271 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -108.34 140.2 41.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.336 -1.096 . . . . 0.0 110.3 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.98 138.83 35.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 120.384 -1.447 . . . . 0.0 108.424 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -130.77 131.11 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.35 160.65 43.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.195 0.998 . . . . 0.0 111.142 -165.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 125.6 43.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.176 1.391 . . . . 0.0 108.987 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.88 139.0 42.83 Favored 'General case' 0 C--N 1.346 0.43 0 O-C-N 120.275 -1.516 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -127.97 119.39 25.41 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 121.1 -1.0 . . . . 0.0 109.405 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.71 138.39 44.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 120.522 -1.361 . . . . 0.0 108.72 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -95.76 110.93 23.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -66.79 129.43 39.85 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -83.62 127.32 33.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.194 0.997 . . . . 0.0 108.742 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -133.51 160.24 38.03 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 120.493 -1.379 . . . . 0.0 109.995 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -70.04 -41.66 73.93 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 61.72 36.64 16.29 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.543 1.937 . . . . 0.0 116.095 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.15 138.07 46.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.71 18.72 18.72 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 122.718 1.247 . . . . 0.0 108.609 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -147.6 145.81 29.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.044 -1.66 . . . . 0.0 108.443 -169.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.92 165.86 17.33 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 124.058 0.943 . . . . 0.0 108.888 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -61.44 -43.71 98.39 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 126.969 2.108 . . . . 0.0 112.934 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.04 156.79 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.714 1.606 . . . . 0.0 109.867 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -69.47 129.31 39.37 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.158 -1.588 . . . . 0.0 109.449 161.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 pt -98.23 163.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 123.351 0.66 . . . . 0.0 109.357 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 92' ' ' ARG . 66.4 mm-40 61.32 36.02 17.79 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.22 -40.04 92.51 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.516 -1.99 . . . . 0.0 112.502 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.78 112.87 41.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 CA-C-O 123.318 1.532 . . . . 0.0 107.871 163.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -64.95 -48.85 72.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.86 109.42 20.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 O-C-N 120.366 -1.458 . . . . 0.0 109.086 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 87' ' ' GLU . 31.5 ptt-85 -161.16 165.89 28.75 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -99.19 20.99 12.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.258 -0.902 . . . . 0.0 109.867 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.8 -40.99 85.67 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 119.418 -2.052 . . . . 0.0 114.229 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -78.54 -7.48 57.57 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.967 1.307 . . . . 0.0 111.978 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -94.18 -34.99 6.18 Favored Glycine 0 C--N 1.36 1.875 0 O-C-N 121.139 -0.976 . . . . 0.0 112.99 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.9 tp -82.31 -27.35 8.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 CA-C-N 118.613 1.206 . . . . 0.0 111.617 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . 0.314 63.3 mtt180 72.85 50.61 0.16 Allowed 'General case' 0 C--N 1.356 0.887 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 161.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mt -52.64 111.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 126.349 1.86 . . . . 0.0 112.553 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 50.88 35.18 11.75 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.618 1.567 . . . . 0.0 114.431 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 60.07 40.47 18.49 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.429 1.492 . . . . 0.0 112.553 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.0 tttp 68.02 43.12 1.7 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.874 1.67 . . . . 0.0 112.924 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -60.13 -33.41 72.1 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.662 1.185 . . . . 0.0 111.298 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.98 64.46 0.87 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 127.038 2.135 . . . . 0.0 113.878 163.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 62.92 50.65 3.15 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -120.61 143.15 48.8 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 122.903 1.335 . . . . 0.0 112.541 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.04 126.04 27.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.5 1.52 . . . . 0.0 114.737 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 81.78 17.26 0.43 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 126.592 1.957 . . . . 0.0 112.477 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.83 23.5 70.91 Favored Glycine 0 C--N 1.351 1.386 0 C-N-CA 123.958 0.789 . . . . 0.0 113.565 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -161.31 159.28 28.31 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.11 178.28 4.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.841 1.256 . . . . 0.0 111.077 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.74 118.51 15.76 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.807 -1.183 . . . . 0.0 111.19 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.04 -1.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 224' ' ' ARG . 21.8 t -86.38 -15.25 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 122.16 0.981 . . . . 0.0 112.763 -168.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 t -85.71 169.56 13.32 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 120.236 -1.54 . . . . 0.0 109.038 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.1 p -168.58 164.44 12.4 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.36 165.96 26.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.41 -132.12 3.41 Favored Glycine 0 CA--C 1.499 -0.947 0 O-C-N 121.556 -0.715 . . . . 0.0 111.738 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 23.0 tp -131.73 139.66 49.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.635 -0.92 . . . . 0.0 109.855 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.3 p -142.35 153.41 43.8 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 119.29 -2.131 . . . . 0.0 109.28 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.66 138.91 50.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 171.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 21.0 tt -147.32 141.07 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 122.135 0.969 . . . . 0.0 108.459 -170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -122.68 136.91 55.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 134' ' ' TYR 0.253 1.9 p30 -116.46 130.35 56.71 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -62.91 141.26 58.77 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.47 17.04 21.83 Favored 'General case' 0 C--O 1.22 -0.451 0 O-C-N 121.342 -0.849 . . . . 0.0 111.25 -166.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 14.11 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 122.67 1.224 . . . . 0.0 109.164 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -130.49 121.68 26.25 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -93.88 -52.18 4.55 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.674 1.226 . . . . 0.0 109.718 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -60.89 -46.09 91.99 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -164.68 149.22 9.42 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 120.971 -1.08 . . . . 0.0 108.223 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 38.4 mtmt -120.13 113.1 34.27 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -163.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -60.29 143.62 99.5 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 123.28 2.207 . . . . 0.0 112.52 155.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 124' ' ' ASP . 84.4 m-85 -110.81 144.63 39.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.61 1.564 . . . . 0.0 110.793 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tp -144.99 144.18 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.0 177.69 47.6 Favored Glycine 0 CA--C 1.491 -1.424 0 O-C-N 120.011 -1.681 . . . . 0.0 109.792 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.92 151.26 48.85 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.109 0.963 . . . . 0.0 108.733 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.5 ttm105 -136.2 137.27 40.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.801 -1.187 . . . . 0.0 112.092 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -107.66 126.76 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.46 133.86 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.033 -1.667 . . . . 0.0 112.2 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.17 133.35 45.85 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.749 1.62 . . . . 0.0 111.814 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.46 160.83 31.81 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 119.066 2.387 . . . . 0.0 119.066 -171.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -100.97 -11.19 19.9 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 113.903 -1.149 . . . . 0.0 111.108 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.47 134.7 62.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.997 1.319 . . . . 0.0 109.126 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -123.76 125.11 44.14 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 101.404 -3.554 . . . . 0.0 101.404 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -17.77 3.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.538 1.063 . . . . 0.0 109.988 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.6 m -91.38 90.81 7.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 125.99 1.716 . . . . 0.0 107.784 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.4 tt -135.53 145.55 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.41 146.02 41.54 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 127.202 2.201 . . . . 0.0 115.968 -171.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.9 t -179.89 119.97 0.06 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.944 1.698 . . . . 0.0 106.802 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -57.79 -40.79 80.71 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.356 2.263 . . . . 0.0 113.046 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -106.06 2.57 27.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.843 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.7 mttm 62.44 38.6 12.68 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.114 1.366 . . . . 0.0 113.79 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.2 t -144.9 158.51 43.78 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.5 tt -98.17 5.86 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 109.392 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -80.57 -15.15 57.37 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.438 1.495 . . . . 0.0 113.625 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.86 158.48 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 170.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 7.2 m -48.45 111.16 0.42 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.6 m -121.57 132.78 54.88 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 64.6 t -98.14 116.3 65.62 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 120.663 -1.273 . . . . 0.0 108.105 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.98 149.2 53.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.481 2.788 . . . . 0.0 115.524 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.1 t -153.21 52.01 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.63 53.94 9.94 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.74 151.15 54.06 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -46.43 148.48 3.35 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.164 3.243 . . . . 0.0 116.466 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -56.08 -43.31 77.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.655 1.582 . . . . 0.0 115.157 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.67 -6.09 85.92 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 120.201 -1.562 . . . . 0.0 114.225 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.39 92.16 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.599 1.2 . . . . 0.0 114.05 -174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.46 -41.49 84.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 126.592 1.957 . . . . 0.0 113.357 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 45.3 m -84.29 124.82 31.65 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.307 0.643 . . . . 0.0 111.52 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.7 t -140.82 134.87 30.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.168 -0.958 . . . . 0.0 108.945 161.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.93 154.89 47.35 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -155.18 162.21 41.01 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.4 p -67.09 -42.33 84.81 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.476 -0.765 . . . . 0.0 112.192 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 141.67 87.11 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.549 1.94 . . . . 0.0 113.209 174.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 148.84 10.45 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-N 123.279 2.207 . . . . 0.0 112.7 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.2 mttm 62.2 30.69 17.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 125.229 1.412 . . . . 0.0 114.484 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.5 p -71.55 143.06 50.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.602 0.761 . . . . 0.0 111.14 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -139.61 160.12 40.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 122.29 1.043 . . . . 0.0 109.697 -170.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 62.24 59.4 1.61 Allowed 'General case' 0 C--N 1.349 0.559 0 C-N-CA 125.476 1.511 . . . . 0.0 113.705 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -68.97 -19.94 64.17 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.463 1.125 . . . . 0.0 113.285 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -72.9 -20.26 61.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.546 1.138 . . . . 0.0 112.952 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 55.9 33.35 21.47 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 127.096 2.158 . . . . 0.0 112.293 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m -83.43 153.17 24.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.33 -0.856 . . . . 0.0 112.33 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -52.3 -41.34 62.85 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.899 1.68 . . . . 0.0 110.796 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 t -149.99 144.31 25.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 157.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.4 pt -93.28 0.89 9.73 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.129 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -78.67 106.25 10.52 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.813 -1.18 . . . . 0.0 108.349 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -89.88 0.83 56.83 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -165.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.43 120.1 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -116.05 159.49 13.84 Favored Glycine 0 CA--C 1.493 -1.315 0 C-N-CA 125.239 1.4 . . . . 0.0 112.369 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.61 138.96 54.11 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 168.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -148.29 -178.69 23.64 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.118 0.866 . . . . 0.0 111.006 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.48 153.58 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.843 1.657 . . . . 0.0 108.708 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.0 mt -119.35 134.91 61.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -144.44 154.02 42.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 120.769 -1.207 . . . . 0.0 108.021 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 165.3 -172.33 40.85 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 120.908 -1.12 . . . . 0.0 111.437 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.17 144.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.33 -179.03 34.84 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 119.482 -2.012 . . . . 0.0 111.237 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 146.66 29.48 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 121.132 -1.216 . . . . 0.0 111.171 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.519 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 28.4 m-20 -75.74 131.62 39.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.574 -1.329 . . . . 0.0 111.044 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.85 -22.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 O-C-N 119.788 -1.82 . . . . 0.0 109.545 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.7 p -150.73 167.27 13.3 Favored Pre-proline 0 C--N 1.345 0.371 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.35 -10.25 18.07 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.162 2.575 . . . . 0.0 115.605 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -105.24 -35.31 7.61 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.536 1.134 . . . . 0.0 112.638 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.69 122.32 46.78 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.032 -1.042 . . . . 0.0 109.326 -174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 t -110.46 138.82 46.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 55.1 mt -105.38 112.26 25.3 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.86 153.97 32.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.714 1.245 . . . . 0.0 109.805 -165.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.65 138.22 47.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.83 171.25 44.17 Favored Glycine 0 CA--C 1.48 -2.103 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.058 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -132.32 152.09 51.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.526 -0.985 . . . . 0.0 109.542 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -118.33 118.72 32.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.37 166.97 23.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.7 1.238 . . . . 0.0 111.065 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -98.84 146.62 25.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.712 1.605 . . . . 0.0 107.596 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.57 22.8 11.51 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 120.775 -1.203 . . . . 0.0 109.348 175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -160.04 160.85 33.7 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.14 88.01 1.43 Allowed Glycine 0 C--N 1.347 1.148 0 O-C-N 121.019 -1.051 . . . . 0.0 110.723 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -157.98 -1.95 0.1 Allowed 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.26 -1.141 . . . . 0.0 112.897 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.2 mt -96.72 153.71 17.71 Favored 'General case' 0 CA--C 1.508 -0.661 0 O-C-N 120.775 -1.203 . . . . 0.0 109.662 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.87 146.08 54.65 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.089 1.355 . . . . 0.0 113.869 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -74.17 -17.6 60.89 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.33 -1.481 . . . . 0.0 114.217 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 58.1 p -96.92 4.05 51.79 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 119.832 -1.792 . . . . 0.0 111.822 -167.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 114' ' ' VAL . 45.6 ptt85 -77.03 -9.92 59.03 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.397 1.079 . . . . 0.0 110.849 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -87.84 24.57 1.73 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.413 1.485 . . . . 0.0 112.324 171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -110.44 14.05 22.64 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 125.296 1.438 . . . . 0.0 111.008 167.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -157.24 149.96 23.31 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 162.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -79.95 117.05 20.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 119.592 -1.943 . . . . 0.0 112.451 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -71.08 -19.7 62.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -165.5 167.97 16.99 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.483 1.113 . . . . 0.0 108.81 -174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.6 t -174.74 -51.44 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.56 154.24 27.47 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.051 -1.03 . . . . 0.0 108.719 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.68 156.16 18.61 Favored Glycine 0 CA--C 1.494 -1.233 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.28 141.88 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -143.27 137.54 28.95 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -116.4 121.2 41.2 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -93.69 121.38 35.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.334 1.053 . . . . 0.0 110.071 164.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.263 1.785 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -178.136 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.75 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -143.89 116.61 8.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.35 170.45 12.41 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 119.016 0.825 . . . . 0.0 113.7 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.74 157.62 23.08 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.215 2.61 . . . . 0.0 114.682 165.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -146.83 149.35 33.14 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.63 139.06 37.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 O-C-N 121.128 -0.983 . . . . 0.0 108.549 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -127.11 142.21 51.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 120.984 -1.073 . . . . 0.0 112.678 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.78 132.25 38.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -122.39 141.53 51.49 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.648 -1.283 . . . . 0.0 110.747 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -99.68 121.21 40.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.374 1.869 . . . . 0.0 106.848 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 13.44 0.08 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 120.759 -1.213 . . . . 0.0 110.728 -162.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -140.44 167.33 22.41 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.188 0.994 . . . . 0.0 110.885 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.14 164.94 25.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.754 1.622 . . . . 0.0 112.557 167.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -59.52 -39.79 85.01 Favored 'General case' 0 C--N 1.362 1.123 0 O-C-N 120.608 -1.307 . . . . 0.0 113.586 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -123.16 122.57 38.75 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -123.58 25.88 8.01 Favored 'General case' 0 CA--C 1.502 -0.87 0 O-C-N 120.754 -1.216 . . . . 0.0 110.397 -171.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 pt -41.36 156.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 C-N-CA 126.867 2.067 . . . . 0.0 116.328 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -30.78 61.56 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 119.374 -2.078 . . . . 0.0 111.426 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -164.3 158.86 19.25 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.149 2.18 . . . . 0.0 105.848 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.84 144.14 49.4 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -68.23 148.57 98.27 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.361 1.464 . . . . 0.0 114.609 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -39.25 123.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 124.722 3.614 . . . . 0.0 117.574 164.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.58 -49.58 92.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.94 133.94 41.0 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 125.062 2.844 . . . . 0.0 112.765 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 p -56.5 158.14 4.62 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 126.314 1.846 . . . . 0.0 112.958 170.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 139.37 92.53 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 118.483 -2.636 . . . . 0.0 113.494 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.05 121.62 2.42 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.641 3.56 . . . . 0.0 117.269 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.03 44.84 15.63 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -50.7 -38.0 44.54 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -163.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -77.29 -16.08 59.14 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.292 -1.505 . . . . 0.0 114.294 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -87.57 -28.51 21.9 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.429 -1.419 . . . . 0.0 110.971 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.8 pt -93.33 146.81 5.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 122.571 1.177 . . . . 0.0 111.759 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 m -59.62 142.5 52.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -53.85 -35.59 61.68 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 120.252 -1.53 . . . . 0.0 114.317 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.98 -9.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -74.44 109.83 8.24 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.877 -1.765 . . . . 0.0 111.911 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -104.22 140.12 38.28 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 123.181 1.467 . . . . 0.0 111.481 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -114.63 6.38 15.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.224 1.81 . . . . 0.0 108.461 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . 0.256 83.2 m-85 69.37 44.59 0.92 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.322 2.249 . . . . 0.0 112.86 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 mtp85 -87.01 -17.12 33.74 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 120.914 -1.116 . . . . 0.0 112.909 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -114.03 -7.89 13.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.141 -0.974 . . . . 0.0 112.282 -164.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.0 pt -67.67 150.11 11.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 124.406 1.082 . . . . 0.0 111.306 165.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.256 86.6 mtm-85 79.15 21.45 0.65 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.138 -1.601 . . . . 0.0 113.049 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 t -120.5 148.67 43.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -73.78 136.23 43.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.774 -1.203 . . . . 0.0 111.179 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.0 p -72.56 168.24 19.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 119.353 -2.092 . . . . 0.0 112.884 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.31 -47.14 91.51 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 O-C-N 119.857 -1.777 . . . . 0.0 111.369 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 41.25 67.08 3.23 Favored Pre-proline 0 C--N 1.349 0.55 0 C-N-CA 125.782 1.633 . . . . 0.0 114.911 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -40.37 154.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 124.731 3.621 . . . . 0.0 116.248 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -72.06 117.51 13.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 121.054 -1.029 . . . . 0.0 111.565 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -128.14 134.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 t -161.21 169.46 22.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.009 0.909 . . . . 0.0 109.139 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -123.82 135.57 63.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -121.21 -176.9 15.47 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -141.97 134.64 28.39 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -114.57 109.51 18.37 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -167.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.64 172.78 8.7 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 123.201 1.477 . . . . 0.0 111.161 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.31 95.4 1.31 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 119.614 -1.929 . . . . 0.0 111.948 168.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -2.22 33.56 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 123.95 0.786 . . . . 0.0 114.987 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -164.88 172.65 12.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -153.29 156.3 38.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.461 -1.399 . . . . 0.0 110.738 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.9 tp -122.79 138.74 51.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.08 140.01 47.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.593 -1.317 . . . . 0.0 111.025 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.76 145.27 40.92 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.17 -0.956 . . . . 0.0 111.88 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -115.19 139.32 50.03 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.311 -1.493 . . . . 0.0 107.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . 0.301 96.5 m-85 82.69 -69.68 0.06 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.998 1.719 . . . . 0.0 115.21 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 48.38 58.39 5.24 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -161.55 154.41 20.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 119.888 -1.758 . . . . 0.0 111.561 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -125.87 24.05 7.12 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.184 0.994 . . . . 0.0 109.928 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -73.67 150.12 41.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -105.99 -70.38 0.79 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.329 1.061 . . . . 0.0 109.438 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.99 167.89 28.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 120.499 -1.375 . . . . 0.0 107.362 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -66.39 127.85 33.88 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 163.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -161.19 162.27 31.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.37 157.18 16.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 110.334 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -95.22 142.08 28.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.56 31.92 0.88 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.518 1.151 . . . . 0.0 108.849 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 m -70.08 -17.24 63.22 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.82 -56.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-O 121.705 0.764 . . . . 0.0 109.584 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -123.82 131.83 53.66 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 120.042 -1.662 . . . . 0.0 107.906 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 pt -84.99 -1.1 6.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 120.353 -1.467 . . . . 0.0 112.565 -167.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.38 5.41 45.25 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.216 1.006 . . . . 0.0 112.316 -167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -90.36 2.62 55.38 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 122.836 1.303 . . . . 0.0 109.649 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.1 135.87 62.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 155.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -124.8 144.54 50.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.254 9.0 mm 51.38 60.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.166 0 CA-C-O 123.261 1.505 . . . . 0.0 112.686 -164.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.684 HH21 ' CD ' ' A' ' 94' ' ' GLU . 47.4 ttp180 -62.0 -41.5 98.12 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . 0.292 93.0 mttt 86.05 32.94 0.03 OUTLIER 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.049 1.739 . . . . 0.0 111.796 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.684 ' CD ' HH21 ' A' ' 92' ' ' ARG . 31.6 tp10 -53.48 -46.75 70.11 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 -168.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.87 10.3 36.46 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.237 -1.539 . . . . 0.0 109.983 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.89 35.06 46.83 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 125.328 1.442 . . . . 0.0 116.501 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.6 mm -60.32 129.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 O-C-N 121.178 -1.189 . . . . 0.0 111.493 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -61.66 133.8 56.04 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 122.676 1.227 . . . . 0.0 112.115 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.3 pt -104.02 -0.37 10.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 122.683 1.23 . . . . 0.0 110.124 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 66.9 102.28 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.545 2.738 . . . . 0.0 114.984 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 57.76 63.8 1.72 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -140.06 159.98 40.96 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.984 1.313 . . . . 0.0 107.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.4 m -77.34 119.14 20.56 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.494 -1.379 . . . . 0.0 111.236 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.72 166.0 25.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 110.051 -170.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -98.38 1.51 47.0 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.204 -0.935 . . . . 0.0 111.761 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 70.16 44.17 0.79 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 110.893 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.97 -15.88 63.11 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -100.12 -1.37 36.91 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 122.369 1.081 . . . . 0.0 111.476 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.46 -62.75 0.43 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 170.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -98.39 108.41 21.1 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 124.242 1.972 . . . . 0.0 110.969 -168.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -153.77 153.18 31.71 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 120.02 15.38 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 121.26 -0.9 . . . . 0.0 108.647 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -111.36 -24.38 10.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.672 0.789 . . . . 0.0 111.433 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.51 119.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.2 m -73.07 122.39 21.71 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -63.93 144.94 56.68 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 tp -145.53 157.43 43.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.85 40.46 Favored Glycine 0 CA--C 1.493 -1.323 0 O-C-N 120.196 -1.565 . . . . 0.0 109.769 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 19.3 tp -139.21 129.45 25.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.5 m -115.1 121.32 42.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.57 -0.707 . . . . 0.0 111.075 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.15 44.87 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.11 -0.994 . . . . 0.0 109.89 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.8 mt -119.7 138.02 51.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 110.335 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -118.73 117.15 28.13 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.23 141.2 29.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 122.325 1.059 . . . . 0.0 110.145 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.35 154.9 19.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.045 -1.659 . . . . 0.0 112.228 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.259 14.3 mt-30 76.45 101.15 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.969 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.9 pt -62.84 -43.35 98.79 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -167.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -115.58 -2.25 12.55 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 120.847 -1.158 . . . . 0.0 112.666 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.67 144.55 52.85 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 123.297 1.522 . . . . 0.0 113.807 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -64.62 -39.71 94.19 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 120.058 -1.651 . . . . 0.0 113.328 164.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -79.48 105.08 10.53 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 109.226 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.43 102.98 54.49 Favored Pre-proline 0 N--CA 1.443 -0.815 0 O-C-N 121.185 -0.947 . . . . 0.0 109.494 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.76 150.28 45.85 Favored 'Trans proline' 0 C--N 1.327 -0.589 0 C-N-CA 123.989 3.126 . . . . 0.0 113.143 159.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -141.14 163.38 33.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 123.328 1.537 . . . . 0.0 110.837 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -142.87 150.83 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.92 167.18 38.51 Favored Glycine 0 CA--C 1.497 -1.067 0 O-C-N 119.904 -1.747 . . . . 0.0 113.256 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.88 141.86 50.84 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 125.678 1.591 . . . . 0.0 108.708 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -135.14 121.1 19.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 O-C-N 120.616 -1.302 . . . . 0.0 112.501 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.85 135.0 26.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 O-C-N 121.151 -0.968 . . . . 0.0 108.599 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.13 145.6 30.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.552 -1.343 . . . . 0.0 113.668 -161.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -142.91 157.94 44.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.065 1.746 . . . . 0.0 109.672 -168.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.16 165.17 10.39 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 107.041 -2.423 . . . . 0.0 107.041 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -145.78 161.24 40.4 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 120.323 -1.692 . . . . 0.0 109.762 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.66 161.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 124.811 1.244 . . . . 0.0 110.236 -171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -145.02 16.77 1.57 Allowed 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.424 -1.422 . . . . 0.0 111.347 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -120.98 159.43 25.61 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.1 m 69.16 43.93 1.04 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 126.856 2.062 . . . . 0.0 111.489 -166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.6 mm -99.44 114.93 39.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.573 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -88.52 -18.07 28.95 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.118 1.367 . . . . 0.0 113.123 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.61 -18.56 44.3 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 118.892 -2.38 . . . . 0.0 115.77 -167.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 p -83.64 156.52 22.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 124.419 2.057 . . . . 0.0 114.653 -171.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -74.93 124.15 26.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.389 -1.444 . . . . 0.0 114.075 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -76.06 -14.5 60.2 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.116 0.966 . . . . 0.0 112.809 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -60.43 -36.87 79.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.899 2.08 . . . . 0.0 114.452 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.6 pt -112.22 15.48 8.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-O 122.408 1.099 . . . . 0.0 110.198 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.52 29.67 19.19 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 160.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 m -90.4 -4.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.499 -1.375 . . . . 0.0 111.695 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.1 t -119.35 155.56 31.66 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -56.88 142.78 39.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 127.42 2.288 . . . . 0.0 113.46 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -60.94 138.32 93.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 0.0 111.945 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -59.03 160.8 17.47 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.83 2.353 . . . . 0.0 113.218 162.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.8 t -163.52 166.98 22.01 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.03 13.57 12.17 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.428 0.632 . . . . 0.0 109.931 165.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.49 120.81 56.8 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 120.561 -1.337 . . . . 0.0 109.441 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -61.63 123.58 12.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.493 2.129 . . . . 0.0 113.096 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -163.22 166.61 23.05 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.865 -1.147 . . . . 0.0 109.237 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.53 68.68 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 120.786 -1.196 . . . . 0.0 114.513 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.06 62.67 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 120.96 -1.318 . . . . 0.0 113.715 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.06 2.47 9.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 121.114 -0.991 . . . . 0.0 110.262 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . 0.336 30.1 p 53.04 36.12 21.31 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 128.912 2.885 . . . . 0.0 115.107 175.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 14.7 t -150.42 148.94 29.38 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-O 122.926 1.346 . . . . 0.0 111.263 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -112.92 8.28 18.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.793 1.637 . . . . 0.0 108.658 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -102.61 137.99 40.1 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 120.345 -1.472 . . . . 0.0 110.444 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 m -61.82 -44.08 97.57 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.376 1.07 . . . . 0.0 113.27 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -65.69 145.21 99.05 Favored Pre-proline 0 C--N 1.343 0.297 0 C-N-CA 125.45 1.5 . . . . 0.0 114.364 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -57.6 154.69 35.14 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.1 2.534 . . . . 0.0 113.569 165.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -62.42 133.14 54.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.2 t -56.29 147.27 21.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.68 -0.57 39.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.201 1.8 . . . . 0.0 110.075 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -99.27 147.81 24.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.32 0.648 . . . . 0.0 109.314 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.287 72.0 m-20 65.99 149.91 0.05 OUTLIER 'General case' 0 C--N 1.351 0.635 0 CA-C-O 124.64 2.162 . . . . 0.0 115.343 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -76.67 131.04 38.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 119.067 -2.27 . . . . 0.0 110.018 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -108.57 1.76 21.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 121.298 -0.876 . . . . 0.0 112.975 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m 55.69 47.08 21.32 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -115.31 -26.71 7.5 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.499 -1.375 . . . . 0.0 112.098 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -65.59 -39.88 92.07 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 120.407 -1.433 . . . . 0.0 114.625 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.2 149.86 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -137.58 136.79 37.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 120.815 -1.178 . . . . 0.0 108.792 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -85.09 172.76 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.912 -1.118 . . . . 0.0 111.131 165.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.0 m -56.99 139.24 16.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 O-C-N 120.682 -1.262 . . . . 0.0 112.73 165.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -108.52 163.52 12.75 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.2 tp -125.01 119.5 28.87 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.93 175.32 17.77 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 124.988 1.28 . . . . 0.0 112.718 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.3 139.71 46.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.36 150.33 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.24 160.24 41.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 177.5 -164.74 34.07 Favored Glycine 0 CA--C 1.487 -1.714 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.119 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.36 129.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -106.69 149.03 16.53 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -129.51 111.78 13.1 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.416 -1.05 . . . . 0.0 109.414 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -72.86 125.39 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.308 1.051 . . . . 0.0 111.995 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.28 -79.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.537 0 O-C-N 120.093 -1.629 . . . . 0.0 109.394 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.7 t -169.4 154.37 5.67 Favored Pre-proline 0 C--N 1.348 0.52 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.75 -46.69 0.35 Allowed 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 122.678 1.992 . . . . 0.0 108.777 -29.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -122.78 15.9 10.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 127.176 2.19 . . . . 0.0 110.247 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.5 117.0 24.14 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.387 -0.82 . . . . 0.0 109.496 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.1 m -108.44 121.35 44.76 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 tp -96.75 142.97 28.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.42 138.62 52.41 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -165.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -126.78 117.3 22.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 162.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.58 159.81 21.53 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 122.936 1.298 . . . . 0.0 112.536 -169.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.0 133.58 47.82 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -116.07 115.25 25.75 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.297 1.439 . . . . 0.0 111.297 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.53 133.57 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -105.16 18.19 22.76 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 118.879 -2.388 . . . . 0.0 114.279 -162.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.23 159.22 42.73 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -84.56 -23.93 29.47 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.121 -0.987 . . . . 0.0 111.869 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.38 -140.4 6.4 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -71.8 149.25 45.47 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 119.983 -1.892 . . . . 0.0 112.543 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.81 144.55 38.15 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -89.55 158.39 17.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.731 1.612 . . . . 0.0 115.016 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.7 m120 55.25 -91.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.86 2.064 . . . . 0.0 114.535 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 62.6 p -99.53 -10.01 22.61 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.368 -1.457 . . . . 0.0 112.418 -168.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 60.09 44.3 13.24 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 166.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.41 156.76 34.85 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 120.536 -1.352 . . . . 0.0 110.952 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -139.02 126.75 22.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 163.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.6 p -113.55 2.24 15.27 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 123.353 0.661 . . . . 0.0 110.908 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.0 140.93 21.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -164.68 -6.95 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.72 -1.238 . . . . 0.0 112.679 -161.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -140.01 149.56 43.37 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 119.754 -1.841 . . . . 0.0 108.296 -172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.9 p -148.37 147.03 28.78 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.335 1.064 . . . . 0.0 110.887 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.93 144.4 42.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.75 177.23 28.92 Favored Glycine 0 CA--C 1.492 -1.357 0 O-C-N 119.218 -2.176 . . . . 0.0 115.503 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 p -139.99 145.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 126.514 1.926 . . . . 0.0 106.402 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -140.23 155.48 46.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.265 -1.522 . . . . 0.0 108.112 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -138.98 129.6 25.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -88.93 142.66 27.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.463 -0.773 . . . . 0.0 109.644 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 C--O 1.266 1.958 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.068 174.845 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.667 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.17 155.22 40.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.166 1.483 . . . . 0.0 110.274 149.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.89 37.62 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -88.6 161.81 6.49 Favored 'Trans proline' 0 C--N 1.321 -0.871 0 C-N-CA 122.471 2.114 . . . . 0.0 110.479 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -149.15 159.2 44.46 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.61 1.195 . . . . 0.0 109.649 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 p -129.0 140.32 49.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 C-N-CA 125.396 1.478 . . . . 0.0 109.009 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -131.17 133.49 45.6 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.36 -1.463 . . . . 0.0 109.907 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.03 138.75 52.63 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 120.585 -1.322 . . . . 0.0 110.277 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -89.09 175.7 7.28 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.356 1.462 . . . . 0.0 110.35 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.91 137.75 56.42 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 115.165 1.542 . . . . 0.0 115.165 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.95 134.25 52.1 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -158.01 -14.89 0.08 Allowed 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.8 -1.187 . . . . 0.0 112.381 -162.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.04 -4.73 29.31 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 119.731 -1.856 . . . . 0.0 113.928 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 60.37 38.38 19.56 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.15 14.09 17.1 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.706 -1.246 . . . . 0.0 111.404 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -96.93 6.4 48.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.114 1.366 . . . . 0.0 110.884 168.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 pt -138.69 163.77 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.321 1.048 . . . . 0.0 108.687 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.8 m -112.48 117.7 33.11 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.497 1.119 . . . . 0.0 109.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -81.26 -21.4 39.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.01 147.7 29.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 119.993 -1.692 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.63 127.36 26.92 Favored Pre-proline 0 C--N 1.356 0.884 0 O-C-N 120.628 -1.295 . . . . 0.0 108.509 -174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.39 -37.58 3.15 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.96 1.774 . . . . 0.0 113.096 -155.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.58 -46.66 97.28 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.25 -31.31 9.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 CA-C-N 123.66 2.343 . . . . 0.0 112.569 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.2 m -59.71 -41.15 90.18 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 119.649 1.113 . . . . 0.0 112.395 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 49.01 58.0 18.12 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -42.83 131.84 5.67 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 124.051 3.168 . . . . 0.0 116.528 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 79.96 15.12 0.85 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -55.4 -33.2 63.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 119.731 -1.855 . . . . 0.0 115.826 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -112.71 22.68 14.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 O-C-N 120.692 -1.255 . . . . 0.0 112.05 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -163.21 158.18 21.33 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 120.353 -1.467 . . . . 0.0 110.448 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.29 -40.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 O-C-N 120.353 -1.467 . . . . 0.0 114.279 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 t -163.85 171.45 15.41 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 119.513 -1.992 . . . . 0.0 109.699 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -143.89 123.93 13.62 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 159.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.47 109.06 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 O-C-N 120.431 -1.418 . . . . 0.0 107.832 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 t -149.23 130.49 14.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.87 -13.78 62.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.11 -18.4 62.53 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 120.265 -1.522 . . . . 0.0 113.939 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -120.82 9.45 10.69 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.195 -0.94 . . . . 0.0 113.233 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.1 172.35 12.96 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 56.57 -148.32 0.49 Allowed 'General case' 0 C--N 1.356 0.873 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.32 138.24 22.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 124.749 1.22 . . . . 0.0 110.286 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -102.28 -4.26 25.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 119.738 -1.851 . . . . 0.0 113.792 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 m -61.96 110.21 1.49 Allowed 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 124.454 1.102 . . . . 0.0 112.258 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -62.36 -42.52 99.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -137.62 120.32 16.24 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -92.86 172.21 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.567 1.147 . . . . 0.0 110.842 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -53.59 136.56 53.19 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -69.58 -8.76 24.45 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.78 2.32 . . . . 0.0 115.017 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -134.32 119.0 18.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.884 0.874 . . . . 0.0 112.358 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.19 130.21 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.279 -1.513 . . . . 0.0 107.765 161.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -113.85 129.35 56.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.628 -169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.08 149.99 33.18 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 CA-C-O 122.426 1.108 . . . . 0.0 110.847 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.34 -161.69 24.05 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.418 -0.801 . . . . 0.0 113.443 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.69 139.16 54.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.197 1.399 . . . . 0.0 108.781 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -115.46 143.78 44.8 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 110.086 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -143.76 175.73 9.77 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.081 1.42 . . . . 0.0 110.766 -172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.72 88.07 1.33 Allowed Glycine 0 C--N 1.361 1.94 0 O-C-N 118.33 -2.731 . . . . 0.0 113.452 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.24 -1.84 35.06 Favored Glycine 0 C--N 1.354 1.567 0 C-N-CA 124.5 1.048 . . . . 0.0 113.723 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -158.9 164.53 35.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.368 -1.666 . . . . 0.0 108.524 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.15 157.53 32.9 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 121.594 -0.691 . . . . 0.0 110.97 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.5 134.08 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.3 160.74 43.63 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 121.417 -0.802 . . . . 0.0 111.654 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.19 140.65 52.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.749 0.819 . . . . 0.0 110.164 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -72.24 135.07 45.94 Favored 'General case' 0 C--N 1.348 0.501 0 O-C-N 121.065 -1.022 . . . . 0.0 110.056 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.57 151.58 39.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.71 1.204 . . . . 0.0 108.112 171.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.92 175.31 14.11 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.491 HH12 ' CE1' ' A' ' 112' ' ' HIS . 11.7 ptm180 -60.41 113.34 2.36 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -87.73 5.21 41.04 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.328 -1.483 . . . . 0.0 110.846 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -125.75 123.86 39.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.764 -1.21 . . . . 0.0 110.119 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -161.16 159.72 29.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.413 1.885 . . . . 0.0 106.404 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -142.88 166.98 23.15 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -96.77 -3.83 41.63 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 120.763 -1.21 . . . . 0.0 112.521 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -118.03 114.33 22.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.95 164.94 27.77 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.914 0.864 . . . . 0.0 111.161 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -105.83 112.92 26.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -100.6 -11.29 20.17 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.9 t -147.91 -174.13 4.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 120.222 -1.549 . . . . 0.0 107.132 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.54 -45.29 94.08 Favored 'Isoleucine or valine' 0 C--N 1.348 0.523 0 O-C-N 120.711 -1.243 . . . . 0.0 113.43 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.1 m120 47.39 53.3 11.14 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 127.221 2.208 . . . . 0.0 114.766 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tp -112.68 -12.78 11.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.35 125.76 40.19 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 119.447 -2.033 . . . . 0.0 110.412 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.04 -9.48 18.78 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 111.75 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.96 -45.11 95.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 125.209 1.404 . . . . 0.0 114.728 -169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -94.62 24.21 4.79 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.608 -1.307 . . . . 0.0 113.856 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.5 mt -109.69 127.7 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.298 1.439 . . . . 0.0 107.673 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -131.87 10.31 4.64 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.944 -1.723 . . . . 0.0 113.413 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -165.28 149.92 8.91 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.8 12.54 18.99 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.481 1.512 . . . . 0.0 111.733 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -139.98 128.82 23.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 119.53 -1.981 . . . . 0.0 108.966 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.3 -174.7 21.44 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 tt -161.07 166.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -120.93 130.18 53.76 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 167.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.96 112.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 118.204 0.456 . . . . 0.0 111.364 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.25 -43.51 92.41 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.534 1.934 . . . . 0.0 115.797 -154.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.1 mmt85 -103.39 3.06 34.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 119.994 -1.691 . . . . 0.0 109.426 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.344 79.7 tttt 76.24 -40.13 0.38 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.581 1.953 . . . . 0.0 115.132 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 p -97.83 -13.08 21.51 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.488 1.115 . . . . 0.0 111.018 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -156.2 151.87 27.13 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -165.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.5 14.91 10.34 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 120.662 -1.274 . . . . 0.0 110.24 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -155.26 161.1 41.21 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.329 1.061 . . . . 0.0 111.4 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.9 126.77 28.53 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 155.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -58.68 138.24 57.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.756 -1.215 . . . . 0.0 111.845 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.43 8.17 58.76 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 121.614 -0.679 . . . . 0.0 114.147 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -90.75 108.54 19.9 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 121.368 -1.078 . . . . 0.0 110.294 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -119.87 108.29 14.18 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.817 -1.177 . . . . 0.0 111.797 -170.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.491 ' CE1' HH12 ' A' ' 73' ' ' ARG . 96.9 m-70 -114.03 -11.43 12.74 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.065 -1.022 . . . . 0.0 111.795 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.78 -59.86 1.62 Allowed 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.66 -1.275 . . . . 0.0 110.187 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.5 t -58.73 126.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.4 m -147.47 150.9 35.47 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 113.61 21.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.93 140.96 49.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.89 170.66 38.93 Favored Glycine 0 CA--C 1.484 -1.848 0 O-C-N 120.044 -1.66 . . . . 0.0 109.565 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.4 tp -139.8 135.04 32.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.3 m -147.13 137.97 23.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.641 -1.287 . . . . 0.0 113.167 -162.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.93 129.93 53.66 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.865 0.866 . . . . 0.0 109.082 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.6 137.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 124.446 1.098 . . . . 0.0 108.825 -167.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -120.47 125.26 47.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.139 1.776 . . . . 0.0 109.819 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -93.49 128.15 39.47 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-O 122.193 0.997 . . . . 0.0 112.662 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.48 98.35 7.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.662 -1.274 . . . . 0.0 108.934 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -79.85 61.88 3.92 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.912 -1.117 . . . . 0.0 112.503 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.1 pt -84.38 -17.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 125.154 1.381 . . . . 0.0 112.631 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -156.81 149.05 23.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.57 -44.04 89.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.73 1.612 . . . . 0.0 113.134 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -103.62 -13.44 16.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 120.606 -1.309 . . . . 0.0 112.028 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 120.04 1.291 . . . . 0.0 109.034 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -129.88 101.69 18.18 Favored Pre-proline 0 C--N 1.351 0.634 0 O-C-N 121.68 -0.638 . . . . 0.0 111.619 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.94 145.93 30.89 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 124.656 3.571 . . . . 0.0 113.945 158.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -146.89 150.89 36.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.565 1.174 . . . . 0.0 111.445 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tp -123.98 149.7 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.15 169.31 38.24 Favored Glycine 0 N--CA 1.438 -1.188 0 O-C-N 119.933 -1.73 . . . . 0.0 110.778 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.85 154.84 46.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -143.0 137.77 29.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.27 134.02 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.64 134.24 55.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 120.304 -1.498 . . . . 0.0 110.073 -174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -120.24 135.01 55.14 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.48 159.2 19.11 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 168.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 t60 69.03 35.11 2.89 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.66 135.85 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.278 75.1 mtp85 59.72 46.3 11.81 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -118.16 164.15 15.59 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.659 1.184 . . . . 0.0 110.277 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t -90.62 -175.77 4.52 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.933 1.293 . . . . 0.0 110.815 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.2 pt -58.27 143.68 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.607 1.963 . . . . 0.0 116.255 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -62.09 149.03 42.38 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.7 p -75.91 152.99 37.0 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.646 -1.284 . . . . 0.0 111.527 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.8 p -83.3 26.22 0.66 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.917 -1.739 . . . . 0.0 112.638 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -126.56 1.96 6.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 120.547 -1.346 . . . . 0.0 110.689 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -113.42 115.22 27.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.177 0.991 . . . . 0.0 108.883 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.8 p -97.36 1.97 50.01 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . 0.299 3.0 mt 47.42 59.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 125.801 1.64 . . . . 0.0 115.185 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -163.41 58.73 0.18 Allowed 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 117.85 -3.031 . . . . 0.0 108.351 20.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.28 4.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 O-C-N 120.693 -1.255 . . . . 0.0 111.367 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 p -118.02 124.04 47.17 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -63.22 128.9 37.97 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.908 -1.12 . . . . 0.0 112.17 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.3 122.42 26.01 Favored Pre-proline 0 C--N 1.347 0.467 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -42.33 139.31 2.88 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.502 3.468 . . . . 0.0 116.815 167.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -145.22 139.88 27.48 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -168.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -108.61 30.73 6.2 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 108.894 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.19 -16.89 0.08 OUTLIER Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.78 146.49 66.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 CA-C-N 127.007 3.538 . . . . 0.0 114.859 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 66.91 39.62 3.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.696 1.199 . . . . 0.0 113.618 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.22 -36.97 0.2 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 120.666 -1.271 . . . . 0.0 114.8 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.37 -21.96 18.63 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 120.393 2.096 . . . . 0.0 110.65 171.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.58 160.11 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 161.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 t -151.13 179.78 7.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . 0.288 95.0 m 78.45 104.81 0.07 Allowed 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.837 2.055 . . . . 0.0 113.332 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 29.75 61.71 0.17 Allowed 'General case' 0 C--N 1.361 1.069 0 N-CA-C 118.105 2.632 . . . . 0.0 118.105 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.87 34.02 0.28 Allowed 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.526 -1.359 . . . . 0.0 114.512 -169.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -42.08 86.16 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.33 2.652 . . . . 0.0 113.168 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.15 114.72 40.27 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.311 1.444 . . . . 0.0 111.776 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.42 141.07 11.1 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 111.978 -167.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -109.59 3.27 20.96 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.327 -1.483 . . . . 0.0 113.859 -169.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m 54.47 57.28 5.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.203 1.801 . . . . 0.0 114.35 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -148.73 147.21 28.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -99.23 -12.12 20.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.17 0.896 . . . . 0.0 110.435 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.4 105.75 15.99 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.019 -1.676 . . . . 0.0 108.36 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -99.76 6.42 45.47 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.312 -1.493 . . . . 0.0 113.56 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.05 1.99 56.1 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.827 1.299 . . . . 0.0 111.408 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.1 t -135.21 160.47 38.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -100.65 7.67 43.81 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 120.8 -1.187 . . . . 0.0 112.829 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.6 t -162.54 154.37 18.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 pt -83.63 -12.4 11.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 C-N-CA 123.503 0.721 . . . . 0.0 110.856 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -67.67 135.36 52.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.325 -1.484 . . . . 0.0 111.821 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.22 -40.03 5.07 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.859 -1.151 . . . . 0.0 111.411 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 t -122.27 125.13 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.78 178.89 19.73 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.2 mt -131.36 161.67 31.85 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.04 178.56 41.21 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.484 ' H ' ' HB2' ' A' ' 214' ' ' TYR . 30.8 m -133.56 157.46 42.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 O-C-N 121.088 -1.242 . . . . 0.0 108.252 -173.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.59 128.15 67.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 123.895 0.878 . . . . 0.0 108.991 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.81 119.91 12.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.007 -1.058 . . . . 0.0 109.885 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.92 -163.07 13.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 120.298 -1.501 . . . . 0.0 113.706 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.58 140.8 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.028 1.331 . . . . 0.0 107.72 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -119.36 140.53 15.02 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 121.858 -0.526 . . . . 0.0 112.192 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -117.78 112.59 20.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.616 1.567 . . . . 0.0 109.854 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -81.9 114.57 20.59 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 123.083 1.42 . . . . 0.0 110.726 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.41 -43.46 23.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.802 1.641 . . . . 0.0 109.77 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 p -140.48 167.77 16.8 Favored Pre-proline 0 C--N 1.347 0.487 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -63.98 -13.29 36.56 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 122.211 1.941 . . . . 0.0 115.501 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -115.96 0.71 13.14 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 119.068 0.849 . . . . 0.0 112.622 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 59.4 tp -135.52 123.7 23.03 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 120.004 1.275 . . . . 0.0 112.222 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 m -130.76 147.16 52.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.727 1.611 . . . . 0.0 109.028 -171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -113.66 133.73 55.14 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 165.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -117.1 140.04 49.99 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 121.853 0.835 . . . . 0.0 109.283 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.35 130.29 47.52 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 174.48 169.86 37.02 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 117.465 -2.302 . . . . 0.0 116.055 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 229' ' ' GLU . 34.8 m-85 -86.4 151.26 23.69 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 128.264 2.625 . . . . 0.0 110.434 171.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.17 98.48 0.73 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 123.895 1.807 . . . . 0.0 108.868 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 194' ' ' VAL . 43.6 m-85 -84.41 133.14 34.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.937 -1.727 . . . . 0.0 109.417 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -118.19 9.03 12.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.13 -0.981 . . . . 0.0 110.035 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -167.36 162.81 14.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.01 18.35 2.29 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.958 1.254 . . . . 0.0 112.381 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.06 -175.89 49.92 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 120.066 -1.646 . . . . 0.0 114.08 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -97.37 -6.92 33.05 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.1 mt -145.29 -64.03 0.33 Allowed 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 59.04 49.76 9.06 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.156 1.782 . . . . 0.0 112.127 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.9 m120 70.98 42.48 0.74 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.549 1.54 . . . . 0.0 111.786 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.0 m 47.35 57.16 6.08 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.705 2.402 . . . . 0.0 114.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 138.57 32.94 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.82 132.65 54.7 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.612 -1.305 . . . . 0.0 109.617 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 67.27 -179.19 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.435 15.6 p 82.34 19.29 0.31 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 130.026 3.33 . . . . 0.0 113.829 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -117.31 -39.29 3.21 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.69 -1.256 . . . . 0.0 110.774 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 212' ' ' TYR . 12.2 pm0 -52.57 177.66 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 131.574 3.95 . . . . 0.0 118.394 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -49.47 118.77 2.94 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.55 1.54 . . . . 0.0 113.77 167.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.0 t -136.57 157.64 46.31 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.99 124.47 47.07 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -126.38 176.08 17.63 Favored Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.611 1.577 . . . . 0.0 111.917 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.13 135.76 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 109.108 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -129.12 131.12 47.19 Favored 'General case' 0 C--N 1.344 0.368 0 O-C-N 121.211 -0.931 . . . . 0.0 112.026 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 122.117 0.96 . . . . 0.0 109.241 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -128.38 136.15 50.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.823 0.849 . . . . 0.0 110.899 -162.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--O 1.264 1.864 0 C-N-CA 125.396 1.479 . . . . 0.0 113.487 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.991 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -163.28 154.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.045 1.423 . . . . 0.0 111.226 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.53 161.14 8.6 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 124.587 1.089 . . . . 0.0 113.23 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 54.1 Cg_exo -43.5 145.63 1.58 Allowed 'Trans proline' 0 CA--C 1.517 -0.366 0 C-N-CA 125.199 3.933 . . . . 0.0 116.694 155.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -145.29 155.42 43.2 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.224 1.011 . . . . 0.0 111.499 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.5 140.97 34.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 C-N-CA 125.024 1.33 . . . . 0.0 107.454 166.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -122.25 134.34 54.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.11 141.94 49.36 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.361 1.465 . . . . 0.0 109.025 171.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.27 153.22 25.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 120.058 -1.651 . . . . 0.0 112.229 -176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -146.67 139.32 25.15 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.414 -1.429 . . . . 0.0 112.544 -169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 60.33 52.55 4.77 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 167.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -129.9 160.29 34.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.07 161.2 40.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 120.812 -1.18 . . . . 0.0 107.938 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.12 135.38 54.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.88 144.18 27.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -158.18 84.62 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.262 -1.524 . . . . 0.0 110.083 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.18 108.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 123.324 1.535 . . . . 0.0 114.724 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.7 p -88.2 -1.21 57.88 Favored 'General case' 0 CA--C 1.506 -0.734 0 O-C-N 118.303 -2.748 . . . . 0.0 111.508 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -93.26 1.94 56.82 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.47 1.508 . . . . 0.0 112.314 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -66.92 149.39 50.67 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 121.673 -0.642 . . . . 0.0 111.805 170.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.3 t80 16.43 78.77 0.11 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 130.245 3.418 . . . . 0.0 118.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.25 -4.24 5.89 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.287 1.991 . . . . 0.0 111.737 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.24 -38.74 71.6 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -103.83 31.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 CA-C-N 125.333 2.94 . . . . 0.0 109.367 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -151.06 -178.06 6.39 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.858 -1.151 . . . . 0.0 108.535 -175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.29 103.84 23.0 Favored Pre-proline 0 N--CA 1.444 -0.751 0 O-C-N 120.567 -1.333 . . . . 0.0 108.822 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.01 146.37 80.76 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 C-N-CA 122.871 2.381 . . . . 0.0 113.377 164.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -115.77 5.27 14.13 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 121.203 -0.936 . . . . 0.0 112.632 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.3 120.97 10.48 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.278 -1.514 . . . . 0.0 108.172 165.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.26 147.03 45.85 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.9 tttt 81.8 -49.3 0.23 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.357 2.263 . . . . 0.0 113.036 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.7 tp -84.96 -25.34 6.9 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 O-C-N 121.845 -0.534 . . . . 0.0 111.847 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.255 72.3 m 64.1 31.37 13.45 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -62.14 127.46 31.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.895 -1.128 . . . . 0.0 113.593 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.07 109.1 26.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-O 122.898 1.332 . . . . 0.0 109.664 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.8 m -76.65 -23.55 53.29 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 120.251 -1.53 . . . . 0.0 112.085 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.75 -45.31 94.45 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 120.144 -1.597 . . . . 0.0 112.842 171.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -60.07 -41.81 93.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.785 1.634 . . . . 0.0 113.894 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -75.37 -10.62 59.62 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -101.72 -10.07 20.3 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.202 -0.936 . . . . 0.0 112.836 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 pt -95.31 179.05 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 119.844 -1.785 . . . . 0.0 111.914 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 63.06 169.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.383 3.7 p 46.37 -147.88 0.14 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.296 2.638 . . . . 0.0 117.461 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 53.06 62.19 2.8 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.2 m 62.72 60.43 1.3 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.09 -43.62 93.22 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 124.96 1.304 . . . . 0.0 114.319 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -142.66 82.11 12.8 Favored Pre-proline 0 C--N 1.347 0.491 0 O-C-N 120.842 -1.161 . . . . 0.0 112.295 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -88.48 75.82 1.71 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.612 1.542 . . . . 0.0 108.679 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.2 160.94 34.65 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 124.491 1.116 . . . . 0.0 109.856 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -119.26 135.71 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 m -121.79 124.99 45.48 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.25 158.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 O-C-N 121.299 -0.876 . . . . 0.0 109.284 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.2 -158.0 18.01 Favored Glycine 0 CA--C 1.491 -1.437 0 O-C-N 120.24 -1.538 . . . . 0.0 110.254 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.1 p90 -151.21 150.62 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -125.74 139.3 53.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 123.016 1.389 . . . . 0.0 110.661 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.83 170.64 15.7 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.67 111.17 3.82 Favored Glycine 0 C--N 1.348 1.199 0 O-C-N 119.626 -1.921 . . . . 0.0 113.535 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.94 1.36 79.89 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.53 -0.982 . . . . 0.0 113.732 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -146.61 134.37 21.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 120.392 -1.652 . . . . 0.0 111.663 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.71 133.04 21.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.234 1.493 . . . . 0.0 109.744 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 tt -142.43 143.24 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.22 157.56 34.56 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.125 0.57 . . . . 0.0 109.693 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.1 156.05 45.37 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -140.51 146.88 38.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.806 0.812 . . . . 0.0 109.299 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -144.67 136.97 26.28 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.492 -1.38 . . . . 0.0 109.31 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.55 118.4 20.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.06 0.933 . . . . 0.0 109.301 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -86.18 -17.86 33.77 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 119.779 -1.825 . . . . 0.0 113.227 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.48 105.3 4.78 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.185 -171.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.28 -28.26 67.03 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 46.44 42.17 10.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 127.473 2.309 . . . . 0.0 114.062 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -66.99 143.11 56.99 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.29 -37.89 70.49 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.82 13.74 34.01 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.998 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 62.74 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -155.73 8.72 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.634 -1.291 . . . . 0.0 113.068 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . 0.268 86.6 m-85 60.03 50.7 6.39 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -63.82 134.7 55.72 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.7 165.51 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.922 1.289 . . . . 0.0 109.298 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.1 m120 55.63 35.37 25.1 Favored 'General case' 0 C--N 1.365 1.266 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.58 -46.22 95.53 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' CD ' HH22 ' A' ' 90' ' ' ARG . 0.4 OUTLIER -145.12 -3.97 0.74 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 120.68 -1.262 . . . . 0.0 111.884 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -162.12 166.13 26.14 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.16 -42.85 94.9 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 120.113 -1.617 . . . . 0.0 112.622 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.475 HH22 ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -61.96 134.35 56.54 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.29 151.18 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 O-C-N 120.727 -1.233 . . . . 0.0 112.478 168.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.19 164.64 28.67 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -79.31 -27.03 42.14 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -85.18 92.85 8.51 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.44 -1.413 . . . . 0.0 110.49 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -104.4 0.94 29.58 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.967 -1.083 . . . . 0.0 111.773 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.13 173.44 50.28 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 124.424 1.012 . . . . 0.0 111.673 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.3 mt -118.82 133.42 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.942 1.297 . . . . 0.0 108.794 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -87.61 116.65 25.88 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 120.829 -1.17 . . . . 0.0 110.325 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.4 pt -92.48 175.2 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 122.499 1.142 . . . . 0.0 112.43 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -95.44 3.03 54.68 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.144 2.978 . . . . 0.0 112.649 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -116.03 148.69 39.91 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 120.756 -1.215 . . . . 0.0 113.963 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -82.32 165.27 20.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.945 1.298 . . . . 0.0 113.339 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -129.29 166.25 19.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.344 3.3 mm-40 70.51 48.43 0.46 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 124.615 2.15 . . . . 0.0 112.781 -169.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -94.38 7.76 44.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.662 -173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 65.98 37.93 5.14 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-O 123.83 1.776 . . . . 0.0 112.273 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 166.77 139.21 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -145.48 132.11 19.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -170.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.24 163.45 0.52 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 119.348 2.499 . . . . 0.0 119.348 -169.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -54.88 136.1 47.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.254 1.821 . . . . 0.0 115.737 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.69 0.72 10.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 122.413 1.101 . . . . 0.0 108.396 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -74.51 -10.56 59.67 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 119.661 -1.899 . . . . 0.0 112.752 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.36 45.75 2.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.725 1.21 . . . . 0.0 109.293 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.93 120.93 61.97 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.804 -1.185 . . . . 0.0 108.598 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . 0.331 92.5 p 10.96 96.76 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 129.195 2.998 . . . . 0.0 118.359 -169.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.4 p -160.46 164.63 32.07 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 121.028 -1.045 . . . . 0.0 110.393 -171.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 tt -140.43 140.36 35.42 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -132.38 161.03 23.89 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-O 122.389 0.994 . . . . 0.0 112.702 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 47.9 tp -142.32 132.09 24.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.2 m -125.4 133.71 52.4 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.702 -0.624 . . . . 0.0 111.414 -171.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.88 114.61 22.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.158 0.983 . . . . 0.0 108.815 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.27 129.71 70.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 123.77 0.828 . . . . 0.0 108.832 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -86.08 139.93 30.69 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 119.477 -2.014 . . . . 0.0 109.761 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.85 109.62 21.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.26 102.46 9.51 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 119.682 -1.886 . . . . 0.0 111.872 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -77.7 54.83 1.27 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.214 1.405 . . . . 0.0 113.275 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.0 tt -92.3 -5.2 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 123.989 1.852 . . . . 0.0 109.303 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -159.13 163.46 36.11 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 164.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.05 -39.36 94.51 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.948 -1.72 . . . . 0.0 112.552 165.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -106.09 -42.26 5.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -163.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -106.39 113.43 26.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.165 0.893 . . . . 0.0 108.986 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.88 123.32 18.08 Favored Pre-proline 0 N--CA 1.441 -0.919 0 O-C-N 121.263 -0.898 . . . . 0.0 111.733 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.02 139.19 26.46 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 123.115 2.544 . . . . 0.0 115.052 151.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -125.43 137.09 53.99 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.594 1.158 . . . . 0.0 109.75 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.9 145.03 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 121.172 -0.955 . . . . 0.0 108.426 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -177.07 -161.14 25.19 Favored Glycine 0 CA--C 1.49 -1.514 0 O-C-N 120.47 -1.394 . . . . 0.0 112.206 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -131.72 158.79 40.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.284 1.04 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -140.65 134.73 30.86 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.065 0.936 . . . . 0.0 110.806 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.57 147.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -141.4 137.04 31.99 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -142.26 163.87 31.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.431 1.11 . . . . 0.0 111.232 -160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.56 154.65 30.32 Favored Glycine 0 C--N 1.351 1.379 0 C-N-CA 125.283 1.42 . . . . 0.0 113.605 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 65.64 32.51 9.1 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.2 m -63.16 -41.14 91.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -163.9 158.47 19.87 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -94.02 -11.61 30.37 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.981 0.896 . . . . 0.0 112.142 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.7 t -167.0 172.85 9.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.8 tt -111.32 -8.35 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.877 0.871 . . . . 0.0 110.557 163.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -63.72 144.59 56.91 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.57 -1.332 . . . . 0.0 113.117 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.4 t -138.44 19.0 2.73 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 78.6 m -60.38 138.87 57.91 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.034 -1.666 . . . . 0.0 114.106 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -138.58 24.79 2.65 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.941 -1.724 . . . . 0.0 110.682 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -128.16 116.56 20.11 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.992 -1.067 . . . . 0.0 109.24 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 m -63.66 -40.24 96.36 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.405 1.082 . . . . 0.0 113.065 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 25.8 pt -143.06 157.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.78 137.91 37.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.123 0.969 . . . . 0.0 110.655 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.96 -5.28 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 123.849 0.86 . . . . 0.0 110.587 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.9 m -85.12 122.4 29.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.344 -0.848 . . . . 0.0 109.163 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 p -59.15 147.75 34.04 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 123.066 1.412 . . . . 0.0 114.134 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 119.59 71.95 Favored Pre-proline 0 C--O 1.243 0.754 0 O-C-N 120.262 -1.524 . . . . 0.0 111.567 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.39 132.82 12.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.391 3.394 . . . . 0.0 116.718 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t 77.54 7.7 2.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.969 2.107 . . . . 0.0 113.618 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -103.56 109.29 20.9 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 120.55 -1.344 . . . . 0.0 109.527 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.85 93.35 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.17 115.75 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 CA-C-N 124.985 2.816 . . . . 0.0 111.93 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -60.32 -42.12 94.96 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.881 -1.137 . . . . 0.0 113.127 165.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 136.12 -174.63 21.34 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 178.33 -57.91 0.01 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.262 1.425 . . . . 0.0 110.374 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.79 -30.03 23.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-O 123.803 1.763 . . . . 0.0 109.919 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -152.51 166.34 32.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 86.7 m -94.7 128.46 41.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.492 1.117 . . . . 0.0 108.852 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -93.43 139.03 31.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.115 -0.991 . . . . 0.0 113.385 -171.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 69.16 48.47 0.67 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.52 1.528 . . . . 0.0 112.642 168.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 p -95.86 8.69 42.88 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.277 1.831 . . . . 0.0 110.178 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.59 112.72 7.1 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.672 2.389 . . . . 0.0 111.264 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -62.02 128.79 25.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.955 1.77 . . . . 0.0 113.885 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -65.98 106.56 1.62 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.682 -0.636 . . . . 0.0 111.547 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.4 p -64.25 148.53 49.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.7 2.0 . . . . 0.0 114.888 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.69 137.21 53.47 Favored 'General case' 0 N--CA 1.438 -1.067 0 O-C-N 120.681 -1.262 . . . . 0.0 109.182 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -118.59 149.55 41.16 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.63 116.6 20.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.892 0.853 . . . . 0.0 112.372 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.64 6.32 14.51 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.382 1.073 . . . . 0.0 109.571 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -104.98 -34.05 8.13 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 120.164 -1.585 . . . . 0.0 111.69 -164.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.4 p -69.47 -29.34 66.98 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 121.05 -1.031 . . . . 0.0 112.636 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 59.28 29.09 18.58 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.673 1.189 . . . . 0.0 112.234 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.4 t 69.76 101.86 0.06 Allowed 'General case' 0 C--N 1.346 0.44 0 C-N-CA 127.841 2.456 . . . . 0.0 113.137 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.6 pt -74.81 -19.78 16.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 122.924 1.345 . . . . 0.0 114.558 -173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -120.09 144.15 47.76 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 119.261 -2.15 . . . . 0.0 106.871 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -137.37 161.09 37.24 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.65 -170.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.73 134.9 29.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 124.936 1.294 . . . . 0.0 111.301 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.99 126.72 8.55 Favored Glycine 0 CA--C 1.497 -1.074 0 O-C-N 121.087 -1.008 . . . . 0.0 111.741 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.13 128.25 54.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.852 1.661 . . . . 0.0 107.435 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -144.54 178.43 22.44 Favored Glycine 0 CA--C 1.493 -1.324 0 CA-C-O 123.439 1.577 . . . . 0.0 113.564 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.7 m -125.95 148.29 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 110.259 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.0 mt -127.59 132.74 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -142.31 136.2 29.48 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 122.338 1.066 . . . . 0.0 109.871 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -177.84 -154.8 12.83 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 120.523 -1.361 . . . . 0.0 112.882 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.6 p -147.01 147.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -133.22 151.52 20.1 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 120.955 -1.091 . . . . 0.0 111.483 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -132.46 116.62 17.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.88 0.872 . . . . 0.0 112.598 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -73.94 97.81 2.9 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 122.425 1.107 . . . . 0.0 111.459 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.2 mt -62.17 -41.04 89.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 125.989 1.716 . . . . 0.0 109.774 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.1 p -143.38 167.41 15.8 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -64.48 -15.34 49.3 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 CA-C-N 122.405 1.895 . . . . 0.0 114.397 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -109.97 -9.9 14.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 112.326 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.8 tp -133.49 117.3 17.0 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.3 t -143.53 144.57 32.02 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.9 1.334 . . . . 0.0 109.269 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 44.0 tp -121.07 116.66 25.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.586 1.154 . . . . 0.0 110.252 -167.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -89.44 147.54 23.96 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.945 0.879 . . . . 0.0 109.478 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -135.49 128.72 31.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -178.86 -160.48 24.91 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 117.547 -2.263 . . . . 0.0 116.548 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -134.23 162.43 32.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.523 1.929 . . . . 0.0 109.745 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -148.6 157.0 43.16 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -145.3 129.76 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 173.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -143.21 171.11 14.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 O-C-N 121.118 -0.989 . . . . 0.0 109.452 -164.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.4 m120 64.0 47.28 3.46 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.509 1.147 . . . . 0.0 112.996 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -56.16 146.09 24.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.77 -163.13 13.98 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 112.224 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -65.51 151.38 46.54 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.635 1.974 . . . . 0.0 115.507 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.23 9.21 34.74 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -165.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -53.73 -37.35 63.24 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -163.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -122.63 22.0 9.96 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 89.9 m -113.71 106.25 14.27 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 120.886 -1.134 . . . . 0.0 110.324 -165.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -65.83 -40.2 91.55 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 120.389 -1.445 . . . . 0.0 114.194 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -143.9 134.32 24.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.965 -1.085 . . . . 0.0 108.659 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -103.59 -5.61 22.51 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.931 1.348 . . . . 0.0 109.606 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 p -91.0 1.64 56.92 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.091 1.756 . . . . 0.0 111.141 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 229' ' ' GLU . 8.9 t-160 59.42 -106.52 0.29 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 165.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HG3' ' CD2' ' A' ' 228' ' ' HIS . 48.7 mt-10 -149.27 142.46 25.04 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.433 1.493 . . . . 0.0 107.807 -171.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -151.67 163.13 39.78 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.318 -1.489 . . . . 0.0 111.162 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . 0.28 8.0 t 111.55 -143.89 0.0 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 127.957 2.503 . . . . 0.0 111.156 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 34.4 mt -90.48 160.22 16.12 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 123.522 1.629 . . . . 0.0 113.341 -174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.39 141.74 9.17 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.38 129.14 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 123.198 1.475 . . . . 0.0 109.132 -173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.7 mtm105 -122.05 131.04 53.78 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -170.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.29 132.23 56.72 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt85 -98.62 121.54 40.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.262 1.728 0 C-N-CA 127.194 2.198 . . . . 0.0 114.104 -172.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.053 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.05 136.95 30.7 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.37 100.03 0.56 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.247 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -86.44 105.86 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 CA-C-N 121.382 2.591 . . . . 0.0 108.31 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -115.87 146.56 41.92 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 123.512 1.625 . . . . 0.0 112.472 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.03 137.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 O-C-N 119.503 -1.998 . . . . 0.0 111.619 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -115.96 137.81 51.76 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 166.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.2 137.68 27.54 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.992 -1.068 . . . . 0.0 109.549 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -89.5 125.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.406 1.098 . . . . 0.0 110.949 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -98.04 -62.55 1.23 Allowed 'General case' 0 C--O 1.221 -0.413 0 O-C-N 120.712 -1.243 . . . . 0.0 111.05 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.57 156.51 32.75 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 121.196 -0.94 . . . . 0.0 112.106 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -124.32 137.03 54.53 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 120.965 -1.085 . . . . 0.0 108.321 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.47 20.57 1.35 Allowed 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.364 1.554 . . . . 0.0 111.81 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . 0.262 26.5 p90 -135.71 162.89 31.47 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.273 -1.517 . . . . 0.0 111.613 173.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.35 136.97 58.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.682 2.393 . . . . 0.0 113.976 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -104.43 -6.19 20.95 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 120.375 -1.453 . . . . 0.0 114.305 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.257 10.4 mm 35.97 60.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 128.517 2.727 . . . . 0.0 116.109 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -59.13 -40.74 86.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -166.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.59 14.53 26.3 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 120.294 -1.504 . . . . 0.0 114.04 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 70.26 17.12 7.17 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 120.42 -1.425 . . . . 0.0 114.579 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -67.73 142.81 96.18 Favored Pre-proline 0 C--O 1.238 0.479 0 O-C-N 120.582 -1.324 . . . . 0.0 112.349 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -103.94 -10.12 0.13 Allowed 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 122.027 1.76 . . . . 0.0 108.299 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.93 153.4 54.85 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 129.256 3.022 . . . . 0.0 113.744 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -38.49 134.52 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.6 2.867 . . . . 0.0 117.059 156.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -72.5 -25.2 61.32 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 126.15 1.78 . . . . 0.0 113.783 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.18 144.4 58.41 Favored Pre-proline 0 N--CA 1.446 -0.641 0 O-C-N 121.488 -0.757 . . . . 0.0 111.627 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -57.05 159.55 14.68 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.248 1.965 . . . . 0.0 113.198 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 76.54 47.19 0.08 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.476 1.11 . . . . 0.0 111.856 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.8 -35.96 75.74 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.493 1.917 . . . . 0.0 115.434 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 55.63 49.16 17.04 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.257 62.9 tttm 92.5 -10.7 0.19 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.742 2.417 . . . . 0.0 112.076 172.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.1 mt -81.66 118.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 O-C-N 120.184 -1.572 . . . . 0.0 109.743 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 t -151.79 -89.87 0.06 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.47 0.708 . . . . 0.0 109.727 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -90.68 -3.94 57.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 O-C-N 119.725 -1.859 . . . . 0.0 112.19 -176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -115.32 120.0 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -154.17 154.49 33.63 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.76 147.85 36.42 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.18 -39.02 69.07 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -71.71 -16.07 62.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.577 1.551 . . . . 0.0 112.422 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -85.65 -1.9 57.63 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 119.423 -2.048 . . . . 0.0 111.554 174.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 48.64 58.27 5.44 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.44 121.95 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.267 92.6 mtt-85 72.22 3.53 4.71 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -152.74 19.96 0.61 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.125 -2.235 . . . . 0.0 110.82 -169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -58.88 -42.93 90.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.7 t -67.08 151.93 46.7 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.26 -68.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.69 1.596 . . . . 0.0 110.385 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -53.31 105.73 0.57 Allowed Pre-proline 0 C--O 1.242 0.697 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -166.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -60.03 173.3 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.677 3.585 . . . . 0.0 115.531 165.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -114.0 -24.09 9.22 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -156.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.79 142.77 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -141.95 131.5 23.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.134 0.968 . . . . 0.0 110.549 -166.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.56 121.63 66.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.534 -1.354 . . . . 0.0 107.552 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 160.05 31.41 Favored Glycine 0 C--N 1.363 2.03 0 O-C-N 119.881 -1.762 . . . . 0.0 114.99 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -77.98 129.81 35.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.527 1.131 . . . . 0.0 111.567 175.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.61 136.93 42.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 171.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -150.8 177.09 10.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.179 . . . . 0.0 109.073 -165.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.03 106.11 1.22 Allowed Glycine 0 C--N 1.357 1.72 0 O-C-N 119.249 -2.157 . . . . 0.0 113.425 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.12 -1.0 82.41 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 125.3 1.428 . . . . 0.0 114.364 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -148.04 142.19 26.07 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.454 1.627 . . . . 0.0 115.147 -161.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.79 115.3 21.13 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.817 2.047 . . . . 0.0 108.23 165.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -122.61 122.73 66.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 O-C-N 120.207 -1.558 . . . . 0.0 108.176 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.44 160.4 42.62 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -166.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.58 137.37 52.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.182 1.393 . . . . 0.0 107.939 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 138' ' ' ARG . 65.8 m-20 -120.81 143.9 48.61 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.858 0.863 . . . . 0.0 110.147 -161.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -142.42 160.74 39.67 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 120.114 -1.616 . . . . 0.0 112.28 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.11 168.97 25.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.584 1.183 . . . . 0.0 110.152 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -133.9 41.32 3.02 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -61.68 -39.43 91.42 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.223 1.409 . . . . 0.0 113.535 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -86.4 161.2 18.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.005 0.922 . . . . 0.0 111.297 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -60.02 147.63 38.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 123.007 1.384 . . . . 0.0 114.231 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -148.71 147.24 28.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -166.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 56.11 53.97 8.43 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.734 1.614 . . . . 0.0 114.384 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -102.95 111.41 23.73 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 120.411 -1.431 . . . . 0.0 111.361 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -116.17 143.42 45.52 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 111.097 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -114.92 115.62 27.21 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.63 -1.294 . . . . 0.0 110.389 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -101.71 -6.02 24.23 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 122.95 0.5 . . . . 0.0 111.26 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 p -85.3 122.03 28.89 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 120.559 -1.338 . . . . 0.0 110.343 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -98.49 -20.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.859 -1.15 . . . . 0.0 111.675 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -97.06 168.56 10.38 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.755 -1.216 . . . . 0.0 112.208 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 mm -63.14 117.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 124.198 0.999 . . . . 0.0 110.544 165.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -85.3 135.33 33.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 120.873 -1.142 . . . . 0.0 110.154 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -124.55 133.06 53.42 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 119.398 -2.063 . . . . 0.0 109.588 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.35 166.99 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.774 0.83 . . . . 0.0 109.861 -164.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -113.74 11.86 18.18 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.368 -0.833 . . . . 0.0 112.071 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 pt -91.28 138.51 19.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.811 0.815 . . . . 0.0 110.549 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -91.08 134.9 34.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 119.982 -1.699 . . . . 0.0 112.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -116.91 120.24 37.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.6 -44.97 93.22 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -109.75 142.75 40.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 120.409 -1.432 . . . . 0.0 109.967 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.17 178.6 0.05 OUTLIER Glycine 0 C--N 1.356 1.684 0 N-CA-C 120.042 2.777 . . . . 0.0 120.042 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.306 9.8 mt 71.44 122.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.339 1.856 . . . . 0.0 114.255 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -78.54 144.13 35.91 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 110.581 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 tp -158.52 10.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.658 0 O-C-N 120.165 -1.584 . . . . 0.0 111.488 -168.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 20.14 -107.44 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 130.142 3.377 . . . . 0.0 118.761 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -96.51 18.47 14.01 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 120.874 -1.141 . . . . 0.0 111.884 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 62.94 51.89 2.77 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.109 2.163 . . . . 0.0 116.805 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.4 p -103.64 -1.04 28.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.238 -0.914 . . . . 0.0 112.142 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.18 140.67 57.87 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.641 1.21 . . . . 0.0 112.888 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -122.01 111.22 16.77 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -167.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . 0.32 36.4 mt-30 110.61 14.42 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 C-N-CA 130.014 3.325 . . . . 0.0 110.912 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.33 165.41 22.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 123.642 1.687 . . . . 0.0 108.892 172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.64 -38.81 82.39 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.404 -1.435 . . . . 0.0 112.813 173.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.95 21.66 29.15 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 124.746 1.165 . . . . 0.0 115.613 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -57.51 119.71 7.0 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 118.779 1.289 . . . . 0.0 110.376 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -67.99 -28.11 67.16 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.643 -1.911 . . . . 0.0 115.564 -168.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -94.58 15.97 16.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.056 -1.028 . . . . 0.0 113.121 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.0 -19.64 57.04 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.833 -1.792 . . . . 0.0 111.666 168.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -118.37 147.62 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 t -84.01 -179.89 7.36 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-O 123.173 1.463 . . . . 0.0 110.361 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.6 m -102.64 9.34 39.35 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 119.777 -1.827 . . . . 0.0 109.396 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.6 mt -128.53 151.07 49.86 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.072 1.349 . . . . 0.0 113.763 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -144.13 -175.22 17.06 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 125.407 1.479 . . . . 0.0 109.755 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.64 141.88 25.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 t -130.25 137.23 49.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.047 0.939 . . . . 0.0 112.867 -170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.46 110.01 15.54 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 123.075 1.417 . . . . 0.0 109.026 167.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.9 mt -119.47 139.75 45.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 C-N-CA 126.639 1.975 . . . . 0.0 109.017 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.33 129.59 35.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.023 -1.048 . . . . 0.0 109.252 171.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.04 150.72 31.6 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.59 112.68 18.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.042 -1.661 . . . . 0.0 110.616 -164.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -105.18 14.25 29.38 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -163.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.45 16.36 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.42 129.14 55.66 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 120.199 -1.563 . . . . 0.0 110.349 -161.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -58.43 -45.03 89.28 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -176.89 2.94 0.01 OUTLIER 'General case' 0 C--N 1.354 0.795 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.024 -166.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -127.21 120.19 28.16 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.208 -1.557 . . . . 0.0 109.257 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -130.38 142.76 46.6 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 120.566 -1.334 . . . . 0.0 110.661 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -55.21 151.33 36.02 Favored 'Trans proline' 0 C--O 1.225 -0.137 0 C-N-CA 122.426 2.084 . . . . 0.0 112.915 147.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -121.37 108.58 13.86 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.8 mt -137.45 130.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 120.577 -1.327 . . . . 0.0 108.527 -169.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.54 172.75 42.52 Favored Glycine 0 CA--C 1.496 -1.113 0 O-C-N 120.223 -1.548 . . . . 0.0 113.489 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.67 149.12 51.56 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.674 1.59 . . . . 0.0 108.319 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' A' ' 70' ' ' ASP . 23.2 ttt180 -145.35 143.82 30.36 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 120.437 -1.415 . . . . 0.0 110.314 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.28 140.11 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.738 1.215 . . . . 0.0 108.244 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.44 130.89 53.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.061 -1.65 . . . . 0.0 108.335 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -87.94 142.16 28.01 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.768 1.271 . . . . 0.0 111.29 -171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 190' ' ' VAL . . . -137.56 154.61 22.62 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -89.53 135.94 33.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.327 1.06 . . . . 0.0 112.778 -167.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.76 159.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -162.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.336 99.2 mtt180 89.21 20.71 0.04 OUTLIER 'General case' 0 C--N 1.362 1.145 0 C-N-CA 126.608 1.963 . . . . 0.0 113.603 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -81.99 128.51 34.15 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.298 1.039 . . . . 0.0 112.475 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.07 125.59 30.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.764 0.825 . . . . 0.0 109.636 166.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.8 tp -67.53 -33.64 63.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 123.098 1.428 . . . . 0.0 111.291 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -44.04 97.02 Favored 'General case' 0 N--CA 1.439 -1.005 1 C-N-CA 133.013 4.525 . . . . 0.0 112.663 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.1 t -85.24 175.56 8.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 124.222 1.963 . . . . 0.0 114.138 -166.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.1 p -65.46 119.37 10.91 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 119.955 -1.716 . . . . 0.0 112.645 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.99 -4.26 49.95 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 120.871 -1.143 . . . . 0.0 112.924 -169.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 78.28 18.42 1.09 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.66 1.584 . . . . 0.0 112.523 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 154.63 38.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.67 2.788 . . . . 0.0 116.445 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 pt -115.55 22.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 120.805 -1.184 . . . . 0.0 110.615 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.52 129.51 40.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.9 m -117.98 11.05 7.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 124.417 1.087 . . . . 0.0 112.705 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.7 m -97.24 104.68 16.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 119.314 -2.116 . . . . 0.0 110.272 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -62.29 113.15 2.73 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.889 1.276 . . . . 0.0 114.26 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.94 147.08 96.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.904 1.282 . . . . 0.0 113.934 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.44 -8.56 18.45 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.391 2.06 . . . . 0.0 112.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.3 t -161.69 155.63 21.93 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -103.1 5.77 38.15 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.641 0.776 . . . . 0.0 111.29 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.05 73.13 Favored Pre-proline 0 N--CA 1.444 -0.768 0 O-C-N 121.448 -0.783 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.2 166.36 3.34 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.614 2.876 . . . . 0.0 116.143 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.259 34.7 m120 80.73 26.6 0.26 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 163.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.51 165.56 6.19 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-O 122.415 1.008 . . . . 0.0 115.54 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.65 135.13 57.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.02 -1.871 . . . . 0.0 115.37 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.276 2.9 t 61.25 42.62 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 123.956 1.836 . . . . 0.0 113.026 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -98.97 3.52 47.03 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 120.044 -1.66 . . . . 0.0 111.914 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -119.11 138.83 52.63 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 120.589 -1.319 . . . . 0.0 110.784 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -69.0 -29.02 67.12 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 77.46 37.55 0.24 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.233 1.413 . . . . 0.0 113.359 168.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.7 m -171.31 107.45 0.26 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -75.07 145.13 80.32 Favored Pre-proline 0 C--N 1.354 0.768 0 O-C-N 120.939 -1.1 . . . . 0.0 113.167 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.16 152.26 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.194 3.263 . . . . 0.0 116.964 157.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.14 149.91 21.23 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-O 121.934 0.873 . . . . 0.0 112.852 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.8 p -85.47 115.48 23.21 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 121.101 -1.0 . . . . 0.0 111.331 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -156.72 150.72 24.95 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 86.76 27.65 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.841 1.656 . . . . 0.0 112.81 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.56 -41.25 76.55 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.983 3.313 . . . . 0.0 113.575 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -60.02 -33.78 72.48 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.157 1.383 . . . . 0.0 114.663 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -99.6 -1.48 38.03 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.141 1.164 . . . . 0.0 114.141 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 98.8 p -153.39 147.45 25.57 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 120.349 -1.469 . . . . 0.0 113.324 -166.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -136.13 124.55 23.43 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 118.305 -2.747 . . . . 0.0 109.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.7 t -59.2 144.67 45.29 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . 0.488 42.2 pt 50.96 13.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.803 0 N-CA-C 119.159 3.022 . . . . 0.0 119.159 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -60.6 -35.96 77.39 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 126.049 1.739 . . . . 0.0 111.791 170.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 79.18 -52.91 0.44 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 127.65 2.38 . . . . 0.0 113.529 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 142' ' ' GLY . 22.9 m -58.62 148.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.644 1.578 . . . . 0.0 114.326 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.98 140.89 16.49 Favored Glycine 0 CA--C 1.498 -0.969 0 O-C-N 120.878 -1.139 . . . . 0.0 113.274 -175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.18 145.45 47.81 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -151.71 168.22 31.07 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.27 157.2 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 O-C-N 121.541 -0.976 . . . . 0.0 110.096 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.64 125.27 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.65 135.63 22.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.731 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 170.41 -145.16 8.88 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.05 -1.031 . . . . 0.0 110.873 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.29 163.02 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 121.2 -1.176 . . . . 0.0 109.02 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.81 171.66 23.72 Favored Glycine 0 CA--C 1.495 -1.196 0 CA-C-O 123.446 1.581 . . . . 0.0 112.291 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -144.77 130.29 18.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.96 120.64 42.28 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -87.73 -20.78 7.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 O-C-N 120.138 -1.601 . . . . 0.0 112.584 -172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.8 p -152.92 162.05 27.46 Favored Pre-proline 0 N--CA 1.446 -0.656 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -72.41 15.3 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.595 0 CA-C-N 122.639 1.978 . . . . 0.0 114.183 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -123.02 -19.78 5.97 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 119.855 1.207 . . . . 0.0 111.847 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.7 124.53 40.01 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 119.21 -2.181 . . . . 0.0 111.108 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.0 t -135.98 135.24 39.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.857 0.463 . . . . 0.0 111.491 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.31 130.4 38.01 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -110.33 107.63 17.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.78 49.72 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 120.467 -1.396 . . . . 0.0 110.923 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.53 174.33 27.1 Favored Glycine 0 CA--C 1.487 -1.704 0 O-C-N 120.007 -1.683 . . . . 0.0 114.669 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -61.53 129.39 40.88 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 125.314 1.446 . . . . 0.0 112.288 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -123.94 59.56 1.14 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -116.51 143.49 45.53 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 123.908 1.813 . . . . 0.0 114.442 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 220' ' ' LEU . 3.0 p-80 -50.55 158.94 0.56 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.75 3.22 . . . . 0.0 116.096 163.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -60.47 147.05 42.5 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -62.33 127.52 31.71 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 119.578 -1.951 . . . . 0.0 110.942 171.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.28 -1.22 57.33 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.691 0.662 . . . . 0.0 113.459 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -128.96 -36.86 1.75 Allowed 'General case' 0 C--N 1.346 0.429 0 C-N-CA 126.746 2.018 . . . . 0.0 108.702 166.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 215' ' ' HIS . 67.1 tp -65.13 128.52 36.13 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.313 1.445 . . . . 0.0 113.773 167.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -157.52 -86.65 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 75.09 12.55 3.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.553 1.541 . . . . 0.0 113.574 165.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 4.4 m 64.94 36.0 7.91 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.539 1.637 . . . . 0.0 111.695 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -94.44 96.98 9.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 119.461 -2.025 . . . . 0.0 114.843 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -75.95 -17.91 59.54 Favored 'General case' 0 C--N 1.356 0.883 0 O-C-N 119.632 -1.917 . . . . 0.0 113.974 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -152.14 157.31 41.37 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.492 1.517 . . . . 0.0 107.086 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.9 m -156.01 146.77 22.02 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -147.43 149.36 32.56 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.32 -159.12 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.176 1.79 . . . . 0.0 113.789 -172.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -167.85 -13.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.457 -1.402 . . . . 0.0 114.104 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.6 m 157.26 90.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.944 2.497 . . . . 0.0 110.036 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.4 tp -51.67 123.7 10.65 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 120.872 -1.142 . . . . 0.0 112.383 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -124.98 174.1 17.23 Favored Glycine 0 CA--C 1.495 -1.215 0 CA-C-O 122.821 1.234 . . . . 0.0 111.077 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.23 141.0 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -127.92 132.91 49.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.29 119.64 40.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.608 1.163 . . . . 0.0 109.136 -171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -129.75 110.7 11.97 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.261 1.682 0 CA-C-O 116.901 -1.524 . . . . 0.0 110.88 -177.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.951 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 -109.93 151.48 27.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 155.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.18 -171.6 38.97 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.097 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -44.65 141.88 5.27 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 125.155 3.904 . . . . 0.0 116.208 164.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -120.27 136.11 54.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.25 0.62 . . . . 0.0 110.076 167.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.81 134.25 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -146.32 142.82 28.66 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 120.723 -1.235 . . . . 0.0 109.842 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.3 156.19 41.72 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 122.253 1.025 . . . . 0.0 110.68 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' CG ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 p30 -152.6 161.61 42.35 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 124.873 1.269 . . . . 0.0 109.066 -170.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.34 144.98 49.42 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.736 1.215 . . . . 0.0 113.908 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.65 12.33 0.61 Allowed 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.561 -1.337 . . . . 0.0 114.334 -167.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -90.19 2.99 54.78 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 118.863 -2.398 . . . . 0.0 112.786 -167.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.68 50.03 8.59 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 118.073 2.619 . . . . 0.0 118.073 170.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -100.6 92.22 5.01 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.165 -1.584 . . . . 0.0 110.768 -164.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.556 ' CD ' ' HZ3' ' A' ' 226' ' ' LYS . 24.9 pt-20 -107.19 -16.08 14.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -100.08 -2.09 35.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.554 -1.341 . . . . 0.0 112.943 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.263 5.0 mm 41.02 56.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 127.967 2.507 . . . . 0.0 115.52 172.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 p -89.46 5.98 42.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 119.665 -1.897 . . . . 0.0 113.014 -167.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 50.35 37.2 14.72 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 128.837 2.855 . . . . 0.0 116.409 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -108.54 -10.57 15.23 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 121.092 -1.005 . . . . 0.0 112.194 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -64.21 -44.52 77.05 Favored Pre-proline 0 C--N 1.349 0.587 0 CA-C-O 116.851 -1.547 . . . . 0.0 114.301 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -44.72 140.19 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.82 3.013 . . . . 0.0 117.3 159.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -64.55 139.87 97.85 Favored Pre-proline 0 C--N 1.354 0.789 0 O-C-N 121.3 -0.875 . . . . 0.0 113.05 164.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -90.05 136.68 2.53 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.598 1.606 . . . . 0.0 112.325 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 p -89.99 -16.55 29.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.79 151.04 22.51 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 120.647 -1.283 . . . . 0.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.06 136.7 76.29 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.607 2.204 . . . . 0.0 112.21 155.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.49 159.38 41.31 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 120.169 1.349 . . . . 0.0 110.815 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 62.54 42.67 8.39 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.646 1.578 . . . . 0.0 112.765 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 65.06 42.78 3.99 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.813 1.245 . . . . 0.0 113.191 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.1 159.88 37.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -138.64 143.2 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 O-C-N 121.167 -0.958 . . . . 0.0 109.35 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.5 m -89.01 12.52 15.28 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 121.111 -0.993 . . . . 0.0 112.193 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.73 3.67 47.65 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 111.424 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.89 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.0 p -63.74 133.63 53.87 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.106 -0.996 . . . . 0.0 113.535 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 65.83 19.63 11.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -96.81 3.81 52.06 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.135 -2.228 . . . . 0.0 111.422 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -156.08 154.06 30.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 119.894 -1.754 . . . . 0.0 109.74 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.328 60.1 ttt180 76.77 -58.57 0.51 Allowed 'General case' 0 C--N 1.353 0.727 0 C-N-CA 127.066 2.147 . . . . 0.0 114.992 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 m120 63.77 44.34 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 160.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.38 -3.68 9.79 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 O-C-N 120.528 -1.357 . . . . 0.0 113.543 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -74.6 -15.95 60.81 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 119.229 -2.169 . . . . 0.0 114.568 -168.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -97.37 -0.71 45.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.629 1.972 . . . . 0.0 111.181 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -75.93 117.41 17.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.048 -1.032 . . . . 0.0 111.693 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -76.59 128.63 35.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.104 -1.622 . . . . 0.0 110.695 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.12 123.79 48.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-O 122.498 1.142 . . . . 0.0 109.032 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -88.36 124.67 65.77 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 126.603 1.961 . . . . 0.0 110.603 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -58.99 147.3 90.72 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 123.701 2.358 . . . . 0.0 111.534 162.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HE ' ' CG ' ' A' ' 14' ' ' ASP . 22.4 tpt180 -120.7 116.02 24.47 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.244 0.545 . . . . 0.0 111.515 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.88 155.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -137.67 137.7 38.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 171.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.24 134.03 61.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 O-C-N 120.427 -1.421 . . . . 0.0 108.815 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.6 -166.53 14.02 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 120.461 -1.399 . . . . 0.0 114.114 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -143.61 136.37 27.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -96.28 132.95 41.21 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.356 1.063 . . . . 0.0 111.661 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.22 177.94 5.14 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 123.577 1.655 . . . . 0.0 110.481 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.18 84.21 0.94 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 119.483 -2.011 . . . . 0.0 113.728 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.94 -7.88 33.42 Favored Glycine 0 C--N 1.344 1.002 0 C-N-CA 124.472 1.034 . . . . 0.0 112.402 175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -149.93 142.14 24.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 120.596 -1.532 . . . . 0.0 108.405 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.483 HH22 ' CG ' ' A' ' 124' ' ' ASP . 25.9 ttp-105 -126.82 137.65 53.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.557 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.7 133.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.96 36.25 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 121.166 -0.959 . . . . 0.0 110.292 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.313 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.47 132.54 39.02 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.353 1.061 . . . . 0.0 109.732 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -157.41 175.46 13.96 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 120.699 -1.251 . . . . 0.0 109.653 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.09 -87.15 0.58 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.656 1.217 . . . . 0.0 109.551 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -144.69 134.12 23.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.199 -1.563 . . . . 0.0 108.131 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -57.78 145.29 35.38 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.73 78.21 1.55 Allowed 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.641 -1.287 . . . . 0.0 112.803 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.08 20.13 16.58 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 120.81 -1.181 . . . . 0.0 110.473 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . 0.26 47.8 m95 64.04 0.91 1.05 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -69.44 -30.72 68.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.041 -1.662 . . . . 0.0 114.517 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.49 160.55 25.35 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 121.044 -1.035 . . . . 0.0 113.222 -165.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.268 14.0 m-80 88.64 43.22 0.01 OUTLIER 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.48 2.312 . . . . 0.0 113.78 176.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -111.59 21.81 15.72 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 121.043 -1.036 . . . . 0.0 112.457 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -59.83 -40.65 89.17 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 126.89 2.076 . . . . 0.0 113.609 -171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -124.73 109.6 13.32 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 120.846 -1.159 . . . . 0.0 110.168 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 86' ' ' ILE . 89.9 t -93.22 127.46 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 O-C-N 120.54 -1.35 . . . . 0.0 108.161 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -120.53 35.83 4.75 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 84' ' ' VAL . 41.1 mt -118.54 116.07 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 165.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -118.71 133.04 56.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.84 2.33 3.4 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.353 -0.842 . . . . 0.0 112.349 -166.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -39.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.878 0.847 . . . . 0.0 109.921 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -97.6 159.99 14.59 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.29 1.519 . . . . 0.0 113.637 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.86 126.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 O-C-N 120.28 -1.512 . . . . 0.0 111.747 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -112.93 131.4 55.76 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.171 -1.581 . . . . 0.0 109.972 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -147.73 151.01 35.36 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.72 163.62 39.63 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -99.93 99.73 10.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.61 -145.37 5.11 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 126.227 1.87 . . . . 0.0 116.492 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.4 pt -43.87 164.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -110.62 20.83 17.26 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 120.232 -1.543 . . . . 0.0 114.845 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.9 mm -112.26 120.24 62.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 O-C-N 120.872 -1.142 . . . . 0.0 109.843 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.64 38.95 6.81 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.882 2.073 . . . . 0.0 115.976 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -114.56 14.76 17.77 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -136.34 127.69 28.36 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 121.017 -1.052 . . . . 0.0 109.006 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -62.53 103.64 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.92 -1.113 . . . . 0.0 112.946 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.88 37.59 12.0 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -154.78 144.6 21.62 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 119.588 -1.945 . . . . 0.0 107.543 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -116.36 132.64 56.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.123 -0.985 . . . . 0.0 112.667 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.26 7.98 9.69 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 120.958 -1.089 . . . . 0.0 112.954 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.4 145.03 56.71 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 119.037 -2.289 . . . . 0.0 113.108 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.24 -7.98 3.81 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 110.634 167.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 88.39 6.09 Favored 'General case' 0 C--N 1.358 0.973 0 O-C-N 121.388 -1.066 . . . . 0.0 108.618 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -116.89 128.75 55.54 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.767 1.27 . . . . 0.0 111.553 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -59.73 151.11 25.99 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 125.784 1.634 . . . . 0.0 113.179 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 54.48 4.52 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 121.053 3.723 . . . . 0.0 121.053 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -33.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 126.539 1.936 . . . . 0.0 116.224 -168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.9 m -127.05 21.56 6.79 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.573 -1.329 . . . . 0.0 112.294 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.0 m -61.92 150.5 37.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.5 mp -113.93 129.89 56.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.02 -169.63 12.25 Favored Glycine 0 C--O 1.22 -0.763 0 O-C-N 120.997 -1.064 . . . . 0.0 111.752 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 mt -143.58 144.7 32.04 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.5 m -132.72 132.51 42.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.15 119.21 30.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.956 -1.09 . . . . 0.0 109.91 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.89 131.73 70.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.35 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.85 93.19 8.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.88 1.672 . . . . 0.0 107.838 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' CG ' HH22 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.73 126.91 55.06 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 120.068 -1.645 . . . . 0.0 107.929 -165.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.16 131.19 47.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 120.383 -1.448 . . . . 0.0 110.697 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -101.33 28.01 5.77 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 113.408 -171.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.84 -20.95 11.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 119.546 -1.971 . . . . 0.0 109.524 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -67.45 131.85 46.48 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.084 -1.635 . . . . 0.0 111.614 160.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.48 -45.41 80.95 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.77 1.628 . . . . 0.0 114.396 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -149.78 -60.57 0.21 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.093 -1.004 . . . . 0.0 109.045 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -74.47 107.52 6.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.704 -1.247 . . . . 0.0 112.922 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -125.76 108.46 25.63 Favored Pre-proline 0 N--CA 1.437 -1.106 0 C-N-CA 124.474 1.11 . . . . 0.0 111.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.57 139.66 46.8 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 123.642 2.895 . . . . 0.0 113.338 157.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -133.96 166.73 22.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 119.348 0.976 . . . . 0.0 111.3 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.5 tp -143.78 141.01 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.57 -169.61 28.39 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 121.307 -0.871 . . . . 0.0 113.409 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.61 162.02 36.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.606 -0.938 . . . . 0.0 110.711 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -144.41 149.34 35.93 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 122.161 0.981 . . . . 0.0 110.722 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 m -133.95 158.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 C-N-CA 124.777 1.231 . . . . 0.0 108.669 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.06 130.14 17.42 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 120.956 -1.09 . . . . 0.0 111.515 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.09 124.32 47.77 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 119.764 -1.835 . . . . 0.0 110.355 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.21 173.18 53.08 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 120.261 -1.524 . . . . 0.0 113.163 168.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -93.79 6.02 49.76 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.549 -1.559 . . . . 0.0 111.778 -172.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 141.48 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.293 1.044 . . . . 0.0 108.231 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -138.07 137.56 37.9 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.255 1.422 . . . . 0.0 107.354 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -110.64 155.78 21.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 122.405 1.097 . . . . 0.0 111.201 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.1 p -72.93 154.82 40.39 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.73 1.212 . . . . 0.0 110.597 158.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.3 tt -89.51 143.31 11.45 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 O-C-N 121.068 -1.02 . . . . 0.0 111.579 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -87.46 141.7 28.43 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-O 121.94 0.876 . . . . 0.0 111.857 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 m -99.76 24.38 8.44 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 120.85 -1.156 . . . . 0.0 113.917 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.22 168.93 24.89 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 119.506 -1.997 . . . . 0.0 109.708 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -82.28 -23.77 35.06 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.476 -1.39 . . . . 0.0 112.717 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -134.39 103.85 5.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.7 m -74.46 -37.18 63.31 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 121.267 -0.896 . . . . 0.0 112.858 -175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.95 160.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.4 -39.81 84.6 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.7 m -75.66 -17.44 15.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 24.5 m -87.15 117.73 26.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 122.021 0.915 . . . . 0.0 109.058 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.1 m -59.8 133.84 56.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.4 130.33 94.6 Favored Pre-proline 0 C--N 1.356 0.883 0 O-C-N 119.86 -1.775 . . . . 0.0 113.21 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 137.03 3.46 Favored 'Trans proline' 0 C--O 1.235 0.356 0 CA-C-N 122.701 2.0 . . . . 0.0 112.528 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 m -94.88 -9.33 34.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.85 1.26 . . . . 0.0 112.307 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -105.93 25.41 10.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.986 0.898 . . . . 0.0 111.061 -167.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -72.62 141.71 82.9 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.31 153.0 18.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.596 3.53 . . . . 0.0 116.822 166.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -58.86 107.42 0.52 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.04 -2.83 33.46 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.165 0.888 . . . . 0.0 111.923 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.52 131.44 55.59 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.346 -1.09 . . . . 0.0 109.587 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.96 9.63 8.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 O-C-N 120.182 -1.573 . . . . 0.0 111.861 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 t -158.6 162.11 37.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -157.47 156.21 31.71 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.93 -1.106 . . . . 0.0 109.291 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -122.35 106.39 11.04 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -107.37 115.17 29.68 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 120.983 -1.073 . . . . 0.0 111.427 -163.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 91.7 m -65.33 -45.44 84.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.55 122.65 88.0 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 125.614 1.566 . . . . 0.0 112.849 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.72 -9.53 19.79 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.427 2.26 . . . . 0.0 113.127 -168.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -64.99 -34.77 79.24 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 112.539 168.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.4 m -95.89 -8.82 32.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.097 1.359 . . . . 0.0 109.326 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.17 133.05 48.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.38 -1.45 . . . . 0.0 112.22 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.84 8.43 44.18 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.72 -1.237 . . . . 0.0 110.983 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.11 -176.26 4.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -77.59 -22.93 50.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.347 -1.471 . . . . 0.0 114.327 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -156.93 163.7 38.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.008 0.909 . . . . 0.0 108.716 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.5 t -138.95 130.07 26.7 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 120.551 -1.343 . . . . 0.0 107.99 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -38.79 155.18 0.02 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 130.891 3.676 . . . . 0.0 118.85 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.9 t -83.24 65.1 8.09 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 110.656 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.4 mm -95.4 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 58.73 36.92 25.11 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -94.95 -0.15 54.16 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.769 -1.207 . . . . 0.0 114.11 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.11 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 O-C-N 119.726 -1.859 . . . . 0.0 112.858 168.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.05 147.38 20.26 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.469 -0.769 . . . . 0.0 112.222 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.1 tp -149.09 137.2 20.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -172.68 -178.55 42.84 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-O 122.769 1.205 . . . . 0.0 112.818 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.19 162.54 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 125.727 1.611 . . . . 0.0 107.977 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -141.83 135.43 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 120.416 -1.428 . . . . 0.0 109.256 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -141.01 141.46 34.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.31 -163.78 32.04 Favored Glycine 0 CA--C 1.492 -1.347 0 O-C-N 120.698 -1.252 . . . . 0.0 111.323 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.3 m -132.77 132.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.464 1.505 . . . . 0.0 110.905 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -103.04 140.49 14.87 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -132.17 116.46 17.02 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 115.93 14.4 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 120.533 -1.355 . . . . 0.0 112.218 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.45 -18.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 110.83 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.2 t -159.25 154.38 21.76 Favored Pre-proline 0 C--N 1.343 0.325 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -69.77 -9.57 26.44 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-N 125.521 3.007 . . . . 0.0 115.826 -160.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -96.64 -6.33 36.91 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 76.6 mt -134.61 114.37 12.7 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.384 -1.448 . . . . 0.0 112.332 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.9 m -95.49 123.62 39.12 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.31 134.73 33.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 119.89 -1.757 . . . . 0.0 107.346 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.18 123.89 39.24 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 121.286 -0.884 . . . . 0.0 108.879 -165.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -132.94 125.65 30.3 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.87 -176.24 32.77 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 119.952 -1.718 . . . . 0.0 114.295 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -123.83 133.86 53.71 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -141.67 152.85 44.29 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.596 -1.315 . . . . 0.0 109.004 -169.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.55 162.39 28.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.883 0.849 . . . . 0.0 109.645 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 18.99 0.38 Allowed 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.498 0.666 . . . . 0.0 111.942 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -162.27 -179.89 7.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -37.7 153.64 0.02 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 128.618 2.767 . . . . 0.0 118.164 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -177.3 -3.74 0.02 OUTLIER Glycine 0 C--N 1.356 1.642 0 O-C-N 119.804 -1.81 . . . . 0.0 116.738 -169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -145.43 135.24 23.53 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.21 -1.759 . . . . 0.0 109.914 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.0 tp 104.11 126.78 0.01 OUTLIER 'General case' 0 C--N 1.351 0.655 0 C-N-CA 127.851 2.46 . . . . 0.0 106.345 -165.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . 0.315 22.5 mt-10 40.89 40.33 0.98 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 118.124 2.638 . . . . 0.0 118.124 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.01 24.19 12.4 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 168.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.2 p -58.88 130.74 48.41 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.589 ' HA ' ' CE1' ' A' ' 228' ' ' HIS . 30.8 ptt180 -151.22 143.39 24.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.139 -1.601 . . . . 0.0 110.69 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -130.73 -166.93 1.76 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-O 122.772 1.272 . . . . 0.0 110.03 -167.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.556 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 92.3 mttt -89.96 -0.86 57.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.29 -1.506 . . . . 0.0 110.796 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.1 p -96.71 12.74 30.83 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.984 1.714 . . . . 0.0 110.848 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 224' ' ' ARG . 8.1 m80 -92.18 83.96 5.17 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 165.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.33 122.44 35.73 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.35 122.92 21.98 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 120.567 -1.333 . . . . 0.0 110.729 154.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.3 t -122.71 130.58 53.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 121.094 -1.004 . . . . 0.0 112.062 -168.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.0 tp -134.25 129.63 35.94 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.798 0.839 . . . . 0.0 108.853 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -163.2 -157.34 9.11 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 123.364 1.536 . . . . 0.0 114.061 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.61 142.78 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.369 1.468 . . . . 0.0 109.189 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -107.82 138.42 44.1 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 170.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -95.73 109.95 22.17 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -91.84 137.92 31.97 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.612 1.565 . . . . 0.0 109.26 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 CA--C 1.561 1.4 0 O-C-N 120.213 -1.554 . . . . 0.0 109.361 175.639 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.996 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -157.43 168.48 27.2 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 171.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.97 159.92 15.81 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.241 167.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.05 140.29 13.95 Favored 'Trans proline' 0 CA--C 1.512 -0.611 1 C-N-CA 125.364 4.043 . . . . 0.0 115.191 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -124.01 142.04 51.52 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-O 121.739 0.78 . . . . 0.0 110.568 -170.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.17 132.99 28.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.25 1.024 . . . . 0.0 109.97 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -131.0 135.51 47.68 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 120.327 -1.483 . . . . 0.0 107.864 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.05 120.65 21.6 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.87 -1.144 . . . . 0.0 110.085 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 8.1 p-10 -125.2 133.97 52.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 169.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 14' ' ' ASP 0.307 26.0 mt 67.13 37.93 3.58 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 131.279 3.832 . . . . 0.0 113.821 0.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.08 110.6 15.98 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -124.62 16.18 8.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 109.763 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.02 113.24 26.06 Favored 'General case' 0 N--CA 1.435 -1.18 0 O-C-N 121.209 -0.932 . . . . 0.0 110.514 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 71.67 44.42 0.51 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-O 122.408 1.099 . . . . 0.0 113.539 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -114.66 141.5 47.72 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.78 -1.2 . . . . 0.0 108.675 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.535 ' CE1' ' H ' ' A' ' 50' ' ' ARG . 30.4 t60 54.55 26.78 7.63 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 128.072 2.549 . . . . 0.0 114.871 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 pt -63.84 140.22 20.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 O-C-N 119.156 -2.215 . . . . 0.0 112.713 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m 63.78 73.07 0.45 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.629 1.204 . . . . 0.0 114.043 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.425 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 28.4 t60 -76.67 170.67 16.0 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.629 -1.295 . . . . 0.0 111.894 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' N ' ' CG ' ' A' ' 24' ' ' HIS . 2.6 t70 -66.14 148.28 52.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.342 1.457 . . . . 0.0 112.815 166.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -96.48 145.21 29.18 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 120.738 -1.226 . . . . 0.0 110.991 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -61.68 150.75 84.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.349 2.699 . . . . 0.0 114.444 169.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 142.11 96.87 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.37 141.92 18.11 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 115.909 158.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -61.33 -40.26 93.57 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.29 136.73 96.88 Favored Pre-proline 0 C--N 1.352 0.686 0 O-C-N 120.366 -1.458 . . . . 0.0 112.269 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.95 117.42 3.54 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 123.005 2.47 . . . . 0.0 114.457 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -153.39 155.31 36.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.275 88.2 mttt 76.6 11.38 2.66 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.619 1.168 . . . . 0.0 113.613 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -49.34 -34.49 15.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 129.195 2.998 . . . . 0.0 114.933 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.04 -42.11 97.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.348 -1.47 . . . . 0.0 114.96 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.83 -49.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 O-C-N 120.981 -1.074 . . . . 0.0 112.358 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.2 t -158.08 150.17 21.95 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.4 p -102.58 -10.68 19.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 120.989 -1.069 . . . . 0.0 111.368 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -121.39 -2.34 8.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.26 62.5 m 84.77 22.41 0.1 Allowed 'General case' 0 C--N 1.347 0.483 0 C-N-CA 125.445 1.498 . . . . 0.0 114.809 166.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.49 -39.1 89.74 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -169.45 105.01 0.36 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.12 0.968 . . . . 0.0 109.032 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -94.02 -21.31 19.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 119.986 -1.696 . . . . 0.0 113.074 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -170.79 171.68 6.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.552 -1.342 . . . . 0.0 110.84 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.66 129.79 40.53 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 47' ' ' ILE . 15.8 tt -68.58 125.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 125.422 1.489 . . . . 0.0 113.706 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -101.11 3.66 41.43 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 119.387 -2.071 . . . . 0.0 114.421 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 m -65.63 111.42 3.16 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.943 -1.723 . . . . 0.0 113.484 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' H ' ' CE1' ' A' ' 21' ' ' HIS . 36.9 mtm180 -126.59 165.46 19.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -157.32 155.65 31.02 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 119.685 -1.885 . . . . 0.0 107.945 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.51 148.57 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 128.121 2.569 . . . . 0.0 114.533 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.546 ' HE1' ' CG ' ' A' ' 112' ' ' HIS . 92.8 m-70 -124.48 96.08 41.94 Favored Pre-proline 0 CA--C 1.501 -0.935 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.295 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.28 122.03 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.267 1.978 . . . . 0.0 110.982 154.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -133.56 158.14 43.92 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.886 0.874 . . . . 0.0 108.834 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -118.27 129.64 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 163.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -110.58 115.77 30.19 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.42 136.24 52.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 O-C-N 121.033 -1.042 . . . . 0.0 110.236 -171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.02 -149.6 5.98 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 119.974 -1.704 . . . . 0.0 113.244 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -146.96 141.91 26.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 7.9 t70 -114.35 137.34 51.94 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-O 123.326 1.536 . . . . 0.0 111.089 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -108.47 14.45 24.68 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 113.682 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.33 29.33 1.63 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 121.074 -1.017 . . . . 0.0 114.252 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.86 -9.76 34.43 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 111.857 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -118.16 129.58 55.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 26.3 ptt-85 -156.16 156.2 33.8 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.145 1.45 . . . . 0.0 113.788 -162.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.5 tp -125.49 134.7 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.715 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.51 158.96 44.21 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 123.535 0.734 . . . . 0.0 110.732 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.22 133.7 54.19 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.12 0.968 . . . . 0.0 111.375 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -82.04 120.94 25.92 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.594 1.557 . . . . 0.0 114.248 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -110.09 122.45 47.62 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.981 -1.075 . . . . 0.0 109.38 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 173.67 15.17 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.421 1.088 . . . . 0.0 108.487 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 172.32 71.88 0.0 OUTLIER 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.907 1.283 . . . . 0.0 113.636 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -103.07 19.81 18.81 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.111 -0.993 . . . . 0.0 113.262 -168.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -114.93 141.55 47.8 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 119.854 -1.779 . . . . 0.0 107.706 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.56 140.35 58.86 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.107 -1.621 . . . . 0.0 112.211 168.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -108.55 -0.01 20.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.908 -1.12 . . . . 0.0 111.577 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.9 69.16 0.76 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.039 1.736 . . . . 0.0 113.858 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 81.0 147.65 0.09 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 127.353 2.261 . . . . 0.0 113.734 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -67.6 101.11 0.96 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.375 1.07 . . . . 0.0 111.166 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -162.86 163.43 26.46 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.058 -1.026 . . . . 0.0 108.591 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.61 96.37 6.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 121.105 -0.997 . . . . 0.0 109.014 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.7 m -73.97 -23.86 59.54 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 119.982 -1.699 . . . . 0.0 112.774 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.23 124.02 53.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -148.85 141.79 24.76 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.815 0.816 . . . . 0.0 110.909 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.8 mt -61.48 -46.47 96.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 126.35 1.86 . . . . 0.0 112.363 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.78 173.72 9.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.64 111.3 19.95 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 120.202 -1.561 . . . . 0.0 112.449 -165.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.65 17.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.907 -1.12 . . . . 0.0 111.873 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -136.56 151.8 49.78 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.806 -1.809 . . . . 0.0 110.72 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -59.81 -41.36 85.36 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-O 123.158 1.456 . . . . 0.0 112.252 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -162.75 177.29 9.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.37 160.71 28.71 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -57.7 -36.39 71.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.364 3.065 . . . . 0.0 112.854 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.38 -15.32 60.93 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.863 1.265 . . . . 0.0 113.088 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.65 68.79 Favored Glycine 0 C--N 1.352 1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 113.786 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 pt -116.7 17.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 C-N-CA 125.482 1.513 . . . . 0.0 110.537 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -149.51 159.83 43.98 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.37 1.89 8.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.98 8.11 43.92 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.157 -1.589 . . . . 0.0 110.58 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -156.25 145.47 20.59 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.308 -1.495 . . . . 0.0 107.99 -168.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -140.26 -21.57 0.85 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.145 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.6 m -71.21 116.15 11.18 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 120.837 -1.165 . . . . 0.0 113.373 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -58.63 126.53 28.01 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 55.28 41.72 31.01 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 125.171 1.388 . . . . 0.0 113.413 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -59.64 -42.25 92.34 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -170.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -83.2 10.69 7.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.633 1.573 . . . . 0.0 110.776 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -112.36 0.45 15.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.437 1.495 . . . . 0.0 111.346 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.9 177.08 13.63 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 125.512 1.529 . . . . 0.0 116.25 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -66.64 132.83 49.0 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 120.205 -1.762 . . . . 0.0 115.066 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 57.48 175.32 0.05 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 126.775 2.03 . . . . 0.0 116.015 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.546 ' CG ' ' HE1' ' A' ' 53' ' ' HIS 0.286 67.7 m-70 80.19 49.98 0.03 OUTLIER 'General case' 0 C--N 1.349 0.575 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 164.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.18 122.59 38.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.799 -1.188 . . . . 0.0 109.755 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . 0.348 39.4 t 78.09 -56.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 126.858 2.063 . . . . 0.0 113.937 174.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.8 t -151.01 139.24 20.24 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.177 0.899 . . . . 0.0 109.961 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.9 p -173.1 -178.99 1.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.49 1.516 . . . . 0.0 108.594 -169.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.357 68.7 mt 66.36 -156.64 0.25 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.561 1.944 . . . . 0.0 114.118 -173.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.15 -145.2 10.65 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.119 -1.613 . . . . 0.0 111.051 -164.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.9 mt -97.42 148.68 22.95 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 121.691 -0.888 . . . . 0.0 113.303 -169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -121.12 135.07 55.24 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.523 1.129 . . . . 0.0 109.014 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.03 121.98 31.08 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.6 mp -138.72 138.57 42.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 120.981 -1.075 . . . . 0.0 109.177 -162.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -119.9 119.59 33.95 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.837 -1.164 . . . . 0.0 110.992 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.72 123.51 29.91 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.467 1.107 . . . . 0.0 109.599 167.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.05 129.98 41.68 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 119.983 -1.698 . . . . 0.0 112.731 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -94.11 20.64 7.71 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.686 -1.259 . . . . 0.0 111.83 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.24 -36.95 71.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.529 1.532 . . . . 0.0 111.844 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -133.19 167.83 19.64 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -92.79 -63.28 1.24 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 125.688 1.595 . . . . 0.0 110.888 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -63.56 -47.44 81.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.953 2.101 . . . . 0.0 114.248 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -97.8 125.94 42.91 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 121.505 -0.747 . . . . 0.0 110.988 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -125.12 102.57 30.79 Favored Pre-proline 0 N--CA 1.442 -0.857 0 O-C-N 121.578 -0.701 . . . . 0.0 109.248 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -57.93 148.62 75.13 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.478 2.786 . . . . 0.0 111.917 155.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -149.42 159.0 44.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 120.366 1.439 . . . . 0.0 112.66 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.4 pt -136.03 151.89 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 126.059 1.744 . . . . 0.0 107.677 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.2 -175.39 46.12 Favored Glycine 0 C--N 1.346 1.097 0 O-C-N 119.941 -1.725 . . . . 0.0 112.214 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.65 169.92 19.88 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.105 -1.233 . . . . 0.0 109.741 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -146.59 145.8 30.22 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.03 116.67 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.39 123.01 19.77 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.193 -0.942 . . . . 0.0 111.463 -163.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -63.39 139.51 58.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.087 -1.008 . . . . 0.0 112.31 171.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.39 -31.89 11.09 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 120.71 -1.244 . . . . 0.0 110.389 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -159.78 156.59 27.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.702 2.001 . . . . 0.0 107.431 171.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.42 140.59 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.576 1.15 . . . . 0.0 113.632 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.06 -45.61 91.37 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . 0.298 87.0 m-70 62.47 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.847 1.259 . . . . 0.0 113.862 -169.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -148.0 -8.36 0.41 Allowed 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.462 -1.399 . . . . 0.0 112.209 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.91 117.96 35.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 O-C-N 120.44 -1.412 . . . . 0.0 107.802 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.07 -47.8 81.4 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 120.486 -1.383 . . . . 0.0 112.309 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -61.33 145.51 51.23 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 128.534 2.733 . . . . 0.0 113.474 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 p -91.25 -1.08 57.76 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.674 0.79 . . . . 0.0 111.243 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 62.27 43.08 8.68 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 124.921 1.288 . . . . 0.0 112.99 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -85.23 121.68 28.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 123.65 0.78 . . . . 0.0 112.615 -170.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 51.5 m -61.1 106.06 0.56 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.086 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.9 pt -49.29 159.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -68.97 133.98 48.89 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.644 1.578 . . . . 0.0 111.483 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.14 -41.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 124.466 1.106 . . . . 0.0 113.34 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.1 m -106.53 105.72 15.88 Favored 'General case' 0 C--N 1.357 0.909 0 CA-C-O 122.604 1.192 . . . . 0.0 108.596 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.9 m -78.32 122.88 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 120.442 -1.411 . . . . 0.0 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.7 t -88.45 115.04 62.18 Favored Pre-proline 0 N--CA 1.447 -0.615 0 O-C-N 121.165 -0.959 . . . . 0.0 108.994 168.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.69 -16.81 18.53 Favored 'Trans proline' 0 CA--C 1.513 -0.573 0 C-N-CA 123.399 2.733 . . . . 0.0 111.499 -170.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.8 m -73.19 -19.4 61.11 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.71 1.604 . . . . 0.0 111.326 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -115.27 -42.77 3.13 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 124.171 0.988 . . . . 0.0 111.004 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.14 145.43 96.81 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -35.15 114.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 124.799 3.666 . . . . 0.0 119.066 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 47.93 42.5 16.42 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 88.57 16.01 59.18 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 120.434 -1.416 . . . . 0.0 113.15 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 67.39 39.94 2.82 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.119 1.368 . . . . 0.0 113.966 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.64 -2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 CA-C-O 122.762 1.268 . . . . 0.0 111.559 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.1 t -154.27 156.36 36.87 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 169.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 99.7 m -143.16 132.09 22.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.55 148.43 41.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -82.6 50.97 1.76 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.336 -0.852 . . . . 0.0 109.466 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 67.4 m -146.08 139.92 26.37 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -57.47 138.78 81.28 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.874 1.27 . . . . 0.0 114.026 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -58.97 149.53 78.59 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 115.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -89.72 -36.1 15.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.362 1.077 . . . . 0.0 111.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.7 p -133.85 158.27 43.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -54.55 -42.91 71.49 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.557 1.143 . . . . 0.0 113.312 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -102.58 106.64 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.58 156.72 16.56 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 123.243 1.497 . . . . 0.0 113.402 -165.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.15 147.46 46.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 123.176 1.465 . . . . 0.0 111.497 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.32 -37.59 83.79 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 119.569 -1.957 . . . . 0.0 113.221 162.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.7 m -55.41 129.85 40.29 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 114.527 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . 0.25 47.7 m-20 80.55 132.63 0.06 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 126.794 2.038 . . . . 0.0 114.525 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.4 m -97.66 154.97 17.21 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.043 -1.661 . . . . 0.0 111.279 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.3 tt -126.62 113.58 33.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 124.539 1.135 . . . . 0.0 109.191 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . 0.45 31.2 ttm180 62.88 64.01 0.91 Allowed 'General case' 0 C--N 1.352 0.704 1 O-C-N 116.067 -4.146 . . . . 0.0 114.884 4.477 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -73.16 68.75 1.01 Allowed 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.393 -1.442 . . . . 0.0 113.69 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.3 t -128.53 128.54 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.34 162.91 28.55 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 122.278 0.932 . . . . 0.0 111.929 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.14 125.2 30.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -136.62 163.61 25.2 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.541 -0.724 . . . . 0.0 112.286 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.94 134.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 pt -122.75 147.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 CA-C-O 123.0 1.381 . . . . 0.0 110.914 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.15 147.2 26.75 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 120.406 -1.434 . . . . 0.0 107.166 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -170.31 -168.99 32.91 Favored Glycine 0 C--N 1.349 1.261 0 O-C-N 120.283 -1.511 . . . . 0.0 114.992 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.79 120.99 53.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 C-N-CA 124.971 1.308 . . . . 0.0 107.612 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -109.98 158.5 14.45 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 120.574 -1.329 . . . . 0.0 110.428 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.3 148.37 32.35 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 121.664 -0.903 . . . . 0.0 110.531 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.07 142.95 52.59 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 122.9 1.333 . . . . 0.0 114.575 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.82 -22.92 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.656 1.693 . . . . 0.0 108.948 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.57 158.68 22.73 Favored Pre-proline 0 C--N 1.348 0.542 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.71 -11.98 13.26 Favored 'Trans proline' 0 N--CA 1.476 0.456 0 N-CA-C 120.018 3.045 . . . . 0.0 120.018 -158.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -122.63 12.01 9.9 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.565 1.529 . . . . 0.0 111.837 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.05 115.84 23.2 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 119.202 0.91 . . . . 0.0 109.288 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -111.18 132.56 54.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.389 1.076 . . . . 0.0 109.01 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.2 tp -91.49 120.91 32.72 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -117.57 107.92 14.85 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.691 1.234 . . . . 0.0 111.45 -158.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -116.14 105.09 12.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.942 1.353 . . . . 0.0 110.701 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.57 -170.13 11.89 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 120.415 -1.428 . . . . 0.0 113.307 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -118.15 139.35 51.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.382 2.273 . . . . 0.0 107.118 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.18 119.38 33.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.508 1.147 . . . . 0.0 110.693 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -114.09 143.92 43.98 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.472 -1.393 . . . . 0.0 108.476 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.94 127.61 54.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.986 -1.071 . . . . 0.0 108.893 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -95.26 -30.89 13.73 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 125.134 1.373 . . . . 0.0 112.177 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -154.14 159.38 41.42 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.28 25.33 55.11 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 121.445 -0.785 . . . . 0.0 112.6 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.63 138.81 53.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.477 1.511 . . . . 0.0 108.253 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.5 -41.72 97.72 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -127.6 137.01 52.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 122.648 1.213 . . . . 0.0 110.094 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -83.38 91.85 7.43 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.3 -1.5 . . . . 0.0 113.3 -168.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.2 m 70.61 45.27 0.6 Allowed 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.543 1.639 . . . . 0.0 110.08 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -153.15 161.15 42.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -28.84 130.47 0.06 Allowed 'General case' 0 C--N 1.353 0.753 0 N-CA-C 121.222 3.786 . . . . 0.0 121.222 -166.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -62.29 150.5 39.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 117.399 -3.313 . . . . 0.0 115.394 -7.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.2 p -140.49 148.99 41.94 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 71.73 38.1 1.0 Allowed 'General case' 0 C--N 1.347 0.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 124.2 20.37 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.548 1.139 . . . . 0.0 111.696 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -133.62 153.83 51.36 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 119.891 -1.756 . . . . 0.0 114.897 -163.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.1 t 84.34 139.6 0.06 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 127.693 2.397 . . . . 0.0 113.341 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 mp -123.72 23.47 8.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.895 -1.128 . . . . 0.0 110.278 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.25 -124.2 32.98 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.19 148.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 121.446 -1.032 . . . . 0.0 109.23 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -151.11 150.43 30.67 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.115 -1.616 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -140.8 151.71 44.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.139 0.975 . . . . 0.0 110.114 -169.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.454 HH21 ' C ' ' A' ' 238' ' ' PHE . 6.2 ttp180 -118.18 129.15 55.34 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' C ' HH21 ' A' ' 237' ' ' ARG . 96.8 m-85 . . . . . 0 C--O 1.252 1.198 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -75.2 153.64 38.02 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.002 1.901 . . . . 0.0 112.697 -162.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 166.23 12.48 Favored Glycine 0 CA--C 1.502 -0.732 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -89.53 124.72 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.083 2.522 . . . . 0.0 110.714 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -131.73 160.52 35.26 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 120.728 -1.233 . . . . 0.0 109.469 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.57 139.58 50.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 120.884 -1.135 . . . . 0.0 112.146 -164.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -132.45 154.16 50.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.5 140.1 31.73 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 120.243 -1.535 . . . . 0.0 108.88 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 138' ' ' ARG . 7.7 p-10 -116.66 117.48 29.93 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 122.531 1.158 . . . . 0.0 110.37 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.1 125.57 27.14 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 120.682 -1.261 . . . . 0.0 108.932 164.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.05 126.88 50.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -134.59 -17.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 121.693 -0.629 . . . . 0.0 111.981 -174.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.72 -173.92 0.07 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.754 1.622 . . . . 0.0 115.005 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -125.34 9.28 7.88 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 120.692 -1.255 . . . . 0.0 108.281 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -65.17 145.48 56.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.942 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -138.59 166.85 23.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.046 -1.034 . . . . 0.0 108.329 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.9 pt -98.62 -7.0 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -163.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 p -83.69 147.13 27.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 119.446 -2.033 . . . . 0.0 114.571 -170.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -72.8 -31.42 64.83 Favored 'General case' 0 C--N 1.354 0.789 0 O-C-N 119.978 -1.701 . . . . 0.0 113.457 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.276 56.4 m-20 60.8 42.05 13.87 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 127.637 2.375 . . . . 0.0 114.312 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -147.93 154.17 43.11 Favored Pre-proline 0 C--N 1.354 0.769 0 C-N-CA 126.111 1.764 . . . . 0.0 106.551 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.49 147.22 0.25 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 124.078 3.185 . . . . 0.0 117.708 161.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -63.28 139.99 97.64 Favored Pre-proline 0 N--CA 1.436 -1.138 0 C-N-CA 123.942 0.897 . . . . 0.0 113.192 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 137.37 4.01 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 121.97 1.78 . . . . 0.0 109.855 -168.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 p -76.49 -20.0 57.43 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 121.402 -0.811 . . . . 0.0 112.92 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.72 149.5 95.25 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.814 1.245 . . . . 0.0 113.935 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.63 82.03 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.852 3.035 . . . . 0.0 119.138 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -104.08 -2.06 26.46 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 119.888 -1.757 . . . . 0.0 113.465 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -59.12 -40.58 85.87 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -165.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -103.27 17.54 23.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.949 -1.094 . . . . 0.0 110.553 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -110.44 3.72 19.91 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 120.49 -1.381 . . . . 0.0 113.528 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -59.84 143.76 13.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.0 m -89.34 -2.5 58.46 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.022 -1.049 . . . . 0.0 112.379 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.5 p -103.65 15.15 29.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.789 1.236 . . . . 0.0 110.526 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -59.06 135.65 23.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.635 1.174 . . . . 0.0 112.38 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 t -76.31 145.67 39.41 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.89 -0.95 57.64 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.178 1.391 . . . . 0.0 110.657 170.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 72.22 11.49 5.91 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.982 2.113 . . . . 0.0 114.768 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -99.22 -15.0 19.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 119.893 -1.754 . . . . 0.0 111.974 -169.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -170.87 174.6 4.77 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 119.906 -1.747 . . . . 0.0 109.135 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -61.36 120.2 9.98 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 120.693 -1.255 . . . . 0.0 111.754 163.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.71 156.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 128.381 2.672 . . . . 0.0 114.484 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -165.75 171.78 12.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.697 -1.252 . . . . 0.0 107.911 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 p -60.75 149.8 34.47 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -89.22 45.98 1.34 Allowed 'General case' 0 C--N 1.355 0.821 0 O-C-N 119.762 -1.836 . . . . 0.0 109.102 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.5 t -92.82 -177.16 4.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.676 1.99 . . . . 0.0 111.69 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.41 153.36 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 125.516 1.526 . . . . 0.0 112.395 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -130.93 144.25 52.76 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 121.112 -0.992 . . . . 0.0 109.675 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.78 160.92 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.682 3.588 . . . . 0.0 117.884 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HE ' ' CB ' ' A' ' 115' ' ' SER . 78.3 mtt180 -134.04 162.62 31.59 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 122.316 1.055 . . . . 0.0 110.267 175.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.62 131.7 69.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 126.495 1.918 . . . . 0.0 106.315 166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 t -117.04 119.99 36.99 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 109.113 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.36 128.85 66.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 119.63 -1.918 . . . . 0.0 108.698 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.36 -176.5 27.62 Favored Glycine 0 CA--C 1.479 -2.19 0 O-C-N 120.263 -1.523 . . . . 0.0 112.387 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -115.15 134.36 55.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.611 0.764 . . . . 0.0 109.489 -175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -85.32 115.09 22.87 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 122.178 0.989 . . . . 0.0 112.01 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -109.94 48.96 0.86 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 111.117 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.48 19.3 5.83 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 120.225 -1.547 . . . . 0.0 112.907 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.07 61.75 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 121.601 -0.941 . . . . 0.0 111.451 -165.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -107.04 115.99 31.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 162.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -102.68 113.0 26.03 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.4 pt -98.05 126.76 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 122.283 1.039 . . . . 0.0 108.364 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.9 166.73 26.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.605 1.193 . . . . 0.0 112.159 -154.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.09 147.55 45.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.291 1.036 . . . . 0.0 108.378 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.4 133.79 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.952 0.882 . . . . 0.0 108.636 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -132.2 132.79 43.47 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.432 1.093 . . . . 0.0 111.391 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.93 167.66 10.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.607 -1.308 . . . . 0.0 109.045 160.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -120.85 108.77 14.33 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.384 -1.447 . . . . 0.0 113.767 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 121.9 22.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.714 -0.616 . . . . 0.0 110.481 154.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -78.28 -18.95 54.59 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.46 -1.4 . . . . 0.0 112.076 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -143.96 126.63 16.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -131.7 157.16 44.49 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -58.75 145.51 40.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.91 126.72 36.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -61.14 125.62 24.41 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.772 1.629 . . . . 0.0 114.548 -163.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -114.69 13.17 17.3 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 121.416 -0.803 . . . . 0.0 111.126 168.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.47 43.31 13.27 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 164.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 p -155.69 168.94 25.54 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.87 15.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-O 122.833 1.301 . . . . 0.0 108.724 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.85 17.58 14.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.447 1.899 . . . . 0.0 108.715 -168.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.79 0.83 10.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 126.014 1.726 . . . . 0.0 111.72 -172.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.8 165.74 34.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -117.15 123.18 46.08 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.936 -1.728 . . . . 0.0 108.474 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.62 -5.58 10.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 O-C-N 120.761 -1.212 . . . . 0.0 110.899 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 56.45 30.9 17.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 119.295 3.072 . . . . 0.0 119.295 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.91 12.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 CA-C-O 124.139 1.923 . . . . 0.0 111.46 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -164.72 175.47 9.68 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -86.09 139.79 30.81 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.526 1.057 . . . . 0.0 109.933 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.7 175.19 6.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.728 1.211 . . . . 0.0 112.053 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -80.8 -5.64 57.47 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 125.518 1.527 . . . . 0.0 111.496 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.67 -179.14 46.35 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 123.589 1.66 . . . . 0.0 113.538 171.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.5 pt -86.51 169.56 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.681 0 O-C-N 119.856 -1.967 . . . . 0.0 111.646 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -147.11 176.65 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -55.91 141.77 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.9 0.88 . . . . 0.0 112.625 167.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.13 -14.99 21.15 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 120.79 -1.194 . . . . 0.0 111.189 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.82 145.9 43.78 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 122.746 1.26 . . . . 0.0 113.494 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -64.66 138.67 58.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.198 -1.564 . . . . 0.0 110.862 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.2 t -151.13 144.68 24.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -99.23 5.14 46.8 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.827 0.823 . . . . 0.0 109.661 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -130.55 136.12 48.6 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 124.776 1.23 . . . . 0.0 108.598 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -104.48 120.97 42.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 25.4 tt0 67.78 14.03 9.36 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.889 1.276 . . . . 0.0 112.516 171.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 m120 64.13 45.05 4.23 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 126.603 1.961 . . . . 0.0 113.684 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.04 28.68 2.58 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' GLU . 1.8 t -64.24 141.82 58.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.653 1.692 . . . . 0.0 113.895 169.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.78 -42.37 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . 0.284 97.9 m-70 81.74 101.27 0.06 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.419 2.288 . . . . 0.0 110.268 -165.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.16 87.05 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -163.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.3 t 35.77 62.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 128.338 2.655 . . . . 0.0 114.191 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.4 ' CB ' ' HE ' ' A' ' 55' ' ' ARG . 25.3 m -159.14 1.85 0.09 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 119.839 -1.788 . . . . 0.0 113.871 -168.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -61.73 -45.6 93.23 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 120.027 -1.671 . . . . 0.0 113.553 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.2 mt -145.74 149.26 34.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.254 1.422 . . . . 0.0 108.417 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.61 170.08 43.04 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 120.82 -1.175 . . . . 0.0 113.237 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.31 138.54 54.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.268 1.827 . . . . 0.0 107.38 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -141.4 135.19 30.15 Favored 'General case' 0 CA--C 1.506 -0.713 0 O-C-N 120.214 -1.554 . . . . 0.0 112.663 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.78 110.96 16.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.928 -1.107 . . . . 0.0 108.697 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.19 129.19 75.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -86.5 110.33 19.69 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -126.47 103.39 7.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.959 1.361 . . . . 0.0 107.964 -152.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -120.98 143.08 49.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -156.69 -67.14 0.1 Allowed 'General case' 0 C--O 1.214 -0.777 0 O-C-N 120.228 -1.545 . . . . 0.0 111.907 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.0 pt -75.11 -13.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 120.667 -1.271 . . . . 0.0 112.463 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.32 -45.43 94.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.026 2.131 . . . . 0.0 116.633 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.68 149.61 29.3 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.63 -41.46 90.51 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.46 110.63 17.15 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -127.48 119.88 21.86 Favored Pre-proline 0 N--CA 1.438 -1.051 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.84 141.55 45.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.22 3.28 . . . . 0.0 117.073 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -122.69 141.21 52.01 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -151.39 143.68 16.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 O-C-N 120.663 -1.273 . . . . 0.0 110.967 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.17 165.82 38.54 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 119.972 -1.705 . . . . 0.0 112.591 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.5 54.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 14' ' ' ASP . 42.9 mtm180 -126.96 122.6 35.01 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.1 p -100.86 139.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.0 38.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.093 -1.629 . . . . 0.0 111.732 -172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -144.74 156.6 44.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.572 1.177 . . . . 0.0 111.416 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.36 -33.44 6.84 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 -168.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -80.12 116.96 20.52 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 118.6 1.2 . . . . 0.0 109.24 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.1 t -64.55 -47.18 90.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-O 121.922 0.868 . . . . 0.0 113.291 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -160.74 157.67 27.33 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 170.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -121.19 6.03 10.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.824 0.821 . . . . 0.0 110.882 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t -154.32 167.53 29.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 119.706 -1.871 . . . . 0.0 106.094 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.55 146.65 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 122.423 1.106 . . . . 0.0 112.792 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -86.47 156.15 20.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.766 1.27 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -130.85 166.58 20.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 m -39.43 -29.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 129.022 2.929 . . . . 0.0 118.354 -166.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.72 11.83 5.74 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.9 pttp 167.0 156.66 0.03 OUTLIER 'General case' 0 C--N 1.359 0.999 0 CA-C-N 121.081 1.764 . . . . 0.0 112.259 -169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.2 t -52.88 145.76 12.02 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 126.406 1.882 . . . . 0.0 113.11 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.8 pt -125.83 138.93 52.93 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 O-C-N 120.343 -1.473 . . . . 0.0 110.482 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.4 126.13 31.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 119.969 -1.707 . . . . 0.0 112.203 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.02 -43.51 13.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 CA-C-O 121.304 0.573 . . . . 0.0 110.635 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 2.5 p -138.91 118.96 13.39 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 37.6 m -63.74 131.43 47.85 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.44 1.496 . . . . 0.0 112.987 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.9 t -95.49 111.97 57.26 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 120.919 -1.113 . . . . 0.0 108.631 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.25 -28.56 10.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 CA-C-N 122.266 1.845 . . . . 0.0 113.234 -163.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 t -160.56 158.4 29.05 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 119.492 1.042 . . . . 0.0 110.821 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -120.36 17.03 12.23 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.041 1.736 . . . . 0.0 111.226 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 127.5 83.24 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-O 118.188 -0.91 . . . . 0.0 112.629 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -59.74 93.98 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 166.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.97 149.34 27.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -64.0 -21.49 65.77 Favored Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.71 8.59 43.03 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 118.36 1.08 . . . . 0.0 113.285 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.02 131.0 43.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 120.33 -1.481 . . . . 0.0 110.22 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -60.26 -32.98 71.67 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.844 2.058 . . . . 0.0 115.976 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.8 p -77.14 -15.03 59.69 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 120.382 -1.449 . . . . 0.0 112.85 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -74.06 -22.91 59.34 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 120.975 -1.078 . . . . 0.0 111.991 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.9 -37.37 84.34 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.097 -1.627 . . . . 0.0 114.221 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -84.44 -20.13 32.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.403 1.081 . . . . 0.0 111.219 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.73 150.38 95.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.445 1.098 . . . . 0.0 112.566 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 -2.58 12.52 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.582 2.188 . . . . 0.0 113.226 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 68.9 39.76 1.8 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-N 120.402 1.456 . . . . 0.0 114.173 166.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.1 p -119.72 138.54 53.24 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.683 0.793 . . . . 0.0 109.509 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 76.91 45.5 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.337 1.455 . . . . 0.0 111.413 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.88 -16.14 58.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.808 -1.183 . . . . 0.0 113.536 -162.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -33.83 74.53 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 128.616 2.767 . . . . 0.0 112.533 174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.93 139.27 58.75 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -57.61 -34.53 69.36 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 t -149.88 142.98 25.0 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.158 -1.589 . . . . 0.0 107.384 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -114.18 19.06 16.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.915 1.286 . . . . 0.0 109.635 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.9 m -60.02 135.82 57.83 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.991 -1.068 . . . . 0.0 112.433 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 29.2 pt -62.66 148.56 10.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 64.77 44.45 3.72 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -59.08 148.19 32.07 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.573 1.149 . . . . 0.0 112.123 173.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.85 133.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.514 0 O-C-N 120.787 -1.196 . . . . 0.0 112.147 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.64 157.76 14.81 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 121.329 -0.857 . . . . 0.0 112.086 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.0 tp -128.0 131.32 49.23 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.299 -1.118 . . . . 0.0 110.959 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 215' ' ' HIS . . . -139.41 171.04 23.91 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 121.343 -0.848 . . . . 0.0 114.425 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.13 126.94 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.5 tt -104.71 128.95 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 122.382 1.086 . . . . 0.0 108.854 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -145.92 132.89 20.22 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.608 -1.307 . . . . 0.0 109.135 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -169.15 -167.88 30.37 Favored Glycine 0 CA--C 1.493 -1.291 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.37 137.38 55.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -88.12 121.64 6.01 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.54 128.23 50.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -68.59 133.51 48.63 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 123.949 1.833 . . . . 0.0 114.164 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.93 -31.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.25 152.89 17.63 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 166.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.74 -26.06 16.62 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 CA-C-N 125.991 3.175 . . . . 0.0 119.156 -167.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.55 -14.71 42.13 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 27.7 tp -127.53 119.68 26.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 O-C-N 120.725 -1.234 . . . . 0.0 109.419 -167.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.1 p -115.19 143.56 45.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.444 1.116 . . . . 0.0 110.109 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.03 116.14 23.25 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 163.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -98.12 120.73 39.04 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -128.06 131.85 49.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 120.694 -1.253 . . . . 0.0 110.343 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.35 -145.57 5.0 Favored Glycine 0 CA--C 1.494 -1.226 0 O-C-N 121.22 -0.925 . . . . 0.0 113.482 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.01 159.52 29.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.297 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -129.37 -17.89 3.69 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -156.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 23.96 61.92 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 130.317 3.447 . . . . 0.0 120.098 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 193' ' ' GLY . 1.8 t60 -97.74 103.18 15.09 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 119.361 -2.087 . . . . 0.0 111.521 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 88.66 1.34 0.33 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 128.868 2.867 . . . . 0.0 112.995 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 74.7 m95 56.07 32.38 19.91 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.26 2.15 46.6 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 -173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 119.186 -2.361 . . . . 0.0 114.733 -166.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.1 mt -102.93 10.74 38.1 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.524 -1.36 . . . . 0.0 110.004 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.75 114.27 6.21 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -170.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -69.36 -42.51 75.12 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.058 -1.651 . . . . 0.0 113.417 164.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.3 t -166.09 159.84 15.78 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . 0.447 77.7 mtt180 74.7 51.28 0.09 Allowed 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 169.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . 0.314 48.7 t80 25.43 84.05 0.01 OUTLIER 'General case' 0 C--N 1.35 0.606 0 C-N-CA 130.795 3.638 . . . . 0.0 119.105 166.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.55 2.19 33.17 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.1 m -61.27 -46.41 90.48 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -89.86 38.12 0.91 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.485 -1.384 . . . . 0.0 113.34 -166.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -59.75 128.2 35.77 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.706 1.241 . . . . 0.0 114.134 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.83 28.89 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.568 1.175 . . . . 0.0 113.752 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.9 t -118.96 115.88 25.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.3 116.36 28.16 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -140.98 -177.32 16.11 Favored Glycine 0 CA--C 1.498 -0.998 0 CA-C-O 124.357 2.087 . . . . 0.0 115.265 -173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.21 144.72 23.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.9 ttp85 -147.78 139.11 23.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -138.97 151.76 47.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.59 141.62 24.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.318 1.047 . . . . 0.0 110.318 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.495 0 C-N-CA 125.503 1.521 . . . . 0.0 114.17 179.49 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.505 0 CA-C-O 118.732 -1.038 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -94.49 143.62 26.26 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 119.264 1.532 . . . . 0.0 107.202 164.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.75 169.75 19.04 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.847 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -57.27 162.29 9.94 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 124.967 3.778 . . . . 0.0 116.052 168.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.22 157.08 36.76 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.42 1.105 . . . . 0.0 112.681 170.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.9 m -107.58 143.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -141.53 138.65 32.88 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-O 123.332 1.539 . . . . 0.0 113.34 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.12 144.19 27.86 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.194 1.398 . . . . 0.0 110.509 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -123.88 113.33 18.36 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.7 mt -116.57 148.37 40.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.56 166.43 28.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 122.833 1.302 . . . . 0.0 111.986 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.82 144.77 51.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.601 1.56 . . . . 0.0 112.303 171.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.61 146.72 30.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 120.472 -1.392 . . . . 0.0 108.882 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -151.44 144.52 24.61 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.48 159.2 42.24 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.792 0.806 . . . . 0.0 111.358 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 113.658 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.341 2.2 mt 51.26 63.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 126.895 2.078 . . . . 0.0 115.807 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.8 p -79.55 156.61 27.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.218 -1.551 . . . . 0.0 109.138 164.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -164.15 -1.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.293 41.3 m-20 61.33 37.59 16.92 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 42.21 60.24 9.56 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.39 135.22 46.69 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.507 2.805 . . . . 0.0 115.921 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.01 -42.02 92.94 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.44 -20.57 18.13 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 126.193 3.248 . . . . 0.0 113.409 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 p -101.96 17.64 22.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.974 0.91 . . . . 0.0 110.577 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.21 142.59 66.81 Favored Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 126.372 1.869 . . . . 0.0 115.144 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -39.98 135.58 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.539 1 C-N-CA 125.336 4.024 . . . . 0.0 117.471 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -158.24 8.4 0.14 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.045 0.839 . . . . 0.0 112.376 -173.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -147.48 133.4 19.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.336 -1.478 . . . . 0.0 113.712 -169.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.12 148.91 45.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.154 1.382 . . . . 0.0 111.493 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -112.02 120.14 40.84 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.581 -1.324 . . . . 0.0 108.343 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.62 123.92 66.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.2 m -135.32 -19.86 1.66 Allowed 'General case' 0 C--N 1.348 0.525 0 O-C-N 122.103 -0.373 . . . . 0.0 111.174 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 m 69.22 34.77 2.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.711 1.719 . . . . 0.0 113.193 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.62 162.21 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 126.801 2.041 . . . . 0.0 107.314 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -66.63 132.0 47.21 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.115 1.366 . . . . 0.0 114.49 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 50.89 54.49 11.13 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 163.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -104.88 -1.31 26.12 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 119.052 -2.28 . . . . 0.0 114.399 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -148.56 115.04 5.92 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.057 -1.652 . . . . 0.0 106.889 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 70.21 59.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 116.827 -3.67 . . . . 0.0 116.172 -11.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -64.97 -34.84 79.4 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 119.83 -1.794 . . . . 0.0 110.869 161.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -57.18 129.16 18.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 129.034 2.934 . . . . 0.0 114.199 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -61.27 121.7 13.24 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 124.044 0.938 . . . . 0.0 111.939 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.8 p -108.43 -1.84 19.53 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.848 -1.782 . . . . 0.0 113.44 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -133.59 109.65 9.37 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 120.43 -1.419 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.2 t -140.79 130.91 24.78 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.038 -2.914 . . . . 0.0 106.631 -20.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.17 1.08 5.48 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 124.248 1.019 . . . . 0.0 111.597 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 40.26 63.37 5.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 120.15 3.389 . . . . 0.0 120.15 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.52 126.54 22.62 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.33 2.687 . . . . 0.0 114.481 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -149.42 146.06 27.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 169.18 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 t -143.03 145.03 32.52 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 120.467 -1.396 . . . . 0.0 110.205 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.63 143.74 31.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 O-C-N 120.668 -1.27 . . . . 0.0 107.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.86 -165.78 18.32 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 120.005 -1.685 . . . . 0.0 114.359 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -144.1 137.64 27.67 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 107.675 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.54 132.05 54.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.311 1.445 . . . . 0.0 112.149 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -121.42 169.1 10.95 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 125.159 1.383 . . . . 0.0 110.735 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.45 100.62 0.9 Allowed Glycine 0 C--N 1.358 1.787 0 O-C-N 119.115 -2.241 . . . . 0.0 111.053 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.03 3.93 67.42 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -161.69 165.08 28.68 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 119.925 -1.927 . . . . 0.0 109.922 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -144.94 155.33 43.36 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.687 -1.258 . . . . 0.0 110.524 164.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.96 132.47 68.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 O-C-N 120.984 -1.073 . . . . 0.0 109.681 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.45 134.55 53.03 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.147 0.979 . . . . 0.0 111.748 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.72 109.61 21.38 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.06 121.07 24.51 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -131.45 145.94 52.02 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.26 -1.525 . . . . 0.0 112.883 -171.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.56 175.7 11.16 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -139.51 125.81 20.17 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.431 -1.418 . . . . 0.0 109.961 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -124.96 19.41 8.43 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 120.499 -1.376 . . . . 0.0 113.697 -168.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 67.03 -179.93 0.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -64.03 136.51 57.36 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 126.316 1.846 . . . . 0.0 113.274 166.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -76.43 -24.53 53.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.515 1.126 . . . . 0.0 112.565 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -85.07 113.38 21.43 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 163.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.21 -11.33 0.05 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.059 -0.401 . . . . 0.0 111.565 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.51 161.36 14.68 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -157.23 -11.82 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 121.094 -1.004 . . . . 0.0 113.356 171.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 57.85 -153.34 0.38 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 m -91.61 16.7 10.0 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 120.828 -1.17 . . . . 0.0 111.547 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.79 112.27 8.5 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 125.132 1.373 . . . . 0.0 112.411 174.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 76.15 141.19 0.07 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.01 1.724 . . . . 0.0 114.394 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 pt -58.85 152.8 3.81 Favored 'Isoleucine or valine' 0 C--N 1.362 1.124 0 O-C-N 120.458 -1.401 . . . . 0.0 112.171 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 92' ' ' ARG . 45.8 mt-10 -90.56 2.99 55.28 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 119.937 -1.727 . . . . 0.0 113.197 -168.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m120 60.51 41.99 14.92 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.977 2.111 . . . . 0.0 115.721 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.18 157.22 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 C-N-CA 124.365 1.066 . . . . 0.0 108.311 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -77.99 -32.66 51.34 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.8 tp -154.7 150.94 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 87' ' ' GLU . 25.4 mmt180 -119.41 127.07 52.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 165.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -69.35 -31.6 70.14 Favored 'General case' 0 C--N 1.347 0.478 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -137.26 153.41 50.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -114.18 5.51 15.93 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 120.784 -1.198 . . . . 0.0 111.386 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.23 -2.44 19.99 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 118.118 2.007 . . . . 0.0 118.118 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.259 9.9 mm 70.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.262 1.825 . . . . 0.0 113.549 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.82 132.08 36.71 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 118.727 -2.483 . . . . 0.0 109.953 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 pt -151.11 14.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.647 0 C-N-CA 125.37 1.468 . . . . 0.0 111.885 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.28 42.5 m-20 53.2 53.81 11.28 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -175.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -126.97 109.2 11.66 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.708 -1.87 . . . . 0.0 113.091 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.8 mttp 72.97 44.32 0.36 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.837 1.655 . . . . 0.0 110.547 -168.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.7 p -108.62 -1.41 19.59 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.473 1.109 . . . . 0.0 110.891 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.39 144.8 50.06 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 128.408 2.683 . . . . 0.0 111.944 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -119.09 0.34 11.24 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.968 -1.083 . . . . 0.0 111.902 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.18 115.91 7.39 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.347 -1.471 . . . . 0.0 113.008 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -89.56 125.2 35.12 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.017 -1.677 . . . . 0.0 110.872 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -129.93 140.55 50.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 119.429 -2.045 . . . . 0.0 109.804 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.55 32.59 41.45 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 120.509 -1.369 . . . . 0.0 112.845 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -119.86 162.11 19.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 127.4 2.28 . . . . 0.0 107.003 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.294 32.2 m-85 73.51 37.33 0.71 Allowed 'General case' 0 C--N 1.354 0.79 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -109.04 108.73 19.55 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.793 -1.192 . . . . 0.0 111.046 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 61.02 51.09 4.65 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.913 1.685 . . . . 0.0 114.957 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.35 141.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.76 1.743 . . . . 0.0 112.686 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 t -158.75 165.52 34.12 Favored 'General case' 0 C--N 1.356 0.853 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -149.76 172.77 14.58 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 120.143 1.338 . . . . 0.0 112.237 -160.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.37 143.04 54.05 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 128.971 2.908 . . . . 0.0 114.649 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 163.11 -158.18 30.46 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 120.88 -1.137 . . . . 0.0 111.314 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 50.3 tp -121.54 124.12 43.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.6 m -125.08 122.72 38.01 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.452 -1.405 . . . . 0.0 110.277 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.56 126.26 49.89 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 120.731 -1.23 . . . . 0.0 112.216 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.98 136.48 57.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 124.379 1.071 . . . . 0.0 110.337 -162.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -89.45 128.97 36.01 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.391 -0.818 . . . . 0.0 108.822 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.82 112.31 21.79 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -64.11 145.95 55.05 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -166.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 65.08 -88.15 0.03 OUTLIER 'General case' 0 C--N 1.358 0.954 0 C-N-CA 126.505 1.922 . . . . 0.0 115.012 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.3 pt -122.79 14.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.394 1.078 . . . . 0.0 111.509 -172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.7 m120 76.39 42.58 0.17 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.23 1.812 . . . . 0.0 108.784 -161.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . 0.265 0.6 OUTLIER -48.85 162.49 0.11 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -161.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -59.17 -41.43 88.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.938 2.495 . . . . 0.0 112.912 169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -132.79 127.39 34.48 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.601 1.16 . . . . 0.0 109.147 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 139.11 15.05 Favored Pre-proline 0 N--CA 1.441 -0.923 0 O-C-N 121.422 -0.799 . . . . 0.0 110.225 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -56.75 151.13 49.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 122.386 1.888 . . . . 0.0 112.305 149.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.15 142.86 41.08 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.178 -0.951 . . . . 0.0 111.912 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.1 tp -152.02 150.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 165.02 -178.61 40.03 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.59 160.39 33.44 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.921 0.867 . . . . 0.0 109.878 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.98 156.69 43.68 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.67 1.224 . . . . 0.0 110.095 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.72 136.36 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -156.9 169.32 25.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.227 1.489 . . . . 0.0 113.696 -165.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -76.04 109.0 9.33 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.712 1.244 . . . . 0.0 108.787 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.37 68.57 0.49 Allowed Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -60.42 -42.75 96.65 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.755 -0.85 . . . . 0.0 113.236 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.525 35.6 m 41.65 -125.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 128.501 2.72 . . . . 0.0 118.322 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -141.95 30.28 1.64 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 120.024 1.284 . . . . 0.0 111.131 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -81.63 132.24 35.29 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 119.178 -2.201 . . . . 0.0 108.432 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -158.11 171.61 19.92 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 120.645 -1.284 . . . . 0.0 107.921 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -45.19 156.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 131.152 3.781 . . . . 0.0 117.701 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -71.59 129.72 39.42 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.161 -0.962 . . . . 0.0 111.082 164.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 91.2 p -69.05 145.59 53.36 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.7 m -63.45 111.3 2.26 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.484 1.113 . . . . 0.0 109.73 156.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -97.95 139.35 33.92 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 120.711 -1.243 . . . . 0.0 111.151 -169.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -102.42 -8.41 21.15 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.807 -1.183 . . . . 0.0 112.556 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 t -160.73 169.5 22.65 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.6 tt -116.33 126.96 74.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 108.577 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.93 -10.11 20.93 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.902 -1.123 . . . . 0.0 113.755 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.26 132.05 33.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 O-C-N 120.707 -1.246 . . . . 0.0 111.354 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 11.4 p -71.78 149.83 44.97 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.3 t -82.41 158.32 23.35 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 120.354 -1.467 . . . . 0.0 110.144 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.56 137.75 94.9 Favored Pre-proline 0 C--N 1.347 0.495 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.74 130.8 41.85 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.819 3.013 . . . . 0.0 112.78 154.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.7 t -85.4 -21.91 28.6 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.03 1.286 . . . . 0.0 112.441 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -145.59 26.89 1.25 Allowed 'General case' 0 C--N 1.349 0.579 0 O-C-N 119.94 -1.725 . . . . 0.0 112.81 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.57 125.82 86.9 Favored Pre-proline 0 C--N 1.353 0.734 0 O-C-N 119.115 -2.24 . . . . 0.0 112.413 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.78 126.11 20.83 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.231 2.621 . . . . 0.0 115.604 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -60.8 -42.94 98.59 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.74 -166.29 46.75 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.92 -1.112 . . . . 0.0 114.544 -167.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.8 143.54 56.14 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.27 109.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 166.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -77.45 -30.54 53.33 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.035 -1.666 . . . . 0.0 112.545 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 57.0 m -142.73 127.85 18.58 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 111.102 171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -83.33 98.86 9.68 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.147 170.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -63.26 -44.94 93.73 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.2 m -108.64 -9.42 15.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 118.776 -2.453 . . . . 0.0 109.845 -16.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -70.62 150.7 95.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.698 1.599 . . . . 0.0 112.613 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -55.57 131.85 48.6 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 123.295 2.663 . . . . 0.0 114.188 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -112.64 2.57 16.21 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.8 m 11.75 77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 130.292 3.437 . . . . 0.0 117.196 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.67 115.53 23.41 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.747 -1.22 . . . . 0.0 108.558 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -115.52 5.06 14.35 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.519 -0.738 . . . . 0.0 112.885 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -64.75 -50.05 68.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.205 1.002 . . . . 0.0 113.56 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -69.43 -33.83 73.54 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.25 -20.51 34.38 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.585 -1.947 . . . . 0.0 114.175 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.7 t -102.91 107.87 18.85 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 118.97 -2.331 . . . . 0.0 111.475 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -57.64 146.79 29.44 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 41.5 t -115.99 124.46 50.57 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 120.775 -1.203 . . . . 0.0 111.215 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.08 -42.32 95.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.0 156.53 29.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 119.028 -2.295 . . . . 0.0 105.497 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -144.59 175.75 9.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 121.116 -0.99 . . . . 0.0 111.426 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -127.55 152.82 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.33 109.01 3.67 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 121.254 -0.903 . . . . 0.0 111.692 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 35.4 tp -119.02 141.31 48.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.734 -0.862 . . . . 0.0 110.541 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.05 -145.34 5.33 Favored Glycine 0 C--N 1.361 1.946 0 O-C-N 120.313 -1.492 . . . . 0.0 114.727 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.64 148.01 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.821 0.848 . . . . 0.0 111.204 -160.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 tp -124.09 125.45 70.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 165.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -164.75 166.33 19.97 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 119.615 -1.928 . . . . 0.0 110.217 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.21 -127.45 2.87 Favored Glycine 0 CA--C 1.496 -1.135 0 O-C-N 120.977 -1.077 . . . . 0.0 112.55 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.7 t -142.86 135.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.59 150.99 19.62 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 112.668 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.57 113.12 12.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.623 1.169 . . . . 0.0 111.365 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.31 105.16 17.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.054 -1.654 . . . . 0.0 108.481 169.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.2 -36.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 126.182 1.793 . . . . 0.0 111.348 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 67.3 p -145.84 170.72 7.48 Favored Pre-proline 0 CA--C 1.516 -0.363 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -46.12 -35.29 14.64 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 123.519 2.813 . . . . 0.0 115.251 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -94.69 -30.13 14.46 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 126.276 1.831 . . . . 0.0 115.5 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 46.0 tp -110.19 123.37 49.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.351 1.072 . . . . 0.0 109.749 -173.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.75 132.43 17.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.4 tt -130.12 141.89 50.64 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 120.587 -1.32 . . . . 0.0 109.146 -161.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -126.13 140.09 52.85 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 125.511 1.525 . . . . 0.0 111.397 -171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -124.81 127.81 47.74 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 162.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.82 136.47 7.13 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 118.686 2.234 . . . . 0.0 118.686 -156.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -71.06 147.0 48.96 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 127.592 2.357 . . . . 0.0 108.875 152.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -147.99 -0.1 0.62 Allowed 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -161.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -63.72 141.82 58.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -130.91 133.62 46.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.4 0.4 OUTLIER 56.24 46.04 22.02 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -172.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -139.73 24.42 2.42 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 113.03 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.25 -6.08 73.81 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.472 -2.018 . . . . 0.0 114.53 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -151.73 174.77 13.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.265 1.826 . . . . 0.0 107.961 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.5 mt -108.04 25.77 11.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 122.748 1.261 . . . . 0.0 111.211 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -55.95 -41.47 74.74 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.85 2.06 . . . . 0.0 115.682 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -128.47 16.26 6.53 Favored 'General case' 0 C--N 1.344 0.336 0 O-C-N 119.109 -2.244 . . . . 0.0 111.921 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 9.9 t -165.42 153.78 11.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -172.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -113.1 8.14 18.23 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.238 -0.914 . . . . 0.0 111.978 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -138.77 149.08 44.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -140.08 -19.69 0.89 Allowed 'General case' 0 C--N 1.35 0.629 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.8 m -79.54 112.43 16.79 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.651 -1.281 . . . . 0.0 113.061 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.46 18.32 12.11 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.665 1.221 . . . . 0.0 110.554 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.41 102.99 13.19 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.241 1.816 . . . . 0.0 111.117 -160.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -174.79 47.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.4 m -92.9 123.6 36.28 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 120.679 -1.263 . . . . 0.0 112.469 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -116.58 132.4 56.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 168.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.14 155.19 26.22 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 119.98 -1.7 . . . . 0.0 112.549 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 6.7 p -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -116.24 132.28 56.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.837 2.055 . . . . 0.0 110.157 -176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -117.71 118.26 31.6 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -98.33 145.49 26.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.569 1.148 . . . . 0.0 109.828 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.267 2.014 0 C-N-CA 125.804 1.642 . . . . 0.0 106.945 175.008 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.13 0 CA-C-O 118.091 -1.394 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -147.35 167.75 23.54 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.02 173.58 14.75 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 120.416 1.462 . . . . 0.0 113.971 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -58.49 154.06 44.25 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 124.457 3.438 . . . . 0.0 115.048 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 165.11 35.64 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.442 1.115 . . . . 0.0 113.332 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.78 147.0 18.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 107.443 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -146.25 150.97 36.81 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.893 0.877 . . . . 0.0 111.025 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.69 160.4 43.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.195 -1.566 . . . . 0.0 108.661 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.9 150.09 34.52 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 120.914 -1.116 . . . . 0.0 112.875 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.8 tp -123.13 117.78 26.16 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 127.365 2.266 . . . . 0.0 110.035 -169.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.72 147.01 23.53 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 119.913 -1.742 . . . . 0.0 113.942 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -62.57 -42.82 99.79 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.99 56.76 3.42 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 159.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -61.03 138.45 58.19 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.87 -174.24 3.21 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 124.711 1.205 . . . . 0.0 112.169 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -70.02 -22.08 63.13 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 118.862 -2.399 . . . . 0.0 114.874 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' ILE . 8.4 tp -156.73 157.34 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 169.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.1 m -116.81 127.97 54.83 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 168.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -152.31 147.53 26.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.73 128.78 37.88 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 26.24 66.26 0.5 Allowed Pre-proline 0 C--N 1.362 1.13 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.8 134.73 17.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.015 3.143 . . . . 0.0 117.962 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.92 -18.37 0.45 Allowed Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 120.44 3.496 . . . . 0.0 120.44 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -66.84 -26.97 44.28 Favored 'Trans proline' 0 C--N 1.351 0.705 1 CA-C-N 128.569 4.096 . . . . 0.0 114.994 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 p -106.2 8.57 32.08 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 111.234 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.74 149.74 84.05 Favored Pre-proline 0 N--CA 1.446 -0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 114.222 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -64.03 -28.77 66.05 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 121.911 1.718 . . . . 0.0 115.183 -165.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -103.01 29.53 5.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.371 1.468 . . . . 0.0 109.683 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -133.92 -65.08 0.68 Allowed 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.494 1.118 . . . . 0.0 110.536 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.07 53.38 6.77 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.344 25.1 mtpp 55.54 -122.3 1.82 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.5 pt -112.46 2.48 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 O-C-N 121.153 -0.967 . . . . 0.0 111.166 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 p -171.48 -4.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -167.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.267 13.7 m 62.95 64.37 0.88 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.33 1.423 . . . . 0.0 113.734 -172.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -62.92 140.4 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.506 -1.371 . . . . 0.0 113.847 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 t -83.87 154.59 23.36 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.7 -1.25 . . . . 0.0 109.732 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 73.67 7.59 5.01 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.691 1.71 . . . . 0.0 113.034 162.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -107.67 -39.39 5.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.445 1.098 . . . . 0.0 111.288 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -96.32 136.68 36.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.081 1.353 . . . . 0.0 112.029 -172.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.273 6.4 mmp_? 59.94 54.33 4.29 Favored 'General case' 0 C--O 1.219 -0.521 1 O-C-N 116.092 -4.13 . . . . 0.0 118.468 -13.835 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.78 -39.37 84.67 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.326 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -58.81 140.64 16.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 125.493 1.517 . . . . 0.0 112.761 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -82.04 113.58 20.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.115 -1.616 . . . . 0.0 112.495 -167.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.3 p -99.07 14.25 29.95 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 126.105 1.762 . . . . 0.0 111.897 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -107.16 155.38 19.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.105 -0.997 . . . . 0.0 108.799 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.99 16.51 11.69 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 119.53 -1.981 . . . . 0.0 113.189 5.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.84 132.43 62.87 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 O-C-N 121.05 -1.031 . . . . 0.0 110.313 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -81.41 141.73 49.53 Favored Pre-proline 0 C--N 1.36 1.029 0 O-C-N 119.73 -1.857 . . . . 0.0 112.375 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -48.52 132.75 25.41 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.595 2.863 . . . . 0.0 115.551 164.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -112.57 135.08 53.71 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.11 146.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 O-C-N 121.069 -1.019 . . . . 0.0 108.425 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -151.47 146.81 26.19 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 120.519 -1.363 . . . . 0.0 109.849 -168.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.06 138.51 54.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 O-C-N 120.233 -1.542 . . . . 0.0 109.348 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.94 -169.6 23.45 Favored Glycine 0 C--N 1.358 1.782 0 O-C-N 120.261 -1.524 . . . . 0.0 115.589 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -141.33 132.05 25.7 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.562 1.145 . . . . 0.0 108.956 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.45 124.4 44.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.686 1.994 . . . . 0.0 111.6 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -105.8 -147.04 0.39 Allowed 'General case' 0 C--N 1.35 0.63 0 CA-C-O 122.471 1.129 . . . . 0.0 111.313 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.65 87.45 0.69 Allowed Glycine 0 C--N 1.349 1.296 0 O-C-N 119.598 -1.939 . . . . 0.0 110.858 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.86 8.5 61.86 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 117.456 0.628 . . . . 0.0 113.227 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -161.39 167.06 26.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 O-C-N 120.481 -1.6 . . . . 0.0 107.386 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -148.61 155.67 41.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.241 1.017 . . . . 0.0 109.254 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -127.9 147.8 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.087 0.955 . . . . 0.0 108.548 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.4 153.66 25.68 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.053 -1.654 . . . . 0.0 112.136 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.12 114.05 26.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.798 0.839 . . . . 0.0 111.039 173.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -82.32 152.27 26.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.74 2.416 . . . . 0.0 111.636 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -152.12 160.21 43.47 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.385 1.874 . . . . 0.0 106.517 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.12 30.16 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 119.758 -1.839 . . . . 0.0 111.072 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -89.17 70.32 8.33 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.311 -1.493 . . . . 0.0 114.483 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -76.94 -20.8 55.71 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 119.337 -2.102 . . . . 0.0 115.158 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . 0.28 77.1 mtp180 101.56 -78.12 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 128.711 2.805 . . . . 0.0 114.516 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.47 138.5 24.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 102.98 -2.97 . . . . 0.0 102.98 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -62.97 -47.05 84.85 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 122.016 0.912 . . . . 0.0 113.095 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -79.94 124.13 28.4 Favored 'General case' 0 C--N 1.344 0.337 0 O-C-N 120.206 -1.559 . . . . 0.0 110.816 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.15 135.23 28.81 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -113.0 125.0 53.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -110.69 1.07 17.69 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.668 -1.27 . . . . 0.0 112.798 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 45.71 37.59 3.48 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.198 2.199 . . . . 0.0 115.11 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.7 m -93.35 58.91 2.91 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 119.378 -2.076 . . . . 0.0 109.118 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -68.16 140.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 73.49 5.04 4.92 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 170.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.7 pt -62.66 138.51 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -97.72 -16.59 19.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.55 1.14 . . . . 0.0 113.278 -169.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 66.35 39.69 3.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.903 2.481 . . . . 0.0 114.463 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.3 125.15 57.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 O-C-N 120.133 -1.605 . . . . 0.0 110.951 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -118.53 33.58 5.58 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 119.901 -1.749 . . . . 0.0 114.223 -162.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.74 -0.6 6.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -169.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -61.52 149.14 39.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 119.772 -1.83 . . . . 0.0 113.918 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -57.22 -41.68 79.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 123.614 1.673 . . . . 0.0 113.489 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -85.19 4.84 32.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.987 2.915 . . . . 0.0 110.249 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -114.09 4.82 15.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 119.757 -1.839 . . . . 0.0 109.988 168.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.51 21.33 64.54 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 125.056 1.312 . . . . 0.0 115.046 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.33 6.7 mt 44.18 55.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 CA-C-O 125.167 2.413 . . . . 0.0 113.435 -177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -94.59 102.87 14.82 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 119.928 -1.733 . . . . 0.0 111.672 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.6 pt -78.15 -16.89 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 O-C-N 120.841 -1.162 . . . . 0.0 112.384 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 138.58 58.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 123.556 1.645 . . . . 0.0 113.987 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -162.66 171.66 16.54 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.897 2.079 . . . . 0.0 107.941 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -109.03 166.74 10.61 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.915 0.886 . . . . 0.0 110.755 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -62.73 -42.86 99.87 Favored 'General case' 0 C--N 1.344 0.359 0 O-C-N 120.766 -1.209 . . . . 0.0 113.227 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -65.21 144.14 57.37 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.85 1.26 . . . . 0.0 113.787 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -79.9 -10.94 59.83 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 120.831 -1.168 . . . . 0.0 112.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.67 142.89 55.23 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.36 150.07 23.09 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.77 152.96 44.63 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.855 2.062 . . . . 0.0 114.198 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.14 22.2 61.38 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -87.94 132.24 34.3 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.55 -1.559 . . . . 0.0 112.218 -176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 78.25 35.97 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 125.829 1.652 . . . . 0.0 114.677 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -75.95 129.2 36.55 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.168 -1.582 . . . . 0.0 114.849 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.8 41.64 14.42 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.4 t -78.96 103.58 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -167.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.8 t -88.32 -51.85 5.53 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 119.9 -1.75 . . . . 0.0 111.479 165.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t 58.57 -171.24 0.11 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.5 tp -53.4 131.45 37.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.298 2.639 . . . . 0.0 112.099 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.69 9.9 Favored Glycine 0 CA--C 1.496 -1.151 0 O-C-N 120.563 -1.336 . . . . 0.0 113.273 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.8 tp -103.87 119.53 39.11 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -117.51 140.01 50.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.795 1.238 . . . . 0.0 110.267 -168.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -139.72 134.7 32.27 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.818 -1.176 . . . . 0.0 109.417 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.11 134.19 50.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 O-C-N 121.07 -1.019 . . . . 0.0 108.758 -167.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -89.6 134.38 34.16 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 125.423 1.489 . . . . 0.0 108.549 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.32 111.12 23.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.69 1.996 . . . . 0.0 105.971 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -80.76 162.68 23.98 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 119.647 -1.908 . . . . 0.0 115.754 -172.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 60.5 -125.22 1.02 Allowed 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.989 1.715 . . . . 0.0 114.622 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.5 pt -100.61 -0.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 O-C-N 120.18 -1.575 . . . . 0.0 113.503 -165.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 m120 64.43 15.71 9.72 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.14 -104.35 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 161.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -89.55 -58.73 2.42 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.19 -0.944 . . . . 0.0 111.886 -153.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.68 126.52 55.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 126.83 10.75 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.85 163.72 5.39 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 123.295 2.663 . . . . 0.0 113.735 153.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.92 142.2 47.64 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.9 tp -140.25 140.97 34.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 159.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.39 176.74 41.55 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 120.44 -1.412 . . . . 0.0 111.678 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.6 24.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.076 0.95 . . . . 0.0 110.309 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -149.11 153.16 37.35 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.14 -0.975 . . . . 0.0 109.425 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.76 127.88 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -145.66 159.43 43.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 123.402 1.572 . . . . 0.0 115.197 -160.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -130.66 116.1 17.61 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 125.873 1.669 . . . . 0.0 109.731 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.95 -6.02 4.17 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.727 -1.233 . . . . 0.0 112.403 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 27.4 t60 70.48 -73.79 0.09 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.73 1.612 . . . . 0.0 113.306 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . 0.415 28.0 m 48.26 -138.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 128.6 2.76 . . . . 0.0 115.605 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -154.51 152.94 30.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -128.69 128.3 43.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 74.6 m -89.12 164.02 15.21 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.003 0.921 . . . . 0.0 108.974 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.5 tt -146.56 129.87 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 120.126 -1.609 . . . . 0.0 109.203 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.44 -23.43 29.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.235 -1.541 . . . . 0.0 112.338 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.7 m -60.52 -22.19 63.31 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.865 1.666 . . . . 0.0 115.285 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -112.56 7.29 18.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.986 -1.071 . . . . 0.0 111.553 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.31 119.47 16.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 120.519 -1.363 . . . . 0.0 114.524 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.65 -35.84 79.09 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.198 -0.939 . . . . 0.0 113.297 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.1 m -123.92 120.73 33.37 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 23.2 pt -80.52 148.2 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.66 -10.27 25.34 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 112.304 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.4 t -126.11 112.41 30.04 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 CA-C-O 122.098 0.951 . . . . 0.0 110.271 -175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.1 m -116.09 129.51 56.37 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.7 m -77.81 112.66 14.9 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.35 -1.469 . . . . 0.0 110.23 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.16 128.08 26.25 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 119.82 -1.8 . . . . 0.0 109.572 -174.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.45 125.29 18.03 Favored 'Trans proline' 0 C--O 1.22 -0.383 0 C-N-CA 123.998 3.132 . . . . 0.0 115.509 170.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 m -82.58 -28.24 31.03 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -119.74 23.09 11.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.964 -1.085 . . . . 0.0 112.051 -165.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.31 149.83 46.07 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.007 -1.058 . . . . 0.0 108.715 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.17 139.58 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.759 2.973 . . . . 0.0 114.453 162.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.49 171.64 18.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.518 0.675 . . . . 0.0 110.7 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.8 177.44 7.17 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 125.024 1.297 . . . . 0.0 114.75 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.87 -17.5 63.36 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.296 -1.709 . . . . 0.0 113.509 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.06 -20.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 C-N-CA 124.613 1.165 . . . . 0.0 111.709 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 m 58.6 56.7 4.12 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.099 1.76 . . . . 0.0 112.721 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.6 t -152.6 169.95 21.41 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 119.682 -1.886 . . . . 0.0 110.462 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.6 158.88 34.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.133 1.373 . . . . 0.0 112.518 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.19 -42.64 91.34 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.66 90.27 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 129.318 3.047 . . . . 0.0 114.755 -16.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.63 135.52 88.2 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.372 2.269 . . . . 0.0 113.593 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.77 133.07 2.6 Favored 'Trans proline' 0 N--CA 1.476 0.451 1 C-N-CA 125.572 4.181 . . . . 0.0 118.888 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -118.78 4.05 11.58 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 p -69.29 139.25 54.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 119.812 -1.805 . . . . 0.0 114.492 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.29 43.02 1.91 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.267 -1.521 . . . . 0.0 112.026 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -77.61 -10.14 59.34 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.953 -1.717 . . . . 0.0 113.082 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 8.64 40.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.52 1.128 . . . . 0.0 111.869 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.69 24.53 9.1 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.92 1.288 . . . . 0.0 108.927 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -122.31 138.24 54.58 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.847 0.859 . . . . 0.0 109.118 -167.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -122.32 125.65 46.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.254 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.8 6.81 15.63 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 119.78 -1.825 . . . . 0.0 113.609 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 47.2 t -136.52 132.45 35.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 122.534 1.159 . . . . 0.0 109.563 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.4 tt -91.62 2.02 8.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 O-C-N 120.974 -1.079 . . . . 0.0 111.471 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.99 163.98 39.54 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 119.834 -1.791 . . . . 0.0 109.454 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -156.51 170.16 22.98 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.6 m -107.8 136.08 44.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 167.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -81.25 84.78 1.43 Allowed Glycine 0 C--N 1.351 1.403 0 O-C-N 120.482 -1.386 . . . . 0.0 114.448 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.83 137.89 33.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.822 -1.399 . . . . 0.0 110.897 171.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 215' ' ' HIS . . . -137.26 -177.43 15.07 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.364 0.906 . . . . 0.0 115.364 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.88 145.32 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.19 130.41 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.51 157.14 36.43 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.564 -1.335 . . . . 0.0 109.122 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 149.48 -146.25 15.35 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 121.467 -0.771 . . . . 0.0 112.386 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.57 143.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.86 159.11 14.01 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.498 -1.377 . . . . 0.0 113.097 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.39 110.51 9.49 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.909 0.884 . . . . 0.0 109.403 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.18 104.33 16.92 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.391 -1.443 . . . . 0.0 107.49 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.9 -42.6 95.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 126.29 1.836 . . . . 0.0 110.13 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.6 p -135.96 164.74 41.01 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.95 11.09 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 122.531 1.94 . . . . 0.0 112.347 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -115.05 -40.99 3.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.083 1.353 . . . . 0.0 110.389 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.4 tp -104.49 118.4 36.5 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.057 1.343 . . . . 0.0 110.407 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.2 t -146.1 133.77 21.05 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.7 0.8 . . . . 0.0 110.434 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 69.1 mt -119.37 142.87 47.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.885 1.674 . . . . 0.0 110.249 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -115.49 135.37 54.16 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.818 0.847 . . . . 0.0 109.842 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -127.38 115.01 18.3 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.589 -1.319 . . . . 0.0 108.604 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.6 -136.84 4.2 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 119.897 -1.752 . . . . 0.0 113.874 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -115.82 133.08 56.4 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.879 1.671 . . . . 0.0 110.162 -175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -133.84 102.68 5.53 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.083 0.953 . . . . 0.0 111.716 168.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -150.98 160.92 43.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 120.911 -1.118 . . . . 0.0 110.604 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.425 ' HA ' ' CA ' ' A' ' 193' ' ' GLY . 34.8 p-80 -127.04 151.76 48.17 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.958 0.903 . . . . 0.0 109.144 169.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . 0.336 0.3 OUTLIER 45.35 54.91 6.93 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 176.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -142.25 37.28 1.54 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-O 123.144 1.449 . . . . 0.0 111.312 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -69.97 -39.32 74.63 Favored Glycine 0 C--N 1.354 1.556 0 O-C-N 120.593 -1.317 . . . . 0.0 114.199 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -134.82 166.11 23.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 102.109 -3.293 . . . . 0.0 102.109 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.9 mp -86.9 45.6 1.28 Allowed 'General case' 0 C--O 1.224 -0.274 0 O-C-N 120.401 -1.437 . . . . 0.0 111.774 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.24 -43.1 82.62 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.481 1.512 . . . . 0.0 114.912 -165.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -115.34 27.88 9.06 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.586 -1.322 . . . . 0.0 111.541 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.0 t -148.87 162.89 38.93 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.313 -2.117 . . . . 0.0 112.528 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -114.34 1.18 14.36 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.985 -1.697 . . . . 0.0 111.176 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -143.63 137.29 28.19 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -106.68 -38.89 5.99 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.644 -1.285 . . . . 0.0 113.665 -163.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.2 m -61.96 106.27 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -163.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.407 ' H ' ' H ' ' A' ' 229' ' ' GLU . 0.3 OUTLIER -162.79 -3.36 0.04 OUTLIER 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.544 -1.348 . . . . 0.0 111.873 175.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 228' ' ' HIS . 27.1 mp0 -58.57 -43.43 89.39 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.339 2.656 . . . . 0.0 113.743 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -67.24 138.38 56.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 95.8 p -155.42 160.55 40.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.99 1.376 . . . . 0.0 109.463 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.4 mt -112.1 133.98 53.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -120.89 155.45 16.26 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.314 0.959 . . . . 0.0 112.582 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.42 138.54 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 122.349 1.071 . . . . 0.0 108.256 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -146.0 144.53 30.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 120.415 -1.428 . . . . 0.0 111.283 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -132.43 126.83 34.01 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 109.02 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 51.8 mtt85 -96.99 124.17 40.89 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -169.639 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.444 0 CA-C-O 118.39 -1.228 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -91.43 170.46 9.95 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 119.436 1.618 . . . . 0.0 109.984 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.2 178.03 47.67 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.43 149.09 8.93 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.479 2.119 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.44 127.19 45.03 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -170.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.32 135.03 60.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 O-C-N 120.267 -1.521 . . . . 0.0 110.431 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -128.79 126.75 40.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.549 -1.969 . . . . 0.0 108.314 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 133.43 54.58 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -143.17 147.0 34.21 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.54 1.638 . . . . 0.0 111.76 -167.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.97 127.73 48.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 125.592 1.557 . . . . 0.0 111.04 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 146.73 52.62 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 121.045 -1.034 . . . . 0.0 112.844 170.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -96.23 -0.84 49.29 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 120.336 -1.478 . . . . 0.0 112.2 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.54 164.36 29.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 171.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.51 -15.27 17.92 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.985 0.898 . . . . 0.0 111.817 -170.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 6.8 pt-20 -168.61 174.34 6.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -162.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -103.17 -2.52 27.19 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.765 -1.209 . . . . 0.0 114.241 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -76.41 144.21 12.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 O-C-N 120.148 -1.595 . . . . 0.0 113.806 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -125.34 8.99 7.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.881 1.324 . . . . 0.0 110.464 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 169.41 20.27 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.416 2.286 . . . . 0.0 106.856 -165.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 44.09 49.97 7.45 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.827 2.051 . . . . 0.0 116.334 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -55.41 -38.18 65.05 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -164.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.5 141.6 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 124.483 3.455 . . . . 0.0 117.131 169.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.76 134.94 94.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -56.12 125.8 20.26 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.805 3.003 . . . . 0.0 118.988 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -68.08 111.19 4.32 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.0 69.34 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -86.85 102.36 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 125.391 2.961 . . . . 0.0 113.709 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.46 -41.22 98.59 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.597 1.159 . . . . 0.0 113.783 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -120.13 141.03 50.2 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 121.203 -0.936 . . . . 0.0 108.502 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -81.81 -15.15 55.12 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-O 121.406 0.622 . . . . 0.0 112.013 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.78 133.84 34.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.592 -1.318 . . . . 0.0 108.615 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.1 mt -69.35 141.96 16.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 C-N-CA 124.9 1.28 . . . . 0.0 113.601 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -90.07 158.43 17.32 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 120.212 -1.555 . . . . 0.0 112.442 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -58.82 -37.39 76.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.026 1.731 . . . . 0.0 114.487 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -78.09 -19.0 13.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 O-C-N 120.658 -1.276 . . . . 0.0 114.104 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.317 10.1 t 79.98 70.17 0.03 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.648 1.579 . . . . 0.0 112.487 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.267 14.7 t70 57.85 -160.54 0.25 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.298 2.639 . . . . 0.0 116.251 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -149.3 146.82 27.74 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 119.968 -1.707 . . . . 0.0 111.049 -161.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.73 154.94 33.62 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.43 -1.419 . . . . 0.0 107.936 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -147.9 147.8 30.13 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 119.116 -2.24 . . . . 0.0 111.276 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -100.42 11.06 40.29 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 120.755 -1.215 . . . . 0.0 112.77 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -62.85 -36.49 75.76 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -80.39 101.49 9.03 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.725 -1.234 . . . . 0.0 112.907 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.0 p -90.32 -8.78 49.98 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.066 -1.021 . . . . 0.0 112.915 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 83.0 mtt180 -55.28 106.44 0.23 Allowed 'General case' 0 C--N 1.351 0.649 0 N-CA-C 115.545 1.684 . . . . 0.0 115.545 171.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.7 t -159.11 175.64 13.23 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.206 -165.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 1.8 t 53.15 61.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 126.79 2.036 . . . . 0.0 114.333 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -59.55 149.26 71.31 Favored Pre-proline 0 C--N 1.352 0.675 0 O-C-N 119.221 -2.174 . . . . 0.0 112.275 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -35.23 133.75 0.2 Allowed 'Trans proline' 0 C--O 1.246 0.925 1 C-N-CA 125.384 4.056 . . . . 0.0 116.708 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.43 170.24 22.38 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.179 -164.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.1 147.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.492 1.139 . . . . 0.0 109.057 -165.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -117.77 132.08 56.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.006 2.122 . . . . 0.0 106.041 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.05 126.48 56.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 O-C-N 120.672 -1.267 . . . . 0.0 107.61 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.89 -157.55 8.57 Favored Glycine 0 CA--C 1.492 -1.344 0 CA-C-O 123.388 1.549 . . . . 0.0 113.326 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -142.18 146.29 35.11 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -171.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -99.49 131.93 45.17 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 124.739 1.216 . . . . 0.0 113.732 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -134.91 164.0 28.58 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.598 1.959 . . . . 0.0 107.739 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.41 95.08 0.24 Allowed Glycine 0 C--N 1.354 1.544 0 O-C-N 119.529 -1.982 . . . . 0.0 115.677 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 13.91 70.44 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 125.723 1.63 . . . . 0.0 112.719 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -148.47 133.52 18.22 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.551 1.167 . . . . 0.0 110.86 -169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -137.73 124.82 21.51 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.414 1.486 . . . . 0.0 108.98 -173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp -109.0 129.48 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.08 145.37 23.96 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 120.398 -1.438 . . . . 0.0 112.791 -169.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.28 149.62 35.37 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 120.293 -1.505 . . . . 0.0 110.082 158.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -129.06 141.31 51.26 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.11 97.37 7.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.87 95.42 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.196 1.398 . . . . 0.0 111.546 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 55.4 52.7 10.9 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.809 1.644 . . . . 0.0 115.063 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -66.38 128.73 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 119.855 -1.778 . . . . 0.0 110.238 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -79.17 104.44 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 119.148 -2.22 . . . . 0.0 112.195 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -119.91 129.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -164.93 156.86 15.52 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.216 1.008 . . . . 0.0 110.395 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -142.57 147.14 35.4 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -60.2 -44.66 94.94 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 122.347 1.07 . . . . 0.0 112.293 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -62.58 151.19 38.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 113.878 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.65 128.88 46.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.645 -1.284 . . . . 0.0 107.98 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.72 -49.91 1.62 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.455 0.702 . . . . 0.0 110.619 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -57.9 -41.62 83.01 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -132.11 127.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 164.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -87.12 136.4 32.94 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.231 0.612 . . . . 0.0 110.716 -173.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -92.23 125.49 44.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 O-C-N 120.954 -1.091 . . . . 0.0 112.742 -175.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.28 -42.25 99.18 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 128.13 2.572 . . . . 0.0 115.917 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -58.21 140.2 53.53 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.48 -11.02 9.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 O-C-N 119.816 -1.803 . . . . 0.0 112.592 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -137.12 160.27 39.46 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 119.342 -2.099 . . . . 0.0 105.445 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.82 25.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 123.477 1.608 . . . . 0.0 111.446 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -66.2 -38.12 87.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 119.477 -2.015 . . . . 0.0 113.915 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 66.25 42.21 3.16 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.285 1.434 . . . . 0.0 113.498 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' CD ' HH12 ' A' ' 101' ' ' ARG . 57.5 mt-10 -97.19 161.11 13.96 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.822 1.649 . . . . 0.0 114.827 -171.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 57.81 -161.47 0.23 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 127.574 2.35 . . . . 0.0 115.713 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -97.82 -164.84 31.54 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 120.77 -1.206 . . . . 0.0 110.452 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.56 7.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 O-C-N 120.707 -1.466 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -158.88 154.39 25.95 Favored 'General case' 0 CA--C 1.509 -0.628 0 O-C-N 119.784 -1.822 . . . . 0.0 107.159 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.332 53.8 mt 86.33 112.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 126.137 1.775 . . . . 0.0 112.476 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -34.99 148.93 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 129.441 3.096 . . . . 0.0 117.823 168.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 94' ' ' GLU . 46.0 ttm-85 -64.69 114.35 4.37 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.81 134.12 56.33 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 120.61 -1.306 . . . . 0.0 113.237 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -63.55 117.56 6.94 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.278 -1.514 . . . . 0.0 111.899 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -157.76 163.98 37.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -167.96 -5.16 0.02 OUTLIER 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -111.27 5.22 19.72 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 119.901 -1.749 . . . . 0.0 111.653 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 108' ' ' ASN . 9.6 tp10 -84.3 173.12 11.22 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.951 1.301 . . . . 0.0 112.572 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.485 ' H ' ' CD ' ' A' ' 107' ' ' GLU 0.282 89.1 m-20 62.01 -125.38 0.76 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 119.214 -2.179 . . . . 0.0 111.781 -168.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.58 -3.92 52.74 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -167.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.8 m -33.06 135.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 128.339 2.655 . . . . 0.0 117.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 62.58 -112.06 0.41 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.318 -1.489 . . . . 0.0 113.113 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -108.77 2.85 22.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.963 1.305 . . . . 0.0 111.88 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.5 53.37 2.59 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -158.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.42 -16.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t 56.55 64.21 1.74 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -159.67 158.03 30.7 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 116.522 -3.861 . . . . 0.0 104.978 7.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 tp -118.28 136.01 53.94 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.3 146.6 18.16 Favored Glycine 0 C--N 1.359 1.834 0 O-C-N 120.568 -1.332 . . . . 0.0 111.719 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 116.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.2 m -120.82 130.95 54.18 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.571 1.177 . . . . 0.0 111.77 -167.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.42 113.35 22.74 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.24 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-O 122.53 1.157 . . . . 0.0 110.57 -155.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.78 117.2 29.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 119.71 -1.869 . . . . 0.0 107.894 166.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -126.09 124.92 41.67 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.587 -1.321 . . . . 0.0 109.106 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -114.92 102.35 9.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.691 1.234 . . . . 0.0 112.433 -163.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -93.41 -5.69 48.82 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.878 0.871 . . . . 0.0 111.49 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.7 pt -62.63 -37.72 79.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 125.691 1.596 . . . . 0.0 114.206 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -63.8 136.26 57.27 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.933 -1.104 . . . . 0.0 113.757 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.06 -44.4 82.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 128.696 2.798 . . . . 0.0 115.385 -162.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -132.19 -60.32 0.91 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.608 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -78.93 119.02 21.51 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.671 -1.268 . . . . 0.0 111.656 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.62 103.84 45.78 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -94.76 -177.83 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.54 2.16 . . . . 0.0 112.222 -171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -153.77 151.45 29.59 Favored 'General case' 0 C--N 1.349 0.543 0 C-N-CA 123.955 0.902 . . . . 0.0 110.506 167.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tp -148.81 138.24 15.8 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 CA-C-O 122.065 0.936 . . . . 0.0 109.68 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.65 -161.07 28.08 Favored Glycine 0 CA--C 1.5 -0.871 0 O-C-N 120.227 -1.546 . . . . 0.0 110.956 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.06 157.31 38.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.539 -0.977 . . . . 0.0 110.581 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -132.81 131.22 40.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.144 0.978 . . . . 0.0 108.605 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.52 52.04 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 123.045 1.402 . . . . 0.0 112.309 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -117.7 157.11 27.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 127.373 2.269 . . . . 0.0 109.47 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.23 30.66 5.59 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 120.238 -1.539 . . . . 0.0 115.375 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -144.08 179.66 7.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 107.885 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.8 145.93 9.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 O-C-N 120.372 -1.455 . . . . 0.0 113.991 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -115.97 15.97 16.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.027 1.331 . . . . 0.0 112.293 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -158.88 163.89 36.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.2 m -60.14 104.05 0.28 Allowed 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 128.868 2.867 . . . . 0.0 113.384 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.2 tp -151.47 153.61 9.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 121.335 -0.853 . . . . 0.0 108.919 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -159.72 178.84 9.4 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 90.5 p -77.0 -21.96 53.84 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.991 1.723 . . . . 0.0 113.433 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 t -60.72 142.12 56.16 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.743 1.258 . . . . 0.0 112.085 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -87.18 -7.03 58.38 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 119.798 -1.814 . . . . 0.0 111.617 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -71.51 131.98 44.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 120.915 -1.116 . . . . 0.0 112.623 168.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -61.78 134.67 57.02 Favored 'General case' 0 C--N 1.345 0.372 0 O-C-N 120.979 -1.076 . . . . 0.0 113.033 170.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.7 pt -124.88 149.98 29.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 110.875 -173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 67.04 46.57 1.52 Allowed 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.63 1.972 . . . . 0.0 110.453 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.57 135.94 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.675 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.8 m -84.76 110.18 18.61 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.673 -1.267 . . . . 0.0 110.961 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 96.2 m -67.71 117.92 10.27 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.317 -1.489 . . . . 0.0 111.266 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.22 111.74 61.64 Favored Pre-proline 0 C--N 1.348 0.536 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -62.19 138.44 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 CA-C-N 122.287 1.852 . . . . 0.0 112.855 168.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -96.12 164.67 12.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -75.72 -18.24 59.65 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 122.019 0.914 . . . . 0.0 110.63 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -75.47 146.15 80.39 Favored Pre-proline 0 N--CA 1.443 -0.816 0 O-C-N 121.169 -0.957 . . . . 0.0 112.251 167.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.17 162.93 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.461 1.44 . . . . 0.0 110.284 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 73.14 41.25 0.5 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 169.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -57.37 149.24 32.27 Favored Glycine 0 C--N 1.359 1.843 0 O-C-N 121.152 -0.967 . . . . 0.0 115.002 167.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.45 -19.45 58.04 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.5 t -127.11 122.76 60.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.8 p -110.49 9.29 23.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.707 0.803 . . . . 0.0 110.693 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.9 t -110.43 144.18 39.61 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.629 -1.294 . . . . 0.0 110.102 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -113.7 4.94 16.23 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.711 175.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -96.25 21.89 8.41 Favored 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.55 -1.344 . . . . 0.0 110.894 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -107.97 1.15 22.35 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.496 2.318 . . . . 0.0 112.764 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -117.65 127.05 26.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 0.0 108.154 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.19 135.57 5.43 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 122.819 2.043 . . . . 0.0 112.405 -167.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -66.65 -29.45 69.48 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 120.074 -1.641 . . . . 0.0 113.767 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.8 t -69.35 140.72 54.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.789 1.236 . . . . 0.0 111.385 165.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -117.23 18.78 14.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.5 5.55 11.1 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 121.011 -1.055 . . . . 0.0 110.296 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -164.48 176.33 9.09 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.38 167.97 11.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.898 2.479 . . . . 0.0 115.134 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -71.92 -38.79 69.83 Favored 'General case' 0 C--N 1.355 0.845 0 O-C-N 120.411 -1.431 . . . . 0.0 112.834 166.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.9 t -151.21 140.29 21.13 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 120.731 -1.231 . . . . 0.0 109.459 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -117.36 18.22 14.45 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 124.334 1.054 . . . . 0.0 109.77 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 78.0 p -59.23 -46.57 88.12 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.1 tt -99.5 134.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.975 1.369 . . . . 0.0 109.486 165.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.62 145.6 48.88 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.72 -1.863 . . . . 0.0 111.565 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -119.69 171.4 8.41 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.96 147.95 6.08 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 O-C-N 121.281 -0.887 . . . . 0.0 111.945 165.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.35 162.39 33.26 Favored Glycine 0 CA--C 1.491 -1.457 0 O-C-N 120.614 -1.304 . . . . 0.0 113.483 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.52 159.99 17.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.773 1.629 . . . . 0.0 109.024 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -167.76 173.01 42.73 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 120.815 -1.178 . . . . 0.0 111.108 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 51.3 t -117.97 135.68 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 126.014 1.726 . . . . 0.0 107.678 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 15.8 tt -114.23 134.95 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 O-C-N 120.961 -1.087 . . . . 0.0 108.951 175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.58 165.23 35.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 120.954 -1.091 . . . . 0.0 108.665 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.16 173.34 41.74 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.364 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.39 136.28 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.666 1.187 . . . . 0.0 108.321 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -144.9 -171.85 14.96 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 120.041 -1.662 . . . . 0.0 110.584 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -149.62 144.88 26.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.074 0.94 . . . . 0.0 111.111 172.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.13 132.65 47.59 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 123.754 1.74 . . . . 0.0 114.549 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.13 -34.08 4.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 126.643 1.977 . . . . 0.0 107.355 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p -145.65 159.04 48.88 Favored Pre-proline 0 C--N 1.343 0.295 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.36 11.06 1.34 Allowed 'Trans proline' 0 C--N 1.329 -0.486 0 CA-C-N 124.653 2.698 . . . . 0.0 113.647 -175.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -127.28 5.18 6.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 118.933 0.788 . . . . 0.0 111.344 165.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.5 tp -127.77 111.01 13.18 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.016 -1.677 . . . . 0.0 110.431 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.9 m -98.19 127.59 44.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.74 1.216 . . . . 0.0 108.218 174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.8 tt -83.46 126.24 32.56 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 164.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -125.11 141.38 52.15 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.849 -157.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -117.69 110.75 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 166.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.4 153.55 17.18 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 124.371 0.986 . . . . 0.0 112.769 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -147.71 135.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.207 1.003 . . . . 0.0 109.481 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -127.53 125.8 41.04 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.526 -1.984 . . . . 0.0 109.754 170.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.71 155.46 17.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -143.12 141.54 31.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.991 -1.693 . . . . 0.0 109.004 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.71 112.4 25.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.717 1.246 . . . . 0.0 110.256 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -172.37 60.04 0.03 OUTLIER 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.6 -165.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 66.15 175.62 6.32 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 125.656 1.598 . . . . 0.0 116.069 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -166.04 -7.72 0.02 OUTLIER 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -48.19 80.52 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 120.483 1.492 . . . . 0.0 113.31 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.91 -46.07 1.41 Allowed 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.329 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -129.77 135.98 49.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 53.4 m -102.97 107.68 18.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 129.005 2.922 . . . . 0.0 110.791 -0.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -61.02 -40.03 92.03 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 119.995 -1.69 . . . . 0.0 115.053 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -56.41 144.38 31.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.77 9.85 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.525 1.13 . . . . 0.0 108.333 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.3 p -105.17 -8.29 18.48 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.171 -0.956 . . . . 0.0 111.61 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -70.84 129.72 39.79 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.058 -1.026 . . . . 0.0 112.033 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.28 34.2 mt-10 67.12 40.53 2.84 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.03 122.96 47.5 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.164 0.983 . . . . 0.0 108.945 168.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.1 p -146.94 155.82 42.58 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.478 1.132 . . . . 0.0 113.416 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.85 140.92 48.88 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.92 -143.93 4.55 Favored Glycine 0 CA--C 1.5 -0.883 0 O-C-N 120.724 -1.235 . . . . 0.0 113.465 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 8.6 m -137.57 139.36 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 122.992 1.377 . . . . 0.0 111.081 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -120.14 108.85 14.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.112 1.365 . . . . 0.0 108.114 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.85 129.26 45.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.383 1.563 . . . . 0.0 110.371 -159.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -118.37 137.29 53.22 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 117.338 -1.315 . . . . 0.0 110.632 177.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.18 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -93.74 160.89 14.56 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 141.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.02 -164.58 25.8 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 121.295 1.861 . . . . 0.0 113.507 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -39.13 145.38 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 1 C-N-CA 126.105 4.537 . . . . 0.0 119.373 170.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -141.29 134.48 29.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.729 1.211 . . . . 0.0 108.321 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.68 137.42 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -129.91 135.07 47.92 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.92 1.288 . . . . 0.0 112.196 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.78 137.89 53.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 120.948 -1.095 . . . . 0.0 108.83 163.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.05 143.46 50.9 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 120.626 -1.296 . . . . 0.0 107.65 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.42 158.31 35.6 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.789 0.804 . . . . 0.0 110.599 -168.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.62 106.29 12.46 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 119.701 -1.874 . . . . 0.0 109.809 172.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 65.43 -23.55 0.09 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.24 2.216 . . . . 0.0 115.945 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.31 157.86 34.96 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.14 -38.44 88.97 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.916 1.287 . . . . 0.0 113.758 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.4 131.34 53.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 153.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -29.59 125.49 0.14 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 120.063 3.357 . . . . 0.0 120.063 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.03 -27.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 120.938 -1.101 . . . . 0.0 112.117 165.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.0 p -99.45 29.98 3.77 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 120.359 -1.463 . . . . 0.0 110.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.09 130.19 45.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.67 152.78 29.95 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.61 123.98 15.53 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 120.106 -1.621 . . . . 0.0 113.569 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.61 -7.9 15.83 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 122.172 1.915 . . . . 0.0 112.73 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.89 151.99 27.44 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.76 -8.21 14.57 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.349 2.033 . . . . 0.0 111.844 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 112.63 78.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 130.164 3.386 . . . . 0.0 106.957 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -175.04 112.29 0.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 120.654 -1.279 . . . . 0.0 110.894 -167.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.97 120.04 7.67 Favored 'Trans proline' 0 C--O 1.23 0.081 0 C-N-CA 123.369 2.712 . . . . 0.0 117.029 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -77.69 134.66 38.08 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 111.412 171.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -99.84 -4.61 30.05 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 47.4 42.14 13.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 119.243 3.053 . . . . 0.0 119.243 166.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -56.76 -37.57 71.25 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -165.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.02 22.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.673 1.189 . . . . 0.0 109.351 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -114.93 126.16 54.46 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.447 -1.408 . . . . 0.0 112.267 -163.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -62.26 126.25 26.68 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.844 0.858 . . . . 0.0 110.297 167.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -97.88 140.94 16.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 O-C-N 121.448 -0.783 . . . . 0.0 112.033 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -62.0 -46.84 87.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.619 -1.926 . . . . 0.0 113.482 168.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.36 134.95 36.56 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -172.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.69 -34.41 78.24 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 122.457 1.122 . . . . 0.0 112.091 166.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.87 143.71 57.76 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -102.02 121.08 41.49 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 120.453 -1.404 . . . . 0.0 109.672 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -84.25 -51.38 7.06 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.423 -1.423 . . . . 0.0 111.921 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . 0.322 19.8 mt 80.55 -55.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 127.733 2.413 . . . . 0.0 112.3 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.46 161.34 38.15 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 t -152.07 176.28 11.69 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 119.982 -1.699 . . . . 0.0 107.402 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -115.02 108.51 16.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -174.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 p -108.04 -54.8 2.45 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.53 -0.732 . . . . 0.0 112.919 -168.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -71.25 -52.53 26.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 72.13 143.32 0.1 OUTLIER Pre-proline 0 C--N 1.352 0.699 0 C-N-CA 125.676 1.59 . . . . 0.0 113.634 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -59.91 132.34 44.43 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.247 2.631 . . . . 0.0 113.292 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -71.99 131.03 42.36 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.4 t -119.61 118.91 58.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 162.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -134.52 129.81 35.69 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 120.018 -1.676 . . . . 0.0 109.19 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.19 142.24 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.536 -1.352 . . . . 0.0 111.441 -167.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.77 -124.96 0.86 Allowed Glycine 0 C--N 1.356 1.647 0 O-C-N 121.051 -1.03 . . . . 0.0 113.106 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.06 148.21 28.74 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 122.125 -0.632 . . . . 0.0 109.626 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.95 127.34 55.92 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 122.666 1.222 . . . . 0.0 110.248 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -101.45 14.79 30.9 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.141 1.376 . . . . 0.0 110.504 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.89 26.25 3.63 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.711 0.672 . . . . 0.0 113.538 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.83 -7.71 9.39 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -114.39 118.91 35.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 163.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.22 139.87 46.09 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.268 1.033 . . . . 0.0 109.019 -169.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.2 tt -125.78 142.52 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.98 33.12 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 123.97 0.908 . . . . 0.0 110.515 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.04 158.39 30.57 Favored 'General case' 0 C--O 1.219 -0.531 0 O-C-N 120.32 -1.487 . . . . 0.0 111.239 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -121.7 120.92 36.1 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 120.688 -1.258 . . . . 0.0 109.225 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.43 139.45 53.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.086 1.754 . . . . 0.0 107.887 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 68.84 1.31 Allowed 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.721 -1.237 . . . . 0.0 110.485 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . 0.385 30.4 mtm180 58.2 166.78 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -165.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -119.29 13.28 12.75 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.142 -1.599 . . . . 0.0 113.229 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.2 24.1 12.49 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -169.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -97.28 10.61 39.09 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 119.775 -1.828 . . . . 0.0 111.658 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -66.98 147.97 52.56 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 121.124 -0.985 . . . . 0.0 112.073 163.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m120 72.26 122.18 0.04 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.684 1.594 . . . . 0.0 112.318 -167.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -147.07 10.31 1.01 Allowed 'General case' 0 C--N 1.351 0.639 0 O-C-N 120.737 -1.227 . . . . 0.0 109.706 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.11 166.96 16.76 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -118.14 17.96 13.91 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.339 1.055 . . . . 0.0 111.054 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.65 124.45 44.33 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.656 -1.278 . . . . 0.0 107.695 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m 71.95 25.2 3.12 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.063 0.945 . . . . 0.0 113.147 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.78 13.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 110.377 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -92.21 154.58 18.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.363 1.465 . . . . 0.0 111.976 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.0 mt -117.65 -30.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.63 145.03 50.55 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.903 1.681 . . . . 0.0 114.346 169.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -100.5 -8.39 23.17 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.17 -1.581 . . . . 0.0 112.517 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -154.99 151.06 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 64.84 48.07 2.51 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -170.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.26 141.41 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.652 1.581 . . . . 0.0 114.394 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -56.58 148.82 18.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -105.49 -6.66 19.24 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.1 -1.625 . . . . 0.0 112.743 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.52 140.26 58.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.247 1.819 . . . . 0.0 114.377 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -116.16 -9.85 11.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.773 -0.58 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.07 11.88 83.73 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 125.423 1.487 . . . . 0.0 114.821 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.72 -31.18 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 124.401 1.08 . . . . 0.0 109.688 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.79 41.06 30.64 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 165.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.265 3.1 mp 55.56 56.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 126.106 1.762 . . . . 0.0 110.799 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.33 50.2 m-20 71.66 40.27 0.8 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.547 1.939 . . . . 0.0 114.719 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 71.59 40.33 0.81 Allowed 'General case' 0 C--N 1.349 0.554 0 C-N-CA 127.015 2.126 . . . . 0.0 112.954 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -61.62 119.18 8.15 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 p -63.87 -41.17 97.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.36 178.83 8.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.767 1.227 . . . . 0.0 110.946 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 59.57 63.79 1.45 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 125.153 1.381 . . . . 0.0 113.937 -172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -170.17 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -170.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 58.04 38.5 26.69 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 123.295 1.521 . . . . 0.0 114.75 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -156.46 165.97 34.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.38 -16.64 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 121.401 -0.812 . . . . 0.0 112.777 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.6 m -70.05 95.69 0.98 Allowed 'General case' 0 C--N 1.353 0.742 0 CA-C-O 123.383 1.563 . . . . 0.0 111.963 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . 0.255 92.2 m-85 49.09 49.14 20.01 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 127.189 2.196 . . . . 0.0 115.847 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -94.73 -1.07 53.69 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.319 -0.863 . . . . 0.0 112.022 166.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.6 159.56 30.18 Favored 'General case' 0 C--N 1.35 0.618 0 O-C-N 121.047 -1.033 . . . . 0.0 110.973 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 50.0 t -57.08 -46.9 84.46 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -172.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.3 t -120.99 12.06 11.12 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 116.468 -3.895 . . . . 0.0 110.995 -3.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -128.43 111.88 13.78 Favored 'General case' 0 C--N 1.358 0.964 0 O-C-N 119.523 -1.986 . . . . 0.0 108.143 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.4 tp -132.21 122.75 25.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 164.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -179.89 -137.96 3.2 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 122.093 0.83 . . . . 0.0 113.449 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.32 159.37 37.45 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.795 1.283 . . . . 0.0 112.554 -170.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 t -139.57 129.25 24.54 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.662 1.185 . . . . 0.0 108.677 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.95 121.43 29.88 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 120.822 -1.174 . . . . 0.0 108.712 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.18 143.88 39.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.588 -0.695 . . . . 0.0 110.037 -160.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -115.66 134.35 55.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.425 1.49 . . . . 0.0 109.758 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.5 116.41 28.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -91.89 92.95 8.58 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.07 -1.018 . . . . 0.0 112.282 -170.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.16 152.6 38.69 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 120.015 -1.678 . . . . 0.0 111.052 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -145.22 -29.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -147.8 -41.37 0.17 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.251 -2.155 . . . . 0.0 108.607 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -85.65 157.99 20.19 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.218 1.008 . . . . 0.0 112.331 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.73 -9.19 35.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -165.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -101.89 108.23 19.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.02 26.28 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -168.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -66.76 145.65 75.93 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.709 1.606 . . . . 0.0 111.059 153.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -136.63 153.23 50.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.88 0.847 . . . . 0.0 109.332 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.23 142.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -157.01 162.61 31.85 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-O 123.201 1.445 . . . . 0.0 113.063 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.49 136.28 33.16 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.708 -1.466 . . . . 0.0 110.533 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.18 118.39 23.27 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 122.21 1.005 . . . . 0.0 109.644 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.79 124.11 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 124.86 1.264 . . . . 0.0 107.851 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -150.42 155.78 40.22 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.479 1.133 . . . . 0.0 112.511 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.65 154.99 51.26 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 124.252 1.021 . . . . 0.0 109.085 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.01 -9.05 26.81 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 116.676 1.431 . . . . 0.0 116.676 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m170 68.85 44.0 1.14 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.976 1.311 . . . . 0.0 113.662 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 m -146.69 146.11 19.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 C-N-CA 123.783 0.833 . . . . 0.0 109.609 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.259 85.8 mtm180 90.0 38.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.717 3.207 . . . . 0.0 110.297 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -133.66 -20.34 2.04 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 t -114.55 137.6 51.67 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-O 122.387 1.089 . . . . 0.0 110.01 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.4 pt -117.66 8.98 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 120.82 -1.175 . . . . 0.0 109.68 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.92 128.04 40.01 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.491 1.516 . . . . 0.0 113.773 -159.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -159.95 164.54 33.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.298 -1.501 . . . . 0.0 110.592 160.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.5 m -61.49 -25.58 67.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 129.467 3.107 . . . . 0.0 116.361 -164.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -135.66 10.78 3.42 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 120.08 -1.637 . . . . 0.0 113.137 169.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -150.4 132.2 15.04 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 120.246 -1.534 . . . . 0.0 112.252 -164.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 m -79.57 115.13 19.01 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.7 mt 68.05 108.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 127.271 2.229 . . . . 0.0 112.864 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -91.58 97.02 10.79 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 119.177 -2.202 . . . . 0.0 108.8 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.68 155.65 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 C-N-CA 126.889 2.076 . . . . 0.0 106.484 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 1.8 p -51.58 148.14 5.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 128.159 2.584 . . . . 0.0 114.54 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -56.61 130.84 46.93 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.615 -1.303 . . . . 0.0 113.316 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.11 131.95 49.49 Favored Pre-proline 0 C--N 1.352 0.713 0 O-C-N 120.963 -1.086 . . . . 0.0 109.592 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.66 123.93 12.45 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.381 2.721 . . . . 0.0 116.972 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -58.72 131.0 49.59 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 15.4 m120 74.5 16.05 3.3 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.8 122.12 85.95 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 118.752 0.706 . . . . 0.0 111.982 168.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -92.06 167.11 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.911 1.741 . . . . 0.0 110.47 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.4 164.6 20.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.4 -118.82 2.07 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.83 5.11 52.74 Favored 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.977 -1.308 . . . . 0.0 112.738 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -91.7 -12.06 9.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.844 -1.16 . . . . 0.0 113.62 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.2 t -163.15 161.71 25.23 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.6 p -98.0 2.64 49.11 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.321 1.058 . . . . 0.0 110.994 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -83.62 123.78 30.13 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 120.923 -1.11 . . . . 0.0 111.682 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 15.3 m120 61.52 40.89 13.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 m -58.96 -45.09 91.34 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.632 1.573 . . . . 0.0 112.621 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.37 132.76 28.33 Favored Pre-proline 0 N--CA 1.436 -1.145 0 C-N-CA 124.516 1.126 . . . . 0.0 111.592 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.09 115.05 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.464 2.776 . . . . 0.0 115.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.282 66.7 mttm 89.69 10.95 0.07 Allowed 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.86 2.064 . . . . 0.0 115.144 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.1 t -94.61 164.91 12.77 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 120.775 -1.203 . . . . 0.0 111.618 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -135.6 159.06 42.78 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.837 1.255 . . . . 0.0 108.789 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -137.53 164.75 27.97 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.202 -1.561 . . . . 0.0 108.273 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -79.64 -16.29 56.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.28 37.94 23.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.447 1.499 . . . . 0.0 114.711 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -157.28 169.02 25.7 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.0 t -106.21 154.56 20.54 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.638 -1.289 . . . . 0.0 107.575 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 69.16 44.18 1.02 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 166.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 t -82.46 138.7 34.3 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.193 -1.567 . . . . 0.0 110.748 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 pt -133.45 161.66 40.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.891 0 O-C-N 119.505 -1.997 . . . . 0.0 111.601 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 57.35 -127.23 1.76 Allowed 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 79.96 -37.66 0.16 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.508 1.523 . . . . 0.0 111.004 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.87 148.61 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -138.12 106.2 0.52 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 172.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.82 114.63 20.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.39 -162.26 31.66 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 120.667 -1.27 . . . . 0.0 113.722 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.5 139.8 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 123.699 0.799 . . . . 0.0 110.393 -167.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 21.2 tt -120.92 137.18 55.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.39 0 O-C-N 120.95 -1.094 . . . . 0.0 108.486 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -152.04 165.02 36.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 121.535 -0.728 . . . . 0.0 109.348 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 176.51 -171.68 44.65 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.58 136.89 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 123.956 0.902 . . . . 0.0 108.907 174.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -139.97 163.0 26.33 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 120.514 -1.366 . . . . 0.0 113.044 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -126.02 129.54 49.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.902 -0.764 . . . . 0.0 110.668 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -71.36 100.13 2.1 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-O 123.319 1.533 . . . . 0.0 112.579 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.2 mm -63.32 -44.16 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.513 1.525 . . . . 0.0 109.486 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 10.7 p -140.58 165.45 29.86 Favored Pre-proline 0 CA--C 1.518 -0.275 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -71.27 7.82 1.32 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 CA-C-N 123.183 2.173 . . . . 0.0 113.815 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -114.11 -15.01 12.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 56.8 tp -132.47 121.86 24.03 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 119.574 1.079 . . . . 0.0 112.98 -165.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 p -106.72 143.6 34.58 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 110.562 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.93 123.78 50.02 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 161.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -122.48 142.83 50.16 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.977 1.311 . . . . 0.0 111.165 -162.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -122.07 120.25 33.75 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 120.617 -1.302 . . . . 0.0 108.786 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.79 -177.3 22.08 Favored Glycine 0 CA--C 1.498 -1.004 0 O-C-N 120.687 -1.258 . . . . 0.0 114.053 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -157.72 153.94 27.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -175.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.675 HH21 ' CE1' ' A' ' 215' ' ' HIS . 42.3 ttp180 -126.23 139.41 53.35 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 119.886 -1.759 . . . . 0.0 109.346 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 115.52 21.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.675 ' CE1' HH21 ' A' ' 213' ' ' ARG . 57.0 p-80 -151.33 159.36 44.34 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.628 -1.295 . . . . 0.0 108.651 -171.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 55.6 55.51 7.16 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 126.295 1.838 . . . . 0.0 114.117 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -57.82 120.26 8.13 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 120.885 -1.134 . . . . 0.0 113.19 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 118.06 -7.31 14.85 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -57.83 -35.65 71.19 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 16.0 tp 62.23 34.37 16.07 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 124.245 1.974 . . . . 0.0 114.497 163.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.96 103.5 10.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 119.757 -1.84 . . . . 0.0 112.288 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.88 -44.08 81.89 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.651 -1.28 . . . . 0.0 113.51 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 m -75.62 -15.35 60.35 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 120.808 -1.182 . . . . 0.0 111.793 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.546 HH11 ' CE1' ' A' ' 228' ' ' HIS . 23.1 ttp180 -147.22 70.74 1.19 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 119.085 -2.26 . . . . 0.0 112.111 -173.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -58.72 -43.15 90.06 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 120.297 -1.502 . . . . 0.0 113.941 173.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -94.63 136.64 34.71 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.223 -1.548 . . . . 0.0 111.629 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.5 m -61.73 121.56 13.15 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 120.964 -1.085 . . . . 0.0 111.835 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.546 ' CE1' HH11 ' A' ' 224' ' ' ARG . 5.8 p-80 -102.22 3.26 38.1 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 120.678 -1.263 . . . . 0.0 112.099 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.89 -35.12 79.3 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.62 132.54 22.78 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 120.789 -1.194 . . . . 0.0 111.445 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.5 p -126.16 -16.47 5.5 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.642 0.734 . . . . 0.0 110.072 163.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.6 156.94 47.03 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.592 1.187 . . . . 0.0 108.05 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.67 23.12 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.72 127.54 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -142.36 147.35 36.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.381 1.086 . . . . 0.0 108.349 -173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.42 135.87 28.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 122.079 0.942 . . . . 0.0 111.159 -167.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -120.49 129.53 53.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.916 1.286 . . . . 0.0 111.65 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 CA--C 1.548 0.888 0 O-C-N 120.735 -1.228 . . . . 0.0 112.974 177.895 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.32 0 CA-C-O 120.31 -0.161 . . . . 0.0 113.437 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -93.14 174.65 7.11 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.601 1.56 . . . . 0.0 107.624 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.99 167.87 26.2 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 119.591 1.087 . . . . 0.0 110.577 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -49.08 147.66 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.314 2.676 . . . . 0.0 114.538 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -122.63 143.9 49.47 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 107.765 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.12 152.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 123.208 1.48 . . . . 0.0 110.017 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -148.88 145.67 27.57 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 125.981 1.712 . . . . 0.0 107.063 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.53 134.66 27.39 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -104.15 135.14 46.2 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.6 1.191 . . . . 0.0 108.068 -172.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -108.17 127.08 53.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.126 2.17 . . . . 0.0 107.683 -168.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.38 140.01 43.62 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.937 1.351 . . . . 0.0 112.59 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -57.09 144.65 33.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.965 1.306 . . . . 0.0 112.236 161.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.73 10.23 31.64 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.082 -1.636 . . . . 0.0 114.912 -153.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.853 -1.154 . . . . 0.0 110.926 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.28 46.2 mt-10 57.21 29.38 16.61 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 164.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 228' ' ' HIS . 14.3 m-70 70.62 32.61 2.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 119.908 -1.745 . . . . 0.0 112.96 165.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.8 pt -52.78 134.64 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.896 1.278 . . . . 0.0 113.465 171.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.7 p -101.54 -3.37 28.6 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 121.182 -0.949 . . . . 0.0 110.348 172.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -84.94 110.86 19.18 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 122.645 1.212 . . . . 0.0 112.268 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -59.75 -41.46 91.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.712 2.405 . . . . 0.0 115.175 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -124.14 145.66 49.01 Favored Pre-proline 0 CA--C 1.51 -0.571 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -88.47 166.21 6.45 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.704 1.602 . . . . 0.0 111.236 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -86.65 142.64 34.94 Favored Pre-proline 0 N--CA 1.441 -0.892 0 C-N-CA 124.326 1.05 . . . . 0.0 108.534 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -53.76 162.03 4.02 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 123.192 2.595 . . . . 0.0 118.561 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -62.33 141.85 58.08 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 113.672 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.18 17.79 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 165.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -44.52 149.84 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 124.823 3.682 . . . . 0.0 118.568 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -148.5 27.96 0.9 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.28 1.514 . . . . 0.0 108.23 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -145.15 138.21 26.43 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.4 11.92 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.812 0.845 . . . . 0.0 112.452 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -91.84 5.07 51.33 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.869 -1.145 . . . . 0.0 111.877 -166.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.8 mt -82.94 114.88 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -162.01 164.18 28.43 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.4 p -101.98 -2.81 28.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.154 0.982 . . . . 0.0 112.773 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.4 m -65.65 -40.56 88.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -109.14 -11.93 14.87 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.693 -1.254 . . . . 0.0 112.93 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 17.3 m-20 -129.47 126.03 37.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 109.065 -167.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 58.47 39.54 24.96 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 131.327 3.851 . . . . 0.0 114.201 0.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -64.28 141.3 58.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -170.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -57.65 152.14 15.85 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -57.38 125.52 23.18 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.2 mt -115.21 108.74 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 166.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -123.43 0.67 8.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.651 -1.281 . . . . 0.0 111.938 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 t -159.88 170.1 22.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -147.16 159.38 43.69 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.8 p -34.83 137.15 0.14 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 159.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t 78.78 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.561 0 C-N-CA 127.445 2.298 . . . . 0.0 113.291 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 47.33 67.28 4.62 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 127.462 2.305 . . . . 0.0 115.793 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 -29.13 10.04 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.678 2.252 . . . . 0.0 113.037 -158.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 ttt-85 -114.98 133.81 55.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 124.901 1.28 . . . . 0.0 109.143 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -131.93 147.87 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 t -144.17 131.08 20.37 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.193 -1.567 . . . . 0.0 107.036 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.64 134.85 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 122.891 1.329 . . . . 0.0 108.362 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.33 -147.03 4.92 Favored Glycine 0 CA--C 1.488 -1.652 0 O-C-N 120.681 -1.262 . . . . 0.0 111.811 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -148.47 152.82 37.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.24 -1.153 . . . . 0.0 108.339 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -106.61 129.41 54.54 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.442 -168.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.96 171.38 9.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.916 1.341 . . . . 0.0 107.714 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.29 99.24 0.7 Allowed Glycine 0 C--O 1.215 -1.073 0 O-C-N 119.059 -2.276 . . . . 0.0 113.882 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.97 -0.08 81.71 Favored Glycine 0 CA--C 1.497 -1.079 0 O-C-N 122.303 -0.528 . . . . 0.0 112.981 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -154.66 152.95 30.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.575 -1.544 . . . . 0.0 110.182 -172.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -138.95 137.88 36.83 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -161.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.6 tt -128.71 141.21 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.36 163.12 37.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 120.318 -1.489 . . . . 0.0 112.766 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.76 120.85 43.42 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.083 1.353 . . . . 0.0 108.587 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 131.13 47.31 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.263 -162.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -135.35 132.66 37.9 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 120.691 -1.255 . . . . 0.0 107.752 -174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.55 135.44 55.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 120.382 -1.448 . . . . 0.0 107.094 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -59.44 -42.53 92.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.3 t80 79.19 -57.92 0.41 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 127.577 2.351 . . . . 0.0 111.937 166.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 81.22 51.93 0.02 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.321 2.649 . . . . 0.0 107.883 -171.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -71.24 -45.97 62.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 119.45 3.13 . . . . 0.0 119.45 -161.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.515 ' HH2' ' HE1' ' A' ' 146' ' ' HIS . 21.4 m-90 -121.66 113.09 19.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 121.021 -1.05 . . . . 0.0 110.788 -175.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -127.98 125.91 40.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 121.467 -0.771 . . . . 0.0 110.505 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.283 98.7 m-20 65.73 60.11 0.72 Allowed 'General case' 0 C--N 1.345 0.377 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 174.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.0 t30 76.9 104.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.236 2.614 . . . . 0.0 114.49 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.96 172.29 13.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 117.007 -3.558 . . . . 0.0 108.232 -4.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.83 5.49 41.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 130.135 3.374 . . . . 0.0 110.813 -7.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -154.94 154.27 32.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.78 130.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 CA-C-O 121.916 0.865 . . . . 0.0 111.256 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.12 10.76 12.19 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 123.781 0.833 . . . . 0.0 112.191 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 tp -138.79 145.96 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 119.493 -2.005 . . . . 0.0 108.142 -174.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.16 149.81 47.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.44 -29.42 70.71 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.37 -31.45 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 O-C-N 120.874 -1.141 . . . . 0.0 113.901 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.7 mtp85 -84.29 -21.38 31.08 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.406 -1.433 . . . . 0.0 113.109 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.2 pt -114.39 6.1 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 123.607 0.763 . . . . 0.0 111.082 -172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.55 148.21 52.21 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.628 1.68 . . . . 0.0 111.549 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.64 -41.08 97.0 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -120.1 132.94 55.61 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.001 0.52 . . . . 0.0 110.019 -168.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 59.85 58.45 2.78 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 124.273 1.029 . . . . 0.0 113.18 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -62.57 -171.82 1.47 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-O 124.046 1.914 . . . . 0.0 113.641 167.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.86 140.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 O-C-N 119.819 -1.989 . . . . 0.0 108.912 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -61.09 132.78 54.86 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 119.86 -1.775 . . . . 0.0 112.725 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -131.99 -6.61 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 121.643 -0.66 . . . . 0.0 112.656 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . 0.26 11.1 m-20 49.22 -160.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -65.47 137.73 57.63 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 119.413 -2.054 . . . . 0.0 114.299 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -150.73 157.81 43.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 -171.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -99.73 146.45 26.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 123.412 1.577 . . . . 0.0 110.932 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -131.7 16.75 4.8 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.127 1.371 . . . . 0.0 107.305 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.91 -9.45 19.86 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 120.493 -1.38 . . . . 0.0 111.725 -173.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.38 -2.42 57.32 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 120.304 -1.497 . . . . 0.0 112.711 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -115.89 15.19 16.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 124.199 0.999 . . . . 0.0 109.685 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 62.07 35.33 15.94 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 125.652 1.581 . . . . 0.0 114.301 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.56 154.96 37.72 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.761 1.172 . . . . 0.0 114.918 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t -147.83 151.16 35.49 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.38 -1.659 . . . . 0.0 108.132 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.88 -39.78 83.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.629 -1.92 . . . . 0.0 113.67 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -161.84 156.69 22.97 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.252 -0.905 . . . . 0.0 109.007 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.41 170.58 21.46 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.06 110.88 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-O 122.695 1.236 . . . . 0.0 110.61 171.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.4 t -155.48 -166.59 2.28 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.238 -1.539 . . . . 0.0 109.092 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.254 21.2 m 78.1 131.62 0.05 Allowed 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 128.141 2.577 . . . . 0.0 113.056 170.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.48 146.82 33.95 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.065 1.412 . . . . 0.0 112.836 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 176.64 -143.94 6.64 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.4 151.5 44.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 m -134.99 157.67 46.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.204 1.002 . . . . 0.0 111.128 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.14 148.42 29.62 Favored 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 120.985 -1.072 . . . . 0.0 110.274 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.4 mt -137.11 138.83 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.955 1.302 . . . . 0.0 108.518 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -114.32 119.05 35.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.79 152.41 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.58 -1.325 . . . . 0.0 109.694 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.3 117.64 34.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 124.155 0.982 . . . . 0.0 108.535 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 179.65 130.25 0.09 Allowed 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 120.144 -1.597 . . . . 0.0 109.051 -166.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 tp -130.04 -48.48 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.612 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -135.44 2.95 3.03 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 120.111 -1.618 . . . . 0.0 113.229 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.58 164.09 16.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.051 0.929 . . . . 0.0 110.149 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.49 -19.99 57.43 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -74.59 128.06 34.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 121.521 -0.737 . . . . 0.0 111.135 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 201' ' ' ASP . 40.3 mttp -101.4 91.87 2.37 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 116.744 -1.598 . . . . 0.0 108.527 156.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -55.19 143.23 75.93 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 CA-C-N 126.453 3.34 . . . . 0.0 110.285 147.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -153.76 157.23 39.14 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.706 1.241 . . . . 0.0 111.28 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.7 tp -142.91 146.3 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.32 -165.43 25.7 Favored Glycine 0 CA--C 1.493 -1.296 0 O-C-N 119.717 -1.864 . . . . 0.0 109.283 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.26 44.22 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 121.622 -0.928 . . . . 0.0 110.536 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 -142.41 143.87 32.85 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.81 142.95 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.41 37.01 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 120.2 -1.562 . . . . 0.0 111.426 -170.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -145.47 154.2 41.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.62 43.91 11.39 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 119.827 -1.796 . . . . 0.0 111.091 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -58.69 -39.24 80.16 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.777 1.631 . . . . 0.0 114.17 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.18 -26.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 123.339 1.542 . . . . 0.0 107.349 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -87.89 172.32 9.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 120.39 -1.444 . . . . 0.0 114.449 -174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.515 ' HE1' ' HH2' ' A' ' 77' ' ' TRP . 16.5 t60 -61.65 153.89 26.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 158.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' ILE . 46.7 m -107.38 103.33 12.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 160.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.6 pt -121.48 144.74 29.59 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 128.153 2.581 . . . . 0.0 108.752 -11.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.8 -37.74 16.32 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m 52.36 32.21 10.75 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.256 1.822 . . . . 0.0 115.01 -170.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 83.6 m -70.02 125.22 26.12 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 120.213 -1.554 . . . . 0.0 112.476 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -61.64 -42.67 99.23 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.13 -40.61 90.78 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 113.338 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 m -70.67 120.67 16.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 123.219 1.485 . . . . 0.0 112.516 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.45 167.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -115.07 150.61 35.67 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 112.087 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.27 5.8 t 66.57 73.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 125.202 1.401 . . . . 0.0 113.317 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 27.1 p -130.89 154.79 47.72 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 119.864 -1.773 . . . . 0.0 111.031 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.4 m -68.48 144.09 54.76 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.965 1.306 . . . . 0.0 111.853 167.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.3 t -107.03 115.96 59.28 Favored Pre-proline 0 N--CA 1.439 -1.015 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.69 163.28 22.01 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.172 1.914 . . . . 0.0 114.463 174.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -87.54 169.01 12.56 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 122.21 1.005 . . . . 0.0 111.083 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -102.11 6.88 41.13 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.145 1.378 . . . . 0.0 110.415 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.7 162.0 48.9 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 125.721 1.608 . . . . 0.0 107.035 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.37 163.98 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.163 2.575 . . . . 0.0 115.673 161.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . 0.255 85.5 m-20 69.49 47.49 0.67 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 122.602 1.192 . . . . 0.0 114.139 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.88 -166.03 34.81 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.495 160.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.51 -23.43 62.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.275 1.83 . . . . 0.0 114.799 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.8 p -56.23 -35.21 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.886 2.074 . . . . 0.0 113.458 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.1 m -83.25 -48.75 10.13 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.091 -1.005 . . . . 0.0 109.893 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -171.21 156.26 4.63 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -122.04 138.17 54.54 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.531 -0.73 . . . . 0.0 109.973 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -115.4 131.17 57.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 O-C-N 121.384 -0.822 . . . . 0.0 108.821 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.5 p -78.58 -21.12 49.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -74.3 119.05 74.53 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.936 1.295 . . . . 0.0 112.262 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -66.17 138.19 50.77 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 123.592 2.862 . . . . 0.0 114.732 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.33 -7.9 15.16 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 122.352 1.072 . . . . 0.0 110.313 165.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 181' ' ' ASP . 4.9 t -164.06 158.75 19.77 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -64.85 -40.92 95.92 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.44 -44.09 95.54 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 182' ' ' TYR . 11.7 t70 58.4 -155.56 0.34 Allowed 'General case' 0 C--N 1.353 0.751 0 C-N-CA 125.095 1.358 . . . . 0.0 114.025 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.487 ' H ' ' CG ' ' A' ' 181' ' ' ASP . 29.9 m-85 -119.41 -32.16 4.43 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 127.191 2.196 . . . . 0.0 108.939 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -160.34 -11.13 0.05 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t -63.05 -48.19 79.77 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.522 -1.361 . . . . 0.0 112.303 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -65.46 -37.34 86.59 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 120.339 -1.476 . . . . 0.0 112.72 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 57.5 m -54.84 -36.17 64.76 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.644 1.978 . . . . 0.0 114.837 -174.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.4 pt -91.4 3.93 6.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 123.805 0.842 . . . . 0.0 111.634 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.7 17.06 11.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 120.777 -1.202 . . . . 0.0 110.243 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -90.07 -2.06 58.05 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.734 -1.229 . . . . 0.0 113.629 -171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.01 123.62 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 122.555 1.169 . . . . 0.0 112.028 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.74 108.45 3.06 Favored Glycine 0 CA--C 1.494 -1.272 0 O-C-N 120.533 -1.355 . . . . 0.0 113.194 -172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.3 159.24 35.71 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -171.22 170.15 43.05 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.93 146.36 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 mt -115.55 136.32 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.91 159.68 43.75 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.065 0.936 . . . . 0.0 108.787 172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 168.44 -167.41 40.25 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 29.2 t -134.41 127.5 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -100.11 152.05 19.24 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.02 116.96 26.05 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 132' ' ' LYS . 96.6 m-20 -68.16 130.06 41.79 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.568 1.175 . . . . 0.0 113.276 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.4 mm -103.66 -40.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.0 p -142.5 173.07 4.97 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -69.0 -6.06 17.27 Favored 'Trans proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.596 2.32 . . . . 0.0 112.827 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -115.07 -8.54 12.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.868 1.267 . . . . 0.0 114.177 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 24.3 tp -138.92 132.41 30.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 120.643 -1.285 . . . . 0.0 107.701 -168.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 235' ' ' ARG . 42.1 m -136.42 130.1 32.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.87 141.19 28.93 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 120.562 -1.336 . . . . 0.0 107.395 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -135.04 125.61 26.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.929 -1.107 . . . . 0.0 110.225 -155.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -123.41 124.45 42.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.77 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.11 179.67 42.81 Favored Glycine 0 CA--C 1.482 -1.983 0 C-N-CA 116.481 -2.771 . . . . 0.0 115.915 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -101.05 135.8 41.93 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.023 1.729 . . . . 0.0 109.49 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -124.74 98.21 5.61 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 165.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -72.2 156.35 39.24 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -141.77 130.34 22.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.14 38.99 30.42 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.461 2.304 . . . . 0.0 114.108 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.41 ' CZ3' ' HD2' ' A' ' 224' ' ' ARG . 73.4 t-105 -151.07 132.98 15.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.816 -1.177 . . . . 0.0 110.929 -176.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.21 160.58 16.29 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 128.484 2.945 . . . . 0.0 114.659 -7.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -149.6 162.03 40.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 117.245 -3.503 . . . . 0.0 107.466 2.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.2 tp -176.64 117.45 0.12 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -82.07 -21.98 36.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -86.31 158.24 19.72 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.635 -1.29 . . . . 0.0 112.372 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.1 m -41.36 115.28 0.6 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.826 2.05 . . . . 0.0 114.863 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.41 ' HD2' ' CZ3' ' A' ' 217' ' ' TRP . 26.5 mtp-105 -86.72 151.25 23.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.62 164.17 13.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.884 167.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -86.08 134.26 33.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 111.074 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 -3.26 15.84 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.371 -176.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 21' ' ' HIS 0.258 92.0 m-70 69.18 40.1 1.6 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 123.515 1.626 . . . . 0.0 111.41 -178.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -59.51 -40.97 88.84 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.2 2.2 . . . . 0.0 114.734 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.51 128.1 34.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.742 1.217 . . . . 0.0 112.441 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.8 t -156.24 148.98 23.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.552 0.692 . . . . 0.0 110.071 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 38.2 mt -82.09 155.97 24.8 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.94 1.352 . . . . 0.0 110.648 159.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.54 -159.62 9.76 Favored Glycine 0 CA--C 1.47 -2.776 0 CA-C-O 124.008 1.894 . . . . 0.0 109.025 163.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.23 147.82 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.491 ' HB2' ' HB ' ' A' ' 207' ' ' THR . 40.3 mtp180 -128.66 143.77 51.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.721 1.208 . . . . 0.0 108.269 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -145.16 147.56 32.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.05 129.61 32.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.262 1.733 0 C-N-CA 124.423 1.089 . . . . 0.0 113.615 -173.944 . . . . . . . . 0 0 . 1 stop_ save_